GLP-1 Market
LLY $1443.50 ▲ +1.1% NVO $41.63 ▲ +2.4% PFE $28.89 ▲ +0.2% VKTX $29.22 ▲ +5.9% KLRA $13.27 ▲ +0.5% GPCR $20.00 ▲ +0.8% RHHBY $60.30 ▼ -0.3%
Market data delayed up to 20 min · Source: Twelve Data
About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

Tacrolimus

Company
University of Alberta
Mechanism
Mechanism not yet reported
Route
Route not yet reported
Recruiting trials
254 recruiting

Efficacy results: Not yet reported

Find a Clinical Trial Near Me

254 recruiting studies currently listed on ClinicalTrials.gov.

Data source: ClinicalTrials.gov · trial data as of Nov 16, 2026

Find a Clinical Trial Near Me

See recruiting studies for Tacrolimus and check eligibility with the study team.

Select conditions
Match
Treatment type

"Added to GLP-1" means the investigational treatment is being studied on top of an existing GLP-1-based therapy.

Your ZIP code is only used to calculate distance to trial sites — it isn't stored.

Trial details
  • Recruiting NCT NCT00920972

    Campath/Fludarabine/Melphalan Transplant Conditioning for Non-Malignant Diseases

    Not yet reported, Not yet reported Washington University School of Medicine 220 participants Est. completion 2031-12 28 sites Stand-alone
    Other conditions: Metabolic Disorders, Hematologic, Immune, or Bone Marrow Disorders, Hemoglobinopathies, Non-malignant Disorders
    View official trial listing →
  • Recruiting NCT NCT01241864

    Islet Transplantation in Type 1 Diabetic Kidney Allograft

    Not yet reported University of Chicago 10 participants Est. completion 2026-12 1 site Stand-alone
    Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Recruiting NCT NCT01459107

    Human Upper Extremity Allotransplantation

    Not yet reported Johns Hopkins University 30 participants Est. completion 2036-06-30 1 site Stand-alone
    Other conditions: Amputation, Traumatic, Wounds and Injuries, Hand Injuries
    View official trial listing →
  • Recruiting NCT NCT01630850

    Islet Transplantation in Patients With "Brittle" Type I Diabetes

    Not yet reported University of Chicago 20 participants Est. completion 2030-06 1 site Stand-alone
    Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Recruiting NCT NCT01706692

    Swiss Dermatology Network of Targeted Therapies (SDNTT)

    Swiss Dermatology Network for Targeted Therapies 1121 participants Est. completion 2032-03-15 6 sites
    Other conditions: Psoriasis
    View official trial listing →
  • Recruiting NCT NCT01804634

    Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

    Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 60 participants Est. completion 2030-01 3 sites Stand-alone
    Other conditions: Refractory and/or Relapsed Metastatic Solid Tumors
    View official trial listing →
  • Recruiting NCT NCT01848028

    PsoBest - The German Psoriasis Registry

    Universitätsklinikum Hamburg-Eppendorf 3500 participants Est. completion 2032-12 1 site
    Other conditions: Psoriasis, Psoriatic-arthritis
    View official trial listing →
  • Recruiting NCT NCT01861106

    Allogeneic Hematopoietic Stem Cell Transplant for GATA2 Mutations

    Not yet reported National Cancer Institute (NCI) 144 participants Est. completion 2028-12-31 1 site
    Other conditions: GATA2, Immunodeficiency, MDS
    View official trial listing →
  • Recruiting NCT NCT01889381

    Human Craniomaxillofacial Allotransplantation

    Not yet reported Johns Hopkins University 15 participants Est. completion 2041-08 1 site Stand-alone
    Other conditions: Facial Injuries, Traumatic Wounds and Injuries, Craniofacial Injuries, Craniofacial Defects, Facial Transplantation, Facial Deformity
    View official trial listing →
  • Recruiting NCT NCT02029001

    Adapting Treatment to the Tumor Molecular Alterations for Patients With Advanced Solid Tumors: MyOwnSpecificTreatment

    Not yet reported Centre Leon Berard 900 participants Est. completion 2028-10 7 sites
    Other conditions: Malignant Solid Neoplasms
    View official trial listing →
  • Recruiting NCT NCT02042326

    Prospective Evaluation of the Efficacy of Sirolimus (Rapamune®) in the Treatment of Severe Arteriovenous Malformations

    Not yet reported Centre Hospitalier Universitaire, Amiens 50 participants Est. completion 2027-09 13 sites Stand-alone
    Other conditions: Arteriovenous Malformations
    View official trial listing →
  • Recruiting NCT NCT02395497

    Human Penile Allotransplantation

    Not yet reported, Not yet reported Johns Hopkins University 60 participants Est. completion 2039-06 1 site Stand-alone
    Other conditions: Amputation, Wounds and Injuries, Amputation, Traumatic, Urologic Surgical Procedures, Male, Amputation, Traumatic/Surgery, Penis/Transplantation, Penis/Surgery, Penis/Injuries, Congenital Anomaly, Male Genitalia
    View official trial listing →
  • Recruiting NCT NCT02432560

    Safety and Durability of Sirolimus for Treatment of LAM

    University of Cincinnati 600 participants Est. completion 2025-07-31 20 sites
    Other conditions: Lymphangioleiomyomatosis
    View official trial listing →
  • Recruiting NCT NCT02446431

    Metronomic Therapy for Pediatric Patients With Solid Tumors at High Risk of Recurrence

    Not yet reported Miller Children's & Women's Hospital Long Beach 20 participants Est. completion 2029-07 2 sites Stand-alone
    Other conditions: Solid Tumor
    View official trial listing →
  • Recruiting NCT NCT02846571

    Pancreatic Islet Transplantation Into the Anterior Chamber of the Eye

    Not yet reported, Not yet reported Midhat H. Abdulreda 2 participants Est. completion 2027-12-31 2 sites
    Other conditions: Diabetes
    View official trial listing →
  • Recruiting NCT NCT03097185

    Analysis of Graft Function Following Autologous Islet Transplantation

    Baylor Research Institute 100 participants Est. completion 2026-12 1 site
    Other conditions: Chronic Pancreatitis
    View official trial listing →
  • Recruiting NCT NCT03128996

    Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders

    Not yet reported, Not yet reported Washington University School of Medicine 29 participants Est. completion 2033-04 4 sites Stand-alone
    Other conditions: Severe Sickle Cell Disease, Bone Marrow Failure Syndromes, Metabolic Disorders, Immunologic Disorders, Hemoglobinopathies, Non-malignant Disorders
    View official trial listing →
  • Recruiting NCT NCT03178149

    A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration

    Not yet reported Astellas Institute for Regenerative Medicine 42 participants Est. completion 2027-12-31 20 sites Stand-alone
    Other conditions: Age-Related Macular Degeneration
    View official trial listing →
  • Recruiting NCT NCT03214354

    Nonmyeloablative Stem Cell Transplant in Children With Sickle Cell Disease and a Major ABO-Incompatible Matched Sibling Donor

    Not yet reported University of Calgary 12 participants Est. completion 2028-07 1 site Stand-alone
    Other conditions: Sickle Cell Disease, Stem Cell Transplant Complications, Red Blood Cell Disorder, Pure Red Cell Aplasia
    View official trial listing →
  • Recruiting NCT NCT03243019

    Efficacy of Rapamycin in the Treatment of Cervico-facial Lymphatic Malformations

    Not yet reported University Hospital, Lille 28 participants Est. completion 2027-02 2 sites Stand-alone
    Other conditions: Lymphatic Malformation, Pediatric
    View official trial listing →
  • Recruiting NCT NCT03297606

    Canadian Profiling and Targeted Agent Utilization Trial (CAPTUR)

    Not yet reported Canadian Cancer Trials Group 720 participants Est. completion 2027-01-31 10 sites
    Other conditions: Lymphoma, Non-Hodgkin, Multiple Myeloma, Advanced Solid Tumors
    View official trial listing →
  • Recruiting NCT NCT03314974

    Myeloablative Allo HSCT With Related or Unrelated Donor for Heme Disorders

    Not yet reported Masonic Cancer Center, University of Minnesota 300 participants Est. completion 2028-06-10 1 site Stand-alone
    Other conditions: Acute Leukemia, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Lymphoma, Chronic Myelogenous Leukemia, Plasma Cell Leukemia, Myeloproliferative Neoplasms, Myelofibrosis, Myelodysplasia, Refractory Anemia, High Risk Anemia, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Marginal Zone B-Cell Lymphoma, Follicular Lymphoma, Lymphoplasmacytic Lymphoma, Mantle-Cell Lymphoma, Prolymphocytic Leukemia, Diffuse Large Cell Non Hodgkins Lymphoma, Lymphoblastic Lymphoma, Burkitt Lymphoma, High Grade Non-Hodgkin's Lymphoma, Adult, Multiple Myeloma, Juvenile Myelomonocytic Leukemia, Biphenotypic/Undifferentiated/Prolymphocytic Leukemias, MRD Positive Leukemia, Natural Killer Cell Malignancies, Acquired Bone Marrow Failure Syndromes
    View official trial listing →
  • Recruiting NCT NCT03321656

    Impact of Envarsus XR® on Kidney Biopsy Subclinical Rejection and Blood Immunologic Profile

    Not yet reported, Not yet reported Roberto Gedaly 78 participants Est. completion 2027-03-31 1 site
    Other conditions: End Stage Renal Disease
    View official trial listing →
  • Recruiting NCT NCT03414502

    Treatment of Rheumatoid Arthritis With DMARDs: Predictors of Response

    Not yet reported University of Nebraska 400 participants Est. completion 2029-03 1 site
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Recruiting NCT NCT03443999

    S-FLEX Netherlands Registry: Prospective Evaluation of the Supraflex Family Sirolimus-eluting Coronary Stent System

    Sahajanand Medical Technologies Limited 10000 participants Est. completion 2027-12 7 sites
    Cardiovascular disease
    View official trial listing →
  • Recruiting NCT NCT03481881

    Pharmacokinetics of Drugs Administered to Children

    Duke University 200 participants Est. completion 2033-08-14 1 site
    Other conditions: Pediatric ALL
    View official trial listing →
  • Recruiting NCT NCT03500731

    Lung and Bone Marrow Transplantation for Lung and Bone Marrow Failure

    Not yet reported, Not yet reported Paul Szabolcs 8 participants Est. completion 2028-12 2 sites Stand-alone
    Other conditions: Idiopathic Pulmonary Fibrosis, Emphysema or COPD
    View official trial listing →
  • Recruiting NCT NCT03587272

    Minimizing Toxicity in HLA-identical Sibling Donor Transplantation for Children With Sickle Cell Disease

    Not yet reported Robert Nickel 100 participants Est. completion 2030-11 7 sites Stand-alone
    Other conditions: Sickle Cell Disease
    View official trial listing →
  • Recruiting NCT NCT03670966

    211At-BC8-B10 Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Acute Leukemia or Myelodysplastic Syndrome

    Not yet reported, Not yet reported Fred Hutchinson Cancer Center 30 participants Est. completion 2029-10-20 1 site Stand-alone
    Other conditions: Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Acute Myeloid Leukemia in Remission, Chronic Myelomonocytic Leukemia, Myelodysplastic Syndrome With Excess Blasts, Recurrent Acute Lymphoblastic Leukemia, Recurrent Acute Myeloid Leukemia, Refractory Acute Lymphoblastic Leukemia, Refractory Acute Myeloid Leukemia, Recurrent Mixed Phenotype Acute Leukemia, Refractory Mixed Phenotype Acute Leukemia, Hematopoietic and Lymphoid Cell Neoplasm
    View official trial listing →
  • Recruiting NCT NCT03746769

    Improving Islet Transplantation Outcomes With Gastrin for Type I Diabetes

    Not yet reported, Not yet reported City of Hope Medical Center 20 participants Est. completion 2028-08-01 1 site
    Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Recruiting NCT NCT03769298

    CIRTEN-Simultaneous Pancreas-Kidney Transplant Recipients

    Not yet reported, Not yet reported University of Wisconsin, Madison 20 participants Est. completion 2027-12 1 site Stand-alone
    Other conditions: Kidney Pancreas Transplantation
    View official trial listing →
  • Recruiting NCT NCT03827876

    Enstilar in Combination With Enbrel or Humira for Plaque Psoriasis

    Not yet reported Psoriasis Treatment Center of Central New Jersey 30 participants Est. completion 2019-12-15 1 site
    Other conditions: Psoriasis
    View official trial listing →
  • Recruiting NCT NCT03839862

    Faecal Analyses in Spondyloarthritis Therapy

    Region Skane 50 participants Est. completion 2026-12-31 1 site
    Other conditions: Spondyloarthropathies, Ankylosing Spondylitis
    View official trial listing →
  • Recruiting NCT NCT03952637

    A Phase 1/2 Study of Intravenous Gene Transfer With an AAV9 Vector Expressing Human Beta-galactosidase in Type I and Type II GM1 Gangliosidosis

    Not yet reported, Not yet reported National Human Genome Research Institute (NHGRI) 54 participants Est. completion 2030-01-01 1 site Stand-alone
    Other conditions: Lysosomal Diseases, Gangliosidosis, GM1
    View official trial listing →
  • Recruiting NCT NCT03955172

    Efficiency of Everolimus for the Treatment of Kidney Transplanted Patients Presenting a Missing Self-induced NK-mediated Rejection

    Not yet reported Hospices Civils de Lyon 20 participants Est. completion 2027-12-03 1 site Stand-alone
    Other conditions: Kidney Transplant Failure and Rejection
    View official trial listing →
  • Recruiting NCT NCT03970096

    Graft Versus Host Disease-Reduction Strategies for Donor Blood Stem Cell Transplant Patients With Acute Leukemia or Myelodysplastic Syndrome (MDS)

    Not yet reported Fred Hutchinson Cancer Center 120 participants Est. completion 2030-12-31 3 sites Stand-alone
    Other conditions: Acute Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Myelodysplastic Syndrome, Myeloproliferative Neoplasm
    View official trial listing →
  • Recruiting NCT NCT03976245

    Advanced Therapeutics in Rheumatoid Arthritis (RA)

    Not yet reported London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 144 participants Est. completion 2025-03 1 site
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Recruiting NCT NCT04022239

    Bendamustine With or Without Cyclophosphamide in Preventing GVHD in Patients Undergoing Stem Cell Transplant

    Not yet reported, Not yet reported M.D. Anderson Cancer Center 25 participants Est. completion 2027-07-31 1 site Stand-alone
    Other conditions: Hematopoietic and Lymphoid System Neoplasm
    View official trial listing →
  • Recruiting NCT NCT04022616

    Myeloid-Derived Suppressor Cell Function in Breast Cancer Patients

    Ohio State University Comprehensive Cancer Center 99 participants Est. completion 2027-12-31 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT04083183

    Total Body Irradiation and Astatine-211-Labeled BC8-B10 Monoclonal Antibody for the Treatment of Nonmalignant Diseases

    Not yet reported, Not yet reported Fred Hutchinson Cancer Center 40 participants Est. completion 2028-01-09 1 site Stand-alone
    Other conditions: Non-Malignant Neoplasm
    View official trial listing →
  • Recruiting NCT NCT04182984

    TheRapeutic Effect of Different immunosuppressAnts on Non-Thymoma Ocular Myasthenia Gravis: a Real-world Study

    Tang-Du Hospital 200 participants Est. completion 2026-06-30 1 site
    Other conditions: Ocular Myasthenia Gravis
    View official trial listing →
  • Recruiting NCT NCT04187105

    BMT-06: Study of Intensity Modulated Total Marrow Irradiation (IM-TMI)

    Not yet reported University of Illinois Chicago 27 participants Est. completion 2026-12 1 site
    Other conditions: Acute Leukemia, MDS
    View official trial listing →
  • Recruiting NCT NCT04199026

    Implantable Microdevice for the Delivery of Drugs and Their Effect on Tumors in Patients With Metastatic or Recurrent Sarcoma

    Not yet reported M.D. Anderson Cancer Center 20 participants Est. completion 2028-12-31 1 site
    Other conditions: Metastatic Sarcoma, Recurrent Sarcoma, Resectable Sarcoma
    View official trial listing →
  • Recruiting NCT NCT04232085

    Regenerative Medicine to Restore Hematopoiesis and Immune Function in Immunodeficiencies and Inherited Bone Marrow Failures

    Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 27 participants Est. completion 2028-12-31 1 site Stand-alone
    Other conditions: Primary Immune Deficiency Disorder, Immune Deficiency Disease, Bone Marrow Failure, Short Telomere Length, Fanconi Anemia, Non Fanconi DNA-DSB Repair Disorder, Hoyeraal-Hreidarsson Syndrome, Dyskeratosis Congenita, Telomere Biology Disorder, Short Telomere Syndrome
    View official trial listing →
  • Recruiting NCT NCT04302870

    Motor Neurone Disease - Systematic Multi-Arm Adaptive Randomised Trial

    Not yet reported, Not yet reported University of Edinburgh 1150 participants Est. completion 2030-12 22 sites Stand-alone
    Other conditions: Motor Neuron Disease, Amyotrophic Lateral Sclerosis
    View official trial listing →
  • Recruiting NCT NCT04314219

    Comparing Post-Transplant Cyclophosphamide As GVHD Prophylaxis to Standard of Care for Acute Leukemia Patients

    Not yet reported King Faisal Specialist Hospital & Research Center 264 participants Est. completion 2026-12 1 site Stand-alone
    Other conditions: Acute Lymphoblastic Leukemia (ALL) in Complete Remission, Acute Myeloid Leukemia (AML) in Remission
    View official trial listing →
  • Recruiting NCT NCT04339777

    Allogeneic Hematopoietic Stem Cell Transplant for Patients With Inborn Errors of Immunity

    Not yet reported National Cancer Institute (NCI) 66 participants Est. completion 2032-11-30 1 site
    Other conditions: Lymphoproliferative Disorders, Autoimmune Lymphoproliferative, Immune System Diseases, Common Variable Immunodeficiency, Primary T-cell Immunodeficiency Disorders
    View official trial listing →
  • Recruiting NCT NCT04370301

    Reduced Intensity Haploidentical Transplantation for the Treatment of Primary or Secondary Myelofibrosis

    Not yet reported Fred Hutchinson Cancer Center 20 participants Est. completion 2029-08-31 1 site Stand-alone
    Other conditions: Primary Myelofibrosis, Secondary Myelofibrosis
    View official trial listing →
  • Recruiting NCT NCT04380740

    Extended vs Short-term Abatacept Dosing for Graft Versus Host Disease Prophylaxis

    Not yet reported Boston Children's Hospital 160 participants Est. completion 2028-06 15 sites Stand-alone
    Other conditions: Graft Vs Host Disease
    View official trial listing →
  • Recruiting NCT NCT04469842

    Early Use of Long-acting Tacrolimus in Lung Transplant Recipients

    Not yet reported Vanderbilt University Medical Center 48 participants Est. completion 2027-12-31 1 site Stand-alone
    Other conditions: Lung Transplant; Complications
    View official trial listing →
  • Recruiting NCT NCT04477629

    Belatacept in De Novo Heart Transplantation

    Not yet reported NYU Langone Health 12 participants Est. completion 2026-09 2 sites Stand-alone
    Other conditions: Heart Transplantation
    View official trial listing →
  • Recruiting NCT NCT04496479

    Allogenic Hepatocyte Transplantation Into Periduodenal Lymph Nodes

    Not yet reported LyGenesis, Inc. 12 participants Est. completion 2027-12-30 2 sites Stand-alone
    Other conditions: End Stage Liver Disease
    View official trial listing →
  • Recruiting NCT NCT04526431

    Tacrolimus Pharmacokinetic Subpopulations

    University Hospital, Grenoble 180 participants Est. completion 2027-08-01 2 sites
    Other conditions: Kidney Transplant Failure and Rejection, Immunosuppression-related Infectious Disease
    View official trial listing →
  • Recruiting NCT NCT04629586

    The T1D Exchange Registry

    T1D Exchange, United States 50000 participants Est. completion 2030-12-31 1 site
    Other conditions: Diabetes Mellitus, Type 1, Diabetes, Type 1 Diabetes, Diabetes Mellitus
    View official trial listing →
  • Recruiting NCT NCT04644016

    Cord Blood Transplant in Children and Young Adults With Blood Cancers and Non-malignant Disorders

    Not yet reported Memorial Sloan Kettering Cancer Center 31 participants Est. completion 2026-12-20 1 site Stand-alone
    Other conditions: AML, ALL, MDS, MPD Withou Myelofibrosis, NHL or HL, Inherited Metabolic Disorders, Hemoglobinopathies, Bone Marrow Failure, HLH
    View official trial listing →
  • Recruiting NCT NCT04665739

    Testing Lutetium Lu 177 Dotatate in Patients With Somatostatin Receptor Positive Advanced Bronchial Neuroendocrine Tumors

    Not yet reported National Cancer Institute (NCI) 70 participants Est. completion 2032-09-01 29 sites
    Other conditions: Advanced Lung Neuroendocrine Tumor, Functioning Lung Neuroendocrine Tumor, Locally Advanced Lung Neuroendocrine Neoplasm, Lung Neuroendocrine Neoplasm, Lung Neuroendocrine Tumor G1, Lung Neuroendocrine Tumor G2, Metastatic Lung Neuroendocrine Neoplasm, Metastatic Lung Neuroendocrine Tumor, Non-Functioning Lung Neuroendocrine Tumor, Recurrent Lung Neuroendocrine Neoplasm, Unresectable Lung Neuroendocrine Neoplasm, Unresectable Lung Neuroendocrine Tumor
    View official trial listing →
  • Recruiting NCT NCT04679740

    Resorbable Magnesium Scaffolds Registry

    Biotronik AG 1106 participants Est. completion 2030-05 13 sites
    Cardiovascular disease
    View official trial listing →
  • Recruiting NCT NCT04802759

    A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Participants With Breast Cancer

    Not yet reported, Not yet reported Hoffmann-La Roche 316 participants Est. completion 2029-05-30 32 sites
    Other conditions: Inoperable, Locally Advanced or Metastatic, ER-positive Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT04871607

    Yttrium-90 Labeled Anti-CD25 Monoclonal Antibody Combined With BEAM Chemotherapy Conditioning for the Treatment of Primary Refractory or Relapsed Hodgkin Lymphoma

    Not yet reported City of Hope Medical Center 33 participants Est. completion 2029-10-02 1 site Stand-alone
    Other conditions: Recurrent Hodgkin Lymphoma, Refractory Hodgkin Lymphoma
    View official trial listing →
  • Recruiting NCT NCT04877288

    A Study to Evaluate the Benefits and Risks of Conversion of Existing Adolescent Kidney Transplant Recipients Aged 12 to <18 Years to a Belatacept-based Immunosuppressive Regimen as Compared to Continuation of a Calcineurin Inhibitor-based Regimen, and Their Adherence to Immunosuppressive Medications

    Not yet reported Bristol-Myers Squibb 102 participants Est. completion 2034-06-30 38 sites Stand-alone
    Other conditions: Renal Allograft Recipients
    View official trial listing →
  • Recruiting NCT NCT04888741

    Methods of T Cell Depletion Trial (MoTD)

    Not yet reported University of Birmingham 400 participants Est. completion 2027-08-23 17 sites Stand-alone
    Other conditions: Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelomonocytic Leukemia, Myelodysplastic Syndromes, Non Hodgkin Lymphoma, Hodgkin Lymphoma, Multiple Myeloma, Chronic Myelogenous Leukemia, Myelofibrosis
    View official trial listing →
  • Recruiting NCT NCT04923191

    The PIONEER-IV Study is Comparing Clinical Outcomes Between Angiography-derived Physiology Guidance to Usual Care in an All-comers PCI Population With Unrestrictive Use of the HT Supreme Sirolimus-eluting Stent

    Not yet reported National University of Ireland, Galway, Ireland 2540 participants Est. completion 2029-01 19 sites
    Cardiovascular disease
    View official trial listing →
  • Recruiting NCT NCT04936854

    Sirolimus vs Corticosteroids in Treatment of Thyroid Eye Disease

    Not yet reported Haukeland University Hospital 60 participants Est. completion 2028-12 1 site
    Other conditions: Thyroid-Associated Ophthalmopathy
    View official trial listing →
  • Recruiting NCT NCT04948749

    Drug Eluting Stenting and Aggressive Medical Treatment for Preventing Recurrent Stroke in Intracranial Atherosclerotic Disease Trial

    Not yet reported Beijing Tiantan Hospital 358 participants Est. completion 2027-12 18 sites Stand-alone
    Cardiovascular disease Other conditions: ICAD - Intracranial Atherosclerotic Disease, ICAS - Intracranial Atherosclerosis, Drug-eluting Stent, Drug Eluting Stents (DES), Medical Treatment
    View official trial listing →
  • Recruiting NCT NCT04959175

    Phase I/II Study to Reduce Post-transplantation Cyclophosphamide Dosing for Older or Unfit Patients Undergoing Bone Marrow Transplantation for Hematologic Malignancies

    Not yet reported, Not yet reported National Cancer Institute (NCI) 320 participants Est. completion 2027-04-30 2 sites Stand-alone
    Other conditions: Hematologic Neoplasms
    View official trial listing →
  • Recruiting NCT NCT04988685

    SIROOP Registry - A Prospective Registry Study to Evaluate the Outcomes of Coronary Artery Disease Patients Treated With SIROlimus Or Paclitaxel Eluting Balloon Catheters

    Luzerner Kantonsspital 2000 participants Est. completion 2031-12-31 1 site
    Cardiovascular disease Other conditions: Coronary Disease, Coronary Restenosis, Coronary Arteriosclerosis, Coronary Artery Calcification, Stable Chronic Angina, Angina Pectoris, Angina, Stable, Angina, Unstable, Stent Thrombosis
    View official trial listing →
  • Recruiting NCT NCT04989491

    Evaluation of the Efficacy of a Treatment by One Single Dose of Rituximab (375mg/m2 ) in the Prevention of the Epstein Barr Virus (EBV) Primary Infection and Post-transplant Lymphoproliferative Disorder in Adult EBV Seronegative Patients Who Received an EBV Seropositive Kidney Allograft

    Not yet reported University Hospital, Strasbourg, France 120 participants Est. completion 2029-12-01 1 site
    Other conditions: Epstein-Barr Virus Infections
    View official trial listing →
  • Recruiting NCT NCT05009992

    Combination Therapy for the Treatment of Diffuse Midline Gliomas

    Not yet reported University of California, San Francisco 360 participants Est. completion 2029-06-30 32 sites
    Other conditions: Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma, H3 K27M-Mutant, Recurrent Diffuse Intrinsic Pontine Glioma, Recurrent Diffuse Midline Glioma, H3 K27M-Mutant, Recurrent WHO Grade III Glioma, WHO Grade III Glioma
    View official trial listing →
  • Recruiting NCT NCT05027945

    A Phase II Study of Allogeneic Hematopoietic Stem Cell Transplant for Subjects With VEXAS (Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic) Syndrome

    Not yet reported National Cancer Institute (NCI) 54 participants Est. completion 2031-07-01 1 site Stand-alone
    Other conditions: Immunodeficiency, Hematopoietic Stem Cell Transplantation
    View official trial listing →
  • Recruiting NCT NCT05031897

    Two Step Haplo With Radiation Conditioning

    Not yet reported Thomas Jefferson University 63 participants Est. completion 2032-04 1 site Stand-alone
    Other conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Adult T-Cell Leukemia/Lymphoma, Aplastic Anemia, Chronic Lymphocytic Leukemia, Chronic Myeloid Leukemia, BCR-ABL1 Positive, Chronic Myelomonocytic Leukemia, Essential Thrombocythemia, Hematopoietic and Lymphatic System Neoplasm, Hodgkin Lymphoma, Multiple Myeloma, Myelodysplastic Syndrome, Myelofibrosis, Myeloid Neoplasm, Non-Hodgkin Lymphoma, Polycythemia Vera, Small Lymphocytic Lymphoma
    View official trial listing →
  • Recruiting NCT NCT05089604

    Tacrolimus Associated Tremors in Liver Transplantation: Immediate-Release Versus Extended-Release Formulations

    Not yet reported University of British Columbia 124 participants Est. completion 2026-12-31 1 site Stand-alone
    Other conditions: Liver Transplantation, Immunosuppression, Neurotoxicity, Tremor, Tacrolimus
    View official trial listing →
  • Recruiting NCT NCT05105152

    PLAT-08: A Study Of SC-DARIC33 CAR T Cells In Pediatric And Young Adults With Relapsed Or Refractory CD33+ AML

    Not yet reported Seattle Children's Hospital 18 participants Est. completion 2041-01-31 1 site
    Other conditions: Acute Myeloid Leukemia, Acute Myeloid Leukemia Refractory, Acute Myeloid Leukemia, in Relapse
    View official trial listing →
  • Recruiting NCT NCT05116072

    Efficacy and Safety of TPIAT for Resectable Adenocarcinoma of the Pancreas Region at High Risk of Postoperative Fistula

    Not yet reported, Not yet reported University Hospital, Lille 36 participants Est. completion 2030-02-20 1 site
    Other conditions: Adenocarcinoma of the Pancreas, Adenocarcinoma of the Duodenum, Ampullary Adenocarcinoma
    View official trial listing →
  • Recruiting NCT NCT05126849

    Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation With Post-transplant Cyclophosphamide in Patients With Acquired Refractory Aplastic Anemia or in Relapse After Immunosuppression

    Not yet reported Assistance Publique - Hôpitaux de Paris 31 participants Est. completion 2027-01-06 35 sites Stand-alone
    Other conditions: Refractory Idiopathic Aplastic Anemia, Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation
    View official trial listing →
  • Recruiting NCT NCT05144698

    RAPA-201 Therapy of Solid Tumors

    Not yet reported, Not yet reported Rapa Therapeutics LLC 37 participants Est. completion 2026-12-31 1 site
    Other conditions: Solid Tumor, Small Cell and Non-small Cell Lung Cancer, Head and Neck Cancer, Squamous Cell Carcinoma of Oral Cavity, Squamous Cell Carcinoma of Larynx, Squamous Cell Carcinoma of Nasopharynx, Squamous Cell Carcinoma of Other Specified Sites of Skin, Malignant Melanoma, Esophageal Squamous Cell Carcinoma
    View official trial listing →
  • Recruiting NCT NCT05242315

    Extended-Release Tacrolimus Following Liver Transplantation

    Not yet reported University of Alberta 94 participants Est. completion 2034-02-15 1 site
    Metabolic syndromeCardiovascular disease Other conditions: Liver Transplant; Complications, Renal Insufficiency, Immunosuppressant Adverse Reaction
    View official trial listing →
  • Recruiting NCT NCT05252754

    Rectal Indomethacin and Oral Tacrolimus Versus Combination to Prevent Post-ERCP Pancreatitis

    Not yet reported Johns Hopkins University 4874 participants Est. completion 2026-12 5 sites Stand-alone
    Other conditions: Post-ERCP Acute Pancreatitis
    View official trial listing →
  • Recruiting NCT NCT05305066

    Stand UP to Rheumatoid Arthritis (SUPRA)

    Not yet reported Marie Hudson, MD 75 participants Est. completion 2030-12 1 site
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Recruiting NCT NCT05327023

    Donor Lymphocyte Infusion After Allogeneic Hematopoietic Cell Transplantation for High-Risk Hematologic Malignancies

    Not yet reported, Not yet reported National Cancer Institute (NCI) 430 participants Est. completion 2029-07-02 1 site Stand-alone
    Other conditions: Hematologic Neoplasms
    View official trial listing →
  • Recruiting NCT NCT05356104

    GLP-1 Analogue in Preventing Progression of Small Vessel Disease (GAPP-SVD)

    Not yet reported Chinese University of Hong Kong 110 participants Est. completion 2027-12 2 sites
    Other conditions: Cerebral Small Vessel Disease
    View official trial listing →
  • Recruiting NCT NCT05365672

    Clinical Trial With Donor Modified Immune Cells in Living Donor Kidney Transplantation

    Not yet reported TolerogenixX GmbH 126 participants Est. completion 2028-12 8 sites Stand-alone
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Recruiting NCT NCT05385432

    Induction in Sensitized Kidney Transplant Recipients Without Pre-existing Donor-specific antiboDies

    Not yet reported University Hospital, Tours 244 participants Est. completion 2030-12-30 1 site Stand-alone
    Other conditions: Renal Transplant Rejection, Induction Therapy
    View official trial listing →
  • Recruiting NCT NCT05426252

    Thal-Fabs: Reduced Toxicity Conditioning for High Risk Thalassemia

    Not yet reported, Not yet reported The Hospital for Sick Children 20 participants Est. completion 2026-12-31 1 site Stand-alone
    Other conditions: Thalassemia in Children
    View official trial listing →
  • Recruiting NCT NCT05476939

    Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication 2.0

    Not yet reported Gustave Roussy, Cancer Campus, Grand Paris 433 participants Est. completion 2031-09 56 sites
    Other conditions: Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma, H3 K27M-Mutant, Diffuse Midline Glioma, H3K27-altered
    View official trial listing →
  • Recruiting NCT NCT05482789

    Exenatide Pharmacokinetics and Pharmacodynamics in Gestational Diabetes

    Not yet reported Maisa N. Feghali, MD 13 participants Est. completion 2026-12-31 1 site Stand-alone
    Other conditions: Gestational Diabetes
    View official trial listing →
  • Recruiting NCT NCT05525507

    Delayed Immunological Tolerance in Patients With Well-functioning Pre-existing HLA-matched Kidney Transplants

    Not yet reported University of California, Los Angeles 10 participants Est. completion 2026-12 1 site Stand-alone
    Chronic kidney disease Other conditions: End Stage Kidney Disease, Immunological Tolerance, Kidney Transplant Failure and Rejection
    View official trial listing →
  • Recruiting NCT NCT05549167

    Efficacy and Safety of Sirolimus in Children and Adolescents With Juvenile Nasopharyngeal Angiofibroma (JNA)

    Not yet reported Federal Research Institute of Pediatric Hematology, Oncology and Immunology 117 participants Est. completion 2029-12-30 1 site Stand-alone
    Other conditions: Juvenile Nasopharyngeal Angiofibroma
    View official trial listing →
  • Recruiting NCT NCT05562869

    Belatacept as a Replacement for CNIs 3 to 12 Months Post-transplantation in Patients With Early Graft Dysfunction

    Not yet reported Nantes University Hospital 30 participants Est. completion 2027-05-03 1 site Stand-alone
    Other conditions: Chronic Kidney Failure
    View official trial listing →
  • Recruiting NCT NCT05627960

    First in Human Phase 1 Study of AG01 Anti-Progranulin/GP88 Antibody in Advanced Solid Tumor Malignancies

    Not yet reported A&G Pharmaceutical Inc. 77 participants Est. completion 2026-11 1 site
    Other conditions: Triple Negative Breast Cancer, Hormone-Resistant Breast Cancer, Non Small Cell Lung Cancer, Mesothelioma
    View official trial listing →
  • Recruiting NCT NCT05646992

    Uterus Transplantation to Treat Infertility

    Not yet reported, Not yet reported Johns Hopkins University 40 participants Est. completion 2043-02-28 1 site Stand-alone
    Other conditions: Uterine Factor Infertility
    View official trial listing →
  • Recruiting NCT NCT05650411

    Ultrathin-strut Biodegradable Polymer Sirolimus-eluting Stents With P2Y12 Inhibitor-based Single Antiplatelet Therapy vs. Conventional DAPT for Unprotected Left Main Coronary Artery Disease (ULTIMATE-LM)

    Not yet reported IGLESIAS Juan Fernando 828 participants Est. completion 2032-05-01 1 site Stand-alone
    Other conditions: Left Main Coronary Artery Stenosis
    View official trial listing →
  • Recruiting NCT NCT05662189

    Assessment of Pancreatic Beta Cell Mass and Function by Positron Emission Tomography Imaging in Human Diabetes Mellitus

    Not yet reported Azienda Ospedaliero-Universitaria di Parma 70 participants Est. completion 2025-12 1 site
    Other conditions: Type1diabetes, Type2diabetes, Pre Diabetes, Hyperinsulinism
    View official trial listing →
  • Recruiting NCT NCT05663515

    A Pan-European Post-Authorisation Safety Study: Risk of Pancreatic Cancer Among Type 2 Diabetes Patients Who Initiated Exenatide as Compared With Those Who Initiated Other Non-Glucagon-Like Peptide 1 Receptor Agonists Based Glucose Lowering Drugs

    AstraZeneca 24000 participants Est. completion 2026-10-01 8 sites
    Other conditions: Pancreatic Cancer
    View official trial listing →
  • Recruiting NCT NCT05692882

    A Registry Study of Intracranial Atherosclerotic Stenosis Treatment by Intracranial Drug-eluting Stenting in China

    Not yet reported Sino Medical Sciences Technology Inc. 1000 participants Est. completion 2029-12-30 5 sites Stand-alone
    Other conditions: Intracranial Arteriosclerosis, Stenosis Artery, Drug-Eluting Stents, Intracranial Artery Stenosis
    View official trial listing →
  • Recruiting NCT NCT05726305

    Transplantation of Uterus for Uterine infertiLIty From Living Donor or Deceased Donor

    Not yet reported Rennes University Hospital 16 participants Est. completion 2037-12 1 site Stand-alone
    Other conditions: Uterine Factor Infertility
    View official trial listing →
  • Recruiting NCT NCT05736419

    A Study of Immune Suppression Treatment for People With Sickle Cell Disease or β-Thalassemia Who Are Going to Receive an Allogeneic Hematopoietic Cell Transplantation (HCT)

    Not yet reported Memorial Sloan Kettering Cancer Center 24 participants Est. completion 2027-02-09 6 sites Stand-alone
    Other conditions: Sickle Cell Disease, Thalassemia, Beta, Thalassemia
    View official trial listing →
  • Recruiting NCT NCT05773274

    Comparing Retreatment of 177Lu-DOTATATE PRRT Versus the Usual Treatment in Patients With Metastatic Unresectable Gastroenteropancreatic Neuroendocrine Tumors, NET RETREAT Trial

    Not yet reported National Cancer Institute (NCI) 100 participants Est. completion 2029-04-30 43 sites
    Other conditions: Metastatic Digestive System Neuroendocrine Tumor G1, Metastatic Digestive System Neuroendocrine Tumor G2, Unresectable Digestive System Neuroendocrine Tumor G1, Unresectable Digestive System Neuroendocrine Tumor G2
    View official trial listing →
  • Recruiting NCT NCT05807932

    Venetoclax in Addition to Sequential Conditioning With Fludarabine / Amsacrine / Ara-C (FLAMSA) + Treosulfan for Allogeneic Blood Stem Cell Transplantation in Patients With MDS, CMML or sAML

    Not yet reported, Not yet reported Heinrich-Heine University, Duesseldorf 38 participants Est. completion 2029-04-30 6 sites Stand-alone
    Other conditions: Myelodysplastic Syndromes, Secondary Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia
    View official trial listing →
  • Recruiting NCT NCT05908331

    MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions

    Not yet reported Concept Medical Inc. 492 participants Est. completion 2028-07 28 sites Stand-alone
    Cardiovascular disease Other conditions: In-Stent Restenosis
    View official trial listing →
  • Recruiting NCT NCT05917522

    Assessment of Biomarker-Guided CNI Substitution In Kidney Transplantation

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 800 participants Est. completion 2029-07 15 sites Stand-alone
    Other conditions: Kidney Transplant
    View official trial listing →
  • Recruiting NCT NCT05918302

    Efficacy and Safety of Radiotherapy Compared to Everolimus in Somatostatin Receptor Positive Neuroendocrine Tumors of the Lung and Thymus.

    Not yet reported Grupo Espanol de Tumores Neuroendocrinos 170 participants Est. completion 2029-10 27 sites
    Other conditions: Neuroendocrine Tumors, Lung Neuroendocrine Neoplasm, Thymus Neoplasms
    View official trial listing →
  • Recruiting NCT NCT05925023

    Sirolimus in the Treatment of Refractory/Relapsed wAIHA

    Not yet reported Peking Union Medical College Hospital 22 participants Est. completion 2025-12 1 site Stand-alone
    Other conditions: Warm Autoimmune Hemolytic Anemia
    View official trial listing →
  • Recruiting NCT NCT05933395

    Genetically-informed Therapy for ER+ Breast Cancer Post-CDK4/6 Inhibitor

    Not yet reported Dartmouth-Hitchcock Medical Center 135 participants Est. completion 2031-10 1 site
    Other conditions: Advanced Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT05949541

    Efficacy of Everolimus Combined With First-line Endocrine Therapy for HR+/HER2- SNF1-subtype Advanced Breast Cancer

    Not yet reported Fudan University 265 participants Est. completion 2028-01 1 site
    Other conditions: Breast Cancer, Advanced Breast Cancer
    View official trial listing →
  • Recruiting NCT NCT05983107

    Chidamide/Everolimus for PIK3CA Wild-type/Mutant HR+/HER2- Advanced Breast Cancer

    Not yet reported Cancer Institute and Hospital, Chinese Academy of Medical Sciences 102 participants Est. completion 2027-07-15 1 site
    Other conditions: HR+/HER2- Advanced Breast Cancer, Targeted Therapy
    View official trial listing →
  • Recruiting NCT NCT05998759

    Telitacicept for the Treatment of Connective Tissue Disease-associated Thrombocytopenia

    Not yet reported Beijing Hospital 296 participants Est. completion 2025-12 23 sites Stand-alone
    Other conditions: Connective Tissue Diseases, Thrombocytopenia
    View official trial listing →
  • Recruiting NCT NCT06011889

    Study of the Efficacy and Safety of Etanercept Treatment in Patients With SAPHO Syndrome

    Not yet reported, Not yet reported National Institute of Geriatrics, Rheumatology and Rehabilitation, Poland 60 participants Est. completion 2028-10-18 1 site Stand-alone
    Other conditions: SAPHO Syndrome
    View official trial listing →
  • Recruiting NCT NCT06018766

    LAM-001 in Lung Transplant Recipients With Bronchiolitis Obliterans Syndrome.

    Not yet reported Steven Hays, MD 30 participants Est. completion 2026-12 1 site
    Other conditions: Bronchiolitis Obliterans Syndrome, Chronic Lung Allograft Dysfunction, Lung Transplantation
    View official trial listing →
  • Recruiting NCT NCT06033196

    Tocilizumab in Lung Transplantation

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 100 participants Est. completion 2029-01-08 21 sites Stand-alone
    Other conditions: Lung Transplant
    View official trial listing →
  • Recruiting NCT NCT06055608

    Advancing Transplantation Outcomes in Children

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 200 participants Est. completion 2028-06-30 21 sites Stand-alone
    Other conditions: Kidney Transplant
    View official trial listing →
  • Recruiting NCT NCT06066450

    Efficacy of OSFIT Drug-Eluting Stent in Coronary Ostial Artery Stenosis

    Genoss Co., Ltd. 1000 participants Est. completion 2026-12-31 1 site
    Cardiovascular disease Other conditions: Drug-eluting Stent
    View official trial listing →
  • Recruiting NCT NCT06075433

    Efficacy and Safety of 1-year Duration of DAPT After GENOSS® DES Implantation in Patients with Coronary Artery Disease According to the Complex Higher-risk Procedure

    Genoss Co., Ltd. 1000 participants Est. completion 2027-12-31 1 site
    Cardiovascular disease Other conditions: Percutaneous Coronary Intervention, Dual Antiplatelet Therapy
    View official trial listing →
  • Recruiting NCT NCT06092034

    A Gene Therapy Study of RP-A501 in Male Patients With Danon Disease

    Not yet reported Rocket Pharmaceuticals Inc. 18 participants Est. completion 2032-06 6 sites Stand-alone
    Other conditions: Danon Disease
    View official trial listing →
  • Recruiting NCT NCT06126588

    Combination of Everolimus and 177Lu-DOTATATE in the Treatment of Grades 2 and 3 Refractory Meningioma: a Phase IIb Clinical Trial

    Not yet reported Central Hospital, Nancy, France 28 participants Est. completion 2028-05-01 2 sites
    Other conditions: Meningioma
    View official trial listing →
  • Recruiting NCT NCT06128070

    Ruxolitinib With Tacrolimus and Methotrexate for the Prevention of Graft Versus Host Disease in Pediatric and Young Adult Patients Undergoing Allogeneic Hematopoietic Cell Transplant for Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Myelodysplastic Syndrome

    Not yet reported City of Hope Medical Center 40 participants Est. completion 2030-11-22 1 site Stand-alone
    Other conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Myelodysplastic Syndrome
    View official trial listing →
  • Recruiting NCT NCT06182397

    Sirolimus Coated BALloon Versus Standard Balloon Angioplasty in The Treatment of Below The Knee Arterial Disease

    Not yet reported Concept Medical Inc. 368 participants Est. completion 2031-02-01 29 sites
    Other conditions: Arterial Disease of Legs, Below-the-knee Obstruction, PAD - Peripheral Arterial Disease
    View official trial listing →
  • Recruiting NCT NCT06183892

    Prospective, Multicenter Clinical Study of Prolonged-release Tacrolimus in Stable Pediatric Liver Transplant Recipients

    Not yet reported RenJi Hospital 80 participants Est. completion 2026-07-01 1 site Stand-alone
    Other conditions: Liver Transplant
    View official trial listing →
  • Recruiting NCT NCT06211790

    Proteomic Guided First-line Precision Treatment of Renal Clear Cell Carcinoma

    Not yet reported Fudan University 66 participants Est. completion 2026-12-30 1 site
    Other conditions: Kidney Cancer, Renal Cell Carcinoma, Renal Clear Cell Carcinoma
    View official trial listing →
  • Recruiting NCT NCT06235892

    Tacrolimus Minimization in Kidney Transplant Recipients Selected According to the AGORA Algorithm for Their Low Immunological Risk and Medium-term Graft Failure

    Not yet reported Nantes University Hospital 300 participants Est. completion 2028-12-10 3 sites Stand-alone
    Other conditions: Organ Grafts
    View official trial listing →
  • Recruiting NCT NCT06254248

    Safety of Atezolizumab-Bevacizumab in Liver Transplanted Patients With Advanced Hepatocellular Carcinoma

    Not yet reported Assistance Publique - Hôpitaux de Paris 50 participants Est. completion 2030-01-01 10 sites Stand-alone
    Other conditions: Liver Transplant, Hepatocellular Carcinoma Recurrent, Systemic Treatment
    View official trial listing →
  • Recruiting NCT NCT06261060

    Low-Dose Sirolimus to Increase Hematopoietic Function in Patients With RUNX1 Familial Platelet Disorder

    Not yet reported M.D. Anderson Cancer Center 10 participants Est. completion 2028-06-11 1 site Stand-alone
    Other conditions: Familial Platelet Disorder, Hematopoietic
    View official trial listing →
  • Recruiting NCT NCT06265584

    Trial of 2 Step ATG for Prevention of Acute GVHD Post Allogeneic Stem Cell Transplant

    Not yet reported University of Alabama at Birmingham 56 participants Est. completion 2028-11 1 site Stand-alone
    Other conditions: Acute Leukemia, Myelodysplastic Syndrome, Myeloproliferative Disorders
    View official trial listing →
  • Recruiting NCT NCT06280950

    Expanding Liver Transplant Immunosuppression Minimization Via Everolimus

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 340 participants Est. completion 2030-06-30 12 sites Stand-alone
    Other conditions: Liver Transplant
    View official trial listing →
  • Recruiting NCT NCT06287944

    225Ac-DOTA-Anti-CD38 Daratumumab Monoclonal Antibody With Fludarabine, Melphalan and Total Marrow and Lymphoid Irradiation as Conditioning Treatment for Donor Stem Cell Transplant in Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia and Myelodysplastic Syndrome

    Not yet reported City of Hope Medical Center 15 participants Est. completion 2029-05-19 1 site Stand-alone
    Other conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Myelodysplastic Syndrome
    View official trial listing →
  • Recruiting NCT NCT06315309

    Trial of 2 Step ATG for Acute GVHD Prevention Post Myeloablative Allogeneic Stem Cell Transplant

    Not yet reported University of Alabama at Birmingham 29 participants Est. completion 2027-05 1 site Stand-alone
    Other conditions: GVHD,Acute, Acute Leukemia, Myelodysplastic Syndromes, Myeloproliferative Disorders
    View official trial listing →
  • Recruiting NCT NCT06325709

    Base Editing for Mutation Repair in Hematopoietic Stem & Progenitor Cells for X-Linked Chronic Granulomatous Disease

    Not yet reported, Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 15 participants Est. completion 2032-12-31 1 site Stand-alone
    Other conditions: Chronic Granulomatous Disease (CGD), X-Linked Chronic Granulomatous Disease
    View official trial listing →
  • Recruiting NCT NCT06326190

    177Lu-DOTATATE for Recurrent Meningioma

    Not yet reported European Organisation for Research and Treatment of Cancer - EORTC 136 participants Est. completion 2028-12-22 19 sites
    Other conditions: Recurrent Meningioma
    View official trial listing →
  • Recruiting NCT NCT06345495

    High Dose Ruxolitinib and Allogeneic Stem Cell Transplantation in Myelofibrosis Patients With Splenomegaly

    Not yet reported M.D. Anderson Cancer Center 30 participants Est. completion 2029-01-01 1 site Stand-alone
    Other conditions: Splenomegaly, Myelofibrosis
    View official trial listing →
  • Recruiting NCT NCT06354179

    Evaluation of the Benefits of Administering Immunosuppressive Drugs as Single Daily Doses Over the First Year After Liver Transplantation (EASY)

    Not yet reported University Hospital, Limoges 162 participants Est. completion 2028-04-15 18 sites Stand-alone
    Other conditions: Liver Transplantation, Immunosuppression
    View official trial listing →
  • Recruiting NCT NCT06358638

    Sickle Cell Disease Transplant Using a Nonmyeloablative Approach for Patients With Anti-donor Red Cell Antibody

    Not yet reported Children's National Research Institute 12 participants Est. completion 2054-09 1 site Stand-alone
    Other conditions: Sickle Cell Disease
    View official trial listing →
  • Recruiting NCT NCT06394232

    Safety & Efficacy of Eyecyte-RPE™ in Patients With Geographic Atrophy Secondary to Dry Age-related Macular Degeneration.

    Not yet reported, Not yet reported Eyestem Research Pvt. Ltd. 54 participants Est. completion 2030-12 3 sites
    Other conditions: Retinal Disease, Macular Degeneration, Age-Related Macular Degeneration, Geographic Atrophy, Eye Diseases
    View official trial listing →
  • Recruiting NCT NCT06412250

    A Multicenter Observational Registry to Evaluate Safety and Performance of Vivo ISAR (SECURE Global Registry)

    Translumina Therapeutics Pvt Ltd. 2000 participants Est. completion 2027-11 32 sites
    Cardiovascular disease
    View official trial listing →
  • Recruiting NCT NCT06412497

    MT2023-20: Hematopoietic Cell Transplant With Reduced Intensity Conditioning and Post-transplant Cyclophosphamide for Severe Aplastic Anemia and Other Forms of Acquired Bone Marrow Failure.

    Not yet reported Masonic Cancer Center, University of Minnesota 60 participants Est. completion 2036-05-01 1 site Stand-alone
    Other conditions: Severe Aplastic Anemia, Acquired Amegakaryocytic Thrombocytopenia, Acquired Pure Red Cell Aplasia, Paroxysmal Nocturnal Hemoglobinuria
    View official trial listing →
  • Recruiting NCT NCT06420505

    Evaluation of the Vivo Isar Stent System in Routine Clinical Practice

    Translumina GmbH 3000 participants Est. completion 2027-01-01 19 sites
    Other conditions: Artery Coronary Stenosis
    View official trial listing →
  • Recruiting NCT NCT06437574

    Intensive Cholesterol-Lowering and CD8+ T Cells in Prostate Cancer

    Not yet reported Cedars-Sinai Medical Center 140 participants Est. completion 2028-05-31 1 site
    Other conditions: Prostate Cancer
    View official trial listing →
  • Recruiting NCT NCT06472388

    Everolimus 5 mg vs 10 mg/Daily for Patients With Neuroendocrine Tumors

    Not yet reported AC Camargo Cancer Center 100 participants Est. completion 2026-12-31 2 sites
    Other conditions: Neuroendocrine Tumors, Progression, Neuroendocrine Tumor Grade 1, Neuroendocrine Tumor Grade 2, Neuroendocrine Tumor of Pancreas, Neuroendocrine Tumor of the Lung, Neuroendocrine Tumor Carcinoid
    View official trial listing →
  • Recruiting NCT NCT06478017

    Belatacept in Heart Transplantation

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 66 participants Est. completion 2028-01-31 8 sites Stand-alone
    Other conditions: Heart Transplant
    View official trial listing →
  • Recruiting NCT NCT06482086

    Efficacy of Organoid-Based Drug Screening to Guide Treatment for Locally Advanced Thyroid Cancer

    Not yet reported West China Hospital 75 participants Est. completion 2025-12-01 1 site
    Other conditions: Locally Advanced Thyroid Gland Carcinoma
    View official trial listing →
  • Recruiting NCT NCT06517641

    Clinical Trial of Upfront Haploidentical or Unrelated Donor BMT to Restore Normal Hematopoiesis in Aplastic Anemia

    Not yet reported Medical College of Wisconsin 60 participants Est. completion 2029-02-01 25 sites
    Other conditions: Severe Aplastic Anemia
    View official trial listing →
  • Recruiting NCT NCT06529536

    Utilising Genotype Informed Bayesian Dosing of Tacrolimus in Children Post Solid Organ Transplantation.

    Not yet reported Murdoch Childrens Research Institute 45 participants Est. completion 2027-08-02 1 site Stand-alone
    Other conditions: Solid Organ Transplant
    View official trial listing →
  • Recruiting NCT NCT06551584

    Trial for Patients w/ Advanced Hematologic Malignancies Undergoing Allogeneic HCT

    Not yet reported Stanford University 24 participants Est. completion 2026-12 1 site Stand-alone
    Other conditions: Acute Myeloid Leukemia, Acute Lymphoid Leukemia, Mixed Phenotype Acute Leukemia, Myelodysplastic Syndromes
    View official trial listing →
  • Recruiting NCT NCT06551662

    DCB vs. DES in Bifurcation Coronary Lesions

    Not yet reported Fondazione Ricerca e Innovazione Cardiovascolare ETS 321 participants Est. completion 2028-02-01 17 sites Stand-alone
    Cardiovascular disease Other conditions: DCB
    View official trial listing →
  • Recruiting NCT NCT06552169

    REgulatory T Cell Therapy to Achieve Immunosuppression REduction

    Not yet reported Singulera Therapeutics Inc. 34 participants Est. completion 2031-12 7 sites Stand-alone
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Recruiting NCT NCT06575426

    A Study to Investigate Safety and Effectiveness of Porcine Pancreatic Cells (OPF-310) in Patients With Type 1 Diabetes Mellitus

    Not yet reported, Not yet reported Otsuka Pharmaceutical Factory, Inc. 13 participants Est. completion 2027-06-30 1 site
    Other conditions: Diabetes Mellitus, Type 1, Hypoglycemia, Islet Cell Transplantation, Type 1 Diabetes, Type 1 Diabetes Mellitus, T1D, T1DM, T1DM - Type 1 Diabetes Mellitus, Type 1 Diabetes (T1D), Severe Hypoglycemia, Xenotransplantation, Hypoglycemic Episode, Islet Transplantation in Diabetes Mellitus Type 1, Glucose Metabolism Disorders (Including Diabetes Mellitus), Immune System Diseases, Autoimmune Diseases, Metabolic Disease
    View official trial listing →
  • Recruiting NCT NCT06585384

    Safety of a Strategy Combining Etanercept Administration With Repeated Contrast Ultrasound in Patients With Alzheimer's Disease

    Not yet reported Fondation Ophtalmologique Adolphe de Rothschild 5 participants Est. completion 2028-12 1 site Stand-alone
    Other conditions: Alzheimer Disease
    View official trial listing →
  • Recruiting NCT NCT06591884

    Evaluation of the Efficacy of 0.08% Tacrolimus Nanoencapsulated Aqueous Solution Spray Vs. 0.1% Free Tacrolimus Commercial Ointment in the Treatment of Oral Lichen Planus

    Not yet reported, Not yet reported Hospital de Clinicas de Porto Alegre 46 participants Est. completion 2028-12 1 site Stand-alone
    Other conditions: Oral Erosive Lichen Planus
    View official trial listing →
  • Recruiting NCT NCT06615050

    A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)

    Not yet reported Incyte Corporation 572 participants Est. completion 2031-01-17 30 sites Stand-alone
    Other conditions: Graft-versus-host Disease (GVHD)
    View official trial listing →
  • Recruiting NCT NCT06618248

    Efficacy and Safety of Sirolimus-Coated Spiral Balloon for Coronary Bifurcation Lesions

    Not yet reported Dongguan TT Medical 280 participants Est. completion 2027-03 1 site Stand-alone
    Other conditions: Coronary Bifurcation Lesion
    View official trial listing →
  • Recruiting NCT NCT06646497

    Indication of HSCT in Patients With Refractory/Relapse AA After First-line Standard Immunosuppressive Therapy Aged More Than 40 Years

    Not yet reported Assistance Publique - Hôpitaux de Paris 52 participants Est. completion 2030-01-24 26 sites Stand-alone
    Other conditions: Aplastic Anemia
    View official trial listing →
  • Recruiting NCT NCT06654882

    Trial of Sequential Medications AfteR TNFi Failure in Juvenile Idiopathic Arthritis

    Not yet reported Duke University 400 participants Est. completion 2029-11 7 sites
    Other conditions: Polyarticular Course Juvenile Idiopathic Arthritis (JIA)
    View official trial listing →
  • Recruiting NCT NCT06663696

    CRUZ Tunisia-Multivessel Registry

    Sahajanand Medical Technologies Limited 1000 participants Est. completion 2028-05 2 sites
    Other conditions: Patient Population With Multivessel Disease
    View official trial listing →
  • Recruiting NCT NCT06676696

    Study to Compare the Outcome of Receiving Continued Immunosuppression Versus Stopping Immunosuppression at 6 Months to Safely Prevent Human Leukocyte Antigen (HLA) Sensitization in Patients With Late Renal Graft Failure

    Not yet reported Hospital Universitari Vall d'Hebron Research Institute 202 participants Est. completion 2028-01-31 1 site
    Other conditions: Renal Failure , Chronic, Graft Failure, Graft Rejection, Allograft, Renal Failure Chronic Requiring Dialysis
    View official trial listing →
  • Recruiting NCT NCT06692426

    Trial of Cell Based Therapy for DMD

    Not yet reported Masonic Cancer Center, University of Minnesota 8 participants Est. completion 2027-03-03 1 site Stand-alone
    Other conditions: Duchenne Muscular Dystrophy
    View official trial listing →
  • Recruiting NCT NCT06701825

    Effectiveness and Cost-effectiveness of a Pre-emptive Genotyping Strategy in Patients Receiving Tacrolimus

    Not yet reported Instituto de Investigación Hospital Universitario La Paz 114 participants Est. completion 2026-12-31 1 site Stand-alone
    Other conditions: Kidney Disease, Chronic, Transplant Recipient (Kidney), Immunosuppression
    View official trial listing →
  • Recruiting NCT NCT06705062

    Study Comparing Reduced Versus Standard Dose Post-transplantation Cyclophosphamide in Combination With Post-engraftment Anti-thymoglobin as Graft Versus Host Disease Prophylaxis in Alternative Donor Peripheral Stem Cell Transplantation

    Not yet reported Shanghai Jiao Tong University School of Medicine 316 participants Est. completion 2028-07-01 1 site Stand-alone
    Other conditions: Allogeneic Hematopoietic Cell Transplant, Graft Versus Host Disease
    View official trial listing →
  • Recruiting NCT NCT06707194

    Effect and Safety of Benzathine Penicillin Combined With Etanercept on Spondyloarthritis

    Not yet reported Nanfang Hospital, Southern Medical University 340 participants Est. completion 2027-07-31 6 sites Stand-alone
    Other conditions: Spondyloarthritis (SpA), Ankylosing Spondylitis (AS)
    View official trial listing →
  • Recruiting NCT NCT06710210

    Hybrid Percutaneous Coronary Intervention Combining a Bioresorbable Scaffold With Drug-coated Balloons Versus a Conventional Drug-eluting Stent-based Strategy in Patients With Long and Diffuse Coronary Artery Disease

    Not yet reported University Hospital, Geneva 150 participants Est. completion 2028-04-01 4 sites Stand-alone
    Cardiovascular disease Other conditions: Percutaneous Coronary Intervention (PCI)
    View official trial listing →
  • Recruiting NCT NCT06719024

    Topical Ruxolitinib for Face and Neck Vitiligo of Adult Chinese Patients Refractory to Topical Tacrolimus

    Not yet reported, Not yet reported Hospital Authority, Hong Kong 20 participants Est. completion 2026-01-30 1 site
    Other conditions: Vitiligo
    View official trial listing →
  • Recruiting NCT NCT06719791

    Sirolomus Adjuvant Treatment of Focal Refractory Epilepsy (SATFRE)

    Not yet reported Xuanwu Hospital, Beijing 15 participants Est. completion 2028-12-01 1 site Stand-alone
    Other conditions: Epilepsy, Drug Resistant
    View official trial listing →
  • Recruiting NCT NCT06722586

    Sirolimus Monotherapy in the Treatment of Antiphospholipid Antibody Related Thrombocytopenia

    Not yet reported Peking University First Hospital 84 participants Est. completion 2027-12 10 sites Stand-alone
    Other conditions: Antiphospholipid (aPL)-Positive, Thrombocytopaenia
    View official trial listing →
  • Recruiting NCT NCT06731504

    HMCT/CT2401: Abatacept GVHD Prophylaxis Following Omidubicel HCT

    Not yet reported Duke University 10 participants Est. completion 2028-07 1 site Stand-alone
    Other conditions: Hematologic Malignancy
    View official trial listing →
  • Recruiting NCT NCT06751199

    UCMSCs Combined With Allogeneic Islet Transplantation for the Treatment of Diabetes

    Not yet reported Shanghai Changzheng Hospital 16 participants Est. completion 2026-12-01 1 site
    Other conditions: Diabetes
    View official trial listing →
  • Recruiting NCT NCT06751992

    Neurocognitive Function Changes With Extended-Release Tacrolimus Among Older Kidney Transplant Recipients

    Not yet reported Massachusetts General Hospital 92 participants Est. completion 2027-10-01 1 site Stand-alone
    Other conditions: Kidney Transplant Recipients, Old Age
    View official trial listing →
  • Recruiting NCT NCT06777719

    Eight-Treg Study:Trial of Adoptive Immunotherapy With Autologous ex Vivo Expanded Regulatory CD8+ T Cells in Living Donor Kidney Transplant Recipients

    Not yet reported Nantes University Hospital 9 participants Est. completion 2027-05-18 1 site Stand-alone
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Recruiting NCT NCT06779630

    Safety and Effectiveness of the Orsiro Mission 48-mm Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions

    Not yet reported Teleflex 150 participants Est. completion 2031-09 23 sites Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Recruiting NCT NCT06799195

    Optimizing GVHD Prophylaxis After Allogeneic Hematopoietic Cell Transplantation

    Not yet reported University of Nebraska 126 participants Est. completion 2031-11 1 site Stand-alone
    Other conditions: Hematological Malignancies, Graft-versus-Host Disease (GVHD)
    View official trial listing →
  • Recruiting NCT NCT06802315

    Intensity Modulated Total Marrow Irradiation in Fully Human Leukocyte Antigen (HLA)-Matched and Partially-HLA Mismatched Allogeneic Transplantation Patients With High-Risk Acute Myeloid Leukemia (AML), Chronic Myeloid Leukemia (CML), and Myelodysplastic Syndrome (MDS)

    Not yet reported University of Illinois Chicago 38 participants Est. completion 2032-03 1 site Stand-alone
    Other conditions: Acute Myeloid Leukemia, Relapsed, Adult, Acute Myeloid Leukemia Refractory, Chronic Myeloid Leukemia - Accelerated Phase, Myelodysplastic Syndromes
    View official trial listing →
  • Recruiting NCT NCT06807606

    Optimized Cord Blood Transplantation for the Treatment of Patients With High-risk Hematologic Malignancies Who Have Relapsed After First Allogeneic Stem Cell Transplantation

    Not yet reported M.D. Anderson Cancer Center 35 participants Est. completion 2029-11-30 1 site Stand-alone
    Other conditions: Hematologic Malignancies
    View official trial listing →
  • Recruiting NCT NCT06815003

    Vedolizumab Plus Post-transplant Cyclophosphamide and Short Course Tacrolimus for the Prevention of Graft Versus Host Disease in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation After Reduced Intensity Conditioning

    Not yet reported City of Hope Medical Center 35 participants Est. completion 2028-10-15 1 site Stand-alone
    Other conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, Graft Versus Host Disease, Myelodysplastic Syndrome, Myeloproliferative Neoplasm
    View official trial listing →
  • Recruiting NCT NCT06822712

    Efficacy and Safety of Sirolimus-coated Coronary Balloon Dilatation Catheter for De Novo Coronary Bifurcation Lesions

    Not yet reported BrosMed Medical Co., Ltd 250 participants Est. completion 2026-06 1 site Stand-alone
    Other conditions: Coronary Arterial Disease (CAD)
    View official trial listing →
  • Recruiting NCT NCT06828796

    Early Use of Tacrolimus in HLA-Mismatched Haploidentical Allogeneic Hematopoietic Transplantation With Post-Transplant Cyclophosphamide

    Not yet reported Northside Hospital, Inc. 20 participants Est. completion 2028-06-30 1 site Stand-alone
    Other conditions: Hematologic Disease and Disorders, Hematopoietic Cell Transplant
    View official trial listing →
  • Recruiting NCT NCT06829719

    TTV-based mAnagement Of Long-term ImmunosuppreSsion in Kidney Transplantation

    Not yet reported Hospices Civils de Lyon 600 participants Est. completion 2031-02-02 4 sites Stand-alone
    Other conditions: Infection, Cancer, Rejection, Kidney Transplantation
    View official trial listing →
  • Recruiting NCT NCT06832189

    EVR and EPO for Liver Transplant Tolerance

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 20 participants Est. completion 2030-06-01 3 sites Stand-alone
    Other conditions: Liver Transplant
    View official trial listing →
  • Recruiting NCT NCT06833463

    Tacrolimus and Risk Factors for Glucose Metabolism Disorders in Kidney Transplant Patients

    Chiesi Poland Sp. z o.o. 120 participants Est. completion 2028-01-30 6 sites
    Other conditions: Kidney Transplant
    View official trial listing →
  • Recruiting NCT NCT06857058

    Standardized Procedure for Intracranial Drug-Eluting Stenting in the Treatment of Intracranial Atherosclerotic Stenosis

    Not yet reported Sino Medical Sciences Technology Inc. 300 participants Est. completion 2026-06-08 1 site Stand-alone
    Other conditions: Intracranial Atherosclerotic Stenosis
    View official trial listing →
  • Recruiting NCT NCT06859424

    A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation

    Not yet reported Center for International Blood and Marrow Transplant Research 358 participants Est. completion 2028-06 13 sites Stand-alone
    Other conditions: AML (Acute Myelogenous Leukemia), Acute Lymphoid Leukemia (ALL), Acute Leukemia (Category), MDS (Myelodysplastic Syndrome), CML (Chronic Myelogenous Leukemia), CLL (Chronic Lymphocytic Leukemia), Prolymphocyctic Leukemia, Chronic Myelomonocytic Leukemia (CMML), Myeloproliferative Neoplasm (MPN), Lymphoma, Myelofibrosis
    View official trial listing →
  • Recruiting NCT NCT06872333

    Allo HSCT for High Risk Hemoglobinopathies

    Not yet reported Masonic Cancer Center, University of Minnesota 62 participants Est. completion 2032-06-01 1 site Stand-alone
    Other conditions: Graft Failure, Sickle Cell Disease, Hemoglobinopathies
    View official trial listing →
  • Recruiting NCT NCT06900777

    Oral Tacrolimus vs Dexamethasone Micro-pulse Therapy in Pediatric Rapidly Progressing Vitiligo: A Multicenter RCT

    Not yet reported Xijing Hospital 90 participants Est. completion 2026-04-01 1 site Stand-alone
    Other conditions: Vitiligo, Child, Progressive Disease
    View official trial listing →
  • Recruiting NCT NCT06918990

    Treatment of Antibody-Mediated Rejection (ABMR) With CarBel

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 25 participants Est. completion 2027-06-30 11 sites Stand-alone
    Other conditions: Kidney Transplant Rejection
    View official trial listing →
  • Recruiting NCT NCT06926595

    Allogeneic HSCT With Low-Dose Post-Transplant Cyclophosphamide for GVHD Prevention

    Not yet reported Milton S. Hershey Medical Center 41 participants Est. completion 2031-11-01 1 site Stand-alone
    Other conditions: Graft-versus-Host Disease (GVHD), Hematologic Malignancies, Allogeneic Stem Cell Transplantation
    View official trial listing →
  • Recruiting NCT NCT06943755

    Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors

    Not yet reported, Not yet reported Exelixis 440 participants Est. completion 2029-06-30 135 sites
    Other conditions: Pancreatic Neuroendocrine Tumor (pNET), Extra-Pancreatic Neuroendocrine Tumor (epNET)
    View official trial listing →
  • Recruiting NCT NCT06950385

    Phase 3 Trial of eRapa in Patients With Familial Adenomatous Polyposis

    Not yet reported Rapamycin Holdings Inc. 168 participants Est. completion 2031-01 29 sites
    Other conditions: Familial Adenomatous Polyposis (FAP)
    View official trial listing →
  • Recruiting NCT NCT06962800

    A Study to Learn More About the Effects and Safety of Felzartamab Infusions in Adults With Primary Membranous Nephropathy (PMN)

    Not yet reported Biogen 180 participants Est. completion 2031-01-17 117 sites Stand-alone
    Other conditions: Primary Membranous Nephropathy
    View official trial listing →
  • Recruiting NCT NCT06973668

    A Randomized Study to Compare Post-transplant Cyclophosphamide, Sirolimus, Ruxolitinib and Post-transplant Cyclophosphamide, Sirolimus, Mycophenolate Mofetil to Prevent Graft Versus Host Disease

    Not yet reported M.D. Anderson Cancer Center 80 participants Est. completion 2030-01-31 1 site Stand-alone
    Other conditions: AML
    View official trial listing →
  • Recruiting NCT NCT06996119

    Emapalumab With Post-Transplant Cyclophosphamide, Tacrolimus and Mycophenolate Mofetil for the Prevention of Graft-versus-Host Disease After Donor Reduced-Intensity Hematopoietic Cell Transplant

    Not yet reported City of Hope Medical Center 15 participants Est. completion 2028-11-05 1 site Stand-alone
    Other conditions: Acute Myeloid Leukemia, Graft Versus Host Disease, Myelodysplastic Syndrome
    View official trial listing →
  • Recruiting NCT NCT07015684

    131I-apamistamab-based Conditioning for Hematopoietic Stem Cell Transplant (HSCT) in Advanced Sickle Cell Disease (SCD)

    Not yet reported Columbia University 24 participants Est. completion 2032-03-12 1 site Stand-alone
    Other conditions: Sickling Disorder Due to Hemoglobin S
    View official trial listing →
  • Recruiting NCT NCT07033858

    Evaluaion the Short Term Effects of Advograf Plus Rapamiune After Kidney Transplantation

    Not yet reported Shahid Beheshti University of Medical Sciences 50 participants Est. completion 2026-07-01 1 site
    Other conditions: Kidney Transplant; Complications
    View official trial listing →
  • Recruiting NCT NCT07042035

    Study of Tacrolimus Melt-Dose® for Lung Transplant Patients

    Chiesi España, S.A.U. 240 participants Est. completion 2026-12-31 2 sites
    Other conditions: Lung Trasplant, Lung Transplantation
    View official trial listing →
  • Recruiting NCT NCT07052929

    Study of ASP2957 in Male Participants With X-linked Myotubular Myopathy Who Need Ventilators

    Not yet reported, Not yet reported Astellas Gene Therapies 9 participants Est. completion 2027-10-31 5 sites Stand-alone
    Other conditions: X-Linked Myotubular Myopathy
    View official trial listing →
  • Recruiting NCT NCT07053462

    CRISPR-Edited HLA Donor Kidney Transplant to Reduce Rejection Risk

    Not yet reported, Not yet reported AMERICAN ORGAN TRANSPLANT AND CANCER RESEARCH INSTITUTE LLC 90 participants Est. completion 2028-12-28 1 site Stand-alone
    Other conditions: End-Stage Renal Disease, End Stage Renal Disease on Dialysis, End Stage Renal Disease With Renal Transplant, Kidney Transplant Rejection, Kidney Tumor, Kidney Failure, Kidney Ischemia
    View official trial listing →
  • Recruiting NCT NCT07077486

    Effects of Telitacicept vs Cyclophosphamide on Lupus Related Interstitial Lung Disease

    Not yet reported Tongji Hospital 100 participants Est. completion 2027-03-25 1 site Stand-alone
    Other conditions: Lupus or SLE, Interstitial Lung Disease, Systemic Lupus Erythematosus
    View official trial listing →
  • Recruiting NCT NCT07092618

    Effectiveness of Alternative Therapies in Maintaining Weight Loss Achieved by GLP-1 Medications Post-Cessation

    Not yet reported, Not yet reported AgelessRx 150 participants Est. completion 2025-08 1 site
    Other conditions: Longevity, GLP-1, Geroscience, Aging
    View official trial listing →
  • Recruiting NCT NCT07104799

    Momelotinib During and After HCT in Myelofibrosis

    Not yet reported Massachusetts General Hospital 28 participants Est. completion 2030-01 1 site Stand-alone
    Other conditions: Myelofibrosis, Hematopoietic Cell Transplantation (HCT)
    View official trial listing →
  • Recruiting NCT NCT07122167

    Post-market Registry Study on the Safety and Efficacy of ZENFLEX Pro™ Peripheral Drug-eluting Stent System for Femoropopliteal Artery Lesions

    Not yet reported MDCECRO LLC 153 participants Est. completion 2027-02-01 1 site
    Other conditions: Peripheral Arterial Disease
    View official trial listing →
  • Recruiting NCT NCT07124078

    A Study to Evaluate Axatilimab Versus Best Available Therapy in Pediatric Participants With Chronic Graft-Versus-Host Disease After at Least 2 Prior Lines of Systemic Therapy (AGAVE-256)

    Not yet reported Incyte Corporation 60 participants Est. completion 2029-07-31 41 sites
    Other conditions: Chronic Graft-versus-host-disease
    View official trial listing →
  • Recruiting NCT NCT07131644

    Sirolimus Discontinuation Strategies in Kaposiform Hemangioendothelioma

    Not yet reported West China Hospital 120 participants Est. completion 2028-02-01 1 site Stand-alone
    Other conditions: Kaposiform Hemangioendothelioma
    View official trial listing →
  • Recruiting NCT NCT07138898

    Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty

    Not yet reported NYU Langone Health 80 participants Est. completion 2028-01 1 site Stand-alone
    Other conditions: Rheumatic Disease
    View official trial listing →
  • Recruiting NCT NCT07144150

    EVERO Drug-coated Balloon (DCB) Randomized Trial

    Not yet reported Cook Research Incorporated 410 participants Est. completion 2032-10 15 sites
    Other conditions: Peripheral Vascular Disease, Peripheral Arterial Disease
    View official trial listing →
  • Recruiting NCT NCT07162038

    Phase I Trial Integrating HLA-Haploidentical Anti-CD19 CAR-T Cells With Post-Transplantation Cyclophosphamide-Based HLA-Haploidentical Hematopoietic Cell Transplantation

    Not yet reported National Cancer Institute (NCI) 155 participants Est. completion 2034-10-01 1 site Stand-alone
    Other conditions: Hematologic Malignancies, Hematologic Neoplasms
    View official trial listing →
  • Recruiting NCT NCT07173114

    New Approaches for Evaluating the Interchangeability of Reference Materials and Quality Controls (COMET-MPL)

    University Hospital, Montpellier 300 participants Est. completion 2026-09-22 2 sites
    Other conditions: Hospitalization, All Conditions
    View official trial listing →
  • Recruiting NCT NCT07191353

    Resistance Training and Rapamycin to Enhance Bone Formation in Postmenopausal Women

    Not yet reported Odense University Hospital 148 participants Est. completion 2027-03-01 2 sites
    Other conditions: Healthy, Osteopenia, Osteoporosis Risk
    View official trial listing →
  • Recruiting NCT NCT07204275

    Evaluation of Efficacy, Safety, and Tolerability of Povetacicept in Participants With Primary Membranous Nephropathy (pMN)

    Not yet reported, Not yet reported Vertex Pharmaceuticals Incorporated 176 participants Est. completion 2028-12-29 117 sites
    Other conditions: Primary Membranous Nephropathy
    View official trial listing →
  • Recruiting NCT NCT07206277

    Fibroscan to Guide Post Transplant Immunosuppression Minimization

    Not yet reported University of Alberta 50 participants Est. completion 2028-12-31 1 site Stand-alone
    Other conditions: Immunosuppression
    View official trial listing →
  • Recruiting NCT NCT07214688

    Fludarabine and Intermediate-dose TBI Followed by PTCy in Patients Undergoing Allo Transplant for Heme Malignancies

    Not yet reported Hackensack Meridian Health 209 participants Est. completion 2032-01 3 sites Stand-alone
    Other conditions: Allogeneic Stem Cell Transplant Recipient
    View official trial listing →
  • Recruiting NCT NCT07216443

    Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome

    Not yet reported Orca Biosystems, Inc. 80 participants Est. completion 2028-12 6 sites Stand-alone
    Other conditions: Leukemia, Myeloid, Acute, Myelodysplastic Syndromes, Mixed Phenotype Acute Leukemia
    View official trial listing →
  • Recruiting NCT NCT07228195

    SGLT2i Therapy in Islet Transplantation (SIT)

    Not yet reported University of Minnesota 40 participants Est. completion 2028-12-01 1 site
    Other conditions: Partial Islet Function, TPIAT, Diabetes
    View official trial listing →
  • Recruiting NCT NCT07228624

    Ruxolitinib Before, During and After Hematopoietic Cell Transplant in Older Patients With Myelofibrosis and Myelodysplastic Syndrome/Myeloproliferative Neoplasm Overlap Syndromes

    Not yet reported Fred Hutchinson Cancer Center 50 participants Est. completion 2030-09-01 1 site Stand-alone
    Other conditions: Myelodysplastic/Myeloproliferative Neoplasm, Primary Myelofibrosis, Secondary Myelofibrosis
    View official trial listing →
  • Recruiting NCT NCT07238712

    Optimization of Post-transplantation Benadamustine and Cyclophosphamide in Patients With High-risk Myeloid Malignancies and a Partially Mismatched Donor

    Not yet reported St. Petersburg State Pavlov Medical University 60 participants Est. completion 2026-12-10 1 site Stand-alone
    Other conditions: Acute Myeloid Leukemia (AML), Chronic Myeloid Leukemia, Myelodysplastic Syndromes (MDS), Myeloprolipherative Neoplsm, Atypical Chronic Myeloid Leukemia
    View official trial listing →
  • Recruiting NCT NCT07241936

    A Study of Sirolimus (Albumin-Bound) in Combination With Different ADCs Treatment of Advanced Solid Tumors

    Not yet reported, Not yet reported CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 444 participants Est. completion 2028-10-30 1 site Stand-alone
    Other conditions: Advanced Solid Tumors
    View official trial listing →
  • Recruiting NCT NCT07249346

    Dose-Expansion Study of Low Dose Post-Transplant Cyclophosphamide/Tacrolimus/Ruxolitinib for Graft-versus-Host Disease (GVHD) Prophylaxis in Myeloablative Allogeneic Peripheral Blood Stem Cell Transplantation

    Not yet reported Hannah Choe, MD 124 participants Est. completion 2027-06-01 3 sites Stand-alone
    Other conditions: Leukemia, Myelodysplasia, Chronic Myelomonocytic Leukemia
    View official trial listing →
  • Recruiting NCT NCT07252050

    Ruxolitinib-Enhanced Haplo HCT for Children and Young Adults With Sickle Cell Disease

    Not yet reported, Not yet reported Arkansas Children's Hospital Research Institute 24 participants Est. completion 2029-11-19 4 sites Stand-alone
    Other conditions: Sickle Cell Disease, Hematopoetic Stem Cell Transplant, Haploidentical Hematopoietic Stem Cell Transplant, Haploidentical Stem Cell Transplantation, Graft Failure
    View official trial listing →
  • Recruiting NCT NCT07258290

    Safety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold (RMS) System in Subjects With Coronary Artery Lesions

    Not yet reported Teleflex 1859 participants Est. completion 2033-06 3 sites Stand-alone
    Cardiovascular disease Other conditions: Coronary Disease, Heart Diseases, Arteriosclerosis, Arterial Occlusive Diseases, Vascular Diseases, Chest Pain, Pain, Neurologic Manifestations, Signs and Symptoms, Pathological Conditions, Signs and Symptoms, Myocardial Ischemia, Acute Coronary Syndrome, Angina Pectoris
    View official trial listing →
  • Recruiting NCT NCT07285070

    Tacrolimus Ophthalmic Solution for the Treatment of Non-infectious Anterior Uveitis

    Not yet reported Novaliq GmbH 20 participants Est. completion 2026-10 6 sites
    Other conditions: Non-infectious Anterior Uveitis
    View official trial listing →
  • Recruiting NCT NCT07290777

    VEL-101 to Prevent Rejection After Kidney Transplantation

    Not yet reported Veloxis Pharmaceuticals 120 participants Est. completion 2028-10 1 site
    Other conditions: Transplantation, Kidney
    View official trial listing →
  • Recruiting NCT NCT07291258

    Long-term Follow-up of the Offspring Born to Mothers With a Solid Organ Transplant, Transplantlines Next Generation

    University Medical Center Groningen 200 participants Est. completion 2028-06 1 site
    Other conditions: Solid Organ Transplantation, Pregnancy, Long-term Follow-up, Kidney Transplant, Liver Transplant, Pancreas Transplant, Heart Transplantation, Lung Transplantation, Offspring, Adult, Children, Cardiovascular Abnormalities, Kidney Disease, Quality of Life
    View official trial listing →
  • Recruiting NCT NCT07297173

    Phase 1 Study of Chemotherapy Plus HLA-mismatched GPBMC Infusion Bridging to Allo-HSCT for R/R Leukemia

    Not yet reported Beijing 302 Hospital 5 participants Est. completion 2030-12-01 1 site Stand-alone
    Other conditions: Relapsed Leukemia, Refractory Leukemia
    View official trial listing →
  • Recruiting NCT NCT07302776

    TACrolimus Targeted Immunosuppression Cessation in ALlogeneic HCT

    Not yet reported Stanford University 50 participants Est. completion 2028-02 1 site Stand-alone
    Other conditions: GVHD, Hematopoietic Cell Transplantation (HCT), Acute Myeloid Leukemia (AML), Myelodysplastic Syndromes, Myelofibrosis (MF), Chronic Myeloid Leukemia (CML), Chronic Myelomonocytic Leukemia (CMML)
    View official trial listing →
  • Recruiting NCT NCT07309094

    Clinical, Morphometric and Biochemical Effects on Adiposopathy Associated With the Use of GLP-1RA in CKD

    Cardenal Herrera University 250 participants Est. completion 2028-12-31 1 site
    Chronic kidney diseaseType 2 diabetes Other conditions: Obesity
    View official trial listing →
  • Recruiting NCT NCT07318324

    Phase Ib Study of Avutometinib, Defactinib, and Everolimus in RAS Pathway Mutant Endometrial Cancer

    Not yet reported M.D. Anderson Cancer Center 31 participants Est. completion 2030-08-01 1 site
    Other conditions: Phase IB, Avutometinib, RAS Pathway, Endometrial
    View official trial listing →
  • Recruiting NCT NCT07340541

    Evolutionary Clinical Trial for Novel Biomarker-Driven Therapies

    Not yet reported UNC Lineberger Comprehensive Cancer Center 700 participants Est. completion 2031-06-02 6 sites
    Other conditions: Breast Cancer, Metastatic Breast Cancer, Triple Negative Breast Cancer, Estrogen-receptor-positive Breast Cancer, Hormone Receptor Negative Breast Carcinoma
    View official trial listing →
  • Recruiting NCT NCT07359859

    A Study of Ruxolitinib for Preventing Graft-Versus-Host Disease in People With a Hematologic Malignancy Who Will Receive a Stem Cell Transplant

    Not yet reported Memorial Sloan Kettering Cancer Center 40 participants Est. completion 2029-01 7 sites Stand-alone
    Other conditions: Hematologic Malignancies
    View official trial listing →
  • Recruiting NCT NCT07363161

    BASel Kosten-Effektivitäts-Trial: Drug-coated BALLoon (DCB) vs. Drug-eluting Stent (DES) Strategy in High-risk Patients With Coronary Artery Disease (CAD)

    Not yet reported B. Braun Melsungen AG 2184 participants Est. completion 2031-03 3 sites
    Cardiovascular disease
    View official trial listing →
  • Recruiting NCT NCT07366801

    Co-infusion of Treg-enriched Donor Lymphocytes With CD3-depleted Hematopoietic Stem Cell Graft to Prevent Graft-versus Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation Among Children With Hematologic Malignancies

    Not yet reported, Not yet reported Federal Research Institute of Pediatric Hematology, Oncology and Immunology 64 participants Est. completion 2028-02-03 1 site
    Other conditions: Acute Myeloid Leukemia, Relapsed, Acute Lymphoblastic Leukemia, High Risk, Acute Myeloid Leukemia, High Risk, Acute Lymphoblastic Leukemia, Relapse
    View official trial listing →
  • Recruiting NCT NCT07377058

    RCT of Tocilizumab for Anti-MDA5+DM

    Not yet reported Peking Union Medical College Hospital 110 participants Est. completion 2026-10 1 site
    Other conditions: Dermatomyositis
    View official trial listing →
  • Recruiting NCT NCT07378657

    Systematic Approach for Children With Orbital Malformation With Sirolimus Use

    Not yet reported Ain Shams University 30 participants Est. completion 2027-11-01 1 site
    Other conditions: Orbital Lymphatic Malformation
    View official trial listing →
  • Recruiting NCT NCT07406932

    A Study on the Efficacy and Safety of JAK Inhibitors Versus Calcineurin Inhibitors as Initial Therapy for Interstitial Lung Disease Associated With Antisynthetase Syndrome

    Not yet reported China-Japan Friendship Hospital 80 participants Est. completion 2027-07-01 1 site Stand-alone
    Other conditions: Antisynthetase Syndrome, Interstitial Lung Disease (ILD)
    View official trial listing →
  • Recruiting NCT NCT07412470

    A Study to Investigate the Efficacy and Safety of Frexalimab Versus Tacrolimus in Adults Undergoing Kidney Transplantation

    Not yet reported, Not yet reported Sanofi 526 participants Est. completion 2033-08-15 73 sites
    Other conditions: Kidney Transplant Rejection
    View official trial listing →
  • Recruiting NCT NCT07444957

    Safety and Effectiveness of the Crystalline Sirolimus-Eluting Device in Patients With Coronary Artery Disease

    Fundación Interhospitalaria para la Investigación Cardiovascular FIC 1118 participants Est. completion 2030-07-06 1 site
    Cardiovascular disease Other conditions: Coronary Arterial Disease (CAD), Stable Angina, Unstable Angina, NSTEMI, Drug Coated Balloon, Silent Ischemia
    View official trial listing →
  • Recruiting NCT NCT07493538

    MT2025-35 Allogeneic Hematopoietic Stem Cell Transplantation Using Reduced Intensity Conditioning Treosulfan and Fludarabine, With Post-Transplant Cytoxan (PTCy) for the Treatment of Hematological Diseases

    Not yet reported Masonic Cancer Center, University of Minnesota 132 participants Est. completion 2035-03 1 site Stand-alone
    Other conditions: AML, MDS, Acute Leukemia, Acute Myeloid Leukemia, Myelodysplastic Syndromes
    View official trial listing →
  • Recruiting NCT NCT07497399

    Targeting Agonists of Glucagon-like Peptide-1 Receptor for Multiple Sclerosis

    Not yet reported Johns Hopkins University 120 participants Est. completion 2030-01 3 sites
    Other conditions: Multiple Sclerosis
    View official trial listing →
  • Recruiting NCT NCT07508787

    A Study Comparing Siplizumab With Rabbit Anti-Thymocyte Globulin to Help the Body Accept a Kidney Transplant

    Not yet reported ITB-Med LLC 120 participants Est. completion 2028-03-28 27 sites
    Other conditions: Renal Transplant Failure and Rejection
    View official trial listing →
  • Recruiting NCT NCT07542938

    Medeliver Intracranial Drug Coated Balloon Catheter for Symptomatic Intracranial Atherosclerotic Stenosis

    Not yet reported Xuanwu Hospital, Beijing 264 participants Est. completion 2027-11-30 15 sites Stand-alone
    Other conditions: Symptomatic Intracranial Atherosclerotic Stenosis
    View official trial listing →
  • Recruiting NCT NCT07548983

    Ruxolitinib With Azacitidine Maintenance for the Treatment of Patients With Acute Myeloid Leukemia Undergoing Reduced Intensity Allogeneic Stem Cell Transplantation

    Not yet reported OHSU Knight Cancer Institute 40 participants Est. completion 2028-12-29 1 site Stand-alone
    Other conditions: Acute Myeloid Leukemia
    View official trial listing →
  • Recruiting NCT NCT07549503

    Early Signals of the Transition From Immune Quiescence to Activation in the Liver Allograft Microenvironment and in the Circulation

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 100 participants Est. completion 2031-10-01 11 sites Stand-alone
    Other conditions: Liver Transplant
    View official trial listing →
  • Recruiting NCT NCT07566091

    Noninferiority Trial Of Sirolimus With Ascorbic Acid Versus Everolimus in All-comers

    Not yet reported Jung-min Ahn 2034 participants Est. completion 2028-06-15 1 site Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Recruiting NCT NCT07566377

    Cord Blood Transplantation in Children and Young Adults With Blood Cancer

    Not yet reported Memorial Sloan Kettering Cancer Center 71 participants Est. completion 2030-04-28 1 site Stand-alone
    Other conditions: Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndromes, Non-hodgkin Lymphoma, Hodgkin Lymphoma, Leukemia, Lymphoma, Graft-versus-host Disease
    View official trial listing →
  • Recruiting NCT NCT07572071

    Safety and Feasibility of Bilateral Striatal Transplantation of DopaCell in Parkinson's Disease

    Not yet reported Royan Institute 6 participants Est. completion 2030-08-01 3 sites Stand-alone
    Other conditions: Parkinson Disease (PD)
    View official trial listing →
  • Recruiting NCT NCT07581704

    Sirolimus Pre-conditioning on T Cell Activity and T-cell Engaging Bispecific Antibody Efficacy in Multiple Myeloma

    Not yet reported Christopher Strouse 10 participants Est. completion 2029-10-01 1 site Stand-alone
    Other conditions: Multiple Myeloma
    View official trial listing →
  • Recruiting NCT NCT07582172

    Total Marrow and Lymphoid Irradiation in Combination With Fludarabine and Melphalan as Conditioning for Allogeneic Peripheral Blood Stem Cell Hematopoietic Cell Transplant in Older Patients With Refractory and Relapsed Acute Myeloid Leukemia and High-risk Myelodysplastic Syndrome

    Not yet reported City of Hope Medical Center 35 participants Est. completion 2031-11-05 1 site Stand-alone
    Other conditions: Acute Myeloid Leukemia With Complex Karyotype, Myelodysplastic Chronic Myelomonocytic Leukemia, Myelodysplastic Syndrome, Recurrent Acute Myeloid Leukemia, Recurrent Myelodysplastic Chronic Myelomonocytic Leukemia, Recurrent Myelodysplastic Syndrome, Recurrent Secondary Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia, Refractory Myelodysplastic Chronic Myelomonocytic Leukemia, Refractory Myelodysplastic Syndrome, Refractory Secondary Acute Myeloid Leukemia
    View official trial listing →
  • Recruiting NCT NCT07592000

    Breakthrough - T1DM and Chronic Kidney Disease

    Not yet reported, Not yet reported University of Chicago 10 participants Est. completion 2030-01-31 2 sites
    Chronic kidney disease Other conditions: Diabete Type 1
    View official trial listing →
  • Recruiting NCT NCT07616154

    Haploidentical Donor Hematopoietic Cell Transplant for Sickle Cell Disease

    Not yet reported St. Jude Children's Research Hospital 45 participants Est. completion 2035-09 1 site Stand-alone
    Other conditions: Sickle Cell Disease
    View official trial listing →
  • Recruiting NCT NCT07656909

    Low- vs High-Dose Sirolimus With Prednisolone for KHE and KMP

    Not yet reported, Not yet reported Yi Ji 76 participants Est. completion 2028-12-31 1 site Stand-alone
    Other conditions: Kaposiform Hemangioendothelioma (KHE), Kasabach Merritt Phenomenon
    View official trial listing →
  • Recruiting NCT NCT07702461

    Determination of Resistance Training Status for Patients on Glucagon-Like Peptide-1 Receptor Agonists

    Ohio State University 300 participants Est. completion 2027-01 1 site
    Other conditions: Obesity & Overweight, Diabetes (DM)
    View official trial listing →
  • Recruiting NCT NCT07725380

    Domatinostat With Sirolimus for Relapsed, Refractory Sarcoma and Osteosarcoma

    Not yet reported, Not yet reported H. Lee Moffitt Cancer Center and Research Institute 74 participants Est. completion 2031-08 4 sites Stand-alone
    Obstructive sleep apnea Other conditions: Sarcoma
    View official trial listing →
  • Recruiting NCT NCT07735533

    A Phase 1/2 Study of UB-VV400 With Rapamycin in Relapsed/Refractory B-cell Malignancies

    Not yet reported, Not yet reported Umoja Biopharma 274 participants Est. completion 2031-08 2 sites Stand-alone
    Other conditions: Lymphoma, B Cell, Lymphoma Non-Hodgkin, High Grade B Cell Lymphoma, Richter Transformation Lymphoma, Grade 3b Follicular Lymphoma, Primary Mediastinal B Cell Lymphoma, Diffuse Large B Cell Lymphoma (DLBCL)
    View official trial listing →
  • Recruiting NCT NCT07735546

    A Phase 1 Study of UB-VV500 With Rapamycin in Relapsed/Refractory Multiple Myeloma

    Not yet reported Umoja Biopharma 100 participants Est. completion 2029-12-31 1 site Stand-alone
    Other conditions: Multiple Myeloma in Relapse, Multiple Myeloma (MM)
    View official trial listing →
  • Recruiting NCT NCT07739914

    Everolimus bAsed caLcineurin inhibiTor frEe immunosuppRession oNe Year AfTer lIver transplantatiON (ALTERNATION)

    Not yet reported Hannover Medical School 150 participants Est. completion 2031-06-30 16 sites
    Other conditions: Liver Allograft, Liver Diseases, Liver Transplantation
    View official trial listing →
  • Recruiting NCT NCT07775235

    Treatment Response in Immune-mediated Myositis Associated Rapidly-progressing Interstitial Lung Disease

    Singapore General Hospital 80 participants Est. completion 2029-07-01 1 site
    Other conditions: Interstitial Lung Disease, Myositis
    View official trial listing →
  • Recruiting NCT NCT07781722

    Tacrolimus as Prophylaxis of Post-ERCP Pancreatitis

    Not yet reported Amsterdam UMC, location VUmc 520 participants Est. completion 2028-12-07 1 site Stand-alone
    Other conditions: Post-ERCP Pancreatitis
    View official trial listing →
  • Recruiting NCT NCT07811024

    First-in-Human Study Using the SiroMax™ Sirolimus-Coated Balloon Catheter as a Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloon Catheter to Treat Subjects Who Have Coronary Artery Disease (CAD) Involving In-Stent Restenosis (ISR) or an Unstented Lesion in a Small Coronary Vessel (DNSV).

    Not yet reported Tonic Medical, Inc. 60 participants Est. completion 2032-05 2 sites Stand-alone
    Cardiovascular disease Other conditions: In-Stent Restenosis or De Novo Coronary Artery Lesions, In-Stent Stenosis (Restenosis) of Coronary Artery Stent, Small Vessel Disease, CAD, CAD Patients, PTCA, PCI, Stenosis Coronary, Stenosis Artery, Stenotic Coronary Lesion
    View official trial listing →
  • Recruiting NCT NCT07843381

    Clinical Efficacy of Telitacicept in Sjögren's Disease With Interstitial Lung Disease

    Peking University People's Hospital 60 participants Est. completion 2027-11-20 1 site
    Other conditions: Sjögren's Disease, Interstitial Lung Disease
    View official trial listing →
  • Recruiting NCT NCT07844694

    Low-Dose Sirolimus for the Treatment of RUNX1 Familial Platelet Disorder

    Not yet reported OHSU Knight Cancer Institute 6 participants Est. completion 2030-12-31 1 site Stand-alone
    Other conditions: Familial Platelet Disorder With Associated Myeloid Malignancy
    View official trial listing →
  • Recruiting NCT NCT07851220

    A Phase 3 Study of Inebilizumab in Participants With Primary Membranous Nephropathy

    Not yet reported Amgen 159 participants Est. completion 2033-09-26 4 sites
    Other conditions: Glomerulonephritis, Membranous
    View official trial listing →
  • Recruiting NCT NCT07904910

    Evaluation of Crisaborole 2% Versus Tacrolimus 0.1% Each Combined With Excimer Light in the Treatment of Stable Non-segmental Facial Vitiligo: a Prospective Randomized Controlled Study.

    Not yet reported Cairo University 35 participants Est. completion 2026-11-30 1 site
    Other conditions: Vitiligo, Non-Segmental Vitiligo (NSV), Stable Vitiligo
    View official trial listing →
  • Completed NCT NCT00000433

    Blocking Tumor Necrosis Factor in Ankylosing Spondylitis

    Not yet reported National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) 42 participants Est. completion 2002-03 1 site
    Other conditions: Spondylitis, Ankylosing
    View official trial listing →
  • Completed NCT NCT00001859

    Screening for Patients Needing Kidney, Kidney-Pancreas, or Islet-Cell Transplant

    National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 621 participants Est. completion 2014-05-30 1 site
    Other conditions: Diabetes Mellitus, Kidney Failure
    View official trial listing →
  • Completed NCT NCT00001901

    Etanercept to Treat Wegener's Granulomatosis

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 60 participants Est. completion 2005-03 1 site
    Other conditions: Vasculitis, Wegener's Granulomatosis
    View official trial listing →
  • Completed NCT NCT00001955

    Study of Etanercept and Celecoxib to Treat Temporomandibular Disorders (Painful Joint Conditions)

    Not yet reported National Institute of Dental and Craniofacial Research (NIDCR) 150 participants Est. completion 2004-02 1 site
    Other conditions: Temporomandibular Joint Disorder
    View official trial listing →
  • Completed NCT NCT00002657

    SWOG-9239 Reduction of Immunosuppression Plus Interferon Alfa and Combination Chemotherapy in Treating Patients With Malignant Tumors That Develop After Organ Transplant

    Not yet reported SWOG Cancer Research Network 20 participants Est. completion 2011-07 86 sites
    Other conditions: Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm
    View official trial listing →
  • Withdrawn NCT NCT00002790

    Prevention of Graft-Versus-Host Disease in Patients With Hematologic Malignancies Who Are Receiving a Bone Marrow Transplant

    Not yet reported, Not yet reported Fred Hutchinson Cancer Center
    Other conditions: Graft Versus Host Disease, Leukemia, Myelodysplastic Syndromes
    View official trial listing →
  • Completed NCT NCT00002792

    Combination Chemotherapy Plus Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Myeloproliferative Disorders

    Not yet reported Fred Hutchinson Cancer Center 20 participants Est. completion 2003-04 1 site
    Other conditions: Chronic Myeloproliferative Disorders, Leukemia, Myelodysplastic/Myeloproliferative Diseases
    View official trial listing →
  • Completed NCT NCT00002809

    Bone Marrow Transplant Plus Cyclophosphamide and Total-Body Irradiation in Treating Patients With Hematologic Cancer

    Not yet reported Temple University 10 participants Est. completion 2003-12 1 site
    Other conditions: Leukemia, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Diseases
    View official trial listing →
  • Completed NCT NCT00002831

    Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous or Acute Leukemia

    Not yet reported, Not yet reported M.D. Anderson Cancer Center 24 participants Est. completion 2002-12-31 1 site Stand-alone
    Other conditions: Leukemia
    View official trial listing →
  • Completed NCT NCT00003572

    Total-Body Irradiation, Tacrolimus, and Mycophenolate Mofetil Plus Bone Marrow Transplantation in Treating Patients With Hematologic Cancers

    Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 20 participants Est. completion 2002-04 1 site
    Other conditions: Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes
    View official trial listing →
  • Completed NCT NCT00003712

    CCI-779 in Treating Patients With Advanced Solid Tumors

    Not yet reported The University of Texas Health Science Center at San Antonio 15 participants Est. completion 2002-06 2 sites
    Other conditions: Brain and Central Nervous System Tumors, Metastatic Cancer, Unspecified Adult Solid Tumor, Protocol Specific
    View official trial listing →
  • Completed NCT NCT00004145

    Chemotherapy Plus Biological Therapy Followed By Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer

    Not yet reported University of Chicago 16 participants Est. completion 2011-08 1 site Stand-alone
    Other conditions: Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes
    View official trial listing →
  • Completed NCT NCT00004255

    Treatment of Bone Marrow to Prevent Graft-Versus-Host Disease in Patients With Acute or Chronic Leukemia Undergoing Bone Marrow Transplantation

    Not yet reported, Not yet reported Chimeric Therapies Est. completion 2003-05 15 sites
    Other conditions: Graft Versus Host Disease, Leukemia, Myelodysplastic Syndromes
    View official trial listing →
  • Withdrawn NCT NCT00004878

    Donor Lymphocytes to Prevent Graft-Versus-Host Disease in Patients With Chronic Myeloid Leukemia

    Not yet reported Jonsson Comprehensive Cancer Center
    Other conditions: Graft Versus Host Disease, Leukemia
    View official trial listing →
  • Completed NCT NCT00004904

    Stem Cell Transplantation in Treating Patients With Hematologic Cancer

    Not yet reported Northwestern University Est. completion 2000-07 1 site
    Other conditions: Chronic Myeloproliferative Disorders, Graft Versus Host Disease, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Precancerous/Nonmalignant Condition, Small Intestine Cancer
    View official trial listing →
  • Terminated NCT NCT00005113

    A Study to Compare Treatment With Sirolimus Versus Standard Treatment in Patients Who Have Received a Kidney Transplant

    Not yet reported Boston Children's Hospital 102 participants Est. completion 2006-03 1 site Stand-alone
    Other conditions: End-Stage Renal Disease, Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT00005853

    Biological Therapy in Treating Patients With Myelodysplastic Syndrome

    Not yet reported Fred Hutchinson Cancer Center Est. completion 2005-08 1 site
    Other conditions: Leukemia, Myelodysplastic Syndromes
    View official trial listing →
  • Completed NCT NCT00006042

    Cyclophosphamide Plus Bone Marrow Transplantation in Treating Patients With Hematologic Cancer

    Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 1 site
    Other conditions: Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Diseases
    View official trial listing →
  • Completed NCT NCT00006070

    Etanercept (Enbrel) to Treat Pain and Swelling After Third Molar Extraction

    Not yet reported National Institute of Dental and Craniofacial Research (NIDCR) 86 participants Est. completion 2004-05 1 site
    Other conditions: Healthy, Inflammation
    View official trial listing →
  • Completed NCT NCT00006350

    Mycophenolate Mofetil, Tacrolimus, Daclizumab, and Donor Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer

    Not yet reported University of Maryland, Baltimore Est. completion 2001-11 1 site
    Other conditions: Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes
    View official trial listing →
  • Completed NCT NCT00006747

    Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Mantle Cell Lymphoma

    Not yet reported Alliance for Clinical Trials in Oncology 4 participants Est. completion 2003-02 48 sites Stand-alone
    Other conditions: Graft Versus Host Disease, Lymphoma
    View official trial listing →
  • Completed NCT NCT00007787

    Antibody and Delayed Cyclosporine Versus Initial Cyclosporine Alone in Patients Receiving Kidney Transplants

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 350 participants Est. completion 2004-03 1 site Stand-alone
    Other conditions: Kidney Transplantation, Chronic Allograft Nephropathy
    View official trial listing →
  • Completed NCT NCT00014469

    Combination Chemotherapy Followed by Bone Marrow Transplantation in Treating Patients With Advanced Hematologic Cancer

    Not yet reported Memorial Sloan Kettering Cancer Center Est. completion 2007-05 1 site
    Other conditions: Graft Versus Host Disease, Leukemia, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
    View official trial listing →
  • Completed NCT NCT00014911

    Islet Transplantation for Type 1 Diabetes

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 36 participants Est. completion 2010-08 9 sites Stand-alone
    Other conditions: Diabetes Mellitus, Insulin-Dependent
    View official trial listing →
  • Status unknown NCT NCT00018122

    Patterns and Natural History of Insulin Secretion in Islet Cell Transplant Recipients and Controls

    National Center for Research Resources (NCRR) 1 site
    Other conditions: Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT00021801

    Islet Cell Transplantation Alone and CD34+ Enriched Bone Marrow Cell Infusion in Patients With Diabetes Mellitus: Steroid-Free Regimen

    Not yet reported National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Est. completion 2000-09 1 site
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT00022464

    CCI-779 in Treating Patients With Metastatic Melanoma

    Not yet reported City of Hope Medical Center Est. completion 2005-09 21 sites
    Other conditions: Melanoma (Skin)
    View official trial listing →
  • Completed NCT NCT00022724

    CCI-779 in Treating Patients With Malignant Glioma

    Not yet reported, Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 49 participants Est. completion 2007-12-15 10 sites
    Other conditions: Brain and Central Nervous System Tumors
    View official trial listing →
  • Terminated NCT NCT00023244

    Steroid Withdrawal in Pediatric Kidney Transplant Recipients

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 274 participants Est. completion 2005-06 19 sites Stand-alone
    Other conditions: End-Stage Renal Disease
    View official trial listing →
  • Withdrawn NCT NCT00025519

    Peripheral Stem Cell Transplantation in Treating Patients With Metastatic or Recurrent Kidney Cancer

    Not yet reported Fox Chase Cancer Center Est. completion 2006-10
    Other conditions: Kidney Cancer
    View official trial listing →
  • Completed NCT NCT00027573

    Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic or Unresectable Kidney Cancer

    Not yet reported Alliance for Clinical Trials in Oncology 36 participants Est. completion 2006-06 6 sites Stand-alone
    Other conditions: Kidney Cancer
    View official trial listing →
  • Completed NCT NCT00028028

    CCI-779 in Treating Patients With Extensive-Stage Small Cell Lung Cancer

    Not yet reported National Cancer Institute (NCI) 80 participants 1 site
    Other conditions: Extensive Stage Small Cell Lung Cancer
    View official trial listing →
  • Completed NCT NCT00028171

    Pharmacokinetics of Tacrolimus in Kidney Transplant Recipients: Once Daily Versus Twice Daily Dosing

    Not yet reported National Center for Research Resources (NCRR) 1 site
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT00028600

    Peripheral Stem Cell Transplant in Treating Patients With Multiple Myeloma

    Not yet reported Alliance for Clinical Trials in Oncology 60 participants Est. completion 2010-02 15 sites Stand-alone
    Other conditions: Multiple Myeloma, Plasma Cell Neoplasm
    View official trial listing →
  • Terminated NCT NCT00031551

    Evaluation of Efficacy and Mechanisms of an Antiinflammatory Intervention for Chemotherapy Related Mucosal Injury

    Not yet reported National Institute of Nursing Research (NINR) 27 participants Est. completion 2010-08 2 sites Stand-alone
    Other conditions: Stomatitis
    View official trial listing →
  • Completed NCT NCT00031824

    Hydroxychloroquine in Treating Patients With Newly Diagnosed Chronic Graft-Versus-Host Disease

    Not yet reported Children's Oncology Group 82 participants Est. completion 2011-01 104 sites
    Other conditions: Graft Versus Host Disease
    View official trial listing →
  • Completed NCT NCT00033267

    CCI-779 in Treating Patients With Mantle Cell Non-Hodgkin's Lymphoma

    Not yet reported National Cancer Institute (NCI) 27 participants Est. completion 2008-02 1 site
    Other conditions: Recurrent Mantle Cell Lymphoma
    View official trial listing →
  • Terminated NCT NCT00034528

    Stem Cell Transplantation After Reduced-Dose Chemotherapy for Patients With Sickle Cell Disease or Thalassemia

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 2 participants Est. completion 2003-11 1 site
    Other conditions: Hemoglobinopathies, Anemia, Sickle Cell, Hemoglobin SC Disease, Thalassemia, Thalassemia Major
    View official trial listing →
  • Terminated NCT NCT00035958

    Understanding the Pathogenesis and Treatment of Childhood Onset Dermatomyositis

    Not yet reported, Not yet reported Children's Hospital Medical Center, Cincinnati 75 participants Est. completion 2002-08 1 site
    Other conditions: Dermatomyositis
    View official trial listing →
  • Completed NCT NCT00036153

    Study to Assess Efficacy of Tacrolimus + Methotrexate Versus Placebo + Methotrexate in Treatment of Rheumatoid Arthritis

    Not yet reported Astellas Pharma Inc 210 participants Est. completion 2004-01 45 sites
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT00037531

    Study Evaluating Sirolimus (Rapamune™) in Solid Organ Transplant Recipients

    Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 769 participants Est. completion 2004-08 20 sites
    Other conditions: Graft vs Host Disease, Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT00038948

    Study Comparing Conversion to Sirolimus vs. Continued Use of Calcineurin Inhibitors in Kidney Transplant Recipients

    Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 830 participants Est. completion 2008-05
    Other conditions: Renal Transplantation
    View official trial listing →
  • Completed NCT NCT00039013

    Evaluation of the Effect on Glucose Control of AC2993 in Patients With Type 2 Diabetes Mellitus Treated With Metformin

    Not yet reported AstraZeneca 336 participants Est. completion 2003-06 129 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00039377

    Chemotherapy, Imatinib Mesylate, and Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia

    Not yet reported National Cancer Institute (NCI) 58 participants Est. completion 2014-02 97 sites Stand-alone
    Other conditions: Adult Acute Lymphoblastic Leukemia in Remission
    View official trial listing →
  • Terminated NCT NCT00040417

    Bone Marrow Transplant From Donor Using Less Toxic Conditioning for Patient With High Risk Hemoglobinopathies

    Not yet reported Baylor College of Medicine 15 participants Est. completion 2003-11-21 2 sites
    Other conditions: Sickle Cell Anemia, Hemoglobinopathy, Thalassemia
    View official trial listing →
  • Terminated NCT NCT00041288

    Study Of Two Non-Myeloablative Stem Cell Transplant Strategies For Low-Grade Lymphoma And CLL

    Not yet reported University of Texas Southwestern Medical Center 10 participants Est. completion 2003-01 23 sites
    Other conditions: Leukemia, Lymphoma
    View official trial listing →
  • Completed NCT NCT00043979

    Stem Cell Transplantation in Patients With High-Risk and Recurrent Pediatric Sarcomas

    Not yet reported National Cancer Institute (NCI) 60 participants Est. completion 2011-12-14 1 site Stand-alone
    Other conditions: Sarcoma
    View official trial listing →
  • Completed NCT NCT00044694

    Evaluation of the Effect on Glucose Control and the Safety and Tolerability of AC2993 in Patients With Type 2 Diabetes Mellitus

    Not yet reported AstraZeneca 156 participants Est. completion 2003-05 33 sites
    Other conditions: Diabetes Mellitus, Non-Insulin-Dependent
    View official trial listing →
  • Completed NCT NCT00044720

    Study Evaluating Sirolimus in End Stage Renal Disease in High Risk Kidney Transplant Recipients

    Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 484 participants Est. completion 2005-07
    Other conditions: Chronic Kidney Failure, Graft vs Host Disease, Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT00045305

    Reduced-Intensity Regimen Before Donor Bone Marrow Transplant in Treating Patients With Myelodysplastic Syndromes

    Not yet reported Eastern Cooperative Oncology Group 17 participants Est. completion 2014-09 6 sites Stand-alone
    Other conditions: Leukemia, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
    View official trial listing →
  • Completed NCT NCT00045370

    Chemotherapy and Biological Therapy in Treating Patients With Locally Advanced or Metastatic Kidney Cancer

    Not yet reported Memorial Sloan Kettering Cancer Center Est. completion 2003-11 1 site
    Other conditions: Kidney Cancer
    View official trial listing →
  • Terminated NCT NCT00048399

    Stem Cell Transplantation for Patients With Graft Failure Following an Allogeneic Transplant, Using Identical or Near Identical Donors and Less Toxic Conditioning With CAMPATH 1H

    Not yet reported, Not yet reported Baylor College of Medicine 40 participants Est. completion 2003-10-31 2 sites
    Other conditions: Graft Failure
    View official trial listing →
  • Completed NCT NCT00049504

    Haploidentical Donor Bone Marrow Transplant in Treating Patients With High-Risk Hematologic Cancer

    Not yet reported Fred Hutchinson Cancer Center 53 participants Est. completion 2014-02 1 site Stand-alone
    Obstructive sleep apnea Other conditions: Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, Childhood Acute Lymphoblastic Leukemia in Remission, Childhood Acute Myeloid Leukemia in Remission, Childhood Burkitt Lymphoma, Childhood Chronic Myelogenous Leukemia, Childhood Myelodysplastic Syndromes, Childhood Nasal Type Extranodal NK/T-cell Lymphoma, Cutaneous B-cell Non-Hodgkin Lymphoma, de Novo Myelodysplastic Syndromes, Hematopoietic/Lymphoid Cancer, Hepatosplenic T-cell Lymphoma, Intraocular Lymphoma, Nodal Marginal Zone B-cell Lymphoma, Peripheral T-cell Lymphoma, Post-transplant Lymphoproliferative Disorder, Previously Treated Myelodysplastic Syndromes, Recurrent Adult Burkitt Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma, Recurrent Adult Diffuse Mixed Cell Lymphoma, Recurrent Adult Diffuse Small Cleaved Cell Lymphoma, Recurrent Adult Grade III Lymphomatoid Granulomatosis, Recurrent Adult Hodgkin Lymphoma, Recurrent Adult Immunoblastic Large Cell Lymphoma, Recurrent Adult Lymphoblastic Lymphoma, Recurrent Adult T-cell Leukemia/Lymphoma, Recurrent Childhood Anaplastic Large Cell Lymphoma, Recurrent Childhood Grade III Lymphomatoid Granulomatosis, Recurrent Childhood Large Cell Lymphoma, Recurrent Childhood Lymphoblastic Lymphoma, Recurrent Childhood Small Noncleaved Cell Lymphoma, Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Grade 3 Follicular Lymphoma, Recurrent Mantle Cell Lymphoma, Recurrent Marginal Zone Lymphoma, Recurrent Mycosis Fungoides/Sezary Syndrome, Recurrent Small Lymphocytic Lymphoma, Recurrent/Refractory Childhood Hodgkin Lymphoma, Refractory Chronic Lymphocytic Leukemia, Refractory Multiple Myeloma, Relapsing Chronic Myelogenous Leukemia, Secondary Myelodysplastic Syndromes, Small Intestine Lymphoma, Splenic Marginal Zone Lymphoma, Stage II Multiple Myeloma, Stage III Adult Burkitt Lymphoma, Stage III Adult Diffuse Large Cell Lymphoma, Stage III Adult Diffuse Mixed Cell Lymphoma, Stage III Adult Diffuse Small Cleaved Cell Lymphoma, Stage III Adult Hodgkin Lymphoma, Stage III Adult Immunoblastic Large Cell Lymphoma, Stage III Adult Lymphoblastic Lymphoma, Stage III Adult T-cell Leukemia/Lymphoma, Stage III Childhood Hodgkin Lymphoma, Stage III Chronic Lymphocytic Leukemia, Stage III Cutaneous T-cell Non-Hodgkin Lymphoma, Stage III Grade 1 Follicular Lymphoma, Stage III Grade 2 Follicular Lymphoma, Stage III Grade 3 Follicular Lymphoma, Stage III Mantle Cell Lymphoma, Stage III Marginal Zone Lymphoma, Stage III Multiple Myeloma, Stage III Mycosis Fungoides/Sezary Syndrome, Stage III Small Lymphocytic Lymphoma, Stage IV Adult Burkitt Lymphoma, Stage IV Adult Diffuse Large Cell Lymphoma, Stage IV Adult Diffuse Mixed Cell Lymphoma, Stage IV Adult Diffuse Small Cleaved Cell Lymphoma, Stage IV Adult Hodgkin Lymphoma, Stage IV Adult Immunoblastic Large Cell Lymphoma, Stage IV Adult Lymphoblastic Lymphoma, Stage IV Adult T-cell Leukemia/Lymphoma, Stage IV Childhood Hodgkin Lymphoma, Stage IV Chronic Lymphocytic Leukemia, Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma, Stage IV Grade 1 Follicular Lymphoma, Stage IV Grade 2 Follicular Lymphoma, Stage IV Grade 3 Follicular Lymphoma, Stage IV Mantle Cell Lymphoma, Stage IV Marginal Zone Lymphoma, Stage IV Mycosis Fungoides/Sezary Syndrome, Stage IV Small Lymphocytic Lymphoma, Testicular Lymphoma, Waldenström Macroglobulinemia
    View official trial listing →
  • Completed NCT NCT00050713

    Sirolimus Therapy for Idiopathic and Lupus Membranous Nephropathy

    Not yet reported National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 12 participants Est. completion 2007-08-27 1 site
    Other conditions: Membranous Glomerulonephritis, Lupus Membranous Nepropathy
    View official trial listing →
  • Completed NCT NCT00053196

    Donor Stem Cell Transplant in Treating Patients With Relapsed Hematologic Cancer

    Not yet reported Alliance for Clinical Trials in Oncology 82 participants Est. completion 2010-08 12 sites Stand-alone
    Other conditions: Leukemia, Lymphoma, Multiple Myeloma, Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myeloproliferative Neoplasms
    View official trial listing →
  • Completed NCT NCT00053989

    NMA Allogeneic Hematopoietic Cell Transplant in Hematologic Cancer/Disorders

    Not yet reported Roswell Park Cancer Institute 41 participants Est. completion 2018-07-19 1 site Stand-alone
    Other conditions: Chronic Myeloproliferative Disorders, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Diseases, Fanconi Anemia, Aplastic Anemia
    View official trial listing →
  • Completed NCT NCT00056966

    Conditioning Regimen for Allogeneic Hematopoietic Stem Cell Transplantation of Patients With Hematological Diseases

    Not yet reported, Not yet reported Baylor College of Medicine 24 participants Est. completion 2006-12 2 sites
    Other conditions: Hematologic Malignancy
    View official trial listing →
  • Terminated NCT NCT00056979

    Monoclonal Antibody Conditioning for Allogeneic Stem Cell Transplantation of Patients With Inherited Metabolic Storage Diseases

    Not yet reported, Not yet reported Baylor College of Medicine 2 participants Est. completion 2003-06 2 sites
    Other conditions: Inherited Metabolic Storage Diseases
    View official trial listing →
  • Terminated NCT NCT00057954

    Reduced-Intensity Regimen Before Allogeneic Transplant for Patients With Relapsed Non-Hodgkin's or Hodgkin's Lymphoma

    Not yet reported Eastern Cooperative Oncology Group 6 participants Est. completion 2011-05 19 sites Stand-alone
    Other conditions: Lymphoma
    View official trial listing →
  • Terminated NCT NCT00058825

    Stem Cell Transplant for Hematologic Diseases

    Not yet reported, Not yet reported Baylor College of Medicine 27 participants Est. completion 2014-09 2 sites Stand-alone
    Other conditions: Hematologic Malignancies
    View official trial listing →
  • Completed NCT NCT00060632

    Safety Study of Ridaforolimus in Patients With Advanced, Refractory or Recurrent Malignancies (MK-8669-001 AM5)(COMPLETED)

    Not yet reported Merck Sharp & Dohme LLC 46 participants Est. completion 2005-10
    Other conditions: Tumors, Lymphoma, Multiple Myeloma
    View official trial listing →
  • Completed NCT NCT00060645

    Safety Study of AP23573 in Patients With Advanced, Refractory or Recurrent Malignancies (8669-013)(COMPLETED)

    Not yet reported Merck Sharp & Dohme LLC 33 participants Est. completion 2009-02 1 site
    Other conditions: Tumors, Lymphoma, Multiple Myeloma
    View official trial listing →
  • Active, not recruiting NCT NCT00061568

    Improving the Results of Bone Marrow Transplantation for Patients With Severe Congenital Anemias

    Not yet reported, Not yet reported National Heart, Lung, and Blood Institute (NHLBI) 130 participants Est. completion 2028-01-20 1 site Stand-alone
    Other conditions: Congenital Hemolytic Anemia, Sickle Cell Disease
    View official trial listing →
  • Completed NCT NCT00062751

    Study Evaluating Temsirolimus (CCI-779) In Breast Neoplasms

    Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 108 participants Est. completion 2009-10
    Other conditions: Breast Neoplasms
    View official trial listing →
  • Completed NCT NCT00064701

    Comparative Study of Modified Release (MR) Tacrolimus/Mycophenolate Mofetil (MMF) in de Novo Kidney Transplant Recipients

    Not yet reported Astellas Pharma Inc 668 participants Est. completion 2009-03 57 sites Stand-alone
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT00065468

    Study Evaluating Interferon And CCI-779 In Advanced Renal Cell Carcinoma

    Not yet reported Pfizer 626 participants Est. completion 2011-03 153 sites
    Other conditions: Carcinoma, Renal Cell, Kidney Neoplasms
    View official trial listing →
  • Terminated NCT NCT00068302

    Sirolimus in Treating Young Patients With Relapsed or Refractory Acute Leukemia or Non-Hodgkin's Lymphoma

    Not yet reported Children's Hospital of Philadelphia 10 participants Est. completion 2013-07 1 site Stand-alone
    Other conditions: Leukemia, Lymphoma
    View official trial listing →
  • Completed NCT NCT00070135

    Fludarabine and Busulfan Followed by Allogeneic Stem Cell Transplant in Treating Older Patients With Acute Myeloid Leukemia in First Complete Remission

    Not yet reported Alliance for Clinical Trials in Oncology 121 participants Est. completion 2016-06-15 21 sites Stand-alone
    Other conditions: Adult Acute Myeloid Leukemia in Remission, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
    View official trial listing →
  • Completed NCT NCT00071968

    Neoadjuvant CCI-779 Followed By Radical Prostatectomy in Treating Patients With Newly Diagnosed Prostate Cancer Who Have a High Risk of Relapse

    Not yet reported Jonsson Comprehensive Cancer Center 15 participants 1 site
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00072176

    Temsirolimus in Treating Patients With Metastatic or Locally Advanced Recurrent Endometrial Cancer

    Not yet reported National Cancer Institute (NCI) 62 participants Est. completion 2009-08 1 site
    Other conditions: Endometrial Adenocarcinoma, Endometrial Adenosquamous Cell Carcinoma, Endometrial Clear Cell Carcinoma, Endometrial Papillary Serous Carcinoma, Recurrent Endometrial Carcinoma, Stage IIIA Endometrial Carcinoma, Stage IIIB Endometrial Carcinoma, Stage IIIC Endometrial Carcinoma, Stage IVA Endometrial Carcinoma, Stage IVB Endometrial Carcinoma
    View official trial listing →
  • Completed NCT NCT00073281

    Islet Transplantation for Patients With Type 1 Diabetes

    Not yet reported National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 10 participants Est. completion 2004-12 1 site
    Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Terminated NCT NCT00074490

    Donor Stem Cell Transplant With No or Low-Intensity Chemotherapy Using Sirolimus and Treated Immune Cells to Treat Blood and Lymph Cancers

    Not yet reported National Cancer Institute (NCI) 442 participants Est. completion 2017-08-16 2 sites Stand-alone
    Other conditions: Lymphoma, Leukemia, Myeloproliferative Disorders, Multiple Myleoma, Myelodysplastic Syndrome
    View official trial listing →
  • Completed NCT NCT00076570

    Combination Drug Therapy Followed by Single Drug Steroid Free Therapy to Prevent Organ Rejection in Kidney Transplantation

    Not yet reported National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 31 participants Est. completion 2012-08 1 site Stand-alone
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT00078559

    Combination Immunosuppressive Therapy to Prevent Kidney Transplant Rejection in Adults

    Not yet reported, Not yet reported University of Wisconsin, Madison 10 participants Est. completion 2010-02 1 site Stand-alone
    Other conditions: Kidney Transplantation, Kidney Disease
    View official trial listing →
  • Completed NCT NCT00078689

    Daclizumab and Sirolimus to Treat Uveitis

    Not yet reported National Eye Institute (NEI) 6 participants Est. completion 2008-07-18 1 site
    Other conditions: Uveitis
    View official trial listing →
  • Terminated NCT NCT00078806

    Safety and Efficacy Study of Etanercept (Enbrel®) In Children With Systemic Onset Juvenile Rheumatoid Arthritis

    Not yet reported Amgen 19 participants Est. completion 2004-05-06 Stand-alone
    Other conditions: Juvenile Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT00079183

    Sirolimus as Secondary Therapy in Chronic Graft-Versus-Host Disease Not Responding To Prior Treatment

    Not yet reported Fred Hutchinson Cancer Center 44 participants Est. completion 2010-06-10 1 site Stand-alone
    Other conditions: Graft Versus Host Disease
    View official trial listing →
  • Completed NCT NCT00079235

    CCI-779 in Treating Patients With Stage IIIB (With Pleural Effusion) or Stage IV Non-Small Cell Lung Cancer

    Not yet reported National Cancer Institute (NCI) 50 participants 1 site
    Other conditions: Recurrent Non-small Cell Lung Cancer, Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer
    View official trial listing →
  • Completed NCT NCT00081874

    RAD001 in Relapsed or Refractory AML, ALL, CML in Blastic-Phase, Agnogenic Myeloid Metaplasia, CLL, T-Cell Leukemia, or Mantle Cell Lymphoma

    Not yet reported, Not yet reported M.D. Anderson Cancer Center 29 participants Est. completion 2006-09 1 site
    Other conditions: Leukemia, Mantle Cell Lymphoma, Myelofibrosis
    View official trial listing →
  • Completed NCT NCT00082381

    Effect of AC2993 Compared With Insulin Glargine in Patients With Type 2 Diabetes Also Using Combination Therapy With Sulfonylurea and Metformin

    Not yet reported AstraZeneca 551 participants Est. completion 2008-07 91 sites Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Terminated NCT NCT00083993

    Study Evaluating CCI-779 and Letrozole in Post-menopausal Women With Breast Cancer

    Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 1236 participants Est. completion 2006-10 129 sites
    Other conditions: Breast Neoplasms, Neoplasm Metastasis
    View official trial listing →
  • Completed NCT NCT00084916

    CCI-779 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndromes, or Chronic Myelogenous Leukemia in Blastic Phase

    Not yet reported National Cancer Institute (NCI) 74 participants 1 site
    Other conditions: Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Blastic Phase Chronic Myelogenous Leukemia, Chronic Myelomonocytic Leukemia, de Novo Myelodysplastic Syndromes, Previously Treated Myelodysplastic Syndromes, Recurrent Adult Acute Lymphoblastic Leukemia, Recurrent Adult Acute Myeloid Leukemia, Refractory Anemia With Excess Blasts, Refractory Anemia With Excess Blasts in Transformation, Relapsing Chronic Myelogenous Leukemia, Secondary Myelodysplastic Syndromes
    View official trial listing →
  • Completed NCT NCT00085566

    Everolimus and Gefitinib in Treating Patients With Progressive Glioblastoma Multiforme or Progressive Metastatic Prostate Cancer

    Not yet reported, Not yet reported Memorial Sloan Kettering Cancer Center 61 participants Est. completion 2008-02 2 sites
    Other conditions: Brain and Central Nervous System Tumors, Prostate Cancer
    View official trial listing →
  • Terminated NCT NCT00086346

    Study Evaluating of Calcineurin Inhibitor and Sirolimus (Rapamune) Treatment in Liver Transplant Recipients

    Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 607 participants Est. completion 2008-07 42 sites
    Other conditions: Liver Transplantation
    View official trial listing →
  • Completed NCT NCT00087581

    Study of Therapeutic Monitoring of Mycophenolate Mofetil (MMF/CellCept) After Kidney Transplantation

    Not yet reported Hoffmann-La Roche 720 participants Est. completion 2007-09 57 sites Stand-alone
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT00089011

    Tacrolimus and Mycophenolate Mofetil in Preventing Graft-Versus-Host Disease in Patients Who Have Undergone Total-Body Irradiation With or Without Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant for Hematologic Cancer

    Not yet reported Fred Hutchinson Cancer Center 150 participants Est. completion 2018-07 5 sites Stand-alone
    Obstructive sleep apnea Other conditions: Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, Blastic Phase Chronic Myelogenous Leukemia, Childhood Acute Lymphoblastic Leukemia in Remission, Childhood Acute Myeloid Leukemia in Remission, Childhood Burkitt Lymphoma, Childhood Chronic Myelogenous Leukemia, Childhood Diffuse Large Cell Lymphoma, Childhood Immunoblastic Large Cell Lymphoma, Childhood Myelodysplastic Syndromes, Childhood Nasal Type Extranodal NK/T-cell Lymphoma, Chronic Phase Chronic Myelogenous Leukemia, Contiguous Stage II Adult Burkitt Lymphoma, Contiguous Stage II Adult Diffuse Large Cell Lymphoma, Contiguous Stage II Adult Diffuse Mixed Cell Lymphoma, Contiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma, Contiguous Stage II Adult Immunoblastic Large Cell Lymphoma, Contiguous Stage II Adult Lymphoblastic Lymphoma, Contiguous Stage II Grade 1 Follicular Lymphoma, Contiguous Stage II Grade 2 Follicular Lymphoma, Contiguous Stage II Grade 3 Follicular Lymphoma, Contiguous Stage II Mantle Cell Lymphoma, Contiguous Stage II Marginal Zone Lymphoma, Contiguous Stage II Small Lymphocytic Lymphoma, Cutaneous B-cell Non-Hodgkin Lymphoma, de Novo Myelodysplastic Syndromes, Essential Thrombocythemia, Hepatosplenic T-cell Lymphoma, Intraocular Lymphoma, Nodal Marginal Zone B-cell Lymphoma, Noncontiguous Stage II Adult Burkitt Lymphoma, Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma, Noncontiguous Stage II Adult Diffuse Mixed Cell Lymphoma, Noncontiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma, Noncontiguous Stage II Adult Immunoblastic Large Cell Lymphoma, Noncontiguous Stage II Adult Lymphoblastic Lymphoma, Noncontiguous Stage II Grade 1 Follicular Lymphoma, Noncontiguous Stage II Grade 2 Follicular Lymphoma, Noncontiguous Stage II Grade 3 Follicular Lymphoma, Noncontiguous Stage II Mantle Cell Lymphoma, Noncontiguous Stage II Marginal Zone Lymphoma, Noncontiguous Stage II Small Lymphocytic Lymphoma, Noncutaneous Extranodal Lymphoma, Peripheral T-cell Lymphoma, Polycythemia Vera, Post-transplant Lymphoproliferative Disorder, Previously Treated Myelodysplastic Syndromes, Primary Myelofibrosis, Prolymphocytic Leukemia, Recurrent Adult Acute Lymphoblastic Leukemia, Recurrent Adult Acute Myeloid Leukemia, Recurrent Adult Burkitt Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma, Recurrent Adult Diffuse Mixed Cell Lymphoma, Recurrent Adult Diffuse Small Cleaved Cell Lymphoma, Recurrent Adult Grade III Lymphomatoid Granulomatosis, Recurrent Adult Hodgkin Lymphoma, Recurrent Adult Immunoblastic Large Cell Lymphoma, Recurrent Adult Lymphoblastic Lymphoma, Recurrent Adult T-cell Leukemia/Lymphoma, Recurrent Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood Acute Myeloid Leukemia, Recurrent Childhood Anaplastic Large Cell Lymphoma, Recurrent Childhood Grade III Lymphomatoid Granulomatosis, Recurrent Childhood Large Cell Lymphoma, Recurrent Childhood Lymphoblastic Lymphoma, Recurrent Childhood Small Noncleaved Cell Lymphoma, Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Grade 3 Follicular Lymphoma, Recurrent Mantle Cell Lymphoma, Recurrent Marginal Zone Lymphoma, Recurrent Mycosis Fungoides/Sezary Syndrome, Recurrent Small Lymphocytic Lymphoma, Recurrent/Refractory Childhood Hodgkin Lymphoma, Refractory Chronic Lymphocytic Leukemia, Refractory Hairy Cell Leukemia, Refractory Multiple Myeloma, Relapsing Chronic Myelogenous Leukemia, Small Intestine Lymphoma, Splenic Marginal Zone Lymphoma, Stage I Adult Burkitt Lymphoma, Stage I Adult Diffuse Large Cell Lymphoma, Stage I Adult Diffuse Mixed Cell Lymphoma, Stage I Adult Diffuse Small Cleaved Cell Lymphoma, Stage I Adult Immunoblastic Large Cell Lymphoma, Stage I Adult Lymphoblastic Lymphoma, Stage I Adult T-cell Leukemia/Lymphoma, Stage I Childhood Anaplastic Large Cell Lymphoma, Stage I Childhood Large Cell Lymphoma, Stage I Childhood Lymphoblastic Lymphoma, Stage I Childhood Small Noncleaved Cell Lymphoma, Stage I Chronic Lymphocytic Leukemia, Stage I Cutaneous T-cell Non-Hodgkin Lymphoma, Stage I Grade 1 Follicular Lymphoma, Stage I Grade 2 Follicular Lymphoma, Stage I Grade 3 Follicular Lymphoma, Stage I Mantle Cell Lymphoma, Stage I Marginal Zone Lymphoma, Stage I Multiple Myeloma, Stage I Small Lymphocytic Lymphoma, Stage IA Mycosis Fungoides/Sezary Syndrome, Stage IB Mycosis Fungoides/Sezary Syndrome, Stage II Adult T-cell Leukemia/Lymphoma, Stage II Childhood Anaplastic Large Cell Lymphoma, Stage II Childhood Large Cell Lymphoma, Stage II Childhood Lymphoblastic Lymphoma, Stage II Childhood Small Noncleaved Cell Lymphoma, Stage II Chronic Lymphocytic Leukemia, Stage II Cutaneous T-cell Non-Hodgkin Lymphoma, Stage II Multiple Myeloma, Stage IIA Mycosis Fungoides/Sezary Syndrome, Stage IIB Mycosis Fungoides/Sezary Syndrome, Stage III Adult Burkitt Lymphoma, Stage III Adult Diffuse Large Cell Lymphoma, Stage III Adult Diffuse Mixed Cell Lymphoma, Stage III Adult Diffuse Small Cleaved Cell Lymphoma, Stage III Adult Immunoblastic Large Cell Lymphoma, Stage III Adult Lymphoblastic Lymphoma, Stage III Adult T-cell Leukemia/Lymphoma, Stage III Childhood Anaplastic Large Cell Lymphoma, Stage III Childhood Large Cell Lymphoma, Stage III Childhood Lymphoblastic Lymphoma, Stage III Childhood Small Noncleaved Cell Lymphoma, Stage III Chronic Lymphocytic Leukemia, Stage III Cutaneous T-cell Non-Hodgkin Lymphoma, Stage III Grade 1 Follicular Lymphoma, Stage III Grade 2 Follicular Lymphoma, Stage III Grade 3 Follicular Lymphoma, Stage III Mantle Cell Lymphoma, Stage III Marginal Zone Lymphoma, Stage III Multiple Myeloma, Stage III Small Lymphocytic Lymphoma, Stage IIIA Mycosis Fungoides/Sezary Syndrome, Stage IIIB Mycosis Fungoides/Sezary Syndrome, Stage IV Adult Burkitt Lymphoma, Stage IV Adult Diffuse Large Cell Lymphoma, Stage IV Adult Diffuse Mixed Cell Lymphoma, Stage IV Adult Diffuse Small Cleaved Cell Lymphoma, Stage IV Adult Immunoblastic Large Cell Lymphoma, Stage IV Adult Lymphoblastic Lymphoma, Stage IV Adult T-cell Leukemia/Lymphoma, Stage IV Childhood Anaplastic Large Cell Lymphoma, Stage IV Childhood Large Cell Lymphoma, Stage IV Childhood Lymphoblastic Lymphoma, Stage IV Childhood Small Noncleaved Cell Lymphoma, Stage IV Chronic Lymphocytic Leukemia, Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma, Stage IV Grade 1 Follicular Lymphoma, Stage IV Grade 2 Follicular Lymphoma, Stage IV Grade 3 Follicular Lymphoma, Stage IV Mantle Cell Lymphoma, Stage IV Marginal Zone Lymphoma, Stage IV Small Lymphocytic Lymphoma, Stage IVA Mycosis Fungoides/Sezary Syndrome, Stage IVB Mycosis Fungoides/Sezary Syndrome, Testicular Lymphoma, Untreated Adult Acute Lymphoblastic Leukemia, Untreated Adult Acute Myeloid Leukemia, Untreated Childhood Acute Lymphoblastic Leukemia, Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies, Waldenström Macroglobulinemia
    View official trial listing →
  • Completed NCT NCT00089037

    Sirolimus, Tacrolimus, and Methotrexate in Preventing Acute Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplantation

    Not yet reported, Not yet reported Fred Hutchinson Cancer Center Est. completion 2005-04 1 site
    Other conditions: Chronic Myeloproliferative Disorders, Graft Versus Host Disease, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Diseases
    View official trial listing →
  • Completed NCT NCT00089947

    A Study to Evaluate the Effect of Thymoglobulin and Reduced Doses of Steroids to Prevent Renal Transplant Rejection

    Not yet reported Genzyme, a Sanofi Company 150 participants Est. completion 2005-12 19 sites
    Other conditions: Renal Transplantation, Graft Rejection
    View official trial listing →
  • Completed NCT NCT00093080

    Study of AP23573/MK-8669 (Ridaforolimus), A Mammalian Target of Rapamycin (mTOR) Inhibitor, in Participants With Advanced Sarcoma (MK-8669-018 AM1)(COMPLETED)

    Not yet reported Merck Sharp & Dohme LLC 216 participants Est. completion 2008-11
    Obstructive sleep apnea Other conditions: Sarcoma, Soft Tissue, Metastases
    View official trial listing →
  • Completed NCT NCT00093366

    Arsenic Trioxide and Etanercept in Treating Patients With Myelodysplastic Syndromes

    Not yet reported, Not yet reported Fred Hutchinson Cancer Center 32 participants Est. completion 2006-07 1 site
    Other conditions: Leukemia, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Diseases
    View official trial listing →
  • Completed NCT NCT00093782

    Temsirolimus in Treating Patients With Metastatic Neuroendocrine Carcinoma

    Not yet reported National Cancer Institute (NCI) 36 participants Est. completion 2011-04 1 site
    Other conditions: Metastatic Gastrointestinal Carcinoid Tumor, Pulmonary Carcinoid Tumor, Recurrent Gastrointestinal Carcinoid Tumor, Recurrent Islet Cell Carcinoma
    View official trial listing →
  • Completed NCT NCT00094341

    Preference of Rheumatoid Arthritis (RA) Patients of Enbrel® (Etanercept) Auto-Injector Versus Enbrel® Pre-Filled Syringes

    Not yet reported Amgen 215 participants
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT00096096

    Tacrolimus and Mycophenolate Mofetil in Preventing Acute Graft-Versus-Host Disease in Patients With Advanced Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplantation

    Not yet reported Fred Hutchinson Cancer Center 1 site
    Other conditions: Chronic Myeloproliferative Disorders, Graft Versus Host Disease, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Diseases
    View official trial listing →
  • Terminated NCT NCT00096460

    Autologous or Donor Stem Cell Transplantation in Treating Patients With Recurrent Non-Hodgkin's Lymphoma (BMT CTN 0202)

    Not yet reported, Not yet reported Medical College of Wisconsin 30 participants Est. completion 2009-03 30 sites
    Other conditions: Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Grade 3 Follicular Lymphoma, Follicular Lymphoma
    View official trial listing →
  • Completed NCT NCT00096486

    Gefitinib and Everolimus in Treating Patients With Stage IIIB or Stage IV or Recurrent Non-Small Cell Lung Cancer

    Not yet reported, Not yet reported Memorial Sloan Kettering Cancer Center 74 participants Est. completion 2010-07 1 site
    Other conditions: Lung Cancer
    View official trial listing →
  • Completed NCT NCT00098007

    A Study of Safety, Tolerability & Efficacy of Certican in de Novo Heart Transplant (Tx) Patients

    Not yet reported Novartis Pharmaceuticals 199 participants Est. completion 2007-01-08 28 sites
    Other conditions: Heart Transplantation
    View official trial listing →
  • Withdrawn NCT NCT00098462

    Gefitinib and Sirolimus in Treating Patients With Recurrent or Refractory Stage IIIB or Stage IV Non-Small Cell Lung Cancer

    Not yet reported, Not yet reported Jonsson Comprehensive Cancer Center
    Other conditions: Lung Cancer
    View official trial listing →
  • Completed NCT NCT00098501

    CCI-779 and EKB-569 in Treating Patients With Advanced Solid Tumors

    Not yet reported National Cancer Institute (NCI) 42 participants 1 site
    Other conditions: Unspecified Adult Solid Tumor, Protocol Specific
    View official trial listing →
  • Completed NCT NCT00098553

    Everolimus in Treating Patients With Stage IV Melanoma

    Not yet reported Alliance for Clinical Trials in Oncology 53 participants Est. completion 2010-02 94 sites
    Other conditions: Melanoma (Skin)
    View official trial listing →
  • Completed NCT NCT00099320

    Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using Thiazolidinediones or Thiazolidinediones and Metformin

    Not yet reported AstraZeneca 182 participants Est. completion 2005-08 51 sites Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00099333

    Study of the Safety of Substituting Exenatide for Insulin in Patients Using Insulin and Oral Antidiabetic Agents

    Not yet reported AstraZeneca 49 participants Est. completion 2005-08 5 sites Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00101738

    Freedom Study: Myfortic in Kidney Transplant Patients

    Not yet reported Novartis Pharmaceuticals 342 participants Est. completion 2005-05 44 sites
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT00103935

    Study Examining Exenatide Long-Acting Release in Subjects With Type 2 Diabetes

    Not yet reported AstraZeneca 45 participants Est. completion 2005-10 7 sites Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00104975

    Alemtuzumab and Combination Chemotherapy Followed By Donor Lymphocytes in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer

    Not yet reported Yale University 20 participants Est. completion 2008-05 1 site
    Other conditions: Chronic Myeloproliferative Disorders, Leukemia, Lymphoma, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
    View official trial listing →
  • Completed NCT NCT00105001

    Tacrolimus and Mycophenolate Mofetil With or Without Sirolimus in Preventing Acute Graft-Versus-Host Disease in Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer

    Not yet reported Fred Hutchinson Cancer Center 210 participants Est. completion 2015-05-08 11 sites Stand-alone
    Other conditions: Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable, Previously Treated Myelodysplastic Syndrome, Refractory Chronic Lymphocytic Leukemia, Refractory Plasma Cell Myeloma, Waldenstrom Macroglobulinemia, Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With t(9;11)(p22;q23); MLLT3-MLL, Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11, Adult Acute Promyelocytic Leukemia With t(15;17)(q22;q12); PML-RARA, Adult Acute Myeloid Leukemia With t(8;21)(q22;q22); RUNX1-RUNX1T1, Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Childhood Acute Lymphoblastic Leukemia in Remission, Childhood Acute Myeloid Leukemia in Remission, Childhood Burkitt Lymphoma, Childhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Childhood Diffuse Large Cell Lymphoma, Childhood Immunoblastic Lymphoma, Childhood Myelodysplastic Syndrome, Stage II Contiguous Adult Burkitt Lymphoma, Stage II Contiguous Adult Diffuse Large Cell Lymphoma, Stage II Contiguous Adult Diffuse Mixed Cell Lymphoma, Stage II Contiguous Adult Diffuse Small Cleaved Cell Lymphoma, Stage II Adult Contiguous Immunoblastic Lymphoma, Stage II Contiguous Adult Lymphoblastic Lymphoma, Stage II Grade 1 Contiguous Follicular Lymphoma, Stage II Grade 2 Contiguous Follicular Lymphoma, Stage II Grade 3 Contiguous Follicular Lymphoma, Stage II Contiguous Mantle Cell Lymphoma, Stage II Non-Contiguous Adult Burkitt Lymphoma, Stage II Non-Contiguous Adult Diffuse Large Cell Lymphoma, Stage II Non-Contiguous Adult Diffuse Mixed Cell Lymphoma, Stage II Non-Contiguous Adult Diffuse Small Cleaved Cell Lymphoma, Stage II Adult Non-Contiguous Immunoblastic Lymphoma, Stage II Non-Contiguous Adult Lymphoblastic Lymphoma, Stage II Grade 1 Non-Contiguous Follicular Lymphoma, Stage II Grade 2 Non-Contiguous Follicular Lymphoma, Stage II Grade 3 Non-Contiguous Follicular Lymphoma, Stage II Non-Contiguous Mantle Cell Lymphoma, Stage II Small Lymphocytic Lymphoma, Recurrent Adult Acute Lymphoblastic Leukemia, Recurrent Adult Acute Myeloid Leukemia, Recurrent Adult Burkitt Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma, Recurrent Adult Diffuse Mixed Cell Lymphoma, Recurrent Adult Diffuse Small Cleaved Cell Lymphoma, Recurrent Adult Hodgkin Lymphoma, Recurrent Adult Immunoblastic Lymphoma, Recurrent Adult Lymphoblastic Lymphoma, Recurrent Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood Acute Myeloid Leukemia, Recurrent Childhood Anaplastic Large Cell Lymphoma, Recurrent Childhood Large Cell Lymphoma, Recurrent Childhood Lymphoblastic Lymphoma, Recurrent Childhood Burkitt Lymphoma, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Grade 3 Follicular Lymphoma, Recurrent Mantle Cell Lymphoma, Recurrent Marginal Zone Lymphoma, Recurrent Small Lymphocytic Lymphoma, Recurrent Childhood Hodgkin Lymphoma, Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Secondary Myelodysplastic Syndrome, Stage I Adult Burkitt Lymphoma, Stage I Adult Diffuse Large Cell Lymphoma, Stage I Adult Diffuse Mixed Cell Lymphoma, Stage I Adult Immunoblastic Lymphoma, Stage I Adult Lymphoblastic Lymphoma, Stage I Childhood Anaplastic Large Cell Lymphoma, Stage I Childhood Large Cell Lymphoma, Stage I Childhood Lymphoblastic Lymphoma, Stage I Childhood Burkitt Lymphoma, Stage I Grade 1 Follicular Lymphoma, Stage I Grade 2 Follicular Lymphoma, Stage I Grade 3 Follicular Lymphoma, Stage I Mantle Cell Lymphoma, Stage I Marginal Zone Lymphoma, Stage I Small Lymphocytic Lymphoma, Stage II Childhood Anaplastic Large Cell Lymphoma, Stage II Childhood Lymphoblastic Lymphoma, Stage II Childhood Burkitt Lymphoma, Stage III Adult Burkitt Lymphoma, Stage III Adult Diffuse Large Cell Lymphoma, Stage III Adult Diffuse Mixed Cell Lymphoma, Stage III Adult Diffuse Small Cleaved Cell Lymphoma, Stage III Adult Immunoblastic Lymphoma, Stage III Adult Lymphoblastic Lymphoma, Stage III Childhood Anaplastic Large Cell Lymphoma, Stage III Childhood Large Cell Lymphoma, Stage III Childhood Lymphoblastic Lymphoma, Stage III Childhood Burkitt Lymphoma, Stage III Grade 1 Follicular Lymphoma, Stage III Grade 2 Follicular Lymphoma, Stage III Grade 3 Follicular Lymphoma, Stage III Mantle Cell Lymphoma, Stage III Marginal Zone Lymphoma, Stage III Small Lymphocytic Lymphoma, Stage IV Adult Burkitt Lymphoma, Stage IV Adult Diffuse Large Cell Lymphoma, Stage IV Adult Diffuse Mixed Cell Lymphoma, Stage IV Adult Diffuse Small Cleaved Cell Lymphoma, Stage IV Adult Immunoblastic Lymphoma, Stage IV Adult Lymphoblastic Lymphoma, Stage IV Childhood Anaplastic Large Cell Lymphoma, Stage IV Childhood Large Cell Lymphoma, Stage IV Childhood Lymphoblastic Lymphoma, Stage IV Childhood Burkitt Lymphoma, Stage IV Grade 1 Follicular Lymphoma, Stage IV Grade 2 Follicular Lymphoma, Stage IV Grade 3 Follicular Lymphoma, Stage IV Mantle Cell Lymphoma, Stage IV Marginal Zone Lymphoma, Stage IV Small Lymphocytic Lymphoma
    View official trial listing →
  • Completed NCT NCT00105235

    Immune System Suppression With Alemtuzumab and Tacrolimus in Liver Transplantation Patients

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 27 participants Est. completion 2011-03 9 sites Stand-alone
    Other conditions: Liver Disease, Liver Transplantation
    View official trial listing →
  • Completed NCT NCT00106392

    A Safety and Efficacy Study of Prograf in the Prevention of Erectile Dysfunction After Radical Prostatectomy

    Not yet reported Astellas Pharma Inc 131 participants Est. completion 2008-11 6 sites Stand-alone
    Other conditions: Erectile Dysfunction, Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00106496

    A Multi-Center Study of Short and Long-term Use of Protopic Ointment in Patients With Atopic Dermatitis

    Not yet reported Astellas Pharma Inc 410 participants Est. completion 2006-07 24 sites
    Other conditions: Dermatitis, Atopic
    View official trial listing →
  • Completed NCT NCT00106639

    A 6-Month Study Of CP-690,550 Versus Tacrolimus In Kidney Transplant Patients

    Not yet reported Pfizer 61 participants Est. completion 2006-07 20 sites
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT00107016

    Everolimus and Letrozole as Preoperative Therapy of Primary Breast Cancer in Post-menopausal Women

    Not yet reported Novartis Pharmaceuticals 267 participants Est. completion 2007-04 46 sites
    Other conditions: Breast Neoplasm
    View official trial listing →
  • Completed NCT NCT00107237

    AEE788 and Everolimus in Treating Patients With Recurrent or Relapsed Glioblastoma Multiforme

    Not yet reported, Not yet reported Novartis Pharmaceuticals 16 participants Est. completion 2006-06 3 sites
    Other conditions: Brain and Central Nervous System Tumors
    View official trial listing →
  • Completed NCT NCT00107991

    Etanercept for Treatment of Hidradenitis

    Not yet reported University of Pennsylvania 15 participants Est. completion 2008-11 Stand-alone
    Other conditions: Hidradenitis Suppurativa
    View official trial listing →
  • Completed NCT NCT00109967

    CCI-779 and Rituximab in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

    Not yet reported National Cancer Institute (NCI) 71 participants Est. completion 2012-03 195 sites
    Other conditions: Recurrent Mantle Cell Lymphoma
    View official trial listing →
  • Completed NCT NCT00109993

    Campath-1H + FK506 and Methylprednisolone for GVHD

    Not yet reported Case Comprehensive Cancer Center 34 participants Est. completion 2007-05 6 sites
    Other conditions: Breast Cancer, Chronic Myeloproliferative Disorders, Gestational Trophoblastic Tumor, Graft Versus Host Disease, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Diseases, Neuroblastoma, Ovarian Cancer, Testicular Germ Cell Tumor
    View official trial listing →
  • Completed NCT NCT00110903

    Treatment for Subjects With Active Rheumatoid Arthritis (RA)

    Not yet reported Amgen
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT00110981

    Utilization of Narrow Band Ultraviolet B (UVB) Light Therapy and Etanercept for the Treatment of Psoriasis

    Not yet reported Amgen 86 participants Est. completion 2006-03 Stand-alone
    Other conditions: Psoriasis
    View official trial listing →
  • Completed NCT NCT00111111

    An Evaluation of Etanercept in the Treatment of Subjects With Psoriasis

    Not yet reported Amgen
    Other conditions: Psoriasis
    View official trial listing →
  • Completed NCT NCT00111124

    Enbrel® in Psoriatic Arthritis

    Not yet reported Amgen
    Other conditions: Psoriasis
    View official trial listing →
  • Completed NCT NCT00111540

    Study to Examine the Effect on Glucose Control and Safety/Tolerability of Exenatide Given Two Times a Day to Subjects With Type 2 Diabetes

    Not yet reported AstraZeneca 456 participants Est. completion 2006-09 60 sites Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00112736

    Erlotinib and Temsirolimus in Treating Patients With Recurrent Malignant Glioma

    Not yet reported, Not yet reported National Cancer Institute (NCI) 69 participants Est. completion 2014-04 8 sites
    Obstructive sleep apnea Other conditions: Adult Anaplastic Astrocytoma, Adult Anaplastic Oligodendroglioma, Adult Diffuse Astrocytoma, Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Mixed Glioma, Adult Pilocytic Astrocytoma, Adult Pineal Gland Astrocytoma, Adult Subependymal Giant Cell Astrocytoma, Recurrent Adult Brain Tumor
    View official trial listing →
  • Completed NCT NCT00112840

    CCI-779 and Bevacizumab in Treating Patients With Metastatic or Unresectable Kidney Cancer

    Not yet reported, Not yet reported National Cancer Institute (NCI) 60 participants Est. completion 2015-09-10 2 sites
    Other conditions: Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage IV Renal Cell Cancer
    View official trial listing →
  • Completed NCT NCT00113269

    Safety/Efficacy of Induction Agents With Tacrolimus, MMF, and Rapid Steroid Withdrawal in Renal Transplant Recipients

    Not yet reported Astellas Pharma Inc 501 participants Est. completion 2009-03 29 sites Stand-alone
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT00116103

    A Study of the Safety and Efficacy of Tacrolimus Inhalation Aerosol in Subjects With Persistent Asthma

    Not yet reported Astellas Pharma Inc Est. completion 2006-04 21 sites
    Other conditions: Asthma
    View official trial listing →
  • Completed NCT NCT00116727

    Rheumatoid Arthritis DMARD Intervention and UtilizationStudy

    Amgen 5103 participants Est. completion 2008-10
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT00117689

    Evaluation of Thymoglobulin Induction and Reduced Doses of Calcineurin Inhibitors on Liver Transplant Rejection

    Not yet reported Genzyme, a Sanofi Company 75 participants Est. completion 2007-12 16 sites Stand-alone
    Other conditions: Liver Dysfunction, Rejection, Transplant, Transplantation, Liver
    View official trial listing →
  • Terminated NCT NCT00117702

    Prevention of the Graft-Versus-Host-Disease in Patients After Stem Cell Transplantation With Tacrolimus and Everolimus

    Not yet reported, Not yet reported Technische Universität Dresden 24 participants Est. completion 2008-05 1 site
    Other conditions: Graft vs Host Disease
    View official trial listing →
  • Completed NCT NCT00118742

    Liver Spare the Nephron (STN) Study - A Study of CellCept (Mycophenolate Mofetil) and Sirolimus in Recipients of a Liver Transplant

    Not yet reported Hoffmann-La Roche 293 participants Est. completion 2008-12 46 sites Stand-alone
    Other conditions: Liver Transplantation
    View official trial listing →
  • Completed NCT NCT00121056

    REKinDLE: Registry With Enbrel® or Kineret® in a Database Using Longitudinal Evaluations

    Amgen
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Terminated NCT NCT00121186

    S0501 Fludarabine, Melphalan, and Donor Stem Cell Transplant Followed By Tacrolimus and Methotrexate in Treating Patients for Relapsed Lymphoma

    Not yet reported SWOG Cancer Research Network 1 participants Est. completion 2011-12 33 sites Stand-alone
    Other conditions: Lymphoma
    View official trial listing →
  • Terminated NCT NCT00121784

    Heart Spare the Nephron (STN) Study - A Study of CellCept (Mycophenolate Mofetil) and Rapamune (Sirolimus) in Heart Transplant Recipients

    Not yet reported Hoffmann-La Roche 12 participants Est. completion 2006-08 29 sites
    Other conditions: Heart Transplantation
    View official trial listing →
  • Completed NCT NCT00121810

    Kidney Spare the Nephron (STN) Study - A Study of CellCept (Mycophenolate Mofetil) and Rapamune (Sirolimus) in Kidney Transplant Recipients

    Not yet reported Hoffmann-La Roche 305 participants Est. completion 2009-11 36 sites Stand-alone
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT00124280

    Study Investigating the Effect of Everolimus Monotherapy in Patients With Advanced Non-small Cell Lung Cancer (NSCLC)

    Not yet reported Novartis Pharmaceuticals 85 participants 2 sites
    Other conditions: Non-small-cell Lung Carcinoma
    View official trial listing →
  • Completed NCT NCT00124982

    Study of Abatacept (BMS-188667) in Subjects With Active Rheumatoid Arthritis on Background Non-biologic DMARDS (Disease Modifying Antirheumatic Drugs) Who Have an Inadequate Response to Anti-TNF Therapy

    Not yet reported Bristol-Myers Squibb 1286 participants Est. completion 2009-08 148 sites Stand-alone
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT00125307

    Tacrolimus for the Treatment of Systemic Lupus Erythematosus With Membranous Nephritis

    Not yet reported Chinese University of Hong Kong 20 participants Est. completion 2008-02 1 site
    Other conditions: Lupus Nephritis, Lupus Erythematosus, Systemic
    View official trial listing →
  • Completed NCT NCT00126672

    RAPAMYCIN FOR KIDNEY ANGIOMYOLIPOMAS

    Not yet reported Dana-Farber Cancer Institute 36 participants Est. completion 2010-04 7 sites
    Other conditions: Nonmalignant Neoplasm, Tuberous Sclerosis, Lymphangioleimyomatosis, Kidney Angiomyolipoma
    View official trial listing →
  • Terminated NCT NCT00127387

    Enbrel Versus Placebo With Radiation Therapy to Combat Fatigue and Cachexia

    Not yet reported, Not yet reported The University of Texas Health Science Center at San Antonio 54 participants Est. completion 2005-11 1 site
    Other conditions: Lung Cancer, Prostate Cancer, Neoplasm Metastasis, Bone Cancer
    View official trial listing →
  • Completed NCT NCT00127842

    REPArE: Rating Evaluations in Psoriatic Arthritis (PsA) With Etanercept (Enbrel®)

    Not yet reported Amgen 110 participants Est. completion 2009-09
    Other conditions: Psoriatic Arthritis
    View official trial listing →
  • Completed NCT NCT00129961

    Study Evaluating the Effect of Sirolimus on Non-Melanoma Skin Cancer in Kidney Transplant Recipients

    Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 86 participants Est. completion 2009-01 23 sites
    Other conditions: Skin Neoplasms, Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT00130546

    Intra-Individual Comparison of Sirolimus and Paclitaxel Coated Stent (FRE-RACE Study)

    Not yet reported University Hospital Freiburg 112 participants Est. completion 2008-07 1 site
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT00132418

    Study of Enbrel in Rheumatoid Arthritis (RA) Subjects With Comorbid Disorders

    Not yet reported Amgen 564 participants Est. completion 2004-02
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT00132691

    Multicenter Uveitis Steroid Treatment (MUST) Trial

    Not yet reported JHSPH Center for Clinical Trials 255 participants Est. completion 2010-12 23 sites
    Other conditions: Uveitis
    View official trial listing →
  • Terminated NCT NCT00133172

    Effect of Rapid Steroid Withdrawal on Subclinical Markers of Rejection

    Not yet reported Astellas Pharma Inc 85 participants Est. completion 2007-03 14 sites Stand-alone
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT00133315

    TNFalfa Blocking Treatment of Spondylarthropathies

    Not yet reported Hvidovre University Hospital 50 participants Est. completion 2007-04 9 sites
    Other conditions: Spondylarthropathies, Ankylosing Spondylitis, Psoriatic Arthritis
    View official trial listing →
  • Completed NCT NCT00133367

    Study of Unrelated Cord Blood Transplantation Using Tacrolimus and Sirolimus

    Not yet reported Massachusetts General Hospital 32 participants Est. completion 2011-11 2 sites
    Other conditions: Multiple Myeloma, Non-Hodgkin's Lymphoma, Hodgkin's Disease, Myelogenous Leukemia, Lymphoblastic Leukemia
    View official trial listing →
  • Completed NCT NCT00133809

    Islet Transplantation in Type 1 Diabetics Using the Edmonton Protocol of Steroid Free Immunosuppression

    Not yet reported Emory University 8 participants Est. completion 2014-12 1 site
    Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT00133887

    TUMORAPA 1: Efficacy of Rapamycin in Secondary Prevention of Skin Cancers in Kidney Transplant Recipients

    Not yet reported Hospices Civils de Lyon 77 participants Est. completion 2014-05 1 site
    Other conditions: Skin Cancer, Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT00134004

    Fludarabine, Cyclophosphamide, and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic Cancer

    Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 210 participants Est. completion 2015-01 3 sites Stand-alone
    Other conditions: Chronic Myeloproliferative Disorders, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes
    View official trial listing →
  • Completed NCT NCT00134394

    Etanercept With Tacrolimus for Psoriasis

    Not yet reported University of Medicine and Dentistry of New Jersey 20 participants Est. completion 2007-12 1 site
    Other conditions: Psoriasis
    View official trial listing →
  • Completed NCT NCT00135330

    An Evaluation of Exenatide and Rosiglitazone in Subjects With Type 2 Diabetes Mellitus

    Not yet reported AstraZeneca 137 participants Est. completion 2008-07 19 sites Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00135694

    Gradual Withdrawal of Immune System Suppressing Drugs in Patients Receiving a Liver Transplant

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 275 participants Est. completion 2015-09 8 sites Stand-alone
    Other conditions: Hepatitis C, Hepatitis C, Chronic, Nonimmune Nonviral Causes of Liver Failure
    View official trial listing →
  • Completed NCT NCT00135720

    Study of Etanercept (Enbrel) in the Treatment of Pemphigus Vulgaris

    Not yet reported Massachusetts General Hospital 12 participants Est. completion 2007-11 1 site
    Other conditions: Pemphigus Vulgaris
    View official trial listing →
  • Completed NCT NCT00136903

    Safety and Efficacy Study of Adult Human Mesenchymal Stem Cells to Treat Acute Graft Versus Host Disease (GVHD)

    Not yet reported Mesoblast, Inc. 32 participants Est. completion 2008-07-14 9 sites
    Other conditions: Graft Vs Host Disease
    View official trial listing →
  • Completed NCT NCT00139386

    Candesartan for Prevention of Cardiovascular Events After Cypher or Taxus Coronary Stenting (4C) Trial

    Not yet reported Kumamoto University 1119 participants Est. completion 2012-04 1 site
    Cardiovascular disease Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT00140530

    Nonpolymer- and Polymer-Based Drug-Eluting Stents for Restenosis (ISAR-TEST-1)

    Not yet reported Deutsches Herzzentrum Muenchen 450 participants Est. completion 2005-06 2 sites
    Other conditions: Coronary Disease
    View official trial listing →
  • Completed NCT NCT00140543

    European Trial of Immunosuppression in SPK Tx

    Not yet reported EUROSPK Study Group 228 participants Est. completion 2005-09-30 14 sites
    Chronic kidney disease Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT00141037

    Steroid-Free Versus Steroid-Based Immunosuppression in Pediatric Renal (Kidney) Transplantation

    Not yet reported, Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 130 participants Est. completion 2010-11 12 sites Stand-alone
    Other conditions: Kidney Diseases, Kidney Transplantation, Kidney Transplant, Renal Transplantation, Renal Transplant
    View official trial listing →
  • Completed NCT NCT00141726

    Study of Enbrel (Etanercept) for the Treatment Sub-Acute Pulmonary Dysfunction After Allogeneic Stem Cell Transplant

    Not yet reported University of Michigan Rogel Cancer Center 34 participants Est. completion 2009-02 1 site Stand-alone
    Other conditions: Lung Injury, Acute, Respiratory Distress Syndrome, Adult, Bronchiolitis Obliterans
    View official trial listing →
  • Completed NCT NCT00141739

    Study of Etanercept for the Prevention of Complications Resulting From Hematopoietic Stem Cell Transplantation (HSCT)

    Not yet reported University of Michigan Rogel Cancer Center 100 participants Est. completion 2012-09 2 sites Stand-alone
    Other conditions: Graft-Versus-Host Disease
    View official trial listing →
  • Completed NCT NCT00141791

    Study Evaluating Etanercept in Moderate to Severe Asthma

    Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 120 participants Est. completion 2006-07 13 sites
    Other conditions: Asthma
    View official trial listing →
  • Status unknown NCT NCT00141804

    Efficacy and Safety of Sirolimus in Combination With Tacrolimus

    Not yet reported University Hospital Muenster 190 participants Est. completion 2005-06 1 site
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT00141921

    Pediatric Open-Label Extension Study of Etanercept in Patients With Plaque Psoriasis

    Not yet reported Amgen 182 participants Est. completion 2017-08-16 Stand-alone
    Other conditions: Pediatric Plaque Psoriasis
    View official trial listing →
  • Completed NCT NCT00143845

    Study of Low-Intensity Conditioning for Allogeneic Stem Cell Transplant

    Not yet reported University of Michigan Rogel Cancer Center 54 participants Est. completion 2013-02 1 site Stand-alone
    Other conditions: Multiple Myeloma, Lymphocytic Leukemia, Chronic, Lymphoma, Low-Grade
    View official trial listing →
  • Completed NCT NCT00144677

    Sirolimus With Tacrolimus for Graft-vs-Host Disease Prophylaxis After Un-Related Stem Cell Transplantation

    Not yet reported Dana-Farber Cancer Institute 30 participants Est. completion 2006-06 1 site
    Other conditions: Acute Myelogenous Leukemia, Graft Versus Host Disease, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, Myelodysplastic Syndromes, Non-Hodgkin's Lymphoma, Hodgkin's Disease
    View official trial listing →
  • Completed NCT NCT00144703

    Sirolimus With Tacrolimus for Graft-vs-Host Disease Prophylaxis After Related Stem Cell Transplantation

    Not yet reported Dana-Farber Cancer Institute 55 participants Est. completion 2006-11 1 site
    Other conditions: Hematologic Malignancies, Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, Non-Hodgkin's Lymphoma, Hodgkin's Disease
    View official trial listing →
  • Completed NCT NCT00146575

    Sirolimus- and Paclitaxel-Eluting Stents for Small Vessels (ISAR-SMART-3)

    Not yet reported Deutsches Herzzentrum Muenchen 360 participants Est. completion 2005-02 2 sites Stand-alone
    Other conditions: Coronary Disease
    View official trial listing →
  • Completed NCT NCT00146614

    Tacrolimus, Sirolimus and Methotrexate as Graft Versus Host Disease Prophylaxis After Blood Stem Cell Transplantation

    Not yet reported Dana-Farber Cancer Institute 105 participants Est. completion 2003-04 3 sites
    Other conditions: Graft Versus Host Disease, Hematologic Malignancies
    View official trial listing →
  • Completed NCT NCT00147381

    Effectiveness and Safety of Campath in Combination With Tacrolimus Monotherapy to Prevent Kidney Graft Rejection

    Not yet reported Dr. Claudia Bösmüller 197 participants Est. completion 2011-07 1 site Stand-alone
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT00148746

    Standardized Time- and Score-oriented Treatment of Moderate and Severe Atopic Dermatitis

    Not yet reported Technische Universität Dresden Est. completion 2008-03 1 site
    Other conditions: Moderate to Severe Atopic Dermatitis
    View official trial listing →
  • No Longer Available NCT NCT00149981

    A Facilitated Access Program to Provide Everolimus (RAD) Maintenance for Patients Completing Therapy in RAD Trials in Solid Organ Transplantation

    Novartis Pharmaceuticals 153 sites
    Other conditions: Organ Transplantation
    View official trial listing →
  • Completed NCT NCT00149994

    Cyclosporine A C-2h Monitoring Versus Tacrolimus C-0h Monitoring in de Novo Liver Transplant Recipients

    Not yet reported Novartis Pharmaceuticals 171 participants Est. completion 2007-12 1 site
    Other conditions: Liver Transplant
    View official trial listing →
  • Terminated NCT NCT00150085

    Safety and Efficacy of Converting Maintenance Kidney and Liver Transplant Recipients With Abnormal Glucose Metabolism From Tacrolimus to Cyclosporine Micro-emulsion

    Not yet reported Novartis 50 participants Est. completion 2005-10
    Other conditions: Tacrolimus-associated Abnormal Glucose Metabolism in Kidney and Liver Transplant Recipients
    View official trial listing →
  • Completed NCT NCT00150891

    Th1, Th2 and Monokine Responses as Risk Factors of Renal Transplant Rejection

    University of Giessen 84 participants Est. completion 2006-01 1 site
    Other conditions: Renal Failure, Chronic
    View official trial listing →
  • Terminated NCT NCT00151632

    Reduction of Tacrolimus Dose in Association With Mycophenolate Mofetil After Liver Transplantation

    Not yet reported Rennes University Hospital 195 participants Est. completion 2009-05 8 sites Stand-alone
    Other conditions: Evidence of Liver Transplantation
    View official trial listing →
  • Completed NCT NCT00151658

    Sirolimus Eluting Stents in Complex Coronary Lesions (SCANDSTENT)

    Not yet reported Copenhagen University Hospital, Rigshospitalet 322 participants Est. completion 2006-06 1 site
    Other conditions: Ischaemic Heart Disease
    View official trial listing →
  • Completed NCT NCT00154297

    Efficacy and Safety of Early Versus Delayed Administration of Everolimus in de Novo Renal Transplant Patients

    Not yet reported Novartis Pharmaceuticals 139 participants 1 site
    Other conditions: Renal Transplantation
    View official trial listing →
  • Completed NCT NCT00156364

    Studies of Organ Transplantation in Animals and Man

    Michael Mauer, MD 655 participants Est. completion 2014-08 1 site
    Other conditions: Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT00157014

    Canadian Cardiology de Novo Study: A Comparison Between Tacrolimus- and Cyclosporine- Based Immunoprophylactic Regimens

    Not yet reported Astellas Pharma Inc 111 participants Est. completion 2008-07-18 13 sites Stand-alone
    Other conditions: Heart Diseases, Heart Transplantation
    View official trial listing →
  • Active, not recruiting NCT NCT00160732

    Allogenic Islet Cell Transplantation

    Not yet reported, Not yet reported University of Chicago 50 participants Est. completion 2030-10 1 site Stand-alone
    Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT00160966

    Impact of Immunosuppressive Regimens on Polyomavirus-related Transplant Nephropathy

    Not yet reported University of Giessen 108 participants Est. completion 2010-03 1 site
    Other conditions: Polyomavirus Infections
    View official trial listing →
  • Completed NCT NCT00161655

    Study Evaluating Etanercept and Methotrexate in Plaque Psoriasis

    Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 60 participants Est. completion 2006-12 8 sites
    Other conditions: Psoriasis, Arthritis, Psoriatic
    View official trial listing →
  • Completed NCT NCT00163657

    Study of Liver Transplant For End-Stage Liver Disease Caused By Chronic Hepatitis C Infection

    Not yet reported Baylor Research Institute 312 participants Est. completion 2007-01 1 site
    Other conditions: End Stage Liver Disease, Hepatitis C
    View official trial listing →
  • Completed NCT NCT00166244

    Fixed Dose MMF vs Concentration Controlled MMF After Renal Transplantation

    Not yet reported Erasmus Medical Center 901 participants Est. completion 2006-04 67 sites
    Other conditions: De Novo Renal Transplant Recipient.
    View official trial listing →
  • Completed NCT NCT00166556

    A Trial to Assess Campath-1H and Tacrolimus Followed by Immunosuppression Withdrawal in Liver Transplantation

    Not yet reported Mayo Clinic 10 participants Est. completion 2006-12 1 site
    Other conditions: Transplantation, Liver
    View official trial listing →
  • Terminated NCT NCT00166712

    A Trial of Two Steroid-Free Approaches Toward Mycophenolate Mofetil-Based Monotherapy Immunosuppression

    Not yet reported Northwestern University 40 participants Est. completion 2010-04 1 site
    Other conditions: Kidney Transplant Failure and Rejection
    View official trial listing →
  • Status unknown NCT NCT00166816

    The Pharmacokinetics of Sirolimus When Combined With Cyclosporine or Tacrolimus in Renal Transplant Patients

    Not yet reported National Taiwan University Hospital 40 participants Est. completion 2003-06 1 site
    Other conditions: Transplantation, Kidney Transplantation, Immunosuppression
    View official trial listing →
  • Status unknown NCT NCT00166829

    The Effect of Sirolimus on the Pharmacokinetics of Tacrolimus

    Not yet reported National Taiwan University Hospital 40 participants 1 site
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Status unknown NCT NCT00166842

    Sirolimus Blood Concentrations on Conversion From Oral Solution to Tablets

    Not yet reported National Taiwan University Hospital 40 participants 1 site
    Other conditions: Transplantation, Kidney Transplantation, Immunosuppression
    View official trial listing →
  • Withdrawn NCT NCT00167557

    Orthotopic Liver Transplant (OLT) Recipients With Hepatitis C Virus (HCV) Under Preemptive Treatment

    Not yet reported The University of Texas Health Science Center, Houston Est. completion 2008-03 1 site
    Other conditions: Hepatitis C
    View official trial listing →
  • Completed NCT NCT00170053

    Comparison of Sirolimus to Tacrolimus for Long Term Therapy in Kidney Transplant With no Steroids

    Not yet reported Mayo Clinic 177 participants Est. completion 2008-09 1 site
    Other conditions: Kidney Diseases
    View official trial listing →
  • Completed NCT NCT00170820

    Efficacy and Safety of the Switch From Sirolimus to Everolimus in Stable Maintenance Renal Transplant Patients Receiving a Calcineurin Inhibitor Free Regimen

    Not yet reported Novartis Pharmaceuticals 20 participants 1 site
    Other conditions: Renal Transplantation
    View official trial listing →
  • Completed NCT NCT00170833

    Safety, Tolerability and Efficacy of Everolimus With Lower Versus Higher Levels of Tacrolimus in de Novo Renal Transplant Patients

    Not yet reported Novartis Pharmaceuticals 80 participants
    Other conditions: Renal Transplantation
    View official trial listing →
  • Completed NCT NCT00170859

    Everolimus Versus Mycophenolate Mofetil in Combination With Reduced Dose Cyclosporine Microemulsion in Maintenance Heart Transplant Recipients

    Not yet reported Novartis Pharmaceuticals Est. completion 2006-12 1 site
    Other conditions: Heart Transplantation
    View official trial listing →
  • Completed NCT NCT00171392

    Clinical Study to Evaluate the Tolerability, Safety and Efficacy of Enteric-coated Mycophenolate Sodium, After Equimolar Conversion From Mycophenolate Mofetil (MMF), in Patients With Stable Renal Transplant Receiving Tacrolimus

    Not yet reported Novartis 132 participants Est. completion 2005-06
    Other conditions: Prevention of Acute Rejection After Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT00171496

    Evaluation of Cyclosporine Microemulsion and Tacrolimus on the Rate of New Onset Diabetes Mellitus in Kidney Transplantation Recipients

    Not yet reported Novartis 693 participants Est. completion 2006-03
    Other conditions: Kidney Transplant
    View official trial listing →
  • Completed NCT NCT00171717

    Conversion From Tacrolimus to Cyclosporine Microemulsion in Liver Transplant Patients With New Onset Diabetes After the 3rd Month Post-transplant

    Not yet reported Novartis 39 participants Est. completion 2005-12
    Other conditions: Maintenance Liver Transplant Patients With New Onset Diabetes
    View official trial listing →
  • Completed NCT NCT00171743

    Efficacy and Safety of Cyclosporine Microemulsion in Diabetic Adult Stable Liver Transplant Recipients

    Not yet reported Novartis 47 participants Est. completion 2006-01
    Other conditions: Liver Transplant
    View official trial listing →
  • Completed NCT NCT00175253

    Alemtuzumab Induction in Islet Transplantation

    Not yet reported University of Alberta 12 participants Est. completion 2012-04 1 site
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT00175266

    Islet Transplantation Using Campath-1H and Infliximab Induction

    Not yet reported University of Alberta 12 participants 1 site
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT00176059

    Immunoregulatory Effects of Immunoglobulin Induction Therapy in Renal Transplant Recipients

    Not yet reported University of Giessen 50 participants Est. completion 2006-05 1 site
    Other conditions: Renal Failure, Chronic, Renal Transplantation
    View official trial listing →
  • Completed NCT NCT00177099

    Effects of Ligands on Human Hair Follicles Grafted Onto SCID Mice

    Not yet reported Hordinsky, Maria K., MD 35 participants Est. completion 2004-09 1 site
    Other conditions: Alopecia
    View official trial listing →
  • Terminated NCT NCT00177138

    Use of Campath for Induction and Maintenance Therapy in Pancreas After Kidney Transplantation

    Not yet reported University of Minnesota 9 participants Est. completion 2006-11 1 site
    Other conditions: Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT00178425

    PK of MMF in Cadaveric vs Living Donor Liver Transplant Recipients

    Not yet reported University of Rochester 24 participants Est. completion 2006-06 1 site
    Other conditions: Transplantation, Liver
    View official trial listing →
  • Completed NCT NCT00182559

    The Vienna Prograf and Endothelial Progenitor Cell Study

    Not yet reported Medical University of Vienna 148 participants Est. completion 2009-05 1 site
    Other conditions: End Stage Renal Disease
    View official trial listing →
  • Completed NCT NCT00183248

    Using Donor Stem Cells and Alemtuzumab to Prevent Organ Rejection in Kidney Transplant Patients

    Not yet reported, Not yet reported University of Miami 9 participants Est. completion 2009-11 1 site Stand-alone
    Other conditions: Kidney Transplantation, Kidney Disease, Kidney Failure
    View official trial listing →
  • Completed NCT NCT00186667

    Sirolimus as Primary Therapy for the Treatment of Chronic Graft Versus Host Disease

    Not yet reported Stanford University 30 participants Est. completion 2005-09 1 site
    Other conditions: Graft vs Host Disease, Blood and Marrow Transplant (BMT)
    View official trial listing →
  • Completed NCT NCT00187174

    Everolimus for Treating Pediatric Patients With Recurrent or Refractory Tumors

    Not yet reported St. Jude Children's Research Hospital 41 participants Est. completion 2008-10 1 site
    Obstructive sleep apnea Other conditions: Tumors, Brain Tumors, Sarcoma, Soft Tissue
    View official trial listing →
  • Completed NCT NCT00187915

    Pilot Trial for Implementation of a MPA PK Monitoring Strategy

    Not yet reported University of Florida 24 participants Est. completion 2004-12 1 site
    Other conditions: Transplant, Kidney
    View official trial listing →
  • Completed NCT NCT00187941

    MPA PK Monitoring Strategy With MMF/FK Based Immunosuppression

    Not yet reported University of Florida 22 participants Est. completion 2006-11 1 site
    Other conditions: Transplantation, Renal, Immunosuppression
    View official trial listing →
  • Completed NCT NCT00188825

    Study Comparing Simulect Plus Standard Immunosuppression to Standard Immunosuppression Alone for the Prevention of Acute Rejection and Bronchiolitis Obliterans in Lung Transplant

    Not yet reported University Health Network, Toronto 22 participants Est. completion 2007-10 1 site Stand-alone
    Other conditions: COPD, Emphysema, Alpha-1 Antitrypsan Deficiency
    View official trial listing →
  • Completed NCT NCT00189202

    Efficacy of Sirolimus-Based, Steroid Avoidance Immunosuppression African Americans

    Not yet reported, Not yet reported University of Michigan 49 participants Est. completion 2008-07-01 1 site Stand-alone
    Other conditions: End Stage Renal Disease, Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT00189722

    Inhaled Tacrolimus, Add-on to Inhaled Corticosteroids & Long Acting B2 Agonists in Moderate to Severe Persistent Asthma

    Not yet reported Astellas Pharma Inc 160 participants Est. completion 2005-07 28 sites
    Other conditions: Asthma, Bronchial, Bronchial Asthma
    View official trial listing →
  • Completed NCT NCT00189735

    A Study to Evaluate FK778 in Kidney Transplant Patients

    Not yet reported Astellas Pharma Inc 364 participants Est. completion 2005-10 37 sites
    Other conditions: Kidney Transplantation, Renal Transplantation, Transplantation, Renal, Transplantation, Kidney, Grafting, Kidney
    View official trial listing →
  • Completed NCT NCT00189748

    A Study to Assess the Safety and Efficacy of a Tacrolimus New Oral Formulation (MR4) in BMT Patients-Extension-

    Not yet reported Astellas Pharma Inc 4 sites
    Other conditions: Bone Marrow Transplantation, Graft Versus Host Disease, Graft-Versus-Host Disease, Graft-Vs-Host Disease
    View official trial listing →
  • Completed NCT NCT00189761

    A Study to Assess Efficacy, Safety and Pharmacokinetics of a Tacrolimus New Oral Formulation (MR4) in BMT Recipients

    Not yet reported Astellas Pharma Inc 4 sites
    Other conditions: Bone Marrow Transplantation, Graft Versus Host Disease, Graft-Vs-Host Disease, Graft-Versus-Host Disease
    View official trial listing →
  • Completed NCT NCT00189787

    Dose Response of Inhaled Tacrolimus in Patients With Moderate Persistent Asthma

    Not yet reported Astellas Pharma Inc 370 participants Est. completion 2005-08 49 sites
    Other conditions: Asthma, Bronchial, Bronchial Asthma
    View official trial listing →
  • Completed NCT NCT00189826

    A Study to Evaluate the Safety and Efficacy of FK506E (MR4) in Patients Undergoing Primary Liver Transplantation.

    Not yet reported Astellas Pharma Inc 475 participants Est. completion 2006-12 51 sites Stand-alone
    Other conditions: Liver Transplantation
    View official trial listing →
  • Completed NCT NCT00189839

    A Study to Evaluate the Safety and Efficacy of FK506E (MR4) in Patients Undergoing Primary Kidney Transplantation

    Not yet reported Astellas Pharma Inc 699 participants Est. completion 2006-12 80 sites Stand-alone
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT00195273

    Study Evaluating Sirolimus in Kidney Transplant Recipients

    Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 61 participants Est. completion 2008-07 3 sites Stand-alone
    Other conditions: Graft vs Host Disease, Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT00195338

    Study Evaluating Enbrel In Adults With Active Rheumatoid Arthritis In Luxemburg

    Pfizer 25 participants Est. completion 2010-12 1 site
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT00195364

    Study Evaluating Etanercept in Patients With Rheumatoid Arthritis Who Completed Trial 0881A1-301-EU in Spain

    Wyeth is now a wholly owned subsidiary of Pfizer 93 participants Est. completion 2008-10 1 site
    Other conditions: Rheumatoid Arthritis, Inflammation
    View official trial listing →
  • Completed NCT NCT00195377

    Study Evaluating Etanercept in Patients With Rheumatoid Arthritis(RA), Juvenile Idiopathic Arthritis (JIA), or Psoriatic Arthritis (PsA) in Spain

    Wyeth is now a wholly owned subsidiary of Pfizer 1000 participants Est. completion 2006-04 1 site
    Other conditions: Arthritis, Psoriatic, Arthritis, Rheumatoid
    View official trial listing →
  • Completed NCT NCT00195403

    A Drug Use Investigation of ENBREL for Post-marketing Surveillance (PMS) for RA and PsA

    Pfizer 1014 participants Est. completion 2008-02 4 sites
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT00195429

    A Study Comparing the Withdrawal of Steroids or Tacrolimus in Kidney Transplant Recipients

    Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 47 participants Est. completion 2007-10 1 site Stand-alone
    Other conditions: Kidney Failure, Graft vs Host Disease
    View official trial listing →
  • Completed NCT NCT00195494

    Study Comparing Etanercept and Methotrexate vs. Methotrexate Alone in Rheumatoid Arthritis

    Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 542 participants Est. completion 2008-03 1 site
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT00195507

    Study Evaluating Etanercept in the Treatment of Subjects With Psoriasis

    Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 720 participants Est. completion 2007-02 127 sites
    Other conditions: Psoriasis
    View official trial listing →
  • Completed NCT NCT00195988

    Comparison of Immunosuppression Protocols After LTx in Children

    Not yet reported Children's Memorial Health Institute, Poland 40 participants Est. completion 2006-07 1 site
    Other conditions: Liver Transplantation
    View official trial listing →
  • Completed NCT NCT00201682

    Etanercept and Rituximab in Patients With Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma

    Not yet reported, Not yet reported John Byrd 36 participants Est. completion 2009-08 1 site Stand-alone
    Other conditions: Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
    View official trial listing →
  • Completed NCT NCT00201838

    Etanercept and Gemcitabine in Patients With Advanced, Chemotherapy Naive Pancreatic Adenocarcinoma

    Not yet reported, Not yet reported Ohio State University Comprehensive Cancer Center 38 participants Est. completion 2007-05 1 site Stand-alone
    Other conditions: Pancreatic Neoplasms, Adenocarcinoma
    View official trial listing →
  • Withdrawn NCT NCT00203281

    Study to Evaluate the Amount of Medications That May be Removed From the Body During Plasmapheresis

    Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University Est. completion 2009-09 2 sites
    Other conditions: Kidney Transplantation, Plasmapheresis
    View official trial listing →
  • Status unknown NCT NCT00204191

    Comparison of the Two Immunosuppressive Regimens Based on Tacrolimus and Cyclosporine Following Kidney Transplantation

    Not yet reported Uniwersytet Mikolaja Kopernika w Toruniu 300 participants Est. completion 2007-12 1 site
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT00204321

    Influence of Sirolimus and MMF on Vascular Function and Markers of Cellular Function in Renal Transplant Recipients

    Not yet reported University Hospital Muenster 80 participants Est. completion 2010-01 1 site
    Other conditions: Renal Transplantation
    View official trial listing →
  • Completed NCT NCT00205231

    A Pilot Study to Examine the Feasibility and Effect of Tumor Necrosis Factor (TNF) Inhibition on HIV Disease

    Not yet reported University of Wisconsin, Madison 25 participants Est. completion 2004-05-01 1 site
    Other conditions: HIV Infections
    View official trial listing →
  • Completed NCT NCT00214201

    Campath-1H Induction to Allow Discontinuation of Calcineurin Inhibitors After Renal Transplantation

    Not yet reported University of Wisconsin, Madison 40 participants Est. completion 2009-05 1 site Stand-alone
    Other conditions: Primary Renal Transplant
    View official trial listing →
  • Completed NCT NCT00214253

    Islet Transplantation in Type 1 Diabetic Patients

    Not yet reported University of Wisconsin, Madison 14 participants Est. completion 2011-10 1 site
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT00214279

    MMF Monotherapy and Immune Regulation in Kidney Transplant Recipients: Part 1 Steroid Withdrawal

    Not yet reported University of Wisconsin, Madison 32 participants Est. completion 2007-11 1 site Stand-alone
    Other conditions: Renal Transplantation
    View official trial listing →
  • Completed NCT NCT00214786

    Pancreatic Islet Cell Transplantation

    Not yet reported Baylor Research Institute 4 participants Est. completion 2007-07 1 site
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT00217256

    The Medtronic Endeavor III Drug Eluting Coronary Stent System Clinical Trial

    Not yet reported Medtronic Vascular 436 participants Est. completion 2010-12
    Cardiovascular disease
    View official trial listing →
  • Status unknown NCT NCT00220558

    GISSOC II: Sirolimus Eluting Stent Versus Bare Metal Stent in Chronic Total Coronary Occlusions

    Not yet reported Società Italiana di Cardiologia Invasiva 150 participants Est. completion 2010-02 14 sites
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT00223015

    Investigation of the Steady State Pharmacokinetics of Tacrolimus, Mycophenolate Mofetil and Fluvastatin After Renal Transplantation

    Not yet reported University Hospital Schleswig-Holstein 15 participants Est. completion 2005-04
    Other conditions: Renal Transplantation
    View official trial listing →
  • Completed NCT NCT00223028

    Investigation of the Steady State Pharmacokinetics of Sirolimus, Mycophenolat Mofetil and Fluvastatin After Renal Transplantation

    Not yet reported University Hospital Schleswig-Holstein 15 participants Est. completion 2005-07
    Other conditions: Renal Transplantation
    View official trial listing →
  • Terminated NCT NCT00223041

    Cranoc Lipid Study in Renal Transplantation

    Not yet reported, Not yet reported University Hospital Schleswig-Holstein 200 participants Est. completion 2010-12 1 site
    Other conditions: Renal Transplantation
    View official trial listing →
  • Completed NCT NCT00223054

    Polymorphism of the Cytochrome P450-system in Renal Transplants

    University Hospital Schleswig-Holstein 200 participants Est. completion 2006-10 1 site
    Other conditions: Function of Renal Transplant
    View official trial listing →
  • Completed NCT NCT00223678

    Mycophenolate Mofetil and Rapamycin as Secondary Intervention vs. Continuation of Calcineurin Inhibitors in Patients at Risk for Chronic Renal Allograft Failure

    Not yet reported Vanderbilt University Medical Center 20 participants Est. completion 2009-10 1 site
    Other conditions: Kidney Transplant
    View official trial listing →
  • Completed NCT NCT00224393

    Phase II Trial of Enbrel in Patients With Primary Systemic Amyloidosis

    Not yet reported The Cleveland Clinic 60 participants Est. completion 2005-08-31
    Other conditions: Primary Systemic Amyloidosis
    View official trial listing →
  • Completed NCT NCT00227240

    Study Evaluating Enbrel (Etanercept) in Adult Patients With Plaque Psoriasis

    Pfizer 753 participants Est. completion 2009-06 2 sites
    Other conditions: Plaque Psoriasis
    View official trial listing →
  • Completed NCT NCT00229138

    Efficacy and Safety of Enteric-Coated Mycophenolate Sodium (EC-MPS) in Kidney Transplant Recipients

    Not yet reported Novartis Pharmaceuticals 291 participants Est. completion 2007-03 1 site Stand-alone
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Status unknown NCT NCT00229515

    Multicentre 2x2 Factorial Randomised Study Comparing Tirofiban Versus Abciximab and SES Versus BMS in AMI

    Not yet reported Marco Valgimigli 744 participants Est. completion 2012-03 1 site Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT00231283

    NEXUS Study for the Treatment of de Novo Native Coronary Artery Lesions

    Not yet reported Cordis US Corp. 100 participants Est. completion 2005-07 1 site Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT00232791

    The Study to Compare Cypher Versus Cypher Select in Treating Cornary Artery Lesions.

    Not yet reported, Not yet reported Cordis US Corp. 102 participants Est. completion 2005-03 1 site Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT00232856

    A Study of the Cypher SES to Treat Restenotic Native Coronary Artery Lesions.

    Not yet reported Cordis US Corp. 162 participants Est. completion 2006-08 2 sites
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT00234455

    A Study of the Cypher Sirolimus-Eluting Stent to Treat Bifurcation Lesions.

    Not yet reported Cordis US Corp. 86 participants Est. completion 2007-04 1 site
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT00234728

    Study of a New Dressing for Use With Topical Medications

    Not yet reported Teikoku Pharma USA, Inc. 120 participants Est. completion 2007-06 1 site
    Other conditions: Psoriasis
    View official trial listing →
  • Completed NCT NCT00235092

    The REALITY Study - Head-to-Head Comparison Between Cypher and Taxus

    Not yet reported Cordis US Corp. 1335 participants Est. completion 2006-03 1 site
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT00235144

    The Study of the BX VELOCITY Stent In Patients With De Novo Coronary Artery Lesions.

    Not yet reported Cordis US Corp. 353 participants Est. completion 2008-09 2 sites Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT00235157

    A Comparison of Coated and Uncoated Stents in Renal Artery Treatment.

    Not yet reported Cordis US Corp. 105 participants Est. completion 2005-07 3 sites Stand-alone
    Other conditions: Renal Artery Stenosis
    View official trial listing →
  • Completed NCT NCT00235170

    The Arterial Revascularization Therapies Study Part II.

    Not yet reported Cordis US Corp. 607 participants Est. completion 2009-04 1 site Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT00235300

    An Open-label, Prospective, Randomized, Multi-center, Phase II Comparative Trial of Thymoglobulin Versus Simulect for the Prevention of Delayed Graft Function and Acute Allograft Rejection in Renal Allograft Recipients.

    Not yet reported Genzyme, a Sanofi Company 240 participants Est. completion 2005-06 28 sites
    Other conditions: Cadaveric Donor Renal Transplantation, Acute Renal Allograft Rejection, Induction Therapy
    View official trial listing →
  • Completed NCT NCT00235560

    Rapamycin in Combination With Low-dose Aracytin in Elderly Acute Myeloid Leukemia Patients

    Not yet reported University Hospital, Toulouse 50 participants Est. completion 2008-06 3 sites Stand-alone
    Other conditions: Acute Myeloid Leukemia
    View official trial listing →
  • Completed NCT NCT00236106

    Short Term Growth in Children With Atopic Dermatitis

    Not yet reported Children´s Clinic, Randers 20 participants Est. completion 2005-06
    Other conditions: Atopic Dermatitis
    View official trial listing →
  • Completed NCT NCT00236171

    Evaluation of Topical Antipsoriatics in the Psoriasis Plaque Test

    Not yet reported Technische Universität Dresden 14 participants Est. completion 2010-06 1 site
    Other conditions: Psoriasis Vulgaris
    View official trial listing →
  • Completed NCT NCT00238979

    A Study to Investigate the Tolerability and Safety of Converting Stable Renal Transplant Recipients Who Receive Tacrolimus With or Without Corticosteroids From Mycophenolate Mofetil (MMF) to Enteric-coated Mycophenolate Sodium (EC-MPS)

    Not yet reported Novartis Pharmaceuticals 50 participants
    Other conditions: Renal Transplantation
    View official trial listing →
  • Completed NCT NCT00239031

    Study of Enteric-Coated Mycophenolate Sodium (EC-MPS) Plus Reduced-dose Cyclosporine Microemulsion (CsA-ME) Compared to EC-MPS Plus Standard Dose CsA-ME in Eldery de Novo Renal Transplant Recipients Treated With Basiliximab and Short-term Steroids

    Not yet reported Novartis 117 participants Est. completion 2005-07
    Other conditions: Denovo Renal Transplantation
    View official trial listing →
  • Completed NCT NCT00239876

    Efficacy and Safety of FTY720 in de Novo Adult Renal Transplant Recipients

    Not yet reported Novartis Pharmaceuticals 140 participants
    Other conditions: Renal Transplantation
    View official trial listing →
  • Completed NCT NCT00240994

    Safety in Immunomodulatory Functions of Alemtuzumab (Campath) in Pediatric Kidney Transplantation Recipients

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 35 participants Est. completion 2009-11 4 sites Stand-alone
    Other conditions: Kidney Failure, Chronic, Kidney Transplantation, Immunosuppression
    View official trial listing →
  • Completed NCT NCT00241189

    Rapamycin vs Methotrexate in Diffuse SSc

    Not yet reported, Not yet reported University of California, Los Angeles 17 participants Est. completion 2006-06 1 site
    Other conditions: Systemic Sclerosis
    View official trial listing →
  • Completed NCT NCT00244556

    Study Comparing Enbrel (Etanercept) Plus Methotrexate Versus Enbrel Alone in Active Rheumatoid Arthritis Despite Current Methotrexate Therapy

    Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 300 participants Est. completion 2004-05
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT00245401

    CYPHERTM Stent Post-Marketing Surveillance Registry (US-PMS)

    Not yet reported Cordis US Corp. 2070 participants Est. completion 2004-12
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT00245934

    Study Evaluating Enbrel in Patients With Rheumatoid Arthritis

    Wyeth is now a wholly owned subsidiary of Pfizer 1500 participants Est. completion 2005-07
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT00245960

    Study Evaluating Etanercept on Skin and Joint Disease in Psoriatic Arthritis

    Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 752 participants Est. completion 2008-03-29 120 sites
    Other conditions: Psoriatic Arthritis
    View official trial listing →
  • Completed NCT NCT00246129

    CamTac Trial:Campath-Tacrolimus vs IL2R MoAb/Tacrolimus/MMF in Renal Transplantation

    Not yet reported EMagnusson 123 participants Est. completion 2011-06 1 site Stand-alone
    Other conditions: Kidney Transplantation, Kidney Diseases, Kidney Failure
    View official trial listing →
  • Completed NCT NCT00251004

    Efficacy and Safety Study of Everolimus Plus Reduced Cyclosporine Versus Mycophenolic Acid Plus Cyclosporine in Kidney Transplant Recipients

    Not yet reported Novartis 833 participants Est. completion 2009-10 1 site Stand-alone
    Other conditions: Kidney Transplantation, Graft Rejection
    View official trial listing →
  • Status unknown NCT NCT00252655

    Use of Sirolimus vs. Tacrolimus For African-American Renal Transplant Recipients

    Not yet reported Wayne State University 40 participants Est. completion 2009-06 1 site
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Terminated NCT NCT00253318

    RAD001 Plus Docetaxel in Patients With Metastatic Breast Cancer

    Not yet reported M.D. Anderson Cancer Center 15 participants Est. completion 2012-04 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00255593

    Safety and Efficacy Study of Rituximab in Renal Transplantation

    Not yet reported Karolinska University Hospital 140 participants Est. completion 2007-10 1 site
    Other conditions: Renal Transplantation
    View official trial listing →
  • Completed NCT NCT00255710

    Cyclophosphamide and/or Mycophenolate Mofetil With or Without Tacrolimus in Treating Patients Who Are Undergoing a Donor Bone Marrow or Peripheral Stem Cell Transplant for Hematologic Cancer

    Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 60 participants 1 site
    Other conditions: Chronic Myeloproliferative Disorders, Graft Versus Host Disease, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Diseases
    View official trial listing →
  • Completed NCT NCT00257387

    Study Evaluating Cyclosporine Dose Reduction and Cyclosporine Elimination in Chinese Kidney Transplants

    Not yet reported, Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 120 participants Est. completion 2006-08
    Other conditions: Kidney Transplant
    View official trial listing →
  • Completed NCT NCT00259610

    Treatment of Early Aggressive Rheumatoid Arthritis (TEAR)

    Not yet reported University of Alabama at Birmingham 755 participants Est. completion 2009-06 1 site
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT00259896

    In-patient Study in Patients With Type 2 Diabetes Mellitus

    Not yet reported GlaxoSmithKline 30 participants
    Type 2 diabetes
    View official trial listing →
  • Terminated NCT NCT00260208

    Liver Fibrosis in Patients Transplanted for Hepatitis C Receiving Either Cyclosporine Microemulsion or Tacrolimus

    Not yet reported Novartis Pharmaceuticals 361 participants 2 sites
    Other conditions: Liver Transplant, Hepatitis C
    View official trial listing →
  • Completed NCT NCT00261820

    Study Comparing Two Immunosuppressive Regimens in De Novo Renal Allograft Recipients

    Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 160 participants Est. completion 2005-01
    Other conditions: Graft Rejection, Kidney Failure, Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT00262886

    Donor Peripheral Stem Cell or Bone Marrow Transplant in Treating Patients With Relapsed or Refractory Metastatic Kidney Cancer

    Not yet reported University of Rochester 35 participants 1 site
    Other conditions: Kidney Cancer
    View official trial listing →
  • Completed NCT NCT00263328

    Extension Study Of Stage 1 Subjects Of Study A3921009 For The Prevention Of Acute Rejection In Kidney Transplant Patient

    Not yet reported Pfizer 46 participants Est. completion 2014-06 27 sites
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT00265473

    MGA031, Sirolimus and Tacrolimus in Islet Transplantation

    Not yet reported, Not yet reported University of Minnesota 5 participants Est. completion 2010-06 1 site
    Other conditions: Type 1 Diabetes Mellitus, Hypoglycemia
    View official trial listing →
  • Completed NCT NCT00266123

    Study Comparing Two Sirolimus Regimens vs. Tacrolimus and Mycophenolate Mofetil Regimen in Kidney Transplant Recipients

    Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 420 participants Est. completion 2007-07
    Other conditions: Graft Rejection, Kidney Failure, Kidney Transplant
    View official trial listing →
  • Completed NCT NCT00267189

    RESCUE Study - Everolimus in Liver Transplantation Recipients With Renal Insufficiency

    Not yet reported Novartis Pharmaceuticals 145 participants Est. completion 2007-11 2 sites
    Other conditions: Liver Transplantation
    View official trial listing →
  • Completed NCT NCT00268515

    Aerosol Cyclosporine for Prevention of Lung Rejection

    Not yet reported National Heart, Lung, and Blood Institute (NHLBI) Est. completion 2003-03
    Other conditions: Lung Diseases
    View official trial listing →
  • Completed NCT NCT00270634

    Study of ISA247 (Voclosporin) in De Novo Renal Transplantation

    Not yet reported Aurinia Pharmaceuticals Inc. 334 participants Est. completion 2009-07 45 sites
    Other conditions: Kidney Diseases
    View official trial listing →
  • Completed NCT NCT00273871

    Study Comparing Conversion From Calcineurin Inhibitors to Rapamune Versus Standard Therapy in Established Renal Allograft Recipients

    Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 190 participants Est. completion 2006-09
    Other conditions: Graft Rejection, Kidney Failure, Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT00275509

    Induction Therapy Study in Live Donor Kidney Transplant Recipients With a Positive Crossmatch

    Not yet reported Johns Hopkins University 56 participants Est. completion 2010-06 1 site Stand-alone
    Other conditions: Kidney Failure, Chronic
    View official trial listing →
  • Completed NCT NCT00275522

    The Comparison of Three Different Immunosuppressant Regimens in Kidney Transplant Recipients.

    Not yet reported Mayo Clinic 16 participants Est. completion 2007-12 1 site
    Other conditions: Kidney Transplant
    View official trial listing →
  • Completed NCT NCT00275535

    The Comparison of Tacrolimus and Sirolimus Immunosuppression Based Drug Regimens in Kidney Transplant Recipients

    Not yet reported Mayo Clinic 165 participants Est. completion 2008-12 1 site
    Other conditions: Kidney Diseases
    View official trial listing →
  • Completed NCT NCT00276250

    Islet Transplantation Using Abatacept

    Not yet reported Emory University 5 participants Est. completion 2014-12 1 site
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT00276575

    Bevacizumab, Everolimus, and Erlotinib in Treating Patients With Advanced Solid Tumors

    Not yet reported Herbert Hurwitz, MD 65 participants Est. completion 2014-09 1 site
    Other conditions: Unspecified Adult Solid Tumor, Protocol Specific
    View official trial listing →
  • Terminated NCT NCT00276744

    Individualized Drug Treatment for Treating Patients With Pancreatic Cancer

    Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 249 participants Est. completion 2010-04 1 site
    Other conditions: Pancreatic Cancer
    View official trial listing →
  • Terminated NCT NCT00278512

    Hematopoietic Stem Cell Support in Vasculitis

    Not yet reported Northwestern University 7 participants Est. completion 2016-06 1 site Stand-alone
    Other conditions: Vasculitis
    View official trial listing →
  • Terminated NCT NCT00281879

    Donor Stem Cell Transplant or Donor White Blood Cell Infusions in Treating Patients With Hematologic Cancer

    Not yet reported OHSU Knight Cancer Institute 200 participants Est. completion 2008-03 1 site
    Other conditions: Chronic Myeloproliferative Disorders, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms, Unusual Cancers of Childhood
    View official trial listing →
  • Completed NCT NCT00281957

    Sorafenib With Either Temsirolimus or Tipifarnib in Treating Patients With Stage IV Malignant Melanoma That Cannot Be Removed By Surgery

    Not yet reported National Cancer Institute (NCI) 109 participants Est. completion 2011-01 173 sites
    Other conditions: Recurrent Melanoma, Stage IV Melanoma
    View official trial listing →
  • Completed NCT NCT00282217

    Study Evaluating Sirolimus in the Treatment of Kidney Transplant

    Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 100 participants 13 sites
    Other conditions: Kidney Failure, Kidney Diseases
    View official trial listing →
  • Terminated NCT NCT00282230

    A Study to Evaluate the Safety and Efficacy of Prograf/FK778 and Prograf/MMF in de Novo Kidney Transplant Recipients

    Not yet reported Astellas Pharma Inc 150 participants Est. completion 2005-10 23 sites
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT00282243

    A Study to Assess the Pharmacokinetics of a Modified-release Tacrolimus Based Immunosuppression Regimen in Stable Liver Transplant Patients

    Not yet reported Astellas Pharma Inc 70 participants Est. completion 2008-10 10 sites Stand-alone
    Other conditions: Liver Transplantation
    View official trial listing →
  • Completed NCT NCT00282256

    A Study of a Modified-Release Tacrolimus Based Immunosuppression Regimen in Stable Pediatric Liver Transplant Patients

    Not yet reported Astellas Pharma Inc 19 participants Est. completion 2008-10 5 sites Stand-alone
    Other conditions: Liver Transplantation
    View official trial listing →
  • Completed NCT NCT00282282

    Tacrolimus and Sirolimus as Prophylaxis After Allogenic Non-myeloablative Peripheral Blood Stem Cell Transplantation

    Not yet reported Dana-Farber Cancer Institute 31 participants Est. completion 2009-07 1 site
    Other conditions: Graft Versus Host Disease, GVHD
    View official trial listing →
  • Completed NCT NCT00282568

    A Study to Assess the Pharmacokinetics of a Modified-release Tacrolimus Based Immunosuppression Regimen in Stable Kidney Transplant Patients

    Not yet reported Astellas Pharma Inc 70 participants Est. completion 2008-10 9 sites Stand-alone
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT00284934

    Enteric-coated Mycophenolate Sodium (EC-MPS) With Reduced-dose Tacrolimus Versus EC-MPS With Standard-dose Tacrolimus in Stable Kidney Transplant Recipients

    Not yet reported Novartis 94 participants Est. completion 2008-06 1 site Stand-alone
    Other conditions: Kidney Diseases
    View official trial listing →
  • Completed NCT NCT00284947

    Safety and Efficacy of Basiliximab in Calcineurin Inhibitor Intolerant Long-term Kidney Transplant Recipients Treated With Mycophenolic Acid and Steroids

    Not yet reported Novartis 7 participants Est. completion 2008-12 1 site Stand-alone
    Other conditions: Kidney Transplantation, Adverse Effects
    View official trial listing →
  • Completed NCT NCT00285194

    hOKT3γ1 (Ala-Ala) Combined With Sirolimus and Delayed Tacrolimus in Type 1 Diabetic Islet Allograft Recipients

    Not yet reported, Not yet reported University of Minnesota 6 participants Est. completion 2004-01 1 site
    Other conditions: Type 1 Diabetes, Hypoglycemia
    View official trial listing →
  • Completed NCT NCT00285233

    Delayed Mycophenolate Mofetil in Single-Donor Islet Allotransplantation in Type 1 Diabetes

    Not yet reported, Not yet reported University of Minnesota 8 participants Est. completion 2005-03 1 site
    Other conditions: Type 1 Diabetes, Hypoglycemia
    View official trial listing →
  • Terminated NCT NCT00285779

    Use of Etanercept in the Treatment of Moderate to Severe Lichen Planus

    Not yet reported Stanford University 27 participants Est. completion 2009-11 12 sites Stand-alone
    Other conditions: Lichen Planus
    View official trial listing →
  • Completed NCT NCT00286156

    Pilot Study of Rapamycin as Treatment for Autosomal Dominant Polycystic Kidney Disease (ADPKD)

    Not yet reported, Not yet reported The Cleveland Clinic 30 participants Est. completion 2014-12 1 site
    Other conditions: Polycystic Kidney Diseases
    View official trial listing →
  • Completed NCT NCT00286871

    Randomized Controlled Trial in Liver Transplant Recipients Treated in Steroid Sparing Regimen

    Not yet reported Duke University 40 participants Est. completion 2009-02 1 site
    Other conditions: Chronic Hepatitis C, Organ Transplantation, Immunosuppression
    View official trial listing →
  • Status unknown NCT NCT00288210

    Sirolimus Eluting Stenting in Acute Myocardial Infarction

    Not yet reported San Camillo Hospital, Rome Est. completion 2006-03 1 site
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT00288977

    Islet Transplantation in Type 1 Diabetic Recipients of Kidney Transplants

    Not yet reported Beth Israel Deaconess Medical Center 8 participants Est. completion 2008-06
    Other conditions: Diabetes, Kidney Transplantation
    View official trial listing →
  • Status unknown NCT NCT00290069

    Renal Function Optimization With Mycophenolate Mofetil (MMF) Immunosuppressor Regimes (ALHAMBRA)

    Not yet reported Sociedad Andaluza de Trasplantes de Organos y Tejidos 94 participants 7 sites
    Other conditions: Kidney Diseases, Graft Rejection
    View official trial listing →
  • Completed NCT NCT00290472

    CCI-779 in Treating Patients With Recurrent or Refractory B-Cell Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia

    Not yet reported National Cancer Institute (NCI) 89 participants Est. completion 2010-04 13 sites
    Obstructive sleep apnea Other conditions: B-cell Chronic Lymphocytic Leukemia, Malignant Neoplasm, Nodal Marginal Zone B-cell Lymphoma, Recurrent Adult Burkitt Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma, Recurrent Adult Diffuse Mixed Cell Lymphoma, Recurrent Adult Diffuse Small Cleaved Cell Lymphoma, Recurrent Adult Immunoblastic Large Cell Lymphoma, Recurrent Adult Lymphoblastic Lymphoma, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Grade 3 Follicular Lymphoma, Recurrent Marginal Zone Lymphoma, Recurrent Small Lymphocytic Lymphoma, Refractory Chronic Lymphocytic Leukemia, Splenic Marginal Zone Lymphoma, Waldenström Macroglobulinemia
    View official trial listing →
  • Terminated NCT NCT00293202

    Safety and Efficacy Study of the Effect of Etanercept in Hemodialysis Patients

    Not yet reported Kaysen, George A., M.D., Ph.D. 10 participants Est. completion 2010-06 1 site
    Other conditions: End Stage Renal Disease
    View official trial listing →
  • Completed NCT NCT00293709

    Study Evaluating the Safety and Efficacy of Etanercept in Patients With Psoriatic Arthritis Treated by Dermatologists

    Pfizer 129 participants Est. completion 2013-02 1 site
    Other conditions: Arthritis, Psoriatic, Psoriasis, Skin Diseases, Papulosquamous
    View official trial listing →
  • Completed NCT NCT00293722

    Study Evaluating the Safety and Efficacy of Etanercept in Patients With Psoriatic Arthritis Treated by Rheumatologists

    Pfizer 1308 participants Est. completion 2013-02 1 site
    Other conditions: Arthritis, Psoriatic, Psoriasis, Skin Diseases, Papulosquamous
    View official trial listing →
  • Completed NCT NCT00293891

    A Study to Assess the Safety and Effectiveness of Tacrolimus Cream in the Treatment of Psoriasis

    Not yet reported Astellas Pharma Inc 658 participants Est. completion 2007-01 33 sites
    Other conditions: Psoriasis
    View official trial listing →
  • Completed NCT NCT00293917

    A Study to Assess the Long-Term Safety of Tacrolimus Cream in the Treatment of Psoriasis

    Not yet reported Astellas Pharma Inc 658 participants Est. completion 2007-08 37 sites
    Other conditions: Psoriasis
    View official trial listing →
  • Completed NCT NCT00293930

    A Study to Assess the Safety and Effectiveness of Tacrolimus Cream in the Treatment of Psoriasis

    Not yet reported Astellas Pharma Inc 645 participants Est. completion 2006-11 32 sites
    Other conditions: Psoriasis
    View official trial listing →
  • Completed NCT NCT00295594

    Comparing Efficacy & Safety of Tacrolimus With/Without MMF or Monoclonal Anti-IL2R Antibody in Liver Transplantation.

    Not yet reported Astellas Pharma Inc 627 participants Est. completion 2007-06 41 sites Stand-alone
    Other conditions: Liver Transplantation
    View official trial listing →
  • Completed NCT NCT00295607

    Comparing Efficacy and Safety of Tacrolimus With Steroids or Monoclonal Anti-IL2R Antibody in Hepatitis C Virus (HCV) Positive Liver Transplant Patients

    Not yet reported Astellas Pharma Inc 138 participants Est. completion 2008-06 17 sites Stand-alone
    Other conditions: Hepatitis C, Liver Transplantation
    View official trial listing →
  • Status unknown NCT NCT00295997

    Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer, Metastatic Kidney Cancer, or Aplastic Anemia

    Not yet reported University of California, San Francisco 35 participants 2 sites
    Other conditions: Chronic Myeloproliferative Disorders, Kidney Cancer, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
    View official trial listing →
  • Completed NCT NCT00296023

    Donor Stem Cell Transplant in Treating Older or Frail Patients With Hematologic Cancer

    Not yet reported University of California, San Francisco 25 participants Est. completion 2008-06 2 sites Stand-alone
    Other conditions: Chronic Myeloproliferative Disorders, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes
    View official trial listing →
  • Completed NCT NCT00296244

    Steroid Free Immunosuppression in Liver Transplantation

    Not yet reported Thomas Jefferson University 40 participants Est. completion 2008-06 1 site
    Other conditions: Liver Cirrhosis, Liver Transplant Disorder
    View official trial listing →
  • Completed NCT NCT00296296

    Immunosuppression Impact on the Metabolic Control of Kidney Transplant With Pre-Existing Type 2 Diabetes (DM)

    Not yet reported Stanford University 29 participants Est. completion 2014-10 1 site
    Type 2 diabetesChronic kidney disease Other conditions: Kidney Transplant
    View official trial listing →
  • Completed NCT NCT00296309

    Comparing Efficacy & Safety of Tacrolimus & MMF With/Without Induction in the Elderly Following Kidney Transplantation.

    Not yet reported Astellas Pharma Inc 267 participants Est. completion 2006-08 33 sites Stand-alone
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT00296348

    Comparing Efficacy and Safety of Steroid Withdrawal With Tacrolimus and MMF With Induction in Children After Kidney Transplantation

    Not yet reported Astellas Pharma Inc 198 participants Est. completion 2008-02 35 sites Stand-alone
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT00296361

    To Compare the Efficacy and Safety of a Therapy of Tacrolimus With Sirolimus or MMF in Kidney Transplantation.

    Not yet reported Astellas Pharma Inc 634 participants Est. completion 2006-07 59 sites Stand-alone
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT00297310

    Pre-transplant Assessment of Tacrolimus Blood Level Concentration, as a Predictor of Tacrolimus Dose Requirements After Kidney Transplantation

    Not yet reported Janssen-Cilag Pty Ltd 89 participants Est. completion 2007-04
    Other conditions: Kidney Transplantation, Transplantation
    View official trial listing →
  • Completed NCT NCT00297661

    Sirolimus-Eluting Versus Paclitaxel-Eluting Stents for Coronary Revascularization

    Not yet reported University of Bern 1012 participants 1 site
    Other conditions: Coronary Heart Disease
    View official trial listing →
  • Completed NCT NCT00297765

    Optimizing Prograf® Therapy in Renal Transplant Patients

    Not yet reported Astellas Pharma Inc 323 participants Est. completion 2006-03 42 sites
    Other conditions: Renal Transplantation
    View official trial listing →
  • Completed NCT NCT00298506

    Study to Assess the Efficacy and Safety of FK506 Combined With Mycophenolate Mofetil (MMF) in Lupus Nephritis (III/IV/V)

    Not yet reported Nanjing University School of Medicine 120 participants Est. completion 2009-06 2 sites
    Other conditions: Lupus Nephritis
    View official trial listing →
  • Status unknown NCT NCT00298662

    Combination Therapy of Betaseron-Prograf in Multiple Sclerosis

    Not yet reported Clinique de sclérose en plaques et neuromusculaire de l'Outaouais 30 participants Est. completion 2006-09 1 site
    Other conditions: Multiple Sclerosis
    View official trial listing →
  • Completed NCT NCT00299221

    Safety Outcomes of Lower Immunosuppression Versus Traditional Immunosuppression in Heart Transplant Recipients

    Not yet reported Newark Beth Israel Medical Center 150 participants Est. completion 2009-12 2 sites
    Other conditions: Immunosuppression
    View official trial listing →
  • Withdrawn NCT NCT00301912

    Busulfan and Fludarabine Before Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer

    Not yet reported University of California, San Francisco 1 site
    Other conditions: Anemia, Chronic Myeloproliferative Disorders, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Diseases
    View official trial listing →
  • Completed NCT NCT00301951

    Low-Dose Fludarabine, Busulfan, and Anti-Thymocyte Globulin Followed By Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer

    Not yet reported University of California, San Francisco 7 participants Est. completion 2009-07 1 site Stand-alone
    Other conditions: Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes
    View official trial listing →
  • Completed NCT NCT00302523

    Tacrolimus Treatment of Patients With Idiopathic Membranous Nephropathy

    Not yet reported Nanjing University School of Medicine 16 participants Est. completion 2009-12 2 sites
    Other conditions: Idiopathic Membranous Nephropathy
    View official trial listing →
  • Withdrawn NCT NCT00302536

    Tacrolimus Treatment of Patients With Idiopathic Focal Segmental Glomerulosclerosis

    Not yet reported Nanjing University School of Medicine Est. completion 2010-09 1 site Stand-alone
    Other conditions: Focal Glomerulosclerosis
    View official trial listing →
  • Completed NCT NCT00302549

    To Compare the Efficacy and Safety of FK506 vs IVC in the Treatment of Class III-IV LN

    Not yet reported Nanjing University School of Medicine 61 participants Est. completion 2006-02 1 site
    Other conditions: Lupus Nephritis
    View official trial listing →
  • Terminated NCT NCT00303134

    Islet Cell Transplants for Diabetes

    Not yet reported Weill Medical College of Cornell University 3 participants Est. completion 2010-06-24 1 site
    Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT00304018

    Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer

    Not yet reported University of California, San Francisco 5 participants Est. completion 2009-03 1 site Stand-alone
    Other conditions: Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes
    View official trial listing →
  • Status unknown NCT NCT00304720

    Tacrolimus and MMF as Post Grafting Immunosuppression After Conditioning With Flu TBI for HLA Matched Family Donor

    Not yet reported Colorado Blood Cancer Institute 40 participants 1 site
    Other conditions: Multiple Myeloma, Lymphoma, Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, Myelodysplastic Syndrome
    View official trial listing →
  • Completed NCT NCT00306397

    Pilot Study to Investigate a Steroid Free Immunosuppressive Regimen for Renal Transplant Recipients

    Not yet reported University Hospital, Basel, Switzerland 100 participants Est. completion 2008-12 1 site
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT00308425

    Safety and Efficacy of Enteric-coated Mycophenolate Sodium (EC-MPS) Plus Valsartan in Patients With Kidney Transplants (MYTHOS

    Not yet reported Novartis 119 participants Est. completion 2005-06
    Other conditions: De Novo Renal Transplantation
    View official trial listing →
  • Completed NCT NCT00309088

    FK506 Phase 3 Study: a Study for Steroid Non-resistant Myasthenia Gravis (MG) Patients

    Not yet reported Astellas Pharma Inc 80 participants Est. completion 2008-06 9 sites Stand-alone
    Other conditions: Myasthenia Gravis
    View official trial listing →
  • Completed NCT NCT00309101

    An Open Study for Steroid Resistant, Non-Thymectomized MG Patients

    Not yet reported Astellas Pharma Inc 11 participants Est. completion 2009-02 9 sites Stand-alone
    Other conditions: Myasthenia Gravis
    View official trial listing →
  • Withdrawn NCT NCT00309231

    Clinical Islet Transplantation Using the Edmonton Protocol

    London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's Est. completion 2008-01 1 site
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT00309907

    Etanercept in Treating Young Patients With Idiopathic Pneumonia Syndrome After Undergoing a Donor Stem Cell Transplant

    Not yet reported Children's Oncology Group 39 participants Est. completion 2011-09 26 sites Stand-alone
    Obstructive sleep apnea Other conditions: Accelerated Phase Chronic Myelogenous Leukemia, Blastic Phase Chronic Myelogenous Leukemia, Childhood Acute Lymphoblastic Leukemia in Remission, Childhood Acute Myeloid Leukemia in Remission, Childhood Chronic Myelogenous Leukemia, Childhood Myelodysplastic Syndromes, Chronic Phase Chronic Myelogenous Leukemia, de Novo Myelodysplastic Syndromes, Disseminated Neuroblastoma, Juvenile Myelomonocytic Leukemia, Previously Treated Myelodysplastic Syndromes, Pulmonary Complications, Recurrent Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood Acute Myeloid Leukemia, Recurrent Childhood Large Cell Lymphoma, Recurrent Childhood Lymphoblastic Lymphoma, Recurrent Childhood Small Noncleaved Cell Lymphoma, Recurrent Neuroblastoma, Recurrent Wilms Tumor and Other Childhood Kidney Tumors, Recurrent/Refractory Childhood Hodgkin Lymphoma, Relapsing Chronic Myelogenous Leukemia, Secondary Acute Myeloid Leukemia, Secondary Myelodysplastic Syndromes
    View official trial listing →
  • Terminated NCT NCT00311311

    Study Comparing Effect On Carotid Atherosclerosis Following Conversion From Tacrolimus To Sirolimus Post-Transplant In Kidney Transplant Patients

    Not yet reported Pfizer 72 participants Est. completion 2012-01 8 sites Stand-alone
    Other conditions: Atherosclerosis, Kidney Failure
    View official trial listing →
  • Completed NCT NCT00311623

    Sirolimus Before Surgery in Treating Patients With Advanced Localized Prostate Cancer

    Not yet reported, Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 32 participants Est. completion 2010-06 3 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00313001

    Effects of Biphasic Insulin Aspart 70/30 vs. Exenatide in Type 2 Diabetes Patients Not Reaching Blood Glucose Targets on Metformin and a Sulfonylurea.

    Not yet reported Novo Nordisk A/S 373 participants Est. completion 2007-07 1 site
    Type 2 diabetes Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT00313625

    Melphalan and Busulfan Followed By Donor Peripheral Stem Cell Transplant, Tacrolimus, and Methotrexate in Treating Patients With Multiple Myeloma

    Not yet reported Fred Hutchinson Cancer Center 20 participants 1 site
    Other conditions: Multiple Myeloma and Plasma Cell Neoplasm
    View official trial listing →
  • Completed NCT NCT00315588

    Islet Cell Transplantation in Patients With Type I Diabetes With Previous Kidney Transplantation

    Not yet reported Rodolfo Alejandro 7 participants Est. completion 2014-05 1 site
    Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Terminated NCT NCT00315614

    Islet Cell Transplantation Alone and CD34+ Donor Bone Marrow Cell Infusion in Type 1 Diabetes Mellitus

    Not yet reported University of Miami 3 participants Est. completion 2010-12 1 site
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT00315627

    Steroid-free and Long-term Calcineurin-free Trial in Islet Cell Transplantation

    Not yet reported Rodolfo Alejandro 3 participants Est. completion 2014-01 1 site
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT00316810

    Simultaneous Pancreas-kidney Transplantation With Campath Protocol

    Not yet reported Dr. Claudia Bösmüller 30 participants Est. completion 2011-06 1 site Stand-alone
    Other conditions: Pancreas-Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT00317499

    Double-blind, Randomized, Placebo-controlled Phase 3 Study of Etanercept in the Treatment of Psoriatic Arthritis and Psoriasis

    Not yet reported Amgen 205 participants Est. completion 2002-07 Stand-alone
    Other conditions: Psoriatic Arthritis, Psoriasis
    View official trial listing →
  • Completed NCT NCT00317538

    Open-label, Pilot Protocol of Patients With Rheumatoid Arthritis Who Switch to Infliximab After Incomplete Response to Etanercept

    Not yet reported Centocor Ortho Biotech Services, L.L.C. 28 participants Est. completion 2004-11
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT00317681

    Efficacy of Topical Tacrolimus in Different Subtypes With Cutaneous Lupus Erythematosus (CLE)

    Not yet reported Heinrich-Heine University, Duesseldorf 30 participants Est. completion 2007-02 1 site
    Other conditions: Cutaneous Lupus Erythematosus
    View official trial listing →
  • Completed NCT NCT00317785

    Total-Body Irradiation and Cyclophosphamide in Treating Patients Who Are Undergoing Donor Stem Cell Transplant for Hematologic Cancer and Other Diseases

    Not yet reported Fred Hutchinson Cancer Center 50 participants 2 sites
    Other conditions: Leukemia, Lymphoma, Myelodysplastic Syndromes
    View official trial listing →
  • Terminated NCT NCT00318110

    Matched Unrelated Donor Transplant for Metastatic Renal Cell Carcinoma

    Not yet reported Center for International Blood and Marrow Transplant Research 4 participants Est. completion 2009-03 5 sites Stand-alone
    Other conditions: Metastatic Renal Cell Carcinoma
    View official trial listing →
  • Status unknown NCT NCT00319878

    Sirolimus and Cyclosporine for Treatment-Resistant Aplastic Anemia

    Not yet reported, Not yet reported Office of Rare Diseases (ORD) 52 participants Est. completion 2009-12 4 sites Stand-alone
    Other conditions: Anemia, Aplastic
    View official trial listing →
  • Completed NCT NCT00319917

    A Double Blind Placebo Controlled Study to Assess the Efficacy on Joint Damage in RA Patients

    Not yet reported Astellas Pharma Inc 123 participants Est. completion 2008-10 8 sites Stand-alone
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT00321074

    Tacrolimus and Daclizumab Versus Tacrolimus and Steroids in Liver Recipients Receiving Sub-optimal Grafts

    Not yet reported Astellas Pharma Inc 101 participants Est. completion 2007-10 9 sites Stand-alone
    Other conditions: LIVER TRANSPLANTATION
    View official trial listing →
  • Completed NCT NCT00321113

    Comparison of Two Tacrolimus Based Immunosuppressive Regimens in Recipients Receiving Marginal Donor Kidneys

    Not yet reported Astellas Pharma Inc 142 participants Est. completion 2008-03 14 sites Stand-alone
    Other conditions: KIDNEY TRANSPLANTATION
    View official trial listing →
  • Completed NCT NCT00321256

    Human Islet Transplantation in Brittle Type 1 Diabetes Mellitus. The GRAGIL 2 Study.

    Not yet reported, Not yet reported University Hospital, Grenoble 22 participants Est. completion 2007-07 6 sites
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT00321906

    Comparison of Sirolimus and Azathioprine in Lung Transplantation

    Not yet reported University of Chicago 181 participants Est. completion 2011-08 1 site
    Other conditions: Delayed Graft Function, Acute Graft Rejection
    View official trial listing →
  • Completed NCT NCT00322101

    Low-Dose or High-Dose Conditioning Followed by Peripheral Blood Stem Cell Transplant in Treating Patients With Myelodysplastic Syndrome or Acute Myelogenous Leukemia

    Not yet reported Fred Hutchinson Cancer Center 25 participants Est. completion 2014-10 8 sites Stand-alone
    Other conditions: Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome, Acute Myeloid Leukemia/Transient Myeloproliferative Disorder, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Childhood Acute Myeloid Leukemia in Remission, Childhood Myelodysplastic Syndromes, de Novo Myelodysplastic Syndromes, Myelodysplastic Syndrome With Isolated Del(5q), Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable, Previously Treated Myelodysplastic Syndromes, Recurrent Adult Acute Myeloid Leukemia, Recurrent Childhood Acute Myeloid Leukemia, Secondary Acute Myeloid Leukemia, Secondary Myelodysplastic Syndromes
    View official trial listing →
  • Completed NCT NCT00323895

    The Intra-Drug Eluting Stent (DES) Restenosis Study

    Not yet reported Cordis US Corp. 320 participants Est. completion 2010-01 2 sites Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Status unknown NCT NCT00325325

    Pharmacokinetic Study on the Combination of Everolimus-Tacrolimus

    Not yet reported Hospital Universitario Ramon y Cajal 40 participants Est. completion 2007-06 1 site
    Other conditions: Kidney Diseases
    View official trial listing →
  • Completed NCT NCT00328770

    De Novo Sirolimus-based Immunosuppression After Liver Transplantation for Hepatocellular Carcinoma

    Not yet reported, Not yet reported University of Alberta 70 participants Est. completion 2006-03 1 site Stand-alone
    Other conditions: Liver Carcinoma
    View official trial listing →
  • Completed NCT NCT00329719

    Sorafenib Tosylate and Temsirolimus in Treating Patients With Recurrent Glioblastoma

    Not yet reported, Not yet reported National Cancer Institute (NCI) 115 participants Est. completion 2013-02-02 190 sites
    Obstructive sleep apnea Other conditions: Adult Glioblastoma, Recurrent Adult Brain Neoplasm
    View official trial listing →
  • Completed NCT NCT00329823

    Etanercept in Hidradenitis Suppurativa

    Not yet reported University of Athens 10 participants Est. completion 2006-05 1 site
    Other conditions: Hidradenitis Suppurativa
    View official trial listing →
  • Completed NCT NCT00331162

    Study of Alemtuzumab Versus Anti-thymocyte Globulin to Help Prevent Rejection in Kidney and Pancreas Transplantation

    Not yet reported Wake Forest University Health Sciences 222 participants Est. completion 2011-11-28 1 site
    Other conditions: Graft Rejection
    View official trial listing →
  • Completed NCT NCT00332332

    Canadian Assessment of Patient Outcomes and Effectiveness of Etanercept (Enbrel) in Psoriasis

    Not yet reported Amgen 246 participants Est. completion 2010-02 Stand-alone
    Other conditions: Psoriasis
    View official trial listing →
  • Completed NCT NCT00332397

    The Efficacy of Three Different Limus Agent-Eluting Stents to Prevent Restenosis

    Not yet reported Deutsches Herzzentrum Muenchen 1007 participants Est. completion 2007-07 2 sites
    Other conditions: Coronary Disease
    View official trial listing →
  • Terminated NCT NCT00332839

    Comparison of CNI-based Regimen Versus CNI-free Regimen in Kidney Transplant Recipients.

    Not yet reported Novartis Pharmaceuticals 93 participants Est. completion 2013-03 11 sites Stand-alone
    Other conditions: Renal Transplantation
    View official trial listing →
  • Terminated NCT NCT00337376

    A Study of the mTOR Inhibitor Rapamycin (Rapamune, Sirolimus) in Combination With Abraxane in Advanced Solid Cancers

    Not yet reported Yale University 23 participants Est. completion 2010-07 1 site
    Other conditions: Advanced Solid Cancers
    View official trial listing →
  • Completed NCT NCT00337493

    Pharmacogenetic Study of CellCept (Mycophenolate Mofetil) in Kidney Transplant Patients.

    Not yet reported Hoffmann-La Roche 155 participants Est. completion 2008-01 20 sites Stand-alone
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT00337545

    Phase II Trial of RAD001 in Refractory Colorectal Cancer

    Not yet reported Swedish Medical Center 22 participants Est. completion 2007-04 1 site
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT00343226

    An Open, Randomized Pilot Study to Evaluate the Use of Basiliximab With an Optimized Cyclosporine Dosing on Renal Function in "de Novo" Liver Transplantation.

    Not yet reported Novartis 48 participants
    Other conditions: Liver Transplantation
    View official trial listing →
  • Completed NCT NCT00344851

    Exenatide and Metformin Therapy in Overweight Women With PCOS

    Not yet reported Metabolic Center of Louisiana Research Foundation 60 participants Est. completion 2007-06 1 site
    Other conditions: Polycystic Ovary Syndrome
    View official trial listing →
  • Terminated NCT NCT00346151

    Belatacept to Prevent Organ Rejection in Kidney Transplant Patients

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 5 participants Est. completion 2010-02 2 sites Stand-alone
    Other conditions: Renal Transplant
    View official trial listing →
  • Completed NCT NCT00346359

    Fludarabine and Busulfan Followed by Donor Peripheral Stem Cell Transplant and Antithymocyte Globulin, Tacrolimus, and Methotrexate in Treating Patients With Myeloid Cancer

    Not yet reported Fred Hutchinson Cancer Center 40 participants Est. completion 2007-11 1 site
    Other conditions: Chronic Myeloproliferative Disorders, Graft Versus Host Disease, Leukemia, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Diseases
    View official trial listing →
  • Completed NCT NCT00347048

    Tacrolimus (FK506) Study in Moderate to Severe Refractory Ulcerative Colitis Patients

    Not yet reported Astellas Pharma Inc 62 participants Est. completion 2008-04 6 sites Stand-alone
    Other conditions: Ulcerative Colitis
    View official trial listing →
  • Completed NCT NCT00350181

    Sirolimus & Mycophenolate Mofetil as GVHD Prophylaxis in Myeloablative, Matched Related Donor HCT

    Not yet reported Stanford University 11 participants Est. completion 2010-04 1 site Stand-alone
    Other conditions: Leukemia, Lymphoma, Non-Hodgkin, Hematologic Diseases, Acute GVHD
    View official trial listing →
  • Completed NCT NCT00350454

    Rapamycin-Eluting Stents With Different Polymer Coating to Reduce Restenosis (ISAR-TEST-3)

    Not yet reported Deutsches Herzzentrum Muenchen 605 participants Est. completion 2007-10 2 sites
    Other conditions: Coronary Heart Disease
    View official trial listing →
  • Completed NCT NCT00350545

    A Phase 2 Trial of Rituximab and Corticosteroid Therapy for Newly Diagnosed Chronic Graft Versus Host Disease

    Not yet reported Stanford University 37 participants Est. completion 2014-10 1 site Stand-alone
    Other conditions: Graft vs Host Disease
    View official trial listing →
  • Withdrawn NCT NCT00352950

    Safety Evaluation of Panitumumab and Sirolimus in Advanced Non-Small Cell Lung Cancer

    Not yet reported Amgen Est. completion 2008-02
    Other conditions: Oncology, Non-Small Cell Lung Cancer
    View official trial listing →
  • Completed NCT NCT00352976

    TBI Dose De-escalation for Fanconi Anemia

    Not yet reported, Not yet reported Masonic Cancer Center, University of Minnesota 83 participants Est. completion 2020-10-09 1 site Stand-alone
    Other conditions: Fanconi Anemia
    View official trial listing →
  • Completed NCT NCT00353119

    A Placebo-Controlled Double-Blind Study on the Safety and Efficacy of Etanercept in Palmoplantar Pustulosis

    Not yet reported Innovaderm Research Inc. 15 participants Est. completion 2007-03 3 sites
    Other conditions: Palmoplantaris Pustulosis
    View official trial listing →
  • Completed NCT NCT00353301

    Erlotinib and Sirolimus for the Treatment of Metastatic Renal Cell Carcinoma

    Not yet reported University of Colorado, Denver 25 participants Est. completion 2012-03 1 site Stand-alone
    Other conditions: Renal Cell Carcinoma
    View official trial listing →
  • Completed NCT NCT00355862

    Immunosuppression in Patients Undergoing Liver Transplantation for Hepatocellular Carcinoma

    Not yet reported University of Regensburg 525 participants Est. completion 2014-05 1 site Stand-alone
    Other conditions: Hepatocellular Carcinoma
    View official trial listing →
  • Completed NCT NCT00356356

    16.0040 Ankylosing Spondylitis Study

    Not yet reported Amgen 257 participants Est. completion 2006-09 Stand-alone
    Other conditions: Ankylosing Spondylitis
    View official trial listing →
  • Completed NCT NCT00356590

    Open-Label Extension Treatment With Etanercept (TNFR:Fc) for Participating Patients in Etanercept (TNFR:Fc) Clinical Trial 016.0012

    Not yet reported Amgen 468 participants Est. completion 2009-04
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Terminated NCT NCT00358657

    Fludarabine Phosphate, Cyclophosphamide, and Total-Body Irradiation Followed by Donor Bone Marrow Transplant and Cyclophosphamide, Mycophenolate Mofetil, Tacrolimus, and Sirolimus in Treating Patients With Primary Immunodeficiency Disorders or Noncancerous Inherited Disorders

    Not yet reported Fred Hutchinson Cancer Center 14 participants Est. completion 2019-05-25 3 sites Stand-alone
    Other conditions: Immunodeficiency Syndrome, Severe Aplastic Anemia, Genetic Disorder
    View official trial listing →
  • Completed NCT NCT00359879

    Comparison of Exenatide Taken Before Lunch and Dinner With Before Breakfast and Dinner in Patients With Type 2 Diabetes

    Not yet reported AstraZeneca 377 participants Est. completion 2007-07 15 sites Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00360334

    A Study Comparing Exenatide With Basal Insulin in Achieving a Target HbA1c With Minimum Weight Gain in Type 2 Diabetes Patients

    Not yet reported AstraZeneca 235 participants Est. completion 2008-04 31 sites Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00360685

    Tacrolimus and Mycophenolate Mofetil (MMF) in GVHD Prophylactic Regimen Compared to Tacrolimus and Methotrexate (MTX

    Not yet reported H. Lee Moffitt Cancer Center and Research Institute 89 participants Est. completion 2011-01 1 site
    Other conditions: Mucositis, Graft-versus-host Disease
    View official trial listing →
  • Completed NCT NCT00361634

    Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) to Measure Response to Etanercept in Rheumatoid Arthritis

    Not yet reported Amgen 14 participants Est. completion 2010-03 3 sites Stand-alone
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT00362531

    Tacrolimus Combined With Prednisone Treatment of Idiopathic Membranous Nephropathy and Nephrotic Syndrome

    Not yet reported, Not yet reported Peking University Est. completion 2007-01
    Other conditions: Idiopathic Membranous Nephropathy, Nephrotic Syndrome
    View official trial listing →
  • Completed NCT NCT00363116

    A Trial of Two Daclizumab Dosing Strategies vs. No Induction Treatment With Tacrolimus, Mycophenolate Mofetil , & Steroids for the Prevention of Acute Allograft Rejection in Simultaneous Kidney/Pancreas Transplant Recipients

    Not yet reported University of Cincinnati 298 participants Est. completion 2004-12 24 sites
    Other conditions: Acute Allograft Rejection in Simultaneous Kidney/Pancreas Transplant Recipients
    View official trial listing →
  • Completed NCT NCT00364572

    Efficacy of Epidural Etanercept in the Treatment of Sciatica

    Not yet reported, Not yet reported Johns Hopkins University 24 participants Est. completion 2007-12 1 site Stand-alone
    Other conditions: Sciatica
    View official trial listing →
  • Completed NCT NCT00365846

    "A Pilot Study to Determine the Safety of Campath-1H (Anti-CD52) Therapy in Primary Renal Allograft Transplantation"

    Not yet reported University of Wisconsin, Madison 29 participants Est. completion 2006-07 1 site Stand-alone
    Other conditions: Renal Transplant
    View official trial listing →
  • Withdrawn NCT NCT00368719

    Evaluation to Assess the Long Term Safety of Tacrolimus Ointment for Atopic Dermatitis

    Not yet reported University of California, Davis Est. completion 2016-07
    Other conditions: Atopic Dermatitis
    View official trial listing →
  • Completed NCT NCT00368914

    Sirolimus in Treating Patients With Metastatic or Unresectable Solid Tumors

    Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 30 participants Est. completion 2009-06 1 site
    Other conditions: Unspecified Adult Solid Tumor, Protocol Specific
    View official trial listing →
  • Completed NCT NCT00369161

    A Twelve-month, Multicenter, Open-label, Randomized Study of the Safety, Tolerability and Efficacy of Everolimus With Basiliximab, Corticosteroids and Two Different Exposure Levels of Tacrolimus in de Novo Renal Transplant Recipients

    Not yet reported Novartis 228 participants Est. completion 2008-12 1 site
    Other conditions: Renal Transplantation
    View official trial listing →
  • Completed NCT NCT00369226

    Bortezomib Plus Tacrolimus and Methotrexate to Prevent Graft Versus Host Disease (GVHD) After Mismatched Allogeneic Non-Myeloablative Blood Stem Cell Transplantation

    Not yet reported, Not yet reported Dana-Farber Cancer Institute 45 participants Est. completion 2011-09 2 sites Stand-alone
    Other conditions: Hematologic Malignancies
    View official trial listing →
  • Completed NCT NCT00369382

    Study Of The Safety And Efficacy Of Conversion From A CNI To Sirolimus In Renally-Impaired Heart Transplant Recipients

    Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 121 participants Est. completion 2010-05 23 sites Stand-alone
    Other conditions: Graft Rejection, Kidney Failure
    View official trial listing →
  • Completed NCT NCT00371319

    Comparing the Efficacy of Tacrolimus and Mycophenolate Mofetil for the Initial Therapy of Active Lupus Nephritis

    Not yet reported Tuen Mun Hospital 150 participants Est. completion 2014-06 1 site
    Other conditions: Lupus Nephritis
    View official trial listing →
  • Terminated NCT NCT00373815

    Everolimus in Combination With Cyclosporine A and Prednisolone for the Treatment of Graft Versus Host Disease

    Not yet reported University Hospital Tuebingen 10 participants Est. completion 2009-10 1 site
    Other conditions: Graft Versus Host Disease
    View official trial listing →
  • Completed NCT NCT00374140

    Phase II Trial of RAD001 (Everolimus) in Previously Treated Small Cell Lung Cancer

    Not yet reported Ahmad Tarhini 40 participants Est. completion 2012-06 19 sites
    Other conditions: Small Cell Lung Cancer
    View official trial listing →
  • Completed NCT NCT00374231

    Single Center Pilot Study of Corticosteroid Discontinuation in Liver Transplant Recipients

    Not yet reported University of Cincinnati 40 participants Est. completion 2008-01 1 site Stand-alone
    Other conditions: Liver Transplantation
    View official trial listing →
  • Completed NCT NCT00374803

    Study of Myfortic in Combination With Tacrolimus and Thymoglobulin in Early Corticosteroid Withdrawal

    Not yet reported University of Cincinnati 45 participants Est. completion 2008-01 2 sites
    Other conditions: End Stage Renal Disease (ESRD)
    View official trial listing →
  • Terminated NCT NCT00375895

    Switch From Tacrolimus to Cyclosporin in the Treatment of Recurrent Hepatitis C After Liver Transplantation

    Not yet reported Rennes University Hospital 11 participants Est. completion 2009-12 13 sites
    Other conditions: Chronic Hepatitis C, Evidence of Liver Transplantation
    View official trial listing →
  • Completed NCT NCT00376688

    Temsirolimus in Treating Patients With Locally Advanced or Metastatic Breast Cancer

    Not yet reported National Cancer Institute (NCI) 31 participants Est. completion 2019-12-16 2 sites
    Other conditions: Recurrent Breast Carcinoma, Stage III Breast Cancer AJCC v7, Stage IIIA Breast Cancer AJCC v7, Stage IIIB Breast Cancer AJCC v7, Stage IIIC Breast Cancer AJCC v7, Stage IV Breast Cancer AJCC v6 and v7
    View official trial listing →
  • Completed NCT NCT00377962

    Nordic Everolimus (Certican) Trial in Heart and Lung Transplantation

    Not yet reported Novartis Pharmaceuticals 282 participants Est. completion 2010-02 6 sites Stand-alone
    Other conditions: Disorder Related to Cardiac Transplantation
    View official trial listing →
  • Completed NCT NCT00378326

    Immunotherapy of the Paraneoplastic Syndromes

    Not yet reported Rockefeller University 26 participants Est. completion 2014-05 1 site Stand-alone
    Other conditions: Paraneoplastic Syndromes
    View official trial listing →
  • Completed NCT NCT00378703

    Bevacizumab, Sorafenib Tosylate, and Temsirolimus in Treating Patients With Metastatic Kidney Cancer

    Not yet reported National Cancer Institute (NCI) 361 participants Est. completion 2017-03-21 559 sites
    Other conditions: Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Carcinoma, Stage IV Renal Cell Cancer AJCC v7
    View official trial listing →
  • Completed NCT NCT00381342

    Safety and Efficacy of Exenatide as Monotherapy

    Not yet reported AstraZeneca 233 participants Est. completion 2007-09 19 sites Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00382109

    Tacrolimus and Methotrexate With or Without Sirolimus in Preventing Graft-Versus-Host Disease in Young Patients Undergoing Donor Stem Cell Transplant for Acute Lymphoblastic Leukemia in Complete Remission

    Not yet reported Children's Oncology Group 146 participants Est. completion 2017-06-30 50 sites Stand-alone
    Other conditions: B-cell Childhood Acute Lymphoblastic Leukemia, Childhood Acute Lymphoblastic Leukemia in Remission, Graft Versus Host Disease, L1 Childhood Acute Lymphoblastic Leukemia, L2 Childhood Acute Lymphoblastic Leukemia, T-cell Childhood Acute Lymphoblastic Leukemia
    View official trial listing →
  • Completed NCT NCT00384137

    A Conversion Study to Assess Safety and Efficacy of a MR4 Based Immunosuppressive Regimen in Stable Kidney Recipients

    Not yet reported Astellas Pharma Inc 128 participants Est. completion 2007-07 13 sites Stand-alone
    Other conditions: Transplantation
    View official trial listing →
  • Completed NCT NCT00384202

    A Conversion Study to Assess Safety and Efficacy of a MR4 Based Immunosuppressive Regimen in Stable Liver Recipients

    Not yet reported Astellas Pharma Inc 112 participants Est. completion 2007-11 13 sites Stand-alone
    Other conditions: Transplantation
    View official trial listing →
  • Completed NCT NCT00384969

    Sorafenib and RAD001 Renal Cell Carcinoma

    Not yet reported University of California, San Francisco 21 participants Est. completion 2014-03 1 site
    Other conditions: Renal Cell Carcinoma
    View official trial listing →
  • Completed NCT NCT00385788

    Allogeneic Blood Stem Cell Transplantation and Adoptive Immunotherapy for Hodgkin's Disease

    Not yet reported M.D. Anderson Cancer Center 52 participants Est. completion 2016-08 1 site Stand-alone
    Other conditions: Hodgkin's Disease
    View official trial listing →
  • Completed NCT NCT00387400

    Temozolomide + Everolimus in Newly Diagnosed, Recurrent, or Progressive Malignant Glioblastoma Multiforme

    Not yet reported NCIC Clinical Trials Group 32 participants Est. completion 2012-01-06 9 sites
    Other conditions: Brain and Central Nervous System Tumors
    View official trial listing →
  • Status unknown NCT NCT00390195

    Randomized Phase I/II of RAD001 in Advanced Hepatocellular Carcinoma (HCC)

    Not yet reported, Not yet reported National Health Research Institutes, Taiwan 134 participants Est. completion 2011-06 2 sites
    Other conditions: Hepatocellular Carcinoma
    View official trial listing →
  • Terminated NCT NCT00390364

    Everolimus in Treating Patients With Advanced or Metastatic Colorectal Cancer That Did Not Respond to Previous Therapy

    Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 1 participants Est. completion 2007-10 1 site
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT00392821

    Dosing and Effectiveness Study of Sorafenib and RAD001 in the Treatment of Patients With Advanced Kidney Cancer

    Not yet reported, Not yet reported SCRI Development Innovations, LLC 78 participants Est. completion 2013-10 11 sites
    Other conditions: Kidney Cancer
    View official trial listing →
  • Completed NCT NCT00392951

    Sirolimus for Autoimmune Disease of Blood Cells

    Not yet reported, Not yet reported Children's Hospital of Philadelphia 30 participants Est. completion 2016-02 1 site Stand-alone
    Other conditions: Autoimmune Pancytopenia, Autoimmune Lymphoproliferative Syndrome (ALPS), Evans Syndrome, Idiopathic Thrombocytopenic Purpura, Anemia, Hemolytic, Autoimmune, Autoimmune Neutropenia, Lupus Erythematosus, Systemic, Inflammatory Bowel Disease, Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT00397982

    Temsirolimus and Bevacizumab in Treating Patients With Stage III or Stage IV Malignant Melanoma

    Not yet reported National Cancer Institute (NCI) 17 participants Est. completion 2013-07 2 sites
    Other conditions: Recurrent Melanoma, Stage IIIB Skin Melanoma, Stage IIIC Skin Melanoma, Stage IV Skin Melanoma
    View official trial listing →
  • Completed NCT NCT00400400

    Enteric-coated Mycophenolate Sodium (EC-MPS) and Mycophenolate Mofetil (MMF) in Renal Transplant Patients With Gastrointestinal (GI) Intolerance

    Not yet reported Novartis Pharmaceuticals 400 participants 53 sites Stand-alone
    Other conditions: Renal Transplantation
    View official trial listing →
  • Completed NCT NCT00401115

    Safety and Tolerability of MS-R001 in Patients With Diabetic Macular Edema Secondary to Diabetic Retinopathy

    Not yet reported Santen Inc. 50 participants Est. completion 2008-06 2 sites
    Other conditions: Diabetic Macular Edema, Diabetic Retinopathy
    View official trial listing →
  • Completed NCT NCT00401778

    Trial of RAD001 in Patients With Operable Non-Small Cell Lung Cancer (NSCLC)

    Not yet reported Emory University 33 participants Est. completion 2013-12 1 site
    Other conditions: Lung Cancer
    View official trial listing →
  • Completed NCT NCT00402168

    A Study of BMS-224818 (Belatacept) in Patients Who Have Undergone a Kidney Transplant and Are Currently on Stable Cyclosporine or Tacrolimus Regimen With or Without Corticosteroids

    Not yet reported Bristol-Myers Squibb 173 participants Est. completion 2013-06 44 sites
    Other conditions: Renal Transplant
    View official trial listing →
  • Completed NCT NCT00402532

    Immunosuppressive Therapy With Certican (Everolimus) After Lung Transplantation

    Not yet reported Hannover Medical School 190 participants Est. completion 2011-12 1 site
    Other conditions: Lung Transplantation
    View official trial listing →
  • Completed NCT NCT00402558

    Alloreactive NK Cells for Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)

    Not yet reported M.D. Anderson Cancer Center 15 participants Est. completion 2014-04 1 site Stand-alone
    Other conditions: Myelodysplastic Syndrome, Leukemia
    View official trial listing →
  • Terminated NCT NCT00402662

    A Study of Everolimus in Combination With Imatinib in Metastatic Melanoma

    Not yet reported Yale University 3 participants Est. completion 2006-06 1 site
    Other conditions: Metastatic Melanoma
    View official trial listing →
  • Completed NCT NCT00403338

    The Impact of Stent Deployment Techniques on Clinical Outcomes of Patient Treated With the CYPHER® Stent (S.T.L.L.R.)

    Cordis US Corp. 1500 participants Est. completion 2006-04
    Other conditions: Coronary Stenosis
    View official trial listing →
  • Completed NCT NCT00403416

    Efficacy and Safety of AEB071 Plus Tacrolimus (Converted to Mycophenolic Acid After 3 Months), in Renal Transplant Patients

    Not yet reported, Not yet reported Novartis Pharmaceuticals 215 participants Est. completion 2008-05 28 sites Stand-alone
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT00404794

    A Study to Compare Mycophenolate Mofetil and Tacrolimus in the Treatment of Membranous Lupus Nephritis

    Not yet reported Hospital Authority, Hong Kong 20 participants Est. completion 2009-10 1 site
    Other conditions: Lupus Nephritis, Glomerulonephritis, Membranous
    View official trial listing →
  • Terminated NCT NCT00406276

    Phase I/II Trial of RAD001 Plus Docetaxel in Patients With Metastatic or Recurrent Non-Small Cell Lung Cancer

    Not yet reported, Not yet reported Emory University 28 participants Est. completion 2013-02 1 site
    Other conditions: Lung Cancer
    View official trial listing →
  • Completed NCT NCT00406393

    Sirolimus/Tacrolimus Versus Tacrolimus/Methotrexate for Preventing Graft-Versus-Host Disease (GVHD) (BMT CTN 0402)

    Not yet reported Medical College of Wisconsin 304 participants Est. completion 2015-10 24 sites Stand-alone
    Other conditions: Leukemia, Myelocytic, Acute, Leukemia, Lymphocytic, Acute, Leukemia, Myeloid, Chronic, Myelodysplastic Syndromes
    View official trial listing →
  • Completed NCT NCT00407160

    A Trial of Tolerogenic Immunosuppression in Highly Sensitized Renal Transplant Recipients

    The University of Texas Medical Branch, Galveston 21 participants Est. completion 2011-01 1 site
    Other conditions: Kidney Diseases
    View official trial listing →
  • Terminated NCT NCT00409461

    Comparison of Sirolimus Alone With Sirolimus Plus Tacrolimus in Type 1 Diabetic Recipients of Cultured Islet Cell Grafts

    Not yet reported Universitair Ziekenhuis Brussel 2 sites
    Other conditions: Islet Transplantation, Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT00410124

    RAD001 Plus Best Supportive Care (BSC) Versus BSC Plus Placebo in Patients With Metastatic Carcinoma of the Kidney Which Has Progressed After Treatment With Sorafenib and/or Sunitinib

    Not yet reported Novartis Pharmaceuticals 416 participants Est. completion 2011-10 93 sites
    Other conditions: Metastatic Renal Cell Carcinoma
    View official trial listing →
  • Completed NCT NCT00411619

    Everolimus (RAD001) Therapy of Giant Cell Astrocytoma in Patients With Tuberous Sclerosis Complex

    Not yet reported, Not yet reported Children's Hospital Medical Center, Cincinnati 28 participants Est. completion 2014-01 1 site
    Other conditions: Tuberous Sclerosis, Subependymal Giant Cell Astrocytoma
    View official trial listing →
  • Completed NCT NCT00411944

    Long-Term Pharmacokinetics of Tacrolimus in Renal Recipients

    KU Leuven 100 participants Est. completion 2005-09 1 site
    Other conditions: Renal Transplantation
    View official trial listing →
  • Completed NCT NCT00413400

    Study of TNF-Antagonism in the Metabolic Syndrome (II)

    Not yet reported Massachusetts General Hospital 40 participants Est. completion 2009-09 1 site
    Metabolic syndrome
    View official trial listing →
  • Completed NCT NCT00413452

    Etanercept SFP in RA Patients

    Not yet reported Amgen 224 participants Est. completion 2007-10 Stand-alone
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT00414440

    Efficacy, Safety and Tolerability of Everolimus in Preventing End-stage Renal Disease in Patients With Autosomal Dominant Polycystic Kidney Disease

    Not yet reported Novartis Pharmaceuticals 431 participants Est. completion 2013-10 24 sites
    Other conditions: Autosomal Dominant Polycystic Kidney Disease
    View official trial listing →
  • Terminated NCT NCT00417677

    A Study Combining Treatment With Temsirolimus and Sunitinib for Subjects With Advanced Renal Cell Carcinoma

    Not yet reported, Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 124 participants Est. completion 2007-05 4 sites
    Other conditions: Renal Cell Carcinoma
    View official trial listing →
  • Completed NCT NCT00418067

    Zotarolimus-Eluting Stent Versus Sirolimus-Eluting Stent and PacliTaxel-Eluting Stent for Coronary Lesions

    Not yet reported Seung-Jung Park 2645 participants Est. completion 2009-01 20 sites
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT00418548

    Study Comparing Etanercept 50 mg Once Weekly to 25 mg Twice Weekly in Patients With Ankylosing Spondylitis

    Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 350 participants Est. completion 2005-02
    Other conditions: Ankylosing Spondylitis
    View official trial listing →
  • Completed NCT NCT00420238

    Study Evaluating Etanercept for the Treatment of Active, Severe, and Advanced Axial Ankylosing Spondylitis

    Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 82 participants Est. completion 2009-05 21 sites Stand-alone
    Other conditions: Ankylosing Spondylitis
    View official trial listing →
  • Completed NCT NCT00420303

    Study Evaluating Etanercept for the Treatment of Refractory Heel Enthesitis in Spondylarthropathy

    Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 24 participants Est. completion 2008-09 15 sites Stand-alone
    Other conditions: Spondylarthropathies, Enthesitis
    View official trial listing →
  • Completed NCT NCT00421174

    Effectiveness of Etanercept for Idiopathic Pneumonia Syndrome Following Stem Cell Transplantation (BMT CTN 0403)

    Not yet reported National Heart, Lung, and Blood Institute (NHLBI) 37 participants Est. completion 2013-07 12 sites Stand-alone
    Other conditions: Pneumonia, Idiopathic Pneumonia Syndrome
    View official trial listing →
  • Completed NCT NCT00421980

    An Open-Label, Multicentre, Long-Term Extension Study of Etanercept in Ankylosing Spondylitis

    Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 84 participants Est. completion 2004-07 1 site
    Other conditions: Ankylosing Spondylitis
    View official trial listing →
  • Completed NCT NCT00422344

    A Study of RAD001 and Sunitinib in Metastatic Renal Cell Carcinoma

    Not yet reported Memorial Sloan Kettering Cancer Center 20 participants Est. completion 2010-02 1 site
    Other conditions: Renal Cell Carcinoma, Kidney Cancer
    View official trial listing →
  • Completed NCT NCT00423514

    Clofarabine, Melphalan, and Thiotepa Followed By a Donor Stem Cell Transplant in Treating Patients With High-Risk and/or Advanced Hematologic Cancer or Other Disease

    Not yet reported, Not yet reported Memorial Sloan Kettering Cancer Center 38 participants Est. completion 2021-06-18 1 site Stand-alone
    Other conditions: Graft Versus Host Disease, Leukemia, Myelodysplastic Syndromes
    View official trial listing →
  • No Longer Available NCT NCT00423826

    Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease

    Barbara Ann Karmanos Cancer Institute Est. completion 2015-01 1 site
    Other conditions: Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Precancerous Condition, Secondary Myelofibrosis
    View official trial listing →
  • Completed NCT NCT00423865

    Cisplatin and Everolimus in Treating Patients With Advanced Solid Tumors

    Not yet reported Memorial Sloan Kettering Cancer Center 30 participants Est. completion 2011-09 1 site
    Other conditions: Unspecified Adult Solid Tumor, Protocol Specific
    View official trial listing →
  • Completed NCT NCT00425308

    Efficacy and Safety of Everolimus in Combination With Cyclosporine Microemulsion Versus Everolimus in Combination With Enteric-coated Mycophenolate Sodium (EC-MPS), in Adult Renal Transplant Patients in Maintenance.

    Not yet reported Novartis Pharmaceuticals 30 participants 1 site
    Other conditions: Renal Transplantation
    View official trial listing →
  • Status unknown NCT NCT00426049

    Systemic Treatment With Everolimus for the Prevention of MACE After Bare Metal Stent Implantation

    Not yet reported German Heart Institute 484 participants 1 site
    Cardiovascular disease Other conditions: Coronary Restenosis
    View official trial listing →
  • Completed NCT NCT00426517

    Donor Stem Cell Transplantation for Congenital Immunodeficiencies

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 48 participants Est. completion 2019-11-01 1 site Stand-alone
    Other conditions: Inherited Immune Deficiencies
    View official trial listing →
  • Completed NCT NCT00426530

    Safety of Everolimus in Combination Therapy, in Patients With HER2-overexpressing Metastatic Breast Cancer

    Not yet reported Novartis Pharmaceuticals 50 participants Est. completion 2010-06 6 sites
    Other conditions: Breast Neoplasms, Neoplasm Metastasis
    View official trial listing →
  • Completed NCT NCT00428454

    Sirolimus-eluting vs Zotarolimus-eluting Stents for Chronic Total Coronary Occlusions

    Not yet reported R&D Cardiologie 301 participants Est. completion 2015-06 5 sites Stand-alone
    Cardiovascular disease Other conditions: Coronary Disease, Coronary Stenosis
    View official trial listing →
  • Terminated NCT NCT00429052

    Mechanism of Percutaneous Revascularization for Coronary Bifurcation Disease

    University of Florida 24 participants Est. completion 2008-09 1 site
    Other conditions: Coronary Disease
    View official trial listing →
  • Completed NCT NCT00429143

    A Two-Step Approach to Bone Marrow Transplant Using Cells From A Partially-Matched Relative

    Not yet reported, Not yet reported Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 27 participants Est. completion 2010-06 1 site Stand-alone
    Other conditions: Hematologic Malignancies
    View official trial listing →
  • Completed NCT NCT00429377

    Phase 3 Study of Tacrolimus (FK506) for Lupus Nephritis: A Placebo Controlled, Double-Blind Multicenter, Comparative Study

    Not yet reported Astellas Pharma Inc 64 participants 7 sites
    Other conditions: Lupus Nephritis
    View official trial listing →
  • Completed NCT NCT00429416

    Research Study to Determine if an Experimental Agent, LLME Can Decrease the Incidence and Severity of Graft-Versus-Host-Disease (GVHD) Following Blood (Hematopoietic) Stem Cell Transplantation

    Not yet reported, Not yet reported Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 14 participants Est. completion 2009-05 1 site Stand-alone
    Other conditions: Hematologic Malignancies
    View official trial listing →
  • Completed NCT NCT00429793

    Temsirolimus in Treating Patients With Refractory or Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer

    Not yet reported National Cancer Institute (NCI) 60 participants Est. completion 2012-01 1 site
    Other conditions: Fallopian Tube Cancer, Primary Peritoneal Cavity Cancer, Recurrent Ovarian Epithelial Cancer
    View official trial listing →
  • Completed NCT NCT00430898

    Basiliximab in Moderate to Severe Ulcerative Colitis

    Not yet reported Cerimon Pharmaceuticals 181 participants Est. completion 2008-09 68 sites Stand-alone
    Other conditions: Ulcerative Colitis
    View official trial listing →
  • Completed NCT NCT00432406

    Tumor Necrosis Factors (TNF)-α Blockade for Psoriatic Arthritis

    Not yet reported Chinese University of Hong Kong 40 participants Est. completion 2009-03 1 site
    Other conditions: Psoriatic Arthritis
    View official trial listing →
  • Completed NCT NCT00433485

    Topical Sirolimus in Patients With Basal Cell Nevus Syndrome and in Healthy Participants

    Not yet reported Yale University 16 participants Est. completion 2008-03
    Other conditions: Neoplastic Syndrome, Non-melanomatous Skin Cancer
    View official trial listing →
  • Completed NCT NCT00434174

    Safety of Everolimus and Pemetrexed in Lung Cancer Patients

    Not yet reported Novartis Pharmaceuticals 48 participants Est. completion 2010-12 5 sites
    Other conditions: Non Small Cell Lung Cancer
    View official trial listing →
  • Completed NCT NCT00434811

    Islet Transplantation in Type 1 Diabetes

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 48 participants Est. completion 2014-05 8 sites Stand-alone
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT00434850

    Peritransplant Deoxyspergualin in Islet Transplantation in Type 1 Diabetes

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 14 participants Est. completion 2013-11 3 sites Stand-alone
    Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT00434954

    Effect of Exenatide Plus Metformin vs. Insulin Aspart Plus Metformin on Glycemic Control and Hypoglycemia in Patients With Type 2 Diabetes

    Not yet reported AstraZeneca 494 participants Est. completion 2009-06 39 sites Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Terminated NCT NCT00436722

    Induction Treatment Followed by Immunosuppression Withdrawal in Liver Transplantation: A Comparative Trial

    Not yet reported Hospital Clinic of Barcelona 72 participants 1 site
    Other conditions: Liver Diseases
    View official trial listing →
  • Terminated NCT NCT00437398

    Islet Transplantation for Type 1 Diabetes Mellitus

    Not yet reported, Not yet reported Mayo Clinic 2 participants Est. completion 2012-01 1 site
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT00439556

    Bortezomib and Chemotherapy in Treating Participants With Lymphoid Malignancies Undergoing Stem Cell Transplant

    Not yet reported M.D. Anderson Cancer Center 40 participants Est. completion 2018-06-07 1 site Stand-alone
    Other conditions: CD20 Positive, Hematopoietic and Lymphoid Cell Neoplasm, Lymphocytic Neoplasm, Lymphoma
    View official trial listing →
  • Status unknown NCT NCT00443105

    Topical Tacrolimus 0.03% Ointment for Intractable Allergic Conjunctivitis: An Open Label Pilot Study

    Not yet reported Assaf-Harofeh Medical Center 1 site
    Other conditions: Allergic Conjunctivitis
    View official trial listing →
  • Status unknown NCT NCT00443508

    Reduction or Discontinuation of CNI's With Conversion to Everolimus-Based Immunosuppresion

    Not yet reported Rabin Medical Center 60 participants Est. completion 2010-02 1 site
    Other conditions: Kidney Diseases
    View official trial listing →
  • Completed NCT NCT00443950

    Study Evaluating the Efficacy and Safety of Etanercept in Chinese Subjects With Rheumatoid Arthritis

    Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 150 participants Est. completion 2007-07 6 sites
    Other conditions: Arthritis, Rheumatoid
    View official trial listing →
  • Completed NCT NCT00444340

    An Open-Label Multicentre Long-Term Extension Study of Etanercept for Ankylosing Spondylitis

    Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 70 participants Est. completion 2007-07
    Other conditions: Ankylosing Spondylitis
    View official trial listing →
  • Completed NCT NCT00445744

    Cyclophosphamide and Busulfan Followed by Donor Stem Cell Transplant in Treating Patients With Myelofibrosis, Acute Myeloid Leukemia, or Myelodysplastic Syndrome

    Not yet reported Fred Hutchinson Cancer Center 52 participants Est. completion 2013-06 1 site Stand-alone
    Other conditions: Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Childhood Acute Myeloid Leukemia in Remission, Childhood Myelodysplastic Syndromes, de Novo Myelodysplastic Syndromes, Essential Thrombocythemia, Myelodysplastic Syndrome With Isolated Del(5q), Polycythemia Vera, Previously Treated Myelodysplastic Syndromes, Primary Myelofibrosis, Recurrent Adult Acute Myeloid Leukemia, Recurrent Childhood Acute Myeloid Leukemia, Secondary Acute Myeloid Leukemia, Secondary Myelodysplastic Syndromes, Secondary Myelofibrosis, Untreated Adult Acute Myeloid Leukemia, Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies
    View official trial listing →
  • Completed NCT NCT00446264

    Islet Allotransplantation With Steroid Free Immunosuppression

    Not yet reported University Hospital, Lille 14 participants Est. completion 2009-02 1 site Stand-alone
    Other conditions: Type 1 Diabetes, Hypoglycemia, Metabolic Diseases
    View official trial listing →
  • Completed NCT NCT00446368

    Safety Study of RAD001 to Treat Patients With Metastatic Kidney Cancer

    Not yet reported The Methodist Hospital Research Institute 66 participants Est. completion 2008-10 1 site
    Other conditions: Carcinoma, Renal Cell
    View official trial listing →
  • Terminated NCT NCT00447265

    Etanercept for the Treatment of Lupus Nephritis

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 1 participants Est. completion 2009-03 6 sites Stand-alone
    Other conditions: Lupus Nephritis
    View official trial listing →
  • Completed NCT NCT00448149

    Phase I/II Trial of RAD001 Plus Nexavar in Patients With Kidney Cancer

    Not yet reported, Not yet reported The Methodist Hospital Research Institute 55 participants Est. completion 2009-06 1 site
    Other conditions: Carcinoma, Renal Cell
    View official trial listing →
  • Completed NCT NCT00448201

    Reduced-Intensity Busulfan and Fludarabine With or Without Antithymocyte Globulin Followed by Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other Disease

    Not yet reported UNC Lineberger Comprehensive Cancer Center 71 participants Est. completion 2012-05-23 1 site
    Other conditions: Chronic Myeloproliferative Disorders, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes
    View official trial listing →
  • Completed NCT NCT00448357

    Allogeneic Hematopoietic Cell Transplantation for Patients With Busulfex-based Regimen

    Not yet reported, Not yet reported UNC Lineberger Comprehensive Cancer Center 54 participants Est. completion 2015-11 1 site Stand-alone
    Other conditions: Chronic Myeloproliferative Disorders, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes
    View official trial listing →
  • Completed NCT NCT00449280

    Drug Interaction Study of Sorafenib and Rapamycin in Advanced Malignancies

    Not yet reported University of Chicago 34 participants Est. completion 2009-09 1 site
    Other conditions: Advanced Solid Tumor
    View official trial listing →
  • Completed NCT NCT00449748

    Everolimus (RAD001) as Therapy for Patients With Systemic Mastocytosis

    Not yet reported M.D. Anderson Cancer Center 10 participants Est. completion 2009-10 1 site
    Other conditions: Systemic Mastocytosis
    View official trial listing →
  • Completed NCT NCT00450320

    Sirolimus in Treating Patients With HIV-Related Kaposi's Sarcoma

    Not yet reported AIDS Malignancy Consortium 7 participants Est. completion 2009-09 3 sites
    Other conditions: Sarcoma
    View official trial listing →
  • Completed NCT NCT00451932

    A Study to Evaluate the Safety and Effectiveness of FK778 in Liver Transplant Patients

    Not yet reported Astellas Pharma Inc 303 participants Est. completion 2005-09 29 sites
    Other conditions: Liver Transplantation
    View official trial listing →
  • Terminated NCT NCT00452361

    Study Evaluating of Calcineurin Inhibitors Versus Sirolimus in Renal Allograft Recipient

    Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 31 participants Est. completion 2008-08 1 site Stand-alone
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT00454584

    An Efficacy and Safety Study of CNTO 1275 Compared to Etanercept in Patients With Plaque Psoriasis

    Not yet reported Centocor, Inc. 903 participants Est. completion 2009-01
    Other conditions: Psoriasis
    View official trial listing →
  • Completed NCT NCT00455013

    A Phase II Study of Belatacept (BMS-224818) With a Steroid-free Regimen in Subjects Undergoing Kidney Transplantation

    Not yet reported Bristol-Myers Squibb 93 participants Est. completion 2012-08 17 sites Stand-alone
    Other conditions: Disorder Related to Renal Transplantation
    View official trial listing →
  • Completed NCT NCT00456235

    Reduction in the Risk of Rejection by Mycophenolate Mofetil Dose Adjustment in Liver Transplant Patients With Side Effects Caused by the Calcineurine Inhibitors

    Not yet reported University Hospital, Limoges 92 participants Est. completion 2011-09 17 sites Stand-alone
    Other conditions: Liver Transplantation
    View official trial listing →
  • Completed NCT NCT00456833

    Combination of RAD001 and Erlotinib in Patients With Advanced Non Small Cell Lung Cancer Previously Treated Only With Chemotherapy

    Not yet reported Novartis Pharmaceuticals 248 participants 14 sites
    Other conditions: Non Small Cell Lung Cancer
    View official trial listing →
  • Completed NCT NCT00456885

    The Effect of Exenatide on Weight and Hunger in Obese, Healthy Women

    Not yet reported Beth Israel Deaconess Medical Center 41 participants Est. completion 2010-09 1 site Stand-alone
    Prediabetes Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT00457808

    Rapamycin Therapy for Patients With Tuberous Sclerosis Complex and Sporadic LAM

    Not yet reported Children's Hospital Medical Center, Cincinnati 25 participants Est. completion 2006-03 1 site
    Other conditions: Tuberous Sclerosis, Lymphangioleiomyomatosis
    View official trial listing →
  • Completed NCT NCT00457964

    RAD001 Therapy of Angiomyolipomata in Patients With TS Complex and Sporadic LAM

    Not yet reported, Not yet reported Children's Hospital Medical Center, Cincinnati 36 participants Est. completion 2013-07 1 site
    Other conditions: Tuberous Sclerosis, Lymphangioleiomyomatosis
    View official trial listing →
  • Completed NCT NCT00459186

    The Use of RAD001 With Docetaxel in the Treatment of Metastatic, Androgen Independent Prostate Cancer

    Not yet reported, Not yet reported Dana-Farber Cancer Institute 19 participants Est. completion 2012-12 5 sites
    Other conditions: Metastatic, Androgen Independent Prostate Cancer, Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00459706

    Study Comparing Perceptions and Satisfaction for Two Different Delivery Mechanisms for Etanercept

    Not yet reported Pfizer 640 participants Est. completion 2009-09 113 sites
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT00459719

    A Study to Compare the Efficacy and Safety of FK506MR vs Prograf® in Patients Undergoing Liver Transplantation

    Not yet reported Astellas Pharma Inc 42 participants Est. completion 2009-03 5 sites Stand-alone
    Other conditions: Liver Transplantation
    View official trial listing →
  • Status unknown NCT NCT00461357

    Sirolimus Based Immunosuppression for Patients Undergoing Kidney Transplantation in the Eurotransplant Senior Program

    Medical University of Vienna 48 participants Est. completion 2007-12
    Other conditions: Kidney Function After Transplantation, Outcome After Kidney Transplantation
    View official trial listing →
  • Terminated NCT NCT00463723

    Topical FK506 (Tacrolimus) for Prevention of Immune Reactions Following Penetrating Keratoplasty

    Not yet reported, Not yet reported University Hospital Freiburg
    Other conditions: Penetrating Keratoplasty
    View official trial listing →
  • Completed NCT NCT00464399

    Feasibility and Safety of Early Switch to Everolimus From Cyclosporine in de Novo Renal Transplant Patients

    Not yet reported Novartis Pharmaceuticals 20 participants 1 site
    Other conditions: De Novo Renal Transplantation
    View official trial listing →
  • Completed NCT NCT00464555

    Strategies to Improve Islet Survival

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 5 participants Est. completion 2014-02 2 sites Stand-alone
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Status unknown NCT NCT00466102

    Efficacy of RAD001 in Breast Cancer Patients With Bone Metastases

    Not yet reported GBG Forschungs GmbH 130 participants Est. completion 2012-12 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00467194

    Sirolimus and Bevacizumab in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery

    Not yet reported National Cancer Centre, Singapore 27 participants 2 sites
    Other conditions: Liver Cancer
    View official trial listing →
  • Completed NCT NCT00468117

    Efficacy of Islet After Kidney Transplantation

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 24 participants Est. completion 2017-07-05 10 sites Stand-alone
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT00468403

    LEA29Y (Belatacept) Emory Edmonton Protocol

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 10 participants Est. completion 2013-04 2 sites Stand-alone
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Terminated NCT NCT00468442

    B-Lymphocyte Immunotherapy in Islet Transplantation

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 2 participants Est. completion 2011-09 1 site Stand-alone
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT00469131

    Effects of Immunosuppression on HCV Recurrence After Living Donor Liver Transplantation - Comparative Study Between Tacrolimus + MMF and Tacrolimus + Steroid

    Not yet reported Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan 79 participants Est. completion 2011-08 1 site
    Other conditions: Hepatitis C, Liver Cirrhosis
    View official trial listing →
  • Completed NCT NCT00470665

    Study Comparing Sirolimus/Prograf vs Sirolimus/CsA in High-Risk Renal Transplant Recipients

    Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 460 participants Est. completion 2004-07
    Other conditions: Renal Allograft Recipients
    View official trial listing →
  • Terminated NCT NCT00472082

    Early Conversion From Tacrolimus to Efalizumab Maintenance Therapy in Kidney Transplant Recipients

    Not yet reported, Not yet reported Emory University 5 participants Est. completion 2009-04 1 site
    Other conditions: Kidney Transplantation, Chronic Kidney Failure
    View official trial listing →
  • Completed NCT NCT00473499

    PEPCAD III Substudy: Stem Cell Mobilization

    Not yet reported, Not yet reported University Hospital, Saarland 60 participants Est. completion 2009-11 1 site
    Cardiovascular disease
    View official trial listing →
  • Terminated NCT NCT00475605

    A Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of Atopic Dermatitis

    LEO Pharma 8071 participants Est. completion 2019-01-31 313 sites
    Other conditions: Atopic Dermatitis
    View official trial listing →
  • Completed NCT NCT00476229

    Thymoglobulin and Total Lymphoid Irradiation for Hematologic Malignancies

    Not yet reported M.D. Anderson Cancer Center 20 participants Est. completion 2009-05 1 site
    Other conditions: Lymphoma, Leukemia
    View official trial listing →
  • Completed NCT NCT00477581

    A Study to Compare the Effects of Exenatide and Sitagliptin on Postprandial Glucose in Subjects With Type 2 Diabetes Mellitus

    Not yet reported AstraZeneca 102 participants Est. completion 2007-09 19 sites Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00480610

    Treatment and Control of Atopic Dermatitis With 0.1% Tacrolimus Ointment

    Not yet reported Astellas Pharma Inc 226 participants Est. completion 2005-11 22 sites Stand-alone
    Other conditions: Dermatitis, Atopic
    View official trial listing →
  • Completed NCT NCT00480896

    Treatment and Control of Atopic Dermatitis With 0.03% Tacrolimus Ointment

    Not yet reported Astellas Pharma Inc 250 participants Est. completion 2005-11 22 sites Stand-alone
    Other conditions: Dermatitis, Atopic
    View official trial listing →
  • Completed NCT NCT00481481

    Conversion Study From Cyclosporine to FK506MR Based Immunosuppression in Kidney Transplant Subjects

    Not yet reported Astellas Pharma Inc 346 participants Est. completion 2009-04 56 sites Stand-alone
    Other conditions: Transplantation
    View official trial listing →
  • Completed NCT NCT00481819

    A Study to Compare the Efficacy and Safety of FK506MR vs Prograf® in Patients Undergoing Kidney Transplantation

    Not yet reported Astellas Pharma Inc 240 participants Est. completion 2009-03 9 sites
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT00482170

    Compare Perceptions and Satisfaction for Two Different Delivery Mechanisms for Etanercept

    Not yet reported Pfizer 421 participants Est. completion 2009-09 78 sites Stand-alone
    Other conditions: Psoriasis
    View official trial listing →
  • Completed NCT NCT00482183

    Comparison Between Pioglitazone and SES With type2 DM

    Not yet reported, Not yet reported Showa University 38 participants Est. completion 2007-06
    Cardiovascular diseaseType 2 diabetes
    View official trial listing →
  • Completed NCT NCT00483262

    Combination CCI-779 (Temsirolimus) and Bortezomib (Velcade) in Relapsed and/or Relapsed/Refractory Multiple Myeloma

    Not yet reported, Not yet reported Dana-Farber Cancer Institute 63 participants Est. completion 2012-02 3 sites
    Other conditions: Multiple Myeloma
    View official trial listing →
  • Completed NCT NCT00484237

    A Study Evaluating 10 mg and 25 mg Doses of Etanercept in Patients With Rheumatoid Arthritis

    Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 80 participants Est. completion 2007-12 13 sites
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT00484809

    Study Evaluating the Tolerance and Safety of Enbrel (Etanercept) in Adults and Children

    Wyeth is now a wholly owned subsidiary of Pfizer 100 participants Est. completion 2006-02
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT00488475

    Observational Trial With Enbrel

    Pfizer 4945 participants Est. completion 2013-04 1 site
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT00489203

    Beclomethasone Dipropionate in Preventing Acute Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer

    Not yet reported Fred Hutchinson Cancer Center 140 participants 2 sites Stand-alone
    Obstructive sleep apnea Other conditions: Hematopoietic/Lymphoid Cancer, Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Atypical Chronic Myeloid Leukemia, Blastic Phase Chronic Myelogenous Leukemia, Childhood Acute Lymphoblastic Leukemia in Remission, Childhood Acute Myeloid Leukemia in Remission, Childhood Chronic Myelogenous Leukemia, Childhood Myelodysplastic Syndromes, Chronic Eosinophilic Leukemia, Chronic Myelomonocytic Leukemia, Chronic Neutrophilic Leukemia, Chronic Phase Chronic Myelogenous Leukemia, Contiguous Stage II Adult Burkitt Lymphoma, Contiguous Stage II Adult Diffuse Large Cell Lymphoma, Contiguous Stage II Adult Diffuse Mixed Cell Lymphoma, Contiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma, Contiguous Stage II Adult Immunoblastic Large Cell Lymphoma, Contiguous Stage II Adult Lymphoblastic Lymphoma, Contiguous Stage II Grade 1 Follicular Lymphoma, Contiguous Stage II Grade 2 Follicular Lymphoma, Contiguous Stage II Grade 3 Follicular Lymphoma, Contiguous Stage II Mantle Cell Lymphoma, Contiguous Stage II Marginal Zone Lymphoma, Contiguous Stage II Small Lymphocytic Lymphoma, de Novo Myelodysplastic Syndromes, Essential Thrombocythemia, Extramedullary Plasmacytoma, Graft Versus Host Disease, Isolated Plasmacytoma of Bone, Juvenile Myelomonocytic Leukemia, Meningeal Chronic Myelogenous Leukemia, Myelodysplastic/Myeloproliferative Disease, Unclassifiable, Nodal Marginal Zone B-cell Lymphoma, Noncontiguous Stage II Adult Burkitt Lymphoma, Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma, Noncontiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma, Noncontiguous Stage II Adult Immunoblastic Large Cell Lymphoma, Noncontiguous Stage II Adult Lymphoblastic Lymphoma, Noncontiguous Stage II Grade 1 Follicular Lymphoma, Noncontiguous Stage II Grade 2 Follicular Lymphoma, Noncontiguous Stage II Grade 3 Follicular Lymphoma, Noncontiguous Stage II Mantle Cell Lymphoma, Noncontiguous Stage II Marginal Zone Lymphoma, Noncontiguous Stage II Small Lymphocytic Lymphoma, Previously Treated Myelodysplastic Syndromes, Primary Myelofibrosis, Recurrent Adult Acute Lymphoblastic Leukemia, Recurrent Adult Acute Myeloid Leukemia, Recurrent Adult Burkitt Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma, Recurrent Adult Diffuse Mixed Cell Lymphoma, Recurrent Adult Diffuse Small Cleaved Cell Lymphoma, Recurrent Adult Grade III Lymphomatoid Granulomatosis, Recurrent Adult Hodgkin Lymphoma, Recurrent Adult Lymphoblastic Lymphoma, Recurrent Adult T-cell Leukemia/Lymphoma, Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Grade 3 Follicular Lymphoma, Recurrent Mantle Cell Lymphoma, Recurrent Marginal Zone Lymphoma, Recurrent Mycosis Fungoides/Sezary Syndrome, Recurrent Small Lymphocytic Lymphoma, Recurrent/Refractory Childhood Hodgkin Lymphoma, Refractory Chronic Lymphocytic Leukemia, Refractory Hairy Cell Leukemia, Relapsing Chronic Myelogenous Leukemia, Secondary Myelodysplastic Syndromes, Stage I Adult Burkitt Lymphoma, Stage I Adult Diffuse Large Cell Lymphoma, Stage I Adult Diffuse Mixed Cell Lymphoma, Stage I Adult Diffuse Small Cleaved Cell Lymphoma, Stage I Adult Hodgkin Lymphoma, Stage I Adult Immunoblastic Large Cell Lymphoma, Stage I Adult Lymphoblastic Lymphoma, Stage I Adult T-cell Leukemia/Lymphoma, Stage I Childhood Hodgkin Lymphoma, Stage I Chronic Lymphocytic Leukemia, Stage I Cutaneous T-cell Non-Hodgkin Lymphoma, Stage I Grade 1 Follicular Lymphoma, Stage I Grade 2 Follicular Lymphoma, Stage I Grade 3 Follicular Lymphoma, Stage I Mantle Cell Lymphoma, Stage I Marginal Zone Lymphoma, Stage I Multiple Myeloma, Stage I Mycosis Fungoides/Sezary Syndrome, Stage I Small Lymphocytic Lymphoma, Stage II Adult Hodgkin Lymphoma, Stage II Adult T-cell Leukemia/Lymphoma, Stage II Chronic Lymphocytic Leukemia, Stage II Cutaneous T-cell Non-Hodgkin Lymphoma, Stage II Multiple Myeloma, Stage II Mycosis Fungoides/Sezary Syndrome, Stage III Adult Burkitt Lymphoma, Stage III Adult Diffuse Large Cell Lymphoma, Stage III Adult Diffuse Mixed Cell Lymphoma, Stage III Adult Diffuse Small Cleaved Cell Lymphoma, Stage III Adult Hodgkin Lymphoma, Stage III Adult Immunoblastic Large Cell Lymphoma, Stage III Adult Lymphoblastic Lymphoma, Stage III Adult T-cell Leukemia/Lymphoma, Stage III Chronic Lymphocytic Leukemia, Stage III Cutaneous T-cell Non-Hodgkin Lymphoma, Stage III Grade 1 Follicular Lymphoma, Stage III Grade 2 Follicular Lymphoma, Stage III Grade 3 Follicular Lymphoma, Stage III Mantle Cell Lymphoma, Stage III Marginal Zone Lymphoma, Stage III Multiple Myeloma, Stage III Mycosis Fungoides/Sezary Syndrome, Stage III Small Lymphocytic Lymphoma, Stage IV Adult Burkitt Lymphoma, Stage IV Adult Diffuse Large Cell Lymphoma, Stage IV Adult Diffuse Mixed Cell Lymphoma, Stage IV Adult Diffuse Small Cleaved Cell Lymphoma, Stage IV Adult Hodgkin Lymphoma, Stage IV Adult Immunoblastic Large Cell Lymphoma, Stage IV Adult Lymphoblastic Lymphoma, Stage IV Adult T-cell Leukemia/Lymphoma, Stage IV Chronic Lymphocytic Leukemia, Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma, Stage IV Grade 1 Follicular Lymphoma, Stage IV Grade 2 Follicular Lymphoma, Stage IV Grade 3 Follicular Lymphoma, Stage IV Marginal Zone Lymphoma, Stage IV Mycosis Fungoides/Sezary Syndrome, Stage IV Small Lymphocytic Lymphoma
    View official trial listing →
  • Status unknown NCT NCT00490789

    Trial of Efficacy and Safety of Sirolimus in Tuberous Sclerosis and LAM

    Not yet reported Cardiff University 14 participants Est. completion 2009-09 3 sites
    Other conditions: Tuberous Sclerosis, Lymphangioleiomyomatosis
    View official trial listing →
  • Completed NCT NCT00492661

    A Pilot Trial to Evaluate the Effect of Diet and Exercise in Renal Transplant Recipients on Tacrolimus

    Not yet reported Janssen-Cilag Pty Ltd 55 participants Est. completion 2010-06 4 sites Stand-alone
    Other conditions: Renal Transplantion, Kidney Transplantion
    View official trial listing →
  • Completed NCT NCT00492869

    Efficacy and Safety of AEB071 Versus Tacrolimus in Combination With Mycophenolate Acid Sodium, Basiliximab and Steroids in Preventing Acute Rejection After Kidney Transplantation

    Not yet reported, Not yet reported Novartis Pharmaceuticals 124 participants 41 sites
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Status unknown NCT NCT00493194

    Fibrosis in Renal Allografts

    Not yet reported University Hospital, Antwerp 100 participants Est. completion 2007-07 3 sites
    Other conditions: Kidney Failure, Chronic, Transplantation, Immunosuppression, Interstitial Fibrosis
    View official trial listing →
  • Completed NCT NCT00494091

    Study Evaluating The Safety, Efficacy & Pharmacokinetics Of Temsirolimus(CCI-779) In Subjects With Advanced Renal Cell Carcinoma

    Not yet reported Pfizer 82 participants Est. completion 2012-03 24 sites
    Other conditions: Advanced Renal Cell Carcinoma
    View official trial listing →
  • Completed NCT NCT00495898

    A Study of Diabetic Patients With De Novo Native Coronary Artery Lesions

    Not yet reported Cordis US Corp. 200 participants Est. completion 2009-11 1 site Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT00496483

    Pharmacokinetics of LCP-Tacro in Stable Kidney Transplant Patients

    Not yet reported Asahi Kasei Therapeutics, Inc. 60 participants Est. completion 2008-03 2 sites
    Other conditions: Renal Failure
    View official trial listing →
  • Completed NCT NCT00497172

    Diabetes Drug Eluting Sirolimus Stent Experience in Restenosis Trial

    Not yet reported Cordis US Corp. 150 participants Est. completion 2009-04 1 site Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT00498316

    Cord Blood Expansion on Mesenchymal Stem Cells

    Not yet reported M.D. Anderson Cancer Center 98 participants Est. completion 2016-10 1 site
    Other conditions: Myelodysplastic Syndrome, Leukemia
    View official trial listing →
  • Completed NCT NCT00498966

    Ph II Study of Perifosine for Patients With Carcinoma of the Kidney

    Not yet reported AEterna Zentaris 50 participants Est. completion 2011-10 3 sites
    Other conditions: Kidney Cancer
    View official trial listing →
  • Status unknown NCT NCT00499603

    Paclitaxel Followed by FEC Versus Paclitaxel and RAD001 Followed by FEC In Women With Breast Cancer

    Not yet reported M.D. Anderson Cancer Center 62 participants Est. completion 2017-04 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Terminated NCT NCT00499889

    Imatinib Mesylate, Busulfan, Fludarabine, and Antithymocyte Globulin for CML Patients

    Not yet reported M.D. Anderson Cancer Center 42 participants Est. completion 2009-11 1 site Stand-alone
    Other conditions: Leukemia
    View official trial listing →
  • Completed NCT NCT00500370

    A Pilot Study of Effects of Exenatide on Body Weight in Non-Diabetic, Obese Patients

    Not yet reported AstraZeneca 163 participants Est. completion 2008-02 16 sites Stand-alone
    Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT00503139

    Study Evaluating the Safety and Efficacy of Enbrel (Etanercept) in Japan

    Pfizer 684 participants Est. completion 2013-04 1 site
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT00504348

    Investigation in Myositis-associated Pneumonitis of Prednisolone And Concomitant Tacrolimus

    Not yet reported, Not yet reported Tokyo Medical and Dental University 25 participants Est. completion 2011-01 11 sites Stand-alone
    Other conditions: Interstitial Pneumonitis, Polymyositis, Dermatomyositis
    View official trial listing →
  • Status unknown NCT NCT00505102

    Safe Renal Function In Long Term Heart Transplanted Patients

    Not yet reported A.O. Ospedale Papa Giovanni XXIII 200 participants Est. completion 2009-07 2 sites
    Other conditions: Kidney Diseases, Heart Transplantation
    View official trial listing →
  • Completed NCT NCT00506922

    Phase I/II Study of Pentostatin Combined With Tacrolimus and Mini-Methotrexate for GVHD Prevention After MUD BMT

    Not yet reported, Not yet reported M.D. Anderson Cancer Center 150 participants Est. completion 2009-11 1 site Stand-alone
    Other conditions: Leukemia, Lymphoma
    View official trial listing →
  • Completed NCT NCT00507793

    Study Evaluating the Efficacy and Safety of Cyclosporine Reduction in Kidney Transplant Recipients Receiving Sirolimus

    Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 385 participants Est. completion 2002-06
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT00510913

    A Study to Compare the Conversion to Prograf® (Tacrolimus) to the Continuation of Cyclosporine in Patients at Risk for Chronic Renal Allograft Failure

    Not yet reported Astellas Pharma Inc 450 participants Est. completion 2000-09 18 sites
    Other conditions: Graft Rejection, Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT00513474

    Rasburicase in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer or Other Disease Undergoing Donor Stem Cell Transplant

    Not yet reported Massachusetts General Hospital 46 participants Est. completion 2013-02-12 1 site Stand-alone
    Other conditions: Chronic Myeloproliferative Disorders, Graft Versus Host Disease, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
    View official trial listing →
  • Withdrawn NCT NCT00514982

    Medical Treatment of Colitis in Patients With Hermansky-Pudlak Syndrome

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) Est. completion 2011-03-08 1 site
    Other conditions: Hermanski-Pudlak Syndrome, Colitis, Cytokines, Lymphocytes, Drug Evaluation
    View official trial listing →
  • Completed NCT NCT00516048

    An Exploratory Study of the Effect of Treatment Interruption on Safety of Exenatide in Patients With Type 2 Diabetes

    Not yet reported AstraZeneca 58 participants Est. completion 2008-04 13 sites Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00516152

    Phase II Study Evaluating Busulfan and Fludarabine as Preparative Therapy in Adults With Hematopoietic Disorders Undergoing MUD SCT

    Not yet reported University of California, San Francisco 36 participants Est. completion 2007-11 1 site
    Other conditions: Chronic Myeloid Leukemia, Acute Myelogenous Leukemia, Myelodysplasia, Acute Lymphocytic Leukemia, Severe Aplastic Anemia, Non-Hodgkin's Lymphoma, Lymphoproliferative Disease, Multiple Myeloma, Advanced Myeloproliferative Disease
    View official trial listing →
  • Completed NCT NCT00517283

    A Study by Scintigraphy to Evaluate the Effect of Exenatide on Gastric Emptying in Subjects With Type 2 Diabetes

    Not yet reported AstraZeneca 17 participants Est. completion 2005-06 1 site Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00518271

    Study Comparing Standard Dose and Reduced Dose Tacrolimus + Sirolimus + Corticosteroids in Renal Allograft Recipients

    Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 120 participants Est. completion 2002-06
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT00518375

    Study Comparing Graft Function in Renal Allograft Recepients Receiving Reduced or Standard Dose CsA With Sirolimus

    Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 250 participants Est. completion 2001-05
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT00519116

    Study Comparing Standard Dose and Reduced Dose Tacrolimus With Sirolimus in Renal Transplant Patients

    Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 150 participants Est. completion 2001-08
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT00520130

    Chemotherapy and Unrelated Donor Stem Cell Transplantation for Patients With Cancers of the Blood and Immune System

    Not yet reported, Not yet reported National Cancer Institute (NCI) 92 participants Est. completion 2018-12-31 1 site Stand-alone
    Other conditions: Myelodysplastic Syndrome, Hodgkin's Lymphoma, Non-Hodgkin's Disease, Acute Leukemia, Multiple Myeloma
    View official trial listing →
  • Completed NCT NCT00521001

    Temozolomide and Everolimus in Treating Patients With Stage IV Melanoma That Cannot be Removed by Surgery

    Not yet reported Alliance for Clinical Trials in Oncology 49 participants Est. completion 2010-12 198 sites
    Other conditions: Melanoma (Skin)
    View official trial listing →
  • Completed NCT NCT00522184

    Intra-articular Injection of Etanercept in Patient Suffering From Rheumatoid Arthritis : a Double-blind Randomized Study

    Not yet reported Centre Hospitalier Universitaire de Nice 34 participants Est. completion 2006-11 1 site Stand-alone
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Terminated NCT NCT00522548

    Myfortic or CellCept Gastrointestinal Effects in African American Kidney Recipients

    Not yet reported University of Pennsylvania 37 participants Est. completion 2011-01 1 site
    Other conditions: Transplants and Implants
    View official trial listing →
  • Completed NCT NCT00523952

    Clinical Trial to Assess the Efficacy and Safety of Tacrolimus Ointment Treatment of Atopic Dermatitis in Adult Patients

    Not yet reported Astellas Pharma Inc 303 participants Est. completion 2005-09 25 sites Stand-alone
    Other conditions: Dermatitis, Atopic
    View official trial listing →
  • Completed NCT NCT00525681

    Interaction Between Rimonabant and Cyclosporine and Tacrolimus

    Not yet reported University of Oslo School of Pharmacy 18 participants Est. completion 2008-05 1 site
    Other conditions: Renal Transplantation
    View official trial listing →
  • Completed NCT NCT00525876

    Non-Myeloablative Allogeneic Stem Cell Transplantation

    Not yet reported M.D. Anderson Cancer Center 49 participants Est. completion 2010-09 1 site Stand-alone
    Other conditions: Lymphoma
    View official trial listing →
  • Completed NCT NCT00525889

    Proleukin and Rapamune in Type 1 Diabetes

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 9 participants Est. completion 2013-09 3 sites Stand-alone
    Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Terminated NCT NCT00529204

    Effects Of Exenatide On Liver Biochemistry, Liver Histology And Lipid Metabolism In Patients With Fatty Liver Disease

    Not yet reported University of California, Davis 1 participants Est. completion 2010-02 1 site Stand-alone
    Other conditions: Diabetes Complications, Fatty Liver
    View official trial listing →
  • Completed NCT NCT00531440

    This is a 2-year Follow-up Study to Evaluate the Long-term Effects in Patients Who Completed the Study CRAD001A2307.

    Not yet reported Novartis Pharmaceuticals 256 participants 1 site
    Other conditions: Renal Transplantation
    View official trial listing →
  • Completed NCT NCT00533442

    Rapamycin Versus Mycophenolate Mofetil in Kidney-Pancreas Recipients

    Not yet reported University of Miami 170 participants Est. completion 2016-05 1 site Stand-alone
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT00533624

    Myfortic vs. Cellcept in Kidney Transplant Recipients

    Not yet reported, Not yet reported University of Miami 150 participants Est. completion 2006-02 1 site
    Other conditions: End Stage Renal Disease
    View official trial listing →
  • Completed NCT NCT00534508

    Distribution of Tacrolimus in Skin, Atopic Dermatitis

    Not yet reported Astellas Pharma Inc 14 participants Est. completion 2001-07 1 site
    Other conditions: Dermatitis, Atopic
    View official trial listing →
  • Completed NCT NCT00535691

    Tacrolimus Ointment Pharmacokinetics in Infants With Atopic Dermatitis

    Not yet reported Astellas Pharma Inc 53 participants Est. completion 2004-12 8 sites
    Other conditions: Dermatitis, Atopic
    View official trial listing →
  • Completed NCT NCT00536978

    Natural Killer (NK) Cell Adback After Allogeneic Stem Cell Transplant With Campath-IH Plus Chemorx for Patients With Lymphoid Malignancies

    Not yet reported M.D. Anderson Cancer Center 22 participants Est. completion 2010-11 1 site Stand-alone
    Other conditions: Lymphoma, Leukemia
    View official trial listing →
  • Completed NCT NCT00538265

    Benefit of Immunoprophylaxis on Fibrosis to Reduce Viral Load After Liver Transplantation

    Not yet reported University Hospital, Toulouse 100 participants Est. completion 2011-01 8 sites Stand-alone
    Other conditions: Liver Transplantation
    View official trial listing →
  • Completed NCT NCT00543569

    A Study to Assess the Safety and Efficacy of Alefacept in Kidney Transplant Recipients

    Not yet reported Astellas Pharma Inc 323 participants Est. completion 2011-02 38 sites Stand-alone
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Active, not recruiting NCT NCT00544115

    Donor Peripheral Stem Cell Transplant in Treating Patients With Advanced Hematologic Cancer or Other Disorders

    Not yet reported City of Hope Medical Center 260 participants Est. completion 2027-03-29
    Other conditions: Chronic Myeloproliferative Disorders, Graft Versus Host Disease, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Diseases, Precancerous/Nonmalignant Condition
    View official trial listing →
  • Active, not recruiting NCT NCT00544466

    Helical Tomotherapy, Fludarabine Phosphate, and Melphalan Followed By Allo-HSCT in Hematological Malignancies

    Not yet reported, Not yet reported City of Hope Medical Center 75 participants Est. completion 2026-12-02 1 site Stand-alone
    Other conditions: Leukemia, Myelodysplastic Syndromes
    View official trial listing →
  • Completed NCT NCT00544557

    Study Evaluating The Use Of Etanercept In Patients With Ankylosing Spondylitis

    Pfizer 1715 participants Est. completion 2014-05 1 site
    Other conditions: Ankylosing Spondylitis
    View official trial listing →
  • Completed NCT NCT00545402

    A Study of CellCept (Mycophenolate Mofetil) in Combination Therapy in Liver Transplant Patients.

    Not yet reported Hoffmann-La Roche 180 participants Est. completion 2011-07 16 sites Stand-alone
    Other conditions: Liver Transplantation
    View official trial listing →
  • Status unknown NCT NCT00545493

    Efficacy of Tacrolimus and I.V.-Immunoglobulins in Rasmussen Encephalitis

    Not yet reported, Not yet reported University Hospital, Bonn 16 participants Est. completion 2010-04 1 site Stand-alone
    Other conditions: Rasmussen Encephalitis
    View official trial listing →
  • Completed NCT NCT00546533

    Study Evaluating the Efficacy and Safety of Etanercept

    Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 40 participants Est. completion 2005-02
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT00546728

    The Vascular Effects of Exenatide Versus Metformin in Patients With Pre-Diabetes

    Not yet reported St. Paul Heart Clinic 50 participants Est. completion 2011-07 2 sites Stand-alone
    Prediabetes
    View official trial listing →
  • Completed NCT NCT00551343

    Gut Derived Hormones, Body Composition and Metabolism in Prader-Willi Syndrome

    Not yet reported Garvan Institute of Medical Research 20 participants Est. completion 2008-09 1 site
    Other conditions: Prader-Willi Syndrome
    View official trial listing →
  • Completed NCT NCT00552201

    TACrolimus in Renal Transplantation: Individualization by Pharmacogenetic

    Not yet reported Centre Hospitalier Universitaire, Amiens 280 participants Est. completion 2008-12 10 sites
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Status unknown NCT NCT00552656

    Long Term Efficacy and Safety of Firebird Sirolimus-Eluting Stent In Complex Coronary Lesions

    Xijing Hospital 1000 participants Est. completion 2010-08 1 site
    Other conditions: Coronary Disease
    View official trial listing →
  • Completed NCT NCT00552669

    Study of Oral Rapamycin Plus Bare Metal Stents vs Drug Eltuting Stents

    Not yet reported Centro de estudios en Cardiologia Intervencionista 200 participants Est. completion 2007-09 3 sites Stand-alone
    Other conditions: Coronary Heart Disease, Coronary Restenosis
    View official trial listing →
  • Completed NCT NCT00553202

    Donor Stem Cell Transplant in Treating Young Patients With Acute Myeloid Leukemia With Monosomy 7, -5/5q-, High FLT3-ITD AR, or Refractory or Relapsed Acute Myelogenous Leukemia

    Not yet reported Children's Oncology Group 158 participants Est. completion 2020-03-31 52 sites Stand-alone
    Other conditions: Leukemia
    View official trial listing →
  • Status unknown NCT NCT00554125

    Sirolimus-Based Immunosuppression Therapy in OLT for Patients With HCC Exceeding Milan Criteria

    Not yet reported Fudan University 220 participants Est. completion 2013-08 1 site
    Other conditions: Hepatocellular Carcinoma
    View official trial listing →
  • Terminated NCT NCT00555048

    Alemtuzumab, Busulfan, and Cyclophosphamide Followed By a Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer

    Not yet reported, Not yet reported Fred Hutchinson Cancer Center 1 participants 2 sites Stand-alone
    Other conditions: Graft Versus Host Disease, Leukemia, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Diseases
    View official trial listing →
  • Terminated NCT NCT00555321

    Belatacept in Liver Transplant Recipients

    Not yet reported Bristol-Myers Squibb 260 participants Est. completion 2011-06 42 sites
    Other conditions: Immunosuppression in Solid Organ Transplant
    View official trial listing →
  • Completed NCT NCT00555373

    Pediatric Kidney Transplant Study of Sirolimus, Mycophenolate Mofetil, and Corticosteroids vs Calcineurin Inhibitor Based Immunosuppression

    Not yet reported Pediatric Nephrology of Alabama 52 participants Est. completion 2012-11 4 sites
    Other conditions: Renal Transplant
    View official trial listing →
  • Terminated NCT NCT00555789

    24 Month Extension to Efficacy and Safety of AEB071 Plus Tacrolimus (Converted to Mycophenolic Acid After 3 Months) in Renal Transplant Patients(Converted to Mycophenolic Acid After 3 Months) in Renal Transplant Patients

    Not yet reported Novartis Pharmaceuticals 137 participants Est. completion 2008-03 27 sites Stand-alone
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT00556933

    Improved Induction and Maintenance Immunosuppression in Kidney Transplantation

    Not yet reported University of Nebraska 180 participants Est. completion 2011-06-01 1 site Stand-alone
    Other conditions: End-stage Renal Disease
    View official trial listing →
  • Completed NCT NCT00560326

    Tacrolimus Ointment Long Term Safety in Young Children With Atopic Dermatitis

    Not yet reported Astellas Pharma Inc 50 participants Est. completion 2006-12 8 sites Stand-alone
    Other conditions: Dermatitis, Atopic
    View official trial listing →
  • Completed NCT NCT00560378

    Long-term Safety of Protopic in Atopic Eczema

    Not yet reported Astellas Pharma Inc 789 participants Est. completion 2005-06 41 sites Stand-alone
    Other conditions: Dermatitis, Atopic, Eczema, Atopic
    View official trial listing →
  • Completed NCT NCT00560417

    Comparison of Two Basal Insulins for Patients With Type 2 Diabetes Taking Oral Diabetes Medicines and Exenatide

    Not yet reported Eli Lilly and Company 339 participants Est. completion 2009-12 52 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00560963

    Treatment of Patients Suffering From a Progressive Pancreas Carcinoma With Everolimus (RAD001) and Gemcitabine

    Not yet reported, Not yet reported Novartis Pharmaceuticals 21 participants Est. completion 2011-01 5 sites
    Other conditions: Advanced or Metastatic Pancreatic Adenocarcinoma
    View official trial listing →
  • Status unknown NCT NCT00563108

    Basiliximab for the Treatment of Acute Graft-versus-host Disease After Allogeneic Stem Cell Transplantation

    Not yet reported Hospital Authority, Hong Kong 60 participants Est. completion 2008-12 1 site
    Other conditions: Graft vs Host Disease, Hematopoietic Stem Cell Transplantation
    View official trial listing →
  • Status unknown NCT NCT00564538

    A Study of Thymoglobulin and Tacrolimus in Liver Transplant

    Not yet reported University of Nebraska 100 participants Est. completion 2009-12 1 site Stand-alone
    Other conditions: Liver Transplantation, Liver Disease, Immunosuppression
    View official trial listing →
  • Completed NCT NCT00565773

    Belatacept Post Depletional Repopulation to Facilitate Tolerance

    Not yet reported Allan D Kirk, MD, PhD 40 participants Est. completion 2017-07-01 2 sites Stand-alone
    Other conditions: Organ Transplantation
    View official trial listing →
  • Completed NCT NCT00566813

    Islet Transplantation in Type 1 Diabetic Patients Using the Edmonton Protocol of Steroid Free Immunosuppression

    Not yet reported, Not yet reported University of Illinois Chicago 10 participants Est. completion 2020-07-15 1 site
    Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT00567554

    Bevacizumab, Everolimus (RAD001), and Lapatinib as Neoadjuvant Chemotherapy Regimes for Primary Breast Cancer

    Not yet reported GBG Forschungs GmbH 2600 participants Est. completion 2015-10 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00567762

    Phase III Study of 0.1% Tacrolimus(FK506) Ophthalmic Suspension in Patients With Vernal Keratoconjunctivitis

    Not yet reported Astellas Pharma Inc 56 participants Est. completion 2004-09 8 sites
    Other conditions: Keratoconjunctivitis, Conjunctivitis
    View official trial listing →
  • Completed NCT NCT00567918

    Phase III, Long-Term, Open-Label, Extension Study of 0.1% Tacrolimus(FK506) Ophthalmic Suspension in Patients With Vernal Keratoconjunctivitis

    Not yet reported Astellas Pharma Inc 52 participants Est. completion 2008-01 8 sites
    Other conditions: Keratoconjunctivitis, Conjunctivitis
    View official trial listing →
  • Status unknown NCT NCT00569101

    A Pilot Study for the Efficacy and Safety of Tacrolimus in the Treatment of Refractory Lupus Nephritis

    Not yet reported Seoul National University Hospital 9 participants Est. completion 2008-03 1 site Stand-alone
    Other conditions: Lupus Nephritis
    View official trial listing →
  • Completed NCT NCT00570921

    Study of Combined Fulvestrant and Everolimus in Advanced/Metastatic Breast Cancer After Aromatase Inhibitor Failure

    Not yet reported Mara Chambers 33 participants Est. completion 2015-01 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Withdrawn NCT NCT00572689

    Pilot Study of Exenatide Pharmacokinetics and Pharmacodynamics in Gestational Diabetes

    Not yet reported Georgetown University Est. completion 2015-08 2 sites Stand-alone
    Other conditions: Gestational Diabetes
    View official trial listing →
  • Completed NCT NCT00574769

    Safety Study & Effectiveness of Docetaxel With RAD001 and Bevacizumab in Men With Advanced Prostate Cancer

    Not yet reported, Not yet reported University of Southern California 27 participants Est. completion 2017-02-17 2 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00577278

    A Phase II Study of Allo-HCT for B-Cell NHL Using Zevalin, Fludarabine and Melphalan

    Not yet reported City of Hope Medical Center 41 participants Est. completion 2023-12-14 1 site Stand-alone
    Other conditions: Graft Versus Host Disease, Leukemia, Lymphoma
    View official trial listing →
  • Completed NCT NCT00577824

    Efficacy and Safety of Exenatide in Japanese Patients With Type 2 Diabetes Who Are Treated With Oral Antidiabetic(s)

    Not yet reported AstraZeneca 181 participants Est. completion 2008-11 12 sites Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00578266

    Allogeneic Stem Cell Transplantation for Patients With Severe Aplastic Anemia

    Not yet reported Mayo Clinic 8 participants Est. completion 2016-08-16 1 site
    Other conditions: Anemia, Aplastic
    View official trial listing →
  • Terminated NCT NCT00578903

    Allogeneic Stem Cell Transplant for Patients With Severe Aplastic Anemia

    Not yet reported Baylor College of Medicine 22 participants Est. completion 2012-07 2 sites
    Other conditions: Aplastic Anemia
    View official trial listing →
  • Terminated NCT NCT00579111

    Reduced Intensity Preparative Regimen Followed by Stem Cell Transplant (FAB)

    Not yet reported, Not yet reported Baylor College of Medicine 4 participants Est. completion 2010-10 2 sites
    Other conditions: Myelodysplastic and Myeloproliferative Disorders, Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, Multiple Myeloma, Plasma Cell Dyscrasia, Lymphoproliferative Disorders, Hematologic Diseases
    View official trial listing →
  • Terminated NCT NCT00579150

    Exenatide Pregnancy Registry - Type 2 Diabetes in Pregnancy

    AstraZeneca 7 participants Est. completion 2016-04 1 site
    Type 2 diabetes Other conditions: Birth Defects, Preterm Birth
    View official trial listing →
  • Completed NCT NCT00579527

    Phase I/II Thymus Transplantation With Immunosuppression #950

    Not yet reported, Not yet reported Sumitomo Pharma Switzerland GmbH 14 participants Est. completion 2017-12-31 1 site Stand-alone
    Other conditions: DiGeorge Anomaly, Complete DiGeorge Anomaly, Complete Atypical DiGeorge Anomaly, Complete DiGeorge Syndrome, Complete Atypical DiGeorge Syndrome
    View official trial listing →
  • Completed NCT NCT00581100

    Effects of Etanercept on Nail Psoriasis and Plaque Psoriasis

    Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 136 participants Est. completion 2009-10
    Other conditions: Nail Psoriasis, Plaque Psoriasis
    View official trial listing →
  • Terminated NCT NCT00582738

    Efficacy of Everolimus as Inhibitor of Fibrosis Progression in Liver Transplant Patients With Recurrence of Hepatitis C Viral Infection

    Not yet reported Novartis Pharmaceuticals 43 participants Est. completion 2010-01 1 site
    Other conditions: Recurrent Hepatitis C
    View official trial listing →
  • Completed NCT NCT00585468

    Pharmacokinetic Profile of Myfortic in Combination With Tacrolimus in Fed Versus Fasting State

    Not yet reported University of Utah 21 participants Est. completion 2011-07 1 site
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT00585650

    Study of Tumor Necrosis Factor Receptor Fusion Protein Etanercept (Enbrel) in Psoriasis of the Hands and/or Feet

    Not yet reported, Not yet reported University of California, Irvine 20 participants Est. completion 2008-05 3 sites Stand-alone
    Other conditions: Psoriasis
    View official trial listing →
  • Completed NCT NCT00586443

    BEP Study Phase I (Bevacizumab, Everolimus, Panitumumab)

    Not yet reported Herbert Hurwitz, MD 56 participants Est. completion 2014-09 1 site
    Other conditions: Solid Tumors
    View official trial listing →
  • Completed NCT NCT00587158

    Oral Paricalcitol in Kidney Transplant Recipients

    Not yet reported Mayo Clinic 100 participants Est. completion 2011-11 2 sites
    Other conditions: Transplant; Failure, Kidney, Renal Disease, End Stage, Hyperparathyroidism, Secondary
    View official trial listing →
  • Terminated NCT NCT00589316

    Iodine I 131 Monoclonal Antibody BC8, Fludarabine Phosphate, Cyclophosphamide, Total-Body Irradiation and Donor Bone Marrow Transplant in Treating Patients With Advanced Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or High-Risk Myelodysplastic Syndrome

    Not yet reported Fred Hutchinson Cancer Center 26 participants Est. completion 2021-10-01 1 site Stand-alone
    Other conditions: Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission, CD45-Positive Neoplastic Cells Present, Chronic Myelomonocytic Leukemia, Previously Treated Myelodysplastic Syndrome, Refractory Anemia With Excess Blasts, Refractory Anemia With Ring Sideroblasts, Refractory Cytopenia With Multilineage Dysplasia, Refractory Cytopenia With Multilineage Dysplasia and Ring Sideroblasts
    View official trial listing →
  • Completed NCT NCT00589563

    Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients Undergoing a Donor Stem Cell Transplant For Hematological Cancer

    Not yet reported City of Hope Medical Center 32 participants Est. completion 2012-02 2 sites Stand-alone
    Other conditions: Chronic Myeloproliferative Disorders, Graft Versus Host Disease, Infection, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms, Precancerous Condition, Secondary Myelofibrosis, Small Intestine Cancer
    View official trial listing →
  • Terminated NCT NCT00589602

    T-Cell Depletion, Donor Hematopoietic Stem Cell Transplant (HSCT), and T-Cell Infusions in Treating Patients With Hematologic Cancer or Other Diseases

    Not yet reported The Cleveland Clinic 13 participants Est. completion 2014-12 1 site Stand-alone
    Other conditions: Chronic Myeloproliferative Disorders, Leukemia, Lymphoma, Multiple Myeloma and Malignant Plasma Cell Neoplasms, Myelodysplastic Syndromes, Precancerous/Nonmalignant Condition, Secondary Myelofibrosis
    View official trial listing →
  • Completed NCT NCT00590876

    The Impact of Pancreatic Islet Cell Allotransplantation on Cognitive Function in Type 1 Diabetes Mellitus

    Yale University 36 participants Est. completion 2011-07 2 sites
    Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Terminated NCT NCT00593008

    Temsirolimus in Combination With Gemcitabine in Previously Untreated Metastatic Pancreatic Cancer

    Not yet reported Massachusetts General Hospital 5 participants Est. completion 2009-10 1 site
    Other conditions: Pancreatic Adenocarcinoma
    View official trial listing →
  • Completed NCT NCT00593060

    Temsirolimus (CCI-770, Torisel) Combined With Cetuximab in Cetuximab-Refractory Colorectal Cancer

    Not yet reported Jeffrey W. Clark, MD 35 participants Est. completion 2010-11 2 sites
    Other conditions: Colorectal Cancer, Colorectal Adenocarcinoma
    View official trial listing →
  • Completed NCT NCT00596557

    Everolimus and Low Dose CNI Compared With MMF and Full CNI Dose in Heart Transplanted Patients: One Year Follow up

    Not yet reported Rabin Medical Center 20 participants Est. completion 2011-07 1 site
    Other conditions: Chronic Rejection of Cardiac Transplant
    View official trial listing →
  • Terminated NCT NCT00596947

    Prednisone Withdrawal Versus Prednisone Maintenance After Kidney Transplant

    Not yet reported University of Pennsylvania 18 participants Est. completion 2009-03 1 site Stand-alone
    Other conditions: Transplants and Implants
    View official trial listing →
  • Completed NCT NCT00597506

    Expanded Cohort for Metastatic Colorectal Cancer (MCRC) Using Bevacizumab + Everolimus

    Not yet reported Herbert Hurwitz 50 participants Est. completion 2010-06 1 site
    Other conditions: Colorectal Adenocarcinoma
    View official trial listing →
  • Completed NCT NCT00598676

    3 Limus Agent Eluting Stents With Different Polymer Coating

    Not yet reported Deutsches Herzzentrum Muenchen 2600 participants Est. completion 2009-04 2 sites
    Other conditions: Coronary Heart Disease
    View official trial listing →
  • Completed NCT NCT00598715

    Efficacy Study of Two Different Strategies for Restenosis in Sirolimus-Eluting Stents

    Not yet reported Deutsches Herzzentrum Muenchen 450 participants Est. completion 2009-08 2 sites Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT00600496

    A Phase I, Open-Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD6244 (ARRY-142886)

    Not yet reported AstraZeneca 140 participants Est. completion 2025-12-18 4 sites
    Other conditions: Breast Cancer, Breast Neoplasms, Colon Cancer, Colonic Cancer, Colon Neoplasms, Lung Cancer, Melanoma, Kidney Cancer
    View official trial listing →
  • Completed NCT NCT00602693

    T-Regulatory Cell Infusion Post Umbilical Cord Blood Transplant in Patients With Advanced Hematologic Cancer

    Not yet reported Masonic Cancer Center, University of Minnesota 41 participants Est. completion 2015-04-16 1 site Stand-alone
    Other conditions: Leukemia, Lymphoma, Multiple Myeloma, Plasma Cell Neoplasm, Myelodysplastic Syndromes
    View official trial listing →
  • Completed NCT NCT00603239

    Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using a Thiazolidinedione or a Thiazolidinedione and Metformin

    Not yet reported AstraZeneca 165 participants Est. completion 2009-07 25 sites Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Status unknown NCT NCT00605592

    UVA Islet Cell Transplantation in Patients With Type I Diabetes

    Not yet reported University of Virginia 20 participants Est. completion 2012-01 1 site
    Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Terminated NCT NCT00606333

    Comparison of the Conor Sirolimus-eluting Coronary Stent to the Taxus Liberte Paclitaxel-eluting Coronary Stent in the Treatment of Coronary Artery Lesions

    Not yet reported Cordis US Corp. 394 participants Est. completion 2012-10 2 sites Stand-alone
    Other conditions: Coronary Atherosclerosis
    View official trial listing →
  • Completed NCT NCT00608244

    Pharmacokinetics of LCP-Tacro in Stable Liver Transplant Patients

    Not yet reported Asahi Kasei Therapeutics, Inc. 59 participants Est. completion 2008-06 1 site Stand-alone
    Other conditions: Liver Failure
    View official trial listing →
  • Terminated NCT NCT00608517

    Treatment of Single or Double Umbilical Cord Trans + Graft-versus-host Disease (GVHD) Prophylaxis w/ Tacrolimus & Mycophenolate Mofetil

    Not yet reported Vanderbilt-Ingram Cancer Center 6 participants Est. completion 2011-05 4 sites
    Other conditions: Graft Versus Host Disease, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes
    View official trial listing →
  • Terminated NCT NCT00608894

    LCP-Tacro vs. Azathioprine for the Treatment of Autoimmune Hepatitis

    Not yet reported Veloxis Pharmaceuticals 13 participants Est. completion 2009-07 12 sites Stand-alone
    Other conditions: Autoimmune Hepatitis
    View official trial listing →
  • Completed NCT NCT00609388

    Tacrolimus During the Implantation and the Effect on Ischemia-reperfusion Injury in Liver Transplantation

    Not yet reported Medical University of Vienna 26 participants Est. completion 2010-12 1 site
    Other conditions: Ischemia Reperfusion Injury
    View official trial listing →
  • Completed NCT NCT00610948

    Everolimus, Fluorouracil, Leucovorin, Panitumumab, and Oxaliplatin in Treating Patients With Tumors That Did Not Respond to Treatment

    Not yet reported UNC Lineberger Comprehensive Cancer Center 74 participants Est. completion 2016-01 1 site
    Other conditions: Unspecified Adult Solid Tumor, Protocol Specific
    View official trial listing →
  • Completed NCT NCT00610961

    Induction Related BK Viremia in Renal Transplant Patients

    University of Florida 60 participants Est. completion 2009-11 1 site
    Other conditions: Disease Due to BK Polyomavirus, Transplantation Infection, Disorder Related to Transplantation
    View official trial listing →
  • Completed NCT NCT00611351

    Busulfan, Cyclophosphamide, & Antithymocyte Globulin Followed by Stem Cell Transplant in Treating Hematologic Cancer

    Not yet reported University of Nebraska 5 participants Est. completion 2008-09-17 1 site Stand-alone
    Other conditions: Graft Versus Host Disease, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Diseases, Secondary Myelofibrosis
    View official trial listing →
  • Completed NCT NCT00611910

    Efficacy Study of Drug-eluting and Bare Metal Stents in Bypass Graft Lesions

    Not yet reported Deutsches Herzzentrum Muenchen 610 participants Est. completion 2011-03 4 sites Stand-alone
    Other conditions: Arteriosclerosis of Arterial Coronary Artery Bypass Graft
    View official trial listing →
  • Completed NCT NCT00612274

    Sirolimus, Tacrolimus and Short Course Methotrexate for Prevention of Acute GVHD in Recipients of Mismatched Unrelated Donor Allogeneic Stem Cell Transplantation

    Not yet reported Yale University 26 participants Est. completion 2014-10 1 site Stand-alone
    Other conditions: Stem Cell Transplantation
    View official trial listing →
  • Completed NCT NCT00612794

    A Study to Examine Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Exenatide Once Weekly in Japanese Patients With Type 2 Diabetes

    Not yet reported AstraZeneca 30 participants Est. completion 2008-05 4 sites Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00613132

    Ph I Gleevec in Combo w RAD001 + Hydroxyurea for Pts w Recurrent MG

    Not yet reported Annick Desjardins 78 participants Est. completion 2013-01 1 site
    Obstructive sleep apnea Other conditions: Glioblastoma
    View official trial listing →
  • Completed NCT NCT00615173

    Prospective, Randomized, Multicenter, Control Study to Assess the Efficacy and Safety of Tacrolimus in Induction and Maintenance Phase Treatment in Lupus Nephritis

    Not yet reported Sun Yat-sen University 81 participants Est. completion 2008-09 1 site Stand-alone
    Other conditions: Kidney Diseases, Lupus Nephritis, Tacrolimus, Induction Phase, Maintenance Phase
    View official trial listing →
  • Completed NCT NCT00615667

    Prospective, Multicenter Study of the Efficacy and Tolerance of Tacrolimus on Refractory Nephrotic Syndrome (RNS)

    Not yet reported Sun Yat-sen University 61 participants Est. completion 2008-09 Stand-alone
    Other conditions: Kidney Diseases, Nephrotic Syndrome, Tacrolimus
    View official trial listing →
  • Completed NCT NCT00617604

    A Study to Assess the Efficacy and Safety of Alefacept in Kidney Transplant Recipients

    Not yet reported Astellas Pharma Inc 218 participants Est. completion 2009-09 33 sites Stand-alone
    Other conditions: De Novo Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT00618345

    Everolimus in Treating Patients With Relapsed or Refractory Multiple Myeloma

    Not yet reported Mayo Clinic 35 participants Est. completion 2008-08
    Other conditions: Multiple Myeloma and Plasma Cell Neoplasm
    View official trial listing →
  • Completed NCT NCT00619216

    Myfortic Conversion Trial in OLT Recipients With GI Intolerance

    University of North Carolina, Chapel Hill 31 participants Est. completion 2009-12 1 site
    Other conditions: GI Disturbance
    View official trial listing →
  • Completed NCT NCT00619268

    Combination of Temsirolimus and Bevacizumab in Patient With Metastatic Renal Cell Carcinoma

    Not yet reported Centre Leon Berard 160 participants Est. completion 2012-02 29 sites
    Other conditions: Metastatic Renal Cell Carcinoma
    View official trial listing →
  • Completed NCT NCT00619398

    A Study to Evaluate and Compare the Efficacy and Safety of FK506MR vs Prograf® in Stable Liver Transplantation Patients

    Not yet reported Astellas Pharma Inc 172 participants Est. completion 2009-03 6 sites
    Other conditions: Liver Transplantation
    View official trial listing →
  • Completed NCT NCT00619528

    HLA-Identical Sibling Renal Transplant Tolerance

    Not yet reported Northwestern University 88 participants Est. completion 2023-09 1 site Stand-alone
    Other conditions: Immunosuppression, Kidney Transplantation, Graft Rejection
    View official trial listing →
  • Completed NCT NCT00620841

    Gene Polymorphisms in Tacrolimus Drug Interactions

    KU Leuven 40 participants Est. completion 2008-01 1 site
    Other conditions: Renal Transplantation
    View official trial listing →
  • Completed NCT NCT00621101

    Pharmacokinetic Drug Interaction Between Ezetimibe and Sirolimus After Single Dose Administration in Healthy Subjects

    Not yet reported University Medicine Greifswald 24 participants Est. completion 2007-06 1 site Stand-alone
    Other conditions: Pharmacokinetics, Drug Interactions, Hypercholesterolemia, Immunosuppression
    View official trial listing →
  • Completed NCT NCT00621699

    Pharmacokinetic Drug Interaction Between Ezetimibe and Tacrolimus After Single Dose Administration in Healthy Subjects

    Not yet reported University Medicine Greifswald 24 participants Est. completion 2007-11 1 site Stand-alone
    Other conditions: Pharmacokinetics, Drug Interactions, Hypercholesterolemia, Immunosuppression
    View official trial listing →
  • Completed NCT NCT00622258

    A Phase I Dose Escalation Study of RAD001 Administered in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

    Not yet reported Novartis Pharmaceuticals 13 participants Est. completion 2014-01 8 sites
    Other conditions: Non-Hodgkin's Lymphoma
    View official trial listing →
  • Completed NCT NCT00622323

    Post Marketing Surveillance Study of Byetta ™ (Exenatide) Use Among Filipino Patients

    AstraZeneca 41 participants Est. completion 2009-09 3 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00622869

    Efficacy and Safety of Concentration-controlled Everolimus to Eliminate or to Reduce Tacrolimus Compared to Tacrolimus in de Novo Liver Transplant Recipients

    Not yet reported Novartis Pharmaceuticals 719 participants Est. completion 2012-04 91 sites Stand-alone
    Other conditions: Liver Transplantation
    View official trial listing →
  • Completed NCT NCT00622895

    Allogeneic Hematopoietic Cell Transplantation for Severe Systemic Sclerosis

    Not yet reported, Not yet reported Fred Hutchinson Cancer Center 3 participants Est. completion 2017-08-01 2 sites Stand-alone
    Other conditions: Systemic Scleroderma, Severe Systemic Sclerosis
    View official trial listing →
  • Terminated NCT NCT00623012

    Rapamycin for Prevention of Chronic Graft-Versus-Host Disease

    Not yet reported, Not yet reported Yale University 2 participants Est. completion 2013-08 1 site Stand-alone
    Other conditions: Graft Versus Host Disease
    View official trial listing →
  • Completed NCT NCT00626483

    Basiliximab in Treating Patients With Newly Diagnosed Glioblastoma Multiforme Undergoing Targeted Immunotherapy and Temozolomide-Caused Lymphopenia

    Not yet reported Gary Archer Ph.D. 34 participants Est. completion 2016-07-06 1 site Stand-alone
    Other conditions: Malignant Neoplasms Brain
    View official trial listing →
  • Completed NCT NCT00629122

    Pharmacokinetics of Sublingual Versus Oral Tacrolimus in Patients Awaiting Kidney Transplantation

    Not yet reported Weill Medical College of Cornell University 5 participants Est. completion 2009-12 1 site Stand-alone
    Other conditions: Kidney Failure, Chronic
    View official trial listing →
  • Completed NCT NCT00630344

    RAD001 and Bicalutamide for Androgen Independent Prostate Cancer

    Not yet reported Dana-Farber Cancer Institute 36 participants Est. completion 2012-05 2 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00632268

    Low-dose RAD001(Everolimus) Plus Cisplatin-HDFL Chemotherapy for the First-line Treatment of Advanced Gastric Cancer

    Not yet reported National Taiwan University Hospital 40 participants Est. completion 2012-12 1 site
    Other conditions: Metastatic Gastric Cancer
    View official trial listing →
  • Completed NCT NCT00634244

    Comparing Three Different Combination Chemotherapy Regimens in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

    Not yet reported National Cancer Institute (NCI) 92 participants Est. completion 2014-10 20 sites Stand-alone
    Other conditions: Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b), Adult Acute Myeloblastic Leukemia With Maturation (M2), Adult Acute Myeloblastic Leukemia Without Maturation (M1), Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Adult Acute Myelomonocytic Leukemia (M4), Adult Erythroleukemia (M6a), Adult Pure Erythroid Leukemia (M6b), Recurrent Adult Acute Myeloid Leukemia
    View official trial listing →
  • Status unknown NCT NCT00636922

    Everolimus (RAD001) in Elderly Patients With Acute Myeloid Leukemia

    Not yet reported Bayside Health 40 participants Est. completion 2014-01 1 site
    Other conditions: Acute Myeloid Leukemia
    View official trial listing →
  • Completed NCT NCT00637143

    Tacrolimus as Secondary Intervention vs. Continuation of Cyclosporine in Renal Transplant Patients With Chronic Renal Allograft Failure (CRAF)

    Not yet reported Astellas Pharma Inc 107 participants Est. completion 2006-02 13 sites Stand-alone
    Other conditions: Renal Transplantation, Chronic Renal Allograft Failure
    View official trial listing →
  • Completed NCT NCT00638794

    Assessment of Dual AntiPlatelet Therapy With Drug Eluting Stents

    Cardiovascular Research Foundation, New York 8575 participants Est. completion 2013-01 8 sites
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT00639717

    Addition of Etanercept and Extracorporeal Photopheresis (ECP) to Standard Graft-Versus-Host Disease (GVHD) Prophylaxis in Stem Cell Transplant

    Not yet reported University of Michigan Rogel Cancer Center 48 participants Est. completion 2016-04 1 site Stand-alone
    Other conditions: Graft Versus Host Disease
    View official trial listing →
  • Completed NCT NCT00640393

    Safety and Efficacy of Combining nbUVB to Etanercept in Patients

    Not yet reported Innovaderm Research Inc. 99 participants Est. completion 2010-03 10 sites
    Other conditions: Psoriasis Vulgaris
    View official trial listing →
  • Terminated NCT NCT00640978

    Erlotinib and RAD001 (Everolimus) in Patients With Previously Treated Advanced Pancreatic Cancer

    Not yet reported M.D. Anderson Cancer Center 16 participants Est. completion 2010-03 1 site
    Other conditions: Pancreatic Cancer
    View official trial listing →
  • Completed NCT NCT00641056

    Efficacy of Exenatide Once Weekly and Once-Daily Insulin Glargine in Patients With Type 2 Diabetes Treated With Metformin Alone or in Combination With Sulfonylurea (DURATION - 3)

    Not yet reported AstraZeneca 467 participants Est. completion 2009-11 75 sites Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00643071

    Tacrolimus (FK506) P-III, Open-label Study in Refractory Ulcerative Colitis Patients

    Not yet reported Astellas Pharma Inc 32 participants Est. completion 2008-05 6 sites Stand-alone
    Other conditions: Ulcerative Colitis
    View official trial listing →
  • Completed NCT NCT00644761

    PK Study of Tacrolimus and Cyclosporine When Co-Administered With Adefovir Dipivoxil in Post-Liver Transplant Patients

    Not yet reported Gilead Sciences 16 participants Est. completion 2005-05 11 sites
    Other conditions: Hepatitis B
    View official trial listing →
  • Status unknown NCT NCT00646724

    Cotransplantation of Islet and Mesenchymal Stem Cell in Type 1 Diabetic Patients

    Not yet reported, Not yet reported Fuzhou General Hospital 30 participants Est. completion 2014-01 1 site
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT00646737

    Conversion From Mycophenolate Mofetil to Mycophenolate Sodium in Renal Transplant

    Not yet reported Novartis 18 participants Est. completion 2008-12 1 site
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT00650468

    A Study to Compare Early Steroid Withdrawal and Long-Term Steroid Maintenance Therapy in Kidney Transplant Patients

    Not yet reported Astellas Pharma Inc 397 participants Est. completion 2007-12 29 sites Stand-alone
    Other conditions: Renal Transplantation
    View official trial listing →
  • Completed NCT NCT00654355

    Measuring Adherence to Topical Therapy in Children With Atopic Dermatitis and the Impact of a Return Visit

    Not yet reported Wake Forest University 30 participants Est. completion 2009-09 1 site Stand-alone
    Other conditions: Atopic Dermatitis
    View official trial listing →
  • No Longer Available NCT NCT00655252

    Expanded Access Study of RAD001 in Metastatic Renal Cell Cancer Patients Who Are Intolerant of or Who Have Failed Despite Prior Vascular Endothelial Growth Factor Therapy

    Novartis Pharmaceuticals 84 sites
    Other conditions: Metastatic Renal Cell Cancer
    View official trial listing →
  • Terminated NCT NCT00656266

    Trial of Calcineurin Inhibitor-Sparing Immunosuppression Regimen in Pediatric Liver Transplantation

    Not yet reported Baylor College of Medicine 13 participants Est. completion 2005-11 1 site Stand-alone
    Other conditions: End-stage Liver Disease, Renal Insufficiency, Renal Failure
    View official trial listing →
  • Status unknown NCT NCT00657982

    Phase II Study of RAD001 in a Neoadjuvant Setting in Men With Intermediate or High Risk Prostate Cancer

    Not yet reported Sheba Medical Center 15 participants 1 site
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00658021

    Safety and Efficacy of Exenatide as Monotherapy and Adjunctive Therapy to Oral Antidiabetic Agents in Adolescents With Type 2 Diabetes

    Not yet reported AstraZeneca 122 participants Est. completion 2020-04-01 53 sites Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00658320

    Concentration Controlled Everolimus With Reduced Dose Cyclosporine Versus Mycophenolate Mofetil With Standard Dose Cyclosporine in de Novo Renal Transplant Adult Recipients Treated With Basiliximab and Corticosteroids

    Not yet reported Novartis 122 participants Est. completion 2012-05 1 site Stand-alone
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Status unknown NCT NCT00659620

    Mesenchymal Stem Cell Transplantation in the Treatment of Chronic Allograft Nephropathy

    Not yet reported, Not yet reported Fuzhou General Hospital 20 participants Est. completion 2010-05 1 site
    Other conditions: Kidney Transplant, Chronic Allograft Nephropathy
    View official trial listing →
  • Completed NCT NCT00660478

    Randomized Clinical Comparison of the Endeavor and the Cypher Coronary Stents in Non-selected Angina Pectoris Patients

    Not yet reported Evald Hoej Christiansen 2342 participants Est. completion 2009-10 1 site
    Other conditions: Ischemic Heart Disease
    View official trial listing →
  • Completed NCT NCT00663052

    Study Evaluating Etanercept for the Treatment of Moderate to Severe Psoriasis

    Not yet reported Pfizer 273 participants Est. completion 2010-01 38 sites Stand-alone
    Other conditions: Plaque Psoriasis, Psoriasis
    View official trial listing →
  • Completed NCT NCT00664963

    YUKON-drug-eluting Stent Below The Knee - Randomised Double-blind Study

    Not yet reported Herz-Zentrums Bad Krozingen 130 participants Est. completion 2010-04 3 sites Stand-alone
    Other conditions: Arterial Occlusive Diseases
    View official trial listing →
  • Completed NCT NCT00666159

    Comparison Study Between Protopic (Tacrolimus Ointment) and Elidel (Pimecrolimus Cream) in Treating Pediatric Patients With Atopic Dermatitis

    Not yet reported Astellas Pharma Inc 226 participants Est. completion 2003-05 12 sites Stand-alone
    Other conditions: Dermatitis, Atopic
    View official trial listing →
  • Completed NCT NCT00666302

    A Comparison Study Between Protopic (Tacrolimus) Ointment and Elidel (Pimecrolimus) Cream in Treating Subjects With Atopic Dermatitis

    Not yet reported Astellas Pharma Inc 413 participants Est. completion 2003-11 15 sites Stand-alone
    Other conditions: Dermatitis, Atopic
    View official trial listing →
  • Completed NCT NCT00667056

    Study of the Safety and Efficacy of Tacrolimus Ointment in Treating Chronic Allergic Contact Dermatitis

    Not yet reported Astellas Pharma Inc 98 participants Est. completion 2004-12 10 sites Stand-alone
    Other conditions: Dermatitis
    View official trial listing →
  • Completed NCT NCT00667160

    Comparison Study Between Protopic (Tacrolimus Ointment) and Elidel (Pimecrolimus Cream) in Pediatric Patients With Mild Atopic Dermatitis

    Not yet reported Astellas Pharma Inc 426 participants Est. completion 2003-11 19 sites Stand-alone
    Other conditions: Dermatitis, Atopic
    View official trial listing →
  • Completed NCT NCT00668369

    Effect of Immunosuppression Drug Weaning on Hepatitis C Virus (HCV)-Induced Liver Damage After Liver Transplantation

    Not yet reported Hospital Clinic of Barcelona 34 participants Est. completion 2011-09 1 site Stand-alone
    Other conditions: Hepatitis C Virus Infection, Liver Transplantation
    View official trial listing →
  • Terminated NCT NCT00669890

    Allogenic Stem Cell Transplantation in Patients With High Risk CD33+ AML/MDS/JMML

    Not yet reported New York Medical College 12 participants Est. completion 2013-12 1 site Stand-alone
    Other conditions: Acute Myeloid Leukemia, Juvenile Myelomonocytic Leukemia, Myelodysplastic Syndrome
    View official trial listing →
  • Terminated NCT NCT00670410

    Autologous Transplant Followed by Allogeneic Transplant for High Risk Neuroblastoma

    Not yet reported Columbia University 15 participants Est. completion 2010-12 1 site Stand-alone
    Other conditions: Neuroblastoma
    View official trial listing →
  • Completed NCT NCT00670423

    A Study Using Tacrolimus, Sirolimus and Bortezomib as Acute Graft Versus Host Disease (GVHD) Prophylaxis in Allogeneic Peripheral Blood Stem Cell (PBSC) Transplantation

    Not yet reported Jennifer E. Schwartz 27 participants Est. completion 2013-10-16 1 site
    Other conditions: Graft vs Host Disease, Peripheral Blood Stem Cell Transplantation, Transplantation, Homologous
    View official trial listing →
  • Terminated NCT NCT00671112

    Everolimus and Bortezomib in Treating Patients With Relapsed or Refractory Lymphoma

    Not yet reported Brian Hill, MD, PhD 30 participants 1 site
    Other conditions: 714leukemia, Lymphoma
    View official trial listing →
  • Terminated NCT NCT00672204

    Raptiva and Sirolimus in Islet Transplantation for Type 1 Diabetes

    Not yet reported, Not yet reported University of Minnesota 23 participants Est. completion 2012-08 1 site Stand-alone
    Other conditions: Type 1 Diabetes Mellitus, Hypoglycemia
    View official trial listing →
  • Completed NCT NCT00672243

    Ph II Erlotinib + Sirolimus for Pts w Recurrent Malignant Glioma Multiforme

    Not yet reported Duke University 32 participants Est. completion 2009-12 1 site Stand-alone
    Obstructive sleep apnea Other conditions: Glioblastoma
    View official trial listing →
  • Terminated NCT NCT00674414

    Trastuzumab With or Without Everolimus in Treating Women With Breast Cancer That Can Be Removed By Surgery

    Not yet reported UNICANCER 82 participants 8 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00676338

    Safety and Efficacy of Exenatide Once Weekly Injection Versus Metformin, Dipeptidyl Peptidase-4 Inhibitor, or Thiazolidinedione as Monotherapy in Drug-Naive Patients With Type 2 Diabetes (DURATION-4)

    Not yet reported AstraZeneca 820 participants Est. completion 2011-01 106 sites Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00678769

    Cixutumumab and Temsirolimus in Treating Patients With Locally Advanced or Metastatic Cancer

    Not yet reported National Cancer Institute (NCI) 72 participants Est. completion 2015-10 2 sites
    Other conditions: Malignant Neoplasm
    View official trial listing →
  • Completed NCT NCT00678782

    Evaluation of The Efficacy And Safety of Intra-Articular Etanercept in Patients With Refractory Knee Joint Synovitis

    Not yet reported University of Padova 31 participants Est. completion 2007-12 1 site
    Other conditions: Persistent Knee Joint Synovitis
    View official trial listing →
  • Status unknown NCT NCT00678990

    Heparinized Islets in Clinical Islet Transplantation

    Not yet reported Corline Biomedical AB 10 participants Est. completion 2019-12 2 sites
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT00679042

    Islet Transplantation in Type 1 Diabetic Patients Using the University of Illinois at Chicago (UIC) Protocol

    Not yet reported CellTrans Inc. 21 participants Est. completion 2026-07-01 1 site Stand-alone
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT00680758

    Cisplatin, Paclitaxel, and Everolimus in Treating Patients With Metastatic Breast Cancer

    Not yet reported Vanderbilt-Ingram Cancer Center 18 participants Est. completion 2010-12 4 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00681213

    Tacrolimus/Sirolimus Versus Tacrolimus/Mycophenolate Mofetil (MMF) Versus Neoral/Sirolimus in Adult, Primary Kidney Transplantation

    Not yet reported University of Miami 150 participants Est. completion 2002-12 1 site Stand-alone
    Other conditions: Adult Primary Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT00682292

    Daclizumab Versus Thymoglobulin in Renal Transplant Recipients With High Immunological Risk

    Not yet reported University Hospital, Lille 227 participants Est. completion 2006-11 1 site
    Other conditions: Renal Transplantation
    View official trial listing →
  • Status unknown NCT NCT00684372

    BK Viremia After Renal Transplantation

    Not yet reported Karolinska University Hospital 100 participants Est. completion 2009-05 1 site
    Other conditions: Terminal Renal Failure, BK Virus Infection
    View official trial listing →
  • Completed NCT NCT00686855

    Topical Dexamethasone and Tacrolimus for the Treatment of Oral Chronic Graft-Versus-Host Disease

    Not yet reported Brigham and Women's Hospital 46 participants Est. completion 2013-03 5 sites Stand-alone
    Other conditions: Oral Chronic Graft-versus-host Disease
    View official trial listing →
  • Completed NCT NCT00688623

    RAMSETE: RAD001 in Advanced and Metastatic Silent Neuro-endocrine Tumors in Europe

    Not yet reported Novartis Pharmaceuticals 73 participants Est. completion 2016-11-07 40 sites
    Other conditions: Advanced and Metastatic Silent Neuro-Endocrine Tumors, Carcinoma, Neuroendocrine, Non Functioning Neuroendocrine Tumors (NETs), Non Syndromic Neuroendocrine Tumors, Carcinoids, Non Functioning
    View official trial listing →
  • Completed NCT NCT00688753

    RAPTOR: RAD001 as Monotherapy in the Treatment of Advanced Papillary Renal Cell Tumors Program in Europe

    Not yet reported Novartis Pharmaceuticals 92 participants Est. completion 2014-10 19 sites
    Other conditions: Carcinoma, Renal Cell, Non Clear Cell Renal Carcinoma, Papillary Cell Renal Carcinoma, Adenocarcinoma
    View official trial listing →
  • Completed NCT NCT00689832

    Protopic Ointment in Children Atopic Eczema

    Not yet reported Astellas Pharma Inc 487 participants Est. completion 2005-08 1 site Stand-alone
    Other conditions: Dermatitis, Atopic
    View official trial listing →
  • Completed NCT NCT00690105

    Protopic Ointment in Adult Atopic Eczema of the Face

    Not yet reported Astellas Pharma Inc 577 participants Est. completion 2005-07 1 site Stand-alone
    Other conditions: Dermatitis, Atopic
    View official trial listing →
  • Completed NCT NCT00691015

    Sirolimus, Tacrolimus, and Antithymocyte Globulin in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer Who Are Undergoing Donor Stem Cell Transplant

    Not yet reported Barbara Ann Karmanos Cancer Institute 48 participants Est. completion 2014-04 1 site
    Other conditions: Chronic Myeloproliferative Disorders, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
    View official trial listing →
  • Completed NCT NCT00691145

    Study to Evaluate the Efficacy and Safety of 0.1% and 0.03% Tacrolimus Ointment Administered in Adults With Moderate to Severe Atopic Dermatitis

    Not yet reported Astellas Pharma Inc 350 participants Est. completion 2005-02 26 sites Stand-alone
    Other conditions: Dermatitis, Atopic
    View official trial listing →
  • Completed NCT NCT00691262

    Study to Evaluate the Response to Treatment and Safety of 0.03% Tacrolimus (FK506) Ointment Administered in Pediatric Patients With Moderate to Severe Atopic Dermatitis

    Not yet reported Astellas Pharma Inc 166 participants Est. completion 2005-02 9 sites Stand-alone
    Other conditions: Dermatitis, Atopic
    View official trial listing →
  • Completed NCT NCT00693381

    Mycophenolate Mofetil (MMF) Discontinuation From a Tacrolimus/MMF/Steroid Triple Regimen After Kidney Transplantation

    Not yet reported Astellas Pharma Inc 152 participants Est. completion 2004-08 14 sites Stand-alone
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Terminated NCT NCT00693433

    Temsirolimus and Dexamethasone in Treating Patients With Recurrent or Refractory Multiple Myeloma

    Not yet reported National Cancer Institute (NCI) 2 participants 2 sites
    Other conditions: DS Stage I Multiple Myeloma, DS Stage II Multiple Myeloma, DS Stage III Multiple Myeloma, Refractory Multiple Myeloma
    View official trial listing →
  • Status unknown NCT NCT00693446

    A Study To Compare Sirolimus Versus Tacrolimus In De Novo Simultaneous Pancreas- Kidney Allograft Recipients Receiving An Induction Therapy With Antithymocyte Globulin Plus Mycophenolate Mofetil Plus Corticosteroids

    Not yet reported Nantes University Hospital 118 participants Est. completion 2017-04 1 site
    Other conditions: Pancreas Transplantation, Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT00693524

    Sequential Therapy (FK506 + Monoclonal Anti-IL2R Antibodies + MMF) Versus FK506 With Steroids in Liver TX

    Not yet reported Astellas Pharma Inc 94 participants Est. completion 2004-03 8 sites Stand-alone
    Other conditions: Liver Transplantation
    View official trial listing →
  • Completed NCT NCT00694005

    Choice Of Optimal Strategy For Bifurcation Lesions With Normal Side Branch

    Not yet reported Seung-Jung Park 504 participants Est. completion 2015-01 11 sites
    Cardiovascular disease
    View official trial listing →
  • Terminated NCT NCT00694408

    A Pilot Trial of Pediatric Liver Transplantation Without Steroids

    Not yet reported Birmingham Women's and Children's NHS Foundation Trust 15 participants Est. completion 2011-08 1 site
    Other conditions: Evidence of Liver Transplantation
    View official trial listing →
  • Status unknown NCT NCT00695344

    Study to Evaluate Effect of Everolimus in Progression of Graft Vascular Illness on Patients With Heart Transplant

    Not yet reported Fundacion Investigacion y Desarrollo 52 participants Est. completion 2010-06 8 sites
    Other conditions: Cardiac Transplant
    View official trial listing →
  • Completed NCT NCT00697112

    Study Evaluating The Use Of Sirolimus In Recipients Of Kidney Allografts From Expanded Criteria Donors (ECD)

    Pfizer 53 participants Est. completion 2012-12 8 sites
    Other conditions: Renal Transplantation
    View official trial listing →
  • Completed NCT NCT00697372

    SEA-SIDE: Sirolimus Versus Everolimus-eluting Stent Randomized Assessment in Bifurcated Lesions and Clinical SIgnificance of Residual siDE-branch Stenosis

    Not yet reported Catholic University of the Sacred Heart 150 participants Est. completion 2010-04 1 site
    Cardiovascular disease Other conditions: Coronary Stenosis
    View official trial listing →
  • Completed NCT NCT00699491

    Cixutumumab and Temsirolimus in Treating Patients With Locally Recurrent or Metastatic Breast Cancer

    Not yet reported, Not yet reported National Cancer Institute (NCI) 48 participants Est. completion 2018-02-14 192 sites
    Other conditions: Male Breast Carcinoma, Recurrent Breast Carcinoma, Stage IV Breast Cancer AJCC v6 and v7
    View official trial listing →
  • Completed NCT NCT00700258

    Registry For Temsirolimus, Sunitinib, And Axitinib Treated Patients With Metastatic Renal Cell Carcinoma (mRCC), Mantle Cell Lymphoma (MCL), And Gastro-Intestinal Stroma Tumor (GIST) [STAR-TOR]

    Pfizer 1520 participants Est. completion 2021-12-28 77 sites
    Other conditions: Carcinoma, Renal Cell, Advanced, Lymphoma, Mantle-Cell, Gastrointestinal Stroma Tumors
    View official trial listing →
  • Terminated NCT NCT00701935

    Effect of Exenatide on Abdominal Fat Distribution in Patients With Type 2 Diabetes Pretreated With Metformin

    Not yet reported AstraZeneca 80 participants Est. completion 2012-01 17 sites Stand-alone
    Other conditions: Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT00702052

    Safety and Efficacy of RAD001 in Participants With Mantle Cell Lymphoma Who Are Refractory or Intolerant to Velcade® Therapy

    Not yet reported Novartis Pharmaceuticals 58 participants Est. completion 2012-04-20 31 sites
    Other conditions: Lymphoma, Mantle- Cell
    View official trial listing →
  • Completed NCT NCT00703170

    Phase I Study of DOXIL and Temsirolimus in Resistant Solid Malignancies

    Not yet reported Washington University School of Medicine 28 participants Est. completion 2011-07 1 site
    Other conditions: Resistant Solid Malignancies
    View official trial listing →
  • Active, not recruiting NCT NCT00706420

    Islet Transplantation Alone (ITA) in Patients With Difficult to Control Type I Diabetes Mellitus Using a Glucocorticoid-free Immunosuppressive Regimen

    Not yet reported City of Hope Medical Center 17 participants Est. completion 2027-09-13 1 site Stand-alone
    Other conditions: Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT00707031

    GLP-1 Receptor Agonist Lixisenatide Versus Exenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Metformin

    Not yet reported Sanofi 639 participants Est. completion 2010-11 18 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00707759

    Steroid Withdrawal in Pediatric Renal Transplant: Impact on Growth, Bone Metabolism and Acute Rejection

    Not yet reported Fondo Nacional de Desarrollo Científico y Tecnológico, Chile 28 participants Est. completion 2014-12 1 site Stand-alone
    Other conditions: Kidney Diseases
    View official trial listing →
  • Completed NCT NCT00708591

    Study of Rapamycin Plus Ketoconazole in Advanced Cancers

    Not yet reported University of Chicago 57 participants Est. completion 2008-12 1 site
    Other conditions: Advanced Cancer
    View official trial listing →
  • Completed NCT NCT00708604

    Islet After Kidney Transplantation (IAK) in Patients With Type 1 Diabetes

    Not yet reported City of Hope Medical Center 3 participants Est. completion 2014-06 1 site
    Other conditions: Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT00709592

    Reduced Intensity Total Body Irradiation + Thymoglobulin Followed by Allogeneic PBSCT

    Not yet reported Virginia Commonwealth University 42 participants Est. completion 2017-06-28 1 site Stand-alone
    Other conditions: Non-Hodgkin's Lymphoma, Leukemia, Multiple Myeloma, Acute Myeloid Leukemia, Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, Chronic Myelogenous Leukemia, Myelodysplastic Syndrome
    View official trial listing →
  • Completed NCT NCT00710801

    Assessment of Biomarkers for Recurrent HCV Infection Post-liver Transplantation

    University of Alberta 40 participants 1 site
    Other conditions: Hepatitis C Virus
    View official trial listing →
  • Completed NCT NCT00711490

    Sirolimus to Treat Diabetic Macular Edema

    Not yet reported, Not yet reported National Eye Institute (NEI) 5 participants Est. completion 2011-01 1 site Stand-alone
    Other conditions: Diabetic Retinopathy
    View official trial listing →
  • Terminated NCT NCT00712491

    Phase 1/2 Study of an Ocular Sirolimus (Rapamycin) Formulation in Patients With Age-Related Macular Degeneration

    Not yet reported, Not yet reported Santen Inc. 20 participants Est. completion 2010-03 1 site Stand-alone
    Other conditions: Age-related Macular Degeneration, Choroidal Neovascularization
    View official trial listing →
  • Completed NCT NCT00713284

    Study Evaluating Conversion From Tacrolimus to Sirolimus in Stable Kidney Transplant Recipients Receiving Myfortic

    Not yet reported California Pacific Medical Center Research Institute 29 participants Est. completion 2010-11 1 site
    Other conditions: Renal Transplantation
    View official trial listing →
  • Completed NCT NCT00713544

    A Proof of Concept and Dose Ranging Study in Patients With Rheumatoid Arthritis

    Not yet reported AstraZeneca 373 participants Est. completion 2009-04 49 sites
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Terminated NCT NCT00713557

    Shanghai Registry of Acute Coronary Events

    Shanghai Jiao Tong University School of Medicine 20000 participants 1 site
    Cardiovascular disease Other conditions: Acute Coronary Syndrome
    View official trial listing →
  • Completed NCT NCT00714025

    A Single Arm, Multicenter, Phase II Trial of RAD001 as Monotherapy in the Palliative Treatment of Patients With TCC After Failure of Chemotherapy

    Not yet reported Cliniques universitaires Saint-Luc- Université Catholique de Louvain 40 participants Est. completion 2012-01 1 site
    Other conditions: Transitional Cell Carcinoma
    View official trial listing →
  • Completed NCT NCT00714493

    RESTART C0168Z05 Rheumatoid Arthritis Study

    Not yet reported Centocor Ortho Biotech Services, L.L.C. 203 participants Est. completion 2010-06 76 sites
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT00714623

    The SCRIPPS DES REAL WORLD Registry

    Paul S Teirstein, MD 859 participants Est. completion 2012-04 1 site
    Cardiovascular disease Other conditions: Coronary Restenosis, Coronary Thrombosis
    View official trial listing →
  • Terminated NCT NCT00714883

    Conor Cobalt Chromium Reservoir Based Stent With Sirolimus Elution in Native Coronary Artery Lesions

    Not yet reported Cordis US Corp. 3 participants Est. completion 2012-10 2 sites
    Other conditions: Coronary Disease
    View official trial listing →
  • Completed NCT NCT00716573

    Efficacy Study of Everolimus on Renal Function in Heart Transplant Recipients With Established Chronic Renal Failure

    Not yet reported Hospices Civils de Lyon 120 participants Est. completion 2014-04-17 1 site Stand-alone
    Other conditions: Cardiac Transplantation, Chronic Renal Insufficiency
    View official trial listing →
  • Completed NCT NCT00717379

    Study of Tacrolimus Immunosuppressive Therapy After Kidney Transplantation

    Not yet reported Astellas Pharma Inc 50 participants Est. completion 2008-10 6 sites Stand-alone
    Other conditions: Kidney Transplantation, Kidney Failure, Chronic, Renal Insufficiency, Chronic
    View official trial listing →
  • Completed NCT NCT00717470

    A Study in Kidney Transplant Subjects to Investigate the Optimal Suppression of Immunity to Help Prevent Kidney Rejection

    Not yet reported Astellas Pharma Inc 1252 participants Est. completion 2010-03-02 110 sites
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT00717678

    A Randomized Study to Assess the Safety and Efficacy of Prograf vs Prograf-XL in de Novo Kidney Transplant Recipients

    Not yet reported Astellas Pharma Inc 73 participants Est. completion 2010-04 5 sites Stand-alone
    Other conditions: Kidney Transplantation, Transplantation Immunology, Host vs Graft Reaction
    View official trial listing →
  • Completed NCT NCT00719264

    Safety and Efficacy of Bevacizumab Plus RAD001 Versus Interferon Alfa-2a and Bevacizumab for the First-line Treatment in Adult Patients With Kidney Cancer

    Not yet reported Novartis Pharmaceuticals 365 participants Est. completion 2013-04-15 109 sites
    Other conditions: Carcinoma, Adenocarcinoma, Renal Cell, Nephroid Carcinoma, Hypernephroid
    View official trial listing →
  • Completed NCT NCT00719745

    A Study to Assess the Safety and Efficacy of Prograf and MR4 in Liver Transplant Recipients

    Not yet reported Astellas Pharma Inc 74 participants Est. completion 2008-06 1 site
    Other conditions: Liver Transplantation
    View official trial listing →
  • Completed NCT NCT00720265

    A Study to Assess the Safety and Efficacy of Prograf and MR4 in Kidney Transplantation Patients

    Not yet reported Astellas Pharma Inc 135 participants Est. completion 2008-03 2 sites
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT00720408

    A Randomized Study to Assess the Safety and Efficacy of Prograf vs Prograf-XL in de Novo Liver Transplant Recipients.

    Not yet reported Astellas Pharma Inc 48 participants Est. completion 2009-09 4 sites Stand-alone
    Other conditions: Liver Transplantation, Transplantation Immunology, Host vs Graft Reaction
    View official trial listing →
  • Terminated NCT NCT00720629

    Visilizumab for the Prevention of Graft-versus-Host Disease After Allogeneic Hematopoietic Cell Transplantation

    Not yet reported H. Lee Moffitt Cancer Center and Research Institute 8 participants Est. completion 2013-12 1 site Stand-alone
    Other conditions: Graft Versus Host Disease
    View official trial listing →
  • Completed NCT NCT00724022

    Phase IV Study to Evaluate Calcineurin Inhibitor Reduced, Steroid Free Immunosuppression After Renal Transplantation

    Not yet reported University Hospital Freiburg 600 participants Est. completion 2014-07 25 sites Stand-alone
    Other conditions: Disorder Related to Renal Transplantation
    View official trial listing →
  • Withdrawn NCT NCT00724672

    A Study of Immune Cells in Patients With Rheumatoid Arthritis During Different Types of Anti-TNF Alpha Treatments (Study P05521)

    Merck Sharp & Dohme LLC Est. completion 2009-07
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT00726375

    The Use of Etanercept Enbrel as Sole Treatment for Grade I Acute Graft Versus Host Disease

    Not yet reported University of Michigan Rogel Cancer Center 34 participants Est. completion 2014-09 1 site Stand-alone
    Other conditions: Acute Graft Versus Host Disease
    View official trial listing →
  • Terminated NCT NCT00726804

    Discontinuation of TNF-alpha Inhibitors in Patients With Spondyloarthritis

    Not yet reported Glostrup University Hospital, Copenhagen 7 participants Est. completion 2012-05 6 sites
    Other conditions: SPONDYLOARTHRITIS
    View official trial listing →
  • Completed NCT NCT00729131

    Functional Implications of TNF

    National Institute of Environmental Health Sciences (NIEHS) 10 participants Est. completion 2012-02 1 site
    Other conditions: Bronchitis
    View official trial listing →
  • Completed NCT NCT00729248

    The Differential Effects of 3 Different Immunosuppressive

    Northwestern University 12 participants Est. completion 2010-01 1 site
    Other conditions: Immunosuppression, Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT00729482

    RAD001 (Everolimus) Salvage Monotherapy in Advanced Gastric Cancer (AGC) Who Failed Standard First-line Treatment

    Not yet reported Asan Medical Center 54 participants Est. completion 2013-03 1 site
    Other conditions: Stomach Neoplasm
    View official trial listing →
  • Terminated NCT NCT00731874

    Thymoglobulin Induction Therapy With Minimal Immunosuppression and Evaluation of Allograft Status

    Not yet reported Weill Medical College of Cornell University 34 participants Est. completion 2013-07 1 site
    Other conditions: Immunosuppression
    View official trial listing →
  • Status unknown NCT NCT00733733

    Anti-T-Lymphocyte Globulin (ATG) in Renal Transplantation of Kidneys With a Non-Heart-Beating (NHB) Donor

    Not yet reported Radboud University Medical Center 180 participants Est. completion 2010-06 1 site
    Other conditions: Renal Transplant Patients, Recipients of a Kidney From a Non-Heart-Beating Donor
    View official trial listing →
  • Completed NCT NCT00736229

    Intravenous Exenatide in Coronary Intensive Care Unit (ICU) Patients

    Not yet reported Saint Luke's Health System 40 participants Est. completion 2012-08 1 site Stand-alone
    Cardiovascular disease Other conditions: Hyperglycemia, Acute Coronary Syndromes
    View official trial listing →
  • Status unknown NCT NCT00737659

    CellCept® Dose Adjustment Versus Fixed Dose (Standard Care) in Renal Transplant Recipients

    Not yet reported Rabin Medical Center 138 participants Est. completion 2013-08 2 sites
    Other conditions: Renal Transplant
    View official trial listing →
  • Completed NCT NCT00745420

    Evaluating the Safety and Effectiveness of Bone Marrow Transplants in Children With Sickle Cell Disease (BMT CTN 0601)

    Not yet reported Medical College of Wisconsin 30 participants Est. completion 2016-09 19 sites Stand-alone
    Other conditions: Sickle Cell Disease
    View official trial listing →
  • Completed NCT NCT00747968

    The Effect of the GLP-1 Analogue Exenatide on Type 2 Diabetes in CNS and Heart During Hyperglycemia Assessed by PET

    Not yet reported, Not yet reported University of Aarhus 8 participants Est. completion 2011-03 4 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00749424

    The Study of the Crushing Technique Application Using SES in Coronary Bifurcations.

    Not yet reported Cordis US Corp. 350 participants Est. completion 2009-04 1 site Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT00752362

    Per-cutaneous Intervention Based Paclitaxel and Sirolimus-Eluting Versus Bare Stents for the Treatment of de Novo Coronary Lesions (PAINT)

    Not yet reported Sahajanand Medical Technologies Limited 280 participants 11 sites Stand-alone
    Other conditions: Coronary Restenosis
    View official trial listing →
  • Completed NCT NCT00757874

    Tacrolimus Versus Clobetasol Propionate in the Treatment of Vulvar Lichen Sclerosus

    Not yet reported Deana Funaro 56 participants Est. completion 2010-01 1 site Stand-alone
    Other conditions: Vulvar Lichen Sclerosus
    View official trial listing →
  • Completed NCT NCT00758602

    A Study of CellCept (Mycophenolate Mofetil) Combined With Tacrolimus and Corticosteroids in Kidney Transplant Patients.

    Not yet reported Hoffmann-La Roche 210 participants Est. completion 2011-02 6 sites Stand-alone
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT00761644

    Doxil, Bevacizumab and Temsirolimus Trial

    Not yet reported M.D. Anderson Cancer Center 200 participants Est. completion 2019-03-28 1 site
    Other conditions: Advanced Cancer
    View official trial listing →
  • Completed NCT NCT00762658

    A Phase I Study to Assess Novel Ointment in a Psoriasis Plaque Test

    Not yet reported Pfizer 12 participants Est. completion 2007-12-07 1 site
    Other conditions: Psoriasis
    View official trial listing →
  • Completed NCT NCT00763490

    Trial Of Double Umbilical Cord Blood Transplantation

    Not yet reported University of Michigan Rogel Cancer Center 20 participants Est. completion 2015-10 1 site Stand-alone
    Other conditions: Hematological Malignancies
    View official trial listing →
  • Completed NCT NCT00765661

    Pharmacokinetics of LCP-Tacro(TM) Once Daily And Prograf® Twice A Day in Adult De Novo Kidney Transplant Patients

    Not yet reported Asahi Kasei Therapeutics, Inc. 63 participants Est. completion 2010-02 1 site Stand-alone
    Other conditions: Kidney Failure, Renal Failure
    View official trial listing →
  • Completed NCT NCT00765817

    Addition Of Exenatide To Insulin Glargine In Type 2 Diabetes Mellitus

    Not yet reported AstraZeneca 261 participants Est. completion 2010-01 59 sites Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Terminated NCT NCT00766337

    Phase 2 Study of an Ocular Sirolimus (Rapamycin) Formulation in Combination With Lucentis® in Patients With Age-Related Macular Degeneration

    Not yet reported Santen Inc. 62 participants Est. completion 2010-03 1 site Stand-alone
    Other conditions: Age-Related Macular Degeneration, Choroidal Neovascularization
    View official trial listing →
  • Completed NCT NCT00766649

    Pilot Study of the Evaluation of Subconjunctival Sirolimus in the Treatment of Bilateral GA Associated With AMD

    Not yet reported, Not yet reported National Eye Institute (NEI) 11 participants Est. completion 2012-07 1 site Stand-alone
    Other conditions: Age-Related Macular Degeneration
    View official trial listing →
  • Completed NCT NCT00766857

    Effects of Exenatide in Type 2 Diabetic Patients With Congestive Heart Failure

    Not yet reported Amsterdam UMC, location VUmc 27 participants Est. completion 2012-12 1 site Stand-alone
    Type 2 diabetesHeart failure
    View official trial listing →
  • Completed NCT NCT00766909

    Diabetogenicity of Cyclosporine and Tacrolimus

    Not yet reported University of Aarhus 18 participants Est. completion 2011-11 1 site Stand-alone
    Other conditions: Complications of Transplanted Organs and Tissue, Diabetes Mellitus Nos New Onset
    View official trial listing →
  • Completed NCT NCT00768053

    Evaluation of EULAR-RAID Score in Rheumatoid Arthritis Patients

    Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 108 participants Est. completion 2010-04 17 sites Stand-alone
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT00768651

    Incretin Effect and Use After Clinical Islet Transplantation

    Not yet reported University of Alberta 8 participants Est. completion 2011-12 1 site
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT00770120

    S0722: Everolimus in Treating Patients With Pleural Malignant Mesothelioma That Cannot Be Removed By Surgery

    Not yet reported SWOG Cancer Research Network 61 participants Est. completion 2014-04 129 sites
    Other conditions: Malignant Mesothelioma
    View official trial listing →
  • Completed NCT NCT00770263

    Erlotinib and Temsirolimus for Solid Tumors

    Not yet reported Washington University School of Medicine 46 participants Est. completion 2014-09 1 site
    Other conditions: Solid Tumors
    View official trial listing →
  • Completed NCT NCT00771745

    Prospective Pilot Study of Pre-Transplant Thymoglobulin Administration in Living Donor Renal Transplant Recipients

    Not yet reported University of Cincinnati 11 participants Est. completion 2010-07 1 site
    Other conditions: Renal Transplant Rejection, Transplants and Implants
    View official trial listing →
  • Completed NCT NCT00772148

    Pharmacokinetics of LCP-Tacro™ Once Daily and Prograf® Twice A Day in Adult De Novo Liver Transplant Patients

    Not yet reported Asahi Kasei Therapeutics, Inc. 58 participants Est. completion 2010-05 1 site Stand-alone
    Other conditions: Liver Failure
    View official trial listing →
  • Completed NCT NCT00775593

    Clofarabine and Temsirolimus in Treating Older Patients With Relapsed or Refractory Acute Myeloid Leukemia

    Not yet reported Gruppo Italiano Malattie EMatologiche dell'Adulto 60 participants Est. completion 2013-10-23 19 sites
    Other conditions: Leukemia
    View official trial listing →
  • Completed NCT NCT00775684

    Effect of Exenatide, Sitagliptin or Glimepiride on Functional ß -Cell Mass

    Not yet reported University of Pennsylvania 47 participants Est. completion 2012-11 3 sites Stand-alone
    PrediabetesType 2 diabetes
    View official trial listing →
  • Terminated NCT NCT00776373

    Rapamycin in With High-Dose Etoposide and Cytarabine in Relapsed/Refractory Aggressive Lymphoid Malignancies

    Not yet reported, Not yet reported Abramson Cancer Center at Penn Medicine 4 participants Est. completion 2009-12 1 site
    Other conditions: ALL, Burkitt's Lymphoma, Lymphoblastic Leukemia, CML
    View official trial listing →
  • Withdrawn NCT NCT00777400

    Pilot Trial to Assess Effect of CNI Conversion of Efalizumab on T Reg Cells

    Not yet reported, Not yet reported University of California, San Francisco Est. completion 2009-04 1 site Stand-alone
    Other conditions: Autoimmune Diseases
    View official trial listing →
  • Completed NCT NCT00777933

    Randomized Trial of Cyclosporine and Tacrolimus Therapy With Steroid Withdrawal in Living-Donor Renal Transplantation

    Not yet reported Samsung Medical Center 131 participants Est. completion 2008-05 1 site Stand-alone
    Other conditions: Kidney Transplantation, Living Donors
    View official trial listing →
  • Status unknown NCT NCT00779792

    Efficacy of Glycerol, Two Topical Steroids, and a Topical Immune Modulator Against Skin Irritation

    Not yet reported Odense University Hospital 36 participants Est. completion 2008-11 1 site
    Other conditions: Dermatitis, Contact, Dermatitis, Occupational
    View official trial listing →
  • Status unknown NCT NCT00780429

    Pharmacokinetics and Pharmacodynamics of MPA in Stable Renal Transplant Patients

    Fondazione IRCCS Policlinico San Matteo di Pavia 54 participants 1 site
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT00780793

    Spacing of TNF-blocker Injections in Rheumatoid Arthritis Study

    Not yet reported Assistance Publique - Hôpitaux de Paris 250 participants Est. completion 2011-09 1 site Stand-alone
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Status unknown NCT NCT00781716

    Safety and Efficacy Study of CYPHER® Sirolimus Stent and ENDEAVOR® Zotarolimus Stent in Patients With Acute ST Elevation Myocardial Infarction (STEMI) and Analysis of Current Status of Emergency PCI Green Channel for STEMI Patients in China

    Not yet reported Beijing Chao Yang Hospital 1020 participants Est. completion 2011-05 1 site
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT00782275

    Avastin and Temsirolimus Following Tyrosine Kinase Inhibitor Failure in Patients With Advanced Renal Cell Carcinoma

    Not yet reported Beth Israel Deaconess Medical Center 41 participants Est. completion 2015-05 3 sites
    Other conditions: Renal Cell Carcinoma, Kidney Cancer
    View official trial listing →
  • Completed NCT NCT00782379

    Combination Chemotherapy, Donor Stem Cell Transplant, Tacrolimus, Mycophenolate Mofetil, and Cyclophosphamide in Treating Patients With Hematologic Cancer

    Not yet reported Northside Hospital, Inc. 20 participants Est. completion 2012-04 1 site Stand-alone
    Other conditions: Leukemia, Lymphoma, Myelodysplastic Syndromes
    View official trial listing →
  • Completed NCT NCT00782418

    A Study to Compare Methodologies for Assessing Glucose-Dependent Insulin Secretion (0000-104)(COMPLETED)

    Not yet reported Merck Sharp & Dohme LLC 27 participants Est. completion 2009-03
    Other conditions: The Methodology Assessment of Glucose Dependent Insulin Secretion
    View official trial listing →
  • Completed NCT NCT00782821

    Randomized Trial of Induction Therapies in High Immunological Risk Kidney Transplant Recipients

    Not yet reported University of Cincinnati 40 participants Est. completion 2013-03 2 sites
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Withdrawn NCT NCT00783536

    A Multicenter Study to Compare the Efficacy and Safety of the Combination of Etanercept and Methotrexate in Treatment of Rheumatoid Arthritis

    Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer Est. completion 2010-06 Stand-alone
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT00784914

    A Feasibility, Dose-Escalation Study Using Intracerebral Microdialysis to Assess the Neuropharmacodynamics of Temsirolimus in Patients With Primary or Metastatic Brain Tumors

    Not yet reported City of Hope Medical Center 12 participants Est. completion 2010-11 1 site Stand-alone
    Other conditions: Brain and Central Nervous System Tumors, Metastatic Cancer
    View official trial listing →
  • Withdrawn NCT NCT00784966

    Islet After Kidney Transplant for Type 1 Diabetes

    Not yet reported, Not yet reported Virginia Commonwealth University Est. completion 2017-09 1 site
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT00785330

    Allo-hNHL (FluBuCy)

    Not yet reported Institut fuer anwendungsorientierte Forschung und klinische Studien GmbH 84 participants Est. completion 2011-04 6 sites Stand-alone
    Other conditions: Non-Hodgkin's Lymphoma
    View official trial listing →
  • Completed NCT NCT00787761

    Early Administration of ATG Followed by Cyclophosphamide, Busulfan and Fludarabine Before a Donor Stem Cell Transplant in Patients With Hematological Cancer

    Not yet reported Northside Hospital, Inc. 24 participants Est. completion 2012-05 1 site Stand-alone
    Other conditions: Myeloproliferative Disorders, Kidney Cancer, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Diseases
    View official trial listing →
  • Completed NCT NCT00788021

    Protective Immunity Project 01

    Emory University 124 participants Est. completion 2011-10 1 site
    Other conditions: Kidney Transplantation, Immunity, Immunosuppression
    View official trial listing →
  • Withdrawn NCT NCT00788580

    S0718 Pazopanib and Temsirolimus in Treating Patients With Advanced Solid Tumors

    Not yet reported SWOG Cancer Research Network
    Other conditions: Unspecified Adult Solid Tumor, Protocol Specific
    View official trial listing →
  • Completed NCT NCT00789308

    Safety and Effectiveness of Low Molecular Weight Sulfated Dextran in Islet Transplantation

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 24 participants Est. completion 2014-08-21 3 sites Stand-alone
    Other conditions: Diabetes Mellitus, Type I
    View official trial listing →
  • Completed NCT NCT00789776

    Fludarabine Phosphate, Cyclophosphamide, Total-Body Irradiation, and Donor Bone Marrow Transplant Followed by Donor Natural Killer Cell Therapy, Mycophenolate Mofetil, and Tacrolimus in Treating Patients With Hematologic Cancer

    Not yet reported, Not yet reported Fred Hutchinson Cancer Center 41 participants Est. completion 2017-05 3 sites Stand-alone
    Other conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Aggressive Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma, Previously Treated Myelodysplastic Syndrome, Recurrent Chronic Lymphocytic Leukemia, Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Recurrent Indolent Adult Non-Hodgkin Lymphoma, Recurrent Mantle Cell Lymphoma, Recurrent Plasma Cell Myeloma, Recurrent Small Lymphocytic Lymphoma, Refractory Chronic Lymphocytic Leukemia, Refractory Hodgkin Lymphoma, Refractory Plasma Cell Myeloma, Refractory Small Lymphocytic Lymphoma, Waldenstrom Macroglobulinemia
    View official trial listing →
  • Completed NCT NCT00790036

    Phase III Study of RAD001 Adjuvant Therapy in Poor Risk Patients With Diffuse Large B-Cell Lymphoma (DLBCL) of RAD001 Versus Matching Placebo After Patients Have Achieved Complete Response With First-line Rituximab-chemotherapy

    Not yet reported Novartis Pharmaceuticals 742 participants Est. completion 2016-06-15 202 sites
    Other conditions: Diffuse Large B-cell Lymphoma
    View official trial listing →
  • Withdrawn NCT NCT00790439

    Safety and Effectiveness of Low Molecular Weight Sulfated Dextran in Islet Transplantation After Kidney Transplant

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) Est. completion 2009-10 Stand-alone
    Other conditions: Diabetes Mellitus, Type I
    View official trial listing →
  • Completed NCT NCT00791765

    Moderate to Severe Plaque Psoriasis With Scalp Involvement

    Not yet reported Amgen 124 participants Est. completion 2010-03 Stand-alone
    Other conditions: Psoriasis
    View official trial listing →
  • Completed NCT NCT00792766

    Long Term Follow Up for RAD001 Therapy of Angiomyolipomata in Patients With Tuberous Sclerosis (TSC) and Sporadic Lymphangioleiomyomatosis (LAM)

    Not yet reported, Not yet reported Children's Hospital Medical Center, Cincinnati 20 participants Est. completion 2013-09 1 site
    Other conditions: Tuberous Sclerosis, Angiolipoma
    View official trial listing →
  • Active, not recruiting NCT NCT00792948

    Combination Chemotherapy With or Without Donor Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia

    Not yet reported National Cancer Institute (NCI) 97 participants Est. completion 2027-01-06 157 sites Stand-alone
    Other conditions: Acute Lymphoblastic Leukemia, Adult B Acute Lymphoblastic Leukemia, Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1, Adult L1 Acute Lymphoblastic Leukemia, Adult L2 Acute Lymphoblastic Leukemia, Adult T Acute Lymphoblastic Leukemia, Recurrent Adult Acute Lymphoblastic Leukemia
    View official trial listing →
  • Completed NCT NCT00793221

    Non-acute Coronary occlusIon Treated By Everolimus ELuting Stent

    Not yet reported Raul Moreno 207 participants
    Cardiovascular disease Other conditions: Coronary Occlusion, Percutaneous Coronary Intervention
    View official trial listing →
  • Completed NCT NCT00795886

    Rapamycin for Immunosuppression and B Cell Modulation Post Stem Cell Transplant for Acute Lymphoblastic Leukemia (ALL)

    Not yet reported University of Utah 63 participants Est. completion 2010-03 1 site Stand-alone
    Other conditions: Acute Lymphoblastic Leukemia
    View official trial listing →
  • Completed NCT NCT00796562

    Safety Study of Bone Marrow Transplant Using Mismatched Tissue Followed by Chemotherapy

    Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 107 participants Est. completion 2016-11 2 sites
    Other conditions: MDS, Leukemias, Lymphomas
    View official trial listing →
  • Terminated NCT NCT00796705

    Switching Anti-TNF-Alpha Agents in Rheumatoid Arthritis (RA)

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 13 participants Est. completion 2010-10 16 sites Stand-alone
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT00796796

    Temsirolimus and Radiation for Non-Small Cell Lung Cancer

    Not yet reported Washington University School of Medicine 10 participants Est. completion 2011-07 1 site
    Other conditions: Carcinoma, Non-Small-Cell Lung
    View official trial listing →
  • Status unknown NCT NCT00797784

    The Safety and Efficacy of Etanercept (Enbrel®) for the Treatment of Discoid Lupus Erythematosus

    Not yet reported Florida Academic Dermatology Centers 20 participants Est. completion 2011-04 1 site
    Other conditions: Discoid Lupus Erythematosus (DLE)
    View official trial listing →
  • Status unknown NCT NCT00798785

    Long-term Function of Beta Cell Allografts in Non-uremic Type 1 Diabetic Patients

    Not yet reported, Not yet reported Universitair Ziekenhuis Brussel 50 participants Est. completion 2014-12 4 sites Stand-alone
    Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT00799188

    CERTICOEUR: A Secondary Prevention Study of Skin Cancers in Heart Transplant Patients. Everolimus Versus Calcineurin Inhibitors Multicenter Trial

    Not yet reported Hospices Civils de Lyon 175 participants 1 site Stand-alone
    Other conditions: Cardiac Transplantation, Skin Cancer
    View official trial listing →
  • Terminated NCT NCT00799435

    Evaluating the Use of Exenatide in People With Type 2 Diabetes and Diastolic Heart Failure

    Not yet reported Baylor College of Medicine 2 participants Est. completion 2012-04 1 site Stand-alone
    Type 2 diabetesHeart failure
    View official trial listing →
  • Completed NCT NCT00800722

    A Randomized Trial to Study Combined Pulsed Dye Laser and Rapamycin Treatment of Port Wine Stain Birthmarks.

    Not yet reported University of California, Irvine 21 participants Est. completion 2014-06 1 site
    Other conditions: Port Wine Stain
    View official trial listing →
  • Completed NCT NCT00801632

    Combined Kidney and Bone Marrow Transplantation to Prevent Kidney Transplant Rejection

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 5 participants Est. completion 2014-11 1 site Stand-alone
    Other conditions: Kidney Transplantation, Kidney Failure, Chronic
    View official trial listing →
  • Terminated NCT NCT00801931

    Double Cord Blood Transplant for Patients With Malignant and Non-malignant Disorders

    Not yet reported, Not yet reported Columbia University 1 participants Est. completion 2009-05-05 1 site Stand-alone
    Other conditions: Leukemia, Lymphoma, Neuroblastoma, Immunodeficiencies, Anemia
    View official trial listing →
  • Completed NCT NCT00801957

    Equivalence of the Response to Vaccination of Tacrolimus Ointment to a Steroid Ointment Regimen in Children With Atopic Dermatitis

    Not yet reported Astellas Pharma Inc 260 participants Est. completion 2004-11 36 sites Stand-alone
    Other conditions: Atopic Dermatitis
    View official trial listing →
  • Completed NCT NCT00802815

    Double-blind, Randomized, Placebo-controlled Trial of Etanercept for 12 Months in Subjects With Inclusion Body Myositis

    Not yet reported Washington University School of Medicine 20 participants Est. completion 2014-05 1 site Stand-alone
    Other conditions: Inclusion Body Myositis
    View official trial listing →
  • Completed NCT NCT00803010

    Graft-Versus-Host Disease (GVHD) Prophylaxis After Allogeneic Peripheral Blood Hematopoietic Cell Transplantation

    Not yet reported H. Lee Moffitt Cancer Center and Research Institute 74 participants Est. completion 2012-12 1 site
    Other conditions: Acute Graft Versus Host Disease
    View official trial listing →
  • Completed NCT NCT00803816

    Everolimus for the Treatment of Uveitis Unresponsive to Cyclosporine A

    Not yet reported Carsten Heinz 12 participants Est. completion 2010-12 1 site
    Other conditions: Uveitis
    View official trial listing →
  • Completed NCT NCT00803920

    Continuous Glucose Monitoring (CGM) in Subjects With Type 2 Diabetes Taking Twice-Daily Exenatide or Once-Weekly Exenatide

    HealthPartners Institute 8 participants Est. completion 2008-02 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00804336

    Pasireotide in Combination With RAD001 in Patients With Advanced Neuroendocrine Tumors

    Not yet reported Dana-Farber Cancer Institute 22 participants Est. completion 2015-04 3 sites
    Other conditions: Neuroendocrine Tumor, Carcinoid Tumor, Pancreatic Neuroendocrine Tumor
    View official trial listing →
  • Completed NCT NCT00805961

    RT, Temozolomide, and Bevacizumab Followed by Bevacizumab/Everolimus in First-line Treatment of GBM

    Not yet reported SCRI Development Innovations, LLC 68 participants Est. completion 2013-05 13 sites
    Other conditions: Glioblastoma Multiforme
    View official trial listing →
  • Completed NCT NCT00806520

    Use of Continuous Glucose Monitoring Combined With Ambulatory Glucose Profiles to Characterize Glycemic Control

    HealthPartners Institute 16 participants Est. completion 2011-08 5 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00807144

    Standard Versus Prolonged-release Tacrolimus Monotherapy After Alemtuzumab Induction in Kidney Transplantation

    Not yet reported Imperial College Healthcare NHS Trust 102 participants Est. completion 2012-03 1 site Stand-alone
    Other conditions: End-stage Renal Failure, Graft Rejection
    View official trial listing →
  • Completed NCT NCT00807690

    Vitiligo Treated With TL01 Combined With Tacrolimus Ointment Versus Placebo

    Not yet reported Oslo University Hospital Est. completion 2008-01
    Other conditions: Vitiligo
    View official trial listing →
  • Terminated NCT NCT00807755

    Everolimus, Carboplatin, and Etoposide in Treating Patients With Small Cell Lung Cancer or Other Advanced Solid Tumors

    Not yet reported University of California, Davis 5 participants Est. completion 2011-12 1 site
    Other conditions: Lung Cancer, Unspecified Adult Solid Tumor, Protocol Specific
    View official trial listing →
  • Terminated NCT NCT00809185

    RAD001(Everolimus) in Treating Patients With Myelodysplastic Syndromes

    Not yet reported Case Comprehensive Cancer Center 7 participants Est. completion 2009-03 1 site
    Other conditions: Myelodysplastic Syndromes
    View official trial listing →
  • Completed NCT NCT00810602

    Vorinostat to Prevent Graft Versus Host Disease Following Reduced Intensity, Related Donor Stem Cell Transplant

    Not yet reported, Not yet reported Pavan Reddy, MD 61 participants Est. completion 2013-07 2 sites Stand-alone
    Other conditions: Hematologic Malignancies, Graft vs Host Disease
    View official trial listing →
  • Completed NCT NCT00811616

    A Safety and Efficacy of Supralimus™ Core™ Sirolimus Eluting Stent at MAX DDHV Institute

    Not yet reported Sahajanand Medical Technologies Limited 105 participants Est. completion 2008-03 1 site Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Terminated NCT NCT00811915

    Study to Compare the Safety and Efficacy of Sirolimus (Rapamune) to Tacrolimus (Advagraf) Associated to Mycophenolate Mofetil (CellCept) Between 12 and 36 Months After Kidney Transplantation

    Not yet reported University Hospital, Rouen 65 participants Est. completion 2014-06 8 sites Stand-alone
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT00812786

    Pharmacokinetics of Immunosuppressive Drugs in Heart Transplant Patients

    Not yet reported University Hospital, Limoges 42 participants Est. completion 2012-05 12 sites
    Other conditions: Heart Transplant
    View official trial listing →
  • Completed NCT NCT00813124

    Azacitidine After Allo Blood And Marrow Transplantation (BMT) for Chronic Myelogenous Leukemia (CML)

    Not yet reported M.D. Anderson Cancer Center 24 participants Est. completion 2014-09 1 site
    Other conditions: Stem Cell Transplantation, Leukemia
    View official trial listing →
  • Completed NCT NCT00814944

    A Dose-Ranging Clinical Study to Assess the Safety and Efficacy of Subconjunctival Injection of Sirolimus in Patients With Dry Eye in the Controlled Adverse Environmental (CAE) Model

    Not yet reported Santen Inc. 143 participants Est. completion 2009-10 1 site Stand-alone
    Other conditions: Dry Eye
    View official trial listing →
  • Completed NCT NCT00817206

    Safety and Efficacy of LCP-Tacro™ Once Daily in Stable Renal Transplant Patients Converted From Prograf® Twice Daily

    Not yet reported Asahi Kasei Therapeutics, Inc. 326 participants Est. completion 2011-02 1 site Stand-alone
    Other conditions: Renal Failure
    View official trial listing →
  • Completed NCT NCT00818194

    Comparison of Extended Release Tacrolimus (Advagraf) and Cyclosporine A Microemulsion on Renal Function in Healthy Volunteers

    Not yet reported Astellas Pharma Inc 18 participants Est. completion 2008-09 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Terminated NCT NCT00818961

    Donor Stem Cell Transplant in Treating Patients With High-Risk Hematologic Cancer

    Not yet reported Northside Hospital, Inc. 36 participants Est. completion 2012-03 1 site
    Other conditions: Leukemia, Lymphoma, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Diseases
    View official trial listing →
  • Active, not recruiting NCT NCT00819546

    RAD001 in Combination With PKC412 in Patients With Relapsed, Refractory or Poor Prognosis AML or MDS

    Not yet reported Richard Stone, MD 29 participants Est. completion 2026-12 3 sites
    Other conditions: Acute Myeloid Leukemia, Myelodysplastic Syndrome
    View official trial listing →
  • Completed NCT NCT00820911

    Efficacy and Safety of AEB071 Versus Cyclosporine in de Novo Renal Transplant Recipients

    Not yet reported Novartis Pharmaceuticals 175 participants Est. completion 2012-07 28 sites
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT00821080

    Vandetanib and Sirolimus in Patients With Recurrent Glioblastoma

    Not yet reported Massachusetts General Hospital 33 participants Est. completion 2015-02 2 sites Stand-alone
    Other conditions: Glioblastoma
    View official trial listing →
  • Completed NCT NCT00821587

    Cyclosporine in Hepatitis C Infection Viral Clearance Following Liver Transplantation

    Not yet reported University of Florida 39 participants Est. completion 2008-05
    Other conditions: Hepatitis C
    View official trial listing →
  • Completed NCT NCT00823459

    Everolimus in Treating Patients With Recurrent Low-Grade Glioma

    Not yet reported Susan Chang 58 participants Est. completion 2017-11-13 1 site
    Other conditions: Adult Diffuse Astrocytoma, Adult Mixed Glioma, Adult Oligodendroglioma, Adult Subependymal Giant Cell Astrocytoma, Recurrent Adult Brain Neoplasm
    View official trial listing →
  • Terminated NCT NCT00827099

    Umbilical Cord Blood (UCB) Transplant, Fludarabine, Melphalan, and Anti-thymocyte Globulin (ATG) in Treating Patients With Hematologic Cancer

    Not yet reported Northside Hospital, Inc. 5 participants Est. completion 2009-11 1 site
    Other conditions: Myeloproliferative Disorders, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes
    View official trial listing →
  • Completed NCT NCT00827359

    Biomarker Trial of Everolimus in Patients With Advanced Renal Cell Carcinoma

    Not yet reported Beth Israel Deaconess Medical Center 25 participants Est. completion 2018-06 3 sites
    Other conditions: Renal Cell Carcinoma, Renal Cancer
    View official trial listing →
  • Terminated NCT NCT00827567

    Trial of RAD001 in Triple Negative Metastatic Breast Cancer

    Not yet reported Milton S. Hershey Medical Center 6 participants Est. completion 2011-02 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT00828503

    Certican® (Everolimus) Against Cytomegalovirus Disease in Renal Transplant Patients

    Not yet reported Marcus Saemann 40 participants Est. completion 2014-06 1 site
    Other conditions: Cytomegalovirus Disease
    View official trial listing →
  • Completed NCT NCT00830297

    Treat-to-target Trial of Basal Insulin in Post-transplant Hyperglycemia

    Not yet reported Marcus Saemann 50 participants Est. completion 2011-05 1 site
    Other conditions: Hyperglycemia
    View official trial listing →
  • Completed NCT NCT00830466

    A Randomized Trial to Study Combined Pulsed Dye Laser and Rapamycin Treatment of Port Wine Stain Birthmarks.

    Not yet reported University of California, Irvine 22 participants Est. completion 2016-01 1 site
    Other conditions: Port Wine Stain
    View official trial listing →
  • Terminated NCT NCT00831480

    Everolimus (RAD001) For Advanced Renal Cell Carcinoma (RCC) Before Kidney Removal

    Not yet reported Linda C. Higgins 15 participants Est. completion 2014-12 2 sites
    Other conditions: Kidney Cancer
    View official trial listing →
  • Completed NCT NCT00833079

    Bioequivalence of Two Tacrolimus 0.1% Topical Ointment Formulations in Patients With Atopic Dermatitis

    Not yet reported Sun Pharmaceutical Industries, Inc. 500 participants Est. completion 2010-03 Stand-alone
    Other conditions: Atopic Dermatitis
    View official trial listing →
  • Completed NCT NCT00833651

    Protective Immunity Project 02

    Emory University 97 participants Est. completion 2011-10 1 site
    Other conditions: Kidney Transplant, Immunology, Immunosuppression
    View official trial listing →
  • Withdrawn NCT NCT00834496

    Switching From One Type of Anti-rejection Drug (Tacrolimus or Cyclosporine) to Another (Sirolimus) Approximately 90-180 Days After Liver Transplantation

    Thomas Jefferson University Est. completion 2010-01 1 site
    Other conditions: Side Effects of Calcineurin Inhibitors, Renal Toxicity, Hepatic Fibrosis on Biopsy, Neurotoxicity, Post Transplant Diabetes
    View official trial listing →
  • Completed NCT NCT00835848

    Pharmacological Postconditioning to Reduce Infarct Size Following Primary PCI

    Not yet reported Copenhagen University Hospital, Rigshospitalet 100 participants Est. completion 2015-05 1 site
    Cardiovascular disease
    View official trial listing →
  • Terminated NCT NCT00836927

    Extension Trial of Deforolimus (Ridaforolimus, MK-8669) in Participants With Advanced Cancer (MK-8669-038)

    Not yet reported Merck Sharp & Dohme LLC 7 participants Est. completion 2018-02-04
    Other conditions: Advanced Cancers
    View official trial listing →
  • Completed NCT NCT00837434

    Anti-TNF Agents for the Treatment of Rheumatoid Arthritis

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 63 participants Est. completion 2014-01 7 sites Stand-alone
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT00838539

    Study Evaluating Neratinib In Combination With Temsirolimus In Subjects With Solid Tumors

    Not yet reported Puma Biotechnology, Inc. 63 participants Est. completion 2013-12 5 sites
    Other conditions: Neoplasms, Malignant Carcinoma
    View official trial listing →
  • Terminated NCT NCT00838955

    Temsirolimus for Relapsed/Refractory Hodgkin's Lymphoma

    Not yet reported Loyola University 14 participants Est. completion 2017-10 1 site
    Other conditions: Hodgkin's Lymphoma
    View official trial listing →
  • Completed NCT NCT00843856

    Mycophenolate Mofetil and Tacrolimus Versus Tacrolimus for the Treatment of Idiopathic Membranous Glomerulonephritis

    Not yet reported Imperial College Healthcare NHS Trust 40 participants Est. completion 2018-09-18 1 site
    Other conditions: Glomerulonephritis, Membranous
    View official trial listing →
  • Status unknown NCT NCT00844142

    Enbrel-Sulfasalazin-Early-Axial Spondyloarthritis (AS)

    Not yet reported Charite University, Berlin, Germany 80 participants Est. completion 2013-07 9 sites
    Other conditions: Moderate to Severe Active Axial Spondyloarthritis
    View official trial listing →
  • Completed NCT NCT00845182

    Effect of Pioglitazone and Exenatide on Body Weight and Beta Cell Function

    Not yet reported The University of Texas Health Science Center at San Antonio 43 participants Est. completion 2010-07 1 site Stand-alone
    Type 2 diabetesPrediabetes Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00845507

    Exenatide for the Treatment of Weight Gain Associated With Olanzapine in Obese Adults

    Not yet reported University of Cincinnati 54 participants Est. completion 2015-07 1 site Stand-alone
    Other conditions: Weight Gain
    View official trial listing →
  • Withdrawn NCT NCT00845559

    The Effects of Exenatide on Post-Meal Sugar Peaks and Vascular Health in Obese/Pre-Diabetic Young Adults

    Not yet reported Yale University Stand-alone
    PrediabetesCardiovascular disease Other conditions: Obesity, Insulin Resistance
    View official trial listing →
  • Completed NCT NCT00849147

    Bone Marrow Transplant From Partially Matched Donors and Nonmyeloablative Conditioning for Blood Cancers (BMT CTN 0603)

    Not yet reported Medical College of Wisconsin 55 participants Est. completion 2013-11 17 sites Stand-alone
    Other conditions: Precursor B-Cell Lymphoblastic Leukemia-Lymphoma, Leukemia, Myeloid, Acute, Burkitt Lymphoma, Lymphoma, B-Cell, Lymphoma, Follicular, Lymphoma, Large B-Cell, Diffuse
    View official trial listing →
  • Withdrawn NCT NCT00853424

    A Comparison of Islet Cell Transplantation With Medical Therapy for the Treatment of Diabetic Eye Disease

    Not yet reported University of British Columbia Est. completion 2010-12 Stand-alone
    Other conditions: Diabetic Retinopathy, Diabetic Macular Edema
    View official trial listing →
  • Terminated NCT NCT00853944

    Effect of Sitagliptin on Graft Function Following Islet Transplantation

    Not yet reported University of British Columbia 12 participants Est. completion 2013-11-01 1 site
    Other conditions: Islet Transplantation
    View official trial listing →
  • Withdrawn NCT NCT00855114

    Everolimus in Treating Women With Breast Cancer That Can Be Removed by Surgery

    Not yet reported Masonic Cancer Center, University of Minnesota Est. completion 2009-06 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00855439

    Evaluation of Exenatide in Patients With Diabetic Neuropathy

    Not yet reported University of Michigan 46 participants Est. completion 2014-05 1 site Stand-alone
    Type 2 diabetes Other conditions: Diabetic Peripheral Neuropathy
    View official trial listing →
  • Status unknown NCT NCT00856505

    Safety Study of Calcineurin Inhibitor Free GvHD Prophylaxis in Allogeneic Stem Cell Transplantation

    Not yet reported, Not yet reported University Hospital Freiburg 38 participants Est. completion 2011-03 1 site
    Other conditions: Hematologic Diseases
    View official trial listing →
  • Completed NCT NCT00856609

    The Effects of Exenatide (Byetta ) on Energy Expenditure and Weight Loss in Nondiabetic Obese Subjects

    Not yet reported National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 150 participants Est. completion 2016-09-19 1 site
    Other conditions: Weight Loss, Obesity
    View official trial listing →
  • Terminated NCT NCT00857259

    The Efficacy of Oral Everolimus in Patients With Neovascular Age-related Macular Degeneration

    Not yet reported Novartis Pharmaceuticals 16 participants 12 sites
    Other conditions: Choroidal Neo-Vascular Age-onset Macular Degeneration, Age-related Macular Degeneration
    View official trial listing →
  • Completed NCT NCT00857389

    Thiotepa-Clofarabine-Busulfan With Allogeneic Stem Cell Transplant for High Risk Malignancies

    Not yet reported M.D. Anderson Cancer Center 60 participants Est. completion 2019-03-09 1 site Stand-alone
    Other conditions: Stem Cell Transplantation, Leukemia, Lymphoma
    View official trial listing →
  • Completed NCT NCT00859131

    Safety and Efficacy Study of Thymoglobulin Versus IL2 Receptor Antagonists

    Not yet reported Medical University of South Carolina 200 participants Est. completion 2014-07 1 site
    Other conditions: End Stage Renal Disease
    View official trial listing →
  • Completed NCT NCT00859183

    Oral Sirolimus for In-Stent Restenosis

    Not yet reported Deutsches Herzzentrum Muenchen 300 participants Est. completion 2004-03 3 sites
    Other conditions: Coronary Restenosis
    View official trial listing →
  • Completed NCT NCT00860496

    A Phase I Open-Label Study of the Effects of Tacrolimus and Cyclosporine on CP-690,555 in Healthy Volunteers

    Not yet reported Pfizer 24 participants Est. completion 2009-08 1 site
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT00860574

    Treosulfan, Fludarabine Phosphate, and Total-Body Irradiation Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Myelodysplastic Syndrome, Acute Lymphoblastic Leukemia

    Not yet reported Fred Hutchinson Cancer Center 96 participants 3 sites Stand-alone
    Other conditions: Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Blastic Phase Chronic Myelogenous Leukemia, Childhood Acute Lymphoblastic Leukemia in Remission, Childhood Acute Myeloid Leukemia in Remission, Childhood Chronic Myelogenous Leukemia, Childhood Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, de Novo Myelodysplastic Syndromes, Previously Treated Myelodysplastic Syndromes, Recurrent Adult Acute Lymphoblastic Leukemia, Recurrent Adult Acute Myeloid Leukemia, Recurrent Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood Acute Myeloid Leukemia, Secondary Myelodysplastic Syndromes, Untreated Adult Acute Lymphoblastic Leukemia, Untreated Childhood Acute Lymphoblastic Leukemia
    View official trial listing →
  • Completed NCT NCT00861874

    A Study of Decitabine in Combination With Escalating Doses of Rapamycin in Patients With Relapsed or Refractory Acute Myeloid Leukemia

    Not yet reported University of Rochester 13 participants 1 site
    Other conditions: Acute Myeloid Leukemia
    View official trial listing →
  • Completed NCT NCT00862979

    A Study Investigating the Renal Tolerability, Efficacy, and Safety of a CNI-free Versus a Standard Regimen in de Novo Heart Transplant (HTx) Recipients

    Not yet reported Novartis Pharmaceuticals 162 participants Est. completion 2017-03-06 9 sites Stand-alone
    Other conditions: Heart Transplantation
    View official trial listing →
  • Completed NCT NCT00863655

    Everolimus in Combination With Exemestane in the Treatment of Postmenopausal Women With Estrogen Receptor Positive Locally Advanced or Metastatic Breast Cancer Who Are Refractory to Letrozole or Anastrozole

    Not yet reported Novartis Pharmaceuticals 724 participants Est. completion 2014-12-04 200 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00865137

    An Open Study Assessing Bioavailability of a Modified Formulation of Tacrolimus in Kidney Transplant Recipients

    Not yet reported Astellas Pharma Inc 27 participants Est. completion 2007-12 1 site Stand-alone
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Terminated NCT NCT00866684

    Prevention of Skin Cancer in High Risk Patients After Conversion to a Sirolimus-based Immunosuppressive Protocol

    Not yet reported Charite University, Berlin, Germany 44 participants Est. completion 2011-04-19 15 sites Stand-alone
    Other conditions: Skin Cancer
    View official trial listing →
  • Completed NCT NCT00866879

    Randomized Conversion of Calcineurin-Inhibitors in Renal Allograft Recipients

    Not yet reported Northwestern University 275 participants Est. completion 2019-03 1 site Stand-alone
    Other conditions: Renal Transplant Rejection
    View official trial listing →
  • Status unknown NCT NCT00868829

    Firebird2 Cobalt-Chromium Alloyed Sirolimus-Eluting Stent Registry Trial

    Not yet reported Shanghai MicroPort Medical (Group) Co., Ltd. 5000 participants Est. completion 2013-03 1 site
    Other conditions: Coronary Heart Disease
    View official trial listing →
  • Completed NCT NCT00869999

    Everolimus Plus Rituximab for Relapsed/Refractory Diffuse Large B Cell Lymphoma

    Not yet reported Massachusetts General Hospital 26 participants Est. completion 2011-11 2 sites
    Other conditions: Diffuse Large B-cell Lymphoma
    View official trial listing →
  • Completed NCT NCT00870194

    A Comparison of Adding Exenatide With Switching to Exenatide in Patients With Type 2 Diabetes Experiencing Inadequate Glycemic Control With Sitagliptin Plus Metformin

    Not yet reported AstraZeneca 255 participants Est. completion 2010-04 36 sites Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Terminated NCT NCT00870831

    Islet Function and Clinical Analyses of Transplant Recipients

    Washington University School of Medicine 8 participants Est. completion 2010-03
    Other conditions: Type One Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT00873730

    Study Evaluating Etanercept in Subjects With Ankylosing Spondylitis in Spain

    Not yet reported Wyeth is now a wholly owned subsidiary of Pfizer 108 participants Est. completion 2008-06 Stand-alone
    Other conditions: Ankylosing Spondylitis
    View official trial listing →
  • Withdrawn NCT NCT00874315

    Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed or Refractory High-Risk NBL.

    Not yet reported Nationwide Children's Hospital Est. completion 2012-06 4 sites
    Other conditions: Neuroblastoma
    View official trial listing →
  • Completed NCT NCT00874562

    Rapamycin in Relapsed Acute Lymphoblastic Leukemia

    Not yet reported Dana-Farber Cancer Institute 6 participants Est. completion 2016-04 1 site
    Other conditions: Acute Lymphoblastic Leukemia
    View official trial listing →
  • Completed NCT NCT00876616

    Assess the Efficacy and Safety of Multi-target Therapy in Lupus Nephritis

    Not yet reported Zhi-Hong Liu, M.D. 362 participants Est. completion 2012-02 1 site Stand-alone
    Other conditions: Lupus Nephritis
    View official trial listing →
  • Completed NCT NCT00877890

    A Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly in Subjects With Type 2 Diabetes Mellitus (DURATION-5)

    Not yet reported AstraZeneca 254 participants Est. completion 2010-01 41 sites Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00879333

    Safety and Efficacy of RAD001 (Everolimus) Monotherapy Plus Best Supportive Care in Patients With Advanced Gastric Cancer (AGC)

    Not yet reported Novartis Pharmaceuticals 656 participants Est. completion 2014-01 122 sites
    Other conditions: Advanced Gastric Cancer
    View official trial listing →
  • Completed NCT NCT00880282

    Cixutumumab and Temsirolimus in Treating Younger Patients With Solid Tumors That Have Recurred or Not Responded to Treatment

    Not yet reported National Cancer Institute (NCI) 39 participants 23 sites
    Other conditions: Unspecified Childhood Solid Tumor, Protocol Specific
    View official trial listing →
  • Completed NCT NCT00880815

    Fludarabine, Bendamustine, and Rituximab in Treating Participants With Lymphoid Cancers Undergoing Stem Cell Transplant

    Not yet reported M.D. Anderson Cancer Center 60 participants Est. completion 2019-05-28 1 site Stand-alone
    Other conditions: CD20 Positive, Chronic Lymphocytic Leukemia, Follicular Lymphoma, Mantle Cell Lymphoma, Marginal Zone Lymphoma, Recurrent Diffuse Large B-Cell Lymphoma, T-Cell Non-Hodgkin Lymphoma
    View official trial listing →
  • Terminated NCT NCT00881556

    Allogeneic Stem Cell Transplantation (ALLOSCT) in Recessive Dystrophic Epidermolysis Bullosa (RDEB)

    Not yet reported Columbia University 3 participants Est. completion 2015-09 3 sites Stand-alone
    Obstructive sleep apnea
    View official trial listing →
  • Completed NCT NCT00882050

    Intravenous Exenatide (Byetta) During Surgery

    Not yet reported, Not yet reported Thomas Jefferson University 104 participants Est. completion 2016-04 1 site Stand-alone
    Other conditions: Euglycemia, Hypoglycemia, Hyperglycemia
    View official trial listing →
  • Active, not recruiting NCT NCT00882895

    Tandem Stem Cell Transplantation for Non-Hodgkin's Lymphoma

    Not yet reported Washington University School of Medicine 18 participants Est. completion 2028-06-01 1 site Stand-alone
    Other conditions: Lymphoma, Non-Hodgkin
    View official trial listing →
  • Completed NCT NCT00885820

    Benefit of Early Protocol Biopsy and Treatment of Subclinical Rejection

    Not yet reported Astellas Pharma Inc 240 participants Est. completion 2006-01 12 sites Stand-alone
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT00886626

    GLP-1 Therapy for Weight Loss and Improved Glucose Tolerance in Obese Children

    Not yet reported University of Minnesota 12 participants Est. completion 2011-02 1 site Stand-alone
    Other conditions: Obesity, Morbid
    View official trial listing →
  • Terminated NCT NCT00887640

    Impact of Temsirolimus Therapy on Circulating Tumor Cell Biology In Men With Castration Resistant Metastatic Prostate Cancer

    Not yet reported Duke University 11 participants Est. completion 2012-08 2 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Status unknown NCT NCT00890253

    Safety Study of Calcineurin-Inhibitor-Free Immunosuppression After Liver Transplantation

    Not yet reported Armin Goralczyk 29 participants Est. completion 2013-01 1 site Stand-alone
    Other conditions: Liver Transplantation, Chronic Renal Insufficiency
    View official trial listing →
  • Completed NCT NCT00890500

    Safety and Efficacy of ProHema Modulated Umbilical Cord Blood Units in Subjects With Hematologic Malignancies.

    Not yet reported Fate Therapeutics 12 participants Est. completion 2013-10 2 sites
    Other conditions: Hematologic Malignancies, Allogeneic Stem Cell Transplantation
    View official trial listing →
  • Completed NCT NCT00891696

    Nutritional and Contractile Regulation of Muscle Growth

    Not yet reported The University of Texas Medical Branch, Galveston 144 participants Est. completion 2015-03 1 site
    Other conditions: Sarcopenia
    View official trial listing →
  • Completed NCT NCT00894322

    A Study to Examine the Pharmacokinetics, Tolerability, Safety and Efficacy of Exenatide Once Weekly Suspension

    Not yet reported, Not yet reported AstraZeneca 65 participants Est. completion 2009-08 1 site Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00895583

    Study Evaluating A Planned Transition From Tacrolimus To Sirolimus In Kidney Transplant Recipients

    Not yet reported Pfizer 254 participants Est. completion 2013-08 44 sites Stand-alone
    Other conditions: Graft Rejection, Kidney Transplant, Renal Allograft Recipients, Renal Transplant
    View official trial listing →
  • Completed NCT NCT00896012

    Kidney Biopsy Controlled Trial of Calcineurin Inhibitor Withdrawal

    Not yet reported University at Buffalo 58 participants Est. completion 2011-12 1 site Stand-alone
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT00899847

    Phase 2 Study of Autologous Followed by Nonmyeloablative Allogeneic Transplantation Using TLI & ATG

    Not yet reported Stanford University 9 participants Est. completion 2014-12 1 site Stand-alone
    Other conditions: Transplantation, Homologous, Transplantation, Autologous, Multiple Myeloma, Blood and Marrow Transplant (BMT)
    View official trial listing →
  • Completed NCT NCT00901849

    Tarceva/Rapamycin for Children With Low-grade Gliomas With or Without Neurofibromatosis Type 1 (NF1)

    Not yet reported Roger Packer 21 participants Est. completion 2012-10 1 site
    Other conditions: Low-grade Gliomas
    View official trial listing →
  • Completed NCT NCT00902980

    Study of Immunosuppressive Therapy Toxicities in Kidney Transplant Recipients at Regional or Satellite Community Clinics

    Astellas Pharma Inc 264 participants Est. completion 2006-12 13 sites
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT00903175

    Efficacy and Safety Comparison of RAD001 Versus Sunitinib in the First-line and Second-line Treatment of Patients With Metastatic Renal Cell Carcinoma

    Not yet reported Novartis Pharmaceuticals 471 participants Est. completion 2015-05 84 sites
    Other conditions: Renal Cell Carcinoma
    View official trial listing →
  • Status unknown NCT NCT00903188

    Calcineurin Inhibitor (CNI) Versus Steroid Cessation in Renal Transplantation

    Not yet reported University Hospital, Antwerp 152 participants Est. completion 2015-04 5 sites
    Other conditions: Renal Transplantation
    View official trial listing →
  • Completed NCT NCT00905515

    Optima: Optimizing Prograf Therapy in Maintenance Allografts II

    Not yet reported East Carolina University 63 participants Est. completion 2008-07 1 site
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT00909571

    Pharmacokinetics of Tacrolimus in Liver Transplantation Patients Treated With Prograf and Modified Release Tacrolimus

    Not yet reported Astellas Pharma Inc 10 participants Est. completion 2010-03 1 site Stand-alone
    Other conditions: Liver Transplantation
    View official trial listing →
  • Terminated NCT NCT00910273

    Effects of Etanercept on the Heart, Veins and Thickness of Certain Major Arteries In Ankylosing Spondylitis Patients

    Not yet reported Pfizer 34 participants Est. completion 2011-10 4 sites Stand-alone
    Other conditions: Ankylosing Spondylitis
    View official trial listing →
  • Completed NCT NCT00912223

    Blood Stem Cell Transplant With Low Dose Chemotherapy for Relapsed Follicular Non-Hodgkin's Lymphoma (BMT CTN 0701)

    Not yet reported Medical College of Wisconsin 65 participants Est. completion 2016-08 21 sites Stand-alone
    Other conditions: Lymphoma, Non-Hodgkin
    View official trial listing →
  • Completed NCT NCT00912340

    Phase II Trial of EVEROLIMUS ± Trastuzumab in Hormone-Refractory Metastatic Breast Cancer

    Not yet reported Emory University 70 participants Est. completion 2017-07 4 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT00912678

    Minimizing Immunosuppression in Old for Old Kidney Transplantation

    Not yet reported University of Luebeck 90 participants Est. completion 2008-10 5 sites
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT00913458

    Study Evaluating Etanercept Plus Methotrexate in Early Rheumatoid Arthritis

    Not yet reported Pfizer 306 participants Est. completion 2012-12 59 sites Stand-alone
    Other conditions: Active Rheumatoid Arthritis, Arthritis, Rheumatoid, Rheumatoid Arthritis
    View official trial listing →
  • Terminated NCT NCT00914940

    Selective Depletion of CD45RA+T Cells From Allogeneic Peripheral Blood Stem Cell Grafts for the Prevention of GVHD

    Not yet reported Fred Hutchinson Cancer Center 41 participants Est. completion 2020-05-26 2 sites Stand-alone
    Other conditions: Graft Versus Host Disease, Leukemia, Myelodysplastic Syndromes
    View official trial listing →
  • Terminated NCT NCT00917163

    SERIES III RUN-IN Clinical Trial: A Comparison of the Supralimus® Stent With the Xience V™ Stent

    Not yet reported Sahajanand Medical Technologies Limited 13 participants Est. completion 2010-05 28 sites Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT00917267

    A Study to Examine the Effects of Exenatide Once-Weekly Injection on Glucose Control and Safety in Asian Subjects

    Not yet reported AstraZeneca 691 participants Est. completion 2011-04 42 sites Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00919035

    Single Agent Temsirolimus (Torisel®) in Chemotherapy-naïve Castration-Resistant Prostate Cancer Patients

    Not yet reported Oncology Specialists, S.C. 21 participants Est. completion 2013-10 2 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT00919503

    Treosulfan and Fludarabine Phosphate Before Donor Stem Cell Transplant in Treating Patients With Nonmalignant Inherited Disorders

    Not yet reported Fred Hutchinson Cancer Center 98 participants Est. completion 2020-06-10 6 sites Stand-alone
    Other conditions: Non-Neoplastic Hematologic and Lymphocytic Disorder
    View official trial listing →
  • Status unknown NCT NCT00920478

    Targeting Synovitis in Early Rheumatoid Arthritis

    Not yet reported NHS Greater Glasgow and Clyde 110 participants Est. completion 2012-09 3 sites
    Other conditions: Rheumatoid Arthritis, Polyarthritis
    View official trial listing →
  • Terminated NCT NCT00921310

    Temsirolimus and Pemetrexed for Recurrent or Refractory Non-Small Cell Lung Cancer

    Not yet reported, Not yet reported Washington University School of Medicine 12 participants Est. completion 2016-04 1 site
    Other conditions: Carcinoma, Non-Small-Cell Lung
    View official trial listing →
  • Withdrawn NCT NCT00922129

    Effectiveness of Conversion to Sirolimus Versus Calcineurin Inhibitor (CNI) Reduction in Renal Transplant Patients With Prostate Cancer

    Not yet reported, Not yet reported St. Joseph's Healthcare Hamilton Est. completion 2011-01 1 site Stand-alone
    Other conditions: Prostate Cancer
    View official trial listing →
  • Terminated NCT NCT00923273

    Sirolimus and Pemetrexed to Treat Non-Small Cell Lung Cancer

    Not yet reported, Not yet reported National Cancer Institute (NCI) 42 participants Est. completion 2013-03-10 1 site Stand-alone
    Other conditions: Carcinoma, Non-Small-Cell Lung
    View official trial listing →
  • Completed NCT NCT00923845

    Low-Intensity Stem Cell Transplantation With Multiple Lymphocyte Infusions to Treat Advanced Kidney Cancer

    Not yet reported National Cancer Institute (NCI) 25 participants Est. completion 2017-06-22 1 site
    Other conditions: Renal Cell Carcinoma, Graft-Versus-Host Disease, Engraftment Syndrome
    View official trial listing →
  • Terminated NCT NCT00926107

    Study of the mTOR Inhibitor Temsirolimus (CCI-779) to Treat Ovarian Cancer With CA125 Only Relapse

    Not yet reported Hellenic Cooperative Oncology Group 9 participants Est. completion 2011-10 12 sites
    Other conditions: Ovarian Cancer
    View official trial listing →
  • Completed NCT NCT00928018

    Tacrolimus/Sirolimus/Methotrexate vs Tacrolimus/Methotrexate or Cyclosporine/Mycophenolate Mofetil for GVHD Prophylaxis After Reduced Intensity Allogeneic Stem Cell Transplantation for Patients With Lymphoma

    Not yet reported Dana-Farber Cancer Institute 139 participants Est. completion 2014-11 5 sites
    Other conditions: Non-hodgkin Lymphoma, Hodgkin Lymphoma
    View official trial listing →
  • Terminated NCT NCT00928811

    Study to Evaluate the Safety of Chronic Administration of Simulect to Subjects Receiving a First Kidney Transplant

    Not yet reported, Not yet reported Drexel University College of Medicine 5 participants Est. completion 2010-04 1 site Stand-alone
    Other conditions: End Stage Renal Disease
    View official trial listing →
  • Terminated NCT NCT00930241

    Twice Daily Versus Once Daily Administration of the Tacrolimus in Lung Transplantation

    Not yet reported Hannover Medical School 25 participants Est. completion 2012-07 3 sites Stand-alone
    Other conditions: Lung Transplantation
    View official trial listing →
  • Status unknown NCT NCT00930475

    Everolimus (RAD001) and Carboplatin in Pretreated Metastatic Breast Cancer

    Not yet reported, Not yet reported Charite University, Berlin, Germany 54 participants 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Terminated NCT NCT00931255

    Tacrolimus to Sirolimus Conversion for Delayed Graft Function

    Not yet reported University of Maryland, Baltimore 32 participants Est. completion 2014-07 1 site
    Other conditions: Kidney Transplant, Delayed Graft Function
    View official trial listing →
  • Status unknown NCT NCT00931957

    Etanercept: Single Blind Control Study in Ocular Manifestations of Behcet's Disease

    Not yet reported Tehran University of Medical Sciences 80 participants Est. completion 2013-10 1 site
    Other conditions: Behcet Syndrome, Uveal Disease
    View official trial listing →
  • Completed NCT NCT00933231

    Comparison of Standard Versus Low Dose Advagraf® With or Without Angiotensin-converting Enzyme Inhibitor (ACEi)/Angiotensin Receptor Blocker (ARB) on Histology and Function of Renal Allografts

    Not yet reported Astellas Pharma Inc 281 participants Est. completion 2018-04-03 13 sites Stand-alone
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Terminated NCT NCT00934791

    Polycystic Liver Disease in Kidney Transplant

    Not yet reported Mayo Clinic 2 participants Est. completion 2012-12 1 site
    Other conditions: Polycystic Liver Disease
    View official trial listing →
  • Completed NCT NCT00935298

    Initial Dosage Range of Tacrolimus by Genotyping in Chinese Renal Transplantation

    Not yet reported The Second Artillery General Hospital 145 participants Est. completion 2011-06 5 sites Stand-alone
    Other conditions: Renal Transplantation
    View official trial listing →
  • Completed NCT NCT00935792

    Everolimus and Alemtuzumab in Treating Patients With Recurrent Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

    Not yet reported, Not yet reported Mayo Clinic 28 participants Est. completion 2015-12 2 sites
    Other conditions: Lymphocytic Leukemia
    View official trial listing →
  • Completed NCT NCT00935961

    RAD001 (Everolimus) + Docetaxel + Cisplatin as Induction Chemotherapy in Patients With Local-Regional Advanced Head and Neck Cancer

    Not yet reported Memorial Sloan Kettering Cancer Center 18 participants Est. completion 2013-08 5 sites
    Other conditions: HEAD & NECK Cancer
    View official trial listing →
  • Completed NCT NCT00936065

    Study Evaluating the Efficacy and Safety of Etanercept and Acitretin in Korean Patient With Moderate to Severe Psoriasis

    Not yet reported Pfizer 60 participants Est. completion 2011-04 10 sites Stand-alone
    Other conditions: Moderate to Severe Psoriasis
    View official trial listing →
  • Completed NCT NCT00936702

    Carboplatin, Paclitaxel, and Everolimus in Treating Patients With Previously Untreated Cancer of Unknown Primary

    Not yet reported Alliance for Clinical Trials in Oncology 46 participants Est. completion 2013-08 141 sites
    Other conditions: Carcinoma of Unknown Primary Origin
    View official trial listing →
  • Completed NCT NCT00936858

    RAD001 for Patients With Radioiodine Refractory Thyroid Cancer

    Not yet reported Dana-Farber Cancer Institute 50 participants Est. completion 2020-02-27 4 sites
    Other conditions: Thyroid Cancer
    View official trial listing →
  • Terminated NCT NCT00938119

    Care China-Diabetes

    Johnson & Johnson Medical, China 1603 participants Est. completion 2012-12 46 sites
    Cardiovascular disease Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT00938860

    Sustained Virological Response (SVR) to Antiviral Treatment of Liver Transplant Recipients With Recurrent Hepatitis C

    Not yet reported Novartis Pharmaceuticals 92 participants Est. completion 2013-05 45 sites
    Other conditions: Hepatitis C, Liver Transplantation
    View official trial listing →
  • Completed NCT NCT00940381

    Sirolimus and Cetuximab in Advanced Malignancies

    Not yet reported M.D. Anderson Cancer Center 165 participants Est. completion 2014-05 1 site Stand-alone
    Other conditions: Advanced Cancer
    View official trial listing →
  • Completed NCT NCT00941824

    Pharmacokinetic Evaluation of an Intensified and Decreasing Dosing Regimen of Mycophenolate Sodium in Combination With Tacrolimus Post Kidney Transplant: The Myfortic Study

    Not yet reported Centre Hospitalier Universitaire de Saint Etienne 15 participants Est. completion 2010-03 1 site
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT00942682

    Sorafenib in Combination With RAD001 in Patients With Advanced Neuroendocrine Tumors

    Not yet reported Dana-Farber Cancer Institute 21 participants Est. completion 2013-03 1 site
    Other conditions: Neuroendocrine Tumor, Carcinoid Tumor, Pancreatic Neuroendocrine Tumor
    View official trial listing →
  • Completed NCT NCT00942734

    Trial of RAD001 and Erlotinib With Recurrent Head and Neck Squamous Cell Carcinoma

    Not yet reported M.D. Anderson Cancer Center 49 participants Est. completion 2014-11 1 site
    Other conditions: Head And Neck Cancer
    View official trial listing →
  • Status unknown NCT NCT00942747

    Temsirolimus in Recurrent Primary Central Nervous System (CNS) Lymphoma

    Not yet reported Charite University, Berlin, Germany 37 participants Est. completion 2014-06 6 sites
    Other conditions: Recurrent or Refractory Primary CNS Lymphoma
    View official trial listing →
  • Completed NCT NCT00943917

    Study of ITCA 650 (Exenatide in DUROS) in Subjects With Type 2 Diabetes Mellitus

    Not yet reported Intarcia Therapeutics 155 participants Est. completion 2011-02 50 sites Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Terminated NCT NCT00946023

    Optimized Donor Selection, Nonmyeloablative BMT for B-cell Lymphomas With Post-transplantation Cy and Rituximab

    Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 135 participants Est. completion 2013-07-17 1 site Stand-alone
    Other conditions: Lymphoma, B-cell Lymphoma, Non Hodgkin Lymphoma, Chronic Lymphocytic Leukemia
    View official trial listing →
  • Completed NCT NCT00947635

    Cholesterol and Fatty Acid Synthesis in Islet and Liver Transplant Patients and Effect of Dietary Intervention

    Not yet reported, Not yet reported University of Alberta 46 participants Est. completion 2009-06 1 site
    Other conditions: Immunosuppression, Hyperlipidemias, Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT00948168

    Effect of Exenatide on Glucose Homeostasis Determinants in Type 2 Diabetes

    Not yet reported Cliniques universitaires Saint-Luc- Université Catholique de Louvain 34 participants Est. completion 2009-07 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00948753

    Maraviroc in Patients Undergoing Non-Myeloablative Allogeneic Stem-Cell Transplantation

    Not yet reported, Not yet reported Abramson Cancer Center at Penn Medicine 38 participants Est. completion 2011-04 Stand-alone
    Other conditions: Graft-versus-host Disease, Hematopoietic Stem Cell Transplantation
    View official trial listing →
  • Completed NCT NCT00949325

    Safety and Efficacy Study of Torisel and Liposomal Doxorubicin for Patients With Recurrent Sarcoma

    Not yet reported, Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 24 participants Est. completion 2012-09 1 site
    Other conditions: Sarcoma
    View official trial listing →
  • Completed NCT NCT00949949

    Everolimus, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Unresectable Solid Tumors Refractory to Standard Therapy

    Not yet reported Mayo Clinic 38 participants Est. completion 2014-07 3 sites
    Other conditions: Cholangiocarcinoma of the Gallbladder, Localized Gallbladder Cancer, Unresectable Gallbladder Cancer, Unspecified Adult Solid Tumor, Protocol Specific
    View official trial listing →
  • Withdrawn NCT NCT00950391

    Enhancement of Functional Recovery After Peripheral Nerve Injury With Tacrolimus

    Not yet reported, Not yet reported Washington University School of Medicine Est. completion 2015-09 Stand-alone
    Other conditions: Peripheral Nerve Injury
    View official trial listing →
  • Completed NCT NCT00950677

    The Effect of Byetta and Symlin on Post-meal Meal Blood Sugar Levels in Children With Type 2 Diabetes

    Not yet reported Baylor College of Medicine 16 participants Est. completion 2011-05 1 site
    Type 2 diabetes
    View official trial listing →
  • Terminated NCT NCT00954512

    Study of Robatumumab (SCH 717454, MK-7454) in Combination With Different Treatment Regimens in Participants With Advanced Solid Tumors (P04722, MK-7454-004)

    Not yet reported, Not yet reported Merck Sharp & Dohme LLC 15 participants Est. completion 2011-06-07
    Other conditions: Neoplasms
    View official trial listing →
  • Completed NCT NCT00955773

    A Study of the GSK MEK Inhibitor GSK1120212 and Everolimus in Cancer Subjects

    Not yet reported GlaxoSmithKline 64 participants Est. completion 2011-11-08 3 sites
    Other conditions: Cancer
    View official trial listing →
  • Status unknown NCT NCT00956059

    Therapeutic Effect of Low-dose Prednisone Combined With MMF and FK506 in Focal Segmental Glomerulosclerosis

    Not yet reported Xi'an Jiaotong University 40 participants Est. completion 2012-12 1 site
    Other conditions: Focal Segmental Glomerulosclerosis
    View official trial listing →
  • Terminated NCT NCT00956293

    Study to Evaluate the Efficacy, Safety and Tolerability of Everolimus in de Novo Renal Transplant Recipients Participating in the Eurotransplant Senior Program

    Not yet reported Novartis Pharmaceuticals 207 participants Est. completion 2013-03 9 sites Stand-alone
    Other conditions: Renal Transplantation
    View official trial listing →
  • Completed NCT NCT00960648

    Registry to Evaluate Efficacy of Xience/Promus Versus Cypher in Reducing Late Loss After Stenting

    Seoul National University Hospital 3056 participants Est. completion 2014-01 18 sites
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT00960661

    A Trial Comparing Two Therapies: Basal Insulin/Glargine, Exenatide and Metformin Therapy (BET) or Basal Insulin/Glargine, Bolus Insulin Lispro and Metformin Therapy (BBT) in Subjects With Type 2 Diabetes

    Not yet reported AstraZeneca 1036 participants Est. completion 2012-08 95 sites Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00964262

    A Study to Evaluate Safety and Pharmacokinetics/Pharmacodynamics of Sustained Release(SR) Exenatide

    Not yet reported Peptron, Inc. 34 participants Est. completion 2010-10 1 site Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT00965094

    Efficacy and Safety of Everolimus+EC-MPS After Early CNI Elimination vs EC-MPS +Tacrolimus in Renal Transplant Recipients

    Not yet reported Novartis Pharmaceuticals 36 participants Est. completion 2013-06 3 sites Stand-alone
    Other conditions: Chronic Renal Failure
    View official trial listing →
  • Completed NCT NCT00965666

    Pilot Study of Etanercept (Enbrel) in Children With Fanconi Anemia

    Not yet reported Children's Hospital Medical Center, Cincinnati 3 participants Est. completion 2010-10 1 site Stand-alone
    Other conditions: Fanconi Anemia
    View official trial listing →
  • Status unknown NCT NCT00966836

    Prevention of Transplant Atherosclerosis With Everolimus and Anti-cytomegalovirus Therapy

    Not yet reported University of Bologna 100 participants 1 site
    Other conditions: Heart Transplantation, Cardiac Allograft Vasculopathy, Cytomegalovirus Infection
    View official trial listing →
  • Completed NCT NCT00967044

    Panobinostat (LBH589) Plus Everolimus (RAD001) in Patients With Relapsed and Refractory Lymphoma

    Not yet reported, Not yet reported M.D. Anderson Cancer Center 31 participants Est. completion 2014-03 1 site
    Other conditions: Lymphoma
    View official trial listing →
  • Completed NCT NCT00967902

    Safety and Effectiveness Study of Combo Bio-engineered Sirolimus Eluting Stent

    Not yet reported OrbusNeich 180 participants Est. completion 2015-09 1 site Stand-alone
    Other conditions: Coronary Artery Lesions
    View official trial listing →
  • Withdrawn NCT NCT00967928

    Everolimus Dose Finding Study for Stage IV or Recurrent Cervical Cancer

    Not yet reported Accelerated Community Oncology Research Network Est. completion 2010-12
    Other conditions: Cervical Cancer
    View official trial listing →
  • Completed NCT NCT00968253

    RAD001 Study in Treatment of Relapsed or Refractory Acute Lymphocytic Leukemia

    Not yet reported, Not yet reported M.D. Anderson Cancer Center 24 participants Est. completion 2015-12 1 site
    Other conditions: Leukemia, Acute Lymphocytic Leukemia
    View official trial listing →
  • Completed NCT NCT00968591

    Pharmacokinetics of Everolimus in Subjects With Hepatic Insufficiency

    Not yet reported Novartis Pharmaceuticals 34 participants 3 sites
    Other conditions: Hepatic Insufficiency
    View official trial listing →
  • Completed NCT NCT00970073

    Low Dose Thymoglobulin to Protect Kidney Function After Liver Transplant

    Not yet reported The Cleveland Clinic 30 participants Est. completion 2015-12 1 site Stand-alone
    Other conditions: Liver Transplantation
    View official trial listing →
  • Completed NCT NCT00971789

    Sirolimus to Treat Cowden Syndrome and Other PTEN Hamartomatous Tumor Syndromes

    Not yet reported National Cancer Institute (NCI) 18 participants Est. completion 2012-10 1 site Stand-alone
    Other conditions: Cowden's Disease, Hamartoma Syndrome, Multiple
    View official trial listing →
  • Withdrawn NCT NCT00972101

    Infusion of Expanded Cord Blood T Cells

    Not yet reported M.D. Anderson Cancer Center Est. completion 2011-09 Stand-alone
    Other conditions: Stem Cell Transplantation, Leukemia, Lymphoma, Pediatric Disorders
    View official trial listing →
  • Terminated NCT NCT00972335

    Trial of the Combination of Bevacizumab and Everolimus in Patients With Refractory, Progressive Intracranial Meningioma

    Not yet reported SCRI Development Innovations, LLC 18 participants Est. completion 2014-07 7 sites
    Other conditions: Intracranial Meningioma
    View official trial listing →
  • Status unknown NCT NCT00972660

    Safety and Efficacy Study of Allogenic Mesenchymal Stem Cells to Treat Extensive Chronic Graft Versus Host Disease

    Not yet reported Guangdong Provincial People's Hospital 52 participants Est. completion 2017-12 1 site Stand-alone
    Other conditions: Graft Versus Host Disease
    View official trial listing →
  • Completed NCT NCT00973076

    Study to Assess the Safety and Tolerability of the Tor Kinase Inhibitor AZD8055

    Not yet reported AstraZeneca 19 participants Est. completion 2010-12 1 site
    Other conditions: Cancer, Solid Tumors, Advanced Solid Malignancies
    View official trial listing →
  • Status unknown NCT NCT00973713

    Study of RAD001 in Advanced Cholangiocarcinoma: RADiChol

    Not yet reported Austin Health 27 participants Est. completion 2012-03 1 site
    Other conditions: Cholangiocarcinoma
    View official trial listing →
  • Terminated NCT NCT00973804

    Pilot Trial of Targeted Immune-Depleting Chemotherapy and Reduced-Intensity Matched Unrelated Double Cord Blood Transplant for the Treatment of Leukemias, Lymphomas, and Pre-Malignant Blood Disorders

    Not yet reported National Cancer Institute (NCI) 4 participants Est. completion 2013-05-20 1 site
    Other conditions: Leukemia, Non-Hodgkins Lymphoma, Hodgkins Lymphoma, MDS, Multiple Myeloma
    View official trial listing →
  • Terminated NCT NCT00975663

    Bayesian Dose Adjustment of Immunosuppressants After Lung Transplantation

    Not yet reported University Hospital, Limoges 180 participants Est. completion 2011-02 9 sites Stand-alone
    Other conditions: Lung and Heart-lung Transplantation
    View official trial listing →
  • Completed NCT NCT00976248

    Everolimus (RAD001) in Primary Therapy of Waldenstrom's Macroglobulinemia

    Not yet reported Dana-Farber Cancer Institute 33 participants Est. completion 2018-07 1 site
    Other conditions: Waldenstrom's Macroglobulinemia
    View official trial listing →
  • Completed NCT NCT00976755

    Everolimus as First-Line Therapy in Treating Patients With Prostate Cancer

    Not yet reported Swiss Cancer Institute 37 participants Est. completion 2019-08-08 13 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT00977574

    Paclitaxel, Carboplatin, and Bevacizumab or Paclitaxel, Carboplatin, and Temsirolimus or Ixabepilone, Carboplatin, and Bevacizumab in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer

    Not yet reported National Cancer Institute (NCI) 349 participants Est. completion 2027-03-06 230 sites
    Obstructive sleep apnea Other conditions: Endometrial Adenocarcinoma, Endometrial Adenosquamous Carcinoma, Endometrial Clear Cell Adenocarcinoma, Endometrial Serous Adenocarcinoma, Recurrent Malignant Uterine Corpus Neoplasm
    View official trial listing →
  • Active, not recruiting NCT NCT00977691

    Haploidentical PBMC Transplant for Severe Congenital Anemias

    Not yet reported, Not yet reported National Heart, Lung, and Blood Institute (NHLBI) 23 participants Est. completion 2026-09-10 1 site Stand-alone
    Other conditions: Sickle Cell Anemia
    View official trial listing →
  • Completed NCT NCT00977938

    The Dual Antiplatelet Therapy Study (DAPT Study)

    Not yet reported Baim Institute for Clinical Research 25682 participants Est. completion 2014-06 256 sites
    Cardiovascular disease
    View official trial listing →
  • Terminated NCT NCT00978432

    Epigenetic Modulation in Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)

    Not yet reported Anne Beaven, MD 50 participants Est. completion 2016-03 1 site
    Other conditions: Diffuse Large B-cell Lymphoma
    View official trial listing →
  • Completed NCT NCT00980460

    Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer

    Not yet reported National Cancer Institute (NCI) 236 participants Est. completion 2026-03-31 209 sites
    Other conditions: PRETEXT I Hepatoblastoma, PRETEXT II Hepatoblastoma, PRETEXT III Hepatoblastoma, PRETEXT IV Hepatoblastoma
    View official trial listing →
  • Completed NCT NCT00982072

    Tacrolimus Versus Prednisolone for the Treatment of Minimal Change Disease

    Not yet reported Imperial College Healthcare NHS Trust 52 participants Est. completion 2019-10-10 1 site Stand-alone
    Other conditions: Minimal Change Disease
    View official trial listing →
  • Status unknown NCT NCT00982631

    A Study of Combination of Temsirolimus (Torisel®) and Pegylated Liposomal Doxorubicin (PLD, Doxil®/Caelyx®) in Advanced or Recurrent Breast, Endometrial and Ovarian Cancer

    Not yet reported Radboud University Medical Center 30 participants Est. completion 2012-08 1 site
    Other conditions: Advanced/Recurrent Breast Cancer, Endometrial Cancer, Ovarian Cancer
    View official trial listing →
  • Terminated NCT NCT00983645

    A Trial Comparing Prograf and Neoral Use in Kidney Transplant Recipients of Hispanic Ethnicity

    Not yet reported Loma Linda University 15 participants Est. completion 2013-03 1 site
    Other conditions: Renal Transplant Rejection
    View official trial listing →
  • Completed NCT NCT00985192

    Everolimus in Treating Patients With Previously Treated Unresectable or Metastatic Esophageal Cancer or Stomach Cancer

    Not yet reported Translational Oncology Research International 49 participants Est. completion 2014-05 18 sites
    Other conditions: Esophageal Cancer, Gastric Cancer
    View official trial listing →
  • Status unknown NCT NCT00987103

    Pharmacokinetic Study to Rectal and Sublingual Administration of Tacrolimus in Future Kidney Transplant Patients

    Not yet reported Maastricht University Medical Center 18 participants Est. completion 2011-09 1 site Stand-alone
    Other conditions: Organ Transplantation
    View official trial listing →
  • Completed NCT NCT00992394

    Study Comparing 2 Different Strategies For Management of Subjects With Plaque Psoriasis Who Have Responded to Etanercept

    Not yet reported Pfizer 174 participants Est. completion 2013-04 46 sites
    Other conditions: Psoriasis
    View official trial listing →
  • Completed NCT NCT00993343

    Randomized Trial Comparing Sirolimus and Tacrolimus Versus Cyclosporine and Methotrexate as Graft-versus-host Disease (GVHD) Prophylaxis After Allogeneic Stem Cell Transplantation

    Not yet reported Karolinska Institutet 215 participants Est. completion 2015-04 1 site
    Other conditions: Graft-versus-host Disease, Survival
    View official trial listing →
  • Withdrawn NCT NCT00995059

    Bortezomib Before Donor Stem Cell Transplant in Treating Patients With Multiple Myeloma

    Not yet reported, Not yet reported Mayo Clinic Stand-alone
    Other conditions: Multiple Myeloma, Refractory Multiple Myeloma
    View official trial listing →
  • Terminated NCT NCT00996346

    Phase I/II Study of Irinotecan and Temsirolimus in Patients With Refractory Sarcomas

    Not yet reported New Mexico Cancer Research Alliance 17 participants Est. completion 2013-11 1 site
    Other conditions: Sarcoma
    View official trial listing →
  • Completed NCT NCT00997763

    Comparison of Everolimus-Eluting Stent vs Sirolimus-Eluting Stent in Patients With DIABETES Mellitus

    Not yet reported Seung-Jung Park 300 participants Est. completion 2015-08 18 sites
    Cardiovascular disease
    View official trial listing →
  • Status unknown NCT NCT00999258

    Impact of Conversion From Tacrolimus to Sirolimus in African American Renal Transplant Recipients

    Not yet reported Temple University 50 participants Est. completion 2011-06 1 site
    Other conditions: Glomerular Filtration Rate, Chronic Allograft Nephropathy
    View official trial listing →
  • Completed NCT NCT00999362

    Is T-lymphocyte Calcineurin Phosphatase Up-regulated by Treatment With Tacrolimus?

    University of Aarhus 40 participants Est. completion 2009-10 1 site
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT00999882

    Safety, Tolerability, Pharmacokinetics (PK) and Preliminary Efficacy of Tor Kinase Inhibitor in Liver Cancer Patients

    Not yet reported AstraZeneca 26 participants Est. completion 2011-12 3 sites
    Other conditions: Cancer, Advanced Hepatocellular Carcinoma
    View official trial listing →
  • Terminated NCT NCT01002339

    Optimum Immunosuppression in Renal Transplant Recipients.New Onset Diabetes After Transplantation

    Not yet reported Armando Torres Ramírez 134 participants Est. completion 2015-06 10 sites Stand-alone
    Other conditions: Diabetes Mellitus, Adult-Onset
    View official trial listing →
  • Completed NCT NCT01003184

    Efficacy of Once-Weekly Exenatide Versus Once or Twice Daily Insulin Detemir in Patients With Type 2 Diabetes

    Not yet reported AstraZeneca 222 participants Est. completion 2011-12 34 sites Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01004432

    Golimumab in Rheumatoid Arthritis Participants With an Inadequate Response to Etanercept (ENBREL) or Adalimumab (HUMIRA)

    Not yet reported Janssen Biotech, Inc. 433 participants Est. completion 2013-10 117 sites
    Other conditions: Arthritis, Arthritis, Rheumatoid, Autoimmune Diseases
    View official trial listing →
  • Completed NCT NCT01005199

    Sorafenib Tosylate With or Without Everolimus in Treating Patients With Localized, Unresectable, or Metastatic Liver Cancer

    Not yet reported Swiss Cancer Institute 106 participants Est. completion 2016-03 15 sites
    Other conditions: Liver Cancer
    View official trial listing →
  • Terminated NCT NCT01005316

    Alloantibodies in Pediatric Heart Transplantation

    National Institute of Allergy and Infectious Diseases (NIAID) 290 participants Est. completion 2014-12 8 sites
    Other conditions: Pediatric Heart Transplantation, Pediatric Heart Transplant Recipients
    View official trial listing →
  • Completed NCT NCT01005706

    Sirolimus Conversions in African-American Renal Transplant Recipients

    Not yet reported Medical University of South Carolina 40 participants Est. completion 2014-07 1 site
    Other conditions: Absence; Kidney
    View official trial listing →
  • Completed NCT NCT01006889

    Adding Exenatide to Insulin Therapy for Patients With Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease

    Not yet reported University of Florida 24 participants Est. completion 2010-02 1 site Stand-alone
    MASLDType 2 diabetes
    View official trial listing →
  • Completed NCT NCT01007942

    Daily Everolimus in Combination With Trastuzumab and Vinorelbine in HER2/Neu Positive Women With Locally Advanced or Metastatic Breast Cancer

    Not yet reported Novartis Pharmaceuticals 569 participants Est. completion 2015-06 161 sites
    Other conditions: HER2/Neu Over-expressing Locally Advanced Breast Cancer, Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT01008462

    Autologous Peripheral Blood Stem Cell Transplant Followed by Donor Bone Marrow Transplant in Treating Patients With High-Risk Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Multiple Myeloma, or Chronic Lymphocytic Leukemia

    Not yet reported Fred Hutchinson Cancer Center 16 participants Est. completion 2018-06-30 2 sites Stand-alone
    Other conditions: B-Cell Prolymphocytic Leukemia, Hypodiploidy, Loss of Chromosome 17p, Plasma Cell Leukemia, Progression of Multiple Myeloma or Plasma Cell Leukemia, Recurrent Adult Hodgkin Lymphoma, Recurrent Adult Non-Hodgkin Lymphoma, Recurrent Childhood Hodgkin Lymphoma, Recurrent Childhood Non-Hodgkin Lymphoma, Recurrent Chronic Lymphocytic Leukemia, Recurrent Plasma Cell Myeloma, Recurrent Small Lymphocytic Lymphoma, Refractory Childhood Hodgkin Lymphoma, Refractory Chronic Lymphocytic Leukemia, Refractory Non-Hodgkin Lymphoma, Refractory Plasma Cell Myeloma, Refractory Small Lymphocytic Lymphoma, t(14;16), t(4;14), T-Cell Prolymphocytic Leukemia, Waldenstrom Macroglobulinemia
    View official trial listing →
  • Completed NCT NCT01008917

    Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma

    Not yet reported University of California, San Francisco 25 participants Est. completion 2013-06-27 2 sites
    Other conditions: Hepatocellular Carcinoma
    View official trial listing →
  • Terminated NCT NCT01009203

    Temsirolimus (Torisel®) and Erlotinib (Tarceva®) in Platinum-Refractory/Ineligible, Advanced, Squamous Cell Carcinoma

    Not yet reported New Mexico Cancer Research Alliance 13 participants Est. completion 2012-12 2 sites
    Other conditions: Squamous Cell Carcinoma
    View official trial listing →
  • Terminated NCT NCT01009801

    Transarterial Chemoembolization With Doxorubicin With or Without Everolimus in Treating Patients With Liver Cancer

    Not yet reported, Not yet reported Swiss Cancer Institute 27 participants Est. completion 2015-06 8 sites
    Other conditions: Liver Cancer
    View official trial listing →
  • Withdrawn NCT NCT01009879

    Human Tumor Necrosis Factor Alpha (TNFa)-Induced Pre-B Cell Bone Marrow Emigrants

    Not yet reported University of Pittsburgh Est. completion 2012-02 1 site Stand-alone
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT01010217

    Mismatched Transplantation Using High-dose Post-transplant Cyclophosphamide

    Not yet reported M.D. Anderson Cancer Center 176 participants Est. completion 2017-10-05 1 site Stand-alone
    Other conditions: Blood Stem Cell Transplant Failure, Leukemia, Hematologic Malignancies
    View official trial listing →
  • Completed NCT NCT01011205

    Phase 3b Study to Evaluate Advagraf in Combination With Mycophenolate Mofetil and Basiliximab in Liver Transplantation

    Not yet reported Astellas Pharma Inc 893 participants Est. completion 2013-01-04 72 sites Stand-alone
    Other conditions: Liver Transplantation
    View official trial listing →
  • Completed NCT NCT01014234

    Rapamycin and Regulatory T Cells in Kidney Transplantation

    Not yet reported Fondazione IRCCS Policlinico San Matteo di Pavia 56 participants Est. completion 2013-06 1 site
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Terminated NCT NCT01015664

    Combination of Cisplatin, Cetuximab and Temsirolimus in Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck

    Not yet reported, Not yet reported University of Tennessee Cancer Institute 11 participants Est. completion 2012-12 1 site
    Other conditions: Squamous Cell Carcinoma of the Head and Neck
    View official trial listing →
  • Completed NCT NCT01016015

    Temsirolimus and Cixutumumab in Treating Patients With Locally Advanced, Metastatic, or Recurrent Soft Tissue Sarcoma or Bone Sarcoma

    Not yet reported National Cancer Institute (NCI) 178 participants Est. completion 2014-07 24 sites
    Obstructive sleep apnea Other conditions: Recurrent Adult Soft Tissue Sarcoma, Stage III Adult Soft Tissue Sarcoma, Stage IV Adult Soft Tissue Sarcoma
    View official trial listing →
  • Completed NCT NCT01018914

    A Study to Compare Safety and Efficacy of Prograf + Myfortic and Advagraf + Myfortic in Liver Transplantation Patients

    Not yet reported Astellas Pharma Inc 44 participants Est. completion 2010-12 3 sites
    Other conditions: Liver Transplantation
    View official trial listing →
  • Completed NCT NCT01019434

    Radiation Therapy and Temsirolimus or Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma

    Not yet reported European Organisation for Research and Treatment of Cancer - EORTC 111 participants Est. completion 2014-03 13 sites
    Other conditions: Brain and Central Nervous System Tumors
    View official trial listing →
  • Terminated NCT NCT01020305

    Temsirolimus to Reverse Androgen Insensitivity for Castration-resistant Prostate Cancer

    Not yet reported, Not yet reported Sandy Srinivas 5 participants Est. completion 2012-04 1 site
    Other conditions: Prostate Cancer, Prostatic Neoplasms, Castrate-resistant Prostate Cancer (CRPC), Androgen-insensitive Prostate Cancer, Hormone-refractory Prostate Cancer, Metastatic Disease
    View official trial listing →
  • Completed NCT NCT01020539

    Allogeneic Stem Cell Transplantation Followed By Targeted Immune Therapy In Average Risk Leukemia

    Not yet reported Columbia University 18 participants Est. completion 2020-12 1 site Stand-alone
    Other conditions: Acute Myelogenous Leukemia, Myelodysplastic Syndrome, Juvenile Myelomonocytic Leukemia
    View official trial listing →
  • Completed NCT NCT01021527

    A Study to Assess the Effects of Exenatide on Insulin Secretion Rates Using a Graded Infusion of Intravenous Glucose (0000-099)(COMPLETED)

    Not yet reported Merck Sharp & Dohme LLC 12 participants Est. completion 2008-04 Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01021735

    Optimal Management of Rheumatoid Arthritis Patients Requiring Biologic Therapy

    Not yet reported University of Glasgow 302 participants Est. completion 2015-04 8 sites
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Terminated NCT NCT01021930

    Comparison of Diabetes Mellitus and Non-diabetes Mellitus Patients for DES Surface COVERage by OCT

    Not yet reported Harbin Medical University 70 participants Est. completion 2010-12 1 site
    Other conditions: Coronary Heart Disease, Diabetes Mellitus
    View official trial listing →
  • Terminated NCT NCT01023919

    Assessment of Surface Coverage of Two Types of Drug-eluting Stent in Diabetes Mellitus and Non-Diabetes Mellitus

    Not yet reported Harbin Medical University 120 participants Est. completion 2010-12 1 site
    Cardiovascular disease Other conditions: Diabetes Mellitus
    View official trial listing →
  • Terminated NCT NCT01024179

    Relationship Between Initial Plaque Characteristics and Stent Surface Coverage Patterns

    Not yet reported Harbin Medical University 90 participants Est. completion 2010-12 1 site
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT01024946

    Everolimus (RAD001) for the Treatment of Malignant Pleural Mesothelioma With Merlin/NF2 Loss as a Biomarker to Predict Sensitivity

    Not yet reported Memorial Sloan Kettering Cancer Center 11 participants Est. completion 2012-07 3 sites
    Other conditions: Malignant Pleural Mesothelioma
    View official trial listing →
  • Completed NCT NCT01025817

    Non-inferiority Study of Safety and Efficacy of Everolimus With Low Dose Tacrolimus to Mycophenolate Mofetil With Standard Dose Tacrolimus in Kidney Transplant Recipients

    Not yet reported Novartis Pharmaceuticals 613 participants Est. completion 2013-03 50 sites Stand-alone
    Other conditions: Kidney Transplant
    View official trial listing →
  • Completed NCT NCT01026623

    Cixutumumab and Temsirolimus in Treating Patients With Metastatic Prostate Cancer

    Not yet reported, Not yet reported National Cancer Institute (NCI) 16 participants Est. completion 2013-02 4 sites
    Other conditions: Hormone-Resistant Prostate Cancer, Prostate Adenocarcinoma, Recurrent Prostate Carcinoma, Stage IV Prostate Cancer
    View official trial listing →
  • Completed NCT NCT01026792

    Temsirolimus in Treating Patients With Cervical Cancer That Is Recurrent, Locally Advanced, Metastatic, or Cannot Be Removed By Surgery

    Not yet reported National Cancer Institute (NCI) 38 participants Est. completion 2012-11 1 site
    Other conditions: Cervical Adenocarcinoma, Cervical Adenosquamous Carcinoma, Cervical Squamous Cell Carcinoma, Recurrent Cervical Carcinoma, Stage IIIA Cervical Cancer, Stage IIIB Cervical Cancer, Stage IVA Cervical Cancer, Stage IVB Cervical Cancer
    View official trial listing →
  • Completed NCT NCT01027000

    Donor Stem Cell Transplant in Treating Patients With High-Risk Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

    Not yet reported Alliance for Clinical Trials in Oncology 68 participants Est. completion 2023-04 25 sites Stand-alone
    Other conditions: Leukemia, Lymphoma
    View official trial listing →
  • Terminated NCT NCT01028716

    Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies

    Not yet reported Fred Hutchinson Cancer Center 46 participants Est. completion 2021-10-07 1 site Stand-alone
    Other conditions: Acute Biphenotypic Leukemia, Acute Erythroid Leukemia in Remission, Acute Leukemia in Remission, Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukaemia With Prior Myelodysplastic Syndrome, Acute Myeloid Leukemia in Remission, Acute Myeloid Leukemia With FLT3/ITD Mutation, Acute Myeloid Leukemia With Inv(3)(Q21Q26.2); RPN1-EVI1, Acute Myeloid Leukemia With Multilineage Dysplasia, Acute Myeloid Leukemia With t(6;9), Acute Undifferentiated Leukemia, Adult Acute Lymphoblastic Leukemia in Complete Remission, B Acute Lymphoblastic Leukemia With T(1;19)(Q23;P13.3); E2A-PBX1 (TCF3-PBX1), Ph+ ALL, Burkitt Lymphoma, Childhood Acute Lymphoblastic Leukemia in Complete Remission, DS Stage II Plasma Cell Myeloma, DS Stage III Plasma Cell Myeloma, Myelodysplastic Syndrome, Recurrent Anaplastic Large Cell Lymphoma, Blasts Under 5 Percent of Bone Marrow Nucleated Cells, Recurrent Follicular Lymphoma, Recurrent Hodgkin Lymphoma, Recurrent Mantle Cell Lymphoma, Recurrent Marginal Zone Lymphoma, Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma, Secondary Acute Myeloid Leukemia, T Lymphoblastic Lymphoma, Hematopoietic Cell Transplant Recipient
    View official trial listing →
  • Completed NCT NCT01031381

    Study of RAD001 and Bevacizumab in Recurrent Ovarian, Peritoneal, and Fallopian Tube Cancer

    Not yet reported University of Pittsburgh 50 participants Est. completion 2014-12 1 site
    Other conditions: Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma
    View official trial listing →
  • Completed NCT NCT01031446

    Cisplatin, Paclitaxel, and Everolimus in Treating Patients With Metastatic Breast Cancer

    Not yet reported, Not yet reported Vanderbilt-Ingram Cancer Center 55 participants Est. completion 2017-08 4 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT01031901

    Topical Rapamycin Therapy to Alleviate Cutaneous Manifestations of Tuberous Sclerosis Complex (TSC) and Neurofibromatosis I (NF1)

    Not yet reported The University of Texas Health Science Center, Houston 52 participants Est. completion 2011-06 1 site Stand-alone
    Other conditions: Tuberous Sclerosis, Neurofibromatoses, Angiofibroma, Neurofibroma
    View official trial listing →
  • Withdrawn NCT NCT01033500

    Calcineurin Inhibitor-free, Steroid-free Immunosuppressive Regimen in Simultaneous Islet-Kidney Transplantation for Uremic Type 1 Diabetic Patients

    Not yet reported University of Wisconsin, Madison Est. completion 2012-12 1 site Stand-alone
    Other conditions: Islets of Langerhans Transplantation, Diabetes Mellitus, Type 1, Kidney Transplantation
    View official trial listing →
  • Status unknown NCT NCT01034371

    Comparison of One-stop Hybrid Revascularization Versus Off-pump Coronary Artery Bypass for the Treatment of Multi-vessel Disease

    Not yet reported China National Center for Cardiovascular Diseases 400 participants 2 sites Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Status unknown NCT NCT01035034

    Comparison of One-stop Hybrid Revascularization Versus Percutaneous Coronary Intervention for the Treatment of Multi-vessel Disease

    Not yet reported China National Center for Cardiovascular Diseases 480 participants 2 sites Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT01038167

    A Study to Examine the Effects of Telaprevir on the Pharmacokinetics of Cyclosporine and Tacrolimus in Healthy Adults

    Not yet reported Vertex Pharmaceuticals Incorporated 20 participants Est. completion 2010-04 1 site Stand-alone
    Other conditions: Hepatitis C
    View official trial listing →
  • Withdrawn NCT NCT01038505

    Comparison of Tacrolimus and Myfortic Versus Tacrolimus and Sirolimus

    Not yet reported University of Miami Est. completion 2013-01
    Other conditions: Living Donor Kidney Transplants Patients
    View official trial listing →
  • Completed NCT NCT01042782

    Phase I Study of Daily RAD001 in Combination With Mitomycin C in Patients With Advanced Gastric Cancer or Cancer of the Esophagogastric Junction

    Not yet reported Krankenhaus Nordwest 16 participants Est. completion 2012-08 1 site
    Other conditions: Advanced Gastric Cancer, Advanced Cancer of the Esophagogastric Junction
    View official trial listing →
  • Terminated NCT NCT01044745

    Rituximab in Preventing Acute Graft-Versus-Host Disease in a Donor Stem Cell Transplant for Hematologic Cancer

    Not yet reported University of Nebraska 20 participants Est. completion 2017-10-10 1 site Stand-alone
    Obstructive sleep apnea Other conditions: Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission, Adult Nasal Type Extranodal NK/T-cell Lymphoma, Blastic Phase Chronic Myelogenous Leukemia, Contiguous Stage II Adult Burkitt Lymphoma, Contiguous Stage II Adult Diffuse Large Cell Lymphoma, Contiguous Stage II Adult Diffuse Mixed Cell Lymphoma, Contiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma, Contiguous Stage II Adult Immunoblastic Large Cell Lymphoma, Contiguous Stage II Adult Lymphoblastic Lymphoma, Contiguous Stage II Grade 1 Follicular Lymphoma, Contiguous Stage II Grade 2 Follicular Lymphoma, Contiguous Stage II Grade 3 Follicular Lymphoma, Contiguous Stage II Mantle Cell Lymphoma, Contiguous Stage II Marginal Zone Lymphoma, Contiguous Stage II Small Lymphocytic Lymphoma, de Novo Myelodysplastic Syndromes, Graft Versus Host Disease, Nodal Marginal Zone B-cell Lymphoma, Noncontiguous Stage II Adult Burkitt Lymphoma, Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma, Noncontiguous Stage II Adult Diffuse Mixed Cell Lymphoma, Noncontiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma, Noncontiguous Stage II Adult Immunoblastic Large Cell Lymphoma, Noncontiguous Stage II Adult Lymphoblastic Lymphoma, Noncontiguous Stage II Grade 1 Follicular Lymphoma, Noncontiguous Stage II Grade 2 Follicular Lymphoma, Noncontiguous Stage II Grade 3 Follicular Lymphoma, Noncontiguous Stage II Mantle Cell Lymphoma, Noncontiguous Stage II Marginal Zone Lymphoma, Noncontiguous Stage II Small Lymphocytic Lymphoma, Previously Treated Myelodysplastic Syndromes, Recurrent Adult Acute Lymphoblastic Leukemia, Recurrent Adult Acute Myeloid Leukemia, Recurrent Adult Burkitt Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma, Recurrent Adult Diffuse Mixed Cell Lymphoma, Recurrent Adult Diffuse Small Cleaved Cell Lymphoma, Recurrent Adult Grade III Lymphomatoid Granulomatosis, Recurrent Adult Immunoblastic Large Cell Lymphoma, Recurrent Adult Lymphoblastic Lymphoma, Recurrent Adult T-cell Leukemia/Lymphoma, Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Grade 3 Follicular Lymphoma, Recurrent Mantle Cell Lymphoma, Recurrent Marginal Zone Lymphoma, Recurrent Mycosis Fungoides/Sezary Syndrome, Recurrent Small Lymphocytic Lymphoma, Refractory Chronic Lymphocytic Leukemia, Relapsing Chronic Myelogenous Leukemia, Secondary Myelodysplastic Syndromes, Splenic Marginal Zone Lymphoma, Stage I Adult Burkitt Lymphoma, Stage I Adult Diffuse Large Cell Lymphoma, Stage I Adult Diffuse Mixed Cell Lymphoma, Stage I Adult Diffuse Small Cleaved Cell Lymphoma, Stage I Adult Immunoblastic Large Cell Lymphoma, Stage I Adult Lymphoblastic Lymphoma, Stage I Adult T-cell Leukemia/Lymphoma, Stage I Chronic Lymphocytic Leukemia, Stage I Cutaneous T-cell Non-Hodgkin Lymphoma, Stage I Grade 1 Follicular Lymphoma, Stage I Grade 2 Follicular Lymphoma, Stage I Grade 3 Follicular Lymphoma, Stage I Mantle Cell Lymphoma, Stage I Marginal Zone Lymphoma, Stage I Mycosis Fungoides/Sezary Syndrome, Stage I Small Lymphocytic Lymphoma, Stage II Adult T-cell Leukemia/Lymphoma, Stage II Chronic Lymphocytic Leukemia, Stage II Cutaneous T-cell Non-Hodgkin Lymphoma, Stage II Mycosis Fungoides/Sezary Syndrome, Stage III Adult Burkitt Lymphoma, Stage III Adult Diffuse Large Cell Lymphoma, Stage III Adult Diffuse Mixed Cell Lymphoma, Stage III Adult Diffuse Small Cleaved Cell Lymphoma, Stage III Adult Immunoblastic Large Cell Lymphoma, Stage III Adult Lymphoblastic Lymphoma, Stage III Adult T-cell Leukemia/Lymphoma, Stage III Chronic Lymphocytic Leukemia, Stage III Cutaneous T-cell Non-Hodgkin Lymphoma, Stage III Grade 1 Follicular Lymphoma, Stage III Grade 2 Follicular Lymphoma, Stage III Grade 3 Follicular Lymphoma, Stage III Mantle Cell Lymphoma, Stage III Marginal Zone Lymphoma, Stage III Mycosis Fungoides/Sezary Syndrome, Stage III Small Lymphocytic Lymphoma, Stage IV Adult Burkitt Lymphoma, Stage IV Adult Diffuse Large Cell Lymphoma, Stage IV Adult Diffuse Mixed Cell Lymphoma, Stage IV Adult Diffuse Small Cleaved Cell Lymphoma, Stage IV Adult Immunoblastic Large Cell Lymphoma, Stage IV Adult Lymphoblastic Lymphoma, Stage IV Adult T-cell Leukemia/Lymphoma, Stage IV Chronic Lymphocytic Leukemia, Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma, Stage IV Grade 1 Follicular Lymphoma, Stage IV Grade 2 Follicular Lymphoma, Stage IV Grade 3 Follicular Lymphoma, Stage IV Mantle Cell Lymphoma, Stage IV Marginal Zone Lymphoma, Stage IV Mycosis Fungoides/Sezary Syndrome, Stage IV Small Lymphocytic Lymphoma, Untreated Adult Acute Lymphoblastic Leukemia, Untreated Adult Acute Myeloid Leukemia, Waldenström Macroglobulinemia
    View official trial listing →
  • Withdrawn NCT NCT01047072

    Low-Dose Conditioning Followed by Donor Stem Cell Transplant in Treating Patients With Severe Systemic Sclerosis

    Not yet reported Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium 1 site Stand-alone
    Other conditions: Systemic Scleroderma
    View official trial listing →
  • Completed NCT NCT01047293

    RAD001, FOLFOX and Bevacizumab in Treatment of Colorectal Carcinoma

    Not yet reported, Not yet reported University of Utah 47 participants Est. completion 2015-08 2 sites
    Other conditions: Colorectal Cancer
    View official trial listing →
  • No Longer Available NCT NCT01049633

    B-Lymphocyte Immunotherapy in Islet Transplantation for Initial Islet Graft Failure

    National Institute of Allergy and Infectious Diseases (NIAID) 1 site
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT01049841

    Perifosine With Temsirolimus for Recurrent Pediatric Solid Tumors

    Not yet reported Memorial Sloan Kettering Cancer Center 23 participants Est. completion 2017-03 1 site
    Other conditions: Pediatric Solid Tumors
    View official trial listing →
  • Completed NCT NCT01049854

    CD34+Selection for Partially Matched Family or Matched Unrelated Adult Donor Transplant

    Not yet reported New York Medical College 20 participants Est. completion 2018-08 1 site Stand-alone
    Other conditions: Leukemia, Lymphoma, Bone Marrow Failure, Immunodeficiencies, Histiocytosis, Sickle Cell Disease, Beta Thalassemia, Inborn Errors of Metabolism
    View official trial listing →
  • Completed NCT NCT01050166

    MRI Imaging of Labeled Human Islets Transplanted Into the Liver

    Frantisek Saudek 8 participants Est. completion 2012-12-31 1 site
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT01050985

    A Study of Temsirolimus Plus Capecitabine in Patients With Advanced Cancer

    Not yet reported Georgetown University 47 participants Est. completion 2013-06 1 site
    Other conditions: Advanced Solid Tumors
    View official trial listing →
  • Completed NCT NCT01051557

    Temsirolimus and Perifosine in Treating Patients With Recurrent or Progressive Malignant Glioma

    Not yet reported, Not yet reported National Cancer Institute (NCI) 36 participants Est. completion 2020-09-30 1 site
    Obstructive sleep apnea Other conditions: Adult Anaplastic Astrocytoma, Adult Anaplastic Oligodendroglioma, Adult Diffuse Astrocytoma, Adult Giant Cell Glioblastoma, Adult Glioblastoma, Adult Mixed Glioma, Adult Oligodendroglioma, Recurrent Adult Brain Neoplasm
    View official trial listing →
  • Terminated NCT NCT01053221

    Mycophenolic Acid Monotherapy in Recipients of HLA-identical Living-Related Transplantation

    Not yet reported University of Wisconsin, Madison 16 participants Est. completion 2012-08 1 site Stand-alone
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT01053247

    Study of 0416 Ointment in the Treatment of Atopic Dermatitis

    Not yet reported Fougera Pharmaceuticals Inc. 793 participants Est. completion 2009-08 1 site
    Other conditions: Atopic Dermatitis
    View official trial listing →
  • Completed NCT NCT01055795

    Safety Study of Bevacizumab, Everolimus and LBH589 (BEL) for Advanced Solid Tumors

    Not yet reported Herbert Hurwitz 14 participants Est. completion 2012-05 1 site
    Other conditions: Advanced Solid Tumors
    View official trial listing →
  • Completed NCT NCT01055964

    a Comparative Pharmacokinetic Study of Two Oral Formulations of Tacrolimus in Renal Allograft Recipients

    Not yet reported Seoul National University Hospital 80 participants 1 site Stand-alone
    Other conditions: Pharmacokinetics, Tacrolimus
    View official trial listing →
  • Completed NCT NCT01056237

    Long-Term Study of Multi-target Therapy as Maintenance Treatment for Lupus Nephritis

    Not yet reported Zhi-Hong Liu, M.D. 206 participants Est. completion 2013-06 1 site Stand-alone
    Other conditions: Lupus Nephritis
    View official trial listing →
  • Completed NCT NCT01056614

    Fludarabine Phosphate, Busulfan, and Anti-Thymocyte Globulin Followed By Donor Peripheral Blood Stem Cell Transplant, Tacrolimus, and Methotrexate in Treating Patients With Myeloid Malignancies

    Not yet reported Fred Hutchinson Cancer Center 23 participants Est. completion 2016-04 1 site Stand-alone
    Other conditions: Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Blastic Phase Chronic Myelogenous Leukemia, Childhood Acute Myeloid Leukemia in Remission, Childhood Chronic Myelogenous Leukemia, Childhood Myelodysplastic Syndromes, Chronic Phase Chronic Myelogenous Leukemia, de Novo Myelodysplastic Syndromes, Hematopoietic/Lymphoid Cancer, Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable, Previously Treated Myelodysplastic Syndromes, Recurrent Adult Acute Myeloid Leukemia, Recurrent Childhood Acute Myeloid Leukemia, Relapsing Chronic Myelogenous Leukemia
    View official trial listing →
  • Completed NCT NCT01056822

    Multicenter, Randomized, Open-label Study to Assess Whether Treatment With Mycophenolate Sodium (MPS) Allows Higher Dose Optimization Versus Mycophenolate Mofetil (MMF) Leading to a Dose Reduction of Tacrolimus. Maximiza Study.

    Not yet reported Novartis Pharmaceuticals 89 participants Est. completion 2013-04 19 sites
    Other conditions: Prophilaxis of Acute Rejection in Patients Receiving a Renal Allograft
    View official trial listing →
  • Completed NCT NCT01060059

    Exenatide and Basal Insulins Use in the Real Setting: an Observational Study in Patients With Type 2 Diabetes

    AstraZeneca 888 participants Est. completion 2012-05 50 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01060098

    T Cells and TNF (Tumor Necrosis Factor): The Impact of TNF Blockade

    Imperial College London 48 participants Est. completion 2012-12 1 site
    Other conditions: Rheumatoid Arthritis, Ankylosing Spondylitis, Psoriatic Arthritis
    View official trial listing →
  • Completed NCT NCT01060475

    Safety and Tolerability of LIM-0705 in Healthy Male Subjects

    Not yet reported Limerick BioPharma 44 participants Est. completion 2010-06 2 sites Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01060605

    Pre Transplant Rapamycin Treatment in Islet Transplantation Alone

    Not yet reported IRCCS San Raffaele 11 participants Est. completion 2009-09 1 site
    Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Terminated NCT NCT01061606

    Temsirolimus in Treating Patients With Recurrent or Persistent Cancer of the Uterus

    Not yet reported National Cancer Institute (NCI) 8 participants Est. completion 2012-10 20 sites
    Obstructive sleep apnea Other conditions: Recurrent Uterine Sarcoma
    View official trial listing →
  • Completed NCT NCT01061788

    A Trial of AMG 479, Everolimus (RAD001) and Panitumumab in Patients With Advanced Cancer - QUILT-3.007

    Not yet reported Jeffrey Clarke 43 participants Est. completion 2018-12-19 1 site
    Other conditions: Advanced Solid Tumors, Non-small Cell Lung Cancer
    View official trial listing →
  • Terminated NCT NCT01061853

    Efficacy of Topical Rapamycin to Treat Chronic Erosive Oral Lichen

    Not yet reported University Hospital, Tours 76 participants Est. completion 2012-11 9 sites Stand-alone
    Other conditions: Oral Lichen Planus
    View official trial listing →
  • Completed NCT NCT01062399

    Everolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

    Not yet reported, Not yet reported Radiation Therapy Oncology Group 279 participants Est. completion 2022-05-20 36 sites
    Other conditions: Brain and Central Nervous System Tumors
    View official trial listing →
  • Completed NCT NCT01062555

    Calcineurin Inhibitor Sparing After Kidney Transplantation

    Not yet reported, Not yet reported University of Minnesota 527 participants Est. completion 2014-04-03 1 site
    Other conditions: CNI Side Effects
    View official trial listing →
  • Completed NCT NCT01064791

    Efficacy, Safety, Tolerability, and Pharmacokinetics of Sotrastaurin Combined With Tacrolimus vs. a Mycophenolic Acid-tacrolimus Regimen in Renal Transplant Patients

    Not yet reported Novartis Pharmaceuticals 298 participants Est. completion 2012-08 44 sites Stand-alone
    Other conditions: Renal Transplantation
    View official trial listing →
  • Completed NCT NCT01065662

    AZD2171 and Temsirolimus in Patients With Advanced Gynecological Malignancies

    Not yet reported Susana M. Campos, MD 11 participants Est. completion 2021-03 3 sites
    Other conditions: Endometrial Cancer, Ovarian Cancer, Cervical Cancer, Fallopian Tube Cancer, Peritoneal Cancer
    View official trial listing →
  • Completed NCT NCT01068054

    Efficacy Study of FK-506 and Cyclosporine in Vernal Keratoconjunctivits (VKC)

    Not yet reported, Not yet reported Siriraj Hospital 24 participants Est. completion 2005-05 1 site
    Other conditions: Keratoconjunctivitis, Vernal
    View official trial listing →
  • Status unknown NCT NCT01068067

    Validation of Pharmacogenetics Plus Drug Combination Guided Initial Tacrolimus Dosage in Renal Transplant Recipients

    Not yet reported Sun Yat-sen University 60 participants 2 sites Stand-alone
    Other conditions: Renal Transplantation
    View official trial listing →
  • Active, not recruiting NCT NCT01068249

    Letrozole and RAD001 With Advanced or Recurrent Endometrial Cancer

    Not yet reported M.D. Anderson Cancer Center 42 participants Est. completion 2028-04-30 2 sites
    Other conditions: Endometrial Cancer
    View official trial listing →
  • Completed NCT NCT01068353

    Safety and Tolerability of Etanercept in Alzheimer's Disease

    Not yet reported University of Southampton 41 participants 1 site Stand-alone
    Other conditions: Alzheimer's Disease
    View official trial listing →
  • Completed NCT NCT01070316

    Everolimus (RAD001) Therapy for Epilepsy in Patients With Tuberous Sclerosis Complex (TSC)

    Not yet reported, Not yet reported Children's Hospital Medical Center, Cincinnati 20 participants Est. completion 2016-04 2 sites
    Other conditions: Epilepsy, Tuberous Sclerosis Complex
    View official trial listing →
  • Status unknown NCT NCT01072058

    Heart Function in Rheumatoid Arthritis and Ankylosing Spondylitis Pre and Post-TNF Blocker

    Not yet reported University of Sao Paulo 100 participants 1 site
    Other conditions: Arthritis, Rheumatoid, Spondylitis, Ankylosing
    View official trial listing →
  • Completed NCT NCT01072890

    Temsirolimus and Pazopanib in Patients With Advanced Solid Tumors

    Not yet reported University of California, Davis 8 participants Est. completion 2012-02 1 site
    Other conditions: Solid Tumors
    View official trial listing →
  • Completed NCT NCT01074086

    Phase I Study in RAD 001 Patients With Relapse AML

    Not yet reported French Innovative Leukemia Organisation 31 participants Est. completion 2012-12 1 site
    Other conditions: AML
    View official trial listing →
  • Completed NCT NCT01075321

    Everolimus and Lenalidomide in Treating Patients With Relapsed or Refractory Non-Hodgkin or Hodgkin Lymphoma

    Not yet reported, Not yet reported Mayo Clinic 58 participants Est. completion 2020-02-13 2 sites
    Obstructive sleep apnea Other conditions: Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, Hepatosplenic T-cell Lymphoma, Nodal Marginal Zone B-cell Lymphoma, Peripheral T-cell Lymphoma, Post-transplant Lymphoproliferative Disorder, Recurrent Adult Burkitt Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma, Recurrent Adult Hodgkin Lymphoma, Recurrent Adult T-cell Leukemia/Lymphoma, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Grade 3 Follicular Lymphoma, Recurrent Mantle Cell Lymphoma, Recurrent Mycosis Fungoides/Sezary Syndrome, Splenic Marginal Zone Lymphoma, Waldenstrom Macroglobulinemia
    View official trial listing →
  • Completed NCT NCT01076543

    Lenalidomide and Temsirolimus in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin Lymphoma

    Not yet reported, Not yet reported National Cancer Institute (NCI) 110 participants Est. completion 2018-09-30 11 sites
    Other conditions: AIDS-Related Hodgkin Lymphoma, Recurrent Adult Hodgkin Lymphoma, Recurrent Follicular Lymphoma, Recurrent Lymphoplasmacytic Lymphoma, Recurrent Marginal Zone Lymphoma, Recurrent Non-Hodgkin Lymphoma, Recurrent T-Cell Non-Hodgkin Lymphoma, Waldenstrom Macroglobulinemia
    View official trial listing →
  • Completed NCT NCT01077986

    Everolimus, Cetuximab and Capecitabine in Patients With Metastatic Pancreatic Cancer

    Not yet reported, Not yet reported Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 35 participants Est. completion 2011-08 1 site
    Other conditions: Metastatic Pancreatic Cancer
    View official trial listing →
  • Completed NCT NCT01078142

    Temsirolimus, Bendamustine and Rituximab for Relapsed Follicular Lymphoma or Mantle Cell Lymphoma

    Not yet reported, Not yet reported Georg Hess, MD 39 participants Est. completion 2017-09-08 1 site
    Other conditions: Follicular Lymphoma, Mantle Cell Lymphoma
    View official trial listing →
  • Completed NCT NCT01079143

    Progression of Renal Interstitial Fibrosis / Tubular Atrophy (IF/TA) According to Epithelial-mesenchymal Transition (EMT) and Immunosuppressive Regimen (Everolimus Based Versus CNI Based) in de Novo Renal Transplant Recipients

    Not yet reported Novartis Pharmaceuticals 194 participants Est. completion 2012-06 23 sites
    Other conditions: Renal Interstitial Fibrosis
    View official trial listing →
  • Completed NCT NCT01079286

    Study of Nelfinavir and Temsirolimus in Patients With Advanced Cancers

    Not yet reported Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 18 participants Est. completion 2011-08 1 site
    Other conditions: Renal Cell Cancer, Cancer
    View official trial listing →
  • Status unknown NCT NCT01079702

    Everolimus and Capecitabine in Patients With Advanced Malignancy

    Not yet reported, Not yet reported Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 35 participants Est. completion 2011-01 2 sites
    Other conditions: Advanced Malignancies
    View official trial listing →
  • Terminated NCT NCT01079767

    Temsirolimus in Treating Patients With Advanced Liver Cancer and Cirrhosis

    Not yet reported Federation Francophone de Cancerologie Digestive 6 participants 1 site
    Other conditions: Liver Cancer
    View official trial listing →
  • Completed NCT NCT01080456

    Bioequivalence Study of Tacrolimus 1 mg Capsule Under Fasting Condition

    Not yet reported Panacea Biotec Ltd 36 participants Est. completion 2007-10 1 site Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT01080469

    Bioequivalence Study of Tacrolimus 1 mg Capsule Under Fed Condition

    Not yet reported Panacea Biotec Ltd 36 participants Est. completion 2007-10 1 site Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT01080482

    Bioequivalence Study of Tacrolimus 5 mg Capsule Under Fasting Condition

    Not yet reported Panacea Biotec Ltd 36 participants Est. completion 2007-10 1 site Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT01080534

    Bioequivalence Study of Tacrolimus 5 mg Capsule Under Fed Condition

    Not yet reported Panacea Biotec Ltd 36 participants Est. completion 2007-10 1 site Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT01082393

    Vitiligo and the Koebner Phenomenon (Model of Vitiligo Induction and Therapy: a Clinical and Immunological Analysis)

    Not yet reported University Hospital, Ghent 14 participants Est. completion 2015-12-01 1 site
    Other conditions: Vitiligo
    View official trial listing →
  • Completed NCT NCT01084980

    Therapeutic Effect of Tacrolimus in Combination With Low Dose Corticosteroid in Adult Patient With Minimal Change Nephritic Syndrome

    Not yet reported, Not yet reported Seoul National University Hospital 20 participants Est. completion 2011-07 1 site Stand-alone
    Other conditions: Minimal Change Disease
    View official trial listing →
  • Active, not recruiting NCT NCT01087554

    Sirolimus or Everolimus or Temsirolimus and Vorinostat in Advanced Cancer

    Not yet reported M.D. Anderson Cancer Center 249 participants Est. completion 2026-08-18 1 site Stand-alone
    Other conditions: Advanced Cancer
    View official trial listing →
  • Completed NCT NCT01087983

    Lapatinib With Sirolimus or Metformin

    Not yet reported M.D. Anderson Cancer Center 111 participants Est. completion 2015-09 1 site Stand-alone
    Other conditions: Advanced Cancers
    View official trial listing →
  • Status unknown NCT NCT01088893

    Everolimus in Breast Cancer Patients After Pre-operative Chemotherapy

    Not yet reported Organisation for Oncology and Translational Research 50 participants Est. completion 2013-03 1 site
    Other conditions: Breast Neoplasms
    View official trial listing →
  • Completed NCT NCT01092806

    Insulin Secretion and Advagraf

    Not yet reported University of Oslo School of Pharmacy 20 participants Est. completion 2010-05 1 site Stand-alone
    Other conditions: Post Transplant Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT01093391

    A Trial of Bare Metal Stent - Cobalt Chromium Versus Stent Coating With Sirolimus

    Not yet reported Scitech Produtos Medicos SA 63 participants Est. completion 2015-07 4 sites Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT01093729

    A Study of HM11260C in Healthy Male Subject

    Not yet reported Hanmi Pharmaceutical Company Limited 41 participants Est. completion 2010-10
    Other conditions: Healthy
    View official trial listing →
  • Status unknown NCT NCT01095172

    RituxiMab INDuction in Renal Transplantation

    Not yet reported Guy's and St Thomas' NHS Foundation Trust 100 participants Est. completion 2022-10 6 sites Stand-alone
    Other conditions: Function of Renal Transplant
    View official trial listing →
  • Completed NCT NCT01099527

    A Trial of RAD001/Capecitabine in Refractory Gastric Cancer

    Not yet reported, Not yet reported Samsung Medical Center 59 participants Est. completion 2013-12 1 site
    Other conditions: Metastatic Gastric Cancer
    View official trial listing →
  • Completed NCT NCT01104701

    A Study to Examine the Efficacy, Safety and Tolerability, and Pharmacokinetics of Exenatide Once Monthly Suspension

    Not yet reported AstraZeneca 121 participants Est. completion 2010-12 2 sites Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Terminated NCT NCT01106378

    Cynergy: the CYPHER-NEVO Registry

    Cordis US Corp. 14000 participants Est. completion 2011-12 3 sites
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT01106833

    Chronic Graft-versus-Host Disease Treatment (BMT CTN 0801)

    Not yet reported, Not yet reported Medical College of Wisconsin 151 participants Est. completion 2018-06 31 sites
    Other conditions: Chronic GVHD
    View official trial listing →
  • Completed NCT NCT01108445

    Phase II Study of Afinitor vs. Sutent in Patients With Metastatic Non-Clear Cell Renal Cell Carcinoma

    Not yet reported Duke University 131 participants Est. completion 2015-04 18 sites
    Other conditions: Advanced Non-clear Cell Renal Cell Carcinoma
    View official trial listing →
  • Completed NCT NCT01109914

    Mucosal Response in Immunocompromised Host

    Not yet reported Leiden University Medical Center 51 participants Est. completion 2015-03 1 site Stand-alone
    Other conditions: Kidney Transplantation, Immunity
    View official trial listing →
  • Terminated NCT NCT01111448

    Temsirolimus in Myelodysplastic Syndrome (MDS)

    Not yet reported Technische Universität Dresden 20 participants Est. completion 2014-06 7 sites
    Other conditions: Myelodysplastic Syndrome
    View official trial listing →
  • Completed NCT NCT01111825

    Temsirolimus Plus Neratinib for Patients With Metastatic HER2-Amplified or Triple Negative Breast Cancer

    Not yet reported, Not yet reported Puma Biotechnology, Inc. 99 participants Est. completion 2016-07 12 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT01114529

    Efficacy, Safety and Evolution of Cardiovascular Parameters in Renal Transplant Recipients

    Not yet reported Novartis Pharmaceuticals 828 participants Est. completion 2014-10-30 77 sites
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Terminated NCT NCT01115803

    A Study of LY2584702 With Erlotinib or Everolimus in Participants With Solid Tumors

    Not yet reported Eli Lilly and Company 29 participants Est. completion 2011-06 3 sites
    Other conditions: Metastases, Neoplasm, Carcinoma, Non-small Cell Lung, Renal Cell Carcinoma, Neuroendocrine Tumors
    View official trial listing →
  • Terminated NCT NCT01116232

    Sirolimus, Tacrolimus, Thymoglobulin and Rituximab as Graft-versus-Host-Disease Prophylaxis in Patients Undergoing Haploidentical and HLA Partially Matched Donor Hematopoietic Cell Transplantation

    Not yet reported Barbara Ann Karmanos Cancer Institute 4 participants Est. completion 2013-06 1 site Stand-alone
    Other conditions: Chronic Myeloproliferative Disorders, Graft Versus Host Disease, Leukemia, Lymphoma, Lymphoproliferative Disorder, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
    View official trial listing →
  • Terminated NCT NCT01118013

    Donor Stem Cell Transplant in Treating Patients With Relapsed Hematologic Malignancies or Secondary Myelodysplasia Previously Treated With High-Dose Chemotherapy and Autologous Stem Cell Transplant

    Not yet reported Alliance for Clinical Trials in Oncology 6 participants Est. completion 2013-08 10 sites Stand-alone
    Other conditions: Leukemia, Lymphoma, Lymphoproliferative Disorder, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Myelodysplastic/Myeloproliferative Neoplasms
    View official trial listing →
  • Completed NCT NCT01120028

    Campath, Calcineurin Inhibitor Reduction and Chronic Allograft Nephropathy

    Not yet reported, Not yet reported University of Oxford 852 participants Est. completion 2020-03 20 sites Stand-alone
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT01121744

    Supralimus-Core™ Pharmacokinetic (PK) Study

    Not yet reported Sahajanand Medical Technologies Limited 20 participants Est. completion 2011-01 4 sites
    Cardiovascular disease
    View official trial listing →
  • Terminated NCT NCT01122719

    Brazilian and Italian Evaluation of Safety Using Tacrolimus-eluting Stent With Short-term Dual Antiplatelet Regimen

    Not yet reported CID - Carbostent & Implantable Devices 16 participants Est. completion 2013-03 2 sites
    Other conditions: Stable Coronary Disease, Unstable Coronary Disease, Documented Silent Ischemia
    View official trial listing →
  • Terminated NCT NCT01125293

    Everolimus, Bortezomib and/or Rituximab in Patients With Relapsed/Refractory Waldenstrom's Macroglobulinemia

    Not yet reported, Not yet reported Dana-Farber Cancer Institute 46 participants Est. completion 2014-08 1 site
    Other conditions: Waldenstrom's Macroglobulinemia
    View official trial listing →
  • Completed NCT NCT01126333

    Long-term Follow-up of Spare the Nephron (STN) Patients

    University of Maryland, Baltimore 128 participants Est. completion 2015-06-30 1 site
    Other conditions: Kidney Transplant
    View official trial listing →
  • Completed NCT NCT01127763

    RAD001 Plus Carboplatin in Breast Cancer Patients

    Not yet reported NYU Langone Health 25 participants Est. completion 2013-03 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT01128335

    Efficacy, Safety, Tolerability, Pharmacokinetics of Sotrastaurin-tacrolimus vs. Mycophenolic Acid-tacrolimus in de Novo Liver Transplant Patients

    Not yet reported Novartis Pharmaceuticals 200 participants Est. completion 2012-07 39 sites Stand-alone
    Other conditions: Liver Transplantation
    View official trial listing →
  • Completed NCT NCT01131988

    Bioavailability Study of Tacrolimus Capsules, 5 mg of Dr. Reddy's Under Fasting Conditions

    Not yet reported Dr. Reddy's Laboratories Limited 40 participants Est. completion 2008-03 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01132027

    Bioavailability Study of Tacrolimus Capsules, 5 mg of Dr. Reddys's Laboratories Limited Under Non-Fasting Conditions

    Not yet reported Dr. Reddy's Laboratories Limited 40 participants Est. completion 2008-03 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Terminated NCT NCT01133678

    Study in Locally Advanced Squamous Cell Carcinoma of Head and Neck

    Not yet reported University of Chicago 50 participants Est. completion 2015-01 2 sites
    Other conditions: Head and Neck Cancer
    View official trial listing →
  • Completed NCT NCT01134952

    Study of Sirolimus Versus Mycophenolate Liver Transplant Recipients With Recurrent Hepatitis C Virus (HCV)

    Not yet reported London Health Sciences Centre 11 participants Est. completion 2014-12 1 site Stand-alone
    Other conditions: Hepatitis C
    View official trial listing →
  • Terminated NCT NCT01135329

    Reduced-intensity, Related-donor Bone Marrow Transplantation Followed by High-dose Cyclophosphamide for Hematologic Cancers

    Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 15 participants Est. completion 2012-05 1 site Stand-alone
    Other conditions: Lymphoma, Leukemia, Myelodysplastic Syndrome
    View official trial listing →
  • Completed NCT NCT01136395

    Impact of Rituximab (RTx) Induction and Living Donation on Immunoregulation and Virus Control in Renal Transplantation

    Not yet reported University of Giessen 85 participants Est. completion 2019-06-18 1 site
    Other conditions: Kidney Transplantation, Rituximab (RTx), Living Donors, Immunology, Virus
    View official trial listing →
  • Completed NCT NCT01136798

    Impact of Exenatide on Sleep in Type 2 Diabetes

    Not yet reported University of Chicago 18 participants Est. completion 2016-09-01 2 sites Stand-alone
    Type 2 diabetes Other conditions: Sleep Disordered Breathing
    View official trial listing →
  • Completed NCT NCT01137084

    Liver Transplantation Results in Hepatocellular Carcinoma Patients With Immunosuppression Without Steroids

    Not yet reported Shanghai Jiao Tong University School of Medicine 300 participants Est. completion 2009-12 1 site
    Other conditions: Immunosuppression, Hepatocellular Carcinoma, Liver Transplantation, Post-operative Complications
    View official trial listing →
  • Completed NCT NCT01139450

    Study of 0417 Ointment in the Treatment of Atopic Dermatitis

    Not yet reported Fougera Pharmaceuticals Inc. 899 participants Est. completion 2009-08 1 site
    Other conditions: Atopic Dermatitis
    View official trial listing →
  • Status unknown NCT NCT01140893

    Effects of Exenatide on Glycemic Control and Weight in Continuous Subcutaneous Insulin Infusion (CSII) Type 2 Treated Patients With Type 2 Diabetes

    Not yet reported, Not yet reported University Hospital, Caen 110 participants 3 sites Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01144338

    Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus

    Not yet reported AstraZeneca 14752 participants Est. completion 2017-04-24 629 sites Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01145950

    Study to Compare the Safety and Pharmacokinetic Characteristics of LBEC0101 25 mg With Those of Enbrel®

    Not yet reported LG Life Sciences 36 participants Est. completion 2011-01 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01147627

    Effect of Different Interventions on Glycemic Control and β-cell Function in Newly Diagnosed Type 2 Diabetic Patients

    Not yet reported Sun Yat-sen University 416 participants Est. completion 2012-12 25 sites
    Type 2 diabetes Other conditions: Newly Diagnosed
    View official trial listing →
  • Status unknown NCT NCT01148628

    Dose-finding Study of CAELYXTM and RAD001 in Patients With Advanced Solid Tumors

    Not yet reported Southern Europe New Drug Organization 54 participants Est. completion 2011-12 3 sites
    Other conditions: Advanced Solid Tumors
    View official trial listing →
  • Completed NCT NCT01148680

    Trial Comparing Metabolic Efficiency of Islet Graft to Intensive Insulin Therapy for Type 1 Diabetes's Treatment

    Not yet reported University Hospital, Grenoble 50 participants Est. completion 2018-09 9 sites
    Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT01149382

    Immune Response to Influenza Vaccine in Islet Cell Transplant Recipients

    University of Alberta 61 participants Est. completion 2011-12 1 site
    Other conditions: Transplant
    View official trial listing →
  • Terminated NCT NCT01149434

    Study of JI-101 in Patients With Advanced Low Grade Endocrine Tumors, Ovarian Cancers or K-RAS Mutant Colon Cancers

    Not yet reported, Not yet reported University of Utah 19 participants Est. completion 2012-08 1 site
    Other conditions: Cancer, Neuroendocrine, Ovarian Cancer, Colon Cancer
    View official trial listing →
  • Completed NCT NCT01150097

    Extension Study to Evaluate the Long-term Efficacy and Safety of Everolimus in Liver Transplant Recipients

    Not yet reported Novartis Pharmaceuticals 284 participants Est. completion 2013-05-03 57 sites Stand-alone
    Other conditions: Liver Transplant Recipient
    View official trial listing →
  • Completed NCT NCT01152801

    Safety of RAD001 in Chinese Patients With Metastatic Renal Cell Cancer

    Not yet reported Novartis Pharmaceuticals 64 participants Est. completion 2013-12 7 sites
    Other conditions: Metastatic Renal Cell Carcinoma
    View official trial listing →
  • Completed NCT NCT01152840

    Study of RAD001 in Adenoid Cystic Carcinoma

    Not yet reported Seoul National University Hospital 33 participants Est. completion 2012-12 1 site
    Other conditions: Adenoid Cystic Carcinoma
    View official trial listing →
  • Completed NCT NCT01154075

    Medication Adherence in Children Who Had a Liver Transplant

    Icahn School of Medicine at Mount Sinai 401 participants Est. completion 2015-06 5 sites
    Other conditions: Pediatric Recipients of a Liver Transplant
    View official trial listing →
  • Completed NCT NCT01154335

    Everolimus and OSI-906 for Patients With Refractory Metastatic Colorectal Cancer

    Not yet reported SCRI Development Innovations, LLC 18 participants Est. completion 2013-05 2 sites
    Other conditions: Metastatic Colorectal Cancer
    View official trial listing →
  • Status unknown NCT NCT01154387

    Evaluating Safety and Efficacy of TOL101 Induction Versus Anti-Thymocyte Globulin to Prevent Kidney Transplant Rejection

    Not yet reported, Not yet reported Tolera Therapeutics, Inc 85 participants Est. completion 2013-06 12 sites Stand-alone
    Other conditions: End Stage Renal Disease, Renal Transplant
    View official trial listing →
  • Completed NCT NCT01157858

    Everolimus and LongActing Octreotide Trial in Polycystic Livers

    Not yet reported Radboud University Medical Center 44 participants Est. completion 2012-07 1 site
    Other conditions: Polycystic Liver Disease
    View official trial listing →
  • Completed NCT NCT01159080

    Treatment of the optImuM Dose of calcineUrin Inhibitor and Mycophenolate Sodium in Kidney Recipients

    Not yet reported Asan Medical Center 350 participants Est. completion 2016-11-30 1 site Stand-alone
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT01160276

    Drug Interaction Between Colchicine and Calcineurin Inhibitors in Renal Graft Recipients

    Not yet reported Assistance Publique - Hôpitaux de Paris 17 participants Est. completion 2012-01 1 site
    Other conditions: Renal Replacement Therapies
    View official trial listing →
  • Completed NCT NCT01161459

    Treatment of Idiopathic Membranous Nephropathy With Tripterygium Wilfordii Plus Steroid vs Tacrolimus Plus Steroid

    Not yet reported Zhi-Hong Liu, M.D. 100 participants Est. completion 2013-10 1 site
    Other conditions: Idiopathic Membranous Nephropathy
    View official trial listing →
  • Completed NCT NCT01162005

    Therapeutic Effect of Tacrolimus on Primary Nephrotic Syndrome in Children

    Not yet reported Seoul National University Hospital 77 participants Est. completion 2013-10 1 site Stand-alone
    Other conditions: Nephrotic Syndrome
    View official trial listing →
  • Completed NCT NCT01163357

    Bortezomib, Total Marrow Irradiation, Fludarabine Phosphate, and Melphalan in Treating Patients Undergoing Donor Peripheral Blood Stem Cell Transplant For High-Risk Stage I or II Multiple Myeloma

    Not yet reported City of Hope Medical Center 18 participants Est. completion 2024-05-20 1 site Stand-alone
    Other conditions: Autologous Hematopoietic Stem Cell Transplant Recipient, Loss of Chromosome 17p, Plasma Cell Leukemia, Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma
    View official trial listing →
  • Withdrawn NCT NCT01163929

    A Study to Look at the Combination of Chemotherapy, Trastuzumab and RAD001 in HER2 Positive Breast Cancer

    Not yet reported University of Kansas Est. completion 2012-03
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT01164176

    Everolimus in Treating Patients With Locally Advanced or Metastatic Thyroid Cancer

    Not yet reported Yonsei University 40 participants Est. completion 2014-10 7 sites
    Other conditions: Head and Neck Cancer
    View official trial listing →
  • Terminated NCT NCT01166724

    Renal Allograft Function and Histology Following Switching From A Tacrolimus to Sirolimus (SRL)-Based Immunosuppression-

    Not yet reported The Cleveland Clinic 12 participants Est. completion 2014-12 1 site
    Other conditions: Kidney Transplant
    View official trial listing →
  • Completed NCT NCT01167530

    Study to Evaluate RAD001 in Combination With Radiotherapy in Non-small Cell Lung Cancer

    Not yet reported Gustave Roussy, Cancer Campus, Grand Paris 26 participants Est. completion 2017-02-09 1 site
    Other conditions: Non-small Cell Lung Cancer, Locally Advanced Disease
    View official trial listing →
  • Completed NCT NCT01168219

    Busulfan, Fludarabine Phosphate, and Anti-Thymocyte Globulin Followed By Donor Stem Cell Transplant and Azacitidine in Treating Patients With High-Risk Myelodysplastic Syndrome and Older Patients With Acute Myeloid Leukemia

    Not yet reported National Cancer Institute (NCI) 68 participants Est. completion 2020-02-01 17 sites Stand-alone
    Other conditions: Acute Myeloid Leukemia, Adult Acute Megakaryoblastic Leukemia, Adult Acute Monoblastic Leukemia, Adult Acute Monocytic Leukemia, Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11, Adult Acute Myeloid Leukemia With Maturation, Adult Acute Myeloid Leukemia With Minimal Differentiation, Adult Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11, Adult Acute Myeloid Leukemia With t(8;21); (q22; q22.1); RUNX1-RUNX1T1, Adult Acute Myeloid Leukemia With t(9;11)(p21.3;q23.3); MLLT3-MLL, Adult Acute Myeloid Leukemia Without Maturation, Adult Acute Myelomonocytic Leukemia, Adult Erythroleukemia, Adult Pure Erythroid Leukemia, Alkylating Agent-Related Acute Myeloid Leukemia, de Novo Myelodysplastic Syndrome, Myelodysplastic Syndrome, Myelodysplastic Syndrome With Excess Blasts, Recurrent Adult Acute Myeloid Leukemia, Secondary Myelodysplastic Syndrome
    View official trial listing →
  • Completed NCT NCT01169701

    24 Months Follow-up, Two Arm Study to Compare the Cardiovascular Profile in a Regimen With Everolimus + Mycophenolic Acid (MPA) Versus (vs.) a Regimen of CNI+MPA in Maintenance Renal Transplant Recipients

    Not yet reported Novartis Pharmaceuticals 71 participants Est. completion 2014-03 9 sites Stand-alone
    Other conditions: Renal Transplant
    View official trial listing →
  • Withdrawn NCT NCT01170052

    Bendamustine and Temsirolimus in Patients With Relapsed or Refractory Mantle Cell Non-Hodgkin's Lymphoma (NHL)

    Not yet reported, Not yet reported Charite University, Berlin, Germany 20 participants Est. completion 2014-04 3 sites
    Other conditions: Mantle Cell Lymphoma
    View official trial listing →
  • Completed NCT NCT01170715

    Psoriasis Inflammation and Systemic Co Morbidities

    Not yet reported Rockefeller University 29 participants Est. completion 2013-09-09 1 site Stand-alone
    Other conditions: Psoriasis
    View official trial listing →
  • Completed NCT NCT01172418

    Randomized Trial of 2 Antibody Induction Steroid Avoidance Protocols

    Not yet reported University of Miami 200 participants Est. completion 2010-05 1 site
    Other conditions: Transplant; Failure, Kidney
    View official trial listing →
  • Completed NCT NCT01172769

    Efficacy Study of Temsirolimus to Treat Head and Neck Cancer

    Not yet reported Hannover Medical School 42 participants Est. completion 2012-03 7 sites
    Other conditions: Head and Neck Squamous Cell Carcinoma
    View official trial listing →
  • Status unknown NCT NCT01174810

    Exendin-4 as a Treatment for Parkinson's Disease - Pilot Study

    Not yet reported University College, London 40 participants Est. completion 2013-03 1 site Stand-alone
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Status unknown NCT NCT01175096

    Safety and Tolerability Profile of RAD001 Daily in Chinese Patients With Advanced Pulmonary Neuroendocrine Tumor

    Not yet reported, Not yet reported Guangdong Provincial People's Hospital 20 participants Est. completion 2012-01 1 site
    Other conditions: Neuroendocrine Tumors, Carcinoid Tumor
    View official trial listing →
  • Completed NCT NCT01177397

    Study to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple Myeloma

    Not yet reported, Not yet reported Celgene 226 participants Est. completion 2016-12-09 16 sites
    Other conditions: Multiple Myeloma, Diffuse Large B-Cell Lymphoma, Glioblastoma Multiforme, Hepatocellular Carcinoma, Non-Small Cell Lung Cancer, Neuroendocrine Tumors of Non-Pancreatic Origin, Hormone Receptor-Positive Breast Cancer
    View official trial listing →
  • Completed NCT NCT01181271

    Tandem Auto-Allo Transplant for Lymphoma

    Not yet reported Massachusetts General Hospital 42 participants Est. completion 2016-02 2 sites Stand-alone
    Other conditions: Diffuse, Large B-Cell, Lymphoma, Lymphoma, Low-Grade, T-Cell Lymphoma, Mantle-Cell Lymphoma, Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, Lymphoma, Small Lymphocytic
    View official trial listing →
  • Completed NCT NCT01181986

    The Study of Exenatide Action on Vessel Function in Type 2 Diabetes and Prediabetes

    Not yet reported Carl T. Hayden VA Medical Center 76 participants Est. completion 2012-12 1 site Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01182168

    Gemcitabine and Split-Dose Cisplatin Plus Everolimus (RAD001) in Patients With Advanced Solid Tumor Malignancies

    Not yet reported Memorial Sloan Kettering Cancer Center 12 participants Est. completion 2016-03 1 site
    Other conditions: Bladder Cancer, Renal Pelvis Cancer, Ureter Cancer
    View official trial listing →
  • Withdrawn NCT NCT01182883

    A Phase I Study of IMC-A12 in Combination With Temsirolimus in Pediatric Patients With Recurrent or Refractory Solid Tumors

    Not yet reported National Cancer Institute (NCI) Est. completion 2012-04-04
    Other conditions: Brain Stem Neoplasms, Glioma, Pinealoma
    View official trial listing →
  • Completed NCT NCT01183247

    An Open, Single Centre, Randomised, Parallel Group Study to Investigate Three Different Immunosuppressive Regimens

    Not yet reported University Hospital, Basel, Switzerland 63 participants Est. completion 2010-06 1 site
    Other conditions: Comparative Study, Immunosuppressive Agents
    View official trial listing →
  • Completed NCT NCT01183663

    Lenalidomide in Combination With Bevacizumab, Sorafenib, Temsirolimus, or 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX)

    Not yet reported M.D. Anderson Cancer Center 180 participants Est. completion 2016-05 1 site
    Other conditions: Advanced Cancers
    View official trial listing →
  • Completed NCT NCT01184885

    A Pilot Study to Determine the Safety and Tolerability of Sirolimus Given With Hyper-CVAD Chemotherapy

    Not yet reported Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 7 participants Est. completion 2013-04 2 sites Stand-alone
    Other conditions: Lymphoid Malignancies (New or Relapsed), Acute Lymphoblastic Leukemia, Burkitt Lymphoma, Lymphoblastic Lymphoma, Mantle Cell Lymphoma, Adult T-cell Leukemia/Lymphoma
    View official trial listing →
  • Completed NCT NCT01184898

    Pilot Trial of Sirolimus/MEC in High Risk Acute Myelogenous Leukemia (AML)

    Not yet reported Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 36 participants Est. completion 2016-02 2 sites Stand-alone
    Other conditions: AML
    View official trial listing →
  • Terminated NCT NCT01185366

    Everolimus Versus Sunitinib in Non-Clear Cell Renal Cell Carcinoma

    Not yet reported M.D. Anderson Cancer Center 73 participants Est. completion 2019-09-09 4 sites
    Other conditions: Kidney Cancer
    View official trial listing →
  • Completed NCT NCT01186107

    Comparison of Zotarolimus-Eluting Stent vs Sirolimus-Eluting Stent for Diabetic Patients

    Not yet reported Seung-Jung Park 256 participants Est. completion 2013-07 11 sites
    Cardiovascular disease Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01187953

    Double-Blind,Double-Dummy,Efficacy/Safety,LCP-Tacro™ Vs Prograf®,Prevention Rejection,De Novo Adult Kidney Tx

    Not yet reported Asahi Kasei Therapeutics, Inc. 543 participants Est. completion 2014-03 86 sites Stand-alone
    Other conditions: Renal Failure
    View official trial listing →
  • Completed NCT NCT01188655

    Observational Non-Interventional Study With Enbrel (Etanercept) in Patients With Ankylosing Spondylitis

    Pfizer 89 participants Est. completion 2010-03
    Other conditions: Spondylitis, Ankylosing
    View official trial listing →
  • Completed NCT NCT01188798

    Methotrexate or Pentostatin for Graft-versus-host Disease Prophylaxis in Risk-adapted Allogeneic Bone Marrow Transplantation for Hematologic Malignancies

    Not yet reported St. Jude Children's Research Hospital 6 participants Est. completion 2012-02 1 site
    Other conditions: Acute Lymphoblastic Leukemia, Acute Myelocytic Leukemia, Chronic Myelocytic Leukemia, Hodgkin's Disease, Myelodysplastic Syndrome
    View official trial listing →
  • Completed NCT NCT01190670

    A Study to Evaluate the Drug Interaction of ASP015K and Tacrolimus

    Not yet reported Astellas Pharma Inc 40 participants Est. completion 2010-09 1 site Stand-alone
    Other conditions: Healthy, Pharmacokinetics of ASP015K and Tacrolimus
    View official trial listing →
  • Completed NCT NCT01195194

    Selection of Immunosuppression in Kidney Transplant Recipients Depending on Pre-transplant Donor-specific T-cell Reactivity.

    Not yet reported Josep M Grinyo 61 participants Est. completion 2013-06 2 sites Stand-alone
    Other conditions: Disorder Related to Renal Transplantation
    View official trial listing →
  • Completed NCT NCT01196819

    Randomized MicroPort's Firehawk DES Versus Xience V: TARGET I Trial

    Not yet reported Shanghai MicroPort Medical (Group) Co., Ltd. 458 participants Est. completion 2016-12 1 site
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT01197170

    Hormone Receptor Positive Disease Across Solid Tumor Types: A Phase I Study of Single-Agent Hormone Blockade and Combination Approaches With Targeted Agents to Provide Synergy and Overcome Resistance

    Not yet reported M.D. Anderson Cancer Center 277 participants Est. completion 2021-01-13 1 site
    Other conditions: Solid Tumors, Advanced Cancer
    View official trial listing →
  • Terminated NCT NCT01198158

    Everolimus With or Without Bevacizumab in Treating Patients With Advanced Kidney Cancer That Progressed After First-Line Therapy

    Not yet reported National Cancer Institute (NCI) 77 participants Est. completion 2017-12-16 524 sites
    Other conditions: Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Carcinoma, Stage III Renal Cell Cancer AJCC v7, Stage IV Renal Cell Cancer AJCC v7
    View official trial listing →
  • Completed NCT NCT01198184

    Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 and Temsirolimus in Treating Patients With Advanced Solid Tumors

    Not yet reported National Cancer Institute (NCI) 18 participants Est. completion 2013-10 2 sites
    Other conditions: Endometrial Papillary Serous Carcinoma, Recurrent Endometrial Carcinoma, Recurrent Renal Cell Cancer, Stage III Endometrial Carcinoma, Stage III Renal Cell Cancer, Stage IV Endometrial Carcinoma, Stage IV Renal Cell Cancer, Unspecified Adult Solid Tumor, Protocol Specific
    View official trial listing →
  • Completed NCT NCT01200693

    Z-SEA-SIDE: Sirolimus Versus Everolimus Versus Zotarolimus-eluting Stent Assessment in Bifurcated Lesions and Clinical SIgnificance of Residual siDE-branch Stenosis

    Not yet reported Catholic University of the Sacred Heart 80 participants Est. completion 2012-03 1 site
    Cardiovascular disease Other conditions: Coronary Stenosis
    View official trial listing →
  • Terminated NCT NCT01202058

    An Observational Safety Evaluation of Patients Treated With the NEVO™ Sirolimus-eluting Coronary Stent. (NEVO II)

    Not yet reported Cordis US Corp. 156 participants Est. completion 2012-10 3 sites Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT01203709

    Low-dose Combination of Mycophenolate Mofetil (MMF) and Tacrolimus (Tac) for Refractory Lupus Nephritis

    Not yet reported Tuen Mun Hospital 20 participants Est. completion 2013-02 1 site Stand-alone
    Other conditions: Lupus Nephritis
    View official trial listing →
  • Completed NCT NCT01203722

    Reduced Intensity, Partially HLA Mismatched BMT to Treat Hematologic Malignancies

    Not yet reported, Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 87 participants Est. completion 2024-05-28 1 site
    Other conditions: Hematologic Malignancies
    View official trial listing →
  • Completed NCT NCT01206569

    Long-Acting Tacrolimus for the Treatment of Resistant Lupus Nephritis

    Not yet reported Chinese University of Hong Kong 2 participants Est. completion 2012-02 1 site Stand-alone
    Other conditions: Lupus Nephritis
    View official trial listing →
  • Completed NCT NCT01207141

    rATG Induction and Tacrolimus Monotherapy in Pediatric Liver Transplantation

    University of Pittsburgh 110 participants Est. completion 2019-05 1 site
    Other conditions: Liver Transplantation, Thymoglobulin, Rejection
    View official trial listing →
  • Completed NCT NCT01207297

    Tacrolimus Versus Cyclophosphamide as Treatment for Lupus Nephritis

    Not yet reported Zhejiang University 40 participants Est. completion 2010-06
    Other conditions: SLE, Lupus Nephritis, Renal Insufficiency, End-stage Renal Disease
    View official trial listing →
  • Completed NCT NCT01208337

    Safety and Efficacy of Alemtuzumab in Pediatric Intestinal Transplantation

    Not yet reported University of Pittsburgh 23 participants Est. completion 2014-11
    Other conditions: Evidence of Liver Transplantation, Rejection, ALEMTUZUMAB
    View official trial listing →
  • Completed NCT NCT01208649

    Effects of Exenatide (Byetta®) on Liver Function in Patients With Nonalcoholic Steatohepatitis (NASH)

    Not yet reported Ruhr University of Bochum 13 participants Est. completion 2010-09 1 site
    MASLD
    View official trial listing →
  • Completed NCT NCT01208896

    Allogeneic Hematopoietic Stem Cell Transplantation After Reduced-intensity Conditioning for Relapsed Follicular Lymphoma

    Not yet reported University Hospital, Bordeaux 32 participants Est. completion 2017-09-28 26 sites Stand-alone
    Other conditions: Lymphoma, Follicular, Stem Cell Transplantation
    View official trial listing →
  • Completed NCT NCT01210482

    Temsirolimus (Torisel) Drug Use Investigation (Regulatory Post Marketing Commitment Plan)

    Pfizer 1050 participants Est. completion 2018-05-31 1 site
    Other conditions: Renal Cell Carcinoma
    View official trial listing →
  • Terminated NCT NCT01215136

    First-line Everolimus +/- Paclitaxel for Cisplatin-ineligible Patients With Advanced Urothelial Carcinoma

    Not yet reported Matthew Galsky 36 participants Est. completion 2018-04-24 11 sites
    Other conditions: Transitional Cell Carcinoma, Bladder Carcinoma, Urothelial Carcinoma
    View official trial listing →
  • Status unknown NCT NCT01216826

    Phase II Study of Everolimus in Children and Adolescents With Refractory or Relapsed Osteosarcoma

    Not yet reported Sidnei Epelman 20 participants Est. completion 2014-12 1 site
    Obstructive sleep apnea
    View official trial listing →
  • Status unknown NCT NCT01216839

    Phase II Study of Everolimus in Children and Adolescents With Refractory or Relapsed Rhabdomyosarcoma and Other Soft Tissue Sarcomas

    Not yet reported Sidnei Epelman 20 participants Est. completion 2013-12 1 site
    Other conditions: Refractory or Relapsed RMS and Soft Tissue Sarcomas
    View official trial listing →
  • Active, not recruiting NCT NCT01217931

    Sequential Two-agent Assessment in Renal Cell Carcinoma Therapy: The START Trial

    Not yet reported M.D. Anderson Cancer Center 180 participants Est. completion 2028-01-31 1 site
    Other conditions: Kidney Cancer
    View official trial listing →
  • Completed NCT NCT01218555

    Study of Everolimus (RAD001) in Combination With Lenalidomide

    Not yet reported Emory University 44 participants Est. completion 2020-11-05 2 sites
    Other conditions: Solid Organ Malignancies, Adenoidcystic Carcinoma, Neuroendocrine Tumors
    View official trial listing →
  • Terminated NCT NCT01220297

    Sirolimus & Mycophenolate Mofetil as GvHD Prophylaxis in Myeloablative, Matched Related Donor HCT

    Not yet reported Stanford University 3 participants Est. completion 2011-08 1 site Stand-alone
    Other conditions: Hematologic Diseases, Acute-graft-versus-host Disease, Leukemia, Non-Hodgkin Lymphoma (NHL), Hodgkin Lymphoma
    View official trial listing →
  • Completed NCT NCT01220856

    Reparixin in Pancreatic Islet Transplantation

    Not yet reported Dompé Farmaceutici S.p.A 9 participants Est. completion 2013-04-30 2 sites
    Other conditions: Pancreatic Islet Transplantation in Type 1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT01222039

    Multicenter Clinical Trial for the Evaluation of Mesenchymal Stem Cells From Adipose Tissue in Patients With Chronic Graft Versus Host Disease.

    Not yet reported, Not yet reported Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud 19 participants Est. completion 2014-06 4 sites Stand-alone
    Other conditions: Graft Versus Host Disease, Chronic and Expanded Graft Versus Host Disease, Immune System Diseases
    View official trial listing →
  • Completed NCT NCT01222715

    Vinorelbine Tartrate and Cyclophosphamide in Combination With Bevacizumab or Temsirolimus in Treating Patients With Recurrent or Refractory Rhabdomyosarcoma

    Not yet reported National Cancer Institute (NCI) 87 participants Est. completion 2015-06 184 sites
    Obstructive sleep apnea Other conditions: Recurrent Adult Soft Tissue Sarcoma
    View official trial listing →
  • Completed NCT NCT01223027

    Study of Dovitinib Versus Sorafenib in Patients With Metastatic Renal Cell Carcinoma

    Not yet reported Novartis Pharmaceuticals 564 participants Est. completion 2014-06 199 sites
    Other conditions: Metastatic Renal Cell Carcinoma
    View official trial listing →
  • Terminated NCT NCT01223755

    Sirolimus In Autosomal Dominant Polycystic Kidney Disease And Severe Renal Insufficiency

    Not yet reported, Not yet reported Mario Negri Institute for Pharmacological Research 41 participants Est. completion 2012-07 1 site Stand-alone
    Other conditions: Autosomal Dominant Polycystic Kidney Disease (ADPKD)
    View official trial listing →
  • Completed NCT NCT01224028

    A Study to Evaluate the Efficacy and Safety of Tacrolimus in Korean Nephropathy Patients

    Not yet reported Astellas Pharma Inc 40 participants Est. completion 2011-06 1 site Stand-alone
    Other conditions: IgA Nephropathy
    View official trial listing →
  • Completed NCT NCT01224041

    Study to Evaluate the Efficacy of Tacrolimus in Rheumatoid Arthritis Patients Shown Unsuccessful Response to Methotrexate

    Not yet reported Astellas Pharma Inc 78 participants Est. completion 2011-06 5 sites Stand-alone
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT01224418

    A Study to Evaluate the Efficacy of Tacrolimus in Rheumatoid Arthritis Patients Shown Unsuccessful Response to Methotrexate

    Not yet reported Astellas Pharma Inc 50 participants Est. completion 2009-08 2 sites Stand-alone
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Suspended NCT NCT01226056

    Sorafenib in Combination With RAD001 in Advanced Solid Tumors Selected on Molecular Targets

    Not yet reported, Not yet reported Southern Europe New Drug Organization 45 participants Est. completion 2012-12 1 site
    Other conditions: Advanced Solid Tumors
    View official trial listing →
  • Status unknown NCT NCT01226355

    NOYA CoCr Biodegradable Coating Sirolimus-Eluting Coronary Stent System

    Not yet reported Medfavour (Beijing) Medical Co., Ltd 300 participants Est. completion 2014-11 1 site Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT01229943

    Everolimus and Octreotide Acetate With or Without Bevacizumab in Treating Patients With Locally Advanced or Metastatic Pancreatic Neuroendocrine Tumors That Cannot Be Removed by Surgery

    Not yet reported National Cancer Institute (NCI) 150 participants Est. completion 2018-01-03 394 sites
    Other conditions: Advanced Pancreatic Neuroendocrine Tumor, Locally Advanced Pancreatic Neuroendocrine Tumor, Pancreatic Gastrinoma, Pancreatic Neuroendocrine Tumor G1, Pancreatic Neuroendocrine Tumor G2, Pancreatic Vipoma
    View official trial listing →
  • Terminated NCT NCT01230502

    Mycophenolic Acid (MPA) Monotherapy in Liver Transplantation

    Not yet reported University of Wisconsin, Madison 11 participants Est. completion 2012-06 1 site Stand-alone
    Other conditions: Liver Transplant
    View official trial listing →
  • Completed NCT NCT01231399

    Everolimus and Combination Chemotherapy in Treating Patients With Metastatic Stomach or Esophageal Cancer

    Not yet reported, Not yet reported City of Hope Medical Center 6 participants Est. completion 2016-07 3 sites
    Other conditions: Adenocarcinoma of the Esophagus, Adenocarcinoma of the Gastroesophageal Junction, Diffuse Adenocarcinoma of the Stomach, Intestinal Adenocarcinoma of the Stomach, Mixed Adenocarcinoma of the Stomach, Recurrent Esophageal Cancer, Recurrent Gastric Cancer, Stage IV Esophageal Cancer, Stage IV Gastric Cancer
    View official trial listing →
  • Status unknown NCT NCT01233167

    Effect of Different Anti-platelet Strategies on the Long-term Outcome After Sirolimus Drug-eluting Stent Implantation

    Not yet reported Sir Run Run Shaw Hospital 5232 participants Est. completion 2013-05
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT01233570

    Topical Tacrolimus 0.1% Ointment For Treatment Of Cutaneous Crohn's Disease

    Not yet reported University of Aberdeen 20 participants 1 site Stand-alone
    Other conditions: Crohn Disease
    View official trial listing →
  • Withdrawn NCT NCT01234974

    IGF-1 Inhibitor Pasireotide Lar in Combination With the m-TOR Inhibitor Everolimus

    Not yet reported Milton S. Hershey Medical Center Est. completion 2013-12 1 site
    Other conditions: Multiple Myeloma
    View official trial listing →
  • Completed NCT NCT01236378

    Study To Evaluate Pharmacokinetics Of Sirolimus In Stable Renal Transplant Recipients

    Not yet reported Pfizer 24 participants Est. completion 2011-04 2 sites Stand-alone
    Other conditions: Transplant Rejection, Renal Transplantation
    View official trial listing →
  • Completed NCT NCT01237197

    Exenatide in Extreme Pediatric Obesity

    Not yet reported University of Minnesota 26 participants Est. completion 2012-10 2 sites Stand-alone
    Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT01237314

    The Impact of Food on Blood Sugar in People With Type 2 Diabetes

    HealthPartners Institute 46 participants Est. completion 2013-05 1 site
    Type 2 diabetes
    View official trial listing →
  • Terminated NCT NCT01239368

    Th1/Tc1 Immunotherapy Following Stem Cell Transplantation in Multiple Myeloma

    Not yet reported, Not yet reported National Cancer Institute (NCI) 34 participants Est. completion 2017-08-16 2 sites
    Other conditions: Myeloma, Plasma-Cell, Myeloma-Multiple, Myelomatosis
    View official trial listing →
  • Completed NCT NCT01239472

    Cytokines Evaluation in Early Calcineurin Inhibitors Withdrawn on Renal Transplant

    Not yet reported Andre Barreto Pereira 30 participants Est. completion 2015-06 1 site
    Other conditions: Renal Transplant Rejection, Immunosuppression
    View official trial listing →
  • Status unknown NCT NCT01239563

    Thymoglobulin Induction in Kidney Transplant Recipients

    Not yet reported University of Oxford 40 participants Est. completion 2016-05 2 sites
    Other conditions: Kidney Transplantation, Ischemia-Reperfusion Injury
    View official trial listing →
  • Completed NCT NCT01241591

    A Phase 3, Multi Site, Randomized, Double Blind, Placebo Controlled Study Of The Efficacy And Safety Comparing CP- 690,550 And Etanercept In Subjects With Moderate To Severe Chronic Plaque Psoriasis

    Not yet reported Pfizer 1101 participants Est. completion 2013-01 122 sites
    Other conditions: Psoriasis
    View official trial listing →
  • Completed NCT NCT01242306

    Comparison of Endothelial Dysfunction (BMS vs SES) in the Same Patient With Multiple Coronary Artery Lesions

    Not yet reported, Not yet reported Azienda Ospedaliera San Camillo Forlanini 25 participants Est. completion 2009-12 1 site
    Other conditions: Endothelial Dysfunction
    View official trial listing →
  • Withdrawn NCT NCT01244659

    A Randomized Study Assess the Safety and Efficacy of Tacrolimus vs Prograf® in Renal Transplantation Treatment

    Not yet reported EMS Est. completion 2014-12 1 site Stand-alone
    Other conditions: Renal Transplant
    View official trial listing →
  • Completed NCT NCT01244906

    Post-transplant Cyclophosphamide and Sirolimus Following Reduced Intensity Conditioning (RIC) Transplant

    Not yet reported Northside Hospital, Inc. 26 participants Est. completion 2014-12 1 site Stand-alone
    Other conditions: Hematologic Neoplasms
    View official trial listing →
  • Completed NCT NCT01246206

    Tacrolimus and Thymoglobulin, as GvHD Prophylaxis in Patients Undergoing Related Donor HCT

    Not yet reported Barbara Ann Karmanos Cancer Institute 21 participants Est. completion 2013-10 1 site Stand-alone
    Other conditions: Hematological Malignancies
    View official trial listing →
  • Status unknown NCT NCT01246817

    Temsirolimus-RCC-imaging

    Not yet reported Radboud University Medical Center 51 participants 1 site
    Other conditions: Renal Cell Cancer
    View official trial listing →
  • Completed NCT NCT01248403

    A Randomized, Double Blind Study Evaluating Paclitaxel With and Without RAD001 in Patients With Gastric Carcinoma After Prior Chemotherapy

    Not yet reported Krankenhaus Nordwest 300 participants Est. completion 2019-10 1 site
    Other conditions: Advanced Gastric Cancer, Esophagogastric Junction Cancer
    View official trial listing →
  • Completed NCT NCT01248494

    PhIb BKM120 or BEZ235+Endocrine Treatment in Post-Menopausal Patients With Hormone Receptor + Metastatic Breast Cancer

    Not yet reported Vanderbilt-Ingram Cancer Center 72 participants Est. completion 2016-05 6 sites
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT01251575

    Sirolimus, Cyclosporine, and Mycophenolate Mofetil in Preventing Graft-versus-Host Disease in Treating Patients With Blood Cancer Undergoing Donor Peripheral Blood Stem Cell Transplant

    Not yet reported Fred Hutchinson Cancer Center 77 participants Est. completion 2019-02-11 5 sites Stand-alone
    Other conditions: Adult Acute Lymphoblastic Leukemia, Adult Acute Myeloid Leukemia, Adult Diffuse Large B-Cell Lymphoma, Adult Myelodysplastic Syndrome, Adult Non-Hodgkin Lymphoma, Aggressive Non-Hodgkin Lymphoma, Childhood Acute Lymphoblastic Leukemia, Childhood Acute Myeloid Leukemia, Childhood Diffuse Large B-Cell Lymphoma, Childhood Myelodysplastic Syndrome, Childhood Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, Chronic Lymphocytic Leukemia in Remission, Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Hematopoietic and Lymphoid Cell Neoplasm, Mantle Cell Lymphoma, Plasma Cell Myeloma, Prolymphocytic Leukemia, Recurrent Chronic Lymphocytic Leukemia, Refractory Chronic Lymphocytic Leukemia, T-Cell Prolymphocytic Leukemia, Waldenstrom Macroglobulinemia, Recurrent Diffuse Large B-Cell Lymphoma, Recurrent Hodgkin Lymphoma
    View official trial listing →
  • Terminated NCT NCT01255163

    A Pilot Clinical Trial of Exendin-4 in Alzheimer's Disease

    Not yet reported National Institute on Aging (NIA) 57 participants Est. completion 2016-11-18 1 site Stand-alone
    Other conditions: Alzheimer's Disease, Mild Cognitive Impairment
    View official trial listing →
  • Status unknown NCT NCT01255956

    Restenosis Treatment With Rapamycin Eluting Stent or Paclitaxel Eluting Balloon Catheter (RESTENOZA)

    Not yet reported Medical University of Warsaw 200 participants Est. completion 2012-07 4 sites
    Other conditions: In-Stent Restenosis
    View official trial listing →
  • Completed NCT NCT01256294

    Pharmacokinetics of Generic to Brand Tacrolimus in Stable Renal Transplant Patients

    Not yet reported Novartis 71 participants Est. completion 2011-05 2 sites Stand-alone
    Other conditions: Renal Transplant
    View official trial listing →
  • Completed NCT NCT01256385

    Temsirolimus With or Without Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Cancer Who Did Not Respond to Previous Therapy

    Not yet reported National Cancer Institute (NCI) 86 participants Est. completion 2013-12 24 sites
    Other conditions: Recurrent Hypopharyngeal Squamous Cell Carcinoma, Recurrent Laryngeal Squamous Cell Carcinoma, Recurrent Laryngeal Verrucous Carcinoma, Recurrent Lip and Oral Cavity Squamous Cell Carcinoma, Recurrent Metastatic Squamous Cell Carcinoma in the Neck With Occult Primary, Recurrent Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma, Recurrent Nasopharyngeal Keratinizing Squamous Cell Carcinoma, Recurrent Oral Cavity Verrucous Carcinoma, Recurrent Oropharyngeal Squamous Cell Carcinoma, Recurrent Salivary Gland Carcinoma, Salivary Gland Squamous Cell Carcinoma, Squamous Cell Carcinoma Metastatic in the Neck With Occult Primary, Stage IV Hypopharyngeal Squamous Cell Carcinoma, Stage IV Nasopharyngeal Keratinizing Squamous Cell Carcinoma, Stage IVA Laryngeal Squamous Cell Carcinoma, Stage IVA Laryngeal Verrucous Carcinoma, Stage IVA Lip and Oral Cavity Squamous Cell Carcinoma, Stage IVA Major Salivary Gland Carcinoma, Stage IVA Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma, Stage IVA Oral Cavity Verrucous Carcinoma, Stage IVA Oropharyngeal Squamous Cell Carcinoma, Stage IVB Laryngeal Squamous Cell Carcinoma, Stage IVB Laryngeal Verrucous Carcinoma, Stage IVB Lip and Oral Cavity Squamous Cell Carcinoma, Stage IVB Major Salivary Gland Carcinoma, Stage IVB Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma, Stage IVB Oral Cavity Verrucous Carcinoma, Stage IVB Oropharyngeal Squamous Cell Carcinoma, Stage IVC Laryngeal Squamous Cell Carcinoma, Stage IVC Laryngeal Verrucous Carcinoma, Stage IVC Lip and Oral Cavity Squamous Cell Carcinoma, Stage IVC Major Salivary Gland Carcinoma, Stage IVC Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma, Stage IVC Oral Cavity Verrucous Carcinoma, Stage IVC Oropharyngeal Squamous Cell Carcinoma, Tongue Carcinoma
    View official trial listing →
  • Completed NCT NCT01256398

    Dasatinib Followed by Stem Cell Transplant in Treating Older Patients With Newly Diagnosed Acute Lymphoblastic Leukemia

    Not yet reported National Cancer Institute (NCI) 66 participants Est. completion 2021-11-15 101 sites Stand-alone
    Other conditions: Acute Lymphoblastic Leukemia, Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1
    View official trial listing →
  • Completed NCT NCT01262703

    Safety Study of a Bioresorbable Coronary Stent

    Not yet reported REVA Medical, Inc. 49 participants Est. completion 2018-12 1 site Stand-alone
    Cardiovascular disease Other conditions: Myocardial Ischemia, Coronary Artery Stenosis, Coronary Disease, Coronary Restenosis
    View official trial listing →
  • Completed NCT NCT01265537

    A Pilot Study Comparing the Use of Low-target Versus Conventional Target Advagraf

    Not yet reported University of British Columbia 30 participants Est. completion 2019-10-11 1 site Stand-alone
    Other conditions: Acute Graft Rejection, Diabetes
    View official trial listing →
  • Completed NCT NCT01266057

    Sirolimus or Vorinostat and Hydroxychloroquine in Advanced Cancer

    Not yet reported M.D. Anderson Cancer Center 143 participants Est. completion 2021-02-11 1 site Stand-alone
    Other conditions: Advanced Cancers
    View official trial listing →
  • Completed NCT NCT01266148

    SCHEDULE - Scandinavian Heart Transplant Everolimus de Novo Study With Early Calcineurin Inhibitor (CNI) Avoidance

    Not yet reported Novartis Pharmaceuticals 115 participants Est. completion 2012-12 6 sites
    Other conditions: Renal Function and Chronic Allograft Vasculopathy
    View official trial listing →
  • Completed NCT NCT01266837

    Open Label, Single Arm Trial to Characterize Patients With Metastatic RCC Treated With Everolimus After Failure of the First VEGF-targeted Therapy (MARC-2)

    Not yet reported iOMEDICO AG 64 participants Est. completion 2017-10-31 8 sites
    Other conditions: Metastatic Renal Cell Carcinoma, Failure of Exactly One Prior VEGF-targeted Therapy
    View official trial listing →
  • Terminated NCT NCT01268995

    Improving Secretion of Insulin in New Onset Diabetes After Renal Transplantation

    Not yet reported Medical University of Vienna 32 participants Est. completion 2010-12 1 site Stand-alone
    Other conditions: New Onset Diabetes Mellitus After Renal Transplantation
    View official trial listing →
  • Withdrawn NCT NCT01269684

    Immediate Conversion From Tacrolimus to Everolimus in Stable Maintenance Renal Transplant Recipients

    Not yet reported Novartis Pharmaceuticals Est. completion 2008-08 1 site
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT01270321

    Pasireotide & Everolimus in Adult Patients With Radioiodine-Refractory Differentiated & Medullary Thyroid Cancer

    Not yet reported Emory University 42 participants Est. completion 2019-02 3 sites
    Other conditions: Thyroid Cancer
    View official trial listing →
  • Completed NCT NCT01270997

    Randomized Double-blind Parallel Trial to Evaluate Equivalence in Efficacy and Safety of HD203 and Enbrel in RA Patients

    Not yet reported Hanwha Chemical 294 participants Est. completion 2012-05 1 site Stand-alone
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Terminated NCT NCT01272141

    A Study of Lapatinib in Combination With Everolimus in Patients With Advanced, Triple Negative Breast Cancer

    Not yet reported Emory University 5 participants Est. completion 2014-01 3 sites
    Other conditions: Breast Neoplasms, Breast Cancer, Cancer of the Breast
    View official trial listing →
  • Completed NCT NCT01274234

    OCT Evaluation of Healing of COMBO Stent

    Not yet reported, Not yet reported Prof. Stephen Lee 61 participants Est. completion 2012-06 1 site Stand-alone
    Other conditions: Coronary Restenosis, Coronary Thrombosis
    View official trial listing →
  • Completed NCT NCT01276314

    Evaluation of TNF-α Blockade Effect in Patients With Severe Cutaneous Adverse Drug Reactions

    Not yet reported Chang Gung Memorial Hospital 135 participants Est. completion 2015-05 1 site Stand-alone
    Other conditions: Drug Hypersensitivity
    View official trial listing →
  • Terminated NCT NCT01276834

    Comparison of Immunosuppression on Progression of Arteriosclerosis in Renal Transplantation

    Not yet reported Dianet Dialysis Centers 13 participants Est. completion 2012-07 1 site
    Other conditions: Renal Transplantation
    View official trial listing →
  • Terminated NCT NCT01278745

    Prevention of Cardiac Allograft Vasculopathy Using Rituximab (Rituxan) Therapy in Cardiac Transplantation

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 362 participants Est. completion 2015-10 24 sites Stand-alone
    Other conditions: Cardiac Allograft Vasculopathy, Heart Transplant Recipients
    View official trial listing →
  • Terminated NCT NCT01279616

    A Reduced Toxicity Allogeneic Unrelated Donor Stem Cell Transplantation (SCT) for Severe Sickle Cell Disease

    Not yet reported Nationwide Children's Hospital 8 participants Est. completion 2015-01 1 site Stand-alone
    Other conditions: Sickle Cell Disease
    View official trial listing →
  • Withdrawn NCT NCT01280669

    Intravitreal Sirolimus as Therapeutic Approach to Uveitis

    Not yet reported Stanford University Est. completion 2024-12 1 site Stand-alone
    Other conditions: Uveitis, Intermediate Uveitis, Posterior Uveitis, Panuveitis
    View official trial listing →
  • Completed NCT NCT01281514

    A Study of Carboplatin, PLD and Everolimus in Certain Gynecologic Cancer

    Not yet reported Fox Chase Cancer Center 21 participants Est. completion 2018-01-08 1 site
    Other conditions: Fallopian Tube Cancer, Peritoneal Cavity Cancer, Recurrent Ovarian Epithelial Cancer
    View official trial listing →
  • Completed NCT NCT01281917

    Study of Velcade and Temsirolimus for Relapsed or Refractory Non-Hodgkin Lymphoma

    Not yet reported University of Wisconsin, Madison 40 participants Est. completion 2014-06 18 sites
    Other conditions: Non-Hodgkins Lymphoma
    View official trial listing →
  • Completed NCT NCT01282697

    Clinical Trial of Rapamycin and Irinotecan in Pediatric Patients With Refractory Solid Tumors

    Not yet reported University Hospital, Strasbourg, France 42 participants Est. completion 2013-02-20 9 sites
    Other conditions: Refractory Solid Tumors in Children
    View official trial listing →
  • Status unknown NCT NCT01283789

    Lapatinib and RAD-001 for HER2 Positive Metastatic Breast Cancer

    Not yet reported University of Kansas Medical Center 23 participants Est. completion 2017-04 1 site
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT01287715

    Withdrawal of Etanercept After Successful Treatment of Juvenile Idiopathic Arthritis

    Not yet reported Erasmus Medical Center 50 participants Est. completion 2013-09 10 sites Stand-alone
    Other conditions: Juvenile Idiopathic Arthritis
    View official trial listing →
  • Completed NCT NCT01288521

    Pharmacogenetics to Predict Drug Interactions in Kidney Transplant Recipients

    Not yet reported Sony Tuteja 8 participants Est. completion 2011-09 1 site Stand-alone
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Withdrawn NCT NCT01288664

    Efficacy and Safety of Tacrolimus Sustained-release Capsules in Induction Phase Treatment in Lupus Nephritis

    Not yet reported Sun Yat-sen University Est. completion 2012-12 1 site Stand-alone
    Other conditions: Lupus Nephritis
    View official trial listing →
  • Status unknown NCT NCT01289301

    Studying the Effect of Changing Immunosuppression in Case of Polyoma BK Virus Infection of the Renal Transplant

    Not yet reported Hannover Medical School 124 participants Est. completion 2018-10 4 sites
    Other conditions: Disorder Related to Renal Transplantation, Immunosuppression Related Infectious Disease, Virus Diseases
    View official trial listing →
  • Status unknown NCT NCT01289730

    Etanercept (Enbrel) in Undifferentiated Spondyloarthritis

    Not yet reported Charite University, Berlin, Germany 8 participants Est. completion 2012-05 2 sites Stand-alone
    Other conditions: Spondyloarthritis
    View official trial listing →
  • Status unknown NCT NCT01289743

    Etanercept (Enbrel) in Ankylosing Spondylitis

    Not yet reported Charite University, Berlin, Germany 24 participants Est. completion 2012-05 2 sites Stand-alone
    Other conditions: Ankylosing Spondylitis
    View official trial listing →
  • Terminated NCT NCT01292525

    Protocol Calcineurin Inhibitor (CNI) Weaning

    Not yet reported Nantes University Hospital 16 participants Est. completion 2015-05 1 site Stand-alone
    Other conditions: Function of Renal Transplant
    View official trial listing →
  • Completed NCT NCT01294020

    Study to Compare the Pharmacokinetics of Tacrolimus in Stable Pediatric Allograft Recipients Converted From Prograf® to Advagraf®

    Not yet reported Astellas Pharma Europe Ltd. 81 participants Est. completion 2025-11-03 16 sites Stand-alone
    Other conditions: Intestine Transplantation, Kidney Transplantation, Lung Transplantation, Liver Transplantation, Heart Transplantation
    View official trial listing →
  • Terminated NCT NCT01294397

    Effects of Denosumab on the Pharmacokinetics of Etanercept

    Not yet reported Amgen 19 participants Est. completion 2016-01 2 sites Stand-alone
    Other conditions: Postmenopausal, Osteopenia, Rheumatoid Arthritis, Osteoporosis
    View official trial listing →
  • Completed NCT NCT01294748

    Clinical Investigation of the MiStent Drug Eluting Stent (DES) in Coronary Artery Disease

    Not yet reported Micell Technologies 184 participants Est. completion 2016-08 28 sites Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT01295151

    SWITCH Clinical Trial for Patients With Rheumatoid Arthritis Who Have Failed an Initial TNF-blocking Drug.

    Not yet reported Julia Brown 122 participants Est. completion 2015-11 1 site Stand-alone
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT01298713

    Tamoxifen-RAD001 Versus Tamoxifen Alone in Patients With Anti-aromatase Resistant Breast Metastatic Cancer

    Not yet reported ARCAGY/ GINECO GROUP 111 participants Est. completion 2018-09-12 1 site
    Other conditions: Breast Neoplasms, mTor Protein
    View official trial listing →
  • Completed NCT NCT01303874

    Etanercept and Methotrexate in Patients to Induce Remission in Early Arthritis (EMPIRE)

    Not yet reported University of Leeds 112 participants Est. completion 2010-11-05 1 site Stand-alone
    Other conditions: Rheumatoid Arthritis, Inflammatory Arthritis
    View official trial listing →
  • Terminated NCT NCT01303965

    Allo Transplant Followed by Lenalidomide and Sirolimus Maintenance in High-Risk Multiple Myeloma (MM)

    Not yet reported, Not yet reported Sherif S. Farag 14 participants Est. completion 2017-07-28 1 site Stand-alone
    Other conditions: Multiple Myeloma
    View official trial listing →
  • Completed NCT NCT01304836

    A Study Looking at Diabetes in Kidney Transplant Recipients Receiving Immunosuppressive Regimen With or Without Steroids

    Not yet reported Astellas Pharma Inc 1166 participants Est. completion 2013-05-22 100 sites Stand-alone
    Other conditions: Kidney Transplantation
    View official trial listing →
  • No Longer Available NCT NCT01309022

    Immunosuppressive Medications for Participants in ITN005CT (NCT00014911)

    National Institute of Allergy and Infectious Diseases (NIAID) 3 sites
    Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT01309477

    The Efficacy and Tolerance of Tacrolimus Sustained-release Capsules on Refractory Nephrotic Syndrome (RNS)

    Not yet reported Sun Yat-sen University 20 participants Est. completion 2011-10 1 site Stand-alone
    Other conditions: Nephrotic Syndrome
    View official trial listing →
  • Terminated NCT NCT01312064

    De Novo Everolimus-based Therapy for Renal Transplantation Using Rituximab Induction

    Not yet reported National Taiwan University Hospital 2 participants Est. completion 2012-04 1 site
    Other conditions: Renal Insufficiency
    View official trial listing →
  • Completed NCT NCT01313208

    Moderate Rheumatoid Arthritis (RA) With Etanercept (Enbrel)

    Not yet reported Amgen 210 participants Est. completion 2013-05 47 sites Stand-alone
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT01313221

    Efficacy and Safety of Etanercept 50 mg Once Weekly Plus As Needed Topical Agent in Moderate to Severe Plaque Psoriasis

    Not yet reported Amgen 310 participants Est. completion 2013-05 24 sites Stand-alone
    Other conditions: Psoriasis
    View official trial listing →
  • Terminated NCT NCT01313390

    Everolimus and Docetaxel in Treating Patients With Recurrent, Locally Advanced, or Metastatic Head and Neck Cancer

    Not yet reported, Not yet reported University College, London 4 participants Est. completion 2011-04 1 site
    Other conditions: Head and Neck Cancer
    View official trial listing →
  • Terminated NCT NCT01313559

    Pasireotide (SOM230) With or Without Everolimus in Treating Patients With Hormone Resistant, Chemotherapy Naive Prostate Cancer

    Not yet reported Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 6 participants Est. completion 2012-11-29 2 sites
    Other conditions: Castrate Resistant Prostate Cancer, Chemotherapy Naive Prostate Cancer, Prostate Cancer
    View official trial listing →
  • Terminated NCT NCT01316133

    A Study to Evaluate the Efficacy and Safety of Tacrolimus With Steroid in Korean Lupus Nephritis Patients

    Not yet reported Astellas Pharma Korea, Inc. 37 participants Est. completion 2016-04-08 7 sites Stand-alone
    Other conditions: Lupus Nephritis
    View official trial listing →
  • Completed NCT NCT01317615

    RAD001 With Paclitaxel and Carboplatin in First Line Treatment of Patients With Advanced Large Cell Lung Cancer With Neuroendocrine Differentiation

    Not yet reported Novartis Pharmaceuticals 49 participants Est. completion 2015-03 9 sites
    Other conditions: Carcinoma, Large Cell, Neuroendocrine Tumors
    View official trial listing →
  • Terminated NCT NCT01318915

    Research Study of ATG and Rituximab in Renal Transplantation

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 10 participants Est. completion 2017-08-25 6 sites Stand-alone
    Other conditions: Renal Transplant Recipients
    View official trial listing →
  • Completed NCT NCT01320579

    Investigation of the Efficacy of 2.5% and 5% Cis-urocanic Acid in Patients With Moderate or Severe Atopic Dermatitis

    Not yet reported BioCis Pharma Ltd 159 participants Est. completion 2012-06 7 sites
    Other conditions: Atopic Dermatitis
    View official trial listing →
  • Completed NCT NCT01323920

    Bortezomib-based GVHD Prophylaxis After Allogeneic Transplant for Patients Without Matched Related Donors

    Not yet reported Dana-Farber Cancer Institute 35 participants Est. completion 2013-11 1 site Stand-alone
    Other conditions: Leukemia, Lymphoma, Myelodysplastic Syndrome
    View official trial listing →
  • Completed NCT NCT01324492

    Safety and Efficacy of RAD001 in Chinese Patients With Advanced Pulmonary Neuroendocrine Tumor

    Not yet reported Novartis Pharmaceuticals 16 participants Est. completion 2014-06 4 sites
    Other conditions: Lung Neuroendocrine Neoplasm
    View official trial listing →
  • Terminated NCT NCT01324934

    Efficacy and Safety of ATG-Fresenius Following a Renal Transplantation, Without Corticosteroids

    Not yet reported Neovii Biotech 40 participants Est. completion 2011-01 10 sites
    Other conditions: Renal Transplant Rejection
    View official trial listing →
  • Completed NCT NCT01325571

    A Study to Compare the Efficacy and Safety of Tacrolimus Capsules in Patient With Myasthenia Gravis

    Not yet reported Astellas Pharma Inc 83 participants Est. completion 2014-05 9 sites Stand-alone
    Other conditions: Myasthenia Gravis
    View official trial listing →
  • Withdrawn NCT NCT01326468

    Torisel in Addition to Standard Chemotherapy With Radiation for Advanced Head and Neck Cancer

    Not yet reported Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University Est. completion 2016-12
    Other conditions: Head and Neck Cancer
    View official trial listing →
  • Completed NCT NCT01327573

    Eculizumab Therapy for Chronic Complement-Mediated Injury in Kidney Transplantation

    Not yet reported Sanjay Kulkarni 16 participants Est. completion 2015-02 1 site Stand-alone
    Other conditions: Kidney; Complications, Allograft
    View official trial listing →
  • Completed NCT NCT01328834

    Efficacy and Safety of Tacrolimus Sustained-release Capsules in Induction Treatment in Refractory Lupus Nephritis

    Not yet reported Sun Yat-sen University 20 participants Est. completion 2011-10 1 site Stand-alone
    Other conditions: Nephritis, Lupus
    View official trial listing →
  • Completed NCT NCT01331135

    Aflac ST0901 CHOANOME - Sirolimus in Solid Tumors

    Not yet reported Emory University 18 participants Est. completion 2017-08-09 1 site Stand-alone
    Obstructive sleep apnea Other conditions: Ewing's Sarcoma, Astrocytoma, Atypical Teratoid/Rhabdoid Tumor, Ependymoma, Germ Cell Tumor, Glioma, Medulloblastoma, Rhabdoid Tumor, Retinoblastoma, Clear Cell Sarcoma, Renal Cell Carcinoma, Wilms Tumor, Hepatoblastoma, Neuroblastoma
    View official trial listing →
  • Completed NCT NCT01332201

    Study to Compare the Pharmacokinetics of Tacrolimus in Adult Transplant Recipients Treated With Advagraf® or Prograf®

    Not yet reported Astellas Pharma Inc 17 participants Est. completion 2013-11 8 sites
    Other conditions: Heart Transplantation, Lung Transplantation, Pancreas (Including SPK) Transplantation
    View official trial listing →
  • Completed NCT NCT01333085

    Everolimus, Carboplatin, and Paclitaxel in Locally Advanced Head and Neck Cancer That Cannot Be Removed by Surgery

    Not yet reported, Not yet reported GERCOR - Multidisciplinary Oncology Cooperative Group 49 participants Est. completion 2013-05 5 sites
    Other conditions: Head and Neck Cancer
    View official trial listing →
  • Status unknown NCT NCT01333410

    Comparison of Efficacy and Safety of 0.1% Tacrolimus and 0.1% Mometasone Furoate for Adult Vitiligo

    Not yet reported Mahidol University 30 participants Est. completion 2013-12 1 site
    Other conditions: Vitiligo
    View official trial listing →
  • Completed NCT NCT01334073

    Study of the Combination of Axitinib Plus Everolimus in Patients With Malignant Advanced Solid Tumors

    Not yet reported University Hospital, Bordeaux 19 participants Est. completion 2015-01 2 sites
    Other conditions: Malignant Advanced Solid Tumors, Carcinoma, Renal Cell
    View official trial listing →
  • Completed NCT NCT01334333

    Comparison of Medication Adherence Between Once and Twice Daily Tacrolimus in Stable Renal Transplant Recipients

    Not yet reported University of British Columbia 46 participants Est. completion 2018-03-01 1 site Stand-alone
    Other conditions: Renal Disease, Renal Transplant
    View official trial listing →
  • Withdrawn NCT NCT01335074

    Temsirolimus + Sorafenib in Advanced Hepatocellular Carcinoma (HCC)

    Not yet reported, Not yet reported Philipps University Marburg 1 site
    Other conditions: Hepatocellular Carcinoma
    View official trial listing →
  • Completed NCT NCT01336296

    Evaluate Effects and Safety of Pre-load Myfortic® in Transplant Patients

    Not yet reported University of Cincinnati 61 participants Est. completion 2014-04 1 site
    Other conditions: Kidney Transplant Recipients
    View official trial listing →
  • Completed NCT NCT01338090

    89Zr-bevacizumab PET Imaging in Patients With Neuroendocrine Tumors

    University Medical Center Groningen 14 participants Est. completion 2012-03 1 site
    Other conditions: Neuroendocrine Tumors
    View official trial listing →
  • Completed NCT NCT01338987

    Pilot Study of Leuprolide to Improve Immune Function After Allogeneic Bone Marrow Transplantation

    Not yet reported National Cancer Institute (NCI) 76 participants Est. completion 2020-11-19 3 sites Stand-alone
    Other conditions: Myelodysplastic Syndrome, Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Chronic Myelogenous Leukemia, Chronic Myelomonocytic Leukemia
    View official trial listing →
  • Completed NCT NCT01339468

    A Study to Assess the Pharmacokinetics, Safety and Efficacy of Advagraf and Prograf in de Novo Liver Transplantation

    Not yet reported Astellas Pharma Inc 100 participants Est. completion 2014-05-27 1 site Stand-alone
    Other conditions: Liver Transplantation
    View official trial listing →
  • Completed NCT NCT01341301

    Donor Stem Cell Transplant in Treating Patients With High-Risk Hematologic Malignancies

    Not yet reported Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 25 participants Est. completion 2014-08-07 1 site Stand-alone
    Other conditions: Hematologic Malignancy
    View official trial listing →
  • Status unknown NCT NCT01341834

    Safety and Tolerability Study of RAD001 and LBH589 in All Solid Tumors With Enrichment for EBV Driven Tumors

    Not yet reported National Cancer Centre, Singapore 49 participants Est. completion 2018-12 1 site
    Other conditions: Nasopharyngeal Carcinoma, Lymphomas, Any EBV+ Solid Tumour
    View official trial listing →
  • Terminated NCT NCT01342016

    A Study to Compare the Efficacy and Safety of Tacrolimus Capsules With Leflunomide Tablets in Lupus Nephritis Patients

    Not yet reported Astellas Pharma Inc 84 participants Est. completion 2013-05 12 sites Stand-alone
    Other conditions: Lupus Nephritis
    View official trial listing →
  • Status unknown NCT NCT01342042

    The Safety,Preliminary Pharmacodynamics and Pharmacokinetics Study of rExenatide-4 in Chinese Type 2 Diabetes Mellitus

    Not yet reported CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 36 participants Est. completion 2011-12 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01342289

    Shorter Course Tacrolimus After Nonmyeloablative, Related Donor BMT With High-dose Posttransplantation Cyclophosphamide

    Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 127 participants Est. completion 2018-03 1 site Stand-alone
    Other conditions: Hodgkin's Lymphoma, Leukemia, Myelodysplastic Syndrome(MDS), Multiple Myeloma, Non Hodgkin's Lymphoma
    View official trial listing →
  • Completed NCT NCT01343498

    Study of PI3 Kinase/mTOR Inhibitor BEZ235 Twice Daily for Advanced Solid Tumors

    Not yet reported SCRI Development Innovations, LLC 33 participants Est. completion 2014-01 2 sites
    Other conditions: Malignant Solid Tumour
    View official trial listing →
  • Completed NCT NCT01345227

    Bone Marrow as an Alternative Site for Islet Transplantation

    Not yet reported Ospedale San Raffaele 8 participants Est. completion 2011-10 1 site
    Other conditions: Type 1 Diabetes, Postpancreatectomy Hyperglycemia
    View official trial listing →
  • Completed NCT NCT01346397

    Study Cyclosporine (CsA) Versus Tacrolimus (Tacro) After Campath Induction in Kidney Transplantation

    Russian Academy of Medical Sciences 170 participants Est. completion 2016-05 1 site
    Other conditions: Acute Graft Rejection, Chronic Allograft Nephropathy, Polyomavirus-related Transplant Nephropathy
    View official trial listing →
  • Terminated NCT NCT01347866

    Clinical Study Of PI3K/mTOR Inhibitors In Combination With An Oral MEK Inhibitor Or Irinotecan In Patients With Advanced Cancer

    Not yet reported Pfizer 105 participants Est. completion 2015-12 18 sites
    Other conditions: Advanced Cancer
    View official trial listing →
  • Completed NCT NCT01349101

    A Research Study of Bone Marrow Transplantation From Unrelated or Partially Matched Related Donors

    Not yet reported Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 78 participants Est. completion 2022-12-07 1 site Stand-alone
    Other conditions: Hematological Malignancies
    View official trial listing →
  • Completed NCT NCT01350245

    Bone Marrow Transplantation of Patients in Remission Using Partially Matched Relative Donor

    Not yet reported Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 28 participants Est. completion 2014-05 1 site Stand-alone
    Other conditions: Acute Myeloid Leukemia, Myelodysplastic Syndromes, Biphenotypic Leukemia, Acute Lymphocytic Leukemia, Chronic Myeloid Leukemia, Chronic Lymphocytic Leukemia, Plasma Cell Neoplasms, Lymphoma, Hodgkin's Disease, Aplastic Anemia
    View official trial listing →
  • Status unknown NCT NCT01353053

    Comparison of Two Immunosuppressive Regimens in Kidney Transplant Recipients With Deceased Donors With the Aim of Preventing the Development of Fibrosis / Atrophy of Reducing the Incidence of Cytomegalovirus Infection

    Federal University of São Paulo 82 participants 1 site
    Other conditions: Disorder of Transplanted Kidney, Cytomegalovirus Infections
    View official trial listing →
  • Completed NCT NCT01353417

    Non-interventional-study With Tacrolimus Sandoz© Capsules for Prophylaxis of Renal Graft Rejection

    Sandoz 102 participants Est. completion 2015-08-31 1 site
    Other conditions: Chronic Kidney Insufficiency
    View official trial listing →
  • Completed NCT NCT01353625

    Study to Assess Safety and Tolerability of Oral CC-115 for Patients With Advanced Solid Tumors, and Hematologic Malignancies.

    Not yet reported Celgene 118 participants Est. completion 2021-03-12 17 sites
    Obstructive sleep apnea Other conditions: Glioblastoma Multiforme, Squamous Cell Carcinoma of Head and Neck, Prostate Cancer, Chronic Lymphocytic Leukemia, Neoplasm Metastasis
    View official trial listing →
  • Completed NCT NCT01354301

    Efficacy and Safety of Induction Strategies Combined With Low Tacrolimus Exposure in Kidney Transplant Recipients Receiving Everolimus or Sodium Mycophenolate

    Not yet reported Hospital do Rim e Hipertensão 300 participants Est. completion 2014-12 1 site Stand-alone
    Other conditions: Cytomegalovirus Infection, Renal Transplant Failure, Transplant; Complication, Rejection
    View official trial listing →
  • Completed NCT NCT01356758

    Cardiovascular Risk Assessment in Patients With Severe Psoriasis Treated With Biologic Agents

    University of Aarhus 126 participants Est. completion 2015-11 1 site
    Other conditions: Psoriasis, Atopic Dermatitis, Atherosclerosis
    View official trial listing →
  • Completed NCT NCT01358578

    Safety and Efficacy of Secukinumab Compared to Etanercept in Subjects With Moderate to Severe, Chronic Plaque-Type Psoriasis

    Not yet reported Novartis Pharmaceuticals 1306 participants Est. completion 2013-07 152 sites Stand-alone
    Other conditions: Chronic Plaque Psoriasis
    View official trial listing →
  • Completed NCT NCT01363752

    A Study Looking at Kidney Function in Kidney Transplant Recipients Who Are Taking Anti-rejection Medication Including Tacrolimus and With or Without Sirolimus.

    Not yet reported Astellas Pharma Inc 853 participants Est. completion 2013-09-18 58 sites Stand-alone
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT01364584

    Impact of Exenatide on Cardiovascular Exercise Performance in Type 2 Diabetes

    Not yet reported University of Colorado, Denver 23 participants Est. completion 2014-12 1 site Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01364844

    Safety and Tolerability of DS-7423 in Subjects With Advanced Solid Malignant Tumors

    Not yet reported Daiichi Sankyo 42 participants Est. completion 2013-11 3 sites
    Other conditions: Solid Tumor, Colorectal Cancer, Endometrial Cancer
    View official trial listing →
  • Terminated NCT NCT01365468

    Efficacy and Safety of RAD001 in Treating Plexiform Neurofibromas (PN) Associated With Neurofibromatosis (NF1)

    Not yet reported Novartis Pharmaceuticals 9 participants Est. completion 2015-04 2 sites
    Other conditions: Plexiform Neurofibroma Associated With Neurofibromatosis Type 1
    View official trial listing →
  • Completed NCT NCT01367457

    INHIBITOR: Retrospective Study Of Patients With Renal Cell Carcinoma And Mantle Cell Lymphoma Treated With Temsirolimus

    Pfizer 243 participants Est. completion 2015-04 16 sites
    Other conditions: Carcinoma, Renal Cell, Lymphoma, Mantle-Cell
    View official trial listing →
  • Completed NCT NCT01368627

    The E-SERIES Registry for Supralimus® Coronary Stent for the Treatment of Unselected Patients With Coronary Lesions

    Not yet reported Sahajanand Medical Technologies Limited 1274 participants Est. completion 2011-12 7 sites Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT01369082

    Extended Follow-Up After Islet Transplantation in T1D

    National Institute of Allergy and Infectious Diseases (NIAID) 75 participants Est. completion 2017-07 8 sites
    Other conditions: Type 1 Diabetes (T1D), Islet Transplantation
    View official trial listing →
  • Terminated NCT NCT01369433

    A Rollover Protocol to Allow Continued Access to Tivozanib (AV 951) for Subjects Enrolled in Other Tivozanib Protocols

    Not yet reported AVEO Pharmaceuticals, Inc. 225 participants Est. completion 2015-10 49 sites
    Other conditions: Solid Tumors
    View official trial listing →
  • Completed NCT NCT01371331

    A Study to Determine Pharmacokinetics of Children Receiving Modigraf (Tacrolimus Granules) Following Solid Organ Transplantation

    Not yet reported Astellas Pharma Europe Ltd. 52 participants Est. completion 2015-02-03 10 sites Stand-alone
    Other conditions: Kidney Transplantation, Heart Transplantation, Liver Transplantation
    View official trial listing →
  • Terminated NCT NCT01371344

    A Paediatric, Open, Follow up Study With Modigraf Examining Safety and Efficacy in de Novo Allograft Recipients

    Not yet reported Astellas Pharma Europe Ltd. 47 participants Est. completion 2017-04-02 12 sites Stand-alone
    Other conditions: Heart Transplantation, Kidney Transplantation, Liver Transplantation
    View official trial listing →
  • Status unknown NCT NCT01372930

    Etanercept Treating Patient With Acute ST Segment Elevated Myocardial Infarction

    Not yet reported Xijing Hospital 200 participants 1 site Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT01374750

    Efficacy of Sirolimus In Liver Transplantation for Hepatocellular Carcinoma (HCC)

    Not yet reported Seoul National University Hospital 45 participants Est. completion 2016-05 1 site
    Other conditions: Hepatocellular Carcinoma
    View official trial listing →
  • Active, not recruiting NCT NCT01375829

    Ixabepilone and Temsirolimus in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery

    Not yet reported National Cancer Institute (NCI) 22 participants Est. completion 2027-03-19 2 sites
    Other conditions: Adult Solid Neoplasm
    View official trial listing →
  • Terminated NCT NCT01376310

    GSK1120212 Rollover Study

    Not yet reported Novartis Pharmaceuticals 159 participants Est. completion 2018-01-18 19 sites
    Other conditions: Cancer
    View official trial listing →
  • Terminated NCT NCT01378377

    Combination Trial of Pimasertib (MSC1936369B) With Temsirolimus

    Not yet reported EMD Serono 33 participants Est. completion 2012-02-23 3 sites
    Other conditions: Advanced Solid Tumor
    View official trial listing →
  • Completed NCT NCT01379209

    Intravenous Administration of RGI-2001 in Patient Undergoing Allogenic Hematopoietic Stem Cell Transplantation (AHSCT)

    Not yet reported, Not yet reported Regimmune Corporation 68 participants Est. completion 2017-04 6 sites Stand-alone
    Other conditions: Graft Versus Host Disease
    View official trial listing →
  • Terminated NCT NCT01379521

    Safety and Efficacy of RAD001 + TACE in Localized Unresectable HCC

    Not yet reported Novartis Pharmaceuticals 65 participants Est. completion 2015-06 5 sites
    Other conditions: Hepatocellular Carcinoma
    View official trial listing →
  • Status unknown NCT NCT01379729

    Bet Cell Therapy in Diabetes Type 1

    Not yet reported Universitair Ziekenhuis Brussel 10 participants Est. completion 2018-05 2 sites
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT01380535

    Extracorporeal Photopheresis (ECP) With Methoxsalen for Chronic Graft Versus Host Disease (cGVHD)

    Not yet reported Mallinckrodt 60 participants Est. completion 2015-03 32 sites Stand-alone
    Other conditions: Chronic Graft Versus Host Disease
    View official trial listing →
  • Withdrawn NCT NCT01383668

    Sirolimus and Gold Sodium Thiomalate in Treating Patients With Advanced Squamous Non-Small Cell Lung Cancer

    Not yet reported Mayo Clinic Est. completion 2013-02-08 Stand-alone
    Other conditions: Recurrent Non-small Cell Lung Cancer, Squamous Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer, Stage IIIB Non-small Cell Lung Cancer, Stage IV Non-small Cell Lung Cancer, Unspecified Adult Solid Tumor, Protocol Specific
    View official trial listing →
  • Completed NCT NCT01384513

    A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies

    Not yet reported Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 40 participants Est. completion 2022-11-16 1 site Stand-alone
    Obstructive sleep apnea Other conditions: Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Adult Nasal Type Extranodal NK/T-cell Lymphoma, Aplastic Anemia, Childhood Acute Lymphoblastic Leukemia in Remission, Childhood Acute Myeloid Leukemia in Remission, Childhood Myelodysplastic Syndromes, Chronic Eosinophilic Leukemia, Chronic Myelomonocytic Leukemia, Chronic Neutrophilic Leukemia, Essential Thrombocythemia, Juvenile Myelomonocytic Leukemia, Mastocytosis, Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable, Nodal Marginal Zone B-cell Lymphoma, Polycythemia Vera, Previously Treated Myelodysplastic Syndromes, Primary Myelofibrosis, Recurrent Adult Acute Lymphoblastic Leukemia, Recurrent Adult Acute Myeloid Leukemia, Recurrent Adult Diffuse Small Cleaved Cell Lymphoma, Recurrent Adult Grade III Lymphomatoid Granulomatosis, Recurrent Adult Hodgkin Lymphoma, Recurrent Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood Acute Myeloid Leukemia, Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Marginal Zone Lymphoma, Recurrent Mycosis Fungoides/Sezary Syndrome, Recurrent Small Lymphocytic Lymphoma, Recurrent/Refractory Childhood Hodgkin Lymphoma, Refractory Anemia, Refractory Anemia With Ringed Sideroblasts, Refractory Hairy Cell Leukemia, Refractory Multiple Myeloma, Secondary Myelodysplastic Syndromes, Splenic Marginal Zone Lymphoma, T-cell Large Granular Lymphocyte Leukemia, Waldenström Macroglobulinemia
    View official trial listing →
  • Terminated NCT NCT01387659

    Evaluate Tolerability of Myfortic®/Simulect® and Tacrolimus Without Steroids in Three Patient Populations

    Not yet reported The University of Texas Medical Branch, Galveston 2 participants Est. completion 2012-10 1 site
    Other conditions: Diabetes, Immunosuppression
    View official trial listing →
  • Completed NCT NCT01388387

    Pharmacogenetic Study of Tacrolimus in Hepatic Transplant (CYPTAC'H)

    Not yet reported Rennes University Hospital 154 participants Est. completion 2018-07-31 1 site Stand-alone
    Other conditions: Hepatic Transplantation
    View official trial listing →
  • Completed NCT NCT01388517

    Clinical Trial of 0.0003% Calcitriol, 0.1% Tacrolimus, and Petrolatum for the Treatment of Pityriasis Alba

    Not yet reported Universidad Autonoma de San Luis Potosí 39 participants Est. completion 2011-01 1 site
    Other conditions: Pityriasis Alba
    View official trial listing →
  • Completed NCT NCT01388608

    Standard Disease Activity Parameters and Step Activity in Patients With Rheumatoid Arthritis Receiving Etanercept

    University Hospital Muenster 28 participants Est. completion 2013-04 1 site
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT01389427

    Escalating Doses of Torisel in Combination With Three Chemotherapies Regimens: R-CHOP, R-FC or R-DHA for Patients With Relapsed/Refractory Mantle Cell Lymphoma (MCL).

    Not yet reported, Not yet reported The Lymphoma Academic Research Organisation 41 participants Est. completion 2015-09 11 sites
    Other conditions: Mantle Cell Lymphoma Refractory
    View official trial listing →
  • Completed NCT NCT01390402

    Alloreactive Haploidentical Natural Killer (NK) Cells With Busulfan and Fludarabine/ATG

    Not yet reported M.D. Anderson Cancer Center 6 participants Est. completion 2014-11 1 site Stand-alone
    Other conditions: Leukemia, Chronic Myelogenous Leukemia
    View official trial listing →
  • Completed NCT NCT01390818

    Trial of MEK Inhibitor and PI3K/mTOR Inhibitor in Subjects With Locally Advanced or Metastatic Solid Tumors

    Not yet reported EMD Serono 146 participants Est. completion 2015-04 8 sites
    Other conditions: Locally Advanced Solid Tumor, Metastatic Solid Tumor, Breast Cancer, Non Small Cell Lung Cancer, Melanoma, Colorectal Cancer
    View official trial listing →
  • Completed NCT NCT01392183

    Pazopanib Versus Temsirolimus in Poor-Risk Clear-Cell Renal Cell Carcinoma (RCC)

    Not yet reported M.D. Anderson Cancer Center 69 participants Est. completion 2019-09-08 1 site
    Other conditions: Kidney Cancer
    View official trial listing →
  • Withdrawn NCT NCT01394913

    Comparison of Two Etanercept Regimens (REUMATOCEPT® Versus ENBREL®) for Treatment of Rheumatoid Arthritis

    Not yet reported EMS Est. completion 2014-06 1 site Stand-alone
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Active, not recruiting NCT NCT01396408

    A Phase II Study of Sunitinib or Temsirolimus in Patients With Advanced Rare Tumours

    Not yet reported Canadian Cancer Trials Group 137 participants Est. completion 2026-12-31 17 sites
    Other conditions: Advanced Rare Tumours
    View official trial listing →
  • Status unknown NCT NCT01399242

    Efficacy of Certican® in Combination With Myfortic® in Renal

    Not yet reported Hospital Universitário São José 40 participants Est. completion 2013-06 1 site
    Other conditions: Disorder Related to Renal Transplantation
    View official trial listing →
  • Completed NCT NCT01400516

    Teriparatide for Joint Erosions in Rheumatoid Arthritis: The TERA Trial

    Not yet reported Brigham and Women's Hospital 26 participants Est. completion 2016-07-28 3 sites Stand-alone
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT01404325

    Efficacy Regarding Renal Function of Everolimus in Combination With Specific Standard Immunosuppressive Regimen Lung Transplant Recipients

    Not yet reported Novartis Pharmaceuticals 130 participants Est. completion 2017-01-05 9 sites
    Other conditions: Lung Transplantation
    View official trial listing →
  • Completed NCT NCT01405287

    Study of Vascular Healing With the Combo Stent Versus the Everolimus Eluting Stent in ACS Patients by Means of OCT

    Not yet reported OrbusNeich 60 participants Est. completion 2014-01 6 sites
    Cardiovascular disease Other conditions: Atherosclerosis, Acute Coronary Syndrome (ACS)
    View official trial listing →
  • Completed NCT NCT01410162

    Advagraf/Prograf Conversion Trial

    Not yet reported Norman Muirhead 53 participants Est. completion 2014-12 1 site
    Other conditions: Renal Transplant, Kidney Pancreas Transplant
    View official trial listing →
  • Completed NCT NCT01410448

    Everolimus in de Novo Kidney Transplant Recipients

    Not yet reported Novartis Pharmaceuticals 383 participants Est. completion 2015-12 22 sites
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT01410747

    A Study to Evaluate the Safety and Efficacy of Tacrolimus for Lupus Nephritis Under Actual Use Situations

    Astellas Pharma Inc 1484 participants Est. completion 2020-01-31 8 sites
    Other conditions: Lupus Nephritis
    View official trial listing →
  • Terminated NCT NCT01411215

    A Study of Rheumatoid Arthritis Treatment With Enbrel in Adult Patient in Outpatient Department

    Pfizer 160 participants Est. completion 2013-01 15 sites
    Other conditions: Rheumatoid Arthritis, Ankylosing Spondylitis
    View official trial listing →
  • Terminated NCT NCT01412515

    A Phase II Study With Tumor Molecular Pharmacodynamic (MPD) Evaluation of Oral mTOR-inhibitor Everolimus (RAD001) 10 mg Daily in Patients Suffering From Classic or Endemic Kaposi's Sarcoma

    Not yet reported Institut National de la Santé Et de la Recherche Médicale, France 11 participants Est. completion 2011-05 1 site
    Other conditions: Kaposi Sarcoma
    View official trial listing →
  • Terminated NCT NCT01413685

    Calcineurin Activity in Renal Recipients

    Not yet reported Assistance Publique - Hôpitaux de Paris 23 participants Est. completion 2010-07 1 site
    Other conditions: Renal Transplant Rejection
    View official trial listing →
  • Completed NCT NCT01414660

    Evolution of Interleukin 7, Fat Mass and Metabolic Profile Before and After Transplantation

    University Hospital, Lille 49 participants Est. completion 2018-02 5 sites
    Other conditions: Immunodeficiency Secondary to Organ Transplantation
    View official trial listing →
  • Completed NCT NCT01416649

    Impact of Exenatide on Sleep Duration

    University of Chicago 8 participants Est. completion 2021-04-21 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01418131

    Rectal Tacrolimus in the Treatment of Resistant Ulcerative Proctitis

    Not yet reported The University of Western Australia 21 participants Est. completion 2016-11 4 sites
    Other conditions: Ulcerative Colitis
    View official trial listing →
  • Completed NCT NCT01419639

    Phase II Study of Everolimus (RAD001) in Children and Adults With Neurofibromatosis Type 2

    Not yet reported NYU Langone Health 10 participants Est. completion 2013-12 1 site
    Other conditions: Neurofibromatosis Type II
    View official trial listing →
  • Terminated NCT NCT01420081

    A Study Of Two Dual PI3K/mTOR Inhibitors, PF-04691502 And PF-05212384 In Patients With Recurrent Endometrial Cancer

    Not yet reported Pfizer 67 participants Est. completion 2015-12-25 51 sites
    Other conditions: Endometrial Neoplasms
    View official trial listing →
  • Status unknown NCT NCT01423708

    Everolimus in de Novo Liver Transplantation: a Multicentre Randomized Study

    Not yet reported Azienda Ospedaliera di Padova 117 participants Est. completion 2014-01 7 sites Stand-alone
    Other conditions: Liver Failure, Liver Diseases, Liver Cirrhosis, Liver Neoplasms
    View official trial listing →
  • Completed NCT NCT01427946

    Phase 1b/2 Study of Retaspimycin HCl (IPI-504) in Combination With Everolimus in KRAS Mutant Non-small Cell Lung Cancer

    Not yet reported, Not yet reported Infinity Pharmaceuticals, Inc. 47 participants Est. completion 2014-10 5 sites
    Other conditions: Non-small Cell Lung Cancer
    View official trial listing →
  • Status unknown NCT NCT01428973

    Minitransplants With HLA-matched Donors : Comparison Between 2 GVHD Prophylaxis Regimens

    Not yet reported University of Liege 200 participants Est. completion 2024-12 13 sites Stand-alone
    Other conditions: Graft-Versus-Host Disease, Hematological Malignancies
    View official trial listing →
  • Completed NCT NCT01429038

    Mesenchymal Stem Cells After Renal or Liver Transplantation

    Not yet reported, Not yet reported University of Liege 40 participants Est. completion 2019-03-11 1 site Stand-alone
    Other conditions: Liver Failure, Kidney Failure
    View official trial listing →
  • Completed NCT NCT01429844

    Tacrolimus Versus Cyclosporine for Immunosuppression After Lung Transplantation

    Not yet reported Universitätsklinikum Hamburg-Eppendorf 274 participants Est. completion 2010-08 14 sites
    Other conditions: Bronchiolitis Obliterans, Immunosuppression
    View official trial listing →
  • Completed NCT NCT01430065

    Pharmacokinetic Interaction Study to Assess the Effect of ASP015K on Tacrolimus in Healthy Volunteers

    Not yet reported Astellas Pharma Inc 24 participants Est. completion 2009-06 1 site Stand-alone
    Other conditions: Pharmacokinetics of ASP015K, Drug Interactions, Healthy Subjects
    View official trial listing →
  • Completed NCT NCT01435291

    AADAPT - Analysis of Advagraf Dose Adaptation Post Transplantation

    Not yet reported Centre Hospitalier Universitaire de Nice 45 participants Est. completion 2013-07 4 sites Stand-alone
    Other conditions: Renal Transplantation
    View official trial listing →
  • Status unknown NCT NCT01436019

    Study of Antibodies to Anti-TNF Agents in Juvenile Idiopathic Arthritis

    Blood Transfusion Centre of Slovenia 100 participants Est. completion 2012-12 1 site
    Other conditions: Juvenile Idiopathic Arthritis
    View official trial listing →
  • Terminated NCT NCT01436305

    Optimization of NULOJIX® Usage As A Means of Avoiding CNI and Steroids in Renal Transplantation

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 19 participants Est. completion 2015-04 3 sites Stand-alone
    Other conditions: Kidney Transplantation, Renal Transplantation
    View official trial listing →
  • Completed NCT NCT01438710

    Switching Study of Kidney Transplant Patients With Tremor to LCP-Tacro (STRATO)

    Not yet reported Veloxis Pharmaceuticals 44 participants Est. completion 2015-07 10 sites Stand-alone
    Other conditions: Renal Failure, Tremors
    View official trial listing →
  • Completed NCT NCT01444898

    Effects of Exenatide on Overweight Adolescents With Prader-Willi Syndrome

    Not yet reported Children's Hospital Los Angeles 10 participants Est. completion 2013-12 1 site Stand-alone
    Other conditions: Prader-Willi Syndrome
    View official trial listing →
  • Completed NCT NCT01445106

    A Phase I Trial of Nelfinavir (Viracept ) in Adults With Solid Tumors

    Not yet reported National Cancer Institute (NCI) 28 participants Est. completion 2011-05-09 1 site
    Other conditions: Solid Tumors
    View official trial listing →
  • Terminated NCT NCT01445236

    Pilot Study of Immunosuppression Drug Weaning in Liver Recipients Exhibiting Biomarkers of High Likelihood of Tolerance

    Not yet reported Hospital Clinic of Barcelona 25 participants Est. completion 2013-01 1 site
    Other conditions: Liver Transplantation
    View official trial listing →
  • Status unknown NCT NCT01446484

    Treatment of Children With Kidney Transplants by Injection of CD4+CD25+FoxP3+ T Cells to Prevent Organ Rejection

    Not yet reported, Not yet reported Pirogov Russian National Research Medical University 30 participants Est. completion 2014-11 2 sites Stand-alone
    Other conditions: End-Stage Renal Disease, Kidney Failure
    View official trial listing →
  • Terminated NCT NCT01451489

    The Efficacy and Safety of Tacrolimus in Treated Refractory Focal Segmental Glomerulosclerosis

    Not yet reported Nanjing University School of Medicine 70 participants Est. completion 2016-10-29 1 site
    Other conditions: FSGS
    View official trial listing →
  • Completed NCT NCT01452451

    Safety, Tolerability, Pharmacokinetics,Pharmacodynamics Study of LAPS-Exendin in Subjects of Type 2 Diabetes Mellitus

    Not yet reported Hanmi Pharmaceutical Company Limited 72 participants 1 site
    Other conditions: Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT01453218

    Safety Use of ATeGe in Liver Transplant Recipients With Pre-transplant Renal Dysfunction

    Not yet reported Hospital Vall d'Hebron 30 participants Est. completion 2020-02 1 site
    Other conditions: Renal Insufficiency
    View official trial listing →
  • Status unknown NCT NCT01455649

    Study to Evaluate the Safety and Efficacy of Switching Calcineurin Inhibitor to Everolimus After Kidney Transplantation in Adults

    Not yet reported Deise de Boni Monteiro de Carvalho 30 participants Est. completion 2013-11 1 site
    Other conditions: Kidney Transplant, Immunosuppression
    View official trial listing →
  • Withdrawn NCT NCT01455909

    A Study to Evaluate ITCA 650 Compared to Sitagliptin for the Treatment of Type 2 Diabetes

    Not yet reported Intarcia Therapeutics Est. completion 2014-07 1 site Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01460979

    Efficacy,Tolerability,Safety of Temsirolimus in Women With Platinum-refractory Ovarian Carcinoma or Advanced Endometrial Carcinoma

    Not yet reported AGO Study Group 47 participants Est. completion 2015-11 18 sites
    Other conditions: Genital Diseases, Female, Ovarian Diseases, Ovarian Neoplasms, Endometrial Neoplasms
    View official trial listing →
  • Completed NCT NCT01462214

    Study of Everolimus and Low-dose Cyclophosphamide in Patients With Metastatic Renal Cell Cancer

    Not yet reported, Not yet reported Hans J. van der Vliet, MD, PhD 96 participants Est. completion 2017-01 13 sites
    Other conditions: Metastatic Renal Cell Cancer
    View official trial listing →
  • Completed NCT NCT01467011

    Myfortic, Prograf, and Corticosteroids in de Novo Liver Transplantation

    R. Mark Ghobrial, MD 25 participants Est. completion 2013-12 1 site
    Other conditions: End Stage Liver Disease
    View official trial listing →
  • Terminated NCT NCT01467505

    An Open Label Study of the Effect of Telaprevir in Combination With Ribavirin and Peginterferon on HCV Infection in Stable Liver Transplant Patients

    Not yet reported Vertex Pharmaceuticals Incorporated 61 participants Est. completion 2014-04 22 sites Stand-alone
    Other conditions: Hepatitis C
    View official trial listing →
  • Completed NCT NCT01467986

    Multimodal Molecular Targeted Therapy to Treat Relapsed or Refractory High-risk Neuroblastoma

    Not yet reported University of Regensburg 130 participants Est. completion 2020-09-30 1 site
    Other conditions: Neuroblastoma Recurrent
    View official trial listing →
  • Completed NCT NCT01469572

    Pasireotide, Everolimus and Selective Internal Radioembolization Therapy for Unresectable Hepatic Metastases

    Not yet reported Emory University 13 participants Est. completion 2018-10 1 site
    Other conditions: Neuroendocrine Tumors
    View official trial listing →
  • Completed NCT NCT01469884

    Effect of Switching to Certican® in Viremia of Hepatitis C Virus in Adult Renal Allograft Recipients

    Not yet reported Irmandade Santa Casa de Misericórdia de Porto Alegre 30 participants Est. completion 2015-04 1 site
    Other conditions: Renal Allograft, Hepatitis C
    View official trial listing →
  • Completed NCT NCT01471067

    Cord Blood Fucosylation to Enhance Homing and Engraftment in Patients With Hematologic Malignancies

    Not yet reported M.D. Anderson Cancer Center 33 participants Est. completion 2017-04-25 1 site Stand-alone
    Other conditions: Blood And Marrow Transplantation, Leukemia, Lymphoma, Transplantation Infection, Transplantation, Bone Marrow
    View official trial listing →
  • Completed NCT NCT01471444

    Fludarabine-IV Busulfan ± Clofarabine and Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)

    Not yet reported M.D. Anderson Cancer Center 256 participants Est. completion 2020-12-14 1 site Stand-alone
    Other conditions: Disorder Related to Bone Marrow Transplantation, Leukemia, Transplantation Infection
    View official trial listing →
  • Completed NCT NCT01472705

    Everolimus- Versus Biolimus-Eluting Stents in All-Comers

    University of Freiburg 814 participants Est. completion 2011-11 1 site
    Cardiovascular disease
    View official trial listing →
  • Terminated NCT NCT01473732

    Mechanisms and Treatment of Chronic Allograft Injury (CAI) Due to Calcineurin Inhibitor (CNI) Toxicity

    Not yet reported Montefiore Medical Center 2 participants Est. completion 2012-08 1 site
    Other conditions: Chronic Allograft Injury, Calcineurin Inhibitor Toxicity
    View official trial listing →
  • Completed NCT NCT01476488

    Conversion of Prograf to Advagraf in Pediatric Renal Transplant Recipients

    Not yet reported, Not yet reported Seoul National University Hospital 1 site
    Other conditions: Kidney Transplantation, Pediatric Patients, Maintenance With Tacrolimus
    View official trial listing →
  • Completed NCT NCT01476839

    Radiolabeled Monoclonal Antibody Therapy and Combination Chemotherapy Before Stem Cell Transplant in Treating Patients With Primary Refractory or Relapsed Hodgkin Lymphoma

    Not yet reported City of Hope Medical Center 25 participants Est. completion 2024-05-31 1 site Stand-alone
    Other conditions: Recurrent Adult Hodgkin Lymphoma
    View official trial listing →
  • Completed NCT NCT01479881

    A Study in Healthy Participants Investigating the Effect of TMC435 on the Pharmacokinetics of Immunosuppressants Cyclosporine and Tacrolimus

    Not yet reported Tibotec Pharmaceuticals, Ireland 29 participants Est. completion 2011-12 1 site Stand-alone
    Other conditions: Hepatitis C Virus
    View official trial listing →
  • Completed NCT NCT01482156

    Dose Finding Study of RAD001 (Everolimus, Afinitor®) in Combination With BEZ235 in Patients With Advanced Solid Tumors

    Not yet reported Novartis Pharmaceuticals 46 participants Est. completion 2015-02 10 sites
    Other conditions: Advanced Solid Tumors, Metastatic Breast Cancer, Metastatic Renal Cell Carcinoma
    View official trial listing →
  • Terminated NCT NCT01485055

    Infliximab and Basiliximab for Treatment of Steroid Refractory Acute Graft Versus Host Disease

    Not yet reported Nationwide Children's Hospital 11 participants Est. completion 2016-09-26 3 sites Stand-alone
    Other conditions: Graft Versus Host Disease, Steroid Refractory GVHD, Acute GVH Disease
    View official trial listing →
  • Terminated NCT NCT01488253

    Sirolimus/Tacrolimus Combination After HLA Matched Related Peripheral Blood Stem Cell Transplants

    Not yet reported The Korean Society of Blood and Marrow Transplantation 3 participants Est. completion 2014-10 1 site Stand-alone
    Other conditions: Acute Leukemia in Remission, Myelodysplastic Syndromes, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myeloid, Accelerated-Phase
    View official trial listing →
  • Completed NCT NCT01488487

    Everolimus and Pasireotide (SOM230) in Patients With Advanced or Metastatic Hepatocellular Carcinoma

    Not yet reported UNC Lineberger Comprehensive Cancer Center 24 participants Est. completion 2015-03 3 sites
    Other conditions: Advanced Adult Hepatocellular Carcinoma
    View official trial listing →
  • Withdrawn NCT NCT01490047

    Single Dose of Intravenous rhTNF-α and Liposomal Doxorubicin in Patients With Advanced Solid Tumors or Lymphomas

    Not yet reported Ludwig Institute for Cancer Research 1 site
    Other conditions: Solid Tumors, Lymphomas
    View official trial listing →
  • Completed NCT NCT01490723

    Zevalin-Containing Nonmyeloablative Conditioning for Stem Cell Transplantation (SCT)

    Not yet reported M.D. Anderson Cancer Center 20 participants Est. completion 2019-04-24 1 site Stand-alone
    Other conditions: Leukemia, Lymphoma
    View official trial listing →
  • Completed NCT NCT01490749

    Trial of XELOX Followed by Radiation Combined With Carboplatin and RAD001 for Esophageal Cancer

    Not yet reported Emory University 17 participants Est. completion 2019-02 3 sites
    Other conditions: Esophageal Cancer, Neoplasms, Esophageal
    View official trial listing →
  • Completed NCT NCT01491672

    Everolimus as Second-line Therapy in Metastatic Renal Cell Carcinoma

    Not yet reported Novartis Pharmaceuticals 134 participants Est. completion 2015-05 17 sites
    Other conditions: Metastatic Renal Cell Carcinoma
    View official trial listing →
  • Completed NCT NCT01491958

    Safety & Efficacy of Atorvastatin for Prophylaxis of Acute Graft Versus Host Disease in Patients With Hematological Malignancies HLA- Donor Hematopoietic Stem Cell Transplantation

    Not yet reported Ohio State University Comprehensive Cancer Center 40 participants Est. completion 2016-06-27 1 site Stand-alone
    Other conditions: Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, Myelodysplastic Syndrome
    View official trial listing →
  • Withdrawn NCT NCT01492894

    Kidney Allograft Dysfunction Without Reversible Causes

    Not yet reported University of Minnesota Est. completion 2011-10 1 site
    Other conditions: Kidney Graft Dysfunction
    View official trial listing →
  • Terminated NCT NCT01495247

    Phase Ib/II Trial of BEZ235 With Paclitaxel in Patients With HER2 Negative, Locally Advanced or Metastatic Breast Cancer

    Not yet reported, Not yet reported Novartis Pharmaceuticals 18 participants Est. completion 2014-05-19 3 sites
    Other conditions: Inoperable Locally Advanced Breast Cancer, Metastatic Breast Cancer (MBC)
    View official trial listing →
  • Completed NCT NCT01501084

    Effects of the GLP-1 Exenatide on Satiety in Lean and Obese Women

    Not yet reported University of California, Los Angeles 34 participants Est. completion 2013-02 1 site
    Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT01507038

    Safety and Efficacy of YH14617 in Diabetes Mellitus

    Not yet reported Yuhan Corporation 84 participants Est. completion 2015-02 1 site
    Other conditions: Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT01507519

    Study Safety and Performance of the Biomime Stent in Patients With Single, De Novo, Non-Complex Coronary Lesions

    Not yet reported Meril Life Sciences Pvt. Ltd. 30 participants Est. completion 2011-03 1 site Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Status unknown NCT NCT01509300

    HLA-haploidentical Hematopoietic Stem Cell Transplantation for Children and Adolescents With Acute Leukemia, Myelodysplastic Syndrome and Solid Tumors

    Not yet reported, Not yet reported Asan Medical Center 10 participants Est. completion 2014-03 1 site Stand-alone
    Other conditions: Acute Leukemia, Myelodysplastic Syndrome, Solid Tumors
    View official trial listing →
  • Completed NCT NCT01510119

    Autophagy Inhibition to Augment Mammilian Target of Rapamycin (mTOR) Inhibition: A Phase I/II Trial of RAD001 and Hydroxychloroquine (HCQ) in Patients With Previously Treated Renal Cell Carcinoma

    Not yet reported, Not yet reported Abramson Cancer Center at Penn Medicine 40 participants Est. completion 2017-01-05 3 sites
    Other conditions: Metastatic Clear Cell Renal Cell Carcinoma
    View official trial listing →
  • Completed NCT NCT01511003

    A Study is to Assess Efficacy and Safety of Tacrolimus in Active Rheumatoid Arthritis Patients Who Showed Unsuccessful Response to Existing Disease Modifying Antirheumatic Drugs (DMARDs)

    Not yet reported Astellas Pharma Inc 128 participants Est. completion 2015-05-11 4 sites Stand-alone
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Terminated NCT NCT01514149

    Dose-Ranging Study to Evaluate Efficacy and Safety of Weekly CJC-1134-PC in Patients With T2DM on Metformin Monotherapy

    Not yet reported ConjuChem 73 participants Est. completion 2013-03 22 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01514448

    Safety and Efficacy of Everolimus in Metastatic Renal Cell Carcinoma After Failure of First Line Therapy With Sunitinib or Pazopanib

    Not yet reported Novartis Pharmaceuticals 29 participants Est. completion 2016-04-01 13 sites
    Other conditions: Metastatic Renal Cell Carcinoma (mRCC)
    View official trial listing →
  • Completed NCT NCT01516723

    Hybrid Sirolimus-eluting Versus Everolimus-eluting Stents for Total Coronary Occlusions

    Not yet reported R&D Cardiologie 330 participants Est. completion 2020-12-31 4 sites Stand-alone
    Cardiovascular disease Other conditions: Coronary Disease, Coronary Stenosis
    View official trial listing →
  • Completed NCT NCT01517074

    Sirolimus Injections for Autoimmune Scleritis

    Not yet reported, Not yet reported National Eye Institute (NEI) 5 participants Est. completion 2014-04 1 site Stand-alone
    Other conditions: Scleritis
    View official trial listing →
  • Completed NCT NCT01517243

    Phase II Study of Alternating Sunitinib and Temsirolimus

    Not yet reported Dartmouth-Hitchcock Medical Center 37 participants Est. completion 2018-08-20 2 sites
    Other conditions: Metastatic Renal Cell Carcinoma
    View official trial listing →
  • Terminated NCT NCT01517984

    Immune Monitoring and CNI Withdrawal in Low Risk Recipients of Kidney Transplantation

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 52 participants Est. completion 2015-05 11 sites Stand-alone
    Other conditions: Kidney Transplant Recipients
    View official trial listing →
  • Terminated NCT NCT01518153

    Planned Donor Lymphocyte Infusion (DLI) After Allogeneic Stem Cell Transplantation (SCT)

    Not yet reported M.D. Anderson Cancer Center 16 participants Est. completion 2014-08 1 site Stand-alone
    Other conditions: Leukemia, Lymphoma, Myeloma, Myeloproliferative Diseases
    View official trial listing →
  • Terminated NCT NCT01522742

    Monitoring and Modifying Atherosclerosis in Psoriasis Patients Study

    Massachusetts General Hospital 29 participants Est. completion 2016-01 1 site
    Other conditions: Psoriasis
    View official trial listing →
  • Completed NCT NCT01522820

    Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors

    Not yet reported Roswell Park Cancer Institute 18 participants Est. completion 2016-07 1 site Stand-alone
    Other conditions: Anaplastic Astrocytoma, Anaplastic Oligoastrocytoma, Anaplastic Oligodendroglioma, Estrogen Receptor Negative, Estrogen Receptor Positive, Glioblastoma, Hormone-Resistant Prostate Cancer, Metastatic Prostate Carcinoma, Metastatic Renal Cell Cancer, Recurrent Adult Brain Neoplasm, Recurrent Bladder Carcinoma, Recurrent Breast Carcinoma, Recurrent Colorectal Carcinoma, Recurrent Esophageal Carcinoma, Recurrent Gastric Carcinoma, Recurrent Hepatocellular Carcinoma, Recurrent Lung Carcinoma, Recurrent Melanoma, Recurrent Ovarian Carcinoma, Recurrent Prostate Carcinoma, Recurrent Renal Cell Carcinoma, Recurrent Uterine Corpus Carcinoma, Resectable Hepatocellular Carcinoma, Sarcoma, Stage IA Breast Cancer, Stage IA Ovarian Cancer, Stage IA Uterine Corpus Cancer, Stage IB Breast Cancer, Stage IB Ovarian Cancer, Stage IB Uterine Corpus Cancer, Stage IC Ovarian Cancer, Stage II Uterine Corpus Cancer, Stage IIA Breast Cancer, Stage IIA Lung Carcinoma, Stage IIA Ovarian Cancer, Stage IIB Breast Cancer, Stage IIB Esophageal Cancer, Stage IIB Lung Carcinoma, Stage IIB Ovarian Cancer, Stage IIB Skin Melanoma, Stage IIC Ovarian Cancer, Stage IIC Skin Melanoma, Stage IIIA Breast Cancer, Stage IIIA Esophageal Cancer, Stage IIIA Lung Carcinoma, Stage IIIA Ovarian Cancer, Stage IIIA Skin Melanoma, Stage IIIA Uterine Corpus Cancer, Stage IIIB Breast Cancer, Stage IIIB Esophageal Cancer, Stage IIIB Ovarian Cancer, Stage IIIB Skin Melanoma, Stage IIIB Uterine Corpus Cancer, Stage IIIC Breast Cancer, Stage IIIC Esophageal Cancer, Stage IIIC Ovarian Cancer, Stage IIIC Skin Melanoma, Stage IIIC Uterine Corpus Cancer, Stage IV Bladder Urothelial Carcinoma, Stage IV Esophageal Cancer, Stage IV Ovarian Cancer, Stage IV Prostate Cancer, Stage IV Skin Melanoma, Stage IVA Uterine Corpus Cancer, Stage IVB Uterine Corpus Cancer
    View official trial listing →
  • Status unknown NCT NCT01525719

    Single Arm Study of RAD001 as Monotherapy in Treatment in Advanced Cholangiocarcinoma

    Not yet reported Ratchavithi Hospital 40 participants Est. completion 2014-06
    Other conditions: Cholangiocarcinoma
    View official trial listing →
  • Completed NCT NCT01526096

    Stem Cell Transplantation for Patients With Multiple Myeloma

    Not yet reported University of Chicago 30 participants Est. completion 2024-08-28 1 site Stand-alone
    Other conditions: Myeloma
    View official trial listing →
  • Completed NCT NCT01526356

    Topical Rapamycin to Erase Angiofibromas in TSC

    Not yet reported The University of Texas Health Science Center, Houston 179 participants Est. completion 2014-08 10 sites
    Other conditions: Angiofibromas, Tuberous Sclerosis
    View official trial listing →
  • Completed NCT NCT01529138

    Study of Axitinib and Temsirolimus in Solid Tumors

    Not yet reported Emory University 13 participants Est. completion 2014-03 1 site Stand-alone
    Other conditions: Cancer
    View official trial listing →
  • Completed NCT NCT01529554

    Controlled Level EVERolimus in Acute Coronary Syndromes

    Not yet reported, Not yet reported University of Zurich 150 participants Est. completion 2021-11-29 8 sites
    Other conditions: Acute Coronary Syndromes
    View official trial listing →
  • Terminated NCT NCT01529593

    Temsirolimus in Combination With Metformin in Patients With Advanced Cancers

    Not yet reported M.D. Anderson Cancer Center 34 participants Est. completion 2025-03-14 1 site
    Other conditions: Advanced Cancers
    View official trial listing →
  • Completed NCT NCT01529827

    Fludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies

    Not yet reported Roswell Park Cancer Institute 94 participants Est. completion 2019-08-29 1 site Stand-alone
    Obstructive sleep apnea Other conditions: Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Adult Grade III Lymphomatoid Granulomatosis, Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, Aplastic Anemia, Burkitt Lymphoma, Childhood Acute Lymphoblastic Leukemia in Remission, Childhood Acute Myeloid Leukemia in Remission, Childhood Chronic Myelogenous Leukemia, Childhood Diffuse Large Cell Lymphoma, Childhood Grade III Lymphomatoid Granulomatosis, Childhood Immunoblastic Large Cell Lymphoma, Childhood Myelodysplastic Syndromes, Childhood Nasal Type Extranodal NK/T-cell Lymphoma, Chronic Myelomonocytic Leukemia, Chronic Phase Chronic Myelogenous Leukemia, Congenital Amegakaryocytic Thrombocytopenia, Diamond-Blackfan Anemia, Hepatosplenic T-cell Lymphoma, Juvenile Myelomonocytic Leukemia, Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable, Nodal Marginal Zone B-cell Lymphoma, Paroxysmal Nocturnal Hemoglobinuria, Peripheral T-cell Lymphoma, Polycythemia Vera, Post-transplant Lymphoproliferative Disorder, Previously Treated Myelodysplastic Syndromes, Primary Myelofibrosis, Recurrent Adult Acute Lymphoblastic Leukemia, Recurrent Adult Acute Myeloid Leukemia, Recurrent Adult Burkitt Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma, Recurrent Adult Diffuse Mixed Cell Lymphoma, Recurrent Adult Diffuse Small Cleaved Cell Lymphoma, Recurrent Adult Grade III Lymphomatoid Granulomatosis, Recurrent Adult Hodgkin Lymphoma, Recurrent Adult Immunoblastic Large Cell Lymphoma, Recurrent Adult Lymphoblastic Lymphoma, Recurrent Adult T-cell Leukemia/Lymphoma, Recurrent Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood Acute Myeloid Leukemia, Recurrent Childhood Anaplastic Large Cell Lymphoma, Recurrent Childhood Grade III Lymphomatoid Granulomatosis, Recurrent Childhood Large Cell Lymphoma, Recurrent Childhood Lymphoblastic Lymphoma, Recurrent Childhood Small Noncleaved Cell Lymphoma, Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Grade 3 Follicular Lymphoma, Recurrent Mantle Cell Lymphoma, Recurrent Marginal Zone Lymphoma, Recurrent Mycosis Fungoides/Sezary Syndrome, Recurrent Small Lymphocytic Lymphoma, Recurrent/Refractory Childhood Hodgkin Lymphoma, Refractory Chronic Lymphocytic Leukemia, Refractory Hairy Cell Leukemia, Refractory Multiple Myeloma, Secondary Acute Myeloid Leukemia, Secondary Myelodysplastic Syndromes, Secondary Myelofibrosis, Severe Combined Immunodeficiency, Severe Congenital Neutropenia, Shwachman-Diamond Syndrome, Splenic Marginal Zone Lymphoma, T-cell Large Granular Lymphocyte Leukemia, Waldenstrom Macroglobulinemia, Wiskott-Aldrich Syndrome
    View official trial listing →
  • Terminated NCT NCT01532635

    A Two-Step Approach to Bone Marrow Transplant Using Cells From Two Partially-Matched Relatives

    Not yet reported Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 4 participants Est. completion 2013-05 1 site Stand-alone
    Other conditions: Hematologic Malignancy, Leukemia, Acute Lymphoblastic Leukemia, ALL, Acute Myelogenous Leukemia, AML, Chronic Lymphocytic Leukemia, CLL, Lymphoma, Hodgkin's Lymphoma, Non-hodgkin's Lymphoma, Myeloma
    View official trial listing →
  • Terminated NCT NCT01534143

    High Dose Busulfan and Bortezomib in Treating Patients With High Risk Multiple Myeloma Undergoing Stem Cell Transplant

    Not yet reported Barbara Ann Karmanos Cancer Institute 1 participants Est. completion 2013-05 1 site Stand-alone
    Other conditions: Refractory Multiple Myeloma, Stage I Multiple Myeloma, Stage II Multiple Myeloma, Stage III Multiple Myeloma
    View official trial listing →
  • Completed NCT NCT01535547

    Drug Interaction Study of Isavuconazole and Tacrolimus

    Not yet reported Astellas Pharma Inc 24 participants Est. completion 2012-01 1 site Stand-alone
    Other conditions: Pharmacokinetics of Isavuconazole, Pharmacokinetics of Tacrolimus, Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT01536054

    Sirolimus and Vaccine Therapy in Treating Patients With Stage II-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer

    Not yet reported Roswell Park Cancer Institute 7 participants Est. completion 2015-04-21 1 site Stand-alone
    Other conditions: Recurrent Fallopian Tube Cancer, Recurrent Ovarian Epithelial Cancer, Recurrent Primary Peritoneal Cavity Cancer, Stage IIA Fallopian Tube Cancer, Stage IIA Ovarian Epithelial Cancer, Stage IIA Primary Peritoneal Cavity Cancer, Stage IIB Fallopian Tube Cancer, Stage IIB Ovarian Epithelial Cancer, Stage IIB Primary Peritoneal Cavity Cancer, Stage IIC Fallopian Tube Cancer, Stage IIC Ovarian Epithelial Cancer, Stage IIC Primary Peritoneal Cavity Cancer, Stage IIIA Fallopian Tube Cancer, Stage IIIA Ovarian Epithelial Cancer, Stage IIIA Primary Peritoneal Cavity Cancer, Stage IIIB Fallopian Tube Cancer, Stage IIIB Ovarian Epithelial Cancer, Stage IIIB Primary Peritoneal Cavity Cancer, Stage IIIC Fallopian Tube Cancer, Stage IIIC Ovarian Epithelial Cancer, Stage IIIC Primary Peritoneal Cavity Cancer, Stage IV Fallopian Tube Cancer, Stage IV Ovarian Epithelial Cancer, Stage IV Primary Peritoneal Cavity Cancer
    View official trial listing →
  • Completed NCT NCT01536535

    Predicting Response to Standardized Pediatric Colitis Therapy

    Not yet reported Connecticut Children's Medical Center 431 participants Est. completion 2018-04-30 29 sites Stand-alone
    Other conditions: Ulcerative Colitis
    View official trial listing →
  • Completed NCT NCT01541176

    Absence of Steroid in Renal Transplantation and Digital Fibrosis Observation

    Not yet reported Nantes University Hospital 193 participants Est. completion 2018-08 8 sites
    Other conditions: Renal Transplant
    View official trial listing →
  • Completed NCT NCT01541384

    Medication Adherence in Kidney Transplant Recipients Using Automated Reminders and Provider Notification

    Not yet reported University of Pennsylvania 120 participants Est. completion 2015-09 1 site Stand-alone
    Other conditions: Medication Adherence
    View official trial listing →
  • Terminated NCT NCT01543204

    Etanercept Treatment in Patients With Moderate to Severe Plaque Psoriasis Who Lost Response to Adalimumab

    Not yet reported Amgen 64 participants Est. completion 2015-05-29 47 sites Stand-alone
    Other conditions: Psoriasis
    View official trial listing →
  • Completed NCT NCT01543373

    Optical Coherence Tomography Comparison of Neointimal Coverage Between CRE8 DES and BMS

    Not yet reported CID - Carbostent & Implantable Devices 38 participants Est. completion 2014-04 6 sites Stand-alone
    Other conditions: Stable Angina, Unstable Angina, NSTEMI
    View official trial listing →
  • Completed NCT NCT01544491

    Efficacy, Tolerability and Safety of Early Introduction of Everolimus, Reduced Calcineurin Inhibitors and Early Steroid Elimination Compared to Standard CNI, Mycophenolate Mofetil and Steroid Regimen in Paediatric Renal Transplant Recipients

    Not yet reported Novartis Pharmaceuticals 106 participants Est. completion 2018-09-24 31 sites Stand-alone
    Other conditions: Prevention of Acute Rejection in Paediatric Recipients of a Renal Transplant
    View official trial listing →
  • Terminated NCT NCT01544842

    Tacrolimus Ointment in Oral Lichen Planus

    Not yet reported University of Oulu 28 participants Est. completion 2015-07 2 sites
    Other conditions: Oral Lichen Planus
    View official trial listing →
  • Completed NCT NCT01548807

    Phase 1 Trial of the Mammalian Target of Rapamycin (mTOR) Inhibitor Everolimus Plus Radiation Therapy (RT) for Salvage Treatment of Biochemical Recurrence in Prostate Cancer Patients Following Prostatectomy

    Not yet reported Abramson Cancer Center at Penn Medicine 19 participants Est. completion 2017-01-04 1 site
    Other conditions: Prostate Cancer Patients With Detectable PSA Following Prostatectomy
    View official trial listing →
  • Status unknown NCT NCT01550445

    Steroid Withdrawal Immunosuppression After Renal Transplantation

    Not yet reported Ajou University School of Medicine 30 participants Est. completion 2012-07 1 site
    Other conditions: Disorder Related to Renal Transplantation
    View official trial listing →
  • Completed NCT NCT01551212

    Efficacy of Everolimus in Combination With Tacrolimus in Liver Transplant Recipients

    Not yet reported Novartis Pharmaceuticals 339 participants Est. completion 2017-08-08 15 sites Stand-alone
    Other conditions: Liver Transplantation
    View official trial listing →
  • Completed NCT NCT01554618

    Safety and Efficacy Study of Exenatide Once Weekly in Adolescents With Type 2 Diabetes

    Not yet reported AstraZeneca 84 participants Est. completion 2021-05-05 35 sites Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01556126

    Clinical Performance of CRE8 Drug Eluting Stent in All Comer Population

    Not yet reported CID - Carbostent & Implantable Devices 1191 participants Est. completion 2018-12 23 sites Stand-alone
    Cardiovascular disease Other conditions: Stable Angina, Unstable Angina
    View official trial listing →
  • Completed NCT NCT01557322

    Characterize Patients With Moderately Active Rheumatoid Arthritis (RA)

    Pfizer 1754 participants Est. completion 2012-09
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT01560572

    Steroid Free Immunosuppression or Calcineurin Inhibitor Minimization After Basiliximab Induction Therapy in Kidney Transplantation: Comparison With a Standard Quadruple Immunosuppressive Regimen

    Not yet reported University Medical Center Groningen 305 participants Est. completion 2016-04 3 sites Stand-alone
    Other conditions: Renal Insufficiency, Kidney Transplantation
    View official trial listing →
  • Terminated NCT NCT01561404

    Effect of the Inhibition of the Mammalian Target of Rapamycin on Metabolism and Exercise

    Not yet reported Josep M Cruzado 3 participants Est. completion 2013-12 1 site Stand-alone
    Other conditions: Disorder Related to Renal Transplantation, Exercise, Aerobic, Muscle Strength
    View official trial listing →
  • Terminated NCT NCT01564095

    TOP-Study (Tacrolimus Organ Perfusion): Treatment of Ischemia Reperfusion Injury in Marginal Organs With an ex Vivo Tacrolimus Perfusion

    Not yet reported, Not yet reported Ludwig-Maximilians - University of Munich 25 participants Est. completion 2013-07 7 sites Stand-alone
    Other conditions: Terminal Liver Disease, Ischemia Reperfusion Injury, Graft Dysfunction, Graft Failure, Poor Graft Quality
    View official trial listing →
  • Completed NCT NCT01565616

    Bone Marrow Transplantation in Young Adults With Severe Sickle Cell Disease

    Not yet reported Emory University 22 participants Est. completion 2016-06-30 8 sites Stand-alone
    Other conditions: Sickle Cell Disease
    View official trial listing →
  • Completed NCT NCT01566279

    A Study to Identify a Biomarker Predictive for Response on Everolimus in Solid Tumors (CPCT-03)

    Not yet reported UMC Utrecht 73 participants Est. completion 2016-11 3 sites
    Other conditions: Unspecified Adult Solid Tumor, Protocol Specific
    View official trial listing →
  • Completed NCT NCT01567488

    Phase II Study of Everolimus Combined With Octreotide LAR to Treat Advanced GI NET

    Not yet reported Grupo Espanol de Tumores Neuroendocrinos 43 participants Est. completion 2017-06-07 1 site
    Other conditions: Gastrointestinal Neoplasms
    View official trial listing →
  • Status unknown NCT NCT01567930

    Temsirolimus as Second-line Therapy in HCC

    Not yet reported University of Tennessee Cancer Institute 25 participants Est. completion 2013-03 1 site
    Other conditions: Unresectable or Metastatic Hepatocellular Carcinoma
    View official trial listing →
  • Terminated NCT NCT01570348

    Crohn's Allogeneic Transplant Study

    Not yet reported Fred Hutchinson Cancer Center 2 participants Est. completion 2019-10-30 1 site Stand-alone
    Other conditions: Crohn Disease
    View official trial listing →
  • Completed NCT NCT01571817

    Pancreatic Islet Transplantation Into the Gastric Submucosa

    Not yet reported Andrew Posselt 1 participants Est. completion 2014-12 1 site
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT01572662

    Allogeneic Transplantation Using Timed Sequential Busulfan and Fludarabine Conditioning

    Not yet reported M.D. Anderson Cancer Center 201 participants Est. completion 2022-08-11 1 site Stand-alone
    Other conditions: Leukemia, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, Chronic Myeloid Leukemia, Chronic Lymphocytic Leukemia, Myeloproliferative Diseases, Non-Hodgkins Lymphoma, Hodgkins Lymphoma, Multiple Myeloma, Myelodysplastic Syndrome
    View official trial listing →
  • Withdrawn NCT NCT01573806

    Pharmacology of Exenatide in Pediatric Sepsis

    Not yet reported, Not yet reported Seattle Children's Hospital Est. completion 2014-10 1 site
    Other conditions: Septic Shock, Inflammation, Glucose Homeostasis, Organ Dysfunction, Health-related Quality of Life
    View official trial listing →
  • Completed NCT NCT01575301

    DIabetes REsearCh on Patient sTratification (DIRECT): GLP-1R Agonists

    Not yet reported University of Dundee 411 participants Est. completion 2015-12-11 4 sites
    Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01578850

    Study Conducted in Subjects With Rheumatoid Arthritis Who Have Moderate to Severe Disease Activity Despite Methotrexate Therapy With or Without Other Non Biologic Disease Modifying Antirheumatic Drugs (DMARDs)for at Least 12 Weeks Prior to Screening

    Not yet reported Pfizer 491 participants Est. completion 2015-03 62 sites Stand-alone
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT01580514

    Myocardial Protection of Exenatide in AMI

    Not yet reported Kyunghee University Medical Center 127 participants Est. completion 2011-08 1 site
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT01580865

    Comparison Between Tacrolimus (TAC) and Mycophenolate Mofetil (MMF) for Induction of Remission in Lupus Nephritis

    Not yet reported Ramathibodi Hospital 84 participants Est. completion 2017-03 1 site Stand-alone
    Other conditions: Lupus Nephritis
    View official trial listing →
  • Terminated NCT NCT01582009

    Panobinostat and Everolimus in Treating Patients With Metastatic or Unresectable Renal Cell Cancer That Does Not Respond to Treatment With Sunitinib Malate or Sorafenib Tosylate

    Not yet reported, Not yet reported Roswell Park Cancer Institute 26 participants Est. completion 2015-12 2 sites
    Other conditions: Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage III Renal Cell Cancer, Stage IV Renal Cell Cancer
    View official trial listing →
  • Completed NCT NCT01582191

    Vandetanib and Everolimus in Treating Patients With Advanced or Metastatic Cancer

    Not yet reported M.D. Anderson Cancer Center 123 participants Est. completion 2025-10-22 1 site
    Other conditions: Advanced Malignant Neoplasm, Metastatic Malignant Neoplasm, Recurrent Malignant Neoplasm, Refractory Malignant Neoplasm
    View official trial listing →
  • Withdrawn NCT NCT01586845

    Safety and Efficacy Study of Voclosporin and Tacrolimus in Transplantation

    Not yet reported Aurinia Pharmaceuticals Inc. Est. completion 2015-12
    Other conditions: Renal Transplantation
    View official trial listing →
  • Completed NCT NCT01591070

    Proactive Treatment of Tacrolimus Ointment for Adult Facial Seborrheic Dermatitis

    Not yet reported Pusan National University Hospital 104 participants Est. completion 2011-05 1 site Stand-alone
    Other conditions: Seborrheic Dermatitis
    View official trial listing →
  • Completed NCT NCT01594268

    A Prospective, Open Label Study of CERtican in KIdney Transplantation

    Not yet reported Novartis Pharmaceuticals 54 participants Est. completion 2013-10 4 sites
    Other conditions: Kidney Transplant
    View official trial listing →
  • Completed NCT NCT01595841

    Sirolimus Use in Angioplasty for Vascular Access Extension

    Not yet reported London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 17 participants Est. completion 2022-03 1 site Stand-alone
    Other conditions: End Stage Renal Disease, Venous Stenosis
    View official trial listing →
  • Completed NCT NCT01595984

    Comparison of Efficacy and Safety of Treatment With a Calcineurin Inhibitor (CNI)Versus a CNI-free Treatment in Renal Transplantation (CIME)

    Not yet reported Centre Hospitalier Universitaire, Amiens 88 participants Est. completion 2024-03-05 2 sites
    Other conditions: Kidney Failure
    View official trial listing →
  • Completed NCT NCT01596062

    Pharmacodynamics, Efficacy and Safety of Basiliximab 40 or 80 mg in Combination With Ciclosporine Microemulsion or Everolimus, in Adult Low Risk de Novo Renal Transplant Recipients (IDEALE Study)

    Not yet reported Novartis Pharmaceuticals 16 participants Est. completion 2013-03 3 sites
    Other conditions: Renal Transplantation
    View official trial listing →
  • Completed NCT NCT01596140

    Vemurafenib in Combination With Everolimus or Temsirolimus With Advanced Cancer

    Not yet reported M.D. Anderson Cancer Center 27 participants Est. completion 2020-06-01 1 site
    Other conditions: Advanced Cancer, Solid Tumor
    View official trial listing →
  • Completed NCT NCT01597778

    Double Cord Versus Haploidentical (BMT CTN 1101)

    Not yet reported Medical College of Wisconsin 368 participants Est. completion 2020-09-11 39 sites Stand-alone
    Other conditions: Acute Lymphocytic Leukemia, Acute Myelogenous Leukemia, Burkitt's Lymphoma, Follicular Lymphoma, Hodgkin Lymphoma, Mantle Cell Lymphoma, Non-Hodgkin Lymphoma
    View official trial listing →
  • Completed NCT NCT01598987

    Efficacy, Safety and Tolerability of Everolimus in Combination With Reduced Exposure Cyclosporine or Tacrolimus in Paediatric Liver Transplant Recipients.

    Not yet reported Novartis Pharmaceuticals 56 participants Est. completion 2016-06 32 sites Stand-alone
    Other conditions: Renal Function, Liver Transplant
    View official trial listing →
  • Completed NCT NCT01601821

    Open Label Comparative Study Of De Novo Renal Allograft Recipients Receiving CSA + MMF + Corticosteroids Versus CSA + Rapamune + Corticosteroids

    Not yet reported Pfizer 245 participants Est. completion 2008-03 4 sites
    Other conditions: Inflammation
    View official trial listing →
  • Completed NCT NCT01602913

    Type II Diabetes Mellitus in Patients Exposed to Pravastatin and Paroxetine

    GlaxoSmithKline 1 participants Est. completion 2012-05
    Other conditions: Depression, Postpartum
    View official trial listing →
  • Completed NCT NCT01604629

    Evaluation of a Protocol for Dose Reduction in Patients With Spondylarthropathies and Clinical Remission With Anti-TNF

    Not yet reported Spanish Clinical Pharmacology Society 120 participants Est. completion 2015-09 31 sites Stand-alone
    Other conditions: Spondylarthropathies
    View official trial listing →
  • Status unknown NCT NCT01608412

    A Clinical Trial to Assess the Efficacy and Safety of the Conversion to Everolimus

    Not yet reported Hospital de Clinicas de Porto Alegre 120 participants Est. completion 2014-07 1 site
    Other conditions: Kidney Transplant Recipients
    View official trial listing →
  • Terminated NCT NCT01609673

    Study of Everolimus in de Novo Renal Transplant Recipients

    Not yet reported Helady Pinheiro, MD, PhD 1 participants Est. completion 2013-05 4 sites
    Other conditions: End Stage Renal Failure With Renal Transplant
    View official trial listing →
  • Completed NCT NCT01611116

    Study With Temsirolimus Added to Standard Chemotherapy for Patients Over 60 Years With Acute Myeloblastic Leukemia

    Not yet reported Goethe University 33 participants Est. completion 2017-04-26 5 sites
    Other conditions: Acute Myeloblastic Leukemia
    View official trial listing →
  • Withdrawn NCT NCT01612299

    Effects of Zortress® + Tacrolimus vs. Standard Immunosuppression on Progression of Coronary Artery Calcifications and Bone Disease in de Novo Renal Transplant Recipients

    Not yet reported University of Kentucky Est. completion 2013-12 1 site Stand-alone
    Other conditions: Renal Transplant
    View official trial listing →
  • Status unknown NCT NCT01613963

    Causes of Visual Loss in Retinal Disease

    Royal Surrey County Hospital NHS Foundation Trust 2000 participants Est. completion 2012-12 2 sites
    Other conditions: Uveitis, Scleritis
    View official trial listing →
  • Completed NCT NCT01614197

    A Trial of Temsirolimus With Etoposide and Cyclophosphamide in Children With Relapsed Acute Lymphoblastic Leukemia and Non-Hodgkins Lymphoma

    Not yet reported Therapeutic Advances in Childhood Leukemia Consortium 16 participants Est. completion 2020-09-04 32 sites
    Other conditions: Lymphoblastic Leukemia, Acute, Childhood, Lymphoblastic Lymphoma, Peripheral T-cell Lymphoma
    View official trial listing →
  • Completed NCT NCT01614665

    A Study to Compare How the Body Absorbs and Processes Two Different Formulations of the Anti-rejection Medication Tacrolimus (Advagraf® or Prograf®) in Children Receiving an Organ Transplant, and How Safe and Effective They Are Over a Longer Period of Time

    Not yet reported Astellas Pharma Europe Ltd. 44 participants Est. completion 2021-04-21 10 sites Stand-alone
    Other conditions: Heart Transplantation, Kidney Transplantation, Liver Transplantation
    View official trial listing →
  • Completed NCT NCT01614795

    Cixutumumab and Temsirolimus in Treating Younger Patients With Recurrent or Refractory Sarcoma

    Not yet reported National Cancer Institute (NCI) 46 participants Est. completion 2014-04-01 76 sites
    Obstructive sleep apnea Other conditions: Childhood Alveolar Soft Part Sarcoma, Childhood Epithelioid Sarcoma, Childhood Malignant Peripheral Nerve Sheath Tumor, Childhood Synovial Sarcoma, Recurrent Childhood Soft Tissue Sarcoma, Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor
    View official trial listing →
  • Withdrawn NCT NCT01616186

    Everolimus/Sorafenib or Sunitinib in Patients With Metastatic Renal Cell Carcinoma (RCC)

    Not yet reported Andrea Harzstark Est. completion 2016-04
    Other conditions: Locally Metastatic Malignant Neoplasm
    View official trial listing →
  • Status unknown NCT NCT01619761

    NK Cells in Cord Blood Transplantation

    Not yet reported M.D. Anderson Cancer Center 13 participants Est. completion 2021-11 1 site Stand-alone
    Other conditions: Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission, Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, DS Stage II Plasma Cell Myeloma, DS Stage III Plasma Cell Myeloma, High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements, ISS Stage II Plasma Cell Myeloma, ISS Stage III Plasma Cell Myeloma, Myelodysplastic Syndrome, Recurrent Acute Lymphoblastic Leukemia, Recurrent Acute Myeloid Leukemia, Recurrent Chronic Lymphocytic Leukemia, Recurrent Hodgkin Lymphoma, Recurrent Non-Hodgkin Lymphoma, Recurrent Small Lymphocytic Lymphoma, Refractory Acute Lymphoblastic Leukemia, Refractory Chronic Lymphocytic Leukemia, Refractory Hodgkin Lymphoma, Refractory Non-Hodgkin Lymphoma, Refractory Small Lymphocytic Lymphoma, Secondary Acute Myeloid Leukemia, Therapy-Related Acute Myeloid Leukemia, Therapy-Related Myelodysplastic Syndrome
    View official trial listing →
  • Completed NCT NCT01620307

    Rapamune Improves Outcomes of Severe H1N1 Pneumonia

    Not yet reported Chang Gung Memorial Hospital 38 participants Est. completion 2011-12
    Other conditions: H1N1 Pneumonia, Hypoxemia
    View official trial listing →
  • Terminated NCT NCT01621477

    T-Cell Replete Haploidentical Donor Hematopoietic Stem Cell Plus Natural Killer (NK) Cell Transplantation in Patients With Hematologic Malignancies Relapsed or Refractory Despite Previous Allogeneic Transplant

    Not yet reported St. Jude Children's Research Hospital 34 participants Est. completion 2015-12 1 site Stand-alone
    Other conditions: Acute Lymphoblastic Leukemia, Acute Myelocytic Leukemia, Chronic Myelocytic Leukemia, Juvenile Myelomonocytic Leukemia, Myelodysplastic Syndrome, Hodgkin or Non-Hodgkin Lymphoma, Sarcoma, Myeloid
    View official trial listing →
  • Completed NCT NCT01624766

    Everolimus and Anakinra or Denosumab in Treating Participants With Relapsed or Refractory Advanced Cancers

    Not yet reported M.D. Anderson Cancer Center 57 participants Est. completion 2021-02-24 1 site
    Other conditions: Advanced Malignant Neoplasm, Metastatic Malignant Neoplasm, Recurrent Malignant Neoplasm, Refractory Malignant Neoplasm
    View official trial listing →
  • Completed NCT NCT01624948

    Safety and Efficacy Study of Everolimus to Treat BK Virus Infection in Kidney Transplant Recipients

    Not yet reported University of California, San Francisco 40 participants Est. completion 2015-11 1 site Stand-alone
    Other conditions: BK Virus Infection
    View official trial listing →
  • Completed NCT NCT01625156

    Tivantinib and Temsirolimus in Treating Patients With Solid Tumors That is Metastatic or Cannot be Removed by Surgery

    Not yet reported National Cancer Institute (NCI) 11 participants Est. completion 2015-10 2 sites
    Other conditions: Adult Solid Neoplasm
    View official trial listing →
  • Completed NCT NCT01625377

    A National Multi-center Randomized, Open Label Study to Evaluate Efficacy and Safety of Everolimus With EC-MPS Compared to Standard Treatment Combination Tacrolimus and EC-MPS in de Novo Liver Transplant Recipients

    Not yet reported Novartis Pharmaceuticals 188 participants Est. completion 2015-03 14 sites Stand-alone
    Other conditions: Liver Transplantation
    View official trial listing →
  • Completed NCT NCT01626170

    Studying Mechanisms of Radiation Therapy Resistance in Samples From Younger Patients With Rhabdomyosarcoma

    Children's Oncology Group 20 participants 1 site
    Obstructive sleep apnea
    View official trial listing →
  • Terminated NCT NCT01628913

    Efficacy and Safety of BEZ235 Compared to Everolimus in Patients With Advanced Pancreatic Neuroendocrine Tumors

    Not yet reported Novartis Pharmaceuticals 62 participants Est. completion 2014-09 26 sites
    Other conditions: Pancreatic Neuroendocrine Tumors (pNET)
    View official trial listing →
  • Terminated NCT NCT01629511

    Allogeneic Stem Cell Transplant for CLL

    Not yet reported, Not yet reported M.D. Anderson Cancer Center 15 participants Est. completion 2018-04-25 1 site Stand-alone
    Other conditions: Allogeneic Hematopoietic Stem Cell Transplantation Recipient, Chronic Lymphocytic Leukemia, Prolymphocytic Leukemia, Richter Syndrome
    View official trial listing →
  • Status unknown NCT NCT01631058

    Renal Transplantation in the Elderly - nEverOld Study

    Not yet reported University of Sao Paulo General Hospital 90 participants Est. completion 2019-06 2 sites Stand-alone
    Other conditions: Chronic Renal Failure (CRF), Graft Failure, Transplant; Failure, Kidney, Renal Transplant Rejection
    View official trial listing →
  • Completed NCT NCT01632605

    The Vienna RAP Pilot Study

    Not yet reported Medical University of Vienna 8 participants Est. completion 2012-04 1 site Stand-alone
    Other conditions: ADPKD
    View official trial listing →
  • Status unknown NCT NCT01635686

    Comparison the Safety and Pharmacokinetic Characteristics of DWP422 25 mg With Those of ENBREL 25MG PFS INJ. After Subcutaneous Injection in Healthy Male Volunteers

    Not yet reported Daewoong Pharmaceutical Co. LTD. 38 participants Est. completion 2013-06 1 site
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT01637012

    Prospective, Single-arm, Multicenter Study for Evaluation the Safety and Effectiveness of the ALEX Stent in a Real-world Setting of Percutaneous Coronary Interventions in Patients With Coronary Heart Disease

    Not yet reported Balton Sp.zo.o. 60 participants Est. completion 2013-09 5 sites
    Cardiovascular disease Other conditions: Stable Angina, Unstable Angina
    View official trial listing →
  • Terminated NCT NCT01637090

    Everolimus in Treating Cutaneous T-cell Lymphoma

    Not yet reported Adam Lerner 3 participants Est. completion 2015-05 1 site
    Other conditions: Cutaneous T-Cell Lymphoma
    View official trial listing →
  • Completed NCT NCT01637194

    Cetuximab and Everolimus in Treating Patients With Metastatic or Recurrent Colon Cancer or Head and Neck Cancer

    Not yet reported Fox Chase Cancer Center 12 participants Est. completion 2011-07 1 site
    Other conditions: Recurrent Adenoid Cystic Carcinoma of the Oral Cavity, Recurrent Basal Cell Carcinoma of the Lip, Recurrent Colon Cancer, Recurrent Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity, Recurrent Inverted Papilloma of the Paranasal Sinus and Nasal Cavity, Recurrent Lymphoepithelioma of the Nasopharynx, Recurrent Lymphoepithelioma of the Oropharynx, Recurrent Metastatic Squamous Neck Cancer With Occult Primary, Recurrent Midline Lethal Granuloma of the Paranasal Sinus and Nasal Cavity, Recurrent Mucoepidermoid Carcinoma of the Oral Cavity, Recurrent Salivary Gland Cancer, Recurrent Squamous Cell Carcinoma of the Hypopharynx, Recurrent Squamous Cell Carcinoma of the Larynx, Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity, Recurrent Squamous Cell Carcinoma of the Nasopharynx, Recurrent Squamous Cell Carcinoma of the Oropharynx, Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Recurrent Verrucous Carcinoma of the Larynx, Recurrent Verrucous Carcinoma of the Oral Cavity, Stage IV Adenoid Cystic Carcinoma of the Oral Cavity, Stage IV Basal Cell Carcinoma of the Lip, Stage IV Lymphoepithelioma of the Nasopharynx, Stage IV Lymphoepithelioma of the Oropharynx, Stage IV Mucoepidermoid Carcinoma of the Oral Cavity, Stage IV Squamous Cell Carcinoma of the Hypopharynx, Stage IV Squamous Cell Carcinoma of the Larynx, Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity, Stage IV Squamous Cell Carcinoma of the Nasopharynx, Stage IV Squamous Cell Carcinoma of the Oropharynx, Stage IV Verrucous Carcinoma of the Larynx, Stage IV Verrucous Carcinoma of the Oral Cavity, Stage IVA Colon Cancer, Stage IVA Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity, Stage IVA Inverted Papilloma of the Paranasal Sinus and Nasal Cavity, Stage IVA Midline Lethal Granuloma of the Paranasal Sinus and Nasal Cavity, Stage IVA Salivary Gland Cancer, Stage IVA Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage IVB Colon Cancer, Stage IVB Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity, Stage IVB Inverted Papilloma of the Paranasal Sinus and Nasal Cavity, Stage IVB Midline Lethal Granuloma of the Paranasal Sinus and Nasal Cavity, Stage IVB Salivary Gland Cancer, Stage IVB Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Stage IVC Esthesioneuroblastoma of the Paranasal Sinus and Nasal Cavity, Stage IVC Inverted Papilloma of the Paranasal Sinus and Nasal Cavity, Stage IVC Midline Lethal Granuloma of the Paranasal Sinus and Nasal Cavity, Stage IVC Salivary Gland Cancer, Stage IVC Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity, Tongue Cancer
    View official trial listing →
  • Completed NCT NCT01640743

    Effect of Different Therapeutic Strategies on Regulatory T Cells in Kidney Transplantation

    Not yet reported Fondazione IRCCS Policlinico San Matteo di Pavia 58 participants Est. completion 2014-04 1 site Stand-alone
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT01642186

    Study of (1) Everolimus, (2) Estrogen Deprivation Therapy (EDT) With Leuprolide + Letrozole and (3) Everolimus + EDT in Patients With Unresectable Fibrolamellar Hepatocellular Carcinoma (FLL-HCC)

    Not yet reported Memorial Sloan Kettering Cancer Center 28 participants Est. completion 2021-07-16 6 sites
    Other conditions: Fibrolamellar Carcinoma, Fibrolamellar Liver Cancer
    View official trial listing →
  • Completed NCT NCT01646177

    A Study in Participants With Moderate to Severe Psoriasis (UNCOVER-3)

    Not yet reported Eli Lilly and Company 1346 participants Est. completion 2019-07-22 101 sites
    Other conditions: Psoriasis
    View official trial listing →
  • Completed NCT NCT01646385

    Study to Assess the Safety and Efficacy of Etanercept in Patients Treated Over the Long-term in Real-world Clinical Practice, Using Data Collected by the British Society of Rheumatology Biologics Registry

    Pfizer 6393 participants Est. completion 2012-08
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT01647945

    FK506 (Tacrolimus) in Pulmonary Arterial Hypertension

    Not yet reported Edda Spiekerkoetter 23 participants Est. completion 2014-08 1 site
    Other conditions: Pulmonary Arterial Hypertension
    View official trial listing →
  • Terminated NCT NCT01648465

    Study of Everolimus Treatment in Newly-diagnosed Patients With Advanced Gastrointestinal Neuroendocrine Tumors

    Not yet reported Hellenic Cooperative Oncology Group 25 participants Est. completion 2019-08-06 12 sites
    Other conditions: Gastrointestinal Tumors, Pancreatic Tumors, Gastrointestinal Neuroendocrine Tumors, Pancreatic Neuroendocrine Tumors
    View official trial listing →
  • Completed NCT NCT01649427

    Comparison of a Tacrolimus Hexal® Based Regimen Versus a Prograf® Based Regimen in de Novo Renal Transplant Recipients

    Not yet reported Novartis Pharmaceuticals 73 participants Est. completion 2015-08-20 5 sites Stand-alone
    Other conditions: Pharmacokinetics Study in de Novo Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT01649609

    Using mTOR Inhibitors in the Prevention of BK Nephropathy

    Not yet reported Columbia University 40 participants Est. completion 2016-12 2 sites
    Other conditions: BK Viremia, BK Nephropathy
    View official trial listing →
  • Completed NCT NCT01649960

    Exercise and Low-Dose Rapamycin in Older Adults With CAD:Cardiac Rehabilitation And Rapamycin in Elderly (CARE) Trial

    Not yet reported Mayo Clinic 13 participants Est. completion 2015-12 1 site
    Other conditions: Aging, CAD
    View official trial listing →
  • Completed NCT NCT01650545

    Aerosol Liposomal Cyclosporine for Chronic Rejection in Lung Transplant Recipients

    Not yet reported, Not yet reported University of Maryland, Baltimore 21 participants Est. completion 2019-11 1 site Stand-alone
    Other conditions: Disorder Related to Lung Transplantation, Bronchiolitis Obliterans, Decreased Immunologic Activity, Chronic Rejection of Lung Transplant
    View official trial listing →
  • Completed NCT NCT01651390

    Clinical Performance of the Pantera Lux Balloon Versus the Orsiro Stent in Patients With In-stent Restenosis.

    Not yet reported Biotronik AG 231 participants Est. completion 2016-07 14 sites
    Cardiovascular disease Other conditions: Coronary Restenosis
    View official trial listing →
  • Withdrawn NCT NCT01652014

    Single or Double Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Hematologic Malignancies

    Not yet reported University of Medicine and Dentistry of New Jersey Est. completion 2017-01 1 site Stand-alone
    Obstructive sleep apnea Other conditions: Accelerated Phase Chronic Myelogenous Leukemia, Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, Blastic Phase Chronic Myelogenous Leukemia, Cutaneous B-cell Non-Hodgkin Lymphoma, de Novo Myelodysplastic Syndromes, Hepatosplenic T-cell Lymphoma, Intraocular Lymphoma, Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable, Nodal Marginal Zone B-cell Lymphoma, Noncutaneous Extranodal Lymphoma, Peripheral T-cell Lymphoma, Post-transplant Lymphoproliferative Disorder, Previously Treated Myelodysplastic Syndromes, Recurrent Adult Acute Lymphoblastic Leukemia, Recurrent Adult Acute Myeloid Leukemia, Recurrent Adult Burkitt Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma, Recurrent Adult Diffuse Mixed Cell Lymphoma, Recurrent Adult Diffuse Small Cleaved Cell Lymphoma, Recurrent Adult Grade III Lymphomatoid Granulomatosis, Recurrent Adult Hodgkin Lymphoma, Recurrent Adult Immunoblastic Large Cell Lymphoma, Recurrent Adult Lymphoblastic Lymphoma, Recurrent Adult T-cell Leukemia/Lymphoma, Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Grade 3 Follicular Lymphoma, Recurrent Mantle Cell Lymphoma, Recurrent Marginal Zone Lymphoma, Recurrent Mycosis Fungoides/Sezary Syndrome, Recurrent Small Lymphocytic Lymphoma, Refractory Chronic Lymphocytic Leukemia, Refractory Hairy Cell Leukemia, Refractory Multiple Myeloma, Relapsing Chronic Myelogenous Leukemia, Secondary Acute Myeloid Leukemia, Secondary Myelodysplastic Syndromes, Small Intestine Lymphoma, Splenic Marginal Zone Lymphoma, T-cell Large Granular Lymphocyte Leukemia, Testicular Lymphoma, Waldenström Macroglobulinemia
    View official trial listing →
  • Completed NCT NCT01652716

    Efficacy and Safety of Exenatide Once Weekly Suspension in Subjects With Type 2 Diabetes

    Not yet reported AstraZeneca 377 participants Est. completion 2014-08 58 sites Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01652729

    Comparison Study of the Glycemic Effects, Safety, and Tolerability of Exenatide Once Weekly Suspension to Sitagliptin and Placebo in Subjects With Type 2 Diabetes Mellitus

    Not yet reported AstraZeneca 365 participants Est. completion 2014-04 60 sites Stand-alone
    Other conditions: Diabetes Type 2
    View official trial listing →
  • Completed NCT NCT01653041

    Certican (Everolimus) for Recipients of Kidney From HLA-identical Living Donors

    Not yet reported Hospital do Rim e Hipertensão 47 participants Est. completion 2015-04 1 site
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Status unknown NCT NCT01653067

    STORM: Temsirolimus, Rituximab and DHAP for Relapsed and Refractory Diffuse Large B-cell Lymphoma

    Not yet reported Mathias Witzens-Harig 88 participants Est. completion 2018-07 9 sites
    Other conditions: Diffuse Large B-Cell Lymphoma
    View official trial listing →
  • Completed NCT NCT01653847

    Study in Recipients of Renal Transplant Allograft to Evaluate the Impact of Two Immunosuppressive Regimens

    Not yet reported Northwestern University 88 participants Est. completion 2020-05 1 site
    Other conditions: End Stage Renal Failure With Renal Transplant
    View official trial listing →
  • Completed NCT NCT01653899

    Caspase Inhibition in Islet Transplantation

    Not yet reported, Not yet reported University of Alberta 12 participants Est. completion 2016-06 1 site
    Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01655563

    Pharmacogenetic Trial of Tacrolimus After Pediatric Transplantation

    Not yet reported The Hospital for Sick Children 75 participants Est. completion 2016-02 1 site Stand-alone
    Other conditions: Heart Transplantation, Liver Transplantation, Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT01656135

    Reference Group Trial for The ONE Study

    Not yet reported University of Regensburg 70 participants Est. completion 2015-12 8 sites
    Other conditions: End-stage Renal Failure, Kidney Graft Rejection
    View official trial listing →
  • Terminated NCT NCT01658007

    Pilot Study Of Sirolimus Plus Multiagent Chemotherapy For Relapsed/Refractory Acute Lymphoblastic Leukemia/Lymphoma

    Not yet reported Children's Hospital Medical Center, Cincinnati 3 participants Est. completion 2017-01 1 site Stand-alone
    Other conditions: Relapsed Lymphoblastic Leukemia, Recurrent Adult Lymphoblastic Lymphoma, Refractory Acute Lymphoblastic Leukemia, Refractory Lymphoblastic Lymphoma
    View official trial listing →
  • Withdrawn NCT NCT01658176

    Study Of PF-04691502 (PI3K/mTOR Inhibitor) In Combination With Exemestane Compared With Exemestane Alone In Patients With Advanced Breast Cancer

    Not yet reported Pfizer Est. completion 2015-04
    Other conditions: Breast Neoplasms
    View official trial listing →
  • Active, not recruiting NCT NCT01659606

    Radiation- and Alkylator-free Bone Marrow Transplantation Regimen for Patients With Dyskeratosis Congenita

    Not yet reported Boston Children's Hospital 40 participants Est. completion 2034-12 13 sites Stand-alone
    Other conditions: Dyskeratosis Congenita, Hoyeraal Hreidarsson Syndrome, Revesz Syndrome, Aplastic Anemia
    View official trial listing →
  • Completed NCT NCT01661283

    SARC016: Study of Everolimus With Bevacizumab to Treat Refractory Malignant Peripheral Nerve Sheath Tumors

    Not yet reported Sarcoma Alliance for Research through Collaboration 25 participants Est. completion 2017-12 12 sites
    Other conditions: Malignant Peripheral Nerve Sheath Tumors, MPNST, Sarcoma
    View official trial listing →
  • Terminated NCT NCT01663766

    Phase I Study of Milatuzumab for Graft Versus Host Disease

    Not yet reported Gilead Sciences 12 participants Est. completion 2015-03 1 site Stand-alone
    Other conditions: GVHD (Acute or Chronic), Acute Myeloid or Lymphoblastic Leukemia (AML or ALL), Myelodysplastic Syndrome, Chronic Myelogenous Leukemia (CML), Multiple Myeloma (MM), Non-Hodgekin Lymphoma (NHL-both Follicular & Diffuse Large Cell), Chronic Lymphocytic Leukemia or Small Lymphocytic Leukemia (CLL or SLL)
    View official trial listing →
  • Completed NCT NCT01664624

    Roflumilast Plus Alogliptin Proof-of-Mechanism Study in Type2 Diabetes

    Not yet reported AstraZeneca 40 participants Est. completion 2012-11 2 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01664910

    CMC-544 and Allogeneic Transplantation for CD22 Positive-Lymphoid Malignancies

    Not yet reported, Not yet reported M.D. Anderson Cancer Center 27 participants Est. completion 2023-06-28 1 site Stand-alone
    Other conditions: Hematopoietic and Lymphoid Cell Neoplasm
    View official trial listing →
  • Completed NCT NCT01665677

    Atorvastatin as GVHD Prophylaxis for Allogeneic Hematopoietic Cell Transplantation

    Not yet reported Mehdi Hamadani 69 participants Est. completion 2021-07-09 2 sites
    Other conditions: Graft vs Host Disease
    View official trial listing →
  • Completed NCT NCT01666951

    Multicenter, Prospective, Rand, PK Study of LCP-Tacro™ Compared to Prograf® Capsules in De Novo Adult Kidney Transplant

    Not yet reported Veloxis Pharmaceuticals 36 participants Est. completion 2013-05 13 sites Stand-alone
    Other conditions: Renal Failure
    View official trial listing →
  • Completed NCT NCT01668485

    Mechanisms of Glucose Counterregulation in Pancreatic Islet Transplantation

    Not yet reported University of Giessen 36 participants Est. completion 2011-11 1 site
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT01668784

    Study of Nivolumab (BMS-936558) vs. Everolimus in Pre-Treated Advanced or Metastatic Clear-cell Renal Cell Carcinoma (CheckMate 025)

    Not yet reported Bristol-Myers Squibb 821 participants Est. completion 2021-07-19 168 sites
    Other conditions: Advanced or Metastatic (Medically or Surgically Unresectable) Clear-cell Renal Cell Carcinoma
    View official trial listing →
  • Completed NCT NCT01670175

    Sirolimus With Cyclophosphamide and Topotecan for Pediatric/Adolescent Relapsed and Refractory Solid Tumors

    Not yet reported University of California, San Francisco 21 participants Est. completion 2016-09 1 site Stand-alone
    Other conditions: Malignant Solid Tumor, Childhood Solid Tumor
    View official trial listing →
  • Completed NCT NCT01672151

    Efficacy of Rapamycin Therapy With Chronic Immune Thrombocytopenia

    First Affiliated Hospital of Suzhou Medical College 35 participants Est. completion 2012-08 1 site
    Other conditions: Immune Thrombocytopenic Purpura
    View official trial listing →
  • Active, not recruiting NCT NCT01674140

    S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer

    Not yet reported SWOG Cancer Research Network 1939 participants Est. completion 2030-01 1458 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT01674803

    Comparison of BIOdegradable Polymer and DuRablE Polymer Drug-eluting Stents in an All COmeRs PopulaTion (BIO-RESORT)

    Not yet reported Foundation of Cardiovascular Research and Education Enschede 3514 participants Est. completion 2020-08-25 1 site
    Cardiovascular disease Other conditions: Acute Coronary Syndrome, Angina Pectoris, Angina, Unstable, Coronary Stenosis, Coronary Restenosis
    View official trial listing →
  • Completed NCT NCT01678664

    Everolimus After (Chemo)Embolization for Liver Metastases From Digestive Endocrine Tumors

    Not yet reported Federation Francophone de Cancerologie Digestive 74 participants Est. completion 2019-04 18 sites
    Other conditions: Neuroendocrine Tumors, Hepatic Metastases, Metastases
    View official trial listing →
  • Completed NCT NCT01678937

    Immune Tolerance and Alloreactivity in Liver Transplant Recipients on Different Monotherapy Immunosuppressive Agents

    Northwestern University 31 participants Est. completion 2008-09 1 site
    Other conditions: Liver Transplant Rejection, Immunosuppression
    View official trial listing →
  • Status unknown NCT NCT01680250

    Sirolimus for Massive Polycystic Liver

    Not yet reported, Not yet reported Seoul National University Hospital 44 participants Est. completion 2015-08 1 site Stand-alone
    Other conditions: Polycystic Kidney Diseases
    View official trial listing →
  • Completed NCT NCT01680861

    Tacrolimus/Everolimus Versus Tacrolimus/Enteric-Coated Mycophenolate Sodium

    Not yet reported Gaetano Ciancio 32 participants Est. completion 2014-12 1 site Stand-alone
    Other conditions: Transplant; Failure, Kidney
    View official trial listing →
  • Completed NCT NCT01680952

    Study to Evaluate the Safety and Efficacy of Extended Release Tacrolimus (Advagraf®) + Sirolimus (Rapamune®), Versus Extended Release Tacrolimus (Advagraf®) + Mycophenolate Mofetil in Kidney Transplant Patients

    Not yet reported Yonsei University 158 participants Est. completion 2016-01 7 sites Stand-alone
    Other conditions: Kidney Transplant Patients
    View official trial listing →
  • Completed NCT NCT01681134

    A Comparison of the Effects of Extended Release Tacrolimus (Advagraf®) vs. Immediate Release Tacrolimus (Prograf®) on Kidney Function in Healthy Male Volunteers

    Not yet reported Astellas Pharma Canada, Inc. 19 participants Est. completion 2012-10 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Status unknown NCT NCT01681381

    Evaluate Safety And Effectiveness Of The Tivoli® DES and The Firebird2® DES For Treatment Coronary Revascularization

    Not yet reported Essen Technology (Beijing) Co., Ltd. 2790 participants Est. completion 2018-09 1 site
    Other conditions: Ischemic Heart Disease, Myocardial Ischemia, Coronary Artery Lesions,Primary, Coronary Disease, Acute Coronary Syndrome, Furcation Lesion of Coronary Artery
    View official trial listing →
  • Completed NCT NCT01684449

    Gemcitabine Plus Rapamycin Versus Gemcitabine to Treat Advanced Soft Tissue Sarcoma

    Not yet reported, Not yet reported Grupo Espanol de Investigacion en Sarcomas 28 participants Est. completion 2013-12 9 sites
    Other conditions: Advanced Soft Tissue Sarcoma
    View official trial listing →
  • Completed NCT NCT01684982

    Everolimus Stent in Myocardial Infarction

    Not yet reported San Giuseppe Moscati Hospital 500 participants Est. completion 2012-06 1 site
    Cardiovascular disease
    View official trial listing →
  • Terminated NCT NCT01685411

    Busulfan and Cyclophosphamide Followed By ALLO BMT

    Not yet reported Masonic Cancer Center, University of Minnesota 5 participants Est. completion 2020-02-10 1 site Stand-alone
    Other conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Myelodysplastic Syndrome
    View official trial listing →
  • Status unknown NCT NCT01686191

    Genetic Predictors of Renal Dysfunction Following Heart Transplantation

    University of Colorado, Denver 300 participants Est. completion 2025-12 1 site
    Other conditions: Heart Transplantation, Chronic Renal Insufficiency
    View official trial listing →
  • Completed NCT NCT01687075

    CRE8 in All Comers Patients

    Not yet reported Tel-Aviv Sourasky Medical Center 215 participants Est. completion 2014-08 1 site Stand-alone
    Other conditions: Consecutive Subjects Who Are Suitable for a Coronary, Angioplasty of de Novo Lesion(s) in Native Coronary, Arteries Should be Screened for Eligibility., A Total Number of 200 Patients Fulfilling the Selection, Criteria and Willing to Sign the Informed Consent Should, be Enrolled in the Trial.
    View official trial listing →
  • Completed NCT NCT01687179

    Safety Study of Sirolimus and Hydroxychloroquine in Women With Lymphangioleiomyomatosis

    Not yet reported Brigham and Women's Hospital 14 participants Est. completion 2015-08 1 site Stand-alone
    Other conditions: Lymphangioleiomyomatosis
    View official trial listing →
  • Completed NCT NCT01687673

    Phase II Combination of Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma

    Not yet reported University of California, San Francisco 29 participants Est. completion 2020-01-09 2 sites
    Other conditions: Hepatocellular Carcinoma
    View official trial listing →
  • Completed NCT NCT01690299

    Phase 3b Safety and Efficacy Study of Apremilast to Treat Moderate to Severe Plaque-plaque Psoriasis

    Not yet reported Amgen 250 participants Est. completion 2016-04-04 82 sites Stand-alone
    Other conditions: Psoriasis, Psoriatic Arthritis
    View official trial listing →
  • Terminated NCT NCT01691014

    Formation of Antibodies and Subsequent Prediction of Clinical Response in Patients With Rheumatoid Arthritis Treated With Four TNF Blocking Agents

    Pfizer 79 participants Est. completion 2015-01 13 sites
    Other conditions: Rheumatoid Arthritis (RA)
    View official trial listing →
  • Completed NCT NCT01692899

    Retention Rates of Adalimumab, Etanercept and Infliximab as First and Second-Line Biotherapy in Patients With Rheumatoid Arthritis in Daily Practice

    Pfizer 780 participants Est. completion 2011-09
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT01698541

    Generic Tacrolimus in the Elderly - Prograf® vs Tacni®

    Not yet reported University of Oslo School of Pharmacy 28 participants Est. completion 2013-11 1 site Stand-alone
    Other conditions: End Stage Renal Disease
    View official trial listing →
  • Status unknown NCT NCT01699360

    The Biomarker for Immunosuppressive Agents Metabolism in Chinese Renal Transplant Recipients

    Not yet reported Central South University 600 participants Est. completion 2013-12 1 site Stand-alone
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT01701986

    Gemcitabine Hydrochloride, Clofarabine, and Busulfan Before Donor Stem Cell Transplant in Treating Patients With Refractory B-Cell or T-Cell Non-Hodgkin Lymphoma or Hodgkin Lymphoma

    Not yet reported, Not yet reported M.D. Anderson Cancer Center 64 participants Est. completion 2024-06-05 1 site Stand-alone
    Other conditions: Hematopoietic Cell Transplantation Recipient, Refractory B-Cell Non-Hodgkin Lymphoma, Refractory Hodgkin Lymphoma, Refractory T-Cell Non-Hodgkin Lymphoma
    View official trial listing →
  • Status unknown NCT NCT01702051

    Extending Indication for Islet Autotransplantation in Pancreatic Surgery

    Ospedale San Raffaele 150 participants Est. completion 2025-10 1 site
    Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT01702181

    A Safety Study to Evaluate the Use and Effectiveness of a Topical Ointment to Treat Adults With Atopic Dermatitis

    Not yet reported Otsuka Pharmaceutical Development & Commercialization, Inc. 92 participants Est. completion 2013-12 12 sites
    Other conditions: Atopic Dermatitis
    View official trial listing →
  • Completed NCT NCT01702207

    Evaluation Of Switching From Twice Daily Tacrolimus To Once Daily Formulation On Cardiovascular Risk

    Not yet reported University of Saskatchewan 36 participants Est. completion 2017-12 1 site
    Cardiovascular disease Other conditions: Immunosuppression, Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT01707004

    Decitabine and Total-Body Irradiation Followed By Donor Bone Marrow Transplant and Cyclophosphamide in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

    Not yet reported University of Wisconsin, Madison 20 participants Est. completion 2017-10-07 1 site Stand-alone
    Other conditions: Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), de Novo Myelodysplastic Syndromes, Previously Treated Myelodysplastic Syndromes, Recurrent Adult Acute Myeloid Leukemia, Secondary Acute Myeloid Leukemia
    View official trial listing →
  • Completed NCT NCT01707849

    The Impact of Everolimus Based Immunosuppression in the Evolution of Hepatitis C Fibrosis After Liver Transplantation

    Not yet reported Hospital Vall d'Hebron 18 participants Est. completion 2016-08 1 site Stand-alone
    Other conditions: Hepatitis C Recurrence After Liver Transplant
    View official trial listing →
  • Terminated NCT NCT01709136

    Pharmacokinetics of Sirolimus and Tacrolimus in Liver Transplant Recipients With Tacrolimus Toxicity

    Not yet reported, Not yet reported University of Pittsburgh 3 participants Est. completion 2010-01 Stand-alone
    Other conditions: Hypertension
    View official trial listing →
  • Completed NCT NCT01712828

    Effect of P-glycoprotein Inhibition on Lenalidomide Pharmacokinetics in Healthy Males

    Not yet reported Celgene 31 participants Est. completion 2013-01-01 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01713400

    Tacrolimus, Sirolimus and Ustekinumab vs. Tacrolimus and Sirolimus for the Prevention of Acute Graft-Versus-Host Disease

    Not yet reported H. Lee Moffitt Cancer Center and Research Institute 54 participants Est. completion 2018-06-14 1 site Stand-alone
    Other conditions: Graft vs. Host Disease
    View official trial listing →
  • Completed NCT NCT01714440

    Genomics of Kidney Transplantation

    National Institute of Allergy and Infectious Diseases (NIAID) 1552 participants Est. completion 2017-01 5 sites
    Other conditions: KidneyTransplant Recipients, Simultaneous Kidney/Pancreas Recipients, Kidney Transplant Donor
    View official trial listing →
  • Completed NCT NCT01722682

    Bone Marrow vs Liver as Site for Islet Transplantation

    Not yet reported, Not yet reported Ospedale San Raffaele 9 participants Est. completion 2017-12 1 site
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT01724060

    Effects of Obesity Treatments on Food Preferences and Metabolism

    Imperial College London 80 participants Est. completion 2017-10 2 sites
    Type 2 diabetes Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT01725620

    Study to Compare the Safety and Pharmacokinetic Characteristics of LBEC0101 25mg With Those of Enbrel®

    Not yet reported LG Life Sciences 48 participants Est. completion 2014-04 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01729494

    Belatacept Early Steroid Withdrawal Trial

    Not yet reported University of Cincinnati 316 participants Est. completion 2019-12 8 sites
    Other conditions: Renal Transplantation
    View official trial listing →
  • Status unknown NCT NCT01730209

    Efficacy of RAD001/Everolimus in Autism and NeuroPsychological Deficits in Children With Tuberous Sclerosis Complex

    Not yet reported, Not yet reported Erasmus Medical Center 60 participants Est. completion 2016-11 1 site
    Other conditions: Tuberous Sclerosis Complex, TSC Related Cognitive Disability, TSC Related Autism, TSC Related Learning Problems
    View official trial listing →
  • Completed NCT NCT01731158

    Sequential Therapy in Metastatic Renal Cell Carinoma

    Not yet reported Central European Society for Anticancer Drug Research 22 participants Est. completion 2016-09 13 sites
    Other conditions: Metastatic Renal Cell Carcinoma
    View official trial listing →
  • Completed NCT NCT01734512

    PNOC 001: Phase II Study of Everolimus for Recurrent or Progressive Low-grade Gliomas in Children

    Not yet reported University of California, San Francisco 65 participants Est. completion 2024-07-31 18 sites
    Other conditions: Pediatric Recurrent Progressive Low-grade Gliomas, Pediatric Progressive Low-grade Gliomas
    View official trial listing →
  • Completed NCT NCT01742624

    Study to Evaluate the Safety and Efficacy of Advagraf vs Prograf in Kidney Transplantation Patients 1 Month After the Transplantation

    Not yet reported Astellas Pharma Korea, Inc. 60 participants Est. completion 2012-06 3 sites
    Other conditions: de Novo Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT01742676

    A Single Center, Open-label, Randomized, Pilot Study to Evaluate the Safety and Efficacy of a Tacrolimus Modified Release, ADVAGRAF®, Versus Tacrolimus Twice Daily, PROGRAF® in Stable Renal Recipients

    Not yet reported Astellas Pharma Korea, Inc. 100 participants Est. completion 2013-04 1 site
    Other conditions: Renal Transplantation, Kidney Transplantation, Stable Renal Recipients
    View official trial listing →
  • Completed NCT NCT01743131

    Abatacept as GVHD Prophylaxis Phase 2

    Not yet reported Boston Children's Hospital 186 participants Est. completion 2024-03-30 14 sites Stand-alone
    Other conditions: Graft vs Host Disease, Malignancy
    View official trial listing →
  • Completed NCT NCT01744067

    The Effects of Omega-3 Fatty Acids in Renal Transplantation

    Not yet reported Oslo University Hospital 132 participants Est. completion 2015-12 2 sites
    Other conditions: Disorder Related to Renal Transplantation
    View official trial listing →
  • Status unknown NCT NCT01744470

    Efficacy and Safety Study of a 4-Month Post-Renal Transplant Dose Reduction of Tacrolimus(ADEQUATE)

    Not yet reported University Hospital, Tours 286 participants Est. completion 2015-03 16 sites Stand-alone
    Other conditions: De Novo Transplant Disease
    View official trial listing →
  • Completed NCT NCT01745159

    Preventive Treatment of Tacrolimus Ointment in Children With Atopic Dermatitis

    Not yet reported Astellas Pharma China, Inc. 125 participants Est. completion 2013-11 4 sites Stand-alone
    Other conditions: Moderate/Severe Atopic Dermatitis
    View official trial listing →
  • Completed NCT NCT01746680

    Efficacy and Safety Study of Tacrobell to Treat Rheumatoid Arthritis

    Not yet reported Chong Kun Dang Pharmaceutical 111 participants Est. completion 2015-06 1 site Stand-alone
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Terminated NCT NCT01749111

    Comparison Between Cyclophosphamide and Combination of Methotrexate + Calcineurin Inhibitor for GVHD Prophylaxis

    Not yet reported Hospital Israelita Albert Einstein 3 participants Est. completion 2016-08 1 site
    Other conditions: Acute Myelogenous Leukemia, Acute Lymphoid Leukemia, Myeloproliferative Disease, Myelodysplastic Syndrome, Chronic Myeloid Leukemia, Chronic Myelomonocytic Leukemia
    View official trial listing →
  • Terminated NCT NCT01749293

    Partially HLA Mismatched (Haploidentical) Allogeneic Bone Marrow Transplantation

    Not yet reported University of Illinois Chicago 3 participants Est. completion 2014-05-15 1 site Stand-alone
    Other conditions: Hematologic Malignancies
    View official trial listing →
  • Completed NCT NCT01751997

    Family-mismatched/Haploidentical Donors Versus Matched Unrelated Donors

    Not yet reported, Not yet reported Byung-Sik Cho 116 participants Est. completion 2019-12-31 1 site Stand-alone
    Other conditions: Acute Myeloid Leukemia
    View official trial listing →
  • Completed NCT NCT01754389

    Standard of Care vs. Bortezomib in Graft-Versus Host Disease After Hematopoietic Stem Cell Transplant

    Not yet reported Dana-Farber Cancer Institute 138 participants Est. completion 2016-11 4 sites Stand-alone
    Other conditions: Graft Versus Host Disease
    View official trial listing →
  • Completed NCT NCT01756118

    A Phase I, Dose-finding Study of BEZ235 in Adult Patients With Relapsed or Refractory Acute Leukemia

    Not yet reported Goethe University 24 participants Est. completion 2020-02-07 1 site
    Other conditions: Acute Lymphoblastic Leukemia, Leukemia, Myelocytic, Acute, Chronic Myelogenous Leukemia With Crisis of Blast Cells
    View official trial listing →
  • Status unknown NCT NCT01758107

    Study of Cyclosporine Withdrawal Regimen in Thai Renal Transplant Recipients

    Not yet reported Chulalongkorn University 30 participants Est. completion 2015-10 1 site Stand-alone
    Other conditions: Renal Transplant
    View official trial listing →
  • Terminated NCT NCT01758575

    Clinical Evaluation of the Underlying Mechanisms of Targeted Therapy Related Toxicities

    Amsterdam UMC, location VUmc 8 participants Est. completion 2017-04 1 site
    Other conditions: Advanced or Metastatic Solid Malignancy
    View official trial listing →
  • Terminated NCT NCT01760356

    Study of PD/PK/PG Relationships of Tacrolimus and Cyclosporin in Liver Transplant Patients

    UDA Centro Nacional Hepato-Bilio-Pancreático 141 participants Est. completion 2021-05-17 1 site
    Other conditions: End Stage Liver Disease, Rejection, Infection, Malignancy, Toxicity, Diabetes
    View official trial listing →
  • Completed NCT NCT01760655

    Reduced-Intensity Conditioning Before Donor Stem Cell Transplant in With High-Risk Hematologic Malignancies

    Not yet reported Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 62 participants Est. completion 2022-12-05 1 site Stand-alone
    Other conditions: Acute Myeloid Leukemia With FLT3/ITD Mutation, Acute Myeloid Leukemia With Gene Mutations, Acute Myeloid Leukemia With Inv(3) (q21.3;q26.2); GATA2, MECOM, Acute Myeloid Leukemia With t(6;9) (p23;q34.1); DEK-NUP214, Aplastic Anemia, Chronic Lymphocytic Leukemia, Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Chronic Myelomonocytic Leukemia, Follicular Lymphoma, Hodgkin Lymphoma, Myelodysplastic Syndrome, Myelofibrosis, Myeloid Leukemia, Non-Hodgkin Lymphoma, Plasma Cell Myeloma, Polycythemia Vera, Recurrent Adult Acute Myeloid Leukemia, Recurrent Childhood Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia, Secondary Acute Myeloid Leukemia, Therapy-Related Acute Myeloid Leukemia
    View official trial listing →
  • Suspended NCT NCT01762410

    Clinical Study of Oral PI3K/mTOR Inhibitor in Patients With Advanced Refractory Solid Tumors

    Not yet reported Piramal Enterprises Limited 60 participants Est. completion 2016-03 4 sites
    Other conditions: Advanced Refractory Solid Tumors
    View official trial listing →
  • Completed NCT NCT01763580

    A Study to Evaluate the Effect of Tacrolimus and Corticosteroid Combination Therapy in Patients With Minimal Change Nephrotic Syndrome

    Not yet reported Astellas Pharma Korea, Inc. 144 participants Est. completion 2017-08-21 1 site Stand-alone
    Other conditions: MCNS, Minimal Change Nephrotic Syndrome (MCNS)
    View official trial listing →
  • Completed NCT NCT01764321

    Noninterventional Examination of Subcutaneous (sc) Tumor Necrosis Factor (TNF) Inhibitors

    UCB Pharma SA 1723 participants Est. completion 2020-06-16 122 sites
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT01764581

    Randomized Controlled Trial of ImmuKnow in Liver Transplantation

    Not yet reported University of Bologna 206 participants Est. completion 2012-03 Stand-alone
    Other conditions: Liver Disease
    View official trial listing →
  • Terminated NCT NCT01764997

    An Evaluation of Sarilumab Plus Methotrexate Compared to Etanercept Plus Methotrexate in RA Patients Not Responding to Adalimumab Plus Methotrexate

    Not yet reported Sanofi 776 participants Est. completion 2015-01 257 sites Stand-alone
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Status unknown NCT NCT01766518

    The Study to Evaluate Efficacy and Safety of MY-REPT Capsule in Primary, Liver Transplantation Recipients (MYLT1)

    Not yet reported Chong Kun Dang Pharmaceutical 120 participants Est. completion 2014-05 3 sites Stand-alone
    Other conditions: Evidence of Liver Transplantation
    View official trial listing →
  • Completed NCT NCT01768845

    Unrelated Umbilical Cord Blood (UBC)Transplantation

    Not yet reported West Virginia University 34 participants Est. completion 2021-04-06 1 site Stand-alone
    Other conditions: Chronic Myelogenous Leukemia (CML), Acute Myelogenous Leukemia (AML), Myelodysplastic Syndrome, Multiple Myeloma, Hodgkin Lymphoma, Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia (CLL), Acute Lymphocytic Leukemia (ALL), Severe Aplastic Anemia
    View official trial listing →
  • Completed NCT NCT01771705

    NFAT-Dependent Cytokine Gene Expression for Immune Monitoring in Kidney Transplant Patients

    Not yet reported University of California, San Francisco 40 participants Est. completion 2017-04-17 1 site
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Terminated NCT NCT01773395

    GVAX vs. Placebo for MDS/AML After Allo HSCT

    Not yet reported Dana-Farber Cancer Institute 123 participants Est. completion 2021-11-24 4 sites
    Other conditions: Myelodysplastic Syndrome, Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia
    View official trial listing →
  • Terminated NCT NCT01773460

    Everolimus Beyond Progress for Patients Who Had Progress Under Everolimus and Exemestane

    Not yet reported GBG Forschungs GmbH 3 participants Est. completion 2014-07 1 site
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT01776788

    Effect of Short-Term Intensive Insulin Sequential Exenatide Therapy in Newly Diagnosed Type 2 Diabetic Patients

    Not yet reported The First Affiliated Hospital of Xiamen University 156 participants Est. completion 2015-02 1 site Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Status unknown NCT NCT01777204

    Gastrointestinal Transit and Motility in Renal Transplant Recipients

    Universidade Estadual de Ciências da Saúde de Alagoas 20 participants Est. completion 2013-01 1 site
    Other conditions: Change of Transit or Circulation, Effects of Immunosuppressant Therapy
    View official trial listing →
  • Completed NCT NCT01780844

    A Study to Assess the Efficacy and Safety of ASKP1240 in de Novo Kidney Transplant Recipients

    Not yet reported Astellas Pharma Global Development, Inc. 149 participants Est. completion 2017-01-27 42 sites Stand-alone
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT01780948

    Pharmacokinetic of Everolimus and Atorvastatin Co-administration

    Not yet reported Chulalongkorn University 18 participants Est. completion 2013-01 1 site
    Other conditions: Difference of 12-hour AUC
    View official trial listing →
  • Withdrawn NCT NCT01781442

    A Post Marketing Surveillance As Required By Philippine Food And Drug Administration

    Pfizer Est. completion 2015-06
    Other conditions: Renal Cell Carcinoma
    View official trial listing →
  • Completed NCT NCT01782729

    An Efficacy and Safety Study of Tacrolimus Ointment in Pediatric Participants With Atopic Dermatitis

    Not yet reported Janssen-Cilag Ltd.,Thailand 30 participants Est. completion 2008-11 1 site Stand-alone
    Other conditions: Dermatitis, Atopic
    View official trial listing →
  • Terminated NCT NCT01783015

    Study of Etanercept in Subjects With Rheumatoid Arthritis Who Have Had an Inadequate Response to Adalimumab or Infliximab Plus Methotrexate

    Not yet reported Pfizer 16 participants Est. completion 2014-08 15 sites Stand-alone
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Status unknown NCT NCT01783717

    Effects of Exenatide on Obesity and/or Diabetes Mellitus Due to Hypothalamic Damage

    Not yet reported Huashan Hospital 10 participants Est. completion 2015-07 1 site Stand-alone
    Other conditions: Hypothalamic Obesity, Diabetes Mellitus
    View official trial listing →
  • Terminated NCT NCT01784861

    VEGFR/PDGFR Dual Kinase Inhibitor X-82 and Everolimus for Treating Patients With Pancreatic Neuroendocrine Tumors

    Not yet reported, Not yet reported Washington University School of Medicine 23 participants Est. completion 2020-08-19 2 sites
    Other conditions: Adenocarcinoma, Pancreatic Neoplasms
    View official trial listing →
  • Completed NCT NCT01785810

    Phase II Maraviroc for GVHD Prevention

    Not yet reported Abramson Cancer Center at Penn Medicine 37 participants Est. completion 2018-07-12 1 site Stand-alone
    Other conditions: Hematologic Malignancy
    View official trial listing →
  • Completed NCT NCT01788150

    Safety and Efficacy Study of the Svelte Drug-Eluting Coronary Stent Delivery System

    Not yet reported Svelte Medical Systems, Inc. 159 participants Est. completion 2019-05-31 18 sites
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT01788501

    Tacrolimus/Methotrexate Versus Cyclosporine/Methotrexate for Prophylaxis of Graft Versus Host Disease

    Not yet reported, Not yet reported Seoul National University Hospital 50 participants Est. completion 2017-03-01 3 sites Stand-alone
    Other conditions: Graft vs Host Disease
    View official trial listing →
  • Completed NCT NCT01789255

    Vorinostat, Tacrolimus, and Methotrexate in Preventing GVHD After Stem Cell Transplant in Patients With Hematological Malignancies

    Not yet reported National Cancer Institute (NCI) 12 participants Est. completion 2014-03 1 site Stand-alone
    Obstructive sleep apnea Other conditions: Accelerated Phase Chronic Myelogenous Leukemia, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Adult Grade III Lymphomatoid Granulomatosis, B-cell Chronic Lymphocytic Leukemia, Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Chronic Myelomonocytic Leukemia, Chronic Phase Chronic Myelogenous Leukemia, Contiguous Stage II Adult Burkitt Lymphoma, Contiguous Stage II Adult Diffuse Large Cell Lymphoma, Contiguous Stage II Adult Diffuse Mixed Cell Lymphoma, Contiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma, Contiguous Stage II Adult Immunoblastic Large Cell Lymphoma, Contiguous Stage II Adult Lymphoblastic Lymphoma, Contiguous Stage II Grade 1 Follicular Lymphoma, Contiguous Stage II Grade 2 Follicular Lymphoma, Contiguous Stage II Grade 3 Follicular Lymphoma, Contiguous Stage II Mantle Cell Lymphoma, Contiguous Stage II Marginal Zone Lymphoma, Contiguous Stage II Small Lymphocytic Lymphoma, Cutaneous B-cell Non-Hodgkin Lymphoma, Graft Versus Host Disease, Intraocular Lymphoma, Myelodysplastic Syndrome With Isolated Del(5q), Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable, Nodal Marginal Zone B-cell Lymphoma, Noncontiguous Stage II Adult Burkitt Lymphoma, Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma, Noncontiguous Stage II Adult Diffuse Mixed Cell Lymphoma, Noncontiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma, Noncontiguous Stage II Adult Immunoblastic Large Cell Lymphoma, Noncontiguous Stage II Adult Lymphoblastic Lymphoma, Noncontiguous Stage II Grade 1 Follicular Lymphoma, Noncontiguous Stage II Grade 2 Follicular Lymphoma, Noncontiguous Stage II Grade 3 Follicular Lymphoma, Noncontiguous Stage II Mantle Cell Lymphoma, Noncontiguous Stage II Marginal Zone Lymphoma, Noncontiguous Stage II Small Lymphocytic Lymphoma, Post-transplant Lymphoproliferative Disorder, Primary Central Nervous System Hodgkin Lymphoma, Primary Central Nervous System Non-Hodgkin Lymphoma, Recurrent Adult Acute Myeloid Leukemia, Recurrent Adult Burkitt Lymphoma, Recurrent Adult Diffuse Large Cell Lymphoma, Recurrent Adult Diffuse Mixed Cell Lymphoma, Recurrent Adult Diffuse Small Cleaved Cell Lymphoma, Recurrent Adult Grade III Lymphomatoid Granulomatosis, Recurrent Adult Hodgkin Lymphoma, Recurrent Adult Immunoblastic Large Cell Lymphoma, Recurrent Adult Lymphoblastic Lymphoma, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Grade 3 Follicular Lymphoma, Recurrent Mantle Cell Lymphoma, Recurrent Marginal Zone Lymphoma, Recurrent Small Lymphocytic Lymphoma, Refractory Anemia, Refractory Anemia With Excess Blasts, Refractory Anemia With Ringed Sideroblasts, Refractory Chronic Lymphocytic Leukemia, Refractory Cytopenia With Multilineage Dysplasia, Refractory Hairy Cell Leukemia, Relapsing Chronic Myelogenous Leukemia, Secondary Central Nervous System Hodgkin Lymphoma, Secondary Central Nervous System Non-Hodgkin Lymphoma, Small Intestine Lymphoma, Splenic Marginal Zone Lymphoma, Stage I Adult Burkitt Lymphoma, Stage I Adult Diffuse Large Cell Lymphoma, Stage I Adult Diffuse Mixed Cell Lymphoma, Stage I Adult Diffuse Small Cleaved Cell Lymphoma, Stage I Adult Hodgkin Lymphoma, Stage I Adult Immunoblastic Large Cell Lymphoma, Stage I Adult Lymphoblastic Lymphoma, Stage I Chronic Lymphocytic Leukemia, Stage I Grade 1 Follicular Lymphoma, Stage I Grade 2 Follicular Lymphoma, Stage I Grade 3 Follicular Lymphoma, Stage I Mantle Cell Lymphoma, Stage I Marginal Zone Lymphoma, Stage I Small Lymphocytic Lymphoma, Stage II Adult Hodgkin Lymphoma, Stage II Chronic Lymphocytic Leukemia, Stage III Adult Burkitt Lymphoma, Stage III Adult Diffuse Large Cell Lymphoma, Stage III Adult Diffuse Mixed Cell Lymphoma, Stage III Adult Diffuse Small Cleaved Cell Lymphoma, Stage III Adult Hodgkin Lymphoma, Stage III Adult Immunoblastic Large Cell Lymphoma, Stage III Adult Lymphoblastic Lymphoma, Stage III Chronic Lymphocytic Leukemia, Stage III Grade 1 Follicular Lymphoma, Stage III Grade 2 Follicular Lymphoma, Stage III Grade 3 Follicular Lymphoma, Stage III Mantle Cell Lymphoma, Stage III Marginal Zone Lymphoma, Stage IV Adult Burkitt Lymphoma, Stage IV Adult Diffuse Large Cell Lymphoma, Stage IV Adult Diffuse Mixed Cell Lymphoma, Stage IV Adult Diffuse Small Cleaved Cell Lymphoma, Stage IV Adult Hodgkin Lymphoma, Stage IV Adult Immunoblastic Large Cell Lymphoma, Stage IV Adult Lymphoblastic Lymphoma, Stage IV Chronic Lymphocytic Leukemia, Stage IV Grade 1 Follicular Lymphoma, Stage IV Grade 2 Follicular Lymphoma, Stage IV Grade 3 Follicular Lymphoma, Stage IV Mantle Cell Lymphoma, Stage IV Marginal Zone Lymphoma, Stage IV Small Lymphocytic Lymphoma, Testicular Lymphoma, Waldenström Macroglobulinemia
    View official trial listing →
  • Completed NCT NCT01789619

    Extended Release Tacrolimus (Advagraf®) in Severe Adult Atopic Dermatitis Patients

    UMC Utrecht 9 participants Est. completion 2014-01 1 site
    Other conditions: Atopic Dermatitis
    View official trial listing →
  • Completed NCT NCT01790568

    Vorinostat Plus Tacrolimus & Methotrexate to Prevent Graft vs Host Disease Following Unrelated Stem Cell Transplant

    Not yet reported University of Michigan Rogel Cancer Center 26 participants Est. completion 2017-10-31 1 site Stand-alone
    Other conditions: Graft vs Host Disease, Hematologic Neoplasms, Non-Neoplastic Hematologic and Lymphocytic Disorder
    View official trial listing →
  • Terminated NCT NCT01790594

    Optimization of NULOJIX® Usage Towards Minimizing CNI Exposure in Simultaneous Pancreas and Kidney Transplantation

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 46 participants Est. completion 2016-08 5 sites Stand-alone
    Other conditions: Simultaneous Kidney and Pancreas Transplantation
    View official trial listing →
  • Completed NCT NCT01791088

    Sirolimus in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed By Surgery

    Not yet reported University of Chicago 56 participants Est. completion 2018-08-17 1 site Stand-alone
    Other conditions: Unspecified Adult Solid Tumor, Protocol Specific, Unspecified Childhood Solid Tumor, Protocol Specific
    View official trial listing →
  • Status unknown NCT NCT01793519

    Stopping TNF Alpha Inhibitors in Rheumatoid Arthritis

    Not yet reported Georgetown University 290 participants Est. completion 2024-08-30 2 sites
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Terminated NCT NCT01793636

    A Study Comparing AZD2014 vs Everolimus in Patients With Metastatic Renal Cancer

    Not yet reported Queen Mary University of London 49 participants Est. completion 2015-11 9 sites
    Other conditions: Metastatic Clear Cell Renal Carcinoma
    View official trial listing →
  • Terminated NCT NCT01797315

    Prevention of Skin Cancer in High Risk Patients After Conversion to a Sirolimus-based Immunosuppressive Protocol

    Not yet reported University Hospital of Berlin 40 participants Est. completion 2013-06
    Other conditions: Renal Transplant Patients at High-risk for Skin Cancer
    View official trial listing →
  • Completed NCT NCT01797341

    Prograf-Advagraf Cross Over Conversion Study

    Not yet reported University Health Network, Toronto 13 participants Est. completion 2014-02 1 site Stand-alone
    Other conditions: Kidney-Pancreas Transplantation
    View official trial listing →
  • Completed NCT NCT01797523

    A Phase II, Single-Arm Study of RAD001 (Everolimus), Letrozole, and Metformin in Patients With Advanced or Recurrent Endometrial Carcinoma

    Not yet reported M.D. Anderson Cancer Center 62 participants Est. completion 2026-02-04 6 sites
    Other conditions: Endometrial Cancer
    View official trial listing →
  • Completed NCT NCT01798264

    Open Label, 4 Week Study of ITCA 650 in Adults With Type 2 Diabetes

    Not yet reported Intarcia Therapeutics 44 participants Est. completion 2009-05 3 sites Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01798446

    A Phase II Study of Axitinib in Metastatic Non-clear Cell Renal Cell Carcinoma Patients Previously Treated With Temsirolimus

    Not yet reported Seoul National University Hospital 41 participants Est. completion 2016-12 1 site
    Other conditions: Renal Cell Carcinoma, Nonclear Cell, Temsirolimus Resistance
    View official trial listing →
  • Status unknown NCT NCT01799460

    Study on Single-nucleotide-polymorphism in Idiopathic Membranous Nephropathy

    Shanghai University of Traditional Chinese Medicine 80 participants Est. completion 2013-08 1 site
    Other conditions: Idiopathic Membranous Nephropathy
    View official trial listing →
  • Completed NCT NCT01801137

    The Efficacy of RAD 001 as Second Line Therapy in Patients With Transitional Cell Carcinoma TCC of the Urothelium

    Not yet reported Hopital Foch 54 participants Est. completion 2014-10 1 site
    Other conditions: Urothelial Cancer
    View official trial listing →
  • Completed NCT NCT01802268

    Planned Conversion From TAC to SRL-based Regimen in de Novo Kidney Transplant Recipients

    Not yet reported Helio Tedesco Silva Junior 320 participants Est. completion 2012-10 6 sites
    Other conditions: Kidney Transplant
    View official trial listing →
  • Completed NCT NCT01804374

    Phase II Open Label, Non-randomized Study of Sorafenib and Everolimus in Relapsed and Non-resectable Osteosarcoma

    Not yet reported Italian Sarcoma Group 38 participants Est. completion 2014-12 1 site
    Obstructive sleep apnea
    View official trial listing →
  • Withdrawn NCT NCT01807767

    Myfortic in High MELD Liver Transplantation

    Not yet reported Medical College of Wisconsin Est. completion 2015-08 1 site Stand-alone
    Other conditions: High Model for End-Stage Liver Disease (MELD) Score
    View official trial listing →
  • Completed NCT NCT01809860

    A Study to Evaluate the Effect of Multiple Doses of Isavuconazole on the Pharmacokinetics of a Single Dose of Sirolimus in Healthy Subjects

    Not yet reported Astellas Pharma Global Development, Inc. 22 participants Est. completion 2012-01 1 site Stand-alone
    Other conditions: Healthy Subjects, Pharmacokinetics of Isavuconazole, Pharmacokinetics of Sirolimus
    View official trial listing →
  • Completed NCT NCT01810588

    Targeting the IPA and Matching for the Non-Inherited Maternal Antigen for Haplo-Cord Transplantation

    Not yet reported Weill Medical College of Cornell University 270 participants Est. completion 2026-03-24 2 sites Stand-alone
    Other conditions: Hematologic Malignancies
    View official trial listing →
  • Completed NCT NCT01812954

    Economic Evaluation of Systemic Treatments for Moderate-to-severe Psoriasis

    Jochen Schmitt. 1 participants Est. completion 2014-06
    Other conditions: Psoriasis
    View official trial listing →
  • Completed NCT NCT01817959

    Study to Assess Efficacy & Safety of Reparixin in Pancreatic Islet Transplantation

    Not yet reported Dompé Farmaceutici S.p.A 51 participants Est. completion 2017-12 9 sites
    Other conditions: Islet Transplantation in Diabetes Mellitus Type 1
    View official trial listing →
  • Withdrawn NCT NCT01818648

    Exenatide on GI Motor Function and Permeability in Short Bowel Syndrome

    Not yet reported Mayo Clinic Est. completion 2014-01 Stand-alone
    Other conditions: Short Bowel Syndrome
    View official trial listing →
  • Completed NCT NCT01820572

    A Study in Maintenance Kidney Transplant Recipients Following Conversion to Nulojix® (Belatacept)-Based

    Not yet reported Bristol-Myers Squibb 446 participants Est. completion 2019-10-24 117 sites
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT01824368

    Extracorporeal Photopheresis in Liver Transplantation. Phase II Clinical Trial in Safety and Efficacy in Patients With Gradual Decrease of Immunosuppression.

    Not yet reported, Not yet reported Red de Terapia Celular 10 participants Est. completion 2016-04 1 site Stand-alone
    Other conditions: Liver Transplantation, Immunosuppression
    View official trial listing →
  • Completed NCT NCT01824693

    Busulfan, Cyclophosphamide, and Melphalan or Busulfan and Fludarabine Phosphate Before Donor Hematopoietic Cell Transplant in Treating Younger Patients With Juvenile Myelomonocytic Leukemia

    Not yet reported Children's Oncology Group 30 participants Est. completion 2017-12-31 50 sites Stand-alone
    Other conditions: Juvenile Myelomonocytic Leukemia
    View official trial listing →
  • Completed NCT NCT01827267

    Neratinib With and Without Temsirolimus for Patients With HER2 Activating Mutations in Non-Small Cell Lung Cancer

    Not yet reported Puma Biotechnology, Inc. 62 participants Est. completion 2017-10-06 21 sites
    Other conditions: HER2-mutant Non-Small Cell Lung Cancer
    View official trial listing →
  • Completed NCT NCT01827618

    Neoadjuvant Rapamycin in Patients Undergoing Radical Cystectomy

    Not yet reported The University of Texas Health Science Center at San Antonio 29 participants Est. completion 2014-04 1 site
    Other conditions: Invasive Bladder Cancer Stage II
    View official trial listing →
  • Completed NCT NCT01828879

    An Efficacy and Safety Study of Tacrolimus Ointment in Adult Participants With Atopic Dermatitis

    Not yet reported Janssen-Cilag Ltd.,Thailand 74 participants Est. completion 2009-12 2 sites Stand-alone
    Other conditions: Dermatitis, Atopic
    View official trial listing →
  • Completed NCT NCT01830010

    A Two-part Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of KRP203 in Patients Undergoing Stem Cell Transplant for Hematological Malignancies

    Not yet reported Novartis Pharmaceuticals 23 participants Est. completion 2018-08-21 8 sites Stand-alone
    Other conditions: Hematological Malignancies
    View official trial listing →
  • Status unknown NCT NCT01837043

    Early Conversion From CNI to Belatacept in Renal Transplant Recipients With Delayed and Slow Graft Function

    Not yet reported Nair, Vinay, D.O. 90 participants Est. completion 2017-06 1 site
    Other conditions: Delayed Graft Function, Kidney Transplant
    View official trial listing →
  • Completed NCT NCT01839929

    A Study to Assess the Safety and Efficacy of ADVAGRAF (Tacrolimus Modified Release Formulation) in Kidney Transplant Patients Who Were Treated With PROGRAF

    Not yet reported Astellas Pharma Korea, Inc. 138 participants Est. completion 2013-02 4 sites Stand-alone
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Terminated NCT NCT01841008

    Maintenance Treatment of Non Segmental Vitiligo With Tacrolimus Ointment 0.1% Versus Control

    Not yet reported, Not yet reported Centre Hospitalier Universitaire de Nice 35 participants Est. completion 2014-06 2 sites Stand-alone
    Other conditions: Pigmentation Disorders, Vitiligo
    View official trial listing →
  • Completed NCT NCT01842139

    Vaccine Therapy and Basiliximab in Treating Patients With Acute Myeloid Leukemia in Complete Remission

    Not yet reported University of Chicago 7 participants Est. completion 2018-03 1 site Stand-alone
    Other conditions: Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22)
    View official trial listing →
  • Completed NCT NCT01842269

    Evaluate the Efficacy and Safety of My-Rept® Tablet vs. My-Rept® Capsule in Combination With Tacrolimus in Kidney Transplant Patients

    Not yet reported Chong Kun Dang Pharmaceutical 156 participants Est. completion 2015-04 11 sites
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Terminated NCT NCT01842594

    A Phase II Trial of Combined Hydroxychloroquine and Sirolimus in Soft Tissue Sarcoma

    Not yet reported Shin Kong Wu Ho-Su Memorial Hospital 13 participants Est. completion 2015-01 1 site Stand-alone
    Other conditions: Sarcoma
    View official trial listing →
  • Completed NCT NCT01843127

    A Study to Evaluate the Effect of Ranolazine on Postprandial Glucagon in Subjects With Type 2 Diabetes.

    Not yet reported Gilead Sciences 24 participants Est. completion 2013-09 3 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT01843348

    12 Month Athena Study: Everolimus vs. Standard Regimen in de Novo Kidney Transplant Patients

    Not yet reported Novartis Pharmaceuticals 612 participants Est. completion 2016-03-23 27 sites Stand-alone
    Other conditions: Kidney Transplantation, Renal Transplantation
    View official trial listing →
  • Withdrawn NCT NCT01843998

    Therapeutic Efficacy of Topical Sirolimus in Early Stage Cutaneous T-cell Lymphoma (CTCL)

    Not yet reported Stefan Schieke MD Est. completion 2015-12 1 site Stand-alone
    Other conditions: Cutaneous T-cell Lymphoma (CTCL)
    View official trial listing →
  • Completed NCT NCT01850979

    Treatment of Dry Eye Using 0.03% Tacrolimus Eye Drops

    Not yet reported University of Sao Paulo General Hospital 24 participants Est. completion 2011-11 1 site
    Other conditions: Sjogren Syndrome, Dry Eye Syndrome
    View official trial listing →
  • Completed NCT NCT01853423

    Tuberous Sclerosis Complex: Facial Angiofibroma Skin Cream

    Not yet reported Le Bonheur Children's Hospital 11 participants Est. completion 2016-07 1 site
    Other conditions: Facial Angiofibroma
    View official trial listing →
  • Completed NCT NCT01854606

    Safety and Efficacy of AEB071 and EVEROLIMUS in Patients With CD79-mutant or ABC Subtype Diffuse Large B-Cell Lymphoma

    Not yet reported Novartis Pharmaceuticals 31 participants Est. completion 2016-06-01 15 sites
    Other conditions: CD79 Mutant or ABC-subtype Diffuse Large B-Cell Lymphoma
    View official trial listing →
  • Completed NCT NCT01855490

    Study of the Acute Metabolic Effect of Exenatide in Type 1 Diabetes

    Not yet reported Yale University 17 participants Est. completion 2013-10 1 site Stand-alone
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Terminated NCT NCT01856257

    Open-Label Phase 2 Trial of a Steroid-Free, CNI-Free, Belatacept-Based Immunosuppressive Regimen

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 71 participants Est. completion 2016-04 3 sites Stand-alone
    Other conditions: Primary Renal Allograft Candidate, Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT01857193

    Phase Ib Trial of LEE011 With Everolimus (RAD001) and Exemestane in the Treatment of Hormone Receptor Positive HER2 Negative Advanced Breast Cancer

    Not yet reported Novartis Pharmaceuticals 132 participants Est. completion 2020-04-16 13 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT01857895

    Feasibility Study of Exenatide by Continuous Subcutaneous Infusion

    Not yet reported GlaxoSmithKline 10 participants Est. completion 2013-11-01 1 site Stand-alone
    Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT01858740

    Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts in Preventing GVHD in Children

    Not yet reported Fred Hutchinson Cancer Center 20 participants Est. completion 2023-07-30 1 site Stand-alone
    Other conditions: Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Biphenotypic Leukemia, Acute Leukemia of Ambiguous Lineage, Acute Undifferentiated Leukemia, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Childhood Acute Lymphoblastic Leukemia in Remission, Childhood Acute Myeloid Leukemia in Remission, Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Myelodysplastic Syndrome With Excess Blasts-1, Myelodysplastic Syndrome With Excess Blasts-2, Recurrent Adult Acute Lymphoblastic Leukemia, Recurrent Adult Acute Myeloid Leukemia, Recurrent Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood Acute Myeloid Leukemia, Refractory Adult Acute Lymphoblastic Leukemia, Refractory Childhood Acute Lymphoblastic Leukemia
    View official trial listing →
  • Completed NCT NCT01860183

    Effect of 3g Versus 2 g MMF in Combination With Tacrolimus on Progression of Renal Allograft Interstitial Fibrosis

    Not yet reported Clinical Hospital Merkur 76 participants Est. completion 2016-06-01 1 site
    Other conditions: Kidney Transplantation, Kidney Failure
    View official trial listing →
  • Completed NCT NCT01860963

    Anal Dysplasia in Patients With Inflammatory Bowel Disease and Healthy Controls

    Not yet reported Stanford University 310 participants Est. completion 2013-06 1 site
    Other conditions: Anal Squamous Intraepithelial Lesion (ASIL), HPV DNA
    View official trial listing →
  • Withdrawn NCT NCT01864070

    Phase 1 TheraSphere + Everolimus With Neuroendocrine Tumors (NETs) + Liver Only or Liver Dominant Disease

    Not yet reported M.D. Anderson Cancer Center
    Other conditions: Liver Cancer
    View official trial listing →
  • Completed NCT NCT01865747

    A Study of Cabozantinib (XL184) vs Everolimus in Subjects With Metastatic Renal Cell Carcinoma

    Not yet reported Exelixis 658 participants Est. completion 2021-01-15 205 sites
    Other conditions: Renal Cell Carcinoma
    View official trial listing →
  • Completed NCT NCT01870908

    Special Drug Use-Results Survey of Prograf Capsule in Rheumatoid Arthritis Patients

    Astellas Pharma Inc 664 participants Est. completion 2015-03 7 sites
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Terminated NCT NCT01871441

    Haploidentical Donor Hematopoietic Stem Cell Transplant in Treating Patients With Hematologic Malignancies

    Not yet reported Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 4 participants Est. completion 2016-10-20 1 site Stand-alone
    Other conditions: Malignant Neoplasm
    View official trial listing →
  • Status unknown NCT NCT01874002

    Prospective Registry to Asses the Long-term Safety and Performance of the Combo Stent

    Robbert J de Winter 1000 participants Est. completion 2019-03 9 sites
    Cardiovascular disease
    View official trial listing →
  • Status unknown NCT NCT01875224

    Comparison of NODAT in Kidney Transplant Patients Receiving Belatacept Versus Standard Immunosuppression

    Not yet reported University of Arizona 32 participants Est. completion 2016-08 1 site
    Other conditions: New Onset Diabetes After Transplant, Kidney Transplantation
    View official trial listing →
  • Terminated NCT NCT01875237

    Donor Lymphocyte Infusion (DLI) of T-cells Genetically Modified With iCasp9 Suicide Gene

    Not yet reported, Not yet reported M.D. Anderson Cancer Center 3 participants Est. completion 2017-03-07 1 site Stand-alone
    Other conditions: Leukemia, Myeloma, Myeloproliferative Diseases
    View official trial listing →
  • Completed NCT NCT01875991

    Preference Between Two Autoinjectors in Patients With Rheumatoid Arthritis and Plaque Psoriasis Treated With Etanercept

    Not yet reported Amgen 217 participants Est. completion 2014-03-04 37 sites Stand-alone
    Other conditions: Rheumatoid Arthritis, Plaque Psoriasis
    View official trial listing →
  • Terminated NCT NCT01878786

    A Pilot Study Comparing the Safety and Efficacy of Everolimus With Other Medicines in Recipients of ECD/DCD Kidneys

    Not yet reported, Not yet reported Matthew Cooper 25 participants Est. completion 2017-12 1 site Stand-alone
    Other conditions: Delayed Graft Function
    View official trial listing →
  • Status unknown NCT NCT01879358

    Sirolimus Eluting ORSIRO Stent Versus Biolimus-eluting NOBORI Stent

    Not yet reported Odense University Hospital 2314 participants Est. completion 2021-02-01 1 site
    Cardiovascular disease Other conditions: Ischemic Heart Disease
    View official trial listing →
  • Completed NCT NCT01882322

    A Study to Evaluate the Effect of Advagraf Conversion From Prograf in Liver Transplant Subjects

    Not yet reported Astellas Pharma Korea, Inc. 36 participants Est. completion 2017-01-03 1 site Stand-alone
    Other conditions: de Novo Liver Transplant Subjects
    View official trial listing →
  • Completed NCT NCT01884480

    Renal Function and Pharmacogenetics in Renal Transplant Recipients Converted From Tac BID to Tac OD

    Unity Health Toronto 60 participants Est. completion 2014-09 1 site
    Other conditions: Real Function Post Conversion From Prograf to Advagraf, Examin Ethnicity and Pharmacogenetics of the Cohort Requiring Dose Adjustment Post-conversion
    View official trial listing →
  • Completed NCT NCT01884571

    Immunosuppression in Amyotrophic Lateral Sclerosis (ALS)

    Not yet reported Emory University 31 participants Est. completion 2016-01 3 sites Stand-alone
    Other conditions: Amyotrophic Lateral Sclerosis (ALS)
    View official trial listing →
  • Active, not recruiting NCT NCT01885689

    Clofarabine and Melphalan Before Donor Stem Cell Transplant in Treating Patients With Myelodysplasia, Acute Leukemia in Remission, or Chronic Myelomonocytic Leukemia

    Not yet reported City of Hope Medical Center 72 participants Est. completion 2026-09-21 1 site Stand-alone
    Other conditions: Adult Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Adult Acute Myeloid Leukemia in Remission, Myelodysplastic Syndrome, Secondary Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia, Therapy-Related Myelodysplastic Syndrome
    View official trial listing →
  • Completed NCT NCT01887171

    Evaluation of Preimplantation Portal Vein and Hepatic Artery Flushing With Tacrolimus

    Not yet reported Republican Scientific and Practical Center for Organ and Tissue Transplantation 86 participants Est. completion 2014-07 1 site Stand-alone
    Other conditions: Early Allograft Dysfunction, Ischemic Reperfusion Injury, Liver Transplantation, Hyperfibrinolysis
    View official trial listing →
  • Completed NCT NCT01888432

    Efficacy and Safety of Everolimus in Liver Transplant Recipients of Living Donor Liver Transplants

    Not yet reported Novartis Pharmaceuticals 285 participants Est. completion 2018-04-21 42 sites Stand-alone
    Other conditions: Liver Transplantation
    View official trial listing →
  • Completed NCT NCT01889758

    Pharmacokinetic Studies of Tacrolimus in Transplant Patients

    Not yet reported University of Cincinnati 78 participants Est. completion 2016-01 2 sites
    Other conditions: Kidney Transplant Recipients, Liver Transplant Recipients
    View official trial listing →
  • Completed NCT NCT01891864

    Study to Demonstrate Equivalent Efficacy and to Compare Safety of Biosimilar Etanercept (GP2015) and Enbrel

    Not yet reported Sandoz 531 participants Est. completion 2015-03 74 sites Stand-alone
    Other conditions: Chronic Stable Plaque Psoriasis
    View official trial listing →
  • Completed NCT NCT01895049

    Comparison Between Two Tacrolimus-based Immunosuppressant Regimens and Induction With Thymoglobulin in Kidney Transplants From Deceased Donors With Expanded Criteria

    Not yet reported Helio Tedesco Silva Junior 171 participants Est. completion 2017-03-07 1 site Stand-alone
    Other conditions: Kidney Transplantation, Cytomegalovirus
    View official trial listing →
  • Completed NCT NCT01901185

    Study to Evaluate the Ability of Subjects With Rheumatoid Arthritis or Psoriatic Arthritis to Effectively Use a Reusable Autoinjector to Self-inject Etanercept

    Not yet reported Amgen 77 participants Est. completion 2013-12-30 13 sites Stand-alone
    Other conditions: Rheumatoid Arthritis, Psoriatic Arthritis
    View official trial listing →
  • Withdrawn NCT NCT01903317

    Evaluation of Vitamin D Levels in Psoriasis Patients

    University of California, Irvine Est. completion 2015-07 1 site
    Other conditions: Psoriasis
    View official trial listing →
  • Terminated NCT NCT01903473

    Donor Regulatory T Cells Infusion in Patients With Chronic Graft-versus-host Disease (GVHD)

    Not yet reported University of Liege 19 participants Est. completion 2022-09-12 2 sites
    Other conditions: Chronic Graft-Versus-Host Disease, Acute Graft-Versus-Host Disease, Steroid Refractory Graft-Versus-Host Disease
    View official trial listing →
  • Completed NCT NCT01904045

    PEL-1235_REN-0176-I (Pelicon)

    Technical University of Munich 51 participants Est. completion 2018-08 1 site
    Other conditions: Immunosuppression After Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT01904136

    Natural Killer Cells Before and After Donor Stem Cell Transplant in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous Leukemia

    Not yet reported, Not yet reported M.D. Anderson Cancer Center 54 participants Est. completion 2022-02-28 1 site Stand-alone
    Other conditions: Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Acute Myeloid Leukemia With Gene Mutations, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, de Novo Myelodysplastic Syndrome, Myelodysplastic Syndrome, Recurrent Acute Myeloid Leukemia, Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Therapy-Related Acute Myeloid Leukemia
    View official trial listing →
  • Active, not recruiting NCT NCT01909245

    Islet Cell Transplant for Type 1 Diabetes

    Not yet reported City of Hope Medical Center 10 participants Est. completion 2027-08-31 1 site
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT01910077

    Bioequivalence Study of Tacrobell Capsule 1mg to Prograf Capsule 1mg

    Not yet reported Chong Kun Dang Pharmaceutical 50 participants Est. completion 2013-11 1 site Stand-alone
    Other conditions: Immunosuppression
    View official trial listing →
  • Completed NCT NCT01911546

    Role of Everolimus in Highly Sensitized Patients

    Not yet reported Joseph Kahwaji, MD, MPH 20 participants Est. completion 2016-01-19 1 site Stand-alone
    Other conditions: Highly-sensitized Kidney Transplant Recipients
    View official trial listing →
  • Completed NCT NCT01920061

    A Study Of PF-05212384 In Combination With Other Anti-Tumor Agents and in Combination With Cisplatin in Patients With Triple Negative Breast Cancer in an Expansion Arm (TNBC)

    Not yet reported Pfizer 110 participants Est. completion 2020-01-08 29 sites
    Other conditions: Neoplasm
    View official trial listing →
  • Completed NCT NCT01921218

    Belatacept Therapy for the Failing Renal Allograft

    Not yet reported Andrew B Adams 13 participants Est. completion 2019-12-12 1 site
    Other conditions: Failing Renal Allograft
    View official trial listing →
  • Status unknown NCT NCT01922492

    Effect of Islet Autotransplantation Compared to Oral Antidiabetic Drug.

    Not yet reported Seoul National University Hospital 28 participants Est. completion 2017-12 1 site
    Other conditions: Partial Pancreatectomy Due to Benign Pancreatic Neoplasm
    View official trial listing →
  • Status unknown NCT NCT01925027

    Efficacy and Safety of Nano+ Polymer-free Sirolimus-Eluting Stent: A Optical Coherent Tomography Study

    Not yet reported Lepu Medical Technology (Beijing) Co., Ltd. 45 participants Est. completion 2016-11 5 sites Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT01927120

    In Vivo Treg Expansion and Graft-Versus-Host Disease Prophylaxis

    Not yet reported H. Lee Moffitt Cancer Center and Research Institute 20 participants Est. completion 2017-03-09 1 site Stand-alone
    Other conditions: Graft-Versus-Host-Disease
    View official trial listing →
  • Status unknown NCT NCT01927588

    Evaluation of Early Use of Everolimus (EVE) on Cytomegalovirus (CMV) Infection in Renal Transplant Recipients

    Not yet reported Fundação Pró Rim 50 participants Est. completion 2015-11 Stand-alone
    Other conditions: Cytomegalovirus Infections
    View official trial listing →
  • Completed NCT NCT01932372

    Tofacitinib (Xeljanz) Special Investigation for Rheumatoid Arthritis

    Pfizer 9968 participants Est. completion 2021-08-24 1 site
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT01935128

    Evaluation of Calcineurin-inhibitor Reduction With Conversion at 2 Months to Everolimus/Reduced Tacrolimus in Renal Transplant Recipients Following Campath® Induction

    Not yet reported University of Toledo Health Science Campus 55 participants Est. completion 2020-07 1 site Stand-alone
    Other conditions: Renal Transplant
    View official trial listing →
  • Completed NCT NCT01936519

    Conversion to Everolimus From Calcineurin Inhibitor With Mycophenolic Acid: Impact on Long Term Renal Function in Liver Transplantation.

    Not yet reported Milton S. Hershey Medical Center 24 participants Est. completion 2019-07-31 1 site
    Other conditions: Immunosuppression, Renal Failure
    View official trial listing →
  • Completed NCT NCT01938625

    A Study of Pharmacokinetics, Efficacy, Safety, Tolerability, of the Combination of Simeprevir (TMC435), Daclatasvir (BMS-790052), and Ribavirin (RBV) in Patients With Recurrent Chronic Hepatitis C Genotype 1b Infection After Orthotopic Liver Transplantation

    Not yet reported Janssen R&D Ireland 35 participants Est. completion 2015-07-28 6 sites Stand-alone
    Other conditions: Hepatitis C, Chronic
    View official trial listing →
  • Status unknown NCT NCT01939249

    Prospective, Randomized, Multicenter Study to Assess the Safety and Effectiveness of the Orsiro Sirolimus-eluting Stent

    Not yet reported Biotronik AG 585 participants Est. completion 2020-01 45 sites
    Cardiovascular disease
    View official trial listing →
  • Terminated NCT NCT01939418

    Phase Ib/II Trials of RAD001 in Triple Negative Metastatic Breast Cancer

    Not yet reported, Not yet reported National Cancer Center, Korea 23 participants Est. completion 2017-07-30 1 site
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT01950819

    Advancing Renal TRANSplant eFficacy and Safety Outcomes With an eveRolimus-based regiMen (TRANSFORM)

    Not yet reported Novartis Pharmaceuticals 2037 participants Est. completion 2018-01-17 184 sites Stand-alone
    Chronic kidney disease Other conditions: End Stage Renal Disease (ESRD), Hemodialysis, Renal Replacement Therapy, Renal Transplantation
    View official trial listing →
  • Completed NCT NCT01951885

    Tac, Mini-MTX, MMF Versus Tac, MTX for GVHD Prevention

    Not yet reported Case Comprehensive Cancer Center 101 participants Est. completion 2021-08-11 1 site Stand-alone
    Other conditions: Chronic Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Acute Biphenotypic Leukemia, Myelodysplastic Syndrome, Myeloproliferative Neoplasm, Non-Hodgkin Lymphoma, Hodgkins Disease, Chronic Lymphocytic Leukemia, Multiple Myeloma
    View official trial listing →
  • Completed NCT NCT01955187

    Sequential Therapy With Tacrolimus and Rituximab in Primary Membranous Nephropathy

    Not yet reported Hospital Universitario 12 de Octubre 86 participants Est. completion 2019-06-26 1 site Stand-alone
    Other conditions: MEMBRANOUS NEPHROPATHY
    View official trial listing →
  • Completed NCT NCT01958190

    Study Comparing in Livertransplantation Recipients With Tacrolimus Alone Versus Tacrolimus&Sirolimus

    Not yet reported Foundation for Liver Research 196 participants Est. completion 2021-05-20 3 sites Stand-alone
    Other conditions: Liver Disease
    View official trial listing →
  • Completed NCT NCT01962922

    Crossover Study to Compare PK of Once Daily LCP-Tacro Tablets to Generic Tacrolimus Capsules Twice Daily.

    Not yet reported Asahi Kasei Therapeutics, Inc. 50 participants Est. completion 2015-08 3 sites
    Other conditions: Renal Failure
    View official trial listing →
  • Completed NCT NCT01964014

    Once-a-day Immunosuppression(CISECON_a_day)

    Not yet reported Ajou University School of Medicine 160 participants Est. completion 2015-10 7 sites Stand-alone
    Other conditions: Chronic Renal Disease
    View official trial listing →
  • Status unknown NCT NCT01967186

    Intraportal or Intramuscular Site for Islets in Simultaneous Islet and Kidney Transplantation

    Not yet reported The Nordic Network For Clinical Islet Transplantation 36 participants Est. completion 2016-07
    Other conditions: Type 1 Diabetes, End Stage Renal Disease
    View official trial listing →
  • Completed NCT NCT01969149

    Exenatide for Stress Hyperglycemia

    Not yet reported, Not yet reported Centre Hospitalier Universitaire de Besancon 110 participants Est. completion 2016-12 1 site Stand-alone
    Other conditions: Stress Hyperglycemia
    View official trial listing →
  • Completed NCT NCT01971242

    Trial of Exenatide for Parkinson's Disease

    Not yet reported University College, London 60 participants Est. completion 2016-08 1 site
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT01971346

    The Immunological Basis for Treatment Resistance to Anti-TNF Treatments

    Not yet reported University of Michigan 50 participants Est. completion 2017-11-01 1 site
    Other conditions: Psoriasis
    View official trial listing →
  • Completed NCT NCT01971684

    ICON1: Treatment Decisions and Outcomes in Pediatric Refractory ITP

    Boston Children's Hospital 120 participants Est. completion 2017-04 29 sites
    Other conditions: Immune Thrombocytopenia
    View official trial listing →
  • Status unknown NCT NCT01974674

    Allogeneic Islet Transplantation for the Treatment of Type 1 Diabetes

    Not yet reported Assistance Publique - Hôpitaux de Paris 19 participants Est. completion 2022-01 1 site Stand-alone
    Other conditions: Patients With Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT01977781

    Safety and Efficacy of Topical Tacrolimus 0.05% in the Treatment of Ocular Graft-Versus-Host Disease

    Not yet reported Massachusetts Eye and Ear Infirmary 40 participants Est. completion 2014-09 1 site Stand-alone
    Other conditions: Ocular GVHD
    View official trial listing →
  • Status unknown NCT NCT01981304

    Effects of a rapamycIn-eluting carboNized Stent With a Completely biodEgradable polymeR Coating

    University of Roma La Sapienza 50 participants Est. completion 2016-12
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT01981473

    Drug Concentration, Immunogenicity, and Efficacy Study in Patients With Rheumatoid Arthritis Currently Treated With Etanercept, Adalimumab, or Infliximab

    Pfizer 605 participants Est. completion 2014-12 54 sites
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT01982682

    Allogeneic Hematopoietic Stem Cell Transplantation for High-Risk Hematologic Malignancies Using One Haploidentical Donor

    Not yet reported Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 41 participants Est. completion 2017-03-27 1 site Stand-alone
    Other conditions: Hematopoietic/Lymphoid Cancer
    View official trial listing →
  • Status unknown NCT NCT01983761

    Study of ASC-101 in Patients With Hematologic Malignancies Who Receive Dual-cord Umbilical Cord Blood Transplantation

    Not yet reported, Not yet reported Targazyme, Inc. 25 participants 4 sites
    Other conditions: Blood And Marrow Transplantation, Leukemia, Lymphoma, Transplantation Infection, Myelodysplastic Syndrome (MDS), Non-Hodgkin's Lymphoma (NHL), Hodgkin's Lymphoma
    View official trial listing →
  • Completed NCT NCT01989689

    Etanercept and Vascular Function in Psoriasis

    Not yet reported Emory University 24 participants Est. completion 2013-09 1 site Stand-alone
    Other conditions: PSORIASIS
    View official trial listing →
  • Terminated NCT NCT01991938

    Phase I Dose Escalation Study of VS-5584 in Subjects With Advanced Non-Hematologic Malignancies or Lymphoma

    Not yet reported Verastem, Inc. 75 participants Est. completion 2016-12 5 sites
    Other conditions: Non Hematologic Cancers, Metastatic Cancer, Lymphoma
    View official trial listing →
  • Withdrawn NCT NCT01997255

    Adjunctive Everolimus (RAD 001) Therapy for Epilepsy in Children With Sturge-Weber Syndrome (SWS)

    Not yet reported Baylor College of Medicine Est. completion 2016-04 1 site
    Other conditions: Sturge Weber Syndrome
    View official trial listing →
  • Status unknown NCT NCT01998789

    Everolimus Post Orthotopic Liver Transplant

    Not yet reported Tomoaki Kato 50 participants Est. completion 2019-02 1 site Stand-alone
    Other conditions: Orthotopic Liver Transplant
    View official trial listing →
  • Completed NCT NCT02004860

    Tacrolimus Ointment Interest (PROTOPIC ®) in the Maintenance Treatment of Severe Seborrheic Dermatitis

    Not yet reported University Hospital, Rouen 120 participants Est. completion 2017-10 1 site
    Other conditions: Severe Seborrheic Dermatitis
    View official trial listing →
  • Completed NCT NCT02004964

    Screening of Subjects With Type I Diabetes to Determine Eligibility for Islet Transplantation

    Rodolfo Alejandro 40 participants Est. completion 2018-11-06 1 site
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT02010320

    Computer Guided Doing of Tacrolimus in Renal Transplantation

    Not yet reported University of Oslo School of Pharmacy 80 participants Est. completion 2014-07 1 site Stand-alone
    Other conditions: Renal Transplantation
    View official trial listing →
  • Completed NCT NCT02014103

    Conversion From Brand to Generic Tacrolimus in High Risk Transplant Recipients

    Not yet reported University of Cincinnati 71 participants Est. completion 2015-08 1 site
    Other conditions: Complication of Transplant
    View official trial listing →
  • Completed NCT NCT02016625

    Investigation of Potential Drug-drug Interactions Between Faldaprevir and the Immunosuppressant Drugs Cyclosporine or Tacrolimus

    Not yet reported Boehringer Ingelheim 32 participants Est. completion 2014-04 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT02017860

    Study to Collect and Assess Long-term Safety of Everolimus in Patients Who Are on Everolimus Treatment in a Novartis-sponsored Study and Are Benefiting From the Treatment as Judged by the Investigator.

    Not yet reported Novartis Pharmaceuticals 4 participants Est. completion 2019-04-25 4 sites
    Other conditions: Neoplasms
    View official trial listing →
  • Completed NCT NCT02019693

    A Phase 2 Study of the MET Kinase Inhibitor INC280 in Papillary Renal Cell Cancer

    Not yet reported National Cancer Institute (NCI) 20 participants Est. completion 2021-12-17 1 site
    Other conditions: Kidney Cancer
    View official trial listing →
  • Terminated NCT NCT02023905

    Everolimus With and Without Temozolomide in Adult Low Grade Glioma

    Not yet reported University of California, San Francisco 27 participants Est. completion 2021-09-30 1 site
    Other conditions: Low Grade Glioma, World Health Organization (WHO) Grade II Astrocytomas, Oligodendrogliomas, Mixed Oligoastrocytomas
    View official trial listing →
  • Completed NCT NCT02027870

    EXCEL-II DES to Treat the Patients With de Novo Coronary Artery Lesions. (CREDIT-III)

    JW Medical Systems Ltd 625 participants Est. completion 2019-11-07 1 site
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT02028364

    Pet Imaging as a Biomarker in Hormone Refractory postmenopausaL Women

    Not yet reported Jules Bordet Institute 55 participants Est. completion 2021-08-09 5 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Terminated NCT NCT02029638

    BMT and High Dose Post-Transplant Cyclophosphamide for Chimerism Induction and Renal Allograft Tolerance

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 4 participants Est. completion 2017-09-06 1 site Stand-alone
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Withdrawn NCT NCT02031211

    TNF-alpha Inhibition in CRPS: A Randomized Controlled Trial

    Not yet reported Stanford University Est. completion 2016-10 1 site Stand-alone
    Other conditions: CRPS, Chronic Regional Pain Syndrome
    View official trial listing →
  • Status unknown NCT NCT02036554

    Evaluate Efficacy Study of Combination Therapy of Everolimus and Low Dose Tacrolimus in Renal Allograft Recipients

    Not yet reported Seoul St. Mary's Hospital 234 participants Est. completion 2015-12 1 site Stand-alone
    Other conditions: Kidney; Complications, Allograft
    View official trial listing →
  • Withdrawn NCT NCT02038478

    Allograft for Sickle Cell Disease and Thalassemia

    Not yet reported University of Texas Southwestern Medical Center Est. completion 2021-05 1 site Stand-alone
    Other conditions: Sickle Cell Disease and Thalassemia
    View official trial listing →
  • Completed NCT NCT02040584

    A Multicentre, Randomised, Open-label, Controlled, 12-month Follow-up Study to Assess Impact on Renal Function of an Immunosuppression Regimen Based on Tacrolimus Minimisation in Association With Everolimus in de Novo Liver Transplant Recipients.

    Not yet reported Novartis Pharmaceuticals 217 participants Est. completion 2016-02-10 20 sites
    Other conditions: Liver Transplant
    View official trial listing →
  • Completed NCT NCT02048384

    A Study of Metformin With or Without Rapamycin as Maintenance Therapy After Induction Chemotherapy in Subjects With Pancreatic Cancer

    Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 22 participants Est. completion 2019-09 2 sites
    Other conditions: Metastatic Pancreatic Adenocarcinoma
    View official trial listing →
  • Completed NCT NCT02049047

    Study of Everolimus in Patients With Thymoma and Thymic Carcinoma Previously Treated With Chemotherapy

    Not yet reported Armando Santoro, MD 41 participants Est. completion 2019-01 1 site
    Other conditions: Thymoma and Thymic Carcinoma
    View official trial listing →
  • Withdrawn NCT NCT02053545

    Haplo-identical SCT for High Risk (HR) Hematologic Malignancies w/Post-Transplant In-Vivo T-cell Depletion

    Not yet reported, Not yet reported Ann & Robert H Lurie Children's Hospital of Chicago Est. completion 2017-05-11 1 site Stand-alone
    Other conditions: Leukemia, Lymphoma, MDS
    View official trial listing →
  • Status unknown NCT NCT02055079

    Pulsed Oral Sirolimus in Autosomal Dominant Polycystic Kidney Disease

    Not yet reported Medical University of Vienna 68 participants Est. completion 2019-12 1 site Stand-alone
    Other conditions: Polycystic Kidney, Type 1 Autosomal Dominant Disease, Polycystic Kidney, Type 2 Autosomal Dominant Disease
    View official trial listing →
  • Completed NCT NCT02056587

    Everolimus in Patients With Metastatic Renal Cell Carcinoma Following Progression on Prior Bevacizumab Treatment

    Not yet reported Kidney Cancer Research Bureau 37 participants Est. completion 2013-10 3 sites
    Other conditions: Metastatic Renal Cell Carcinoma
    View official trial listing →
  • Completed NCT NCT02057172

    Glycaemic Control of Weekly LAPS-Exendin Versus Placebo in Subjects of Type 2 Diabetes

    Not yet reported Hanmi Pharmaceutical Company Limited 254 participants Est. completion 2014-12 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT02057484

    A 5 Year Follow-up of Patients Who Were Previously Enrolled Into an Advagraf Trial Following a Liver or Kidney Transplant

    Astellas Pharma Europe Ltd. 2300 participants Est. completion 2017-10-17 145 sites
    Other conditions: Liver Transplant, Kidney Transplant
    View official trial listing →
  • Status unknown NCT NCT02057965

    Mesenchymal Stromal Cell Therapy in Renal Recipients

    Not yet reported Leiden University Medical Center 70 participants Est. completion 2022-01 1 site
    Other conditions: Renal Transplant Rejection, Fibrosis
    View official trial listing →
  • Completed NCT NCT02057978

    EXCEL-II Stent Vesus EXCEL Stent to Treat the Patients With de Novo Coronary Artery Lesions.

    JW Medical Systems Ltd 419 participants Est. completion 2019-12-25 1 site
    Cardiovascular disease Other conditions: Myocardial Ischemia, Coronary Disease, Heart Diseases, Arteriosclerosis, Arterial Occlusive Diseases, Vascular Diseases
    View official trial listing →
  • Withdrawn NCT NCT02058875

    Cardiovascular Risk Following Conversion to Full Dose Myfortic® and Neoral® Two-hour Post Level Monitoring

    Not yet reported University of Saskatchewan Est. completion 2015-10 2 sites
    Cardiovascular disease Other conditions: Cardiovascular Outcomes, Kidney Transplant Recipients, Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT02058940

    Intravenous Exenatide in Patients With Acute Brain Injury

    Not yet reported University of North Carolina, Chapel Hill 8 participants Est. completion 2017-08 1 site Stand-alone
    Other conditions: Brain Injuries
    View official trial listing →
  • Status unknown NCT NCT02059564

    A Phase 1b Study of LAPS-Exendin in Subjects of Type 2 Diabetes Mellitus

    Not yet reported Hanmi Pharmaceutical Company Limited 44 participants Est. completion 2014-12 1 site
    Other conditions: Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT02061397

    Safety of Simvastatin in LAM and TSC

    Not yet reported, Not yet reported University of Pennsylvania 10 participants Est. completion 2019-12-13 1 site Stand-alone
    Other conditions: Lymphangioleiomyomatosis, Tuberous Sclerosis Complex
    View official trial listing →
  • Status unknown NCT NCT02061800

    CD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell Transplant

    Not yet reported, Not yet reported Diane George 14 participants Est. completion 2026-07 1 site Stand-alone
    Other conditions: Chronic Myeloid Leukemia (CML), Acute Myelogenous Leukemia (AML), Myelodysplastic Syndrome (MDS), Juvenile Myelomonocytic Leukemia (JMML), Acute Lymphoblastic Leukemia (ALL), Lymphoma (Hodgkin's and Non-Hodgkin's)
    View official trial listing →
  • Withdrawn NCT NCT02062892

    Differentiating Everolimus Versus Sirolimus in Combination With Calcineurin Inhibitors in Kidney Transplant Patients

    Not yet reported University of Colorado, Denver Est. completion 2014-06 Stand-alone
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Status unknown NCT NCT02064777

    Prospective Tacrolimus Pharmacokinetics Study in Pediatric Living Donor Liver Transplantation

    Not yet reported Cliniques universitaires Saint-Luc- Université Catholique de Louvain 60 participants Est. completion 2014-09 1 site Stand-alone
    Other conditions: Pediatric Liver Transplantation
    View official trial listing →
  • Completed NCT NCT02068170

    Risk of QT-prolongation and Torsade de Pointes in Patients Treated With Acute Medication in a University Hospital

    KU Leuven 178 participants Est. completion 2015-06 1 site
    Other conditions: Delirium, QT-prolongation
    View official trial listing →
  • Completed NCT NCT02073565

    HARMONEE - Japan-USA Harmonized Assessment by Randomized, Multi-Center Study of OrbusNEich's Combo StEnt

    Not yet reported OrbusNeich 572 participants Est. completion 2021-12 50 sites Stand-alone
    Other conditions: Coronary Arteriosclerosis, Non ST Segment Elevation Acute Coronary Syndrome
    View official trial listing →
  • Status unknown NCT NCT02075242

    TO Compare the Triple Drug Therapy and Dual Therapy .

    Not yet reported Asan Medical Center 170 participants Est. completion 2016-01 1 site Stand-alone
    Other conditions: HEPATITIS
    View official trial listing →
  • Status unknown NCT NCT02075697

    Spanish Registry of Systemic Treatments in Psoriasis

    Fundación Academia Española de Dermatología 3500 participants Est. completion 2025-10 13 sites
    Other conditions: Psoriasis
    View official trial listing →
  • Status unknown NCT NCT02076516

    Pilot Evaluation Of CORACTO® (THE PILOT-SECRET TRIAL)

    Not yet reported Alvimedica 100 participants Est. completion 2015-05 5 sites
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT02077556

    Effect of Everolimus on the Pharmacokinetics of Tacrolimus in Renal Transplant Patients

    Not yet reported National Taiwan University Hospital 14 participants Est. completion 2019-01-15 1 site Stand-alone
    Other conditions: Drug Interaction Potentiation
    View official trial listing →
  • Terminated NCT NCT02080195

    Nonmyeloablative Conditioning and Transplantation for Patients With Refractory Systemic Lupus Erythematosus (SLE)

    Not yet reported, Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 1 participants Est. completion 2017-03-29 1 site Stand-alone
    Other conditions: Lupus Erythematosus, Graft-versus-host Disease
    View official trial listing →
  • Enrolling by invitation NCT NCT02081755

    Safety and Efficacy of Everolimus Treatment in Liver Transplantation for Liver Cancer

    Not yet reported Baylor Research Institute 336 participants Est. completion 2027-03 9 sites Stand-alone
    Other conditions: Carcinoma, Hepatocellular
    View official trial listing →
  • Completed NCT NCT02083991

    Trial of Steroid Avoidance and Low-dose CNI by ATG-induction in Renal Transplantation

    Not yet reported Vastra Gotaland Region 224 participants Est. completion 2017-12 1 site
    Other conditions: Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT02084251

    Clinical Trial for PB-119 in Healthy Subjects (Phase I)

    Not yet reported PegBio Co., Ltd. 70 participants Est. completion 2014-11 1 site Stand-alone
    Other conditions: Type II Diabetes
    View official trial listing →
  • Completed NCT NCT02084446

    Everolimus + Very Low Tacrolimus vs Enteric-coated Mycophenolate Sodium + Low Tacrolimus in de Novo Renal Transplant

    Not yet reported Ronaldo de Matos Esmeraldo, MD 120 participants Est. completion 2017-07 1 site Stand-alone
    Other conditions: Transplantation Infection, Cytomegalovirus Infections
    View official trial listing →
  • Completed NCT NCT02084654

    Exenatide and Weight Loss for Diabetes Prevention

    Not yet reported Stanford University 66 participants Est. completion 2013-02
    Other conditions: Pre Diabetes, Insulin Resistance
    View official trial listing →
  • Terminated NCT NCT02085629

    The ONE Study M Reg Trial

    Not yet reported, Not yet reported University of Regensburg 8 participants Est. completion 2018-12-03 1 site Stand-alone
    Other conditions: Renal Failure, End Stage
    View official trial listing →
  • Completed NCT NCT02088931

    Treg Adoptive Therapy for Subclinical Inflammation in Kidney Transplantation

    Not yet reported University of California, San Francisco 3 participants Est. completion 2016-12-31 1 site Stand-alone
    Other conditions: Late Complication From Kidney Transplant
    View official trial listing →
  • Status unknown NCT NCT02091973

    MicroRNA Expression in Everolimus-based Versus Tacrolimus-based Regimens in Kidney Transplantation

    Not yet reported Chulalongkorn University 50 participants Est. completion 2015-12 1 site Stand-alone
    Other conditions: microRNA Profiles
    View official trial listing →
  • Completed NCT NCT02092467

    Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis

    Not yet reported Pfizer 4372 participants Est. completion 2020-07-22 345 sites
    Other conditions: Arthritis, Rheumatoid
    View official trial listing →
  • Status unknown NCT NCT02095418

    Comparison of New-onset Diabetes After Transplantation Between Two Steroid Withdrawal Group With CellCept

    Not yet reported Samsung Medical Center 152 participants Est. completion 2018-02 5 sites Stand-alone
    Other conditions: Diabetes
    View official trial listing →
  • Completed NCT NCT02096107

    Novartis Everolimus Transition

    Not yet reported Medical University of South Carolina 60 participants Est. completion 2017-05 1 site
    Other conditions: Graft Dysfunction, Interstitial Fibrosis
    View official trial listing →
  • Terminated NCT NCT02102997

    Deutsches Dual Therapy Stent Register

    OrbusNeich 130 participants Est. completion 2017-11 1 site
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT02103855

    Switch From Calcineurin Inhibitor to Belatacept in Pancreas Transplant Recipients

    Not yet reported Indiana University 6 participants Est. completion 2016-03 1 site Stand-alone
    Other conditions: Nephrotoxicity
    View official trial listing →
  • Completed NCT NCT02105155

    Conversion Prograf® to Advagraf® at D7 Versus D90 After Liver Transplantation

    Not yet reported Assistance Publique - Hôpitaux de Paris 90 participants Est. completion 2016-10-17 1 site Stand-alone
    Other conditions: Immunosuppression After Liver Transplantation
    View official trial listing →
  • Active, not recruiting NCT NCT02105766

    Nonmyeloablative Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Sickle Cell Disease and Beta-thalassemia in People With Higher Risk of Transplant Failure

    Not yet reported National Heart, Lung, and Blood Institute (NHLBI) 56 participants Est. completion 2027-12-31 1 site Stand-alone
    Other conditions: Sickle Cell Disease, Thalassemia, Stem Cell Transplantation, Graft vs Host Disease
    View official trial listing →
  • Completed NCT NCT02106507

    ARN 509 Plus Everolimus in Men With Progressive Metastatic Castration-Resistant Prostate Cancer After Treatment With Abiraterone Acetate

    Not yet reported Memorial Sloan Kettering Cancer Center 9 participants Est. completion 2021-06-28 1 site
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT02107833

    Study to Evaluate the Safety and Pharmacokinetics of Oral OPRX-106 (TNFR-Fc Fusion Protein) in Healthy Volunteers

    Not yet reported Protalix 18 participants Est. completion 2014-12 1 site
    Other conditions: Human Volunteer
    View official trial listing →
  • Status unknown NCT NCT02108301

    Hepatitis C in Renal Transplant Recipients

    Not yet reported Prof. Dr. Alice Schmidt 30 participants 1 site Stand-alone
    Other conditions: Chronic Hepatitis C-virus Infection, Renal Transplantation
    View official trial listing →
  • Status unknown NCT NCT02109913

    Analysis of Tumor Tissue and Circulating Genetic Material in the Blood to Obtain Further Insight in the Effectiveness of Everolimus When Combined With Exemestane

    Not yet reported Amsterdam UMC, location VUmc 175 participants Est. completion 2021-01 28 sites
    Other conditions: Hormone Receptor Positive Malignant Neoplasm of Breast, Metastatic Breast Cancer
    View official trial listing →
  • Terminated NCT NCT02110069

    A Study to Compare Vincristine to Sirolimus for Treatment of High Risk Vascular Tumors

    Not yet reported Boston Children's Hospital 4 participants Est. completion 2020-10-27 7 sites Stand-alone
    Other conditions: Kaposiform Hemangioendothelioma (KHE), Kasabach-Merritt Syndrome, Tufted Angioma
    View official trial listing →
  • Status unknown NCT NCT02112097

    ASIS for Enbrel in Plaque Psoriasis

    Not yet reported, Not yet reported ASIS Corporation 60 participants Est. completion 2017-06 2 sites
    Other conditions: Plaque Psoriasis.
    View official trial listing →
  • Status unknown NCT NCT02112981

    BioMime Vs. Xience Randomised Control Clinical Study

    Not yet reported Meril Life Sciences Pvt. Ltd. 256 participants Est. completion 2019-12-01 15 sites Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Withdrawn NCT NCT02113891

    Eculizumab Therapy for Subclinical Antibody-mediated Rejection in Kidney Transplantation

    Not yet reported, Not yet reported Assistance Publique - Hôpitaux de Paris Est. completion 2017-11 Stand-alone
    Other conditions: Subclinical Acute Antibody-mediated Rejection in Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT02115113

    REnal Function in Liver Transplantation: Everolimus With Calcineurin Inhibitor (CNI)-Sparing sTrategy

    Not yet reported Novartis Pharmaceuticals 78 participants Est. completion 2016-09-30 14 sites Stand-alone
    Other conditions: Liver Transplantation
    View official trial listing →
  • Completed NCT NCT02115750

    Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Rheumatoid Arthritis (RA)

    Not yet reported Coherus Oncology, Inc. 647 participants Est. completion 2016-05 141 sites
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Status unknown NCT NCT02116504

    Anti-Biopharmaceutical Immunization: Prediction and Analysis of Clinical Relevance to Minimize the Risk of Immunization in Rheumatoid Arthritis Patients or Juvenile Idiopathic Arthritis Patients

    Not yet reported Assistance Publique - Hôpitaux de Paris 156 participants Est. completion 2017-11 1 site
    Other conditions: Rheumatoid Arthritis, Juvenile Idiopathic Arthritis
    View official trial listing →
  • Completed NCT NCT02117596

    Calcineurin Inhibitor Based Immunosuppression Withdrawal

    Not yet reported Pediatric Nephrology of Alabama 52 participants Est. completion 2012-11 4 sites
    Other conditions: Renal Transplant
    View official trial listing →
  • Status unknown NCT NCT02118376

    Effects of GLP-1 Receptor Agonist on Fat Redistribution and Inflammatory Status

    Not yet reported Shanghai 10th People's Hospital 20 participants Est. completion 2014-12 1 site Stand-alone
    Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT02118896

    Study to Ascertain if Prolonged Release Tacrolimus (FK506E - MR4) is Safe and Effective When Used in the Long Term and in Combination With Other Immunosuppressive Drugs in Patients Who Have Received a Transplant

    Not yet reported Astellas Pharma Europe Ltd. 850 participants Est. completion 2009-10-07 105 sites
    Other conditions: Heart Transplantation, Liver Transplantation, Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT02120157

    Myeloablative Haploidentical BMT With Post-transplant Cyclophosphamide for Pediatric Patients With Hematologic Malignancies

    Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 35 participants Est. completion 2020-10-01 9 sites Stand-alone
    Other conditions: Myeloablative Conditioning, HLA-mismatched Bone Marrow Transplantation, Graft Survival, Transplantation, Bone Marrow
    View official trial listing →
  • Completed NCT NCT02120469

    Eribulin Mesylate and Everolimus in Treating Patients With Triple-Negative Metastatic Breast Cancer

    Not yet reported City of Hope Medical Center 27 participants Est. completion 2020-03-03 3 sites
    Other conditions: Estrogen Receptor Negative, HER2/Neu Negative, Progesterone Receptor-negative, Stage IV Breast Cancer, Triple-negative Breast Carcinoma
    View official trial listing →
  • Completed NCT NCT02122081

    Organ-Sparing Marrow-Targeted Irradiation Before Stem Cell Transplant in Treating Patients With High-Risk Hematologic Malignancies

    Not yet reported Sumithira Vasu 33 participants Est. completion 2022-09-06 1 site Stand-alone
    Other conditions: Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Myeloid Leukemia in Remission, Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(15;17)(q22;q12), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), de Novo Myelodysplastic Syndromes, Previously Treated Myelodysplastic Syndromes, Recurrent Adult Acute Lymphoblastic Leukemia, Recurrent Adult Acute Myeloid Leukemia, Secondary Myelodysplastic Syndromes, Untreated Adult Acute Lymphoblastic Leukemia, Untreated Adult Acute Myeloid Leukemia
    View official trial listing →
  • Completed NCT NCT02122406

    Depression and Anxiety in Rheumatoid Arthritis

    University of Pavia 200 participants Est. completion 2015-12 1 site
    Other conditions: Rheumatoid Arthritis, Depression, Anxiety
    View official trial listing →
  • Completed NCT NCT02123108

    Safety and Efficacy of Basiliximab, Delayed Dose Tacrolimus Plus ECMPA (Enteric Coated Mycophenolic Acid) Following Liver Transplantation

    Not yet reported University of California, Los Angeles 59 participants Est. completion 2015-01 1 site Stand-alone
    Other conditions: Liver Transplantation
    View official trial listing →
  • Completed NCT NCT02123823

    BI 836845 in Estrogen Receptor Positive Metastatic Breast Cancer

    Not yet reported Boehringer Ingelheim 164 participants Est. completion 2021-12-14 38 sites
    Other conditions: Neoplasms
    View official trial listing →
  • Completed NCT NCT02126176

    Protopic Adherence and Efficacy in Korean Eczema Patient

    Pusan National University Hospital 50 participants Est. completion 2016-03 1 site
    Other conditions: Atopic Dermatitis
    View official trial listing →
  • Completed NCT NCT02127541

    New Imaging Procedure for the Localisation of Insulinoma

    Not yet reported University Hospital, Basel, Switzerland 52 participants Est. completion 2017-11 1 site
    Other conditions: Endogenous Hyperinsulinaemic Hypoglycaemia
    View official trial listing →
  • Completed NCT NCT02129582

    Targeted Marrow Irradiation, Fludarabine Phosphate, and Busulfan Before Donor Progenitor Cell Transplant in Treating Patients With Hematologic Malignancies

    Not yet reported Case Comprehensive Cancer Center 14 participants Est. completion 2020-03-05 1 site Stand-alone
    Other conditions: Acute Myeloid Leukemia, Hematologic Malignancies, Acute Lymphocytic Leukemia, Non Hodgkin Lymphoma, Hodgkin Lymphoma, Multiple Myeloma, Myelodysplastic Syndrome, Chronic Lymphocytic Leukemia, Chronic Myeloid Leukemia, Myelofibrosis, Myeloproliferative Syndrome
    View official trial listing →
  • Completed NCT NCT02129881

    The ONE Study UK Treg Trial

    Not yet reported, Not yet reported Guy's and St Thomas' NHS Foundation Trust 15 participants Est. completion 2017-03-23 2 sites Stand-alone
    Other conditions: End-stage Renal Failure
    View official trial listing →
  • Withdrawn NCT NCT02130817

    Belatacept in Kidney Transplantation of Moderately Sensitized Patients

    Not yet reported University of Wisconsin, Madison Est. completion 2015-10-09 1 site Stand-alone
    Other conditions: End Stage Renal Disease, Antibody Mediated Rejection
    View official trial listing →
  • Status unknown NCT NCT02132234

    Effects of Biological Treatment on Blood Pressure and Endothelial Function in Patients With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis

    Not yet reported Jagiellonian University 100 participants 1 site Stand-alone
    Other conditions: Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Hypertension
    View official trial listing →
  • Status unknown NCT NCT02133287

    To Evaluate The Safety and Efficacy of 'AVI' Stent Comparing With Firebird2® For Treating Coronary Revascularization

    Not yet reported Beijing AmsinoMed Medical Device Co., Ltd 2000 participants Est. completion 2022-11 1 site
    Other conditions: Ischemic Heart Disease, Myocardial Ischemia, Coronary Disease, Acute Coronary Syndrome
    View official trial listing →
  • Completed NCT NCT02134210

    Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Chronic Plaque Psoriasis (PsO)

    Not yet reported Coherus Oncology, Inc. 521 participants Est. completion 2016-05-12 100 sites
    Other conditions: Plaque Psoriasis
    View official trial listing →
  • Completed NCT NCT02137239

    Regimen Optimization Study

    Not yet reported Bristol-Myers Squibb 58 participants Est. completion 2019-05-02 20 sites Stand-alone
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT02142036

    N-of-1 Trial: Actionable Target Identification in Metastatic Cancer for Palliative Systemic Therapy

    Not yet reported Oslo University Hospital 50 participants Est. completion 2018-08 2 sites
    Other conditions: Metastatic Cancer
    View official trial listing →
  • Completed NCT NCT02143479

    A Multicenter Study in Liver Transplant Patients Converted From Prograf® to Advagraf® During the First Post-transplantation Year

    Astellas Pharma S.A.S. 398 participants Est. completion 2017-05-03 18 sites
    Other conditions: Liver Transplantation
    View official trial listing →
  • Active, not recruiting NCT NCT02143726

    Sorafenib Tosylate With or Without Everolimus in Treating Patients With Advanced, Radioactive Iodine Refractory Hurthle Cell Thyroid Cancer

    Not yet reported Alliance for Clinical Trials in Oncology 35 participants Est. completion 2028-08-06 21 sites
    Other conditions: Refractory Hurthle Cell Thyroid Cancer
    View official trial listing →
  • Status unknown NCT NCT02144857

    Effects of Treatment With Biological Agents on Vascular and Cardiac Function in Psoriasis

    Not yet reported University of Athens 200 participants Est. completion 2023-12-31 1 site
    Other conditions: Psoriasis
    View official trial listing →
  • Completed NCT NCT02145403

    Phase 1/2 Study of Carfilzomib for the Prevention of Relapse and GVHD in Allo-HCT for Hematologic Malignancies

    Not yet reported, Not yet reported University of Michigan Rogel Cancer Center 53 participants Est. completion 2020-10-16 1 site Stand-alone
    Other conditions: Hematologic Malignancies, Relapse, Graft-Versus-Host Disease
    View official trial listing →
  • Completed NCT NCT02147938

    A Study of Renal Transplant Patients Converted From the Twice Per Day Form of Tacrolimus (Prograf®) to the Once Per Day Form (Advagraf®)

    Astellas Pharma S.A.S. 578 participants Est. completion 2017-05-15 26 sites
    Other conditions: Renal Transplantation
    View official trial listing →
  • Completed NCT NCT02152007

    Topical Sirolimus for the Treatment of Pachyonychia Congenita (PC)

    Not yet reported TransDerm, Inc. 15 participants Est. completion 2015-11 1 site Stand-alone
    Other conditions: Pachyonychia Congenita
    View official trial listing →
  • Completed NCT NCT02152345

    Belatacept Compared to Tacrolimus in Deceased Donor Renal Transplant Recipients

    Not yet reported Columbia University 57 participants Est. completion 2016-12-31 1 site
    Other conditions: Implant or Graft; Rejection
    View official trial listing →
  • Completed NCT NCT02152943

    Everolimus, Letrozole and Trastuzumab in HR- and HER2/Neu-positive Patients

    Not yet reported M.D. Anderson Cancer Center 37 participants Est. completion 2020-12-14 5 sites
    Other conditions: Advanced Malignant Solid Neoplasm, Estrogen Receptor Positive, HER2/Neu Positive, Postmenopausal, Premenopausal, Progesterone Receptor Positive, Recurrent Breast Carcinoma, Refractory Breast Carcinoma, Refractory Hormone Receptor Positive Breast Carcinoma, Stage IIIA Breast Cancer AJCC v7, Stage IIIB Breast Cancer AJCC v7, Stage IIIC Breast Cancer AJCC v7, Stage IV Breast Cancer AJCC v6 and v7
    View official trial listing →
  • Status unknown NCT NCT02154854

    Prospective Study to Measure Vascular Parameters (Ancillary Study of ADEQUATE)

    Not yet reported University Hospital, Tours 104 participants Est. completion 2015-03 11 sites Stand-alone
    Other conditions: De Novo Transplant Disease
    View official trial listing →
  • Completed NCT NCT02155920

    Everolimus for Children With Recurrent or Progressive Ependymoma

    Not yet reported University of Texas Southwestern Medical Center 11 participants Est. completion 2023-07-14 4 sites
    Other conditions: Recurrent Childhood Ependymoma
    View official trial listing →
  • Completed NCT NCT02158052

    Combined Bone Marrow and Renal Transplantation for Hematologic Disorders With End Stage Renal Disease

    Not yet reported Massachusetts General Hospital 2 participants Est. completion 2021-06-22 1 site Stand-alone
    Other conditions: Multiple Myeloma, Amyloidosis
    View official trial listing →
  • Completed NCT NCT02159651

    A Survey for Long-term Use of Prograf Capsules in Patient With Interstitial Pneumonia

    Astellas Pharma Inc 179 participants Est. completion 2019-12-23 8 sites
    Other conditions: Interstitial Pneumonia Associated With Polymyositis/Dermatomyositis
    View official trial listing →
  • Completed NCT NCT02160054

    Specified Drug Use-results Survey of Graceptor in Patients With Kidney Transplantation (Switching From Cyclosporine)

    Astellas Pharma Inc 289 participants Est. completion 2016-03-31 30 sites
    Other conditions: the Maintenance Phase After Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT02160990

    Effect of Exenatide in Obese Patients With Accelerated Gastric Emptying

    Not yet reported Mayo Clinic 20 participants Est. completion 2015-03 1 site Stand-alone
    Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT02161237

    Asian Study to Investigate Safety and Efficacy of Optimized Dosing of Advagraf in Kidney Transplantation

    Not yet reported Astellas Pharma Inc 73 participants Est. completion 2016-12-22 2 sites
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Status unknown NCT NCT02162550

    Effect of Bydureon on Carotid Atherosclerosis Progression in Type 2 Diabetes Mellitus

    Not yet reported Phoenix VA Health Care System 148 participants Est. completion 2019-09 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT02166177

    Safety and Efficacy Study of Regulatory T Cell Therapy in Liver Transplant Patients

    Not yet reported, Not yet reported Guy's and St Thomas' NHS Foundation Trust 9 participants Est. completion 2018-01-22 1 site Stand-alone
    Other conditions: End-stage Liver Disease
    View official trial listing →
  • Completed NCT NCT02167958

    Nonmyeloablative Hematopoietic Cell Transplantation (HCT) for Patients With Hematologic Malignancies Using Related, HLA-Haploidentical Donors: A Pilot Trial of Peripheral Blood Stem Cells (PBSC) as the Donor Source

    Not yet reported Rafic Farah, MD 28 participants Est. completion 2019-09-21 1 site Stand-alone
    Other conditions: Leukemia, MDS, Myelofibrosis, Lymphoma
    View official trial listing →
  • Completed NCT NCT02170324

    GLP-1 Agonism Stimulates Browning of Subcutaneous White Adipose Tissue in Obesity Men

    Not yet reported Xiang Guang-da 20 participants Est. completion 2015-07 1 site Stand-alone
    Other conditions: Obesity
    View official trial listing →
  • Status unknown NCT NCT02178683

    Tacrolimus and Mycophenolate Mofetil as Post-Grafting Immunosuppression

    Not yet reported Colorado Blood Cancer Institute 50 participants Est. completion 2018-12 1 site
    Other conditions: Graft Versus Host Disease
    View official trial listing →
  • Completed NCT NCT02183454

    MASCOT - Post Marketing Registry

    OrbusNeich 2500 participants Est. completion 2017-05-31 1 site
    Cardiovascular disease Other conditions: Atherosclerosis
    View official trial listing →
  • Completed NCT NCT02184416

    Study Of The Impact Of Inlyta In 2nd Line On The Treatment Outcomes Of mRCC Patients Treated With Sutent In 1st Line In The Real Life Setting

    Pfizer 554 participants Est. completion 2022-09-30 110 sites
    Other conditions: Metastatic Renal Cell Carcinoma (mRCC)
    View official trial listing →
  • Status unknown NCT NCT02188550

    Single Arm Trial With Combination of Everolimus and Letrozole in Treatment of Platinum Resistant Relapse or Refractory or Persistent Ovarian Cancer/Endometrial Cancer

    Not yet reported Sinai Hospital of Baltimore 20 participants 1 site
    Other conditions: Ovarian Cancer, Endometrial Cancer
    View official trial listing →
  • Terminated NCT NCT02188719

    Donor-Alloantigen-Reactive Regulatory T Cell (darTregs) in Liver Transplantation

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 15 participants Est. completion 2019-06-18 3 sites Stand-alone
    Other conditions: Liver Transplantation
    View official trial listing →
  • Completed NCT NCT02192164

    Non-interventional Study of the Effect of Smoking Status of the Patient on the Success of Etanercept Therapy in Psoriasis

    Pfizer 126 participants Est. completion 2016-05 8 sites
    Other conditions: Plaque Psoriasis
    View official trial listing →
  • Status unknown NCT NCT02195414

    NeoVas Bioresorbable Coronary Scaffold First-in-Man Study

    Not yet reported Lepu Medical Technology (Beijing) Co., Ltd. 31 participants Est. completion 2019-09 2 sites Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Status unknown NCT NCT02196467

    Transplantation of Myoblasts to Duchenne Muscular Dystrophy (DMD) Patients

    Not yet reported, Not yet reported CHU de Quebec-Universite Laval 10 participants Est. completion 2024-01 2 sites
    Other conditions: Duchenne Muscular Dystrophy
    View official trial listing →
  • Completed NCT NCT02198300

    DES Versus BiOSS LIM - POLBOS II Study

    Not yet reported Central Clinical Hospital of the Ministry of Internal Affairs and Administration, Warsaw, Poland 202 participants Est. completion 2015-03 1 site
    Cardiovascular disease
    View official trial listing →
  • Terminated NCT NCT02199041

    Combined T Cell Depleted Haploidentical Peripheral Blood Stem Cell and Unrelated Umbilical Cord Blood Transplantation in Patients With Hematologic Malignancies Using a Total Lymphoid Irradiation Based Preparative Regimen

    Not yet reported St. Jude Children's Research Hospital 24 participants Est. completion 2017-05-23 1 site Stand-alone
    Other conditions: Hematological Malignancies
    View official trial listing →
  • Completed NCT NCT02201212

    Everolimus for Cancer With TSC1 or TSC2 Mutation

    Not yet reported Dana-Farber Cancer Institute 30 participants Est. completion 2019-06 2 sites
    Other conditions: TSC1, TSC2, Tuberous Sclerosis Complex, MTOR
    View official trial listing →
  • Completed NCT NCT02202837

    Study With Etanercept Focusing on Remission and Predictability of Remission in Real Life Clinical Practice

    Pfizer 157 participants Est. completion 2017-04-24 35 sites
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT02206035

    A Study of Tacrolimus/Methotrexate and Tocilizumab to Prevent Acute Graft-Versus-Host Disease (AGVD) After Allogeneic Hematopoietic Stem Cell Transplant

    Not yet reported William R. Drobyski, MD 45 participants Est. completion 2018-09 1 site Stand-alone
    Other conditions: Hematopoietic Stem Cell Transplantation
    View official trial listing →
  • Completed NCT NCT02208037

    Novel Approaches for Graft-versus-Host Disease Prevention Compared to Contemporary Controls (BMT CTN 1203)

    Not yet reported National Heart, Lung, and Blood Institute (NHLBI) 279 participants Est. completion 2017-10 30 sites Stand-alone
    Other conditions: Acute Leukemia, Chronic Myelogenous Leukemia, Myelodysplasia, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Lymphoma, B-Cell, Lymphoma, Follicular, Lymphoma, Large B-Cell, Diffuse, Hodgkin's Lymphoma
    View official trial listing →
  • Status unknown NCT NCT02208128

    Molecular Determinants for Therapy Response on Renal Cell Carcinoma

    Not yet reported Heidelberg University 4 participants Est. completion 2018-02 1 site
    Other conditions: Renal Cell Carcinoma
    View official trial listing →
  • Status unknown NCT NCT02208791

    Effects of the Quadruple Immunosuppression on Peripheral Blood Lymphocytes and Development of Anti-HLA Antibodies in Kidney Transplant

    Not yet reported University of Sao Paulo General Hospital 45 participants Est. completion 2017-07 1 site Stand-alone
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT02213068

    Belatacept 3 Month Post Transplant Conversion Study

    Not yet reported Lorenzo Gallon 28 participants Est. completion 2020-09 1 site Stand-alone
    Other conditions: Transplant; Failure, Kidney, EBV
    View official trial listing →
  • Terminated NCT NCT02214706

    Treatment of Port Wine Stains Using Pulsed Dye Laser, Erbium Yag Laser and Topical Sirolimus

    Not yet reported Erasmus Medical Center 17 participants Est. completion 2016-12 1 site Stand-alone
    Other conditions: Port-Wine Stain
    View official trial listing →
  • Completed NCT NCT02215720

    Temsirolimus and Cetuximab in Patients With Advanced or Metastatic Solid Tumors

    Not yet reported Gustave Roussy, Cancer Campus, Grand Paris 45 participants Est. completion 2016-05-04 1 site
    Other conditions: Patients With Advanced or Metastatic Solid Tumors
    View official trial listing →
  • Status unknown NCT NCT02216058

    Safety and Efficacy Study of NOYA Sirolimus-Eluting Stent to Treat Coronary Artery Disease

    Not yet reported Medfavour (Beijing) Medical Co., Ltd 2000 participants Est. completion 2020-06 1 site Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT02217410

    CCFZ533X2201 - PoC Study in de Novo Renal Transplantation

    Not yet reported, Not yet reported Novartis Pharmaceuticals 59 participants Est. completion 2017-11-29 14 sites Stand-alone
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT02220985

    Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts From HLA-Matched Related and Unrelated Donors in Preventing GVHD

    Not yet reported Fred Hutchinson Cancer Center 84 participants Est. completion 2025-05-01 2 sites Stand-alone
    Other conditions: Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Biphenotypic Leukemia, Acute Leukemia of Ambiguous Lineage, Acute Undifferentiated Leukemia, Allogeneic Hematopoietic Stem Cell Transplant Recipient, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Blastic Plasmacytoid Dendritic Cell Neoplasm, Childhood Acute Lymphoblastic Leukemia in Remission, Childhood Acute Myeloid Leukemia in Remission, Donor, Lymphoblastic Lymphoma, Myelodysplastic Syndrome With Excess Blasts, Myelodysplastic Syndrome With Excess Blasts-1, Myelodysplastic Syndrome With Excess Blasts-2, Recurrent Acute Lymphoblastic Leukemia, Recurrent Acute Myeloid Leukemia, Recurrent Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood Acute Myeloid Leukemia, Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Refractory Acute Lymphoblastic Leukemia, Refractory Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia in Remission
    View official trial listing →
  • Completed NCT NCT02221583

    Pharmacokinetics of Immunosuppressants in Renal Transplant Candidates Who Have Undergone Laparoscopic Sleeve Gastrectomy

    Not yet reported University of Cincinnati 26 participants Est. completion 2015-02 1 site Stand-alone
    Other conditions: End Stage Renal Disease
    View official trial listing →
  • Completed NCT NCT02224872

    Transplantation of Partially Mismatched Related or Matched Unrelated Bone Marrow for Patients With Refractory Severe Aplastic Anemia

    Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 18 participants Est. completion 2021-12 2 sites Stand-alone
    Other conditions: Severe Aplastic Anemia, Bone Marrow Failure Syndromes
    View official trial listing →
  • Completed NCT NCT02229383

    Phase III Study to Evaluate Safety and Efficacy of Added Exenatide Versus Placebo to Titrated Basal Insulin Glargine in Inadequately Controlled Patients With Type II Diabetes Mellitus

    Not yet reported AstraZeneca 464 participants Est. completion 2016-08-29 123 sites Stand-alone
    Other conditions: Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT02229396

    Phase 3 28-Week Study With 24-Week and 52-week Extension Phases to Evaluate Efficacy and Safety of Exenatide Once Weekly and Dapagliflozin Versus Exenatide and Dapagliflozin Matching Placebo

    Not yet reported AstraZeneca 695 participants Est. completion 2017-12-28 133 sites Stand-alone
    Other conditions: Diabetes Mellitus
    View official trial listing →
  • Status unknown NCT NCT02233049

    Biological Medicine for Diffuse Intrinsic Pontine Glioma (DIPG) Eradication

    Not yet reported Gustave Roussy, Cancer Campus, Grand Paris 250 participants Est. completion 2018-10 1 site
    Other conditions: Diffuse Intrinsic Pontine Glioma
    View official trial listing →
  • Completed NCT NCT02236975

    First-in-man Trial Examining the Safety and Efficacy of BuMA Supreme and Resolute Integrity in Patients With de Novo Coronary Artery Stenosis

    Not yet reported, Not yet reported Sino Medical Sciences Technology Inc. 168 participants Est. completion 2019-03 12 sites
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT02238496

    Perifosine and Torisel (Temsirolimus) for Recurrent/Progressive Malignant Gliomas

    Not yet reported Andrew B Lassman, MD 10 participants Est. completion 2021-02-14 2 sites
    Other conditions: Brain Tumor, Recurrent, Glioblastoma, Anaplastic Astrocytoma, Anaplastic Oligodendroglioma, Mixed Glioma
    View official trial listing →
  • Completed NCT NCT02240407

    Re-administration of Intramuscular AAV9 in Patients With Late-Onset Pompe Disease

    Not yet reported University of Florida 2 participants Est. completion 2021-08-26 1 site Stand-alone
    Other conditions: Pompe Disease
    View official trial listing →
  • Completed NCT NCT02240719

    Everolimus and Bendamustine Hydrochloride in Treating Patients With Relapsed or Refractory Hematologic Cancer

    Not yet reported University of California, Davis 20 participants Est. completion 2018-04-09 1 site
    Other conditions: Recurrent Adult Diffuse Large Cell Lymphoma, Recurrent Adult Hodgkin Lymphoma, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma, Recurrent Grade 3 Follicular Lymphoma, Recurrent Mantle Cell Lymphoma, Refractory Chronic Lymphocytic Leukemia, Multiple Myeloma
    View official trial listing →
  • Completed NCT NCT02241564

    Malignancies in Transplanted Patients

    Uppsala University 95 participants Est. completion 2017-06 1 site
    Other conditions: Neoplasms
    View official trial listing →
  • Terminated NCT NCT02244164

    Pathophysiological Study of the Increase in Pancreatic Volume in Type 2 Diabetes Treatments.

    Not yet reported Erasme University Hospital 5 participants Est. completion 2023-02-13 1 site
    Type 2 diabetes Other conditions: Incretinomimetics, Pancreas
    View official trial listing →
  • Completed NCT NCT02246127

    Sequentiality of Everolimus and STZ-5FU in Advanced Pancreatic Neuroendocrine Tumor

    Not yet reported Grupo Espanol de Tumores Neuroendocrinos 141 participants Est. completion 2021-07-12 37 sites
    Other conditions: Neuroendocrine Tumors
    View official trial listing →
  • Completed NCT NCT02248012

    Everolimus and Temozolomide in Advanced Gastroenteropancreatic Neuroendocrine Carcinoma (G3)

    Not yet reported Haukeland University Hospital 38 participants Est. completion 2019-12-01 1 site
    Other conditions: Neuroendocrine Carcinoma
    View official trial listing →
  • Completed NCT NCT02248571

    Patient Preference for Everolimus in Combination With Exemestane or Capecitabine in Combination With Bevacizumab

    Not yet reported iOMEDICO AG 85 participants Est. completion 2017-09-30 1 site
    Other conditions: Breast Cancer Recurrent, HER2/Neu-negative Carcinoma of Breast, Hormone Receptor Positive Malignant Neoplasm of Breast
    View official trial listing →
  • Completed NCT NCT02248597

    Donor Stem Cell Transplant Followed by Cyclophosphamide in Treating Patients With Hematological Diseases

    Not yet reported Wake Forest University Health Sciences 27 participants Est. completion 2023-01-18 1 site Stand-alone
    Other conditions: Graft Versus Host Disease, Hematopoietic/Lymphoid Cancer
    View official trial listing →
  • Status unknown NCT NCT02251691

    Influence of Once-daily Versus Twice-daily Immunosuppressant on Renal Transplant

    Not yet reported National Taiwan University Hospital 90 participants Est. completion 2020-03-31 1 site
    Other conditions: Adherence to Medication Regime
    View official trial listing →
  • Completed NCT NCT02251821

    JAK Inhibitor Before Donor Stem Cell Transplant in Treating Patients With Primary or Secondary Myelofibrosis

    Not yet reported Fred Hutchinson Cancer Center 61 participants Est. completion 2026-01-22 1 site Stand-alone
    Other conditions: Primary Myelofibrosis, Secondary Myelofibrosis
    View official trial listing →
  • Completed NCT NCT02251938

    A Phase IIIb, Multinational, Multicenter, Open-Label Extension Study Assessing the Long-Term Safety of PRN Intravitreal Injections of DE-109 in Subjects With Non-Infectious Uveitis of the Posterior Segment of the Eye Who Have Participated in the SAKURA Development Program

    Not yet reported Santen Inc. 60 participants Est. completion 2017-11-27 25 sites Stand-alone
    Other conditions: Non-Infectious Uveitis of the Posterior Segment of the Eye
    View official trial listing →
  • Completed NCT NCT02252055

    The ONE Study ATDC Trial

    Not yet reported, Not yet reported Nantes University Hospital 11 participants Est. completion 2018-11-14 1 site Stand-alone
    Other conditions: Renal Failure, End Stage
    View official trial listing →
  • Status unknown NCT NCT02254668

    Intracoronary Analysis of Cardiac Allograft Vasculopathy by Means of Optical Coherence Tomography

    Not yet reported University of Zurich 278 participants Est. completion 2023-02 1 site
    Other conditions: Intimal Proliferation, Immunosuppression
    View official trial listing →
  • Status unknown NCT NCT02258282

    Safety and Efficacy of Etanercept in Patients With Psoriasis

    Not yet reported Chengdu PLA General Hospital 80 participants Est. completion 2022-12 1 site Stand-alone
    Other conditions: Psoriasis
    View official trial listing →
  • Completed NCT NCT02258451

    Study of Radium-223 Dichloride in Combination With Exemestane and Everolimus Versus Placebo in Combination With Exemestane and Everolimus in Subjects With Bone Predominant HER2 Negative Hormone Receptor Positive Metastatic Breast Cancer

    Not yet reported Bayer 283 participants Est. completion 2022-10-28 92 sites
    Other conditions: Breast Neoplasms
    View official trial listing →
  • Completed NCT NCT02264665

    OPALINE : A Study Of Morbidity And Mortality At 2 Years

    Pfizer 144 participants Est. completion 2019-11-18 35 sites
    Other conditions: Pancreatic Neuroendocrine Tumor, Well Differentiated and Progressive
    View official trial listing →
  • Completed NCT NCT02266888

    B Cell Induction in Pediatric Lung Transplantation

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 45 participants Est. completion 2019-06-30 7 sites Stand-alone
    Other conditions: Lung Transplant
    View official trial listing →
  • Terminated NCT NCT02268201

    A Study to Evaluate the Efficacy and Safety in Kidney Transplant Recipients When Changed From Cyclosporine to Tacrolimus Prolonged-release Capsule or Tacrolimus Capsule

    Not yet reported Astellas Pharma China, Inc. 17 participants Est. completion 2015-03-31 7 sites Stand-alone
    Other conditions: Kidney Transplant Recipients
    View official trial listing →
  • Completed NCT NCT02274662

    Expanded Access Protocol Thymus Transplantation

    Not yet reported Sumitomo Pharma Switzerland GmbH 11 participants Est. completion 2023-08 Stand-alone
    Other conditions: Poor Thymic Function, Immunodeficiency, Athymia, Immunoreconstitution, Thymus Transplantation, Low T Cell Numbers
    View official trial listing →
  • Completed NCT NCT02274792

    Study to Assess the Immunogenicity and Safety of Etanercept Produced Using a Modified Process in Patients With Plaque Psoriasis

    Not yet reported Amgen 132 participants Est. completion 2015-11 45 sites Stand-alone
    Other conditions: Plaque Psoriasis
    View official trial listing →
  • Completed NCT NCT02278952

    Tacrolimus Adjustment by NFAT-related Gene Expression in Lung Allograft Recipients.

    University of California, San Francisco 50 participants Est. completion 2018-01 1 site
    Other conditions: Transplantation, Lung
    View official trial listing →
  • Terminated NCT NCT02282904

    Haploidentical Transplant for People With Chronic Granulomatous Disease Using Post Transplant Cyclophosphamide

    Not yet reported, Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 7 participants Est. completion 2019-12-10 1 site Stand-alone
    Other conditions: Chronic Granulomatous Disease
    View official trial listing →
  • Completed NCT NCT02283658

    Everolimus and Letrozole in Treating Patients With Recurrent Hormone Receptor Positive Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer

    Not yet reported Mayo Clinic 20 participants Est. completion 2018-06-21 2 sites
    Other conditions: Ovarian Endometrioid Adenocarcinoma, Ovarian Seromucinous Carcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Serous Surface Papillary Adenocarcinoma, Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma, Recurrent Ovarian Germ Cell Tumor, Recurrent Primary Peritoneal Carcinoma, Undifferentiated Ovarian Carcinoma
    View official trial listing →
  • Completed NCT NCT02284464

    Steroid Withdrawal and Donor-specific Anti-HLA Antibodies in Renal Transplant Patients

    Not yet reported Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud 230 participants Est. completion 2019-12 5 sites Stand-alone
    Other conditions: Other Complication of Kidney Transplant, Renal Transplant Rejection
    View official trial listing →
  • Completed NCT NCT02288273

    Study to Evaluate the Effect of BYDUREON on 24-hour Glucose Control in Metformin Treated Patients With Type 2 Diabetes.

    Not yet reported AstraZeneca 239 participants Est. completion 2015-08 29 sites Added to GLP-1
    Type 2 diabetes
    View official trial listing →
  • Status unknown NCT NCT02291770

    Treatment of Chronic Graft-Versus-Host Disease With Mesenchymal Stromal Cells

    Not yet reported Guangdong Provincial People's Hospital 130 participants Est. completion 2019-12 1 site
    Other conditions: Chronic Graft-Versus-Host Disease
    View official trial listing →
  • Completed NCT NCT02291913

    Everolimus Combined With Anti-estrogen Therapy in Hormone-Receptor-Positive HER-2 Negative Advanced Breast Cancer

    Not yet reported SCRI Development Innovations, LLC 48 participants Est. completion 2019-01-31 8 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT02294006

    Activity and Safety of Everolimus+Octreotide LAR+Metformin in Advanced Pancreatic Well-differentiated NETs

    Not yet reported Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 26 participants Est. completion 2021-10 1 site
    Other conditions: Well Differentiated Pancreatic Endocrine Tumor
    View official trial listing →
  • Completed NCT NCT02294032

    The Role of B Cells in Kidney Allograft Dysfunction

    Loma Linda University 180 participants Est. completion 2023-04-24 1 site
    Other conditions: Kidney; Complications, Allograft, Transplantation Infection
    View official trial listing →
  • Completed NCT NCT02294552

    Post-transplantation Cyclophosphamide as GVHD Prophylaxis After HSCT

    Not yet reported Ivan S Moiseev 200 participants Est. completion 2017-11 1 site Stand-alone
    Other conditions: Acute Myeloid Leukemia, Acute Lymphoid Leukemia, Lymphoma, Myelodysplastic Syndromes, Chronic Lymphocytic Leukemia, Immune System Diseases
    View official trial listing →
  • Completed NCT NCT02297126

    A Prospective Trial to Assess Cost and Clinical Outcomes of a Clinical Pharmacogenomic Program

    Not yet reported Indiana University 4465 participants Est. completion 2019-05-03 1 site
    Other conditions: Adverse Drug Reaction
    View official trial listing →
  • Status unknown NCT NCT02300571

    Observational Study of the Combination of Post-transplant High Dose Cyclophosphamide, Tacrolimus and Mycophenolate Mofetil for the Prevention of Acute Graft-versus-Host Disease in Patients Eligible to Allogeneic Hematopoietic Stem Cell Transplant

    Fondazione del Piemonte per l'Oncologia 60 participants Est. completion 2018-01 2 sites
    Other conditions: Hematological Malignancies
    View official trial listing →
  • Completed NCT NCT02303730

    Exenatide Compared With Insulin Glargine to Change Liver Fat Content in Type 2 Diabetes

    Not yet reported Fudan University 76 participants Est. completion 2017-11 5 sites Stand-alone
    Type 2 diabetes Other conditions: Non-alcoholic Fatty Liver Disease
    View official trial listing →
  • Status unknown NCT NCT02305472

    NeoVas Bioresorbable Coronary Scaffold Registry Study

    Not yet reported Lepu Medical Technology (Beijing) Co., Ltd. 825 participants Est. completion 2020-09 27 sites Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Status unknown NCT NCT02311010

    Practical Use of Advagraf de Novo After Kidney Transplantation According to Recipient Genetic Polymorphism

    Not yet reported Université Catholique de Louvain 150 participants Est. completion 2015-01 1 site
    Other conditions: Kidney Diseases
    View official trial listing →
  • Status unknown NCT NCT02313051

    Everolimus trIal for Advanced prememopausaL Breast Cancer Patients

    Not yet reported Chinese Academy of Medical Sciences 200 participants Est. completion 2017-12 1 site
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT02313220

    Exploratory Study to Investigate the Effect of Dapagliflozin and Exenatide Combined on Body Weight

    Not yet reported Uppsala University 50 participants Est. completion 2016-03 1 site Stand-alone
    Other conditions: Obesity
    View official trial listing →
  • Status unknown NCT NCT02314312

    Efficacy and Safety of Everolimus in de Novo Kidney Transplant Recipients of ECD or AKI Donors

    Not yet reported Mahidol University 48 participants Est. completion 2015-06
    Other conditions: Transplantation of Kidney, Expanded Criteria Donor, ECD
    View official trial listing →
  • Completed NCT NCT02314403

    Renal Allograft Tolerance Through Mixed Chimerism (Belatacept)

    Not yet reported Massachusetts General Hospital 2 participants Est. completion 2021-07 1 site Stand-alone
    Other conditions: Kidney Failure, Chronic, Renal Insufficiency
    View official trial listing →
  • Terminated NCT NCT02315625

    Study of Mutation-Targeted Therapy With Sunitinib or Everolimus in People With Advanced Low- or Intermediate-Grade Neuroendocrine Tumors of the Gastrointestinal Tract and Pancreas With or Without Cytoreductive Surgery

    Not yet reported National Cancer Institute (NCI) 16 participants Est. completion 2019-05-22 1 site
    Other conditions: Neuroendocrine Tumors, Neuroendocrine Carcinoma, Neuroendocrine Neoplasms, Carcinoma, Neuroendocrine, Neuroendocrine Tumors of the Gastrointestinal Tract and Pancreas
    View official trial listing →
  • Completed NCT NCT02318030

    CNTRP POSITIVE Study

    The Hospital for Sick Children 600 participants Est. completion 2020-04 1 site
    Other conditions: Transplant, Adaptive Immunity, EBV, Medication Adherence, PTLD
    View official trial listing →
  • Active, not recruiting NCT NCT02321501

    Ceritinib and Everolimus in Treating Patients With Locally Advanced or Metastatic Solid Tumors or Stage IIIB-IV Non-small Cell Lung Cancer

    Not yet reported M.D. Anderson Cancer Center 37 participants Est. completion 2026-12-31 1 site
    Other conditions: ALK Positive, Locally Advanced Malignant Solid Neoplasm, Metastatic Malignant Solid Neoplasm, ROS1 Gene Rearrangement, Stage IIIB Lung Non-Small Cell Cancer AJCC v7, Stage IV Lung Non-Small Cell Cancer AJCC v7
    View official trial listing →
  • Completed NCT NCT02322580

    An Observational Monocentric Study Investigating the Association Between Trough Serum Levels of Etanercept, Antibodies Towards Etanercept and Its Effectiveness in Psoriasis Patients

    Universitaire Ziekenhuizen KU Leuven 56 participants Est. completion 2016-11
    Other conditions: Psoriasis
    View official trial listing →
  • Completed NCT NCT02325960

    A Comparison of Exenatide and Insulin Glargine

    Not yet reported The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 44 participants Est. completion 2016-10 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT02328222

    ESTEROID WITHDRAWAL STUDY, SAFETY AND EFFICACY IN RENAL TRANPLANTATION

    Not yet reported Unidad de Investigacion Medica en Enfermedades Renales 71 participants Est. completion 2011-06 1 site
    Other conditions: END STAGE RENAL DISEASE
    View official trial listing →
  • Completed NCT NCT02328755

    Peginterferon Alfa-2a to Enhance Anti-leukemic Responses After Allogeneic Transplantation in Acute Myeloid Leukemia

    Not yet reported, Not yet reported University of Michigan Rogel Cancer Center 37 participants Est. completion 2019-03-25 1 site Stand-alone
    Other conditions: Acute Myeloid Leukemia
    View official trial listing →
  • Completed NCT NCT02328963

    Proportion of CMV Seropositive Kidney Transplant Recipients Who Will Develop a CMV Infection When Treated With an Immunosuppressive Regimen Including Everolimus and Reduced Dose of Cyclosporine Versus an Immunosuppressive Regimen With Mycophenolic Acid and Standard Dose of Cyclosporine A

    Not yet reported University Hospital, Bordeaux 186 participants Est. completion 2018-10-10 9 sites Stand-alone
    Other conditions: Transplantation Infection, Cytomegalovirus Infection
    View official trial listing →
  • Completed NCT NCT02329808

    Clinical Validation of a Dried Blood Spot Method for Analysis of Immunosuppressives and Antifungals in Pediatrics

    Radboud University Medical Center 93 participants Est. completion 2021-12-03 1 site
    Other conditions: Hematologic Diseases, Oncology Problem, Kidney Diseases, Transplantation Infection
    View official trial listing →
  • Completed NCT NCT02330380

    Comparative Effectiveness of Psoriasis Treatments on Systemic Inflammation

    University Hospitals Cleveland Medical Center 26 participants Est. completion 2016-12 1 site
    Other conditions: Psoriasis, Inflammation
    View official trial listing →
  • Completed NCT NCT02332902

    Everolimus for Treatment of Disfiguring Cutaneous Lesions in Neurofibromatosis1 CRAD001CUS232T

    Not yet reported The University of Texas Health Science Center, Houston 24 participants Est. completion 2016-03 1 site
    Other conditions: Neurofibromatosis 1
    View official trial listing →
  • Suspended NCT NCT02333162

    Intensity Modulated Total Marrow Irradiation, Fludarabine Phosphate, and Melphalan in Treating Patients With Relapsed Hematologic Cancers Undergoing a Second Donor Stem Cell Transplant

    Not yet reported University of Chicago 30 participants Est. completion 2028-12-01 1 site Stand-alone
    Other conditions: Previously Treated Myelodysplastic Syndrome, Recurrent Adult Acute Lymphoblastic Leukemia, Recurrent Adult Acute Myeloid Leukemia, Recurrent Hematologic Malignancy
    View official trial listing →
  • Completed NCT NCT02333565

    Combination of Everolimus and Octreotide LAR in Aggressive Recurrent Meningiomas

    Not yet reported Assistance Publique Hopitaux De Marseille 20 participants Est. completion 2023-05-24 1 site
    Other conditions: Recurrent Meningiomas, Resistant Meningiomas
    View official trial listing →
  • Completed NCT NCT02334488

    Study Evaluating the Benefit of Two Immunosuppressive Strategies on Renal Function

    Not yet reported Poitiers University Hospital 329 participants Est. completion 2020-07-03 14 sites Stand-alone
    Chronic kidney disease
    View official trial listing →
  • Completed NCT NCT02336854

    Tacrobell tab_Phase1_PK

    Not yet reported Chong Kun Dang Pharmaceutical 50 participants Est. completion 2015-03-19
    Other conditions: Immunosuppressant(Organ Transplantation, RA)
    View official trial listing →
  • Status unknown NCT NCT02337036

    Pharmacokinetic of Tacrolimus in Paediatric Liver Transplant Patients

    Not yet reported Assistance Publique - Hôpitaux de Paris 80 participants Est. completion 2020-12 1 site Stand-alone
    Other conditions: Liver Transplantation, Child
    View official trial listing →
  • Completed NCT NCT02339246

    Pharmacokinetic Comparison Of All FK-506 Formulations

    Not yet reported Veloxis Pharmaceuticals 32 participants Est. completion 2015-03 1 site
    Other conditions: Renal Failure
    View official trial listing →
  • Completed NCT NCT02341274

    Effects of Altered Formulation on the Bioequivalence of Tacrolimus in Healthy Female and Male Volunteeers

    Not yet reported Indiana University 24 participants Est. completion 2018-01-20 1 site
    Other conditions: Bioequivalence
    View official trial listing →
  • Completed NCT NCT02342145

    Efficacy of Basiliximab in the Prevention of Acute Graft-versus-host Disease in Unrelated Allogeneic Hematopoietic Stem Cell Transplantation Therapy for Thalassemia Major

    Not yet reported Zhongming Zhang 205 participants Est. completion 2022-08-20 3 sites Stand-alone
    Other conditions: Beta-Thalassemia Major, Graft-versus-host Disease (GVHD)
    View official trial listing →
  • Completed NCT NCT02342782

    Yttrium Y 90 Basiliximab and Combination Chemotherapy Before Stem Cell Transplant in Treating Patients With Mature T-cell Non-Hodgkin Lymphoma

    Not yet reported City of Hope Medical Center 20 participants Est. completion 2024-11-18 1 site Stand-alone
    Other conditions: Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma, Recurrent Mature T- and NK-Cell Non-Hodgkin Lymphoma, Refractory Mature T-Cell and NK-Cell Non-Hodgkin Lymphoma, Recurrent Cutaneous T-Cell Non-Hodgkin Lymphoma, Refractory Cutaneous T-Cell Non-Hodgkin Lymphoma
    View official trial listing →
  • Status unknown NCT NCT02344641

    Efficacy and Mechanism of Exenatide on Improving Heart Function in Type 2 Diabetes With Heart Failure Patients

    Not yet reported Chinese Academy of Medical Sciences, Fuwai Hospital 234 participants Est. completion 2016-12 Stand-alone
    Type 2 diabetesHeart failure
    View official trial listing →
  • Completed NCT NCT02345850

    Calcineurin Inhibitor-Free Interventions BMT CTN 1301 for Prevention of Graft-versus-Host Disease (BMT CTN 1301)

    Not yet reported National Heart, Lung, and Blood Institute (NHLBI) 346 participants Est. completion 2020-10-05 28 sites
    Other conditions: Acute Leukemia, Myelodysplasia
    View official trial listing →
  • Completed NCT NCT02346240

    Efficacy and Safety Study of Certolizumab Pegol (CZP) Versus Active Comparator and Placebo in Subjects With Plaque Psoriasis (PSO)

    Not yet reported UCB Biopharma S.P.R.L. 559 participants Est. completion 2018-12-17 70 sites
    Other conditions: Psoriasis, Plaque Psoriasis
    View official trial listing →
  • Terminated NCT NCT02346877

    Evaluate Effects of Personalized Patient Counselling for Enbrel® Therapy in Adults With Rheumatoid Arthritis

    Not yet reported Amgen 19 participants Est. completion 2015-10 15 sites
    Other conditions: Persistence to Enbrel
    View official trial listing →
  • Status unknown NCT NCT02356146

    First Tacrolimus Dose Trough Level is Better Than CYP3A5 Genotyping in Tacrolimus Dose Prediction

    Chulalongkorn University 60 participants Est. completion 2015-06 1 site
    Other conditions: Kidney Transplantation Recipients
    View official trial listing →
  • Completed NCT NCT02356159

    Study of Palifermin (Kepivance) in Persons Undergoing Unrelated Donor Allogeneic Hematopoietic Cell Transplantation

    Not yet reported, Not yet reported National Cancer Institute (NCI) 34 participants Est. completion 2025-03-25 2 sites Stand-alone
    Other conditions: Myelodysplastic Syndromes, Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma, Acute Leukemia, Multiple Myeloma
    View official trial listing →
  • Status unknown NCT NCT02360423

    Safety and Efficacy of the CRE8 Stent for the Treatment of De Novo Coronary Artery Lesions

    Not yet reported CID S.p.A. 430 participants Est. completion 2021-04 1 site Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Status unknown NCT NCT02360709

    Safety and Efficacy of the CRE8 Sirolimus-Eluting Stent for the Treatment of De Novo Coronary Artery Lesions

    CID S.p.A. 800 participants Est. completion 2021-04 1 site
    Cardiovascular disease
    View official trial listing →
  • Withdrawn NCT NCT02365415

    Systemic Rapamycin (Sirolimus) to Prevent In-Stent Restenosis Following Pulmonary Artery Stent Placement

    Not yet reported Boston Children's Hospital Est. completion 2018-04 1 site Stand-alone
    Other conditions: Peripheral Pulmonary Stenosis, In-stent Stenosis
    View official trial listing →
  • Completed NCT NCT02366728

    DC Migration Study for Newly-Diagnosed GBM

    Not yet reported Mustafa Khasraw, MBChB, MD, FRCP, FRACP 64 participants Est. completion 2020-10-31 1 site Stand-alone
    Other conditions: Glioblastoma, Astrocytoma, Grade IV, Giant Cell Glioblastoma, Glioblastoma Multiforme
    View official trial listing →
  • Completed NCT NCT02371434

    The ONE Study nTreg Trial (ONEnTreg13)

    Not yet reported, Not yet reported Prof. Dr. Petra Reinke 17 participants Est. completion 2017-11-01 1 site Stand-alone
    Other conditions: Immunosuppressive Treatment of Living-donor Renal Transplantation
    View official trial listing →
  • Completed NCT NCT02373202

    A Study Assessing the Safety and Efficacy of Sarilumab Added to Non-MTX DMARDs or as Monotherapy in Japanese Patients With Active Rheumatoid Arthritis (SARIL-RA-HARUKA)

    Not yet reported Sanofi 91 participants Est. completion 2016-11 40 sites Stand-alone
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT02373813

    Study of Etanercept Monotherapy vs Methotrexate Monotherapy for Maintenance of Rheumatoid Arthritis Remission

    Not yet reported Amgen 371 participants Est. completion 2019-12-06 136 sites Stand-alone
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT02376478

    On the Impact of Therapeutic Tumor Necrosis Factor-alpha Inhibition on Anogenital Human Papillomavirus Infection

    Medical University of Vienna 222 participants Est. completion 2011-01
    Other conditions: Psoriasis, Inflammatory Bowel Diseases
    View official trial listing →
  • Completed NCT NCT02376790

    Etanercept and Methotrexate in Combination or as Monotherapy in Psoriatic Arthritis

    Not yet reported Amgen 851 participants Est. completion 2018-07-06 138 sites Stand-alone
    Other conditions: Psoriatic Arthritis
    View official trial listing →
  • Completed NCT NCT02376985

    Evaluation of Oral Care to Prevent Oral Mucositis in ER Positive MBC Patients Treated With Everolimus: Phase 3 RCT

    Not yet reported Comprehensive Support Project for Oncology Research 174 participants Est. completion 2018-10-16 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT02377193

    Simulect Versus ATG in Sensitized Renal Transplant Patient

    Not yet reported University Hospital, Toulouse 60 participants Est. completion 2017-01 1 site Stand-alone
    Other conditions: Renal Transplant Rejection
    View official trial listing →
  • Terminated NCT NCT02377609

    To Validate an Analytical Method to Measure Concentration of Tacrolimus in Blood Taken From Finger Pricks

    Astellas Pharma Europe Ltd. 108 participants Est. completion 2014-09 6 sites
    Other conditions: Validation, Dried Blood Spot, Transplant Patients
    View official trial listing →
  • Status unknown NCT NCT02377791

    Impact of CYP3A5 Gene Polymorphisms on Tacrolimus Concentrations and Outcomes in Thai Transplant Recipients

    Mahidol University 170 participants Est. completion 2015-10
    Other conditions: Kidney Transplant
    View official trial listing →
  • Status unknown NCT NCT02382575

    Efficacy and Safety of Rituximab to That of Calcineurin Inhibitors in Children With Steroid Resistant Nephrotic Syndrome

    Not yet reported Nilratan Sircar Medical College 120 participants Est. completion 2023-12 1 site
    Other conditions: Nephrotic Syndrome
    View official trial listing →
  • Completed NCT NCT02384018

    Mesenchymal Stem Cell and Islet Co-transplantation

    Not yet reported Medical University of South Carolina 3 participants Est. completion 2017-11-21 1 site
    Other conditions: Chronic Pancreatitis, Diabetes
    View official trial listing →
  • Completed NCT NCT02384837

    Effect of TCFA on Neointimal Coverage After PCI at 9 Months Follow-up

    General Hospital of Chinese Armed Police Forces 33 participants Est. completion 2016-11 1 site
    Other conditions: Unrecognized Condition
    View official trial listing →
  • Completed NCT NCT02385279

    Study Comparing the MiStent SES Versus the XIENCE EES Stent

    Not yet reported ECRI bv 1398 participants Est. completion 2021-02-04 20 sites Stand-alone
    Other conditions: Coronary Stenosis
    View official trial listing →
  • Status unknown NCT NCT02392780

    Cannabidiol for the Treatment of Severe (Grades III/IV) Acute Graft-versus-host Disease

    Not yet reported moshe yeshurun 10 participants 1 site Stand-alone
    Other conditions: Acute-graft-versus-host Disease
    View official trial listing →
  • Status unknown NCT NCT02398955

    Biomime Stent in All-comers PCI Patients Registry

    Azienda Ospedaliero Universitaria Maggiore della Carita 250 participants Est. completion 2016-12 1 site
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT02400632

    MagicTouch Sirolimus Drug Coated Balloon Catheter for the Treatment of Coronary Lesions

    Not yet reported Scitech Produtos Medicos SA 60 participants Est. completion 2019-12-30 3 sites
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT02402140

    Influence of Pharmaceutical Care on the Intraindividual Variability of Tacrolimus Concentrations

    Not yet reported Hospital do Rim e Hipertensão 128 participants Est. completion 2014-12
    Other conditions: Renal Transplant Graft Failure
    View official trial listing →
  • Completed NCT NCT02404376

    COMBinAtion Therapy in Myocardial Infarction: The COMBAT-MI Trial

    Not yet reported Hospital Universitari Vall d'Hebron Research Institute 378 participants Est. completion 2020-06 6 sites
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT02406326

    An Evaluation of BioMime™ - Sirolimus Eluting Coronary Stent in a Multi- Centre Study.

    Meril Life Sciences Pvt. Ltd. 250 participants Est. completion 2016-12-27 11 sites
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT02407054

    A Study of Enzalutamide and LY3023414 in Men With Prostate Cancer

    Not yet reported Eli Lilly and Company 142 participants Est. completion 2020-04-16 36 sites
    Other conditions: Prostate Cancer Metastatic
    View official trial listing →
  • Completed NCT NCT02407509

    Phase I Trial of VS-6766 Alone and in Combination With Everolimus

    Not yet reported Royal Marsden NHS Foundation Trust 104 participants Est. completion 2025-10-15 3 sites
    Other conditions: Solid Tumours, Multiple Myeloma, Lung Cancer, Ovarian Cancer
    View official trial listing →
  • Withdrawn NCT NCT02409147

    Initiation of a Deceased Donor Uterine Transplantation Program at the University of Nebraska Medical Center

    Not yet reported University of Nebraska Est. completion 2018-07-24 Stand-alone
    Other conditions: Uterus Transplant
    View official trial listing →
  • Approved For Marketing NCT NCT02411604

    Expanded Access Study for Renal Transplant Patients With Envarsus XR ™

    Asahi Kasei Therapeutics, Inc.
    Other conditions: Renal Failure
    View official trial listing →
  • Status unknown NCT NCT02415452

    Researches of Retinal Artery Lesions and Acute Coronary Syndrome

    Capital Medical University 660 participants Est. completion 2018-01
    Other conditions: Acute Coronary Syndrome
    View official trial listing →
  • Status unknown NCT NCT02416674

    Vascularized Composite Allotransplantation for Treatment of Abdominal Wall Defects

    Not yet reported Brigham and Women's Hospital 10 participants Est. completion 2025-02 1 site Stand-alone
    Other conditions: Abdominal Wall Defect
    View official trial listing →
  • Completed NCT NCT02417142

    Exenatide Weekly Injections as an Adjunctive Treatment in Patients With Schizophrenia

    Not yet reported University of Massachusetts, Worcester 70 participants Est. completion 2020-07 1 site Stand-alone
    Other conditions: Schizophrenia, Schizoaffective Disorder
    View official trial listing →
  • Completed NCT NCT02420613

    Vorinostat and Temsirolimus With or Without Radiation Therapy in Treating Younger Patients With Newly Diagnosed or Progressive Diffuse Intrinsic Pontine Glioma

    Not yet reported M.D. Anderson Cancer Center 18 participants Est. completion 2025-03-28 1 site
    Other conditions: Diffuse Intrinsic Pontine Glioma
    View official trial listing →
  • Terminated NCT NCT02423954

    Study of Nivolumab Plus Chemotherapy in Patients With Advanced Cancer (NivoPlus)

    Not yet reported, Not yet reported Western Regional Medical Center 33 participants Est. completion 2017-11-01 1 site
    Other conditions: Advanced Cancer, Pancreatic Cancer, Renal Cell Cancer, Non Small Cell Lung Cancer, Colorectal Carcinoma, Endometrial, Uterine
    View official trial listing →
  • Status unknown NCT NCT02426502

    Once Daily Dosing to Improve Medication Adherence and Patient Satisfaction in Kidney Transplant Recipients

    Not yet reported University of British Columbia 76 participants Est. completion 2024-12 3 sites Stand-alone
    Other conditions: End-Stage Renal Disease
    View official trial listing →
  • Completed NCT NCT02428296

    Study of Sirolimus Therapy for Segmental Overgrowth Caused by Somatic PI3K Activation

    Not yet reported National Human Genome Research Institute (NHGRI) 39 participants Est. completion 2018-02-14 1 site Stand-alone
    Other conditions: PIK3CA-Related Overgrowth Spectrum (PROS), Growth Disorder, Genetics
    View official trial listing →
  • Completed NCT NCT02432053

    A Study to Demonstrate Safety and Efficacy of Advagraf in Patients Undergoing Kidney or Liver Transplantation in India

    Not yet reported Astellas Pharma Inc 92 participants Est. completion 2013-05 7 sites
    Other conditions: Kidney Transplantation, Liver Transplantation
    View official trial listing →
  • Completed NCT NCT02432833

    Multicentre, Open Label, Randomized, Two-arm, Parallel-group Study to Assess Efficacy and Safety of ENVARSUS® Compared With Tacrolimus Used as Per Current Clinical Practice in the Initial Maintenance Setting in de Novo Kidney Transplant Patients

    Not yet reported Chiesi Farmaceutici S.p.A. 428 participants Est. completion 2017-01-24 1 site Stand-alone
    Other conditions: End Stage Renal Disease
    View official trial listing →
  • Completed NCT NCT02432976

    Impact of Perioperative Exenatide Infusion on Quality of Life in Cardiac Surgery Patients

    Not yet reported, Not yet reported Centre Hospitalier Universitaire de Besancon 64 participants Est. completion 2017-01 1 site Stand-alone
    Other conditions: Quality of Life
    View official trial listing →
  • Completed NCT NCT02435901

    HSCT For Patients With High Risk Hemoglobinopathies Using Reduced Intensity

    Not yet reported, Not yet reported Northwell Health 29 participants Est. completion 2019-12 1 site Stand-alone
    Other conditions: Sickle Cell Disease, Beta Thalassemia-Major
    View official trial listing →
  • Completed NCT NCT02438982

    Efficacy and Safety of Rituximab to That of Calcineurin Inhibitors in Children With Steroid Dependent Nephrotic Syndrome

    Not yet reported Nilratan Sircar Medical College 120 participants Est. completion 2016-09 1 site
    Other conditions: Nephrotic Syndrome
    View official trial listing →
  • Completed NCT NCT02440464

    Allogeneic Hematopoietic Stem Cell Transplantation With Ixazomib for High Risk Multiple Myeloma (BMT CTN 1302)

    Not yet reported National Heart, Lung, and Blood Institute (NHLBI) 57 participants Est. completion 2020-10-01 15 sites Stand-alone
    Other conditions: Multiple Myeloma
    View official trial listing →
  • Completed NCT NCT02441075

    70% Ethanol for Decontamination of CVL Exposed to Calcineurine Inhibitors Version 1.0, 1/9/2014

    Not yet reported Nationwide Children's Hospital 13 participants Est. completion 2016-01 1 site
    Other conditions: Hematopoietic Stem Cell Transplant, GVHD
    View official trial listing →
  • Completed NCT NCT02441543

    Regulation of Lymphocyte Anti-tumor Response in Metastatic Patients Treated With the mTOR Inhibitor Everolimus

    Istituto Clinico Humanitas 45 participants Est. completion 2018-05 1 site
    Other conditions: SOLID TUMOR
    View official trial listing →
  • Completed NCT NCT02441803

    Allogeneic Hematopoietic Stem Cell Transplantation (AlloSCT) Initial Salvage Therapy for Induction Failure Acute Myeloid Leukemia (AML)

    Not yet reported M.D. Anderson Cancer Center 11 participants Est. completion 2021-09-22 1 site Stand-alone
    Other conditions: Leukemia
    View official trial listing →
  • Completed NCT NCT02443818

    Sirolimus Effect on Hypertrophic Syndromes Related Gene PIK3CA

    Not yet reported Centre Hospitalier Universitaire Dijon 16 participants Est. completion 2016-11 11 sites
    Other conditions: Segmental Overgrowth Disorders Due to PIK3CA
    View official trial listing →
  • Completed NCT NCT02444143

    A Pharmacokinetic Analysis of Tacrolimus ER Dosing in Obese Kidney Transplant Recipients

    Not yet reported University of Illinois Chicago 20 participants Est. completion 2017-06-09 1 site Stand-alone
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT02446964

    Total Marrow and Lymphoid Irradiation and Chemotherapy Before Donor Transplant in Treating Patients With Myelodysplastic Syndrome or Acute Leukemia

    Not yet reported City of Hope Medical Center 31 participants Est. completion 2025-05-20 1 site Stand-alone
    Other conditions: Adult Acute Lymphoblastic Leukemia in Complete Remission, Acute Myeloid Leukemia in Remission, Previously Treated Myelodysplastic Syndrome, Recurrent Adult Acute Lymphoblastic Leukemia, Recurrent Adult Acute Myeloid Leukemia, Recurrent Childhood Acute Lymphoblastic Leukemia, Recurrent Childhood Acute Myeloid Leukemia, Childhood Acute Lymphoblastic Leukemia in Complete Remission
    View official trial listing →
  • Withdrawn NCT NCT02447055

    Allogeneic Stem Cell Transplantation for Patients With Multiple Myeloma

    Not yet reported Washington University School of Medicine Est. completion 2016-06 Stand-alone
    Other conditions: Multiple Myeloma, Myeloma-Multiple
    View official trial listing →
  • Status unknown NCT NCT02448524

    Clinical Trial on the Efficacy and Safety of Sirolimus-Eluting Stent (MiStent® System)

    Not yet reported Micell Technologies 428 participants Est. completion 2022-11 16 sites Stand-alone
    Other conditions: Coronary Heart Disease
    View official trial listing →
  • Completed NCT NCT02449564

    The Pilot Study Evaluate the Safety and Efficacy of Sirolimus in Patients With PIK3CA Mutation and/or PIK3CA Amplification Refractory Solid Tumors

    Not yet reported Samsung Medical Center 5 participants Est. completion 2017-11-03 1 site Stand-alone
    Other conditions: Solid Tumor
    View official trial listing →
  • Completed NCT NCT02449603

    Comparison of Exenatide vs. Biphasic Insulin Aspart 30 on Glucose Variability in Type 2 Diabetes

    Not yet reported Xijing Hospital 150 participants Est. completion 2018-04 1 site Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT02451696

    A Pilot Study To Evaluate The Effects of Everolimus on Brain mTOR Activity and Cortical Hyperexcitability in TSC and FCD

    Not yet reported NYU Langone Health 15 participants Est. completion 2017-12-28 1 site
    Other conditions: Epilepsy, Tuberous Sclerosis Complex, Focal Cortical Dysplasia
    View official trial listing →
  • Completed NCT NCT02451748

    IL-7 and IL-7R Expression in RA Patients With Active vs. Inactive Disease Treated With DMARD or CIMZIA

    Not yet reported University of Illinois Chicago 32 participants Est. completion 2017-12 1 site
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Status unknown NCT NCT02453867

    Efficacy and Safety of a Reduced Immunosuppression vs. Standard Triple Therapy in Senior Renal Transplant Recipients

    Not yet reported Klemens Budde 400 participants Est. completion 2019-07 Stand-alone
    Other conditions: Immunosuppression After Renal Transplantation
    View official trial listing →
  • Completed NCT NCT02454478

    Study of Lenvatinib in Combination With Everolimus in Participants With Unresectable Advanced or Metastatic Renal Cell Carcinoma (RCC)

    Not yet reported Eisai Co., Ltd. 7 participants Est. completion 2017-05-29 3 sites
    Other conditions: Carcinoma, Renal Cell
    View official trial listing →
  • Status unknown NCT NCT02456025

    Topical Tacrolimus in Vernal Keratoconjunctivitis

    Not yet reported The Eye Center and The Eye Foundation for Research in Ophthalmology 20 participants Est. completion 2016-12 1 site
    Other conditions: Vernal Keratoconjunctivitis
    View official trial listing →
  • Status unknown NCT NCT02456363

    Anti-Tumor Necrosis Factor Therapy In Patients With Ankylosing Spondylitis

    Not yet reported Chung Shan Medical University 300 participants Est. completion 2019-12 1 site Stand-alone
    Other conditions: Ankylosing Spondylitis
    View official trial listing →
  • Completed NCT NCT02456857

    Liposomal Doxorubicin, Bevacizumab, and Everolimus in Patients With Locally Advanced TNBC With Tumors Predicted Insensitive to Standard Chemotherapy; A Moonshot Initiative

    Not yet reported M.D. Anderson Cancer Center 17 participants Est. completion 2023-05-24 1 site
    Other conditions: Invasive Breast Carcinoma, Triple-Negative Breast Carcinoma
    View official trial listing →
  • Completed NCT NCT02457221

    A Study to Compare the Efficacy and Safety of Tacrolimus Capsules and Cyclophosphamide Injection in Treatment of Lupus Nephritis

    Not yet reported Astellas Pharma China, Inc. 314 participants Est. completion 2018-09-10 35 sites Stand-alone
    Other conditions: Lupus Nephritis
    View official trial listing →
  • Status unknown NCT NCT02459977

    The Usefulness of Tacrolimus Without Basiliximab in Well Matched Living Renal Transplantation in Korea

    Not yet reported Asan Medical Center 40 participants 1 site Stand-alone
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT02464878

    Multicenter Trial of the Effect of AAT on Islet Transplant Engraftment and Durability After Renal Transplant

    Not yet reported Massachusetts General Hospital 2 participants Est. completion 2022-12 1 site
    Other conditions: Kidney Transplant, Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT02466997

    Efficacy of Tacrolimus in Adults With Facial Non-segmental Vitiligo - VITAC

    Not yet reported University Hospital, Bordeaux 42 participants Est. completion 2018-09-30 4 sites Stand-alone
    Other conditions: Vitiligo
    View official trial listing →
  • Terminated NCT NCT02479490

    PRednisone Plus EVerolimus in Patients With Metastatic Renal Cell Cancer After Failure of VEGFR -TKI

    Not yet reported Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS 8 participants Est. completion 2017-09 4 sites
    Other conditions: Metastatic Renal Cancer
    View official trial listing →
  • Completed NCT NCT02481453

    Rapamycine vs Placebo for the Treatment of Inclusion Body Myositis

    Not yet reported, Not yet reported Institut National de la Santé Et de la Recherche Médicale, France 44 participants Est. completion 2018-01-22 1 site
    Other conditions: Inclusion Body Myositis (IBM)
    View official trial listing →
  • Completed NCT NCT02482974

    Conversion From Sirolimus to Everolimus in the Maintenance Treatment of Liver Transplant Recipients

    Ege University 66 participants Est. completion 2016-07 1 site
    Other conditions: Liver Transplant Recipients
    View official trial listing →
  • Completed NCT NCT02486302

    A Study To Evaluate The Efficacy Of Enbrel (REGISTERED) Etanercept Over A Period Of 12 Months In The Routine Treatment Of Patients With Rheumatoid Arthritis, Axial Spondyloarthritis, Psoriatic Arthritis, Or Plaque Psoriasis.

    Pfizer 1534 participants Est. completion 2017-12-11 180 sites
    Other conditions: Rheumatoid Arthritis, Psoriatic Arthritis, Axial Spondyloarthritis, Plaque Psoriasis
    View official trial listing →
  • Completed NCT NCT02486315

    Treatment of Coronary ARtery bIfurcation Narrowing by AXxess Stent Implantation

    Clinica Mediterranea 326 participants Est. completion 2015-06
    Cardiovascular disease
    View official trial listing →
  • Status unknown NCT NCT02489760

    Etanercept Versus Adalimumab in the Treatment of Patients With Ankylosing Spondylitis. A Switch Study

    Not yet reported Chung Shan Medical University 30 participants Est. completion 2016-10 1 site Stand-alone
    Other conditions: Ankylosing Spondylitis
    View official trial listing →
  • Status unknown NCT NCT02492308

    Induction With SVF Derived MSC in Living-related Kidney Transplantation

    Not yet reported, Not yet reported Fuzhou General Hospital 120 participants Est. completion 2017-12 2 sites
    Other conditions: Living-relative Kidney Transplantation
    View official trial listing →
  • Status unknown NCT NCT02492490

    Effect of SVF Derived MSC in DCD Renal Transplantation

    Not yet reported, Not yet reported Fuzhou General Hospital 120 participants Est. completion 2016-11 1 site Stand-alone
    Other conditions: Uremia
    View official trial listing →
  • Status unknown NCT NCT02493465

    Effects of Everolimus in Left Ventricular Hypertrophy After Conversion From Azathioprine: A Pilot Study

    Not yet reported Instituto de Urologia e Nefrologia 50 participants Est. completion 2017-07 1 site
    Other conditions: Left Ventricular Hypertrophy
    View official trial listing →
  • Completed NCT NCT02494570

    A Phase 2 Study of Nab-sirolimus (ABI-009) in Patients With Advanced Malignant PEComa

    Not yet reported Aadi Bioscience, Inc. 34 participants Est. completion 2022-04 9 sites Stand-alone
    Other conditions: Malignant PEComa
    View official trial listing →
  • Completed NCT NCT02495077

    Effects of Inhibiting Early Inflammation in Kidney Transplant Patients

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 290 participants Est. completion 2021-07-23 15 sites Stand-alone
    Other conditions: Kidney Transplant
    View official trial listing →
  • Status unknown NCT NCT02496494

    The Effects of Conversion From Cyclosporine to Tacrolimus on the Changes of Cardiovascular Risk Profiles and Serum Metabolites in Renal Transplant Recipients

    Not yet reported Kyungpook National University Hospital 50 participants Est. completion 2015-12 1 site Stand-alone
    Other conditions: CYCLOSPORINE/TACROLIMUS
    View official trial listing →
  • Terminated NCT NCT02498977

    Liver Immunosuppression Free Trial

    Not yet reported King's College London 116 participants Est. completion 2021-12-31 2 sites
    Other conditions: Transplantation, Liver
    View official trial listing →
  • Completed NCT NCT02500212

    Pharmacokinetic Study of ENVARSUS in Adult De-novo Kidney Transplant Patients

    Not yet reported Chiesi Farmaceutici S.p.A. 75 participants Est. completion 2016-06 7 sites Stand-alone
    Other conditions: Organ or Tissue Transplant; Complications
    View official trial listing →
  • Status unknown NCT NCT02501850

    The Effect of the GLP-1 Receptor Agonists on Blood Levels of Lipoprotein (a)

    Not yet reported Hospital Universitari Vall d'Hebron Research Institute 40 participants Est. completion 2015-10 1 site Added to GLP-1
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT02503059

    Etanercept Survival in Elderly Population

    Fundación Pública Andaluza Progreso y Salud 70 participants Est. completion 2015-02 5 sites
    Other conditions: Psoriasis
    View official trial listing →
  • Completed NCT NCT02504047

    Use of Haploidentical Related Donors for Patients Without Matched Sibling, Unrelated Donor or Cord Blood Units

    Not yet reported University of Calgary 40 participants Est. completion 2019-02 5 sites Stand-alone
    Other conditions: Hematologic Neoplasms
    View official trial listing →
  • Completed NCT NCT02504359

    Combination Chemotherapy and Donor Stem Cell Transplant Followed by Ixazomib Citrate Maintenance Therapy in Treating Patients With Relapsed High-Risk Multiple Myeloma

    Not yet reported OHSU Knight Cancer Institute 11 participants Est. completion 2020-09-09 2 sites Stand-alone
    Other conditions: Plasma Cell Leukemia, Recurrent Plasma Cell Myeloma
    View official trial listing →
  • Completed NCT NCT02509468

    suPERficial Slow-flow Vascular malFORMations Treated With sirolimUS

    Not yet reported University Hospital, Tours 63 participants Est. completion 2019-03 12 sites Stand-alone
    Other conditions: Vascular Malformation
    View official trial listing →
  • Completed NCT NCT02517918

    Metronomic Chemotherapy in Patients With Advanced Solid Tumor With Bone Metastasis and Advanced Pretreated Osteosarcoma

    Not yet reported Institut Bergonié 23 participants Est. completion 2021-11-16 3 sites Stand-alone
    Obstructive sleep apnea Other conditions: Solid Tumor
    View official trial listing →
  • Terminated NCT NCT02523768

    Prevention in Recipients With Primary IgA Nephropathy of Recurrence After Kidney Transplantation: ATG-F Versus Basiliximab as Induction Immunosuppressive Treatment

    Not yet reported Centre Hospitalier Universitaire de Saint Etienne 117 participants Est. completion 2020-02-24 15 sites
    Other conditions: Glomerulonephritis, IgAN
    View official trial listing →
  • Withdrawn NCT NCT02524639

    Sirolimus for the Treatment of Hyperinsulinism

    Not yet reported, Not yet reported Children's Hospital of Philadelphia Est. completion 2018-05-29 1 site Stand-alone
    Other conditions: Hyperinsulinism
    View official trial listing →
  • Status unknown NCT NCT02528292

    Clinical Disease Activity and Modulation of Synovial Lymphoid Structures and B Cell Function in Rheumatoid Arthritis

    Barts & The London NHS Trust 24 participants Est. completion 2018-04 1 site
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Withdrawn NCT NCT02528877

    Ruxolitinib Phosphate, Tacrolimus and Sirolimus in Preventing Acute Graft-versus-Host Disease During Reduced Intensity Donor Hematopoietic Cell Transplant in Patients With Myelofibrosis

    Not yet reported City of Hope Medical Center 1 site Stand-alone
    Other conditions: Acute Myeloid Leukemia in Remission, Primary Myelofibrosis, Primary Myelofibrosis, Prefibrotic Stage, Secondary Acute Myeloid Leukemia, Secondary Myelofibrosis
    View official trial listing →
  • Completed NCT NCT02531932

    Comparison of Single-Agent Carboplatin vs the Combination of Carboplatin and Everolimus for the Treatment of Advanced Triple-Negative Breast Cancer

    Not yet reported Amy Tiersten 64 participants Est. completion 2024-10-19 3 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Terminated NCT NCT02539459

    Sporadic Angiomyolipomas (AMLs) Growth Kinetics While on Everolimus

    Not yet reported Fox Chase Cancer Center 20 participants Est. completion 2018-08-20 8 sites
    Other conditions: Sporadic Angiomyolipomas (AMLs)
    View official trial listing →
  • Completed NCT NCT02540395

    Prospective Donor Specific T Response Measurment for IS Minimization in de Novo Renal Transplantation

    Not yet reported Prof. Dr. Petra Reinke 184 participants Est. completion 2020-10-31 8 sites Stand-alone
    Other conditions: Disorder Related to Renal Transplantation, Effects of Immunosuppressant Therapy
    View official trial listing →
  • Completed NCT NCT02541916

    Liver Immune Tolerance Marker Utilization Study

    Not yet reported University of Toronto 69 participants Est. completion 2021-05-31 1 site Stand-alone
    Other conditions: Immunosuppression, Immune Tolerance
    View official trial listing →
  • Completed NCT NCT02542007

    Safety and Efficacy of the Combo Bio-engineered Sirolimus-eluting Stent Versus the Nano Polymer-free Sirolimus-eluting Stent in the Treatment of Patients With de Novo Stenotic Lesions

    Not yet reported OrbusNeich 440 participants Est. completion 2021-06-10 15 sites Stand-alone
    Other conditions: Coronary Arteriosclerosis
    View official trial listing →
  • Status unknown NCT NCT02545972

    Once-a-day Tacrolimus Conversion Study: The OneTAC Trial

    Not yet reported Newark Beth Israel Medical Center 100 participants Est. completion 2019-02 1 site Stand-alone
    Heart failure
    View official trial listing →
  • Completed NCT NCT02545985

    First-in-man Sirolimus-eluting Prolim® Stent Registry

    Not yet reported Central Clinical Hospital of the Ministry of Internal Affairs and Administration, Warsaw, Poland 204 participants Est. completion 2015-06
    Other conditions: Sirolimus-eluting Stainless Steel Coronary Stent Prolim®
    View official trial listing →
  • Withdrawn NCT NCT02548468

    Reduced Intensity Conditioning Before Partially Matched Donor Stem Cell Transplant in Treating Patients With Advanced Cutaneous T Cell Lymphoma

    Not yet reported Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University Est. completion 2017-03-16 Stand-alone
    Other conditions: Cutaneous T-Cell Non-Hodgkin Lymphoma, Recurrent Mycosis Fungoides and Sezary Syndrome, Stage IIB Mycosis Fungoides and Sezary Syndrome, Stage IIIA Mycosis Fungoides and Sezary Syndrome, Stage IIIB Mycosis Fungoides and Sezary Syndrome, Stage IVA Mycosis Fungoides and Sezary Syndrome, Stage IVB Mycosis Fungoides and Sezary Syndrome
    View official trial listing →
  • Completed NCT NCT02551718

    High Throughput Drug Sensitivity Assay and Genomics- Guided Treatment of Patients With Relapsed or Refractory Acute Leukemia

    Not yet reported University of Washington 34 participants Est. completion 2021-05-13 1 site
    Other conditions: Recurrent Acute Leukemia of Ambiguous Lineage, Recurrent Acute Lymphoblastic Leukemia, Recurrent Acute Myeloid Leukemia, Refractory Acute Lymphoblastic Leukemia, Refractory Acute Myeloid Leukemia, Refractory Acute Leukemia of Ambiguous Lineage
    View official trial listing →
  • Completed NCT NCT02554955

    A Study of Daclizumab (Zenapax) in Combination With Mycophenolate Mofetil (CellCept) and Sirolimus in Prevention of Acute Rejection in Heart Transplant Participants

    Not yet reported Hoffmann-La Roche 36 participants Est. completion 2007-12 14 sites Stand-alone
    Other conditions: Heart Transplantation
    View official trial listing →
  • Completed NCT NCT02555787

    Global, Multicentre, Non Interventional Advagraf Conversion Registry in Kidney Transplant Patients

    Astellas Pharma Europe Ltd. 4430 participants Est. completion 2022-09-30 129 sites
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT02556931

    Shorter Course Tacro After NMA, Related Donor PBSCT With High-dose Posttransplant Cy for Hard-to-Engraft Malignancies

    Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 117 participants Est. completion 2021-04 1 site Stand-alone
    Other conditions: Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia, Small Lymphocytic Lymphoma, Chronic Lymphocytic Leukemia, Prolymphocytic Leukemia, Chronic Myeloid Leukemia, Chronic Myeloproliferative Disorders, Multiple Myeloma, Plasma Cell Neoplasm, Plasma Cell Dyscrasia, Myelofibrosis, Polycythemia Vera, Essential Thrombocythemia, Plasma Cell Leukemia
    View official trial listing →
  • Not yet recruiting NCT NCT02558452

    European Transplant Registry of Senior Renal Transplant Recipients on Advagraf

    Klemens Budde 1000 participants Est. completion 2028-01
    Other conditions: Graft Failure, Death, Acute Rejection of Renal Transplant, Infections, Bone Disease, Post Transplant Diabetes Mellitus, Quality of Life, HLA Antibody Production, Cardiovascular Risk Factors, Non-HLA Antibody Production
    View official trial listing →
  • Terminated NCT NCT02560012

    Personalized Targeted Inhibitors Treatment in Renal Cell Cancer

    Not yet reported The University of Texas Health Science Center, Houston 4 participants Est. completion 2017-07-27 1 site
    Other conditions: Carcinoma, Renal Cell
    View official trial listing →
  • Status unknown NCT NCT02560376

    68Ga-NOTA-exendin-4 PET/CT for the Localization of Insulinoma and Diagnosis of Nesidioblastosis

    Not yet reported Peking Union Medical College Hospital 100 participants Est. completion 2016-12 1 site
    Other conditions: Insulinoma, Nesidioblastosis
    View official trial listing →
  • Status unknown NCT NCT02561767

    Effect of BM-MSCs in DCD Kidney Transplantation

    Not yet reported, Not yet reported First Affiliated Hospital, Sun Yat-Sen University 120 participants Est. completion 2017-10 1 site Stand-alone
    Other conditions: Kidney Transplantation, Acute Kidney Tubular Necrosis
    View official trial listing →
  • Withdrawn NCT NCT02563782

    Study to Evaluate Sub-retinal Transplantation of Retinal Pigmented Epithelial Cells in Patients With Dry AMD

    Not yet reported Astellas Institute for Regenerative Medicine Est. completion 2017-05-05 1 site
    Other conditions: Age-Related Macular Degeneration
    View official trial listing →
  • Completed NCT NCT02566304

    Reduced Intensity Chemotherapy and Radiation Therapy Before Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies

    Not yet reported Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 35 participants Est. completion 2024-02-13 1 site Stand-alone
    Other conditions: Acute Myeloid Leukemia, Acute Myeloid Leukemia in Remission, Aplastic Anemia, Chronic Myelomonocytic Leukemia, Hodgkin Lymphoma, Indolent Non-Hodgkin Lymphoma, Malignant Neoplasm, Myelodysplastic Syndrome, Myeloproliferative Neoplasm, Plasma Cell Myeloma, Refractory Anemia, Refractory Anemia With Excess Blasts, Refractory Anemia With Ring Sideroblasts, Refractory Cytopenia With Multilineage Dysplasia, Refractory Cytopenia With Multilineage Dysplasia and Ring Sideroblasts
    View official trial listing →
  • Withdrawn NCT NCT02569125

    Open Label Study of Everolimus (RAD001) in Patients With Segmental Overgrowth Syndrome

    Not yet reported Jochen Roessler Est. completion 2016-02 4 sites
    Other conditions: Segmental Overgrowth Syndrome
    View official trial listing →
  • Completed NCT NCT02570750

    The Effect Of Smoking Status Of The Patient On The Success Of Etanercept Therapy In Psoriasis

    Pfizer 183 participants Est. completion 2016-12-05 30 sites
    Other conditions: Chronic Plaque Psoriasis
    View official trial listing →
  • Completed NCT NCT02576366

    Phenotypic Drug Probes as Predictors of Drug-drug Interactions With Tacrolimus

    Not yet reported Universitaire Ziekenhuizen KU Leuven 24 participants Est. completion 2017-12 1 site
    Other conditions: Drug Interactions, Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT02579031

    A Comparison of an Ultrathin Strut Biodegradable Polymer Sirolimus-Eluting Stent With a Durable Polymer Everolimus-Eluting Stent for Patients With Acute ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention

    Not yet reported Insel Gruppe AG, University Hospital Bern 1300 participants Est. completion 2020-05 10 sites
    Cardiovascular disease Other conditions: Acute Coronary Syndrome
    View official trial listing →
  • Enrolling by invitation NCT NCT02579044

    Phase I/II Trial of Everolimus in Combination With Lonafarnib in Progeria

    Not yet reported, Not yet reported Boston Children's Hospital 80 participants Est. completion 2027-03 1 site
    Other conditions: Progeria
    View official trial listing →
  • Completed NCT NCT02581436

    Testing Immunosuppression Threshold in Renal Allografts To Extend eGFR

    Not yet reported Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran 70 participants Est. completion 2018-02-01 1 site Stand-alone
    Other conditions: Disorder Related to Renal Transplantation, Renal Transplant Rejection, Acute Graft Rejection
    View official trial listing →
  • Completed NCT NCT02582775

    MT2015-20: Biochemical Correction of Severe EB by Allo HSCT and Serial Donor MSCs

    Not yet reported Masonic Cancer Center, University of Minnesota 17 participants Est. completion 2023-07-26 1 site Stand-alone
    Obstructive sleep apnea
    View official trial listing →
  • Completed NCT NCT02583893

    Biomarkers in Predicting Treatment Response to Sirolimus and Chemotherapy in Patients With High-Risk Acute Myeloid Leukemia

    Not yet reported Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 39 participants Est. completion 2023-05-17 1 site Stand-alone
    Other conditions: Recurrent Adult Acute Myeloid Leukemia, Secondary Acute Myeloid Leukemia, Untreated Adult Acute Myeloid Leukemia
    View official trial listing →
  • Status unknown NCT NCT02584075

    Evaluate the Effect of Exenatide Treatment on Coronary Artery Endothelial Function

    Not yet reported Beijing Chao Yang Hospital 100 participants Est. completion 2018-01 Stand-alone
    Other conditions: Coronary Endothelial Function
    View official trial listing →
  • Status unknown NCT NCT02584582

    The Effect of GLP-1 on Postprandial Glucagon Secretion Independent of The Gastric Emptying Rate

    Not yet reported, Not yet reported Hvidovre University Hospital 10 participants Stand-alone
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Terminated NCT NCT02584647

    PLX3397 Plus Sirolimus in Unresectable Sarcoma and Malignant Peripheral Nerve Sheath Tumors

    Not yet reported, Not yet reported Gulam Manji 39 participants Est. completion 2024-10-01 5 sites Stand-alone
    Other conditions: Sarcoma, Malignant Peripheral Nerve Sheath Tumors
    View official trial listing →
  • Completed NCT NCT02587052

    A 1-year Comparison of Generic Tacrolimus (Tacni) and Prograf in Renal Transplant Patients - a Retrospective Matched Pair Analysis, GenTac

    Vastra Gotaland Region 186 participants Est. completion 2016-12 1 site
    Other conditions: Renal Transplantation
    View official trial listing →
  • Completed NCT NCT02588339

    Panobinostat (LBH589): Acute Graft Versus Host Disease (aGVHD) Prevention

    Not yet reported H. Lee Moffitt Cancer Center and Research Institute 42 participants Est. completion 2021-07-13 1 site Stand-alone
    Other conditions: Graft Versus Host Disease, GVHD
    View official trial listing →
  • Completed NCT NCT02596828

    Prospective Pilot Trial to Assess a Multimodal Molecular Targeted Therapy in Children, Adolescent and Young Adults With Relapsed or Refractory High-grade Pineoblastoma

    Not yet reported University of Regensburg 4 participants Est. completion 2021-04 1 site
    Other conditions: Pineoblastoma
    View official trial listing →
  • Withdrawn NCT NCT02597283

    Coronary Bifurcation Lesions Treated With Biguard Stent System

    Not yet reported Nanjing First Hospital, Nanjing Medical University Est. completion 2015-12 Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT02599324

    Study to Evaluate Ibrutinib Combination Therapy in Patients With Selected Gastrointestinal and Genitourinary Tumors

    Not yet reported, Not yet reported Pharmacyclics LLC. 263 participants Est. completion 2021-08-20 65 sites
    Other conditions: Metastatic Renal Cell Carcinoma, Advanced Urothelial Carcinoma, Advanced Gastric Adenocarcinoma, Metastatic Colorectal Adenocarcinoma
    View official trial listing →
  • Completed NCT NCT02601703

    To Study Generic Tacrolimus Ointment, 0.1% in the Treatment of Moderate to Severe Atopic Dermatitis (Inflammation of Skin: Itchy, Red, Swollen, and Cracked Skin)

    Not yet reported Glenmark Pharmaceuticals Ltd. India 1110 participants Est. completion 2016-10 60 sites Stand-alone
    Other conditions: Atopic Dermatitis
    View official trial listing →
  • Status unknown NCT NCT02602873

    Study of Tacrolimus Used for Pediatric Patients With Nephrotic Syndrome Based on Pharmacogenomics and Metabonomics

    Guangzhou Women and Children's Medical Center 150 participants Est. completion 2020-08 1 site
    Other conditions: Nephrotic Syndrome
    View official trial listing →
  • Completed NCT NCT02602925

    Tight Control Dose Reductions of Biologics in Psoriasis Patients With Low Disease Activity

    Not yet reported Radboud University Medical Center 120 participants Est. completion 2018-07-20 6 sites Stand-alone
    Other conditions: Psoriasis
    View official trial listing →
  • Completed NCT NCT02608606

    Determining Equivalence Dose for Oral Versus Sublingual Administration of Tacrolimus in Hepatic Receptors

    Not yet reported Pontificia Universidad Catolica de Chile 20 participants Est. completion 2016-03 1 site
    Other conditions: Evidence of Liver Transplantation, Effects of Immunosuppressant Therapy
    View official trial listing →
  • Status unknown NCT NCT02616848

    Safety and Tolerability of Everolimus in Combination With Eribulin in Triple-negative Breast Cancers

    Not yet reported Istituti Ospitalieri di Cremona 1 participants 1 site
    Other conditions: Triple Negative Breast Cancer
    View official trial listing →
  • Withdrawn NCT NCT02619669

    Neoadjuvant Run-In Study With TAK-228 Followed by Letrozole/TAK-228 in Women With High-Risk ER+/HER2- Breast Cancer

    Not yet reported Gary Schwartz Est. completion 2019-06-14 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT02620189

    Th17 Responses Evaluated in RA Patients on Inhibitors of TNFα

    Queen Mary University of London 60 participants Est. completion 2017-05-24 8 sites
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT02621489

    Effects on Re-endothelialisation With Bydureon Treatment in Type 2 Diabetes Subjects

    Not yet reported Karolinska Institutet 38 participants Est. completion 2022-10 1 site
    Other conditions: Atherosclerosis, Diabetes, Restenosis
    View official trial listing →
  • Completed NCT NCT02623140

    BIOFREEDOM Stent Versus ORSIRO Stent: SORT OUT IX

    Not yet reported Odense University Hospital 3150 participants Est. completion 2023-10-01 1 site
    Other conditions: Ischaemic Heart Disease
    View official trial listing →
  • Terminated NCT NCT02627573

    Trial of GVHD Prophylasxis With PTCy or Thymoglobulin in Unrelated SCT

    Not yet reported St. Petersburg State Pavlov Medical University 32 participants Est. completion 2019-04-03 1 site Stand-alone
    Other conditions: Leukemia, Chronic Myeloid, Myelodysplastic Syndromes, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
    View official trial listing →
  • Completed NCT NCT02627690

    Nephrologic Prognosis 10 Years After Diabetes Cell Therapy

    University Hospital, Lille 45 participants Est. completion 2021-11-29 1 site
    Other conditions: Islet Transplantation
    View official trial listing →
  • Active, not recruiting NCT NCT02629120

    High Dose Peripheral Blood Stem Cell Transplantation With Post Transplant Cyclophosphamide for Patients With Chronic Granulomatous Disease

    Not yet reported, Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 45 participants Est. completion 2028-12-30 1 site
    Other conditions: Chronic Granulomatous Disease Transplant
    View official trial listing →
  • Completed NCT NCT02630628

    Efficacy and Safety of Tacrolimus Versus Mycophenolate in Lupus Nephritis

    Not yet reported The University of Hong Kong 130 participants Est. completion 2024-12-27 1 site Stand-alone
    Other conditions: Lupus Nephritis
    View official trial listing →
  • Completed NCT NCT02635386

    EQW, DAPA, EQW/DAPA, DAPA/MET ER and PHEN/TPM ER in Obese Women With PolycysticOvary Syndrome (PCOS)

    Not yet reported Woman's 119 participants Est. completion 2020-10-09 1 site Stand-alone
    Other conditions: Polycystic Ovary Syndrome, Obesity
    View official trial listing →
  • Completed NCT NCT02638259

    Comparative Efficacy and Safety Study of GP2015 and Enbrel® in Patients With Rheumatoid Arthritis

    Not yet reported Sandoz 376 participants Est. completion 2017-06-12 92 sites
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT02641990

    Study of the Effect of ITCA 650 on the PK/PD of Oral Contraceptive in Healthy Female Subjects

    Not yet reported Intarcia Therapeutics 28 participants Est. completion 2016-02 2 sites Stand-alone
    Other conditions: Healthy Adult Premenopausal Female Volunteers
    View official trial listing →
  • Completed NCT NCT02644395

    Thiazide Diuretics for Hypertension in Kidney Transplant Recipients Using Tacrolimus

    Not yet reported Erasmus Medical Center 49 participants Est. completion 2016-12-19 1 site
    Other conditions: Hypertension, Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT02646319

    Nanoparticle Albumin-Bound Rapamycin in Treating Patients With Advanced Cancer With mTOR Mutations

    Not yet reported Mayo Clinic 2 participants Est. completion 2018-04-24 2 sites
    Other conditions: Advanced Malignant Neoplasm, Cervical Squamous Cell Carcinoma, Endometrial Carcinoma, Malignant Uterine Neoplasm, Recurrent Bladder Carcinoma, Recurrent Breast Carcinoma, Recurrent Cervical Carcinoma, Recurrent Head and Neck Carcinoma, Recurrent Malignant Neoplasm, Recurrent Ovarian Carcinoma, Recurrent Prostate Carcinoma, Recurrent Renal Cell Carcinoma, Solid Neoplasm, Stage III Bladder Cancer, Stage III Prostate Cancer, Stage III Renal Cell Cancer, Stage IIIA Breast Cancer, Stage IIIA Cervical Cancer, Stage IIIA Ovarian Cancer, Stage IIIB Breast Cancer, Stage IIIB Cervical Cancer, Stage IIIB Ovarian Cancer, Stage IIIC Breast Cancer, Stage IIIC Ovarian Cancer, Stage IV Breast Cancer, Stage IV Ovarian Cancer, Stage IV Prostate Cancer, Stage IV Renal Cell Cancer, Stage IVA Bladder Cancer, Stage IVA Cervical Cancer, Stage IVB Bladder Cancer, Stage IVB Cervical Cancer
    View official trial listing →
  • Completed NCT NCT02652468

    TCR-α/β and CD19 Depleted Stem Cell Grafts From Haplo Donors for HSCT in Relapsed Lymphoma

    Not yet reported University of Wisconsin, Madison 11 participants Est. completion 2021-09-17 1 site Stand-alone
    Other conditions: Lymphoma
    View official trial listing →
  • Terminated NCT NCT02653196

    A Multi-Institutional Pilot Study of Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Malignant Neuro-Epithelial and Other Solid Tumors

    Not yet reported Montefiore Medical Center 1 participants Est. completion 2017-08 1 site Stand-alone
    Other conditions: Neuroepithelial Tumor, Solid Tumor, Allogeneic Hematopoietic Stem Cell Transplantation
    View official trial listing →
  • Completed NCT NCT02656082

    Targeted Therapy Using Intradermal Injection of Etanercept for Remission Induction in Discoid Lupus Erythematosus

    Not yet reported University of Leeds 25 participants Est. completion 2017-12-31 1 site Stand-alone
    Other conditions: Lupus Erythematosus, Discoid, Lupus Erythematosus, Cutaneous, Lupus Erythematosus, Chronic Cutaneous
    View official trial listing →
  • Completed NCT NCT02660684

    Study to Assess the Safety and Efficacy of Tacrolimus (Prograf Capsule/Injection) and Methotrexate (MTX) Combination Therapy for Prevention of Graft Versus Host Disease (GVHD) in Patients Who Received Peripheral Hematopoietic Stem Cell Transplantation From a Sibling Donor

    Not yet reported Astellas Pharma Korea, Inc. 39 participants Est. completion 2010-02 3 sites Stand-alone
    Other conditions: Graft Versus Host Disease
    View official trial listing →
  • Completed NCT NCT02661035

    Allo HSCT Using RIC for Hematological Diseases

    Not yet reported Masonic Cancer Center, University of Minnesota 156 participants Est. completion 2023-05-29 1 site Stand-alone
    Other conditions: Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, Chronic Myelogenous Leukemia, Plasma Cell Leukemia, Myelodysplastic Syndromes, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, B-Cell Lymphoma, Follicular Lymphoma, Lymphoplasmacytic Lymphoma, Mantle-Cell Lymphoma, Prolymphocytic Leukemia, Lymphoblastic Lymphoma, Burkitt's Lymphoma, Non-Hodgkin's Lymphoma, Multiple Myeloma, Myeloproliferative Syndromes, Hematological Diseases
    View official trial listing →
  • Status unknown NCT NCT02663323

    Pilot Clinical Study of MeRes100 Sirolimus Eluting Bioresorbable Vascular Scaffold System

    Not yet reported Meril Life Sciences Pvt. Ltd. 64 participants Est. completion 2020-07-05 4 sites Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT02663622

    Phase II Trial of Efprezimod Alfa (CD24Fc, MK-7110) for the Prevention of Acute Graft-Versus-Host Disease (GVHD) Following Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation (HSCT) (MK-7110-002)

    Not yet reported Oncoimmune, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 44 participants Est. completion 2021-05-18 4 sites Stand-alone
    Other conditions: Graft Versus Host Disease, Hematopoietic Stem Cell Transplantation, Leukemia
    View official trial listing →
  • Completed NCT NCT02664441

    Energy Balance & Weight Loss in Craniopharyngioma-related or Other Hypothalamic Tumors in Hypothalamic Obesity

    Not yet reported Seattle Children's Hospital 42 participants Est. completion 2020-07-31 3 sites
    Other conditions: Hypothalamic Obesity
    View official trial listing →
  • Status unknown NCT NCT02671318

    Conversion to Sirolimus: Effects in Cytomegalovirus Infection Recurrence

    Not yet reported Hospital do Rim e Hipertensão 250 participants Est. completion 2020-08 1 site
    Other conditions: Cytomegalovirus Infections
    View official trial listing →
  • Status unknown NCT NCT02675153

    To Evaluate the Efficacy and Safety of Rapamycin for Crohn's Disease-related Stricture

    Not yet reported The Second Hospital of Nanjing Medical University 15 participants Est. completion 2020-10 1 site Stand-alone
    Other conditions: Crohn's Diseases
    View official trial listing →
  • Terminated NCT NCT02678143

    Nonmyeloablative Conditioning for Mismatched Hematopoietic Stem Cell Transplantation for Severe Sickle Cell Disease

    Not yet reported Washington University School of Medicine 1 participants Est. completion 2021-11-16 1 site Stand-alone
    Other conditions: Sickle Cell Disease
    View official trial listing →
  • Withdrawn NCT NCT02680717

    Comparative Effectiveness Trial in the Treatment of Pediatric Plaque Morphea

    Not yet reported Medical College of Wisconsin Est. completion 2017-05
    Other conditions: Scleroderma
    View official trial listing →
  • Completed NCT NCT02681016

    Sirolimus-eluting Stent CALYPSO vs Everolimus-eluting Stent XIENCE

    Not yet reported Meshalkin Research Institute of Pathology of Circulation 610 participants Est. completion 2017-07 1 site Stand-alone
    Cardiovascular disease Other conditions: Ischemic Heart Disease, Coronary Atherosclerosis, Coronary Artery Stenosis
    View official trial listing →
  • Completed NCT NCT02683291

    Sirolimus Associated With Tacrolimus at Low Doses in Elderly Kidney Transplant Patients

    Not yet reported Associação Médico Espírita de Botucatu 48 participants Est. completion 2016-01 Stand-alone
    Other conditions: Disorder Related to Renal Transplantation, Cytomegalovirus Infections
    View official trial listing →
  • Completed NCT NCT02685852

    Evaluating Exenatide for the Treatment of Postprandial Hyperinsulinemic Hypoglycemia

    Not yet reported University of Minnesota 11 participants Est. completion 2019-07-22 1 site Stand-alone
    Other conditions: Hyperinsulinemic Hypoglycemia
    View official trial listing →
  • Status unknown NCT NCT02687958

    Study of Everolimus as Maintenance Therapy for Metastatic NEC With Pulmonary or Gastroenteropancreatic Origin

    Not yet reported Gruppo Oncologico Italiano di Ricerca Clinica 30 participants Est. completion 2023-12 5 sites
    Other conditions: Neuroendocrine Carcinoma
    View official trial listing →
  • Completed NCT NCT02688829

    The First-In-Man Pilot Study of Firehawk

    Not yet reported Shanghai MicroPort Medical (Group) Co., Ltd. 21 participants Est. completion 2015-01
    Other conditions: Coronary Heart Disease
    View official trial listing →
  • Completed NCT NCT02688881

    Study to Evaluate the Safety and Efficacy of Sirolimus, in Subject With Refractory Solid Tumors

    Not yet reported Samsung Medical Center 6 participants Est. completion 2021-02-24 1 site Stand-alone
    Other conditions: Refractory Solid Tumors
    View official trial listing →
  • Completed NCT NCT02689479

    11C-5-HTP PET in Clinical Islet Transplantation

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 8 participants Est. completion 2014-09 2 sites
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT02690883

    Effect of Exenatide on 24h-UAER in Patients With Diabetic Nephropathy

    Not yet reported Nanfang Hospital, Southern Medical University 92 participants Est. completion 2019-12-30 Stand-alone
    Other conditions: Diabetic Nephropathies
    View official trial listing →
  • Status unknown NCT NCT02690987

    Gut Hormones in Obesity, Nicotine and Alcohol Dependence

    Not yet reported Imperial College London 95 participants Est. completion 2020-08 1 site Stand-alone
    Other conditions: Obesity, Smoking Cessation, Alcoholism
    View official trial listing →
  • Completed NCT NCT02693158

    The Direct III Post Market Study

    Svelte Medical Systems, Inc. 440 participants Est. completion 2020-01 8 sites
    Cardiovascular disease
    View official trial listing →
  • Withdrawn NCT NCT02694770

    A Study Evaluating the Efficacy and Safety of Neihulizumab vs "Conventional Treatment" to Treat Sr-aGvHD

    Not yet reported AbGenomics B.V Taiwan Branch Est. completion 2018-02 2 sites
    Other conditions: Steroid-refractory aGvHD Subsequent to Allogeneic Hematopoietic Cell Transplantation
    View official trial listing →
  • Status unknown NCT NCT02695459

    Cisplatinum and Everolimus in Patients With Metastatic or Unresectable NEC of Extrapulmonary Origin

    Not yet reported The Netherlands Cancer Institute 39 participants Est. completion 2021-08 3 sites
    Other conditions: Neuroendocrine Carcinomas
    View official trial listing →
  • Status unknown NCT NCT02698852

    A Study to Evaluate the Efficacy and Safety of BuMA Supreme Drug Eluting Stent(DES)

    Not yet reported Sino Medical Sciences Technology Inc. 1000 participants Est. completion 2025-12 1 site
    Cardiovascular disease
    View official trial listing →
  • Withdrawn NCT NCT02702960

    Sequential, Related Donor Partial Liver Transplantation Followed by Bone Marrow Transplantation for Hepatocellular Carcinoma (HCC)

    Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Est. completion 2018-01-03 1 site Stand-alone
    Other conditions: Fibrolamellar Hepatocellular Carcinoma, Hepatocellular Carcinoma (Fibrolamellar Variant), Hepatocellular Carcinoma
    View official trial listing →
  • Completed NCT NCT02706678

    Efficacy and Safety Study of the Switch From Cyclosporin to Tacrolimus in Renal Transplant Recipients

    Not yet reported Astellas Pharma China, Inc. 105 participants Est. completion 2012-08-01 9 sites Stand-alone
    Other conditions: Renal Transplant Recipients
    View official trial listing →
  • Status unknown NCT NCT02707822

    The Influence of ABCB1、CYP3A4、CYP3A5、POR Genetic Polymorphism and Other Factors on Tacrolimus Blood Concentration

    National Taiwan University Hospital 440 participants Est. completion 2018-12 1 site
    Other conditions: Kidney Transplantation, Liver Transplantation
    View official trial listing →
  • Completed NCT NCT02711202

    Sequential Targeting of Cluster of Differentiation 52 (CD52) and Tumor Necrosis Factor (TNF) Allows Early Minimization Therapy in Kidney Transplantation

    Not yet reported Institute for Clinical and Experimental Medicine 20 participants Est. completion 2009-03
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT02711826

    Treg Therapy in Subclinical Inflammation in Kidney Transplantation

    Not yet reported, Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 32 participants Est. completion 2023-08-04 6 sites Stand-alone
    Other conditions: Kidney Transplant, Adult Living Donor Kidney Transplant Recipients, Renal Transplant, Living Kidney Donor
    View official trial listing →
  • Status unknown NCT NCT02722772

    Efficacy of Intra-Articular Injection of Etanercept for Moderate and Severe Knee Osteoarthritis

    Not yet reported First Affiliated Hospital of Harbin Medical University 60 participants Est. completion 2017-08 1 site Stand-alone
    Osteoarthritis
    View official trial listing →
  • Completed NCT NCT02723591

    To Compare the Effects of Immediate-release Tacrolimus and Astagraf XL on Donor-Specific Antibody (DSA) Formation and the Development of Immune Activation (IA) in de Novo Kidney Transplant Recipients

    Not yet reported Astellas Pharma Global Development, Inc. 599 participants Est. completion 2019-06-14 30 sites
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Terminated NCT NCT02723786

    Efficacy, Safety, Tolerability and Pharmacokinetic (PK) Study of GSK1070806 for the Prevention of Delayed Graft Function (DGF) in Adult Subjects After Renal Transplantation

    Not yet reported GlaxoSmithKline 7 participants Est. completion 2018-03-06 4 sites Stand-alone
    Other conditions: Kidney Transplantation (Status Post)
    View official trial listing →
  • Completed NCT NCT02723877

    PQR309 and Eribulin in Metastatic HER2 Negative and Triple-negative Breast Cancer (PIQHASSO)

    Not yet reported, Not yet reported PIQUR Therapeutics AG 41 participants Est. completion 2018-10-03 5 sites
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Withdrawn NCT NCT02723981

    COMBO-Stent in Patients on Chronic Anticoagulant Therapy (COSTA) COSTA-Bleed and COSTA-Outcome Trials

    Not yet reported IHF GmbH - Institut für Herzinfarktforschung Est. completion 2018-12 10 sites Stand-alone
    Other conditions: Stable Angina, Unstable Angina, STEMI, NSTEMI, Coronary Disease
    View official trial listing →
  • Completed NCT NCT02727608

    Complement Inhibitor Eculizumab in Clinical Islet Transplantation

    Not yet reported Uppsala University 3 participants Est. completion 2018-06 1 site
    Other conditions: Diabetes Mellitus
    View official trial listing →
  • Terminated NCT NCT02730715

    Effect of Thymoglobulin Versus Basiliximab on Regulatory T Cell Function in Live Donor Kidney Transplant Recipients

    University of Pennsylvania 30 participants Est. completion 2020-04 1 site
    Other conditions: KIDNEY TRANSPLANTATION
    View official trial listing →
  • Status unknown NCT NCT02730923

    Hormone Receptor Positive endometrIal Carcinoma Treated by Dual mTORC1/mTORC2 Inhibitor and Anastrozole (VICTORIA)

    Not yet reported, Not yet reported Centre Leon Berard 72 participants Est. completion 2024-12 12 sites
    Other conditions: Endometrial Carcinoma, Metastatic Carcinoma, Hormone Receptor Positive Tumor
    View official trial listing →
  • Completed NCT NCT02732119

    Study of Ribociclib With Everolimus + Exemestane in HR+ HER2- Locally Advanced/Metastatic Breast Cancer Post Progression on CDK 4/6 Inhibitor.

    Not yet reported, Not yet reported Novartis Pharmaceuticals 104 participants Est. completion 2020-02-25 25 sites
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT02735031

    Exenatide and Impaired Hypoglycaemic Awareness in Type 1 Diabetes

    Not yet reported, Not yet reported Radboud University Medical Center 10 participants Est. completion 2018-04-09 1 site
    Other conditions: Diabetes Mellitus, Type 1, Hypoglycemia
    View official trial listing →
  • Completed NCT NCT02736227

    Biomarkers Predicting Successful Tacrolimus Withdrawal and Everolimus (Zortress) Monotherapy Early After Liver Transplantation

    Not yet reported Northwestern University 28 participants Est. completion 2021-03 1 site Stand-alone
    Other conditions: Liver Transplantation
    View official trial listing →
  • Withdrawn NCT NCT02741102

    Uterine Transplant in Absolute Uterine Infertility (AUIF)

    Not yet reported, Not yet reported Brigham and Women's Hospital Est. completion 2028-06 1 site Stand-alone
    Other conditions: Female Infertility
    View official trial listing →
  • Completed NCT NCT02741323

    Impact of CCR5 Blockade in HIV+ Kidney Transplant Recipients

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 97 participants Est. completion 2022-05-10 10 sites Stand-alone
    Other conditions: HIV Infections, Kidney Diseases
    View official trial listing →
  • Completed NCT NCT02742051

    A Trial of Neoadjuvant Everolimus Plus Letrozole Versus FEC in Women With ER-positive, HER2-negative Breast Cancer

    Not yet reported Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 40 participants Est. completion 2020-03-14 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT02743247

    Identification of Drug-drug Interaction Between Tacrolimus and Mycophenolate Mofetil in Healthy Adults

    Not yet reported Seoul National University Hospital 18 participants Est. completion 2016-04 1 site Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT02744378

    Comparison of Tacrolimus 0.1% and Clobetasol 0.05% in the Management of Symptomatic Oral Lichen Planus

    Not yet reported University of Peradeniya 68 participants Est. completion 2015-12
    Other conditions: Oral Lichen Planus
    View official trial listing →
  • Completed NCT NCT02749370

    Study to Evaluate the Efficacy of Etanercept Treatment in Adults Who Failed Therapy With Apremilast

    Not yet reported Amgen 80 participants Est. completion 2017-12-06 22 sites Stand-alone
    Other conditions: Plaque Psoriasis
    View official trial listing →
  • Status unknown NCT NCT02752529

    The Establishment of Multiple Point Prediction Model About Tacrolimus Metabolic Differences Based on Genetic Network After Liver Transplantation and the Application of Multicenter

    Not yet reported Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 415 participants 1 site Stand-alone
    Other conditions: Cirrhosis, Liver
    View official trial listing →
  • Completed NCT NCT02753309

    A Study of Rapamycin Combined With Intravesical BCG in Patients With Non-muscle Invasive Bladder Cancer

    Not yet reported The University of Texas Health Science Center at San Antonio 33 participants Est. completion 2021-03-02 1 site
    Other conditions: Bladder Cancer
    View official trial listing →
  • Status unknown NCT NCT02759822

    Haploidentical Hematopoietic Stem Cell Transplantation for Acute Leukemias

    Leonardo Javier Arcuri 30 participants 1 site
    Other conditions: Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma
    View official trial listing →
  • Completed NCT NCT02766439

    Rhupus Syndrome and Efficacy of Etanercept Treatment

    Yang Beibei 6 participants Est. completion 2015-03
    Other conditions: Rhupus Syndrome, Etanercept
    View official trial listing →
  • Completed NCT NCT02766465

    Bone Marrow Transplantation vs Standard of Care in Patients With Severe Sickle Cell Disease (BMT CTN 1503)

    Not yet reported Medical College of Wisconsin 138 participants Est. completion 2023-08-02 35 sites Stand-alone
    Other conditions: Sickle Cell Disease
    View official trial listing →
  • Status unknown NCT NCT02768116

    The Study of Active Transfer of Plaque Technique for Non-Left Main Coronary Bifurcation Lesions

    Not yet reported Beijing Anzhen Hospital 316 participants Est. completion 2021-12 Stand-alone
    Other conditions: Coronary Heart Disease
    View official trial listing →
  • Status unknown NCT NCT02776202

    HLA-Identical Sibling Donor Bone Marrow Transplantation for Individuals With Severe Sickle Cell Disease Using a Reduced Intensity Conditioning Regimen

    Not yet reported National Guard Health Affairs 15 participants Est. completion 2019-12 1 site Stand-alone
    Other conditions: Sickle Cell Disease
    View official trial listing →
  • Completed NCT NCT02776644

    Clinical Outcome Of Advanced Renal Cell Carcinoma In Taiwan

    Pfizer 1349 participants Est. completion 2017-12-30
    Other conditions: Renal Cell Carcinoma
    View official trial listing →
  • Status unknown NCT NCT02779114

    RETRO (REduction of Therapy in RA Patients in Ongoing Remission)

    Not yet reported University of Erlangen-Nürnberg Medical School 318 participants Est. completion 2018-06 12 sites
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Active, not recruiting NCT NCT02782546

    Cytokine Induced Memory-like NK Cell Adoptive Therapy After Haploidentical Donor Hematopoietic Cell Transplantation

    Not yet reported Washington University School of Medicine 60 participants Est. completion 2028-02-13 1 site Stand-alone
    Other conditions: Acute Myeloid Leukemia
    View official trial listing →
  • Completed NCT NCT02787551

    Efficacy and Safety of the Insulin Glargine/Lixisenatide Fixed Ratio Combination (FRC) Versus GLP-1 Receptor Agonist in Patients With Type 2 Diabetes, With a FRC Extension Period

    Not yet reported Sanofi 514 participants Est. completion 2018-11-17 124 sites Added to GLP-1
    Type 2 diabetes
    View official trial listing →
  • Active, not recruiting NCT NCT02790515

    Provision of TCRγδ T Cells and Memory T Cells Plus Selected Use of Blinatumomab in Naïve T-cell Depleted Haploidentical Donor Hematopoietic Cell Transplantation for Hematologic Malignancies Relapsed or Refractory Despite Prior Transplantation

    Not yet reported St. Jude Children's Research Hospital 170 participants Est. completion 2026-07-01 1 site Stand-alone
    Other conditions: Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML), Myeloid Sarcoma, Chronic Myeloid Leukemia (CML), Juvenile Myelomonocytic Leukemia (JMML), Myelodysplastic Syndrome (MDS), Non-Hodgkin Lymphoma (NHL)
    View official trial listing →
  • Completed NCT NCT02794402

    Double-blinded, 6 Months Study With Bydureon® or Placebo in Adolescents With Obesity to Explore Changes in BMI

    Not yet reported Uppsala University 44 participants Est. completion 2016-11 2 sites
    Other conditions: Obesity
    View official trial listing →
  • Status unknown NCT NCT02794610

    Ocular Penetration of Topical Tacrolimus Eye Drops

    Not yet reported The Eye Center and The Eye Foundation for Research in Ophthalmology 10 participants Est. completion 2016-07 1 site Stand-alone
    Other conditions: Ocular Penetration of Topical Tacrolimus
    View official trial listing →
  • Status unknown NCT NCT02799888

    Maraviroc-Based GVHD Prophylaxis in HLA-Unrelated and HLA-Mismatched Related Transplantation

    Not yet reported Affiliated Hospital to Academy of Military Medical Sciences 40 participants Est. completion 2017-04 1 site Stand-alone
    Other conditions: Graft-versus-host Disease, Hematopoietic Stem Cell Transplantation
    View official trial listing →
  • Status unknown NCT NCT02803905

    Islet Transplant Alone in OMENtum

    Not yet reported Lorenzo Piemonti 12 participants Est. completion 2024-12 1 site
    Other conditions: Islets of Langerhans Transplantation, Diabetes Mellitus, Type 1
    View official trial listing →
  • Status unknown NCT NCT02805842

    Incidence of Non Adherence to Treatment With Once-daily Formulation of Tacrolimus

    Not yet reported Rabin Medical Center 60 participants Est. completion 2018-08 1 site
    Other conditions: Medication Adherence
    View official trial listing →
  • Status unknown NCT NCT02808065

    Validation of Population Pharmacokinetic Model Derived From Healthy Volunteer in Kidney Transplant Recipients

    Seoul National University Hospital 40 participants Est. completion 2016-10 1 site
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Active, not recruiting NCT NCT02811861

    Lenvatinib/Everolimus or Lenvatinib/Pembrolizumab Versus Sunitinib Alone as Treatment of Advanced Renal Cell Carcinoma

    Not yet reported Eisai Inc. 1069 participants Est. completion 2027-03-31 183 sites
    Other conditions: Renal Cell Carcinoma
    View official trial listing →
  • Completed NCT NCT02812940

    Single-centre Study of Everolimus as GvHD Prophylaxis After Post-Transplantation Cyclophosphamide After Allogeneic SCT

    Not yet reported University of Cologne 19 participants Est. completion 2020-12 1 site
    Other conditions: Graft-versus-Host Disease
    View official trial listing →
  • Completed NCT NCT02820259

    Therapeutic Drug Monitoring of Tacrolimus Biliary Concentrations for Liver-transplanted Patients (STABILE)

    Rennes University Hospital 42 participants Est. completion 2017-04-07 1 site
    Other conditions: Biliary Concentration of Tacrolimus
    View official trial listing →
  • Completed NCT NCT02821026

    Omental Islet Transplant

    Not yet reported, Not yet reported University of Alberta 4 participants Est. completion 2019-11-13 1 site Stand-alone
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT02821507

    Sirolimus and Cyclophosphamide in Metastatic or Unresectable Myxoid Liposarcoma and Chondrosarcoma

    Not yet reported Leiden University Medical Center 70 participants Est. completion 2021-12 7 sites Stand-alone
    Obstructive sleep apnea
    View official trial listing →
  • Terminated NCT NCT02829424

    Multicenter Randomized Double Blind Controlled-study to Assess the Potential of Methotrexate Versus Placebo to Improve and Maintain Response to Anti TNF- Alpha Agents in Adult Patients With Moderate to Severe Psoriasis

    Not yet reported Assistance Publique Hopitaux De Marseille 78 participants Est. completion 2024-02-10 1 site
    Other conditions: Psoriasis
    View official trial listing →
  • Withdrawn NCT NCT02833506

    Sirolimus and Vaccine Therapy in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

    Not yet reported Roswell Park Cancer Institute Est. completion 2019-08-15 1 site Stand-alone
    Other conditions: Recurrent Fallopian Tube Carcinoma, Recurrent Ovarian Carcinoma, Recurrent Primary Peritoneal Carcinoma, Stage IIA Fallopian Tube Cancer, Stage IIA Ovarian Cancer, Stage IIB Fallopian Tube Cancer, Stage IIB Ovarian Cancer, Stage IIC Fallopian Tube Cancer, Stage IIC Ovarian Cancer, Stage IIIA Fallopian Tube Cancer, Stage IIIA Ovarian Cancer, Stage IIIA Primary Peritoneal Cancer, Stage IIIB Fallopian Tube Cancer, Stage IIIB Ovarian Cancer, Stage IIIB Primary Peritoneal Cancer, Stage IIIC Fallopian Tube Cancer, Stage IIIC Ovarian Cancer, Stage IIIC Primary Peritoneal Cancer, Stage IV Fallopian Tube Cancer, Stage IV Ovarian Cancer, Stage IV Primary Peritoneal Cancer
    View official trial listing →
  • Completed NCT NCT02833805

    NMA Haplo or MUD BMT for Newly Diagnosed Severe Aplastic Anemia

    Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 21 participants Est. completion 2021-07 1 site Stand-alone
    Other conditions: Severe Aplastic Anemia, Aplastic Anemia, Bone Marrow Failure, Immunosuppression
    View official trial listing →
  • Status unknown NCT NCT02836847

    Molecularly Target Therapy With GEMOX in Advanced or Recurrent Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma

    Not yet reported Shanghai Jiao Tong University School of Medicine 152 participants Est. completion 2020-12 1 site
    Other conditions: Cholangiocarcinoma of the Extrahepatic Bile Duct, Gallbladder Cancer
    View official trial listing →
  • Status unknown NCT NCT02837003

    3-Month Discontinuation of Dual Antiplatelet Therapy After Ultimaster Sirolimus-Eluting Stent Implantation

    Teikyo University 1500 participants Est. completion 2019-03 1 site
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT02837978

    The Efficacy and Safety of Tacrolimus in Refractory Rheumatoid Arthritis Patients for 6 Months and Long-term Treatment

    Not yet reported Qiang Shu 150 participants Est. completion 2022-12-30 1 site Stand-alone
    Other conditions: Arthritis, Rheumatoid
    View official trial listing →
  • Status unknown NCT NCT02839941

    Iguratimod in Kidney Transplant Recipients

    Not yet reported The First Affiliated Hospital with Nanjing Medical University 60 participants Est. completion 2019-07 1 site Stand-alone
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT02842749

    Phase IV Study of the Safety and Efficacy of Everolimus in Adult Patients With Progressive pNET in China

    Not yet reported Novartis Pharmaceuticals 61 participants Est. completion 2024-02-22 5 sites
    Other conditions: Pancreatic Neuroendocrine Tumors
    View official trial listing →
  • Completed NCT NCT02843399

    Economic Outcomes of EQW (Exenatide Once Weekly) vs. IG (Insulin Glargine) in T2D Patients Who Are New to Injectable Therapy

    AstraZeneca 15498 participants Est. completion 2016-12-15 1 site
    Type 2 diabetes
    View official trial listing →
  • Status unknown NCT NCT02843841

    Polyclonal Antilymphocyte Globulin (ATG) & Intestinal Immune Barrier After Kidney Transplantation

    Not yet reported Centre Hospitalier Universitaire de Besancon 63 participants Est. completion 2017-03-01 1 site
    Other conditions: Disorder Related to Renal Transplantation
    View official trial listing →
  • Status unknown NCT NCT02844270

    Galaxy Rapamycin Drug-Eluting Bioresorbable Coronary Stent System First-in-man Study

    Not yet reported Shanghai Bio-heart Biological Technology Co., Ltd. 45 participants Est. completion 2021-12
    Other conditions: Heart Diseases
    View official trial listing →
  • Status unknown NCT NCT02847403

    Long-acting Exenatide and Cognitive Decline in Dysglycemic Patients

    Not yet reported Azienda Ospedaliero-Universitaria di Parma 40 participants Est. completion 2021-10-31 2 sites Stand-alone
    Other conditions: Dysglycemia, Cognitive Deficit
    View official trial listing →
  • Status unknown NCT NCT02853994

    Safety and Efficacy of the DEVOIR Sirolimus-Coated Coronary Balloon in the Real-world Clinical Practice

    MINVASYS 500 participants Est. completion 2018-09
    Other conditions: CAD
    View official trial listing →
  • Status unknown NCT NCT02854696

    Health Economic Analysis of Islet Cell Transplantation for the Stabilization of the Severe Forms of Type 1 Diabetes

    Not yet reported University Hospital, Grenoble 42 participants Est. completion 2023-12 11 sites
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT02860923

    Efficacy and Safety of Exenatide in the Treatment of Hypothalamic Obesity After Craniopharyngioma Therapy

    Not yet reported University Hospital, Bordeaux 42 participants Est. completion 2018-09-30 11 sites Stand-alone
    Other conditions: Craniopharyngiomas, Hypothalamic Obesity
    View official trial listing →
  • Active, not recruiting NCT NCT02861417

    Busulfan, Fludarabine Phosphate, and Post-Transplant Cyclophosphamide in Treating Patients With Blood Cancer Undergoing Donor Stem Cell Transplant

    Not yet reported M.D. Anderson Cancer Center 204 participants Est. completion 2028-08-31 1 site Stand-alone
    Other conditions: Hematopoietic and Lymphoid Cell Neoplasm, High Risk Acute Myeloid Leukemia, High Risk Myelodysplastic Syndrome, Lymphoproliferative Disorder, Myelodysplastic Syndrome, Myelodysplastic/Myeloproliferative Neoplasm, Recurrent Acute Lymphoblastic Leukemia, Recurrent Acute Myeloid Leukemia, Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Recurrent High Risk Myelodysplastic Syndrome, Recurrent Hodgkin Lymphoma, Recurrent Myelodysplastic Syndrome, Recurrent Non-Hodgkin Lymphoma, Recurrent Plasma Cell Myeloma
    View official trial listing →
  • Completed NCT NCT02864706

    SCHEDULE Follow Up Visit 5-7 yr

    Not yet reported Novartis Pharmaceuticals 95 participants Est. completion 2017-09-25 6 sites
    Other conditions: Heart Transplantation
    View official trial listing →
  • Completed NCT NCT02866682

    Prospective Study Comparing Brand and Generic Immunosuppression on Transplant Outcomes, Adherence, & Immune Response in Kidney Transplant Recipients

    Not yet reported University of California, Los Angeles 176 participants Est. completion 2021-06-11 1 site
    Other conditions: Renal Transplant Rejection
    View official trial listing →
  • Completed NCT NCT02867800

    Abatacept for GVHD Prophylaxis After Hematopoietic Stem Cell Transplantation for Pediatric Sickle Cell Disease

    Not yet reported Monica Bhatia 24 participants Est. completion 2023-12-30 7 sites Stand-alone
    Other conditions: Sickle Cell Disease, Graft Versus Host Disease
    View official trial listing →
  • Completed NCT NCT02869087

    The DESappear Study: Drug Eluting Scaffold

    Not yet reported Elixir Medical Corporation 21 participants Est. completion 2021-04-30 11 sites Stand-alone
    Other conditions: Peripheral Vascular Disease
    View official trial listing →
  • Completed NCT NCT02870140

    Thin Strut Sirolimus-eluting Stent in All Comers Population vs Everolimus-eluting Stent

    Not yet reported ECRI bv 1435 participants Est. completion 2020-08-26 23 sites Stand-alone
    Other conditions: Coronary Stenosis
    View official trial listing →
  • Completed NCT NCT02870985

    BIOTRONIK Orsiro Pre-Marketing Registration

    Not yet reported Biotronik (Beijing) Medical Device Ltd. 440 participants Est. completion 2021-12 1 site Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT02874924

    Effect of mTOR Inhibition and Other Metabolism Modulating Interventions on the Elderly

    Not yet reported The University of Texas Health Science Center at San Antonio 34 participants Est. completion 2018-09 1 site
    Other conditions: Aging
    View official trial listing →
  • Terminated NCT NCT02877082

    Tacrolimus, Bortezomib, & Thymoglobulin in Preventing Low Toxicity GVHD in Donor Blood Stem Cell Transplant Patients

    Not yet reported Emory University 5 participants Est. completion 2017-07 1 site Stand-alone
    Other conditions: Acute Leukemia, Chronic Lymphocytic Leukemia, Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Graft Versus Host Disease, Mantle Cell Lymphoma, Marginal Zone Lymphoma, Myelodysplastic Syndrome, Myelofibrosis, Myeloproliferative Neoplasm, Small Lymphocytic Lymphoma
    View official trial listing →
  • Completed NCT NCT02877628

    Immunosuppressive Therapy Optimization: Development of a Population Pharmacokinetic-pharmacodynamic (PK-PD) Model in Liver Transplantation

    Rennes University Hospital 110 participants Est. completion 2018-12 1 site
    Other conditions: Liver Transplantation
    View official trial listing →
  • Completed NCT NCT02880293

    Haploidentical (Half-matched) Related Donor Stem Cell Transplantation Using Killer Immunoglobulin-like Receptors in Addition to Normal Selection Factors to Determine the Best Donor

    Not yet reported Memorial Sloan Kettering Cancer Center 44 participants Est. completion 2023-11-20 1 site Stand-alone
    Other conditions: Hematologic Malignancy
    View official trial listing →
  • Status unknown NCT NCT02882113

    Influence of CYP3A5 Polymorphism on Liver Function Abnormality and the Trough Level Change After Conversion

    Not yet reported Seoul National University Hospital 60 participants Est. completion 2018-12 1 site Stand-alone
    Other conditions: Liver Dysfunction
    View official trial listing →
  • Completed NCT NCT02882828

    PK Assessment of Tacrolimus Exposure Before and After a Switch From Twice Daily Immediate-release (Prograf®) to Once-daily Prolonged Release Tacrolimus (Envarsus®)

    Not yet reported University Hospital, Limoges 134 participants Est. completion 2020-03 9 sites Stand-alone
    Other conditions: Allograft
    View official trial listing →
  • Completed NCT NCT02885610

    Study of RC18 Administered Subcutaneously to Subjects With Systemic Lupus Erythematosus(SLE)

    Not yet reported RemeGen Co., Ltd. 249 participants Est. completion 2019-07-09 1 site Stand-alone
    Other conditions: Systemic Lupus Erythematosus
    View official trial listing →
  • Completed NCT NCT02890069

    A Study of PDR001 in Combination With LCL161, Everolimus or Panobinostat

    Not yet reported Novartis Pharmaceuticals 298 participants Est. completion 2022-02-22 25 sites
    Other conditions: Colorectal Cancer, Non-small Cell Lung Carcinoma (Adenocarcinoma), Triple Negative Breast Cancer, Renal Cell Carcinoma
    View official trial listing →
  • Completed NCT NCT02890160

    A Trial of Firesorb in Patients With Coronary Artery Disease: FUTURE-II

    Not yet reported Shanghai MicroPort Medical (Group) Co., Ltd. 430 participants Est. completion 2024-10-03 1 site Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT02891603

    A Phase I/II GVHD Prevention Trial Combining Pacritinib With Sirolimus-Based Immune Suppression

    Not yet reported, Not yet reported H. Lee Moffitt Cancer Center and Research Institute 40 participants Est. completion 2022-04-18 2 sites Stand-alone
    Other conditions: Graft Vs Host Disease, GVHD
    View official trial listing →
  • Completed NCT NCT02892266

    Post-Traumatic Stress Symptoms (PTSS) in Transplant Recipients

    National Institute of Allergy and Infectious Diseases (NIAID) 124 participants Est. completion 2018-11-24 13 sites
    Other conditions: Solid Organ Transplant Recipients, Parent(s)/Guardian of Referenced Transplant Recipients
    View official trial listing →
  • Completed NCT NCT02894606

    Influence of Thymoglobuline on Phenotypic and Functional Profiles of B Lymphocytes in Renal Transplant Recipients

    University Hospital, Brest 49 participants Est. completion 2018-05-22 2 sites
    Other conditions: Renal Transplant
    View official trial listing →
  • Completed NCT NCT02895672

    GLP-1/Basal Insulin Combination Therapy

    Albany College of Pharmacy and Health Sciences 150 participants Est. completion 2016-12
    Type 2 diabetes
    View official trial listing →
  • Status unknown NCT NCT02908035

    Temsirolimus Adventitial Delivery to Improve Angiographic Outcomes Below the Knee (TANGO)

    Not yet reported Mercator MedSystems, Inc. 100 participants Est. completion 2021-09 8 sites
    Other conditions: Chronic Limb Ischemia
    View official trial listing →
  • Withdrawn NCT NCT02909335

    De Novo Everolimus Versus Tacrolimus in Combination With Mofetil Mycophenolate and Low Dose Corticosteroids to Reduce Tacrolimus Induced Nephrotoxicity in Liver Transplantation: a Prospective, Multicentric, Randomised Study

    Not yet reported Rennes University Hospital Est. completion 2021-11 Stand-alone
    Other conditions: Liver Transplantation
    View official trial listing →
  • Completed NCT NCT02913261

    Safety and Efficacy of Ruxolitinib Versus Best Available Therapy in Patients With Corticosteroid-refractory Acute Graft vs. Host Disease After Allogeneic Stem Cell Transplantation

    Not yet reported Novartis Pharmaceuticals 310 participants Est. completion 2021-04-23 103 sites
    Other conditions: Corticosteroid Refractory Acute Graft vs Host Disease
    View official trial listing →
  • Completed NCT NCT02915107

    The SORT OUT IX STEMI OCT Trial

    Not yet reported Odense University Hospital 80 participants Est. completion 2023-09-01 3 sites
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT02915783

    A Trial to Evaluate Efficacy and Safety of Lenvatinib in Combination With Everolimus in Subjects With Unresectable Advanced or Metastatic Non Clear Cell Renal Cell Carcinoma (nccRCC) Who Have Not Received Any Chemotherapy for Advanced Disease

    Not yet reported Eisai Inc. 41 participants Est. completion 2021-11-02 8 sites
    Other conditions: Non Clear Cell Renal Cell Carcinoma (nccRCC)
    View official trial listing →
  • Status unknown NCT NCT02916680

    Pancreatic Islet Transplantation in the Anterior Chamber of the Human Eye - a Pilot Study

    Not yet reported University Hospital, Basel, Switzerland 4 participants Est. completion 2025-04 1 site
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT02917096

    Ruxolitinib Phosphate and Chemotherapy Given Before and After Reduced Intensity Donor Stem Cell Transplant in Treating Patients With Myelofibrosis

    Not yet reported City of Hope Medical Center 18 participants Est. completion 2023-08-31 1 site Stand-alone
    Other conditions: Primary Myelofibrosis, Secondary Myelofibrosis
    View official trial listing →
  • Completed NCT NCT02918292

    Optimizing Haploidentical Aplastic Anemia Transplantation (BMT CTN 1502)

    Not yet reported Medical College of Wisconsin 32 participants Est. completion 2021-08-17 28 sites Stand-alone
    Other conditions: Severe Aplastic Anemia
    View official trial listing →
  • Completed NCT NCT02921789

    Study to Assess the Efficacy and Safety of Bleselumab in Preventing the Recurrence of Focal Segmental Glomerulosclerosis in de Novo Kidney Transplant Recipients

    Not yet reported Astellas Pharma Global Development, Inc. 67 participants Est. completion 2021-05-18 23 sites Stand-alone
    Other conditions: Kidney Transplantation, Primary Focal Segmental Glomerulosclerosis (FSGS)
    View official trial listing →
  • Status unknown NCT NCT02929030

    Clinical Performance of Nano Plus Sirolimus-Eluting Stents in Patients With Coronary Artery Disease

    Xijing Hospital 2500 participants Est. completion 2022-01 1 site
    Cardiovascular disease
    View official trial listing →
  • Status unknown NCT NCT02936505

    Clinical Study Evaluating Two Treatment Protocols for Immunosuppressive Drugs. Looking at 3-year Incidence of CLAD.

    Not yet reported Vastra Gotaland Region 249 participants Est. completion 2026-10-30 5 sites Stand-alone
    Other conditions: Lung Transplantation, Allografts
    View official trial listing →
  • Withdrawn NCT NCT02939365

    Precision Medicine Offers Belatacept Monotherapy

    Not yet reported University of California, San Francisco Est. completion 2022-12
    Other conditions: Transplantation
    View official trial listing →
  • Completed NCT NCT02941224

    First-in-human Evaluation of the SELUTION DCB, a Novel Sirolimus Coated Balloon in Peripheral Arteries

    Not yet reported M.A. Med Alliance S.A. 50 participants Est. completion 2019-09 4 sites Stand-alone
    Other conditions: Patients With Peripheral Artery Disease in the SFA or PA
    View official trial listing →
  • Completed NCT NCT02953873

    Dosing Requirements of Astagraf XL® in African American Kidney Transplant Recipients

    Not yet reported Medical University of South Carolina 25 participants Est. completion 2018-12-14 1 site
    Other conditions: Immunosuppression
    View official trial listing →
  • Terminated NCT NCT02954159

    Vedolizumab Monotherapy Vs Combination Therapy With Tacrolimus in UC

    Not yet reported Medical College of Wisconsin 4 participants Est. completion 2019-01-31 1 site
    Other conditions: Ulcerative Colitis
    View official trial listing →
  • Completed NCT NCT02954198

    Once-daily Regimen With Envarsus® to Optimize Immunosuppression Management and Outcomes in Kidney Transplant Recipients

    Not yet reported Medical University of South Carolina 40 participants Est. completion 2018-12-27 1 site
    Other conditions: Immunosuppression
    View official trial listing →
  • Terminated NCT NCT02956005

    Envarsus XR in African American Renal Transplant Recipients

    Not yet reported Georgetown University 18 participants Est. completion 2018-09 1 site
    Other conditions: Renal Transplant Recipients
    View official trial listing →
  • Status unknown NCT NCT02957552

    Safety and Tolerance of Immunomodulating Therapy With Donor-specific MSC in Pediatric Living-Donor Liver Transplantation

    Not yet reported University Hospital Tuebingen 7 participants Est. completion 2021-12 1 site Stand-alone
    Other conditions: Pediatric Liver Transplantation
    View official trial listing →
  • Completed NCT NCT02959918

    Multi-Dose Safety/Pharmacodynamic Study of SEL-212/SEL-037 in Subjects With Symptomatic Gout & Elevated Blood Uric Acid

    Not yet reported Selecta Biosciences, Inc. 152 participants Est. completion 2019-01 13 sites
    Other conditions: Gout Chronic, Hyperuricemia
    View official trial listing →
  • Completed NCT NCT02960035

    A Study of the MASEI in the Treatment of Anti-TNF Blocker to Peripheral Tendonitis in Patients With Spondyloarthritis

    Not yet reported Sun Yat-sen University 96 participants Est. completion 2018-10 1 site Stand-alone
    Other conditions: Spondyloarthropathy
    View official trial listing →
  • Completed NCT NCT02960646

    Engineered Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies

    Not yet reported M.D. Anderson Cancer Center 11 participants Est. completion 2023-02-13 1 site Stand-alone
    Other conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Aplastic Anemia, Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Chronic Myelomonocytic Leukemia, Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Lymphoblastic Lymphoma, Myelodysplastic Syndrome, Myeloproliferative Neoplasm, Plasma Cell Myeloma, Recurrent Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Recurrent Hodgkin Lymphoma, Recurrent Non-Hodgkin Lymphoma, Recurrent Plasma Cell Myeloma, Therapy-Related Myelodysplastic Syndrome
    View official trial listing →
  • Completed NCT NCT02961608

    Conversion Pharmacodynamic Study in Stable Renal Transplant Patients Receiving Tacrolimus Two Times a Day to a New Formulation of Tacrolimus - LCP Tacro - 1 Time a Day.

    Not yet reported Hospital Universitari de Bellvitge 25 participants Est. completion 2018-09 1 site Stand-alone
    Other conditions: Kidney Transplant; Complications
    View official trial listing →
  • Active, not recruiting NCT NCT02962414

    Roll-over Study to Collect and Assess Long-term Safety of Everolimus in Patients With TSC and Refractory Seizures Who Have Completed the EXIST-3 Study [CRAD001M2304] and Who Are Benefitting From Continued Treatment

    Not yet reported Novartis Pharmaceuticals 206 participants Est. completion 2026-12-30 67 sites
    Other conditions: Tuberous Sclerosis Complex
    View official trial listing →
  • Completed NCT NCT02962492

    An Investigation Into the Effect of Dapagliflozin on Ketogenesis in Type 1 Diabetes

    Not yet reported University at Buffalo 70 participants Est. completion 2021-10-24 1 site
    Other conditions: Evaluate Ketogenic Stress
    View official trial listing →
  • Terminated NCT NCT02963103

    A Study to Assess the Safety and Efficacy of a Tacrolimus Based Immunosuppressive Regimen in Stable Kidney Transplant Recipients Converted From Cyclosporine Based Immunosuppressive Regimen

    Not yet reported Astellas Pharma Korea, Inc. 13 participants Est. completion 2012-10 1 site Stand-alone
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT02970630

    Envarsus® Once Daily With Everolimus in Elderly Kidney Transplant Recipients: Pharmacokinetic and Clinical Study

    Not yet reported Chiesi Farmaceutici S.p.A. 28 participants Est. completion 2018-02-22 6 sites Stand-alone
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Status unknown NCT NCT02972671

    Trial of MiStent Compared to Xience in Japan

    Not yet reported Micell Technologies 120 participants Est. completion 2022-04-30 10 sites Stand-alone
    Other conditions: Coronary (Artery); Disease
    View official trial listing →
  • Completed NCT NCT02973204

    Circulating Tumor Cells and Tumor DNA in HCC and NET

    University of Aarhus 167 participants Est. completion 2020-01-08 1 site
    Other conditions: Carcinoma, Hepatocellular, Neuroendocrine Tumors
    View official trial listing →
  • Completed NCT NCT02974244

    Comparison of the Effectiveness and Tolerability of Exenatide Once-weekly Compared to Basal Insulins

    AstraZeneca 7000 participants Est. completion 2014-10-28 1 site
    Type 2 diabetes
    View official trial listing →
  • Terminated NCT NCT02974686

    Conversion From MPA to Zortress (Everolimus) for GI Toxicity Post-renal Transplantation

    Not yet reported Washington University School of Medicine 1 participants Est. completion 2019-09 1 site
    Other conditions: Kidney Transplant Rejection, Gastrointestinal Disorder, Functional
    View official trial listing →
  • Completed NCT NCT02975882

    Nanoparticle Albumin-Bound Rapamycin, Temozolomide, and Irinotecan Hydrochloride in Treating Pediatric Patients With Recurrent or Refractory Solid Tumors

    Not yet reported Children's Oncology Group 33 participants Est. completion 2024-12-31 21 sites Stand-alone
    Other conditions: Childhood Solid Neoplasm, Recurrent Malignant Solid Neoplasm, Recurrent Primary Central Nervous System Neoplasm, Refractory Malignant Solid Neoplasm, Refractory Primary Central Nervous System Neoplasm
    View official trial listing →
  • Active, not recruiting NCT NCT02979873

    Sirolimus (Rapamune ) for Relapse Prevention in People With Severe Aplastic Anemia Responsive to Immunosuppressive Therapy

    Not yet reported National Heart, Lung, and Blood Institute (NHLBI) 84 participants Est. completion 2030-06-30 1 site Stand-alone
    Other conditions: Severe Aplastic Anemia
    View official trial listing →
  • Completed NCT NCT02986139

    Study to Assess the Injection Site Pain Associated With a New Etanercept Formulation in Adults With Rheumatoid Arthritis or Psoriatic Arthritis

    Not yet reported Amgen 111 participants Est. completion 2017-10-09 30 sites Stand-alone
    Other conditions: Arthritis, Rheumatoid; Arthritis, Psoriatic
    View official trial listing →
  • Terminated NCT NCT02987959

    Study of TAK-228 (MLN0128) in Soft Tissue Sarcomas

    Not yet reported Fox Chase Cancer Center 6 participants Est. completion 2020-07-24 1 site
    Other conditions: Soft-tissue Sarcoma
    View official trial listing →
  • Completed NCT NCT02988466

    Reduced Intensity (RIC) Conditioning And Transplantation of HLA-Haplo-HCT

    Not yet reported Masonic Cancer Center, University of Minnesota 78 participants Est. completion 2025-03-24 1 site Stand-alone
    Other conditions: Hematologic Malignancies
    View official trial listing →
  • Terminated NCT NCT02995330

    Sex-Mismatched Allogeneic Bone Marrow Transplantation for Men With Metastatic Castration-Resistant Prostate Cancer

    Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 3 participants Est. completion 2021-06-16 1 site Stand-alone
    Other conditions: Prostate Cancer
    View official trial listing →
  • Status unknown NCT NCT02999776

    Laser-assisted Topical Administration of Etanercept (Enbrel®) in Patients With Mild to Moderate Plaque-type Psoriasis

    Not yet reported Pantec Biosolutions AG 30 participants Est. completion 2018-06 1 site Stand-alone
    Other conditions: Psoriatic Plaque
    View official trial listing →
  • Status unknown NCT NCT03005236

    AGe-adapted Benefits of Envarsus Versus Twice-daily Tacrolimus ImmunosuppressioN druGs After Kidney Transplantation

    Not yet reported University Hospital Birmingham NHS Foundation Trust 40 participants Est. completion 2019-10 Stand-alone
    Other conditions: Kidney Transplant Failure and Rejection
    View official trial listing →
  • Status unknown NCT NCT03008083

    Comparison Three vs Twelve Months of Dual Anti-Platelet Therapy After Stent Implantation

    Not yet reported Shanghai MicroPort Medical (Group) Co., Ltd. 2446 participants Est. completion 2022-10 1 site
    Other conditions: Drug-Eluting Stents, Percutaneous Coronary Intervention
    View official trial listing →
  • Status unknown NCT NCT03008148

    Phase II/III Trial of CCRT With or Without JP001 for Newly Diagnosed GBM

    Not yet reported, Not yet reported Johnpro Biotech, Inc. 288 participants Est. completion 2025-04 2 sites
    Other conditions: Glioblastoma
    View official trial listing →
  • Terminated NCT NCT03014297

    Fosbretabulin With Everolimus in Neuroendocrine Tumors With Progression

    Not yet reported Lowell Anthony, MD 17 participants Est. completion 2018-11-16 1 site
    Other conditions: Neuroendocrine Tumors, Everolimus
    View official trial listing →
  • Terminated NCT NCT03016260

    RABIOPRED - a Validation Study of Theranostic Test to PREDict Treatment Response of Anti-TNFα BIologicals in Rheumatoid Arthritis

    TcLand Expression S.A. 250 participants Est. completion 2019-12-20 8 sites
    Other conditions: RheumatoId Arthritis
    View official trial listing →
  • Status unknown NCT NCT03016715

    Using Topical Sirolimus 2% for Patients With Epidermolysis Bullous Simplex (EBS) Study

    Not yet reported Premier Specialists, Australia 8 participants 1 site Stand-alone
    Obstructive sleep apnea Other conditions: Weber-Cockayne Syndrome
    View official trial listing →
  • Completed NCT NCT03017352

    Meal-time Administration of Exenatide for Glycaemic Control in Type 1 Diabetic Cases

    Not yet reported Filip Krag Knop 108 participants Est. completion 2019-06 1 site Stand-alone
    Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT03020589

    Study of Pharmacogenomic-Guided Tacrolimus Dosing and Monitoring in Kidney Transplant Recipients

    Not yet reported University of North Carolina, Chapel Hill 97 participants Est. completion 2022-06-28 1 site Stand-alone
    Other conditions: Renal Transplant
    View official trial listing →
  • Completed NCT NCT03026465

    Vessel Injury in Relation With Strut Thickness Assessed by OCT

    Not yet reported Fundacion Investigacion Interhospitalaria Cardiovascular 50 participants Est. completion 2018-07-27 3 sites Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT03027856

    The BIFSORB Pilot Study II

    Not yet reported Aarhus University Hospital Skejby 20 participants Est. completion 2024-12-31 1 site Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Terminated NCT NCT03031470

    Pilot Study of Reparixin for Early Allograft Dysfunction Prevention in Liver Transplantation

    Not yet reported Dompé Farmaceutici S.p.A 40 participants Est. completion 2017-03-31 7 sites
    Other conditions: Ischemia-reperfusion Injury in Liver Transplant, Early Allograft Dysfunction
    View official trial listing →
  • Active, not recruiting NCT NCT03032406

    CLEVER Pilot Trial: A Phase II Pilot Trial of HydroxyChLoroquine, EVErolimus or the Combination for Prevention of Recurrent Breast Cancer

    Not yet reported Abramson Cancer Center at Penn Medicine 53 participants Est. completion 2027-01-01 1 site
    Other conditions: Breast Cancer Stage IIB
    View official trial listing →
  • Completed NCT NCT03032783

    A Two Step Approach to Allogeneic Hematopoietic Stem Cell Transplantation for Patients With Hematologic Malignancies-Increasing GVT Effects Without Increasing Toxicity

    Not yet reported Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 51 participants Est. completion 2025-12-02 1 site Stand-alone
    Other conditions: Hematopoietic and Lymphoid Cell Neoplasm
    View official trial listing →
  • Status unknown NCT NCT03040934

    Firehawk™ Coronary Stent System in the Treatment of Coronary Chronic Total Occlusion Lesion(s)

    Not yet reported Shanghai MicroPort Medical (Group) Co., Ltd. 196 participants Est. completion 2023-10 1 site
    Other conditions: Drug-Eluting Stents, Percutaneous Coronary Intervention, Tomography, Optical Coherence
    View official trial listing →
  • Suspended NCT NCT03042637

    Safety and Efficacy of Combination Acthar Gel and Tacrolimus in the Treatment of Steroid Resistant Nephrotic Syndrome

    Southeast Renal Research Institute Est. completion 2021-12 1 site
    Other conditions: Nephrotic Syndrome
    View official trial listing →
  • Completed NCT NCT03045913

    Genoss DES Prospective Multicenter Registry

    Young Jin Youn, MD, PhD 2000 participants Est. completion 2022-12-31 17 sites
    Cardiovascular disease Other conditions: Myocardial Ischemia
    View official trial listing →
  • Withdrawn NCT NCT03047200

    Pancreatic Islet Cell Transplantation After Kidney Transplantation - A Novel Approach to Immunosupression

    Not yet reported Baylor Research Institute Est. completion 2017-01 1 site
    Other conditions: Islet Cell Transplantation, Type 1 Diabetes
    View official trial listing →
  • Active, not recruiting NCT NCT03047213

    Sapanisertib in Treating Patients With Locally Advanced or Metastatic Bladder Cancer With TSC1 and/or TSC2 Mutations

    Not yet reported National Cancer Institute (NCI) 17 participants Est. completion 2026-11-12 20 sites
    Other conditions: Locally Advanced Bladder Urothelial Carcinoma, Metastatic Transitional Cell Carcinoma, Metastatic Urothelial Carcinoma, Recurrent Bladder Carcinoma, Stage III Bladder Urothelial Carcinoma AJCC v6 and v7, Stage IV Bladder Urothelial Carcinoma AJCC v7
    View official trial listing →
  • Completed NCT NCT03047733

    Comparison of Cyclic On-off and Continuous Excimer Laser Treatment for Vitiligo

    Not yet reported Ajou University School of Medicine 12 participants Est. completion 2016-12-31 1 site Stand-alone
    Other conditions: Dermatologic Disease, Vitiligo
    View official trial listing →
  • Completed NCT NCT03047980

    Trial of Sirolimus for Cognitive Impairment in Sturge-Weber Syndrome

    Not yet reported, Not yet reported Anne Comi, MD 10 participants Est. completion 2020-10-27 2 sites Stand-alone
    Other conditions: Sturge-Weber Syndrome
    View official trial listing →
  • Active, not recruiting NCT NCT03049189

    Efficacy and Safety of 177Lu-edotreotide PRRT in GEP-NET Patients

    Not yet reported ITM Solucin GmbH 324 participants Est. completion 2029-11 52 sites
    Other conditions: Neuroendocrine Tumors
    View official trial listing →
  • Terminated NCT NCT03060980

    Comparison of Efficacy, Safety, and Tolerability of ITCA 650 to Empagliflozin and Glimepiride as add-on Metformin

    Not yet reported Intarcia Therapeutics 245 participants Est. completion 2018-01-26 101 sites Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Status unknown NCT NCT03062813

    Tacrolimus Combined With Entecavir on HBV Associated Glomerulonephritis(HBV-GN)

    Not yet reported Guangdong Provincial People's Hospital 112 participants Est. completion 2020-03-31 1 site Stand-alone
    Other conditions: Hepatitis B Virus Associated Nephrotic Syndrome
    View official trial listing →
  • Terminated NCT NCT03063229

    Energy Balance Following Islet Transplantation

    Not yet reported University of Edinburgh 2 participants Est. completion 2019-10-23 1 site
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Terminated NCT NCT03065387

    Neratinib and Everolimus, Palbociclib, or Trametinib in Treating Participants With Refractory and Advanced or Metastatic Solid Tumors With EGFR Mutation/Amplification, HER2 Mutation/Amplification, or HER3/4 Mutation or KRAS Mutation

    Not yet reported M.D. Anderson Cancer Center 84 participants Est. completion 2026-04-23 1 site
    Other conditions: Advanced Malignant Solid Neoplasm, EGFR Gene Amplification, EGFR Gene Mutation, ERBB2 Gene Amplification, ERBB2 Gene Mutation, ERBB3 Gene Mutation, ERBB4 Gene Mutation, KRAS Gene Mutation, Metastatic Malignant Solid Neoplasm, Refractory Malignant Solid Neoplasm
    View official trial listing →
  • Withdrawn NCT NCT03066466

    Randomized Study: Standard of Care With or Without Atorvastatin for Prevention of GVHD for Matched Unrelated Donor BMT

    Not yet reported Loyola University Est. completion 2021-02-28 1 site Stand-alone
    Other conditions: Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, Myelodysplastic Syndrome
    View official trial listing →
  • Status unknown NCT NCT03067324

    Quality Control of Pancreatic Islet Intended to Islet Graft Cells Intended to Stabilot Islet Graft Protocol

    University Hospital, Grenoble 40 participants Est. completion 2021-07-01 8 sites
    Other conditions: Pancreatic Islet Quality Control
    View official trial listing →
  • Completed NCT NCT03070301

    A Study of LEE011 With Everolimus in Patients With Advanced Neuroendocrine Tumors

    Not yet reported Memorial Sloan Kettering Cancer Center 21 participants Est. completion 2024-01-31 5 sites
    Other conditions: Neuroendocrine Tumors
    View official trial listing →
  • Completed NCT NCT03072485

    Phase 1 Study of the Effects of Combining Topical FDA-approved Drugs on Age-related Pathways on the Skin of Healthy Volunteers

    Not yet reported Anne Chang 10 participants Est. completion 2019-02-22 1 site
    Other conditions: Aging
    View official trial listing →
  • Completed NCT NCT03076151

    Pharmacokinetic Study of Adoport® (Tacrolimus) in Patients With de Novo Kidney Transplantation

    Not yet reported University Hospital, Limoges 30 participants Est. completion 2019-07-31 5 sites Stand-alone
    Other conditions: Transplantation, Kidney, Pharmacokinetic
    View official trial listing →
  • Completed NCT NCT03083769

    Functional Genetic Variants Affecting Tacrolimus Trough Levels and Side Effects in Chinese Renal Transplantation.

    Southern Medical University, China 1502 participants Est. completion 2019-08-01 2 sites
    Other conditions: Transplantation
    View official trial listing →
  • Completed NCT NCT03083782

    Drug Interaction Study of Apixaban With Cyclosporine and Tacrolimus

    Not yet reported Thomas Jefferson University 12 participants Est. completion 2017-06-30 1 site Stand-alone
    Other conditions: Venous Thromboembolism, Pharmacokinetics, Healthy
    View official trial listing →
  • Terminated NCT NCT03088709

    Haploidentical Stem Cell Transplantation Using Post-Transplant Cyclophosphamide

    Not yet reported Loyola University 5 participants Est. completion 2022-01-31 1 site Stand-alone
    Other conditions: Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, Myelodysplastic Syndrome, Non-hodgkin Lymphoma, Chronic Lymphocytic Leukemia
    View official trial listing →
  • Completed NCT NCT03091465

    Validation of the International Metastatic Renal Cell Carcinoma Database Consortium (IMDC) Prognostic Classification for Targeted Therapies (TKI/mTOR Inhibitors) in Second Line After First Line Treatment With Pazopanib

    Spanish Oncology Genito-Urinary Group 530 participants Est. completion 2017-04-17 57 sites
    Other conditions: Metastatic Renal Cell Carcinoma
    View official trial listing →
  • Withdrawn NCT NCT03095547

    Drug/Drug Interactions With F901318

    Not yet reported F2G Ltd Est. completion 2017-10 Stand-alone
    Other conditions: Invasive Aspergillosis
    View official trial listing →
  • Completed NCT NCT03096782

    Umbilical Cord Blood Transplant With Added Sugar and Chemotherapy and Radiation Therapy in Treating Patients With Leukemia or Lymphoma

    Not yet reported M.D. Anderson Cancer Center 6 participants Est. completion 2022-09-20 1 site Stand-alone
    Other conditions: Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Biphenotypic Leukemia, Acute Leukemia, Acute Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Chemotherapy-Related Leukemia, Chronic Lymphocytic Leukemia, Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Chronic Myelomonocytic Leukemia, Hodgkin Lymphoma, Langerhans Cell Histiocytosis, Minimal Residual Disease, Myelodysplastic Syndrome, Myelodysplastic Syndrome With Excess Blasts, Non-Hodgkin Lymphoma, Recurrent Hodgkin Lymphoma, Refractory Acute Lymphoblastic Leukemia, Refractory Myelodysplastic Syndrome, Small Lymphocytic Lymphoma, Therapy-Related Myelodysplastic Syndrome
    View official trial listing →
  • Completed NCT NCT03099122

    A Study of Thymoglobuline® Induction Therapy in Adult Recipients of Donated After Cardiac Death Kidney Transplant

    Not yet reported Sanofi 115 participants Est. completion 2019-11-12 1 site Stand-alone
    Other conditions: End-stage Renal Disease
    View official trial listing →
  • Completed NCT NCT03100734

    Observational Study to Evaluate the Real-Life Effectiveness of Benepali Following Transition From Enbrel

    Biogen 585 participants Est. completion 2018-11-30 1 site
    Other conditions: Rheumatoid Arthritis, Axial Spondyloarthritis
    View official trial listing →
  • Status unknown NCT NCT03105466

    Prospective Study of Deep Anterior Lamellar Keratoplasty Using Acellular Porcine Cornea

    Not yet reported Zhongshan Ophthalmic Center, Sun Yat-sen University 50 participants Est. completion 2020-02 1 site Stand-alone
    Other conditions: Corneal Transplantation
    View official trial listing →
  • Active, not recruiting NCT NCT03114865

    A Study of Blinatumomab in Patients With Pre B-cell ALL and B-cell NHL as Post-allo-HSCT Remission Maintenance

    Not yet reported, Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 44 participants Est. completion 2026-12-30 1 site
    Other conditions: Acute Lymphoblastic Leukemia, B-cell Non Hodgkin Lymphoma, Pre B-Cell Acute Lymphoblastic Leukaemia
    View official trial listing →
  • Active, not recruiting NCT NCT03118492

    Combination Chemotherapy, Total Body Irradiation, and Donor Blood Stem Cell Transplant in Treating Patients With Secondary Myelofibrosis

    Not yet reported City of Hope Medical Center 22 participants Est. completion 2027-04-29 1 site Stand-alone
    Other conditions: Secondary Myelofibrosis
    View official trial listing →
  • Withdrawn NCT NCT03120000

    PQR309 in Phase 2 in Patients With Relapsed or Refractory Primary Central Nervous System Lymphoma

    Not yet reported PIQUR Therapeutics AG Est. completion 2019-12 4 sites
    Other conditions: Primary Central Nervous System Lymphoma
    View official trial listing →
  • Active, not recruiting NCT NCT03121014

    Study of Intensity Modulated Total Marrow Irradiation (IM-TMI) in Addition to Fludarabine/Busulfan Conditioning for Allogeneic Transplantation in High Risk AML and Myelodysplastic Syndromes

    Not yet reported University of Illinois Chicago 38 participants Est. completion 2026-11 1 site Stand-alone
    Other conditions: Acute Myeloid Leukemia, Myelodysplastic Syndromes
    View official trial listing →
  • Completed NCT NCT03125772

    Trial on Safety & Performance of TAXUS Element vs. XIENCE Prime Stent in Treatment of Coronary Lesion in Diabetics

    Not yet reported Fortis Escorts Heart Institute 1830 participants Est. completion 2016-05 1 site
    Type 2 diabetes Other conditions: Coronary Heart Disease
    View official trial listing →
  • Completed NCT NCT03128359

    High Dose Cyclophosphamide, Tacrolimus, and Mycophenolate Mofetil in Preventing Graft Versus Host Disease in Patients With Hematological Malignancies Undergoing Myeloablative or Reduced Intensity Donor Stem Cell Transplant

    Not yet reported City of Hope Medical Center 38 participants Est. completion 2021-09-15 1 site Stand-alone
    Other conditions: Acute Leukemia, Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma, Graft Versus Host Disease, Hodgkin Lymphoma, Mantle Cell Lymphoma, Marginal Zone Lymphoma, Myelodysplastic Syndrome, Myeloproliferative Neoplasm, Recurrent Acute Myeloid Leukemia With Myelodysplasia-Related Changes, Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma, Secondary Myelodysplastic Syndrome
    View official trial listing →
  • Completed NCT NCT03129126

    The Safety, Tolerability and Efficacy of LP-10 in Subjects With Refractory Moderate to Severe Hemorrhagic Cystitis

    Not yet reported Lipella Pharmaceuticals, Inc. 13 participants Est. completion 2023-09-29 9 sites Stand-alone
    Other conditions: Hemorrhagic Cystitis
    View official trial listing →
  • Completed NCT NCT03131934

    Immunotherapy With Tacrolimus Resistant EBV CTL for Lymphoproliferative Disease After Solid Organ Transplant

    Not yet reported University College, London 4 participants Est. completion 2026-03-12 2 sites Stand-alone
    Other conditions: Post-transplant Lymphoproliferative Disease, Transplant-Related Hematologic Malignancy
    View official trial listing →
  • Completed NCT NCT03140449

    Topical Rapamycin and Calcitriol for Angiofibroma of Tuberous Sclerosis

    Not yet reported National Taiwan University Hospital 52 participants Est. completion 2017-04-25
    Other conditions: Facial Angiofibroma
    View official trial listing →
  • Completed NCT NCT03140462

    Influence of Genetic Polymorphism of Donor on Tacrolimus Concentration in Liver Transplant

    National Taiwan University Hospital 96 participants Est. completion 2020-12-31 2 sites
    Other conditions: Liver Transplantation
    View official trial listing →
  • Status unknown NCT NCT03147157

    The Effect of Human Leukocyte Antigen Macthing on Guiding Tacrolimus Regimen After Liver Transplantation

    Not yet reported The First Hospital of Jilin University 120 participants Est. completion 2025-04 Stand-alone
    Other conditions: Liver Transplantation, Graft Versus Host Disease, Graft Rejection, Drug-Related Side Effects and Adverse Reactions
    View official trial listing →
  • Active, not recruiting NCT NCT03150914

    Multicenter Interventional Lymphangioleiomyomatosis (LAM) Early Disease Trial

    Not yet reported University of Cincinnati 60 participants Est. completion 2025-06-30 8 sites
    Other conditions: LAM, Lymphangioleiomyomatosis
    View official trial listing →
  • Completed NCT NCT03151005

    The Effect of GLP-1 Agonists Versus OCs on Reproductive Disorders and Cardiovascular Risks in Overweight PCOS

    Not yet reported Xinqiao Hospital of Chongqing 70 participants Est. completion 2021-04-23 1 site Stand-alone
    Other conditions: Polycystic Ovary Syndrome (PCOS), Overweight, Obesity
    View official trial listing →
  • Completed NCT NCT03152019

    Efficacy and Safety of a 0.1% Tacrolimus Nasal Ointment as a Treatment for Epistaxis in Hemorrhagic Hereditary Telangiectasia (HHT)

    Not yet reported Hospices Civils de Lyon 50 participants Est. completion 2018-11-08 3 sites
    Other conditions: Hemorrhagic Hereditary Telangiectasia (HHT)
    View official trial listing →
  • Active, not recruiting NCT NCT03155620

    Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)

    Not yet reported National Cancer Institute (NCI) 1377 participants Est. completion 2027-01-06 172 sites
    Obstructive sleep apnea Other conditions: Advanced Malignant Solid Neoplasm, Ann Arbor Stage III Non-Hodgkin Lymphoma, Ann Arbor Stage IV Non-Hodgkin Lymphoma, Histiocytic Sarcoma, Juvenile Xanthogranuloma, Langerhans Cell Histiocytosis, Malignant Glioma, Recurrent Ependymoma, Recurrent Ewing Sarcoma, Recurrent Glioma, Recurrent Hepatoblastoma, Recurrent Langerhans Cell Histiocytosis, Recurrent Malignant Germ Cell Tumor, Recurrent Malignant Solid Neoplasm, Recurrent Medulloblastoma, Recurrent Neuroblastoma, Recurrent Non-Hodgkin Lymphoma, Recurrent Peripheral Primitive Neuroectodermal Tumor, Recurrent Primary Central Nervous System Neoplasm, Recurrent Rhabdoid Tumor, Recurrent Soft Tissue Sarcoma, Refractory Ewing Sarcoma, Refractory Glioma, Refractory Hepatoblastoma, Refractory Langerhans Cell Histiocytosis, Refractory Malignant Germ Cell Tumor, Refractory Malignant Solid Neoplasm, Refractory Medulloblastoma, Refractory Neuroblastoma, Refractory Non-Hodgkin Lymphoma, Refractory Peripheral Primitive Neuroectodermal Tumor, Refractory Primary Central Nervous System Neoplasm, Refractory Rhabdoid Tumor, Rhabdoid Tumor, Stage III Soft Tissue Sarcoma AJCC v7, Stage IV Soft Tissue Sarcoma AJCC v7, Wilms Tumor
    View official trial listing →
  • Completed NCT NCT03158389

    NCT Neuro Master Match - N²M² (NOA-20)

    Not yet reported, Not yet reported University Hospital Heidelberg 228 participants Est. completion 2023-02-22 13 sites
    Other conditions: Glioblastoma, Adult
    View official trial listing →
  • Completed NCT NCT03160261

    Effect of Exenatide on Cortisol Secretion

    Not yet reported University of Tartu 10 participants Est. completion 2017-12-28 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT03161340

    Immunomodulatory Effects of Rapamycin on Pregnancy Rate of Patient With Recurrent Implantation Failure

    Not yet reported Mehdi Yousefi 121 participants Est. completion 2018-06-20 2 sites
    Other conditions: Recurrent Implantation Failure
    View official trial listing →
  • Completed NCT NCT03162237

    Safety and Efficacy Study of Islets Xenotransplantation

    Not yet reported Wei Wang,MD 20 participants Est. completion 2018-12 1 site Stand-alone
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Completed NCT NCT03167411

    Bexagliflozin Drug/Drug Interaction Study With Exenatide Injection

    Not yet reported Theracos 20 participants Est. completion 2017-06-29 1 site
    Type 2 diabetes
    View official trial listing →
  • Status unknown NCT NCT03171831

    Haploidentical Hematopoietic Stem Cell Transplantation for Patients With Thalassemia Major

    Not yet reported First Affiliated Hospital of Guangxi Medical University 30 participants Est. completion 2022-04-01 1 site Stand-alone
    Other conditions: Thalassemia Major
    View official trial listing →
  • Status unknown NCT NCT03173820

    Clinical Trial in Assigning of Tacrolimus Dosage Regimen According to CYP3A5 Genotype in Kidney Transplant Recipients

    Not yet reported Khon Kaen University 120 participants Est. completion 2018-06-30 1 site
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT03174171

    Open-label Study on Treatment of Primary Aldosteronism With Everolimus

    Not yet reported University Hospital, Basel, Switzerland 12 participants Est. completion 2018-06-25 1 site
    Other conditions: Primary Aldosteronism
    View official trial listing →
  • Completed NCT NCT03176381

    Tissue Predictors of Abiraterone Benefit

    Tianjin Medical University Second Hospital 110 participants Est. completion 2023-11-01 1 site
    Other conditions: Metastatic Castration-resistant Prostate Cancer
    View official trial listing →
  • Withdrawn NCT NCT03178955

    Circadian RA Study in Rheumatoid Arthritis Subjects

    University of California, Davis Est. completion 2019-08-16 1 site
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Status unknown NCT NCT03182192

    GLP1R-imaging in Hypoglycemia

    Not yet reported Radboud University Medical Center 12 participants Est. completion 2024-07-01 2 sites
    Other conditions: Hypoglycemia
    View official trial listing →
  • Status unknown NCT NCT03182231

    GLP1-imaging Before and After Bariatric Surgery

    Not yet reported, Not yet reported Radboud University Medical Center 12 participants Est. completion 2023-07-01 2 sites
    Type 2 diabetes Other conditions: Bariatric Surgery Candidate
    View official trial listing →
  • Status unknown NCT NCT03182296

    Visualizing Beta Cells in Patients With a History of Gestational Diabetes

    Not yet reported Radboud University Medical Center 24 participants Est. completion 2026-01-01 1 site
    Other conditions: Gestational Diabetes
    View official trial listing →
  • Status unknown NCT NCT03185221

    Cordimax China Post Market Surveillance

    Not yet reported Shandong Branden Med.Device Co.,Ltd 3660 participants Est. completion 2020-06-20 1 site
    Other conditions: Coronary Artery Stenosis
    View official trial listing →
  • Completed NCT NCT03188068

    Sirolimus Versus Sirolimus Plus Prednisolone for Kaposiform Hemangioendothelioma

    Not yet reported West China Hospital 30 participants Est. completion 2021-12-31 1 site
    Other conditions: Kaposiform Hemangioendothelioma, Kasabach Merritt Phenomenon
    View official trial listing →
  • Completed NCT NCT03189953

    68Ga-NODAGA-exendin-4 PET/CT for Diagnostic Imaging in AHH

    Not yet reported, Not yet reported Radboud University Medical Center 56 participants Est. completion 2021-05
    Other conditions: Insulinoma
    View official trial listing →
  • Completed NCT NCT03190174

    Nivolumab (Opdivo®) Plus ABI-009 (Nab-rapamycin) for Advanced Sarcoma and Certain Cancers

    Not yet reported, Not yet reported Sarcoma Oncology Research Center, LLC 34 participants Est. completion 2021-12-02 1 site
    Other conditions: Ewing Sarcoma, PEComa, Epithelioid Sarcoma, Desmoid Tumor, Chordoma, Non Small Cell Lung Cancer, Urothelial Carcinoma, Melanoma, Renal Cell Carcinoma, Squamous Cell Carcinoma, Hepatocellular Carcinoma, Classical Hodgkin Lymphoma, Colorectal Cancer, MTOR Activating Mutation
    View official trial listing →
  • Active, not recruiting NCT NCT03192397

    Chemotherapy, Total Body Irradiation, and Post-Transplant Cyclophosphamide in Reducing Rates of Graft Versus Host Disease in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant

    Not yet reported, Not yet reported Roswell Park Cancer Institute 35 participants Est. completion 2027-05-21 1 site Stand-alone
    Other conditions: Acute Myeloid Leukemia in Remission, Adult Acute Lymphoblastic Leukemia in Complete Remission, Chronic Myelogenous Leukemia, BCR-ABL1 Positive in Remission, Chronic Myelomonocytic Leukemia in Remission, Graft Versus Host Disease, Hodgkin Lymphoma, Minimal Residual Disease, Myelodysplastic Syndrome, Myeloproliferative Neoplasm, Non-Hodgkin Lymphoma, Plasma Cell Myeloma, Severe Aplastic Anemia, Waldenstrom Macroglobulinemia
    View official trial listing →
  • Status unknown NCT NCT03192657

    Basiliximab Treating Interstitial Pneumonia of CADM

    Not yet reported RenJi Hospital 100 participants Est. completion 2020-06 1 site Stand-alone
    Other conditions: Lung; Disease, Interstitial, With Fibrosis, Dermatomyositis
    View official trial listing →
  • Completed NCT NCT03193203

    Pharmacokinetics, Safety, and Tolerability Study of the Autoinjector and Pre-filled Syringe of SB4 in Healthy Male Subjects

    Not yet reported Samsung Bioepis Co., Ltd. 50 participants Est. completion 2017-08-07 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT03194321

    Trial to Evaluate Safety and Tolerability of Tacrolimus Extended-Release (Astagraf XL) in Human Leukocyte Antigen (HLA) Sensitized Kidney Transplant Recipients

    Not yet reported Cedars-Sinai Medical Center 20 participants Est. completion 2020-10-27 1 site Stand-alone
    Other conditions: End Stage Renal Disease
    View official trial listing →
  • Completed NCT NCT03198949

    A Study Investigating the Anti-epileptic Efficacy of Afinitor (Everolimus) in Patients With Refractory Seizures Who Have Focal Cortical Dysplasia Type II (FCD II)

    Not yet reported Yonsei University 23 participants Est. completion 2020-09-11 1 site
    Other conditions: Epilepsy and Focal Cortical Dysplasia II
    View official trial listing →
  • Status unknown NCT NCT03199664

    Effectiveness of Narrow-band Ultraviolet B Combined With Topical Tacrolimus 0.03% in Treatment of Patients With Vitiligo

    Not yet reported South Valley University 100 participants Est. completion 2018-12-01 1 site
    Other conditions: Vitiligo
    View official trial listing →
  • Status unknown NCT NCT03204136

    Tacrolimus Versus Methotrexate as Rescue Therapy for Refractory Inflammatory Bowel Disease

    Key Laboratory of Gastroenterology and Hepatology, Ministry of Health, China 60 participants Est. completion 2019-12-01 1 site
    Other conditions: Inflammatory Bowel Diseases
    View official trial listing →
  • Status unknown NCT NCT03216447

    A Study of Patient Adherence and Convenience to Immunosuppressive Agents in Newly Liver Transplant

    Not yet reported Chang Gung Memorial Hospital 150 participants Est. completion 2025-09-30 1 site Stand-alone
    Other conditions: Liver Transplantation
    View official trial listing →
  • Completed NCT NCT03216967

    Multicenter Randomized Two-arms Study Evaluating the BK Viral Clearance in Kidney Transplant Recipients With BK Viremia.

    Not yet reported University Hospital, Strasbourg, France 130 participants Est. completion 2024-08-01 15 sites
    Other conditions: BK Virus Nephropathy After Kidney Transplantation
    View official trial listing →
  • Status unknown NCT NCT03217669

    Epacadostat (INCB24360) in Combination With Sirolimus in Advanced Malignancy

    Not yet reported Chao Huang 15 participants Est. completion 2025-08-01 2 sites Stand-alone
    Other conditions: Advanced Solid Tumor, Non-small Cell Lung Cancer (NSCLC)
    View official trial listing →
  • Completed NCT NCT03222687

    Tacrolimus in Children With Henoch-Schönlein Purpura Nephritis

    Not yet reported Shandong University 25 participants Est. completion 2017-05-31 Stand-alone
    Other conditions: Henoch-Schönlein Purpura Nephritis
    View official trial listing →
  • Status unknown NCT NCT03225417

    Ixazomib in the Prophylaxis of Chronic Graft-versus-host Disease.

    Not yet reported, Not yet reported Fundación Pública Andaluza para la gestión de la Investigación en Sevilla 142 participants Est. completion 2024-12-31 8 sites Stand-alone
    Other conditions: Hematopoietic Stem Cell Transplantation, Multiple Myeloma
    View official trial listing →
  • Terminated NCT NCT03228576

    Prospective Cohort of Kidney Transplanted Patients Receiving an Extended Releasing Tacrolimus-Everolimus Association

    Poitiers University Hospital 16 participants Est. completion 2018-12-18 9 sites
    Other conditions: Kidney Transplant, Immunosuppression
    View official trial listing →
  • Completed NCT NCT03229265

    Pharmacokinetic Study of Tacrolimus and Mycophenolate Mofetil in Kidney Transplant Recipients With Hyperkalemia Receiving Patiromer

    Not yet reported The Rogosin Institute 8 participants Est. completion 2019-08-07 1 site Stand-alone
    Other conditions: Hyperkalemia, Kidney Transplant
    View official trial listing →
  • Completed NCT NCT03232112

    Does Treatment With GLP-1 Reduce Alcohol Intake in Patients With Alcohol Dependence?

    Not yet reported Anders Fink-Jensen, MD, DMSci 152 participants Est. completion 2020-10-05 1 site
    Alcohol use disorder Other conditions: Addiction, Alcohol
    View official trial listing →
  • Completed NCT NCT03234348

    MAGnesium-based Bioresorbable Scaffold in ST Segment Elevation Myocardial Infarction

    Not yet reported Hospital Clinic of Barcelona 151 participants Est. completion 2019-10-31 11 sites Stand-alone
    Cardiovascular disease Other conditions: Acute Coronary Syndrome, Stent
    View official trial listing →
  • Status unknown NCT NCT03234673

    The Effect of Fractional Co2 Laser Either With Tacrolimus, Calcipotriol or NB-UVB in Stable Generalized Vitiligo

    Not yet reported Assiut University 30 participants Est. completion 2019-01 Stand-alone
    Other conditions: Vitiligo Vulgaris
    View official trial listing →
  • Status unknown NCT NCT03239015

    Efficacy and Safety of Precision Therapy in Refractory Tumor

    Not yet reported Baodong Qin 300 participants Est. completion 2023-12-31 1 site
    Other conditions: Rare Tumor, Refractory Tumor
    View official trial listing →
  • Status unknown NCT NCT03239119

    The Effectivity and Safety Study of rExenatide-4 in Chinese Type 2 Diabetes Mellitus

    Not yet reported CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 456 participants Est. completion 2019-01-15
    Type 2 diabetes
    View official trial listing →
  • Withdrawn NCT NCT03240822

    Human Penile Tissue Allotransplantation for Devastating Penile and Concomitant Genital Trauma

    Not yet reported Wake Forest University Health Sciences Est. completion 2025-12 Stand-alone
    Other conditions: Urologic Injuries, Genital Diseases, Male, Amputation
    View official trial listing →
  • Completed NCT NCT03241043

    Study to Evaluate Pharmacokinetic and Bioavailability of Envarsus® vs. Advagraf® in Liver Transplant Recipients

    Not yet reported Universitätsklinikum Hamburg-Eppendorf 20 participants Est. completion 2019-04 1 site
    Other conditions: Liver Transplantation
    View official trial listing →
  • Completed NCT NCT03245151

    Study of Lenvatinib in Combination With Everolimus in Recurrent and Refractory Pediatric Solid Tumors, Including Central Nervous System Tumors

    Not yet reported, Not yet reported Eisai Inc. 64 participants Est. completion 2022-09-30 50 sites
    Other conditions: Recurrent and Refractory Solid Tumors
    View official trial listing →
  • Terminated NCT NCT03246906

    Comparison of Triple GVHD Prophylaxis Regimens for Nonmyeloablative or Reduced Intensity Conditioning Unrelated Mobilized Blood Cell Transplantation

    Not yet reported Fred Hutchinson Cancer Center 150 participants Est. completion 2025-05-03 1 site Stand-alone
    Other conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Aggressive Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, Diffuse Large B-Cell Lymphoma, Mantle Cell Lymphoma, Myelodysplastic Syndrome, Myelodysplastic/Myeloproliferative Neoplasm, Prolymphocytic Leukemia, Recurrent Chronic Lymphocytic Leukemia, Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Recurrent Hodgkin Lymphoma, Recurrent Plasma Cell Myeloma, Recurrent Small Lymphocytic Lymphoma, Recurrent Waldenstrom Macroglobulinemia, Hematologic and Lymphocytic Disorder, Blastic Plasmacytoid Dendritic Cell Neoplasm
    View official trial listing →
  • Active, not recruiting NCT NCT03247088

    Sorafenib, Busulfan and Fludarabine in Treating Patients With Recurrent or Refractory Acute Myeloid Leukemia Undergoing Donor Stem Cell Transplant

    Not yet reported, Not yet reported M.D. Anderson Cancer Center 74 participants Est. completion 2027-12-31 1 site Stand-alone
    Other conditions: Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia
    View official trial listing →
  • Active, not recruiting NCT NCT03249831

    A Blood Stem Cell Transplant for Sickle Cell Disease

    Not yet reported City of Hope Medical Center 3 participants Est. completion 2027-01-25 1 site Stand-alone
    Other conditions: Sickle Cell Disease, Sickle Cell Disorder, Hemoglobinopathies, Thalassemia, Anemia, Sickle Cell
    View official trial listing →
  • Completed NCT NCT03256864

    Twice-daily Tacrolimus and Everolimus Convert to Once-daily Tacrolimus and Everolimus in Liver Transplant Recipient

    Not yet reported Chang Gung Memorial Hospital 10 participants Est. completion 2020-05-30 1 site Stand-alone
    Other conditions: Liver Transplantation
    View official trial listing →
  • Status unknown NCT NCT03259256

    Islet Allotransplantation for Type 1 Diabetic Patients

    Not yet reported Second Affiliated Hospital of Guangzhou Medical University 5 participants Est. completion 2019-06-30 1 site Stand-alone
    Other conditions: Type 1 Diabetic
    View official trial listing →
  • Completed NCT NCT03263052

    Converting Elderly Kidney Transplant Recipients From Tacrolimus to Envarsus to Limit Neurological AE and Improve QOL

    University of Illinois Chicago 40 participants Est. completion 2020-01-01 1 site
    Other conditions: Disorder Related to Renal Transplantation
    View official trial listing →
  • Completed NCT NCT03263260

    Post-marketing Registry of Inspiron Sirolimus Eluting Coronary Stent

    Scitech Produtos Medicos SA 2504 participants Est. completion 2024-01-21 1 site
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT03263559

    Haploidentical Bone Marrow Transplantation in Sickle Cell Patients (BMTCTN1507)

    Not yet reported Medical College of Wisconsin 95 participants Est. completion 2025-01-29 32 sites Stand-alone
    Other conditions: Sickle Cell Disease
    View official trial listing →
  • Active, not recruiting NCT NCT03266393

    Envarsus XR® in Adolescent Renal Transplant Recipients

    Not yet reported University of California, Los Angeles 28 participants Est. completion 2023-03-31 1 site Stand-alone
    Other conditions: Kidney Transplantation, Renal Transplantation, Grafting, Kidney
    View official trial listing →
  • Completed NCT NCT03270462

    CNS Study of Patients Switching From Tacrolimus to Envarsus

    Not yet reported University of Colorado, Denver 20 participants Est. completion 2020-06-02 1 site
    Other conditions: Renal Transplant Patients
    View official trial listing →
  • Completed NCT NCT03270748

    Post Transplant High-Dose Cy as GvHD Prophylaxis in 1 HLA Mismatched Unrelated HSCT for Myeloid Malignancies

    Not yet reported Gruppo Italiano Trapianto di Midollo Osseo 78 participants Est. completion 2022-11-20 33 sites Stand-alone
    Other conditions: Myeloid Malignancies
    View official trial listing →
  • Completed NCT NCT03273088

    Pharmacokinetic, Safety and Tolerability Study of Altebrel in Healthy Male Subjects

    Not yet reported AryoGen Pharmed Co. 34 participants Est. completion 2017-03-15 1 site Stand-alone
    Other conditions: Phase 1, Bioequivalence
    View official trial listing →
  • Status unknown NCT NCT03277430

    Uterus Transplantation From Live Donors and From Deceased Donors - Clinical Study

    Not yet reported Institute for Clinical and Experimental Medicine 20 participants Est. completion 2025-12-31 1 site Stand-alone
    Other conditions: Mayer Rokitansky Kuster Hauser Syndrome, Mullerian Aplasia, Uterus; Absence, Congenital, Infertility, Female, Uterus Absence, Acquired, Absolute Uterine Factor Infertility
    View official trial listing →
  • Completed NCT NCT03285802

    Treatment Plan for an Individual Patient With Recurrent Uterine Papillary Serous Carcinoma (UPSC) With PIK3CA Gene Mutation

    Not yet reported, Not yet reported Greater Baltimore Medical Center 1 participants Est. completion 2019-02-12 1 site
    Other conditions: Uterine Cancer
    View official trial listing →
  • Status unknown NCT NCT03287076

    Trial of EXenatide in Acute Ischaemic Stroke

    Not yet reported Neuroscience Trials Australia 350 participants Est. completion 2021-12-31 15 sites Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Status unknown NCT NCT03287167

    Comparison One vs Six Months of Dual Antiplatelet Therapy After Implanted Firehawk TM Stent in High Bleeding Risk Patients With Coronary Artery Disease

    Not yet reported Shanghai MicroPort Medical (Group) Co., Ltd. 1720 participants Est. completion 2023-07-30 1 site
    Other conditions: Coronary Disease, Drug Eluting Stent, Percutaneous Coronary Intervention, Dual Antiplatelet Therapy
    View official trial listing →
  • Completed NCT NCT03289650

    Extended Release Tacrolimus vs. Twice-Daily Tacrolimus

    Not yet reported Lorenzo Gallon 29 participants Est. completion 2021-02-23 1 site
    Other conditions: End Stage Renal Disease, Rejection of Renal Transplant
    View official trial listing →
  • Status unknown NCT NCT03292445

    Inducing Graft Tolerance in HLA Haplotype Matched Related and 3 Ag Matched Unrelated Living Donor Kidney Transplantation

    Not yet reported Samuel Strober 24 participants Est. completion 2024-02-14 2 sites Stand-alone
    Other conditions: Immune Tolerance
    View official trial listing →
  • Enrolling by invitation NCT NCT03292861

    The Effect and Safety Profile of Thymoglobulin® in Primary Cardiac Transplant Recipients

    Not yet reported Cedars-Sinai Medical Center 60 participants Est. completion 2026-03-31 2 sites
    Other conditions: Heart Transplantation
    View official trial listing →
  • Withdrawn NCT NCT03298958

    Secondary Prevention Trial of Rapamycin in Patients With Resected Non-muscle Invasive Bladder Cancer

    Not yet reported The University of Texas Health Science Center at San Antonio Est. completion 2022-05-01 1 site
    Other conditions: Bladder Cancer
    View official trial listing →
  • Completed NCT NCT03304678

    Discovery of Sirolimus Sensitive Biomarkers in Blood

    Not yet reported National Heart, Lung, and Blood Institute (NHLBI) 33 participants Est. completion 2025-03-14 1 site
    Other conditions: Lymphangioleiomyomatosis
    View official trial listing →
  • Withdrawn NCT NCT03315052

    Budesonide for Immunosuppression After Liver Transplantation to Reduce Side Effects

    Not yet reported Montefiore Medical Center Est. completion 2022-01 Stand-alone
    Other conditions: Acute Cellular Graft Rejection, Liver Transplant Rejection
    View official trial listing →
  • Completed NCT NCT03315858

    NFAT-regulated Gene Expression After Tacrolimus

    Medical University of Graz 40 participants Est. completion 2021-11-29 1 site
    Other conditions: NFAT Regulated Gene Expression in Tacrolimus Treated Patients
    View official trial listing →
  • Terminated NCT NCT03320642

    GRAVITAS-119: Itacitinib in Combination With Calcineurin Inhibitor-Based Interventions for the Prophylaxis of Graft-Versus Host Disease

    Not yet reported Incyte Corporation 84 participants Est. completion 2022-02-17 17 sites Stand-alone
    Other conditions: Hematologic Malignancies
    View official trial listing →
  • Completed NCT NCT03327454

    Benepali® PEN Patient Satisfaction Survey

    Biogen 500 participants Est. completion 2018-06-21 38 sites
    Other conditions: Rheumatoid Arthritis, Spondyloarthropathies
    View official trial listing →
  • Completed NCT NCT03328104

    Everolimus in Combination With Nelarabine, Cyclophosphamide and Etoposide in Lymphoblastic Leukemia/Lymphoma

    Not yet reported Emory University 8 participants Est. completion 2023-06-29 4 sites
    Other conditions: Lymphoblastic Leukemia, Lymphoblastic Lymphoma
    View official trial listing →
  • Completed NCT NCT03331289

    Can Exenatide Prevent Increase in EGP in Response to Dapagliflozin-induced Increase in Glucosuria

    Not yet reported The University of Texas Health Science Center at San Antonio 107 participants Est. completion 2022-11-04 1 site
    Type 2 diabetes
    View official trial listing →
  • Terminated NCT NCT03333694

    Safety, Tolerability, and Efficacy Study of CLL442 in Patients With Cutaneous Squamous Cell Carcinoma in Situ (SCCis)

    Not yet reported Novartis Pharmaceuticals 40 participants Est. completion 2018-11-01 8 sites
    Other conditions: Cutaneous Squamous Cell Carcinoma in Situ (CSCCis)
    View official trial listing →
  • Active, not recruiting NCT NCT03334617

    Phase II Umbrella Study of Novel Anti-cancer Agents in Participants With NSCLC Who Progressed on an Anti-PD-1/PD-L1 Containing Therapy

    Not yet reported AstraZeneca 528 participants Est. completion 2026-09-11 45 sites
    Other conditions: Non-Small Cell Lung Cancer
    View official trial listing →
  • Completed NCT NCT03347357

    Pharmacokinetics of Tacrolimus in Children

    Not yet reported Shandong University 28 participants Est. completion 2017-09-30 Stand-alone
    Other conditions: Nephrotic Syndrome
    View official trial listing →
  • Completed NCT NCT03350191

    A Clinical Study to Investigate if SAR425899 Binds to the Liver and Pancreas in Overweight to Obese Type 2 Diabetes Mellitus Patients

    Not yet reported Sanofi 13 participants Est. completion 2018-06-07 1 site
    Type 2 diabetes
    View official trial listing →
  • Status unknown NCT NCT03352622

    Pharmacogenomic in Colombian Patients With Rheumatoid Arthritis

    Not yet reported Universidad de Antioquia 372 participants Est. completion 2020-09-17 1 site
    Other conditions: Pharmacological Action
    View official trial listing →
  • Completed NCT NCT03352869

    Research of Exenatide for Overweight/Obese PCOS Patients With IGR

    Not yet reported RenJi Hospital 183 participants Est. completion 2018-07-31 1 site Stand-alone
    Other conditions: Polycystic Ovary Syndrome, Overweight and Obesity, Disorder of Glucose Regulation
    View official trial listing →
  • Completed NCT NCT03355794

    A Study of Ribociclib and Everolimus Following Radiation Therapy in Children With Newly Diagnosed Non-biopsied Diffuse Pontine Gliomas (DIPG) and RB+ Biopsied DIPG and High Grade Gliomas (HGG)

    Not yet reported Children's Hospital Medical Center, Cincinnati 19 participants Est. completion 2022-07-31 7 sites
    Other conditions: Diffuse Intrinsic Pontine Glioma, Malignant Glioma of Brain, High Grade Glioma, Bithalamic High Grade Glioma, Brainstem Glioma, Glioblastoma, Anaplastic Astrocytoma
    View official trial listing →
  • Status unknown NCT NCT03358082

    Effectivness of Topical Tacrolimus Monotherapy in Patients With Vitiligo

    Not yet reported, Not yet reported Sohag University 100 participants Est. completion 2019-02-01 1 site
    Other conditions: Vitiligo, Tacrolimus
    View official trial listing →
  • Terminated NCT NCT03363763

    Topical Sirolimus Ointment for Cutaneous Angiofibromas in Subjects With Tuberous Sclerosis Complex

    Not yet reported Aucta Pharmaceuticals, Inc 24 participants Est. completion 2023-03-24 8 sites
    Other conditions: Angiofibroma of Face, Tuberous Sclerosis
    View official trial listing →
  • Status unknown NCT NCT03365141

    Efficacy of Intralesional Triamcinolone Injection in the Treatment of Vitiligo

    Not yet reported The Catholic University of Korea 12 participants Est. completion 2018-09-15 1 site Stand-alone
    Other conditions: Vitiligo, Treatment, Intralesional Injection, Corticosteroid
    View official trial listing →
  • Status unknown NCT NCT03365869

    A Pilot-Study of Sirolimus for the Treatment of Systemic Sclerosis

    Not yet reported Peking University People's Hospital 72 participants Est. completion 2019-06-30
    Other conditions: Systemic Sclerosis
    View official trial listing →
  • Completed NCT NCT03373227

    Phase II Study Evaluating the Efficacy of Tacrolimus Extended Release Tablets to Twice Daily Tacrolimus Dosing Regimen

    Not yet reported Baylor Research Institute 50 participants Est. completion 2023-12-30 1 site
    Other conditions: Heart Transplant Rejection, Graft Failure, Compliance, Patient
    View official trial listing →
  • Active, not recruiting NCT NCT03373903

    Dose Finding Study to Determine if BEZ235 Alone or in Combination With RAD001 Decreases the Incidence of Respiratory Tract Infections in the Elderly

    Not yet reported Restorbio Inc. 652 participants Est. completion 2018-07 1 site
    Other conditions: Respiratory Tract Infections
    View official trial listing →
  • Terminated NCT NCT03380936

    Pilot Study of Treatment for Subclinical AMR (Antibody-mediated Rejection) in Kidney Transplant Recipients

    Not yet reported University of Colorado, Denver 4 participants Est. completion 2019-10-16 1 site
    Other conditions: Kidney Transplant Rejection
    View official trial listing →
  • Status unknown NCT NCT03383068

    Research of Intensive Metabolic Intervention Before Pregnancy in PCOS

    Not yet reported RenJi Hospital 160 participants Est. completion 2020-06-30 1 site Stand-alone
    Prediabetes Other conditions: PCOS
    View official trial listing →
  • Completed NCT NCT03383380

    Rapamycin Treatment for Activated Phosphoinositide 3-Kinase δ Syndrome

    Not yet reported, Not yet reported Children's Hospital of Fudan University 30 participants Est. completion 2023-11-30 2 sites
    Other conditions: Activated PI3K-delta Syndrome, Immunodeficiency Primary
    View official trial listing →
  • Active, not recruiting NCT NCT03386305

    Evaluate the Clinical Benefits of EnvarsusXR in Post Liver Transplant

    Not yet reported, Not yet reported Albert Einstein Healthcare Network 35 participants Est. completion 2021-12-31 1 site
    Other conditions: Post Liver Transplant
    View official trial listing →
  • Completed NCT NCT03386539

    Tacrolimus/Everolimus vs. Tacrolimus/MMF in Pediatric Heart Transplant Recipients Using the MATE Score

    Not yet reported Boston Children's Hospital 211 participants Est. completion 2023-05-17 25 sites Stand-alone
    Chronic kidney disease Other conditions: Pediatric Heart Transplantation, Immunosuppression, Cardiac Allograft Vasculopathy, Heart Transplant Failure and Rejection, Post-transplant Lymphoproliferative Disorder, Heart Transplant Infection
    View official trial listing →
  • Completed NCT NCT03388008

    Belatacept Pilot Study in Lung Transplantation Immunosuppression in Lung Transplantation

    Not yet reported Washington University School of Medicine 27 participants Est. completion 2022-08-31 2 sites Stand-alone
    Other conditions: Lung Transplant Rejection, Antibody-mediated Rejection
    View official trial listing →
  • Completed NCT NCT03399994

    Clinical Trial of Abluminus DES+ Sirolimus Eluting Stent Versus Everolimus-eluting DES

    Not yet reported Fondazione Evidence per Attività e Ricerche Cardiovascolari ONLUS 137 participants Est. completion 2022-07-26 6 sites
    Cardiovascular disease Other conditions: Diabetes
    View official trial listing →
  • Status unknown NCT NCT03408210

    Total Marrow and Lymphoid Irradiation and Chemotherapy for Myelodysplastic Syndrome or Acute Leukemia

    Not yet reported Affiliated Hospital to Academy of Military Medical Sciences 191 participants Est. completion 2022-08 1 site Stand-alone
    Other conditions: Myelodysplastic Syndromes, Acute Leukemia
    View official trial listing →
  • Status unknown NCT NCT03408223

    Total Marrow and Lymphoid Irradiation and Chemotherapy for High-Risk Acute Leukemia

    Not yet reported Affiliated Hospital to Academy of Military Medical Sciences 100 participants Est. completion 2022-12 1 site Stand-alone
    Other conditions: Acute Leukemia
    View official trial listing →
  • Completed NCT NCT03410654

    Assessment of Cognitive Function Before and After Conversion From Immediate Release Tacrolimus to Envarsus XR.

    Not yet reported Yale University 28 participants Est. completion 2024-07-01 1 site Stand-alone
    Other conditions: Kidney Transplant; Complications
    View official trial listing →
  • Completed NCT NCT03413722

    Alterations in Cognitive Function and Cerebral Blood Flow After Conversion From Calcineurin Inhibitors (CNIs) to Everolimus

    University of Kansas Medical Center 30 participants Est. completion 2022-10-01 1 site
    Other conditions: End Stage Renal Disease
    View official trial listing →
  • Completed NCT NCT03415750

    Everolimus and Tacrolimus Combination for Regression of Left Ventricular Hypertrophy in Renal Transplants

    Not yet reported Edoardo Melilli 20 participants Est. completion 2020-05 1 site Stand-alone
    Other conditions: Hypertrophy, Left Ventricular
    View official trial listing →
  • Terminated NCT NCT03419624

    The Potential of Dapagliflozin Plus Exenatide in Obese Insulin-resistant Patients

    Not yet reported Universitätsklinikum Hamburg-Eppendorf 13 participants Est. completion 2019-08-05 4 sites Stand-alone
    Type 2 diabetes Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT03423225

    To Evaluate the Efficacy and Safety of ADVAGRAF® After Treatment With a Tacrolimus in New Liver Transplant Recipients

    Not yet reported Kim, Seoung-Hoon 31 participants Est. completion 2017-12-14 Stand-alone
    Other conditions: Liver Transplantation
    View official trial listing →
  • Status unknown NCT NCT03425071

    Monitoring Concentration and Pharmacodynamic Effects of Tacrolimus in Peripheral Blood Lymphocytes of Kidney Transplant Recipients

    University of Sao Paulo General Hospital 45 participants Est. completion 2018-12 1 site
    Other conditions: Kidney Transplantation, Rejection
    View official trial listing →
  • Completed NCT NCT03426969

    Combination Chemotherapy, Total Body Irradiation, and Donor Blood Stem Cell Transplant in Treating Patients With Primary or Secondary Myelofibrosis

    Not yet reported M.D. Anderson Cancer Center 3 participants Est. completion 2020-09-21 1 site Stand-alone
    Other conditions: Primary Myelofibrosis, Secondary Myelofibrosis
    View official trial listing →
  • Completed NCT NCT03433183

    SARC031: MEK Inhibitor Selumetinib (AZD6244) in Combination With the mTOR Inhibitor Sirolimus for Patients With Malignant Peripheral Nerve Sheath Tumors

    Not yet reported Sarcoma Alliance for Research through Collaboration 21 participants Est. completion 2023-10-01 5 sites Stand-alone
    Other conditions: Malignant Peripheral Nerve Sheath Tumors, Neurofibromatosis 1
    View official trial listing →
  • Terminated NCT NCT03436732

    Mesothelin-Targeted Immunotoxin LMB-100 in Combination With SEL-110 in Subjects With Malignant Pleural or Peritoneal Mesothelioma

    Not yet reported National Cancer Institute (NCI) 5 participants Est. completion 2019-04-30 1 site
    Other conditions: Mesothelioma
    View official trial listing →
  • Completed NCT NCT03437577

    Comparison of the Cognitive and Motor Effects of Treatment Between an Immediate- and Extended-release Tacrolimus (Envarsus® XR) Based Immunosuppression Regimen in Kidney Transplant Recipients

    Not yet reported, Not yet reported University of Minnesota 18 participants Est. completion 2020-03-31 1 site Stand-alone
    Other conditions: Kidney Transplant Failure and Rejection
    View official trial listing →
  • Status unknown NCT NCT03438773

    Prospective Pilot Feasibility Study Comparing Envarsus Once-a-day to Tacrolimus Twice-a-day Immunosuppressive Regimen on Drug Bioavailability in Hispanic First Time Kidney Transplant Recipients

    Not yet reported California Institute of Renal Research 50 participants Est. completion 2023-12 1 site
    Other conditions: Kidney Transplant; Complications, Kidney Transplant Failure and Rejection
    View official trial listing →
  • Completed NCT NCT03439462

    Nab-Sirolimus in Combination With FOLFOX & BEV as 1st Line Therapy in Patients With Advanced or Metastatic Colorectal Cancer

    Not yet reported, Not yet reported Aadi Bioscience, Inc. 60 participants Est. completion 2022-08-26 6 sites Stand-alone
    Other conditions: Colorectal Cancer Metastatic
    View official trial listing →
  • Completed NCT NCT03441958

    ECT-001 (UM171) Expanded Cord Blood Transplant to Treat High-risk Multiple Myeloma

    Not yet reported, Not yet reported Ciusss de L'Est de l'Île de Montréal 19 participants Est. completion 2025-10-17 1 site Stand-alone
    Other conditions: Multiple Myeloma
    View official trial listing →
  • Completed NCT NCT03444064

    PolyTreg Immunotherapy in Islet Transplantation

    Not yet reported University of Alberta 11 participants Est. completion 2024-12-17 1 site
    Other conditions: Diabetes, Diabetes Mellitus, Type 1
    View official trial listing →
  • Active, not recruiting NCT NCT03451851

    A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Subcutaneously Administered Guselkumab for the Treatment of Chronic Plaque Psoriasis in Pediatric Participants

    Not yet reported Janssen Research & Development, LLC 120 participants Est. completion 2026-12-18 39 sites
    Other conditions: Psoriasis
    View official trial listing →
  • Status unknown NCT NCT03454724

    Study of MeRes100 in the Treatment of Patient With Coronary Artery Disease.

    Not yet reported Meril Life Sciences Pvt. Ltd. 484 participants Est. completion 2024-12-01 Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT03461445

    Effect of Tacrolimus Formulation on Neurological Side Effects in Older Kidney Transplant Recipients

    Not yet reported University of California, Davis 64 participants Est. completion 2023-07-31 1 site Stand-alone
    Other conditions: Kidney Transplant; Complications, Toxicity, Drug Toxicity, Neurotoxicity
    View official trial listing →
  • Completed NCT NCT03464435

    A Novel Combined Therapy for Refractory Vernal Keratoconjunctivitis

    Not yet reported Zhongshan Ophthalmic Center, Sun Yat-sen University 20 participants Est. completion 2018-02-01 Stand-alone
    Other conditions: Vernal Keratoconjunctivitis
    View official trial listing →
  • Completed NCT NCT03465410

    OPTImization of the Dose of tacroliMUS by Bayesian Prediction

    Not yet reported NURIA LLOBERAS BLANCH 96 participants Est. completion 2020-09-21 2 sites Stand-alone
    Other conditions: KIDNEY TRANSPLANTATION
    View official trial listing →
  • Completed NCT NCT03465969

    A Study to Compare the Finger Prick Whole Blood MITRA Assay Method With the Established Venepuncture Whole Blood Method for Quantitative Determination of Tacrolimus Blood Concentrations in Transplant Patients

    Not yet reported Astellas Pharma Europe Ltd. 80 participants Est. completion 2018-09-14 4 sites
    Other conditions: Kidney Transplantation, Liver Transplantation
    View official trial listing →
  • Active, not recruiting NCT NCT03467386

    Total Marrow and Lymphoid Irradiation Before Donor Transplant and Cyclophosphamide in Treating Patients With Acute Myeloid Leukemia

    Not yet reported City of Hope Medical Center 56 participants Est. completion 2027-04-12 1 site Stand-alone
    Other conditions: Acute Myeloid Leukemia
    View official trial listing →
  • Completed NCT NCT03468478

    Comparison of the Efficacy and Safety of Sirolimus Versus Everolimus Versus Mycophenolate in Kidney Transplantation

    Not yet reported Hospital do Rim e Hipertensão 1209 participants Est. completion 2021-08-23 1 site Stand-alone
    Other conditions: Kidney Transplant Infection
    View official trial listing →
  • Completed NCT NCT03471234

    Latin America Real World Study With Inspiron Drug Eluting Stent - INSPIRON LATITUDE

    Scitech Produtos Medicos SA 299 participants Est. completion 2022-08-02 2 sites
    Cardiovascular disease
    View official trial listing →
  • Status unknown NCT NCT03475563

    BiOSS Study (BiOSS LIM C Stent Registry in Bifurcated Lesions)

    Hospital Universitari Vall d'Hebron Research Institute 100 participants Est. completion 2019-12-30 3 sites
    Cardiovascular disease
    View official trial listing →
  • Active, not recruiting NCT NCT03478215

    Mesenchymal Stromal Cells in Living Donor Kidney Transplantation

    Not yet reported The Methodist Hospital Research Institute 24 participants Est. completion 2026-12 1 site Stand-alone
    Other conditions: Renal Transplantation, Mesenchymal Stem Cells
    View official trial listing →
  • Completed NCT NCT03480360

    Haploidentical Allogeneic Peripheral Blood Transplantation: Examining Checkpoint Immune Regulators' Expression

    Not yet reported Dartmouth-Hitchcock Medical Center 21 participants Est. completion 2025-10-17 1 site
    Other conditions: Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia, Chronic Myeloid Leukemia, Myelodysplasia, Myeloproliferative Disorder, Myelofibrosis, Lymphoma, Lymphoma, Non-Hodgkin, Plasma Cell Disorder
    View official trial listing →
  • Terminated NCT NCT03484234

    Percutaneous Treatment of LONG Native Coronary Lesions With Drug-Eluting Stent-VII: Sirolimus-eluting (Ultimaster) vs. Everolimus-Eluting Stents (Xience)

    Not yet reported Seung-Jung Park 36 participants Est. completion 2019-09-06 2 sites
    Cardiovascular disease Other conditions: Coronary Stenosis
    View official trial listing →
  • Completed NCT NCT03492580

    A Study for Comparison of Canagliflozin Versus Alternative Antihyperglycemic Treatments on Risk of Heart Failure Hospitalization and Amputation for Participants With Type 2 Diabetes Mellitus and the Subpopulation With Established Cardiovascular Disease

    Janssen Research & Development, LLC 714582 participants Est. completion 2018-06-25 1 site
    Type 2 diabetesCardiovascular disease
    View official trial listing →
  • No Longer Available NCT NCT03493165

    Expanded Access to Everolimus, for an Individual Patient With Uterine Sarcoma (CTMS#18-0020)

    The University of Texas Health Science Center at San Antonio
    Other conditions: Uterine Sarcoma
    View official trial listing →
  • Status unknown NCT NCT03500848

    Sirolimus-based Immunosuppression Treatment Regimen for Liver Transplantation

    Not yet reported, Not yet reported Southern Medical University, China 130 participants Est. completion 2023-05-31 3 sites Stand-alone
    Other conditions: Liver Transplantation
    View official trial listing →
  • Completed NCT NCT03507205

    Korean Nationwide Multicenter Pooled Registry of Drug-Eluting Stents

    Seoul National University Hospital 17286 participants Est. completion 2017-11-30 37 sites
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT03511560

    Envarsus on the Effect of Total Tacrolimus Dose/Trough Level Ratio on Renal Function (eGFR) in Kidney Transplantation

    Not yet reported Columbia University 50 participants Est. completion 2021-07-17 1 site Stand-alone
    Other conditions: Renal Transplant Rejection, Kidney Transplant Failure and Rejection
    View official trial listing →
  • Completed NCT NCT03512431

    Dose Adjustment of Tacrolimus Based on Home Sampling in Renal Transplant Recipients

    Oslo University Hospital 27 participants Est. completion 2018-11-01 1 site
    Other conditions: Renal Transplant Rejection
    View official trial listing →
  • Terminated NCT NCT03512756

    A Randomized Phase 2/3 Multi-Center Study of SM-88 in Participants With Metastatic Pancreatic Cancer

    Not yet reported, Not yet reported Tyme, Inc 130 participants Est. completion 2021-12-28 20 sites Stand-alone
    Other conditions: Pancreatic Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT03513939

    A Safety, Tolerability and Efficacy Study of Sernova's Cell Pouch™ for Clinical Islet Transplantation

    Not yet reported, Not yet reported Sernova Biotherapeutics Inc. 17 participants Est. completion 2026-10 1 site
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT03522298

    Safety, Pharmacokinetics and Efficacy of Paxalisib (GDC-0084) in Newly-diagnosed Glioblastoma

    Not yet reported Kazia Therapeutics Limited 30 participants Est. completion 2023-03-30 6 sites
    Other conditions: Glioblastoma, Adult
    View official trial listing →
  • Completed NCT NCT03525834

    Safety and Efficacy of Everolimus (Afinitor®) in Chinese Adult Patients With Angiomyolipoma Associated With Tuberous Sclerosis Complex.

    Not yet reported Novartis Pharmaceuticals 40 participants Est. completion 2020-09-25 5 sites
    Other conditions: Renal Angiomyolipoma
    View official trial listing →
  • Completed NCT NCT03527238

    Optimizing Immunosuppression Drug Dosing Via Phenotypic Precision Medicine

    Not yet reported University of Florida 62 participants Est. completion 2021-08-31 3 sites Stand-alone
    Other conditions: Liver Transplant, Kidney Transplant
    View official trial listing →
  • Withdrawn NCT NCT03531281

    Human Lysozyme Goat Milk in Treating Patients With Blood Cancer Undergoing Donor Stem Cell Transplant

    Not yet reported City of Hope Medical Center Est. completion 2022-12-30 1 site Stand-alone
    Other conditions: Hematopoietic and Lymphoid Cell Neoplasm, Hematopoietic Cell Transplantation Recipient
    View official trial listing →
  • Completed NCT NCT03535051

    Efficiency of Fractional-Laser Resurfacing Followed by Topical Tacrolimus 0.03% Cream vs Tacrolimus Alone in Vitiligo

    Not yet reported Kasr El Aini Hospital 27 participants Est. completion 2017-02-01 Stand-alone
    Other conditions: Stable Vitiligo
    View official trial listing →
  • Status unknown NCT NCT03540472

    Tacrolimus Treatment for Refractory PRCA

    Not yet reported Peking Union Medical College Hospital 30 participants Est. completion 2020-06-10 1 site Stand-alone
    Other conditions: Pure Red Cell Aplasia
    View official trial listing →
  • Terminated NCT NCT03544242

    Nitrite Infusion in Islet Cell Transplantation

    Not yet reported University of Alabama at Birmingham 4 participants Est. completion 2019-06-27 1 site
    Other conditions: Diabetes
    View official trial listing →
  • Status unknown NCT NCT03548272

    BiOSS LIM C vs 2nd Generation DES in Non-LM Bifurcations

    Not yet reported Central Clinical Hospital of the Ministry of Internal Affairs and Administration, Warsaw, Poland 518 participants Est. completion 2020-06 1 site Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Status unknown NCT NCT03549663

    Tacrolimus Monotherapy for Idiopathic Membranous Nephropathy (IMN)

    Not yet reported Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 108 participants Est. completion 2021-10 1 site Stand-alone
    Other conditions: Idiopathic Membranous Nephropathy
    View official trial listing →
  • Terminated NCT NCT03555448

    Once Daily Immunosuppression Regimen

    Not yet reported Washington University School of Medicine 51 participants Est. completion 2023-11-10 1 site
    Other conditions: Kidney Transplant; Complications
    View official trial listing →
  • Status unknown NCT NCT03557203

    Dermatologic Tacrolimus Ointment on Eyelids in the Treatment of Refractory Vernal Keratoconjunctivitis and Atopic Keratoconjunctivitis

    National Taiwan University Hospital 10 participants Est. completion 2019-05-31 1 site
    Other conditions: Vernal Keratoconjunctivitis, Atopic Keratoconjunctivitis, Tacrolimus
    View official trial listing →
  • Completed NCT NCT03558373

    The Adherence of Immunosuppressive Therapy Including Tacrolimus Once-daily in Italian Kidney Transplant Recipients

    Chiesi Farmaceutici S.p.A. 158 participants Est. completion 2020-02-26 12 sites
    Other conditions: Kidney Transplant
    View official trial listing →
  • Status unknown NCT NCT03571438

    Evaluation of a Promising New Combination of Protein Kinase Inhibitors on Organotypic Cultures of Human Renal Tumors

    Not yet reported University Hospital, Grenoble 100 participants Est. completion 2024-09-30 1 site
    Other conditions: Kidney Cancer
    View official trial listing →
  • Completed NCT NCT03577431

    Liver Transplantation With Tregs at MGH

    Not yet reported, Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 9 participants Est. completion 2026-02-05 1 site Stand-alone
    Other conditions: Liver Transplant
    View official trial listing →
  • Status unknown NCT NCT03580239

    Everolimus in Castrated Resistant Prostate Cancer(CRPC)Patients With PI3K-AKT-mTOR Signaling Pathway Deficiency

    Not yet reported Tianjin Medical University Second Hospital 120 participants Est. completion 2023-12-01 4 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT03582878

    Sirolimus vs Mycophenolate With Tacrolimus in Simultaneous Pancreas and Kidney Transplantation

    Not yet reported Institute for Clinical and Experimental Medicine 238 participants Est. completion 2019-01-01 1 site Stand-alone
    Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT03583307

    Efficacy and Safety of Sirolimus to Vascular Anomalies

    Not yet reported West China Hospital 126 participants Est. completion 2021-02-19 1 site Stand-alone
    Other conditions: Vascular Anomaly
    View official trial listing →
  • Withdrawn NCT NCT03585946

    Outcomes in Stevens Johnsons Syndrome and Toxic Epidermal Necrolysis

    Massachusetts General Hospital Est. completion 2040-12-31
    Other conditions: Stevens-Johnson Syndrome, Toxic Epidermal Necrolysis, Drug Reaction
    View official trial listing →
  • Status unknown NCT NCT03587922

    FANTOM Post Market Clinical Trial

    Not yet reported REVA Medical, Inc. 1500 participants Est. completion 2025-05-01 10 sites
    Cardiovascular disease
    View official trial listing →
  • Terminated NCT NCT03591380

    CAMPath and BELimumab for Transplant Tolerance in Sensitized Kidney Transplant Recipients

    Not yet reported University of Wisconsin, Madison 3 participants Est. completion 2021-12-03 1 site Stand-alone
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Withdrawn NCT NCT03596970

    Study of the Effect of Everolimus Immunosuppressive Combination Therapies on Renal Function When Used as a Maintenance Treatment for Liver Transplant Patients.

    Not yet reported Novartis Pharmaceuticals Est. completion 2020-12
    Other conditions: Liver Transplantation
    View official trial listing →
  • Terminated NCT NCT03600948

    BIOFLOW-SV All Comers Registry

    Biotronik AG 261 participants Est. completion 2021-10-06 2 sites
    Other conditions: de Novo, Symptomatic Ischemic Heart Disease, Restenoses, Coronary
    View official trial listing →
  • Terminated NCT NCT03600961

    BIOFLOW-SV Portugal Registry

    Biotronik AG 173 participants Est. completion 2021-12-21 4 sites
    Other conditions: Ischemic Heart Disease
    View official trial listing →
  • Status unknown NCT NCT03601208

    Mitra v Fingerprick Tacrolimus Creatinine

    Not yet reported Nottingham University Hospitals NHS Trust 100 participants Est. completion 2019-01 Stand-alone
    Other conditions: Transplant;Failure,Kidney
    View official trial listing →
  • Withdrawn NCT NCT03602898

    Comparing ATG or Post-Transplant Cyclophosphamide to Calcineurin Inhibitor-Methotrexate as GVHD Prophylaxis After Myeloablative Unrelated Donor Peripheral Blood Stem Cell Transplantation

    Not yet reported Fred Hutchinson Cancer Center Est. completion 2023-09-17 1 site Stand-alone
    Other conditions: Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia, Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Hematopoietic and Lymphoid System Neoplasm, Myelodysplastic Syndrome, Myelofibrosis, Myeloproliferative Neoplasm, Recurrent Acute Myeloid Leukemia, Recurrent Hodgkin Lymphoma, Recurrent Non-Hodgkin Lymphoma, Refractory Acute Myeloid Leukemia, Therapy-Related Acute Myeloid Leukemia
    View official trial listing →
  • Status unknown NCT NCT03603548

    Comparison of Safety and Efficacy of Two Variants of Prolonged - Released Tacrolimus (Advagraf vs. Envarsus ) in Patients After Liver Transplantation : Single Center Randomised Control Trial

    Not yet reported Medical University of Warsaw 200 participants Est. completion 2023-07-09 1 site Stand-alone
    Other conditions: Liver Transplant Rejection, Immunosuppression
    View official trial listing →
  • Withdrawn NCT NCT03605654

    Cellular Immunotherapy in Recipients of Human Leukocyte Antigen (HLA)-Mismatched, Living Donor Kidney Transplants

    Not yet reported, Not yet reported Medeor Therapeutics, Inc. Est. completion 2026-10
    Other conditions: Kidney Transplant Rejection
    View official trial listing →
  • Completed NCT NCT03605927

    CD40-L Blockade for Prevention of Acute Graft-Versus-Host Disease

    Not yet reported H. Lee Moffitt Cancer Center and Research Institute 45 participants Est. completion 2023-07-25 3 sites Stand-alone
    Other conditions: Graft-versus-host-disease, GVHD, GVHD, Acute
    View official trial listing →
  • Terminated NCT NCT03610347

    Paclitaxel Eluting Balloon After Bare Metal Stent Implantation vs. Drug-Eluting Stent in St Elevation Myocardial Infarction

    Not yet reported Fundacion Investigacion Interhospitalaria Cardiovascular 199 participants Est. completion 2020-03-31 16 sites
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT03614221

    Comparison of Lindioil (Indigo Naturalis Oil Extract) Ointment to Protopic® Ointment 0.1% in Treating Atopic Dermatitis

    Not yet reported Chang Gung Memorial Hospital 22 participants Est. completion 2021-12-06 2 sites Stand-alone
    Other conditions: Atopic Dermatitis
    View official trial listing →
  • Status unknown NCT NCT03616132

    A First-in-Man Study to Evaluate the Feasibility and Safety of Sirolimus-eluting Iron Bioresorbable Coronary Scaffold System

    Not yet reported Lifetech Scientific (Shenzhen) Co., Ltd. 15 participants Est. completion 2023-03-30 2 sites Stand-alone
    Other conditions: Single Coronary Vessel Disease
    View official trial listing →
  • Completed NCT NCT03618355

    Trial of eRapa in Prostate Cancer Patients

    Not yet reported Rapamycin Holdings, Inc. dba Emtora Biosciences 15 participants Est. completion 2019-12-02 1 site Stand-alone
    Other conditions: Prostate Cancer
    View official trial listing →
  • Status unknown NCT NCT03621501

    Direct Complete Versus Staged Complete Revascularization in Patients Presenting With Acute Coronary Syndromes and Multivessel Disease

    Not yet reported Erasmus Medical Center 1525 participants Est. completion 2026-10-31 1 site
    Other conditions: Acute Coronary Syndrome
    View official trial listing →
  • Completed NCT NCT03623217

    Quality of Life Questionnaire Validation for Patients With Changed Tacrolimus Dosing After Kidney Transplantation

    Astellas Pharma Korea, Inc. 56 participants Est. completion 2017-10-17 1 site
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT03626714

    Safety and Pharmacokinetics of Sustained-release Depot Tacrolimus: A First-in-human Study

    Not yet reported Auritec Pharmaceuticals 8 participants Est. completion 2019-01-05 1 site Stand-alone
    Other conditions: Organ Transplant Rejection, Psoriasis
    View official trial listing →
  • Completed NCT NCT03634020

    DynamX Sirolimus Study Sirolimus Eluting Coronary Bioadaptor System

    Not yet reported Elixir Medical Corporation 44 participants Est. completion 2021-03-08 7 sites Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Terminated NCT NCT03636373

    Pilot Study Evaluating The Efficacy Of Etanercept In Acute Gout

    Not yet reported Rutgers, The State University of New Jersey 5 participants Est. completion 2021-08-13 1 site Stand-alone
    Other conditions: Gout Attack
    View official trial listing →
  • Terminated NCT NCT03640026

    Glucose Disorders Induced by Tacrolimus on Pre Transplantation Endstage Renal Disease Patients

    Not yet reported Centre Hospitalier Departemental Vendee 61 participants Est. completion 2025-11-10 2 sites Stand-alone
    Other conditions: Kidney Failure, Chronic
    View official trial listing →
  • Completed NCT NCT03644485

    Clinical Outcome of Delayed or Standard Prograf Together With Induction Therapy Followed by Conversion to Advagraf in Donation After Cardiac (or Circulatory) Death (DCD) Kidney Transplant Recipients

    Not yet reported Astellas Pharma China, Inc. 284 participants Est. completion 2022-07-15 14 sites Stand-alone
    Other conditions: Kidney Transplant
    View official trial listing →
  • Completed NCT NCT03644667

    Tocilizumab in Cardiac Transplantation

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 385 participants Est. completion 2025-03-25 20 sites Stand-alone
    Other conditions: Heart Transplant
    View official trial listing →
  • Completed NCT NCT03645057

    ASPIRE: PROs & Caregiver Burden in Children With Atopic Dermatitis

    Not yet reported University of Rochester 92 participants Est. completion 2021-08-01 1 site
    Other conditions: Atopic Dermatitis
    View official trial listing →
  • Terminated NCT NCT03645408

    The Effects of Exenatide, a GLP-1 Agonist, on Alcohol Self-Administration in Heavy Drinkers

    Not yet reported Boston Medical Center 8 participants Est. completion 2021-07-01 1 site Stand-alone
    Alcohol use disorder
    View official trial listing →
  • Terminated NCT NCT03654040

    Liver Transplantation With Tregs at UCSF

    Not yet reported, Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 42 participants Est. completion 2023-03-06 1 site Stand-alone
    Other conditions: Liver Transplant
    View official trial listing →
  • Completed NCT NCT03654794

    Study of the Cellular Diffusion of Tacrolimus Across the Membrane of Mononuclear Cells

    Rennes University Hospital 26 participants Est. completion 2017-07-06 1 site
    Other conditions: Hemochromatosis
    View official trial listing →
  • Completed NCT NCT03656926

    Efficacy + Safety of Liposome Cyclosporine A to Treat Bronchiolitis Obliterans Post Double Lung Transplant (BOSTON-2)

    Not yet reported Zambon SpA 169 participants Est. completion 2024-03-12 40 sites
    Other conditions: Bronchiolitis Obliterans, Chronic Rejection of Lung Transplant, Lung Transplant Rejection, Lung Transplant; Complications, Lung Transplant Failure and Rejection, Chronic Lung Allograft Dysfunction
    View official trial listing →
  • Completed NCT NCT03657342

    Efficacy + Safety of Liposome Cyclosporine A to Treat Bronchiolitis Obliterans Post Single Lung Transplant (BOSTON-1)

    Not yet reported Zambon SpA 62 participants Est. completion 2024-04-16 39 sites
    Other conditions: Bronchiolitis Obliterans, Chronic Rejection of Lung Transplant, Lung Transplant Rejection, Lung Transplant; Complications, Lung Transplant Failure and Rejection, Chronic Lung Allograft Dysfunction
    View official trial listing →
  • Terminated NCT NCT03660930

    Nab-Sirolimus and Pazopanib Hydrochloride in Treating Patients With Advanced Nonadipocytic Soft Tissue Sarcomas

    Not yet reported, Not yet reported University of Washington 19 participants Est. completion 2024-07-31 1 site Stand-alone
    Other conditions: Advanced Soft Tissue Sarcoma, Locally Advanced Soft Tissue Sarcoma, Metastatic Soft Tissue Sarcoma
    View official trial listing →
  • Completed NCT NCT03663335

    Study of Efficacy, Safety, Tolerability, Pharmacokinetic (PK) and Pharmacodynamic (PD) of an Anti-CD40 Monoclonal Antibody, CFZ533, in Kidney Transplant Recipients

    Not yet reported Novartis Pharmaceuticals 418 participants Est. completion 2021-10-29 74 sites Stand-alone
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Active, not recruiting NCT NCT03663933

    Allogeneic Hematopoietic Cell Transplantation for Disorders of T-cell Proliferation and/or Dysregulation

    Not yet reported National Cancer Institute (NCI) 71 participants Est. completion 2030-04-03 2 sites Stand-alone
    Other conditions: Lymphoproliferative Disorders, Autoimmune Lymphoproliferative, Primary T-cell Immunodeficiency Disorders, Immune System Diseases, Common Variable Immunodeficiency
    View official trial listing →
  • Completed NCT NCT03665766

    Effect of Cyclosporine A Versus Tacrolimus on Response to Antiviral Therapy After Hepatitis C Genotype -4 Recurrence Post Liver Transplantation

    Ain Shams University 126 participants Est. completion 2018-04-02
    Other conditions: Liver Transplantation
    View official trial listing →
  • Completed NCT NCT03666208

    Sirolimus Coated Angioplasty Balloon in the Salvage of Thrombosed Arteriovenous Graft

    Not yet reported Singapore General Hospital 20 participants Est. completion 2019-09-02 1 site Stand-alone
    Other conditions: End Stage Renal Failure on Dialysis, Arteriovenous Graft Occlusion
    View official trial listing →
  • Terminated NCT NCT03670030

    A Study to testABI-009 in Patients With Metastatic, Unresectable, Low or Intermediate Grade Neuroendocrine Tumors of the Lung or Gastroenteropancreatic System

    Not yet reported Robert Ramirez 5 participants Est. completion 2021-02-26 1 site
    Other conditions: Neuroendocrine Tumors
    View official trial listing →
  • Status unknown NCT NCT03671733

    Effects of GLP-1 RAs on Weight and Metabolic Indicators in Obese Patients

    Not yet reported Xiangya Hospital of Central South University 150 participants Est. completion 2022-09-01 1 site Stand-alone
    Other conditions: Obesity
    View official trial listing →
  • Status unknown NCT NCT03672110

    Slow and Low Start of a Tacrolimus Once Daily Immunosuppressive Regimen

    Not yet reported Technische Universität Dresden 400 participants Est. completion 2025-12 1 site Stand-alone
    Other conditions: Renal Failure, Renal Insufficiency, Renal Disease, Renal Insufficiency, Chronic
    View official trial listing →
  • Completed NCT NCT03673527

    Tacrolimus Blood Levels After Topical Application of Tacrolimus on Healthy Skin

    Not yet reported LEO Pharma 24 participants Est. completion 2019-02-11 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Active, not recruiting NCT NCT03674411

    Trial Evaluating MGTA-456 in Patients With High-Risk Malignancy

    Not yet reported Masonic Cancer Center, University of Minnesota 22 participants Est. completion 2026-12-01 1 site Stand-alone
    Other conditions: Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, Biphenotypic/Undifferentiated Leukemia, Chronic Myelogenous Leukemia, Myelodysplasia, Relapsed Large Cell Lymphoma, Mantle Cell Lymphoma, Hodgkin Lymphoma, Burkitt Lymphoma, Relapsed T-Cell Lymphoma, Lymphoplasmacytic Lymphoma
    View official trial listing →
  • Completed NCT NCT03680092

    Comparing Cyclophosphamide and Abatacept With Standard of Care Treatment Following Stem Cell Transplantation

    Not yet reported Dimitrios Tzachanis, MD PhD 43 participants Est. completion 2023-06-15 1 site
    Other conditions: GVHD, Hematologic Neoplasms
    View official trial listing →
  • Status unknown NCT NCT03688191

    Study of Sirolimus in CTD-TP in China

    Not yet reported Peking Union Medical College Hospital 20 participants Est. completion 2019-09-30 1 site Stand-alone
    Other conditions: Connective Tissue Diseases, Thrombocytopenia
    View official trial listing →
  • Terminated NCT NCT03689075

    Extended Release Versus Immediate Release Tacrolimus Following Renal Allograft Failure to Reduce Allosensitisation

    Not yet reported Imperial College Healthcare NHS Trust 35 participants Est. completion 2025-02-25 1 site
    Other conditions: Kidney Transplant Failure, Allosensitization, Immunosuppression
    View official trial listing →
  • Completed NCT NCT03696355

    Study of GDC-0084 in Pediatric Patients With Newly Diagnosed Diffuse Intrinsic Pontine Glioma or Diffuse Midline Gliomas

    Not yet reported St. Jude Children's Research Hospital 27 participants Est. completion 2022-09-04 1 site
    Other conditions: Brain and Central Nervous System Tumors
    View official trial listing →
  • Active, not recruiting NCT NCT03697408

    Itacitinib + Everolimus in Hodgkin Lymphoma

    Not yet reported, Not yet reported University of Pennsylvania 23 participants Est. completion 2027-06 1 site
    Other conditions: Classical Hodgkin Lymphoma
    View official trial listing →
  • Status unknown NCT NCT03698396

    Islet Transplant in Patients With Type I Diabetes

    Not yet reported, Not yet reported Kenneth Brayman, MD 10 participants Est. completion 2023-12-01 1 site
    Other conditions: Diabetes Mellitus, Type 1
    View official trial listing →
  • Completed NCT NCT03699631

    PROACTIVE: Preventing Acute/Chronic GVHD With TocIlizumab Combined With GVHD Prophylaxis Post allogEneic Transplant

    Not yet reported Medical College of Wisconsin 29 participants Est. completion 2023-04-01 1 site Stand-alone
    Other conditions: Hematologic Malignancy
    View official trial listing →
  • Completed NCT NCT03703154

    Alterations in Cognitive Function and Cerebral Blood Flow After Conversion From Immediate Release Tacrolimus to Slow Release Envarsus

    University of Kansas Medical Center 30 participants Est. completion 2021-03-03 1 site
    Other conditions: End Stage Renal Disease
    View official trial listing →
  • Terminated NCT NCT03711929

    LUMINA Phase III Study Assessing the Efficacy and Safety of Intravitreal Injections of 440 ug DE-109 Sirolimus for the Treatment of Active, Non-Infectious Uveitis of the Posterior Segment of the Eye

    Not yet reported Santen Inc. 145 participants Est. completion 2022-06-14 65 sites
    Other conditions: Non Infectious Uveitis
    View official trial listing →
  • Completed NCT NCT03712878

    2-Step Approach to Stem Cell Transplant in Treating Participants With Hematological Malignancies

    Not yet reported Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 10 participants Est. completion 2025-03-19 1 site Stand-alone
    Other conditions: Hematopoietic and Lymphoid Cell Neoplasm
    View official trial listing →
  • Completed NCT NCT03713645

    Dosing Strategies for de Novo Once-daily Extended Release Tacrolimus (LCPT) in Kidney Transplant Recipients

    Not yet reported Temple University 36 participants Est. completion 2022-01-31 1 site Stand-alone
    Other conditions: Kidney Transplant
    View official trial listing →
  • Status unknown NCT NCT03715387

    Tacrolimus for Malar Edema

    Not yet reported, Not yet reported University of British Columbia 100 participants Est. completion 2019-07-01 1 site Stand-alone
    Other conditions: Edema Face
    View official trial listing →
  • Status unknown NCT NCT03721614

    Clinical Study Comparing Single Long BioMimeTM Morph Coronary Stent System vs. Two Overlapping Xience Family Coronary Stent Systems in the Treatment of Patients With Long de Novo Lesions.

    Not yet reported Meril Life Sciences Pvt. Ltd. 200 participants Est. completion 2022-06-22 Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Active, not recruiting NCT NCT03726307

    Allogeneic Regulatory Dendritic Cell (DCreg) Renal Study

    Not yet reported Angus W. Thomson PhD DSc 28 participants Est. completion 2028-05 1 site Stand-alone
    Other conditions: Kidney Transplant, Renal Transplant Recipients
    View official trial listing →
  • Completed NCT NCT03730142

    A Study of WXFL10030390 in Patients With Advanced Solid Tumors or Lymphoma

    Not yet reported Shanghai Jiatan Pharmatech Co., Ltd 82 participants Est. completion 2020-07-25 1 site
    Other conditions: Advanced Cancer
    View official trial listing →
  • Completed NCT NCT03730428

    Everolimus Related Pneumonitis in MBC

    Fudan University 86 participants Est. completion 2020-06-15 1 site
    Other conditions: Everolimus, Pneumonitis
    View official trial listing →
  • Completed NCT NCT03732248

    Altering Memories That Increase Risk of Relapse in Alcohol Use Disorders

    Not yet reported Medical University of South Carolina 21 participants Est. completion 2020-01-20 1 site
    Alcohol use disorder
    View official trial listing →
  • Completed NCT NCT03734601

    Total Body Irradiation +/- Total Lymphoid Irradiation & Anti-Thymocyte Globulin in Non-myeloablative Hematopoietic Cell Transplantation

    Not yet reported Stanford University 22 participants Est. completion 2020-11-17 1 site Stand-alone
    Other conditions: Acute Myeloid Leukemia, Myelodysplastic Syndromes, Myeloproliferative Disorder, Chronic Lymphocytic Leukemia, B-cell Lymphoma, T-cell Lymphoma, Non Hodgkin Lymphoma, Hodgkin Lymphoma, Chronic Myelomonocytic Leukemia
    View official trial listing →
  • Completed NCT NCT03737708

    A Study Comparing Biologics + Methotrexate With Biologics + Tacrolimus in Patients With Rheumatoid Arthritis (RA)

    Not yet reported Astellas Pharma Korea, Inc. 21 participants Est. completion 2020-06-16 10 sites Stand-alone
    Other conditions: Rheumatoid Arthritis (RA)
    View official trial listing →
  • Terminated NCT NCT03740100

    Single-arm Study With Bimiralisib in Patients With HNSCC Harboring NOTCH1 Loss of Function Mutations

    Not yet reported M.D. Anderson Cancer Center 8 participants Est. completion 2020-12-09 1 site
    Other conditions: HNSCC
    View official trial listing →
  • Active, not recruiting NCT NCT03740334

    Ribociclib in Combination With Everolimus and Dexamethasone in Relapsed ALL

    Not yet reported Dana-Farber Cancer Institute 45 participants Est. completion 2027-04-30 12 sites
    Other conditions: Acute Lymphoblastic Leukemia ALL
    View official trial listing →
  • Status unknown NCT NCT03747614

    Ocular Micro-vascular Research Base on Functional Slip Lamp Biomicroscopy

    Not yet reported Zhongshan Ophthalmic Center, Sun Yat-sen University 20 participants Est. completion 2020-06-30 1 site Stand-alone
    Other conditions: Dry Eye Syndromes, Inflammation, Microvessels
    View official trial listing →
  • Completed NCT NCT03749356

    Study to Evaluate the Efficacy and Safety of Once-Daily Tacrolimus in Kidney Transplant Recipients

    Not yet reported Chong Kun Dang Pharmaceutical 141 participants Est. completion 2020-12-04 1 site Stand-alone
    Other conditions: Kidney Transplant
    View official trial listing →
  • Completed NCT NCT03751332

    The Vienna Prograf and Endothelial Progenitor Cell Extension Study

    Not yet reported Medical University of Vienna 87 participants Est. completion 2010-10
    Other conditions: Immunosuppression, Renal Failure
    View official trial listing →
  • Completed NCT NCT03760263

    Evaluation Dose Adjustments in Kidney Transplant Patients on Immediate Release and Extended Release Tacrolimus

    Not yet reported Sentara Norfolk General Hospital 46 participants Est. completion 2023-11-01 1 site
    Other conditions: Transplant;Failure,Kidney
    View official trial listing →
  • Completed NCT NCT03762473

    Conversion to Envarsus Post Kidney Transplant Protects Against BK Infection

    Not yet reported University of Alabama at Birmingham 89 participants Est. completion 2022-03-16 1 site Stand-alone
    Other conditions: Renal Transplant Infection
    View official trial listing →
  • Completed NCT NCT03764670

    Genetic Factors on Outcomes of Kidney Transplant Patients With Tacrolimus-based Therapy

    National Taiwan University Hospital 98 participants Est. completion 2020-09-22 1 site
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Status unknown NCT NCT03767660

    Efficacy of Rapamycin (Sirolimus) in the Treatment of BRBNS, Hereditary or Sporadic Venous Malformation

    Not yet reported Peking Union Medical College Hospital 20 participants Est. completion 2022-07-01 1 site
    Other conditions: Blue Rubber Bleb Nevus Syndrome, Venous Malformation
    View official trial listing →
  • Status unknown NCT NCT03768518

    GLP-1 Receptor Expression in CHI

    Radboud University Medical Center 40 participants Est. completion 2019-02-01 1 site
    Other conditions: Congenital Hyperinsulinism
    View official trial listing →
  • Status unknown NCT NCT03770663

    Cyclophosphamide and Azathioprine vs Tacrolimus in Antisynthetase Syndrome-related Interstitial Lung Disease

    Not yet reported Assistance Publique - Hôpitaux de Paris 76 participants Est. completion 2024-01-02 1 site Stand-alone
    Other conditions: Antisynthetase Syndrome (ASS), Interstitial Lung Disease
    View official trial listing →
  • Completed NCT NCT03775824

    Faecal Analyses in Rheumatoid Arthritis Therapy

    Region Skane 50 participants Est. completion 2019-06-01
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Active, not recruiting NCT NCT03778996

    SM-88 Maintenance Therapy for Advanced Ewing's Sarcoma and as Salvage Therapy for Sarcoma

    Not yet reported Sarcoma Oncology Research Center, LLC 31 participants Est. completion 2028-03-31 1 site Stand-alone
    Other conditions: Sarcoma, Ewing, Sarcoma
    View official trial listing →
  • Active, not recruiting NCT NCT03779854

    Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant

    Not yet reported Fred Hutchinson Cancer Center 45 participants Est. completion 2027-08-31 9 sites Stand-alone
    Other conditions: Acute Biphenotypic Leukemia, Acute Leukemia, Acute Leukemia of Ambiguous Lineage, Acute Lymphoblastic Leukemia, Acute Undifferentiated Leukemia, Allogeneic Hematopoietic Stem Cell Transplantation Recipient, Blastic Plasmacytoid Dendritic Cell Neoplasm, Blasts Under 25 Percent of Bone Marrow Nucleated Cells, Blasts Under 5 Percent of Bone Marrow Nucleated Cells, Mixed Phenotype Acute Leukemia, Myelodysplastic Syndrome With Excess Blasts-1, Myelodysplastic Syndrome/Acute Myeloid Leukemia, Burkitt Leukemia, Chronic Monocytic Leukemia, Lymphoblastic Lymphoma, Mast Cell Leukemia, Myeloproliferative Neoplasm
    View official trial listing →
  • Completed NCT NCT03780959

    Safety and Efficacy of Etanercept (Recombinant Human Tumor Necrosis Factor Receptor Fusion Protein [TNFR:Fc]) in Children With Juvenile Rheumatoid Arthritis (JRA)

    Not yet reported, Not yet reported Amgen 69 participants Est. completion 1998-07-08 Stand-alone
    Other conditions: Juvenile Rheumatoid Arthritis
    View official trial listing →
  • Status unknown NCT NCT03781050

    Efficacy of Rapamycin (Sirolimus) in the Treatment of Peutz-Jeghers Syndrome

    Not yet reported Peking Union Medical College Hospital 10 participants Est. completion 2022-07-01 1 site
    Other conditions: Peutz-Jeghers Syndrome
    View official trial listing →
  • Terminated NCT NCT03781414

    Study of Efficacy, Safety, Tolerability, Pharmacokinetic (PK) and Pharmacodynamic (PD) of an Anti-CD40 Monoclonal Antibody, CFZ533, in Liver Transplant Recipients With Additional 12-month Follow-up and Long-term Extension

    Not yet reported Novartis Pharmaceuticals 129 participants Est. completion 2023-04-20 29 sites
    Other conditions: Liver Transplant Rejection
    View official trial listing →
  • Status unknown NCT NCT03785431

    Vascular Healing After Implantation of FANTOM Bioresorbable Scaffold in STEMI: A FANTOM STEMI Study

    Not yet reported Medical University of Warsaw 20 participants Est. completion 2022-06-06 1 site
    Cardiovascular disease Other conditions: STEMI, Bioresorbable Scaffold
    View official trial listing →
  • Status unknown NCT NCT03789006

    Antithymocyte Globulin and Azathioprine Versus Basiliximab and Mycophenolate Mofetil in Living Donor Kidney Transplantation

    Not yet reported University of Khartoum 300 participants Est. completion 2024-03-21 1 site
    Other conditions: Kidney Transplant Rejection
    View official trial listing →
  • Status unknown NCT NCT03791827

    Multicenter Registry of Pediatric Lupus Nephritis in China

    Xiqiang Dang 1200 participants Est. completion 2024-11-30 1 site
    Other conditions: Lupus Nephritis, Children, Steroid, Immunosuppressive Treatment
    View official trial listing →
  • Completed NCT NCT03794492

    Impact of Lymphocyte Anti-metabolite Immunosuppressions on Donor-Specific Anti-HLA Antibody and Kidney Graft Outcome

    Not yet reported Chong Kun Dang Pharmaceutical 169 participants Est. completion 2023-04-27 1 site Stand-alone
    Other conditions: Kidney Transplant
    View official trial listing →
  • Active, not recruiting NCT NCT03797196

    RCT Comparing Immunosuppressive Regimens in Elderly Renal Transplant Recipients

    Not yet reported University Medical Center Groningen 374 participants Est. completion 2026-12 7 sites Stand-alone
    Other conditions: Renal Transplant Recipients, Elderly Patients, Immunosuppression
    View official trial listing →
  • Completed NCT NCT03799770

    ONSD and Neurotoxicity in Liver Transplant

    Mansoura University 100 participants Est. completion 2021-03-23 1 site
    Other conditions: Liver Transplant; Complications
    View official trial listing →
  • Completed NCT NCT03800576

    Clinical Outcome of Liver Transplant Patients With Tacrolimus-based Immunosuppression

    National Taiwan University Hospital 113 participants Est. completion 2020-09-22 1 site
    Other conditions: Liver Transplantation
    View official trial listing →
  • Status unknown NCT NCT03804411

    Prognostic Predictors of Response to Hypoglycemic Therapy

    Not yet reported Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health 800 participants Est. completion 2020-05 1 site Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Active, not recruiting NCT NCT03816332

    Tacrolimus, Nivolumab, and Ipilimumab in Treating Kidney Transplant Recipients With Selected Unresectable or Metastatic Cancers

    Not yet reported National Cancer Institute (NCI) 12 participants Est. completion 2027-09-17 7 sites Stand-alone
    Other conditions: Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage III Cutaneous Merkel Cell Carcinoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Merkel Cell Carcinoma AJCC v8, Metastatic Basal Cell Carcinoma, Metastatic Melanoma, Metastatic Merkel Cell Carcinoma, Metastatic Skin Squamous Cell Carcinoma, Pathologic Stage III Cutaneous Melanoma AJCC v8, Pathologic Stage III Cutaneous Merkel Cell Carcinoma AJCC v8, Pathologic Stage IIIA Cutaneous Melanoma AJCC v8, Pathologic Stage IIIA Cutaneous Merkel Cell Carcinoma AJCC v8, Pathologic Stage IIIB Cutaneous Melanoma AJCC v8, Pathologic Stage IIIB Cutaneous Merkel Cell Carcinoma AJCC v8, Pathologic Stage IIIC Cutaneous Melanoma AJCC v8, Pathologic Stage IIID Cutaneous Melanoma AJCC v8, Pathologic Stage IV Cutaneous Melanoma AJCC v8, Pathologic Stage IV Cutaneous Merkel Cell Carcinoma AJCC v8, Unresectable Basal Cell Carcinoma, Unresectable Melanoma, Unresectable Merkel Cell Carcinoma
    View official trial listing →
  • Completed NCT NCT03823768

    Envarsus Neurotoxicity Burden in Liver Transplant Patients

    Not yet reported Medical University of South Carolina 30 participants Est. completion 2024-01-30 1 site
    Other conditions: Neurotoxicity, Liver Transplant; Complications
    View official trial listing →
  • Completed NCT NCT03828019

    Adalimumab vs. Conventional Immunosuppression for Uveitis Trial

    Not yet reported JHSPH Center for Clinical Trials 227 participants Est. completion 2024-09-09 26 sites
    Other conditions: Uveitis
    View official trial listing →
  • Completed NCT NCT03828058

    Envarsus XL Immunosuppression Following Liver Transplantation

    Not yet reported Methodist Healthcare - Memphis 110 participants Est. completion 2020-12-31 1 site
    Other conditions: Recipients of Liver Transplant
    View official trial listing →
  • Status unknown NCT NCT03828682

    Veloxis de Novo Kidney Transplant ECSWD

    Not yet reported Simon Tremblay, PharmD, PhD 60 participants Est. completion 2022-06-30 2 sites Stand-alone
    Other conditions: Kidney Transplantation, Immunosuppression
    View official trial listing →
  • Completed NCT NCT03830255

    Effect of Genetic Polymorphism on Calcineurin Inhibitors Levels in Egyptian Renal Transplant Patients

    Helwan University 143 participants Est. completion 2020-03-29 1 site
    Other conditions: Renal Transplantation
    View official trial listing →
  • Completed NCT NCT03834740

    A Phase 0/I Study of Ribociclib (LEE011) in Combination With Everolimus in Preoperative Recurrent High-Grade Glioma Patients Scheduled for Resection

    Not yet reported St. Joseph's Hospital and Medical Center, Phoenix 27 participants Est. completion 2022-02-18 3 sites
    Other conditions: Glioblastoma Multiforme, Glioma of Brain
    View official trial listing →
  • Terminated NCT NCT03839940

    Dexamethasone in Reducing Everolimus-Induced Oral Stomatitis in Patients With Cancer

    Not yet reported Alliance for Clinical Trials in Oncology 39 participants Est. completion 2022-08-03 319 sites
    Other conditions: Malignant Neoplasm
    View official trial listing →
  • Status unknown NCT NCT03840512

    An Open Label Study of Multiple Doses of Cannabidiol in the Prevention of Acute Graft-Versus-Host Disease (GVHD)

    Not yet reported Kalytera Therapeutics Israel, Ltd. 36 participants Est. completion 2022-12-15 5 sites Stand-alone
    Other conditions: Prevention aGVHD
    View official trial listing →
  • Active, not recruiting NCT NCT03841097

    Pulse Wave Velocity, Tacrolimus Time in Therapeutic Range and CV in African American Kidney Transplants

    Not yet reported Roy D. Bloom, MD 60 participants Est. completion 2026-12 1 site
    Other conditions: Kidney Transplant; Complications
    View official trial listing →
  • Active, not recruiting NCT NCT03842696

    Vorinostat for Graft vs Host Disease Prevention in Children, Adolescents and Young Adults Undergoing Allogeneic Blood and Marrow Transplantation

    Not yet reported, Not yet reported University of Michigan Rogel Cancer Center 43 participants Est. completion 2026-04-01 7 sites Stand-alone
    Other conditions: Hematologic Diseases, Acute Leukemia in Remission, Chronic Myelogenous Leukemia - Chronic Phase, Chronic Myelogenous Leukemia, Accelerated Phase, Chronic Myelogenous Leukemia, Blastic Phase, Myelodysplastic Syndromes, Mantle Cell Lymphoma, Follicular Lymphoma, Diffuse Large B Cell Lymphoma, Non Hodgkin Lymphoma, Graft Vs Host Disease, Graft-versus-host-disease
    View official trial listing →
  • Terminated NCT NCT03856216

    Inotuzumab Ozogamicin and Chemotherapy in Treating Patients With Leukemia or Lymphoma Undergoing Stem Cell Transplantation

    Not yet reported M.D. Anderson Cancer Center 15 participants Est. completion 2025-10-13 1 site Stand-alone
    Other conditions: Acute Lymphoblastic Leukemia, B Acute Lymphoblastic Leukemia, Lymphocytic Neoplasm, Lymphoma
    View official trial listing →
  • Status unknown NCT NCT03864250

    Tacrolimus Monotherapy for Idiopathic Membranous Nephropathy

    Not yet reported Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 124 participants Est. completion 2021-11 1 site Stand-alone
    Other conditions: Tacrolimus, Idiopathic Membranous Nephropathy, Clinical Trial
    View official trial listing →
  • Completed NCT NCT03864926

    Envarsus in Delayed Graft Function (E-DGF)

    Not yet reported University of Wisconsin, Madison 100 participants Est. completion 2022-07-22 1 site Stand-alone
    Other conditions: Delayed Graft Function
    View official trial listing →
  • Completed NCT NCT03865888

    Comparing Effect of Topical Tacrolimus 0.03% Versus Cyclosporine 0.05% in Dry Eyes of Secondary Sjogren Syndrome

    Not yet reported Pavly Moawd 60 participants Est. completion 2019-04-30 1 site
    Other conditions: Dry Eye, Sjogren Syndrome
    View official trial listing →
  • Status unknown NCT NCT03866681

    Sirolimus Combined With Low-dose Warfarin for the Treatment of Refractory PNH

    Not yet reported Peking Union Medical College Hospital 40 participants Est. completion 2022-04-01 1 site Stand-alone
    Other conditions: Paroxysmal Nocturnal Hemoglobinuria
    View official trial listing →
  • Completed NCT NCT03871361

    Abatacept in Patients With Birdshot HLA A29 Uveitis

    Not yet reported Universitaire Ziekenhuizen KU Leuven 15 participants Est. completion 2023-12-01 1 site Stand-alone
    Other conditions: Eye Diseases, Uveitis
    View official trial listing →
  • Completed NCT NCT03880968

    Treat-to-Target Strategy With Etanercept for Ankylosing Spondylitis

    Second Affiliated Hospital, Zhejiang University, School of Medicine 311 participants Est. completion 2014-09-30
    Other conditions: Spondylitis, Ankylosing
    View official trial listing →
  • Status unknown NCT NCT03882164

    Blood-Bile Ratio Tacrolimus After Liver Transplantation

    Fondazione Policlinico Universitario Agostino Gemelli IRCCS 55 participants Est. completion 2020-05 1 site
    Other conditions: Liver Transplant; Complications, Immunosuppression, Transplant Failure, Transplant; Complication, Rejection
    View official trial listing →
  • Status unknown NCT NCT03886233

    Treatment Outcome of Uveitis in Autoimmune Diseases

    Assiut University 1 participants Est. completion 2021-02
    Other conditions: Autoimmune Uveitis
    View official trial listing →
  • Terminated NCT NCT03889496

    Quantitative GLP-1 Receptor Imaging Correlated to ex Vivo Distribution of In-111-exendin

    Not yet reported Radboud University Medical Center 12 participants Est. completion 2021-06-14 1 site
    Other conditions: Diabetes Mellitus
    View official trial listing →
  • Completed NCT NCT03908450

    Treatment of Coronary De-novo Stenosis by a Sirolimus Coated Balloon or a Paclitaxel Coated Balloon Catheter

    Not yet reported InnoRa GmbH 70 participants Est. completion 2023-07-31 4 sites Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT03910868

    Impact of P-gp, MRP2, ENT-1 and CNT3 on the Blood Concentration / Intra-PBMC Concentration of Tacrolimus

    Rennes University Hospital 60 participants Est. completion 2020-12-16 1 site
    Other conditions: Liver Transplantation, Kidney Transplantation
    View official trial listing →
  • Active, not recruiting NCT NCT03913026

    UM171 Expanded Cord Blood In Patients With High-Risk Acute Leukemia/Myelodysplasia

    Not yet reported Ciusss de L'Est de l'Île de Montréal 30 participants Est. completion 2027-06 1 site Stand-alone
    Other conditions: High Risk Hematologic Malignancy, Cord Blood Transplant
    View official trial listing →
  • Completed NCT NCT03916380

    Drug Interaction With Envarsus XR and Grapefruit Juice

    Shirley M. Tsunoda 11 participants Est. completion 2023-12-31 1 site
    Other conditions: Kidney Transplant; Complications, Drug Interaction Food
    View official trial listing →
  • Status unknown NCT NCT03916432

    HELIOS China Registry: Evaluation of the HELIOS Stent in a 'Real-World' Patient Population

    Not yet reported Xijing Hospital 3000 participants Est. completion 2025-12-01 1 site Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Status unknown NCT NCT03918265

    Tacrolimus Treatment for Refractory Autoimmune Cytopenia

    Not yet reported Peking Union Medical College Hospital 80 participants Est. completion 2021-11-10 1 site Stand-alone
    Other conditions: Autoimmune Hemolytic Anemia, Pure Red Cell Aplasia, Evans Syndrome
    View official trial listing →
  • Active, not recruiting NCT NCT03922724

    Allogeneic Hematopoietic Cell Transplantation for Peripheral T Cell Lymphoma

    Not yet reported National Cancer Institute (NCI) 118 participants Est. completion 2030-10-31 2 sites Stand-alone
    Other conditions: Peripheral T-cell Lymphomas, Lymphoproliferative Disorders, Immune System Diseases
    View official trial listing →
  • Completed NCT NCT03923114

    Imaging Pituitary ActiVation by Exendin

    Not yet reported Radboud University Medical Center 20 participants Est. completion 2024-04-03 1 site
    Type 2 diabetes
    View official trial listing →
  • Status unknown NCT NCT03932539

    Improving Immunosuppressive Therapy in Heart Transplantation

    Fondazione IRCCS Policlinico San Matteo di Pavia 25 participants Est. completion 2021-12 4 sites
    Other conditions: Rejection Heart Transplant, Immunosuppression
    View official trial listing →
  • Active, not recruiting NCT NCT03933904

    Sirolimus in Previously Treated Idiopathic Multicentric Castleman Disease

    Not yet reported University of Pennsylvania 7 participants Est. completion 2027-06-30 2 sites Stand-alone
    Other conditions: Castleman Disease, Castleman's Disease, Multicentric
    View official trial listing →
  • Completed NCT NCT03959241

    TAC/MTX vs. TAC/MMF/PTCY for Prevention of Graft-versus-Host Disease and Microbiome and Immune Reconstitution Study (BMT CTN 1703/1801)

    Not yet reported Medical College of Wisconsin 431 participants Est. completion 2022-09-19 39 sites Stand-alone
    Other conditions: Acute Leukemia, Chronic Myelogenous Leukemia (CML), Myelodysplasia, Lymphoma
    View official trial listing →
  • Terminated NCT NCT03963024

    Treosulfan-TMI Conditioning and Rapamycin GvHD Prophylaxis Before Allo-HSCT

    Not yet reported IRCCS San Raffaele 9 participants Est. completion 2019-01-31 1 site
    Other conditions: Irradiated Bone Marrow, Transplant-Related Hematologic Malignancy, Leukemia, Acute, Multiple Myeloma, Graft Vs Host Disease
    View official trial listing →
  • Completed NCT NCT03968588

    Standard- Versus Reduced-dose Tacrolimus Combined With Generic Mycophenolate Mofetil in De Novo Renal Transplantation

    Not yet reported Ajou University School of Medicine 108 participants Est. completion 2017-06-14 4 sites Stand-alone
    Other conditions: Disorder Related to Renal Transplantation
    View official trial listing →
  • Completed NCT NCT03970044

    Effectiveness of Exenatide Plus Dapagliflozin on 24 Hour Glucose Variability Measured by CGM. A Proof of Concept.

    Not yet reported Consano Clinical Research, LLC 67 participants Est. completion 2021-06-01 1 site Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT03972462

    NPC-12G Gel 0.2% Sirolimus PK Bridging Study

    Not yet reported Nobelpharma 12 participants Est. completion 2019-06-17 1 site Stand-alone
    Other conditions: Bioavailability Study
    View official trial listing →
  • Withdrawn NCT NCT03978494

    Study to Compare Pharmacokinetics of Tacrolimus Prolonged-release (PR) Capsules and Advagraf® PR Capsules in Stable Kidney Transplant Patients.

    Not yet reported Sandoz Est. completion 2020-05-03 13 sites Stand-alone
    Other conditions: Kidney Transplant
    View official trial listing →
  • Completed NCT NCT03979365

    Envarsus XR Compared to Immediate Release Tacrolimus

    Not yet reported Mayo Clinic 261 participants Est. completion 2022-03-29 3 sites
    Other conditions: Kidney Transplant Recipients
    View official trial listing →
  • Active, not recruiting NCT NCT03983850

    Optimizing PTCy Dose and Timing

    Not yet reported, Not yet reported National Cancer Institute (NCI) 105 participants Est. completion 2026-10-26 1 site Stand-alone
    Other conditions: Graft Versus Host Disease, Hematologic Neoplasms
    View official trial listing →
  • Status unknown NCT NCT03987152

    Treatment of Congenital Vascular Malformations Using Sirolimus: Improving Quality of Life

    Not yet reported Radboud University Medical Center 75 participants Est. completion 2023-03-01 1 site
    Other conditions: Vascular Malformations
    View official trial listing →
  • Terminated NCT NCT03995901

    A Safety and Efficacy Study of FCR001 vs Standard of Care in de Novo Living Donor Kidney Transplantation

    Not yet reported Talaris Therapeutics Inc. 15 participants Est. completion 2023-02-16 18 sites
    Other conditions: Transplanted Organ Rejection
    View official trial listing →
  • Active, not recruiting NCT NCT03997786

    A Study of Tildrakizumab in Pediatric Subjects With Chronic Plaque Psoriasis

    Not yet reported, Not yet reported Sun Pharmaceutical Industries Limited 135 participants Est. completion 2031-08-05 27 sites Stand-alone
    Other conditions: Moderate-to-severe Chronic Plaque Psoriasis
    View official trial listing →
  • Withdrawn NCT NCT04001231

    Study of Exenatide Once-Weekly Suspension in Chinese Patients With Type 2 Diabetes Mellitus

    Not yet reported AstraZeneca Est. completion 2021-07-02 Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Terminated NCT NCT04002115

    Clofarabine Pre-conditioning Followed by Stem Cell Transplant for Non-remission AML

    Not yet reported Milton S. Hershey Medical Center 2 participants Est. completion 2022-11-07 1 site Stand-alone
    Other conditions: Acute Myeloid Leukemia
    View official trial listing →
  • Completed NCT NCT04009525

    Hematopoietic Stem Cell Transplantation for Patients With Thalassemia Major: A Multicenter, Prospective Clinical Study

    Not yet reported First Affiliated Hospital of Guangxi Medical University 823 participants Est. completion 2023-10-31 1 site Stand-alone
    Other conditions: Thalassemia Major
    View official trial listing →
  • Status unknown NCT NCT04013620

    CNI Transient Replacement by Belatacept From 3 to 12 Months Post Transplantation in Patients With Early Graft Dysfunction

    Not yet reported Nantes University Hospital 48 participants Est. completion 2022-07-09 1 site Stand-alone
    Other conditions: Chronic Kidney Failure
    View official trial listing →
  • Status unknown NCT NCT04014595

    PREPARE-CALC-COMBO: Severely Calcified Coronary Lesions Prepared With Rotational Atherectomy and Modified Balloons

    Segeberger Kliniken GmbH 100 participants Est. completion 2025-07-31 1 site
    Cardiovascular disease
    View official trial listing →
  • Active, not recruiting NCT NCT04018937

    Early Human Leukocyte Antigen (HLA) Matched Sibling Hematopoietic Stem Cell Transplantation

    Not yet reported Emory University 43 participants Est. completion 2026-11 15 sites Stand-alone
    Other conditions: Sickle Cell Disease
    View official trial listing →
  • Completed NCT NCT04023760

    Drug Interaction Study of Apixaban With Cyclosporine or Tacrolimus in Transplant Recipients

    Not yet reported University of Saskatchewan 14 participants Est. completion 2020-03-30 1 site Stand-alone
    Other conditions: Pharmacokinetics, Kidney Transplant, Lung Transplant
    View official trial listing →
  • Status unknown NCT NCT04027023

    Evaluation of the Impact of Intensive Short-Term Drug Therapy in Patients With Type 2 Diabetes Mellitus

    Not yet reported Sciema UG 9 participants Est. completion 2021-05-31 2 sites
    Type 2 diabetes
    View official trial listing →
  • Status unknown NCT NCT04029272

    Metformin vs Metformin Combined With GLP-1RA (Glucagon-like Peptide 1 Receptor Agonist) on Overweight/Obese PCOS Patients

    Not yet reported Peking Union Medical College Hospital 80 participants Est. completion 2020-12-31 1 site Stand-alone
    Other conditions: Polycystic Ovary Syndrome
    View official trial listing →
  • Completed NCT NCT04041219

    Use of Sublingual Tacrolimus in Adult Blood and Marrow Transplant Patients

    Not yet reported Mayo Clinic 10 participants Est. completion 2019-10-08 1 site Stand-alone
    Other conditions: Immunosuppression, Stem Cell Transplant, Bone Marrow Transplant
    View official trial listing →
  • Status unknown NCT NCT04045171

    Population Pharmacokinetics of Tacrolimus in Nephrotic Syndrome

    The Third Xiangya Hospital of Central South University 200 participants Est. completion 2020-12-31
    Other conditions: Nephrotic Syndrome, Tacrolimus, Pharmacokinetics
    View official trial listing →
  • Completed NCT NCT04048161

    Study of Tacrolimus vs Mycophenolate Mofetil in Pediatric Patients With Nephrotic Syndrome

    Not yet reported The Children's Hospital of Zhejiang University School of Medicine 270 participants Est. completion 2023-07-12 12 sites Stand-alone
    Other conditions: Nephrotic Syndrome in Children
    View official trial listing →
  • Completed NCT NCT04049552

    RAPA-Keloid Study of Keloid Regression

    Not yet reported The University of Texas Health Science Center at San Antonio 4 participants Est. completion 2021-05-02 1 site
    Other conditions: Keloid
    View official trial listing →
  • Status unknown NCT NCT04056962

    Tacrolimus for the Treatment of Superficial Kaposiform Hemangioendothelioma and Tufted Angioma

    Not yet reported West China Hospital 50 participants Est. completion 2024-10-28 1 site Stand-alone
    Other conditions: Tacrolimus, Kaposiform Hemangioendothelioma, Tufted Angioma
    View official trial listing →
  • Terminated NCT NCT04063865

    Everolimus Monotherapy as Immunosuppression After Liver Transplant

    Not yet reported Indiana University 14 participants Est. completion 2020-07-02 1 site
    Other conditions: Kidney Failure
    View official trial listing →
  • Completed NCT NCT04066114

    Treg Modulation With CD28 and IL-6 Receptor Antagonists

    Not yet reported, Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 24 participants Est. completion 2023-09-14 7 sites
    Other conditions: Living-Donor Kidney Transplant, Kidney Transplant Recipients
    View official trial listing →
  • Active, not recruiting NCT NCT04066348

    TNF-α Treatment of Blast-Induced Tinnitus

    Not yet reported Wayne State University 88 participants Est. completion 2027-02 4 sites Stand-alone
    Other conditions: Tinnitus, Noise Induced
    View official trial listing →
  • Status unknown NCT NCT04069065

    Efficacy and Safety of Once-Daily Tacrolimus in Liver Transplant Recipients (SOUL)

    Not yet reported Chong Kun Dang Pharmaceutical 146 participants Est. completion 2021-04-08 1 site Stand-alone
    Other conditions: Liver Transplant
    View official trial listing →
  • Status unknown NCT NCT04078750

    PLATO - Medication Adherence in Transplant Recipients

    Not yet reported University of British Columbia 99 participants Est. completion 2024-12-31 2 sites Stand-alone
    Other conditions: Kidney Disease, Chronic, Medication Adherence, Renal Disease, Kidney Rejection Transplant
    View official trial listing →
  • Status unknown NCT NCT04079374

    Comparative Efficacy, Safety and Immunogenicity Study of Etanercept and Enbrel

    Not yet reported Joint Stock Company "Farmak" 160 participants Est. completion 2023-12-03 10 sites Stand-alone
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Withdrawn NCT NCT04080076

    Comparative and Efficacy Study of ACTHar Gel Alone or in Combination With Tacrolimus in Fibrillary Glomerulopathy

    Not yet reported NephroNet, Inc. Est. completion 2024-09-06 1 site
    Other conditions: Renal Disease
    View official trial listing →
  • Completed NCT NCT04082416

    Study of Recombinant Human B Lymphocyte(RC18) Administered Subcutaneously to Subjects With Systemic Lupus Erythematosus(SLE)

    Not yet reported RemeGen Co., Ltd. 335 participants Est. completion 2022-06-30 1 site Stand-alone
    Other conditions: Systemic Lupus Erythematosus
    View official trial listing →
  • Status unknown NCT NCT04082910

    Metoprolol Treatment for Cytokine Release Syndrome in Patients Treated With Chimeric Antigen Receptor T Cells

    Not yet reported, Not yet reported Chinese PLA General Hospital 30 participants Est. completion 2023-12-30 1 site Stand-alone
    Other conditions: Solid Tumor, Hematological Malignancy
    View official trial listing →
  • Completed NCT NCT04086745

    A Study of Baricitinib in Participants With Rheumatoid Arthritis

    Not yet reported Eli Lilly and Company 1050 participants Est. completion 2025-05-19 119 sites
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT04094675

    Sirolimus for Cowden Syndrome With Colon Polyposis

    Not yet reported Ohio State University 5 participants Est. completion 2025-06-05 1 site Stand-alone
    Other conditions: PTEN Gene Mutation, PTEN Hamartoma Tumor Syndrome, PTEN Hamartoma Syndrome, Cowden Syndrome, Bannayan Syndrome, Bannayan Zonana Syndrome, Polyposis
    View official trial listing →
  • Terminated NCT NCT04095858

    Efprezimod Alfa (CD24Fc, MK-7110) for the Prevention of Acute Graft Versus Host Disease (GVHD) Following Myeloablative Hematopoietic Stem Cell Transplantation (HSCT) (MK-7110-005)

    Not yet reported Oncoimmune, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 11 participants Est. completion 2021-11-05 4 sites Stand-alone
    Other conditions: Hematopoietic Stem Cell Transplantation, Acute Graft Versus Host Disease, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndromes
    View official trial listing →
  • Status unknown NCT NCT04101578

    Clinical Prognosis and Progression of Myasthenia Gravis Patients

    Da, Yuwei, M.D. 2000 participants Est. completion 2024-12-31 1 site
    Other conditions: Myasthenia Gravis
    View official trial listing →
  • Completed NCT NCT04102943

    Study to Evaluate the Pharmacokinetics and Tolerability of Tacrolimus in Kidney Transplant Recipients.

    Not yet reported Chong Kun Dang Pharmaceutical 128 participants Est. completion 2020-09-29 1 site Stand-alone
    Other conditions: Kidney Transplant
    View official trial listing →
  • Completed NCT NCT04103879

    US Study of UM171-Expanded CB in Patients With High Risk Leukemia/Myelodysplasia

    Not yet reported ExCellThera inc. 30 participants Est. completion 2026-02-28 3 sites Stand-alone
    Other conditions: High Risk Hematological Malignancy, Cord Blood Transplant
    View official trial listing →
  • Completed NCT NCT04104438

    Examination of Immunosuppression Adjustment Impact on Kidney Function in Liver Transplant

    Not yet reported Fady M Kaldas, M.D., F.A.C.S. 71 participants Est. completion 2024-09-30 1 site
    Other conditions: Asses Immunosuppression Modulation on Renal Recovery Post LT
    View official trial listing →
  • Completed NCT NCT04107298

    Safety and Feasibility of Surmodics SUNDANCE™ Drug Coated Balloon

    Not yet reported SurModics, Inc. 35 participants Est. completion 2024-01-30 8 sites Stand-alone
    Other conditions: Peripheral Arterial Disease, Critical Lower Limb Ischemia
    View official trial listing →
  • Completed NCT NCT04114097

    The Effects of Topical Corticosteroid Use on Insulin Sensitivity and Bone Turnover

    Not yet reported Jacob Thyssen 36 participants Est. completion 2021-03-15 1 site
    Other conditions: Atopic Dermatitis, Atopic Eczema
    View official trial listing →
  • Completed NCT NCT04114188

    Tacrolimus After rATG and Infliximab Induction Immunosuppression (RIMINI)

    Not yet reported Prof. Dr. Petra Reinke 68 participants Est. completion 2020-12-31 1 site
    Other conditions: Renal Transplant Rejection
    View official trial listing →
  • Status unknown NCT NCT04115423

    A Retrospective Cohort Study on the Risk of Serious Infections in Rheumatoid Arthritis Patients Receiving Tocilizumab

    Sungkyunkwan University 9508 participants Est. completion 2021-10-01 1 site
    Other conditions: Infection, Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT04118075

    PT-CY With or Without Low-dose ATG for Lymphoid Malignancies Undergoing Allo-HSCT

    Not yet reported Shanghai Jiao Tong University School of Medicine 23 participants Est. completion 2021-05-01 1 site Stand-alone
    Other conditions: GVHD, Acute
    View official trial listing →
  • Withdrawn NCT NCT04127721

    Itacitinib for the Prevention of Graft Versus Host Disease in Patients Undergoing Donor Stem Cell Transplantation

    Not yet reported M.D. Anderson Cancer Center Est. completion 2020-09-22 1 site Stand-alone
    Other conditions: Allogeneic Stem Cell Transplant Recipient, Hematologic and Lymphocytic Disorder, Hematopoietic and Lymphoid Cell Neoplasm
    View official trial listing →
  • Completed NCT NCT04128722

    TOPical Sirolimus in linGUal Microcystic Lymphatic Malformation -TOPGUN

    Not yet reported University Hospital, Tours 12 participants Est. completion 2025-01-08 2 sites Stand-alone
    Other conditions: Lingual Microcystic Lymphatic Malformations
    View official trial listing →
  • Status unknown NCT NCT04135989

    Personalized Vs. Standard Duration of Dual Antiplatelet Therapy and New-generation Polymer-Free vs- Biodegradable-Polymer DES

    Not yet reported Federico II University 2106 participants Est. completion 2024-10-24 13 sites
    Cardiovascular disease Other conditions: Acute Coronary Syndrome, Chronic Coronary Syndrome
    View official trial listing →
  • Completed NCT NCT04138238

    Cruz HBR Registry - Post-market Registry to Evaluate the Safety and Efficacy of the Supraflex Cruz Stent

    Sahajanand Medical Technologies Limited 1200 participants Est. completion 2022-05-31 26 sites
    Cardiovascular disease
    View official trial listing →
  • Withdrawn NCT NCT04139915

    Effect of RTB101 on Illness Associated With Respiratory Tract Infections in the Elderly

    Not yet reported Restorbio Inc. Est. completion 2019-11-15
    Other conditions: Clinically Symptomatic Respiratory Illness
    View official trial listing →
  • Active, not recruiting NCT NCT04141020

    Effect of Sirolimus on Molecular Alterations in Cerebral Aneurysms

    Not yet reported University of Miami 26 participants Est. completion 2027-11-01 1 site Stand-alone
    Other conditions: Cerebral Aneurysm
    View official trial listing →
  • Status unknown NCT NCT04147390

    Immunosuppression After Repeat Keratoplasty

    Not yet reported, Not yet reported Shahid Beheshti University of Medical Sciences 58 participants Est. completion 2020-08 1 site
    Other conditions: Keratopathy
    View official trial listing →
  • Status unknown NCT NCT04150016

    In-stent Repair and Vessel Reaction of STEMI Patients With OCT

    Not yet reported Xijing Hospital 44 participants Est. completion 2021-12-01 1 site Stand-alone
    Cardiovascular disease Other conditions: Drug-eluting Stents, Percutaneous Coronary Intervention, Optical Coherence Tomography
    View official trial listing →
  • Withdrawn NCT NCT04154735

    Autologous Transplant Targeted Against Crohn's

    Not yet reported Northwestern University Est. completion 2024-03 1 site Stand-alone
    Other conditions: Crohn's Disease
    View official trial listing →
  • Terminated NCT NCT04156204

    Immunosuppressant Medication Dosed Daily After Kidney Transplant

    Not yet reported University of Colorado, Denver 1 participants Est. completion 2020-11-27 1 site Stand-alone
    Other conditions: Kidney Transplant Rejection, Medication Adherence
    View official trial listing →
  • Active, not recruiting NCT NCT04157153

    First in Men Study: BIOMAG-I

    Not yet reported Biotronik AG 116 participants Est. completion 2027-02 14 sites Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Status unknown NCT NCT04168944

    Lenvatinib Following Liver Transplantation in Patients With High-Risk Hepatocellular Carcinoma

    Not yet reported, Not yet reported RenJi Hospital 108 participants Est. completion 2022-09 Stand-alone
    Other conditions: Hepatocellular Carcinoma
    View official trial listing →
  • Terminated NCT NCT04172922

    Topical Rapamycin/Sirolimus for Complicated Vascular Anomalies and Other Susceptible Lesions

    Not yet reported Nemours Children's Clinic 5 participants Est. completion 2024-02-15 2 sites Stand-alone
    Other conditions: Vascular Anomaly
    View official trial listing →
  • Completed NCT NCT04176380

    RAPA-201 T Cell Therapy for Relapsed, Refractory Multiple Myeloma

    Not yet reported Rapa Therapeutics LLC 15 participants Est. completion 2023-06-06 1 site
    Other conditions: Relapsed, Refractory Multiple Myeloma
    View official trial listing →
  • Active, not recruiting NCT NCT04177004

    Human Lysozyme Goat Milk for the Prevention of Graft Versus Host Disease in Patients With Blood Cancer Undergoing a Donor Stem Cell Transplant

    Not yet reported City of Hope Medical Center 52 participants Est. completion 2027-03-23 1 site Stand-alone
    Other conditions: Allogeneic Hematopoietic Stem Cell Transplant Recipient, Hematopoietic and Lymphoid Cell Neoplasm
    View official trial listing →
  • Completed NCT NCT04184947

    Cardiovascular Outcomes SGLT-2 Inhibitors Versus GLP-1 Receptor Agonists

    University of Padova 10000 participants Est. completion 2020-02-29 1 site
    Type 2 diabetes
    View official trial listing →
  • Status unknown NCT NCT04185350

    Clinical Evaluation of 68Ga-NOTA-MAL-Cys39-exendin-4 Positron Emission Tomography in the Detection of Insulinoma

    Not yet reported Nanjing First Hospital, Nanjing Medical University 60 participants Est. completion 2020-05-05 1 site
    Other conditions: Insulinoma
    View official trial listing →
  • Active, not recruiting NCT NCT04188548

    A Study of LY3484356 in Participants With Advanced or Metastatic Breast Cancer or Endometrial Cancer

    Not yet reported Eli Lilly and Company 379 participants Est. completion 2027-12 74 sites
    Other conditions: Breast Cancer, Advanced Breast Cancer, Metastatic Breast Cancer, Endometrial Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT04195750

    A Study of Belzutifan (MK-6482) Versus Everolimus in Participants With Advanced Renal Cell Carcinoma (MK-6482-005)

    Not yet reported Merck Sharp & Dohme LLC 755 participants Est. completion 2026-10-14 172 sites
    Other conditions: Carcinoma, Renal Cell
    View official trial listing →
  • Withdrawn NCT NCT04198350

    Pancreatic Islet Transplantation to the Anterior Chamber of the Eye

    Not yet reported Imperial College London Est. completion 2025-08-31 1 site
    Other conditions: Type 1 Diabetes, Visual Impairment
    View official trial listing →
  • Completed NCT NCT04198506

    Viral Load Guided Immunosuppression After Lung Transplantation

    Not yet reported Philipps University Marburg 146 participants Est. completion 2025-03-10 2 sites Stand-alone
    Other conditions: Transplantation Lung
    View official trial listing →
  • Completed NCT NCT04200911

    Cognition, Age, and RaPamycin Effectiveness - DownregulatIon of thE mTor Pathway

    Not yet reported The University of Texas Health Science Center at San Antonio 10 participants Est. completion 2022-01-13 1 site Stand-alone
    Other conditions: Cognitive Impairment, Mild, Alzheimer Disease
    View official trial listing →
  • Terminated NCT NCT04203901

    Dendritic Cell Immunotherapy Plus Standard Treatment of Advanced Renal Cell Carcinoma

    Not yet reported CoImmune 16 participants Est. completion 2023-09-28 9 sites
    Other conditions: Advanced Renal Cell Carcinoma
    View official trial listing →
  • Terminated NCT NCT04205240

    Reduce Intensity Conditioning Donor Stem Cell Transplant for the Treatment of Relapsed Multiple Myeloma

    Not yet reported Srinivas Devarakonda 1 participants Est. completion 2021-11-22 1 site Stand-alone
    Other conditions: Recurrent Plasma Cell Myeloma
    View official trial listing →
  • Status unknown NCT NCT04207177

    Immunosuppressive Drugs and Gut Microbiome: Pharmacokinetic- and Microbiome Diversity Effects

    Not yet reported Oslo University Hospital 100 participants Est. completion 2025-12-31 1 site
    Other conditions: Kidney Transplant; Complications, Immune Suppression
    View official trial listing →
  • Status unknown NCT NCT04212702

    ESR1 Mutations in Asian ER+ Metastatic Breast Cancer on Hormonal Therapy-based Treatments

    National Taiwan University Hospital 123 participants Est. completion 2021-12-31 2 sites
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Withdrawn NCT NCT04220008

    Vorinostat and Combination Chemotherapy Before Donor Stem Cell Transplantation for the Treatment of Relapsed Aggressive B-cell or T-cell Non-Hodgkin Lymphoma

    Not yet reported M.D. Anderson Cancer Center Est. completion 2021-10-29 Stand-alone
    Other conditions: Recurrent Aggressive Non-Hodgkin Lymphoma, Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Burkitt Lymphoma, Recurrent Diffuse Large B-Cell Lymphoma, Recurrent High Grade B-Cell Lymphoma, Recurrent T-Cell Non-Hodgkin Lymphoma, Recurrent Transformed B-Cell Non-Hodgkin Lymphoma
    View official trial listing →
  • Status unknown NCT NCT04224350

    Study to Evaluate the Efficacy and Safety of Tacrolimus in Kidney Transplant Recipients (BLOSSOM)

    Not yet reported Chong Kun Dang Pharmaceutical 184 participants Est. completion 2020-11-30 1 site Stand-alone
    Other conditions: Kidney Transplant
    View official trial listing →
  • Completed NCT NCT04225988

    Comparison of Tacrolimus Extended-Release (Envarsus XR) to Tacrolimus Immediate-Release in Human Leukocyte Antigen (HLA) Sensitized Kidney Transplant Recipients

    Not yet reported Cedars-Sinai Medical Center 20 participants Est. completion 2023-07-11 1 site Stand-alone
    Other conditions: Kidney Transplant Rejection
    View official trial listing →
  • Completed NCT NCT04229004

    A Multi-center Trial to Evaluate Multiple Regimens in Metastatic Pancreatic Cancer

    Not yet reported Pancreatic Cancer Action Network 502 participants Est. completion 2025-02-05 25 sites Stand-alone
    Other conditions: Metastatic Pancreatic Cancer, Metastatic Pancreatic Adenocarcinoma
    View official trial listing →
  • Completed NCT NCT04230499

    Trial of eRapa to Prevent Progression in Familial Adenomatous Polyposis Patients Under Active Surveillance

    Not yet reported Rapamycin Holdings Inc. 30 participants Est. completion 2025-05-22 4 sites
    Other conditions: Familial Adenomatous Polyposis
    View official trial listing →
  • Completed NCT NCT04237246

    Comparative FK506 Drug Levels of Once Daily Advagraf in First Nations and Caucasian Patients With Liver Transplants

    Not yet reported University of Manitoba 20 participants Est. completion 2019-11-27 1 site Stand-alone
    Other conditions: Liver Failure
    View official trial listing →
  • Active, not recruiting NCT NCT04238546

    Major Adverse Limb Events in Patients With Femoro-popliteal and Below-the-knee Peripheral Arterial Disease Treated With Either Sirolimus-coated Balloon or Standard Uncoated Balloon Angioplasty

    Not yet reported Nils Kucher 1200 participants Est. completion 2029-12-31 2 sites Stand-alone
    Other conditions: Peripheral Arterial Disease
    View official trial listing →
  • Completed NCT NCT04240444

    Sirolimus-Coated Balloon Versus Paclitaxel-Coated Balloon for the Treatment of Coronary In-Stent Restenosis

    Not yet reported B. Braun Medical International Trading Company Ltd. 260 participants Est. completion 2022-08-30 16 sites Stand-alone
    Cardiovascular disease Other conditions: In Stent Restenosis
    View official trial listing →
  • Status unknown NCT NCT04247750

    Testing SIROLIMUS in Beta-thalassemia Transfusion Dependent Patients (THALA-RAP)

    Not yet reported Università degli Studi di Ferrara 45 participants Est. completion 2022-04-30 4 sites Stand-alone
    Other conditions: Beta-Thalassemia
    View official trial listing →
  • Terminated NCT NCT04258423

    Everolimus Plus Mycophenolic Acid for Kidney Preservation in Liver Transplant Recipients With Impaired Kidney Function

    Not yet reported Indiana University 4 participants Est. completion 2020-06-27 1 site
    Other conditions: Kidney Failure
    View official trial listing →
  • Active, not recruiting NCT NCT04262843

    Total Marrow and Lymphoid Irradiation as Conditioning Regimen Before Hematopoietic Cell Transplantation in Patients With Myelodysplastic Syndrome or Acute Leukemia

    Not yet reported City of Hope Medical Center 33 participants Est. completion 2027-05-11 1 site Stand-alone
    Other conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, High Risk Myelodysplastic Syndrome, Myelodysplastic Syndrome
    View official trial listing →
  • Withdrawn NCT NCT04263519

    A Pilot Open Labeled Study of Tacrolimus in Alzheimer's Disease.

    Not yet reported Massachusetts General Hospital Est. completion 2023-01-01
    Other conditions: Alzheimer Disease, Mild Cognitive Impairment
    View official trial listing →
  • Completed NCT NCT04267991

    Corneal Densitometry Changes With Adenoviral SEI

    Benha University 63 participants Est. completion 2020-04-15 1 site
    Other conditions: Corneal Disease
    View official trial listing →
  • Active, not recruiting NCT NCT04280029

    SELUTION SLR™ 014 In-stent Restenosis

    Not yet reported M.A. Med Alliance S.A. 418 participants Est. completion 2029-08 48 sites Stand-alone
    Other conditions: Coronary Restenosis
    View official trial listing →
  • Terminated NCT NCT04280276

    TruGraf Utilization in High IPV Levels

    Not yet reported University of Maryland, Baltimore 13 participants Est. completion 2022-03-01 1 site
    Other conditions: Kidney Transplant; Complications
    View official trial listing →
  • Status unknown NCT NCT04292418

    Predictors of Rejection in Pediatric Kidney Transplantation

    Assiut University 70 participants Est. completion 2021-10-01
    Other conditions: Rejection Acute Renal
    View official trial listing →
  • Status unknown NCT NCT04299399

    Corneal Biomechanical Changes of Allergic Conjunctivitis

    Zhongshan Ophthalmic Center, Sun Yat-sen University 100 participants Est. completion 2021-06-30 1 site
    Other conditions: Conjunctivitis, Allergic, Keratoconus
    View official trial listing →
  • Terminated NCT NCT04305444

    Study of a Triple Combination Therapy, DTRM-555, in Patients With R/R CLL or R/R Non-Hodgkin's Lymphomas

    Not yet reported Zhejiang DTRM Biopharma 55 participants Est. completion 2024-12-31 8 sites
    Other conditions: Relapsed Chronic Lymphocytic Leukemia, Refractory Chronic Lymphocytic Leukemia, Diffuse Large B Cell Lymphoma, Follicular Lymphoma, Richter's Transformation
    View official trial listing →
  • Completed NCT NCT04307797

    Effect of Glucagon and Glucagon-like Peptide-1 Co-agonism on Cardiac Function and Metabolism in Overweight Participants with Type 2 Diabetes

    Not yet reported Cambridge University Hospitals NHS Foundation Trust 10 participants Est. completion 2022-10-07 1 site
    Type 2 diabetes Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT04311632

    A Dose Escalation Study in de Novo Renal Transplantation

    Not yet reported ITB-Med LLC 13 participants Est. completion 2023-10-03 4 sites Stand-alone
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT04323033

    Safety and Efficacy of Peripheral, Cobalt-chromium Sirolimus Eluting Stent (PERS) Versus Cobalt-chromium Stent (Neptune C)

    Not yet reported Balton Sp.zo.o. 40 participants Est. completion 2021-11-09 3 sites Stand-alone
    Other conditions: Peripheral Arterial Disease
    View official trial listing →
  • Withdrawn NCT NCT04324411

    Sirolimus Combined With ATRA for the Treatment of Auto-Immune Anemia

    Not yet reported Peking Union Medical College Hospital Est. completion 2023-09-01 1 site Stand-alone
    Other conditions: Autoimmune Anemia
    View official trial listing →
  • Completed NCT NCT04327609

    SAVE Trial - Use of the Selution Sirolimus Eluting Balloon for Dysfunctional AV accEss Treatment Indications

    Not yet reported M.A. Med Alliance S.A. 84 participants Est. completion 2025-07-23 3 sites Stand-alone
    Other conditions: AV Fistula
    View official trial listing →
  • Completed NCT NCT04339062

    Cemiplimab in AlloSCT/SOT Recipients With CSCC

    Not yet reported, Not yet reported Dana-Farber Cancer Institute 12 participants Est. completion 2025-03-01 1 site Stand-alone
    Other conditions: Cutaneous Squamous Cell Carcinoma, Advanced Cancer
    View official trial listing →
  • Completed NCT NCT04339101

    Itacitinib, Tacrolimus, and Sirolimus for the Prevention of GVHD in Patients With Acute Leukemia, Myelodysplastic Syndrome, or Myelofibrosis Undergoing Reduced Intensity Conditioning Donor Stem Cell Transplantation

    Not yet reported City of Hope Medical Center 59 participants Est. completion 2025-10-09 1 site Stand-alone
    Other conditions: Acute Leukemia, Hematologic and Lymphocytic Disorder, Myelodysplastic Syndrome, Primary Myelofibrosis, Secondary Myelofibrosis
    View official trial listing →
  • Status unknown NCT NCT04341038

    Clinical Trial to Evaluate Methylprednisolone Pulses and Tacrolimus in Patients With COVID-19 Lung Injury

    Not yet reported Hospital Universitari de Bellvitge 84 participants Est. completion 2020-07-01 1 site Stand-alone
    Other conditions: COVID-19, Lung Injury
    View official trial listing →
  • Completed NCT NCT04341675

    Sirolimus Treatment in Hospitalized Patients With COVID-19 Pneumonia

    Not yet reported University of Cincinnati 32 participants Est. completion 2020-09-15 2 sites
    Other conditions: COVID-19
    View official trial listing →
  • Status unknown NCT NCT04345965

    Sirolimus Eluting Balloon Utilization for Treatment of Vasculogenic Erectile Dysfunction

    Clinica San Gaudenzio 100 participants Est. completion 2023-12-01 1 site
    Other conditions: Erectile Dysfunction
    View official trial listing →
  • Terminated NCT NCT04348292

    Sirolimus and Durvalumab for the Treatment of Stage I-IIIA Non-small Cell Lung Cancer

    Not yet reported Emory University 3 participants Est. completion 2022-11-04 1 site Stand-alone
    Other conditions: Lung Non-Small Cell Carcinoma, Stage I Lung Cancer AJCC v8, Stage IA1 Lung Cancer AJCC v8, Stage IA2 Lung Cancer AJCC v8, Stage IA3 Lung Cancer AJCC v8, Stage IB Lung Cancer AJCC v8, Stage II Lung Cancer AJCC v8, Stage IIA Lung Cancer AJCC v8, Stage IIB Lung Cancer AJCC v8, Stage IIIA Lung Cancer AJCC v8
    View official trial listing →
  • Status unknown NCT NCT04355858

    Molecularly Targeted Umbrella Study in Luminal Advanced Breast Cancer

    Not yet reported Fudan University 319 participants Est. completion 2025-04-01 1 site
    Other conditions: Breast Cancer, Metastatic Cancer
    View official trial listing →
  • Status unknown NCT NCT04360031

    The Effects of Microbiota Composition on Immunosuppression Protocols in Transplantation

    Université Catholique de Louvain 100 participants Est. completion 2021-03 1 site
    Other conditions: Kidney Transplant; Complications, Immunosuppression, Transplant Failure
    View official trial listing →
  • Completed NCT NCT04368091

    Clinical Use and Safety of the Xtreme Touch (Magic Touch PTA)- Neo Sirolimus Coated PTA Balloon Catheter in the Treatment of Infrainguinal Peripheral Arterial Disease

    Concept Medical Inc. 50 participants Est. completion 2021-12-30 1 site
    Other conditions: Peripheral Artery Disease, Atherosclerosis
    View official trial listing →
  • Withdrawn NCT NCT04371640

    Sirolimus in COVID-19 Phase 1

    Not yet reported Walter K. Kraft Est. completion 2021-07-30 1 site
    Other conditions: SARS-CoV-2, Covid-19
    View official trial listing →
  • Withdrawn NCT NCT04374903

    Hydroxychloroquine in Combination With Sirolimus and Dexamethasone for Treating COVID-19 Patients

    Not yet reported King Hussein Cancer Center Est. completion 2022-04-01 1 site Stand-alone
    Other conditions: COVID-19 Patients
    View official trial listing →
  • Completed NCT NCT04377776

    Observational Study Concerning COVID-19 Infection in Transplanted Kidney, Pancreas or Pancreatic Islet Patients

    IRCCS San Raffaele 644 participants Est. completion 2020-05-18 1 site
    Other conditions: Kidney Transplant, Pancreas Tranplant, Pancreatic Islet Transplantation
    View official trial listing →
  • Completed NCT NCT04380311

    Precision Guided Tacrolimus Dosing in Pediatric Heart Transplant

    Not yet reported University of Utah 17 participants Est. completion 2025-04-30 2 sites Stand-alone
    Other conditions: Heart Transplant Failure and Rejection
    View official trial listing →
  • Active, not recruiting NCT NCT04384692

    Peritransplant Ruxolitinib for Patients With Primary and Secondary Myelofibrosis

    Not yet reported Fred Hutchinson Cancer Center 53 participants Est. completion 2030-04-23 1 site Stand-alone
    Other conditions: Primary Myelofibrosis, Secondary Myelofibrosis
    View official trial listing →
  • Completed NCT NCT04388371

    Glutamine PET Imaging in LAM

    Not yet reported Vanderbilt University Medical Center 5 participants Est. completion 2021-08-10 1 site Stand-alone
    Other conditions: Lymphangioleiomyomatosis (LAM)
    View official trial listing →
  • Status unknown NCT NCT04390685

    Prevention of Breast Cancer-related Lymphedma With Tacrolimus

    Not yet reported, Not yet reported Odense University Hospital 60 participants Est. completion 2022-09 3 sites Stand-alone
    Other conditions: Lymphedema
    View official trial listing →
  • Terminated NCT NCT04393454

    Study to Evaluate the Efficacy and Safety of Sirolimus in Subjects With Metastatic, Mismatch Repair Deficient Solid Tumors After Immunotherapy

    Not yet reported Albert Einstein College of Medicine 6 participants Est. completion 2023-05-16 1 site Stand-alone
    Other conditions: Metastatic dMMR Solid Cancer, Solid Tumor, Cancer, Metastatic Solid Tumor
    View official trial listing →
  • Completed NCT NCT04398732

    Study to Evaluate the Efficacy of Enbrel as a Biological Treatment in Moderate to Severe Plaque Psoriasis Patients

    Pfizer 486 participants Est. completion 2020-10-01 1 site
    Other conditions: Plaque Psoriasis
    View official trial listing →
  • Status unknown NCT NCT04399382

    A Clinical Study to Evaluate the Efficacy of Biologics in SpA

    The University of Hong Kong-Shenzhen Hospital 40 participants Est. completion 2022-12 1 site
    Other conditions: Spondyloarthritis (SpA)
    View official trial listing →
  • Completed NCT NCT04403321

    Efficacy and Safety of Eltrombopag + Tacrolimus in Chinese Refractory or Relapsed Aplastic Anemia Patients

    Not yet reported Peking Union Medical College Hospital 114 participants Est. completion 2022-07-31 1 site Stand-alone
    Other conditions: Aplastic Anemia, Drug Effect
    View official trial listing →
  • Status unknown NCT NCT04404127

    Standard Induction With Basiliximab Versus No-Induction in Low Immunological Risk Kidney Transplant Recipients

    Not yet reported King Faisal Specialist Hospital & Research Center 140 participants Est. completion 2025-05 1 site
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Status unknown NCT NCT04406870

    Sirolimus in the Treatment for Infantile Hepatic Hemangioendothelioma(IEEH)

    Not yet reported Shanghai Children's Medical Center 36 participants Est. completion 2025-06-30 1 site Stand-alone
    Other conditions: Hemangioendothelioma of Liver
    View official trial listing →
  • Terminated NCT NCT04409327

    Phase 2 Study to Determine if RTB101 Reduces the Severity of COVID-19 in Older Adults Residing in Nursing Homes

    Not yet reported Restorbio Inc. 36 participants Est. completion 2021-01-24 1 site
    Other conditions: COVID19
    View official trial listing →
  • Status unknown NCT NCT04409691

    SCMC Trial on KHE With KMP (V.2020)

    Not yet reported Shanghai Children's Medical Center 20 participants Est. completion 2023-06-30 1 site Stand-alone
    Other conditions: Kaposiform Hemangioendothelioma (KHE) With Kasabach-Merritt Phenomenon (KMP)
    View official trial listing →
  • Status unknown NCT NCT04409912

    Sirolimus Coated Angioplasty Versus Plain Balloon Angioplasty

    Not yet reported Singapore General Hospital 170 participants Est. completion 2024-10 3 sites Stand-alone
    Other conditions: End Stage Renal Failure on Dialysis, Arteriovenous Graft Occlusion
    View official trial listing →
  • Status unknown NCT NCT04414735

    Impact of Photopheresis in the Prevention of Acute Rejection in Highly Sensitized de Novo Kidney Transplant Recipients

    Not yet reported Fundacion Clinic per a la Recerca Biomédica 30 participants Est. completion 2025-12 1 site Stand-alone
    Other conditions: Kidney Transplant Rejection
    View official trial listing →
  • Withdrawn NCT NCT04415476

    Standard Therapy Using Tacrolimus, Mycophenolate Mofetil and Prednisone For Chronic Lung Transplant Rejection (BOS)

    Not yet reported University of Maryland, Baltimore Est. completion 2028-06-30 Stand-alone
    Other conditions: Disorder Related to Lung Transplantation, Chronic Rejection of Lung Transplant, Decreased Immunologic Activity
    View official trial listing →
  • Completed NCT NCT04420195

    Envarsus XR in Lung Transplant

    Not yet reported NYU Langone Health 41 participants Est. completion 2022-11-30 1 site Stand-alone
    Other conditions: Lung Transplant
    View official trial listing →
  • Withdrawn NCT NCT04420364

    Maintenance Versus Reduction of Immunosuppression for Renal Transplant Patients Hospitalized With COVID-19 Disease

    Not yet reported, Not yet reported Brigham and Women's Hospital Est. completion 2021-05-04
    Other conditions: COVID, Kidney Transplant; Complications, Immunosuppression
    View official trial listing →
  • Completed NCT NCT04428411

    Study To Evaluate The Impact Of Difficult To Treat Sites On Biological Response In Moderate-To-Severe Plaque Psoriasis(PsO).

    Pfizer 486 participants Est. completion 2020-08-30 1 site
    Other conditions: Plaque Psoriasis
    View official trial listing →
  • Completed NCT NCT04428424

    Study To Evaluate The Response To Enbrel And The Impact Of Rheumatoid Factor(RF) And Anti-Cyclic Citrullinated Peptide(Anti-CCP) In Rheumatoid Arthritis(RA) Patients

    Pfizer 1493 participants Est. completion 2020-08-30 1 site
    Other conditions: Arthritis, Rheumatoid
    View official trial listing →
  • Completed NCT NCT04431219

    First in Human Study: LIS1, an Induction Treatment in Kidney Transplanted Patients

    Not yet reported, Not yet reported Xenothera SAS 10 participants Est. completion 2022-03-28 1 site Stand-alone
    Other conditions: Kidney Transplant
    View official trial listing →
  • Completed NCT NCT04431713

    Exenatide Once-weekly as a Treatment for Multiple System Atrophy

    Not yet reported University College, London 50 participants Est. completion 2024-03-22 1 site Stand-alone
    Other conditions: Multiple System Atrophy
    View official trial listing →
  • Completed NCT NCT04440371

    Phototherapy Combination With Topicals in Vitiligo

    Not yet reported Jordan University of Science and Technology 41 participants Est. completion 2023-03-30 1 site
    Other conditions: Vitiligo, Generalized
    View official trial listing →
  • Status unknown NCT NCT04444817

    Evaluation of the Impact of Tacrolimus-based Immunosuppression on Heidelberg Liver Transplant Cohort (HDTACRO): Study Protocol for an Investigator Initiated, Non-interventional Prospective Study

    University Hospital Heidelberg 100 participants Est. completion 2021-12-30 1 site
    Other conditions: Liver Transplantation
    View official trial listing →
  • Status unknown NCT NCT04444843

    Risk Factors of Chinese Kidney Transplant Recipients DSA Based on MPA Immunosuppressive Regimen

    Not yet reported First Affiliated Hospital Xi'an Jiaotong University 300 participants Est. completion 2023-12-31 1 site
    Other conditions: Kidney Transplant Recipients
    View official trial listing →
  • Completed NCT NCT04448873

    Guided Discontinuation Versus Maintenance Treatment of Sirolimus in Pediatric Patients With Kaposiform Hemangioendothelioma

    Not yet reported Children's Hospital of Fudan University 30 participants Est. completion 2023-07-01 1 site Stand-alone
    Other conditions: Kaposiform Hemangioendothelioma, Kasabach-Merritt Syndrome
    View official trial listing →
  • Status unknown NCT NCT04449224

    Comparative Effectiveness of Targeted Therapy in RA Patients

    Hanyang University 506 participants Est. completion 2024-08-19 1 site
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Status unknown NCT NCT04461340

    Efficacy and Safety of Sirolimus in COVID-19 Infection

    Not yet reported Alexandria University 40 participants Est. completion 2020-11-30 1 site Stand-alone
    Other conditions: COVID 19
    View official trial listing →
  • Terminated NCT NCT04461886

    A Long-term Study of NPC-12G Gel in Neurofibromatosis Type I

    Not yet reported Nobelpharma 100 participants Est. completion 2021-12-07 4 sites Stand-alone
    Other conditions: Neurofibromatosis
    View official trial listing →
  • Completed NCT NCT04470804

    Sirolimus Treatment for Newly Diagnosed Primary Acquired PRCA

    Not yet reported Bing Han 56 participants Est. completion 2022-07-31 1 site Stand-alone
    Other conditions: Pure Red Cell Aplasia, Acquired
    View official trial listing →
  • Completed NCT NCT04473911

    Haplo Peripheral Blood Sct In GVHD Prevention

    Not yet reported Zachariah Michael DeFilipp 25 participants Est. completion 2024-08-19 1 site Stand-alone
    Other conditions: GVHD, AML, ALL, MDS, MPN, CMML, Hodgkin Lymphoma, Non Hodgkin Lymphoma, Blood Stem Cell Transplant Failure, Graft Vs Host Disease, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndromes, Myeloproliferative Disorder, Chronic Myelomonocytic Leukemia, Chemosensitive Hodgkin Lymphoma
    View official trial listing →
  • Active, not recruiting NCT NCT04475783

    Sirolimus- vs. Paclitaxel-Drug Coated Ballons in Patients With Peripheral Artery Disease

    Not yet reported Jena University Hospital 478 participants Est. completion 2027-12-31 22 sites Stand-alone
    Other conditions: Peripheral Artery Disease
    View official trial listing →
  • Withdrawn NCT NCT04482712

    Effects of mTOR Inhibition With Sirolimus (RAPA) in Patients With COVID-19 to Moderate the Progression of ARDS

    Not yet reported, Not yet reported The University of Texas Health Science Center at San Antonio Est. completion 2023-01 2 sites
    Other conditions: Acute Lung Injury/Acute Respiratory Distress Syndrome (ARDS), Respiratory Failure, Sars-CoV2
    View official trial listing →
  • Completed NCT NCT04487197

    SARS-CoV2 (COVID-19) Seroepidemiological Transplanted Subjects (Kidney, Kidney-pancreas, Pancreas, Langerhans Islets)

    Antonio Secchi 282 participants Est. completion 2021-01-15 1 site
    Other conditions: Kidney Transplant, Pancreatic Transplat, Pancreatic Islets Langerhans
    View official trial listing →
  • Completed NCT NCT04489134

    P-glypoprotein Inhibition Effect on the Pharmacokinetics of Two Tacrolimus Formulations: Prolonged and Extended-release

    Not yet reported Rennes University Hospital 27 participants Est. completion 2023-05-16 1 site Stand-alone
    Other conditions: Pharmacokinetics
    View official trial listing →
  • Completed NCT NCT04496401

    PK Study in Diabetic Transplant récipients : From Twice-daily Tacrolimus to Once-daily Extended-release Tacrolimus

    Not yet reported Nantes University Hospital 25 participants Est. completion 2023-11-07 1 site Stand-alone
    Other conditions: Kidney Transplantation, Pancreas Transplantation, Diabetes
    View official trial listing →
  • Completed NCT NCT04498741

    Drug-Drug Interaction Study Between EDP-938, Tacrolimus, Dabigatran, Rosuvastatin and Midazolam in Healthy Subjects

    Not yet reported Enanta Pharmaceuticals, Inc 89 participants Est. completion 2021-06-01 1 site Stand-alone
    Other conditions: RSV Infection
    View official trial listing →
  • Completed NCT NCT04503616

    Cyclophosphamide, Abatacept, and Tacrolimus for GvHD Prevention

    Not yet reported, Not yet reported NYU Langone Health 46 participants Est. completion 2024-08-15 1 site Stand-alone
    Other conditions: Graft-versus-host Disease
    View official trial listing →
  • Completed NCT NCT04504370

    Safety and Efficacy of Pegylated Exenatine Injection (PB-119) in Drug-naïve T2DM Subjects

    Not yet reported PegBio Co., Ltd. 273 participants Est. completion 2022-11-28 1 site Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT04504396

    Safety and Efficacy of PB-119 in Subjects With Type 2 Diabetes and Not Well-controlled by Metformin Monotherapy

    Not yet reported PegBio Co., Ltd. 620 participants Est. completion 2023-05-26 1 site Stand-alone
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT04507776

    Study To Evaluate The Efficacy And Long-Term Adherence Of Spondyloarthropathies(SpA) Patients On Enbrel

    Pfizer 763 participants Est. completion 2020-10-01 1 site
    Other conditions: Spondyloarthrosis
    View official trial listing →
  • Active, not recruiting NCT NCT04520490

    Brain Activation and Satiety in Children 2

    Not yet reported Seattle Children's Hospital 63 participants Est. completion 2026-02-12 1 site
    Other conditions: Childhood Obesity
    View official trial listing →
  • Withdrawn NCT NCT04521946

    Chemotherapy and Donor Stem Transplant for the Treatment of Patients With High Grade Brain Cancer

    Not yet reported M.D. Anderson Cancer Center Est. completion 2022-12-20 Stand-alone
    Other conditions: Anaplastic Ependymoma, Atypical Teratoid/Rhabdoid Tumor, Central Nervous System Germ Cell Tumor, Choroid Plexus Carcinoma, Intracranial Myeloid Sarcoma, Malignant Brain Neoplasm, Malignant Glioma, Medulloblastoma, Primitive Neuroectodermal Tumor, Recurrent Anaplastic Ependymoma, Recurrent Atypical Teratoid/Rhabdoid Tumor, Recurrent Malignant Brain Neoplasm, Recurrent Malignant Glioma, Recurrent Medulloblastoma, Recurrent Primitive Neuroectodermal Tumor
    View official trial listing →
  • Terminated NCT NCT04530487

    Donor Stem Cell Transplant After Chemotherapy for the Treatment of Recurrent or Refractory High-Risk Solid Tumors in Pediatric and Adolescent-Young Adults

    Not yet reported M.D. Anderson Cancer Center 1 participants Est. completion 2024-08-26 1 site Stand-alone
    Obstructive sleep apnea Other conditions: Desmoplastic Small Round Cell Tumor, Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor, Recurrent Desmoplastic Small Round Cell Tumor, Recurrent Malignant Peripheral Nerve Sheath Tumor, Recurrent Malignant Solid Neoplasm, Recurrent Neuroblastoma, Refractory Desmoplastic Small Round Cell Tumor, Refractory Malignant Peripheral Nerve Sheath Tumor, Refractory Malignant Solid Neoplasm, Refractory Neuroblastoma
    View official trial listing →
  • Completed NCT NCT04532710

    Therapeutic Effect of Tacrosolv in Patients With Allergic Rhinoconjunctivitis

    Not yet reported Marinomed Biotech AG 64 participants Est. completion 2021-05-27 1 site
    Other conditions: Allergic Conjunctivitis, Allergic Rhinitis
    View official trial listing →
  • Completed NCT NCT04539470

    Study to Evaluate the Safety and Pharmacokinetics of Efmarodocokin Alfa in Combination With Standard of Care in Participants Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

    Not yet reported Genentech, Inc. 18 participants Est. completion 2023-02-24 8 sites Stand-alone
    Other conditions: Acute Graft-versus-host Disease
    View official trial listing →
  • Completed NCT NCT04541290

    Tacrolimus as Treatment of Breast Cancer-Related Lymphedema

    Not yet reported, Not yet reported Odense University Hospital 20 participants Est. completion 2022-01-06 1 site
    Other conditions: Breast Cancer Lymphedema
    View official trial listing →
  • Active, not recruiting NCT NCT04542733

    The Efficacy of Everolimus With Reduced-dose Tacrolimus Versus Reduced-dose Tacrolimus and Leflunomide in Treatment of BK Virus Infection in Kidney Transplantation Recipient

    Not yet reported King Chulalongkorn Memorial Hospital 50 participants Est. completion 2028-07 1 site
    Other conditions: Kidney Transplant Infection, BK Virus Infection
    View official trial listing →
  • Status unknown NCT NCT04559048

    Investigation of Pain Incidence After FK506 Immunosuppressive Therapy in Liver Transplantation Patients

    The Second Hospital of Tangshan 300 participants Est. completion 2024-06-30 1 site
    Other conditions: Chronic Pain, Liver Transplantation
    View official trial listing →
  • Active, not recruiting NCT NCT04561739

    Paclitaxel-coated Balloon for Treatment of De-novo Non-complex Coronary Artery Lesions

    Not yet reported Xijing Hospital 2272 participants Est. completion 2027-05-05 1 site
    Cardiovascular disease Other conditions: De Novo Stenosis
    View official trial listing →
  • Active, not recruiting NCT NCT04561986

    TocIlizumab in Late/Chronic Active Antibody-mediated Rejection in Kidney Transplant Recipients

    Not yet reported Vastra Gotaland Region 50 participants Est. completion 2029-06 6 sites
    Other conditions: Antibody-mediated Rejection
    View official trial listing →
  • Status unknown NCT NCT04562740

    ABLUMINUS DES BTK Registry - FIM

    Not yet reported Concept Medical Inc. 30 participants Est. completion 2024-12-02 1 site Stand-alone
    Other conditions: Peripheral Artery Disease, Arterial Disease of Legs, Atherosclerosis
    View official trial listing →
  • Active, not recruiting NCT NCT04562805

    Infinity-Swedeheart Registry Based Randomized Clinical Trial (R-RCT)

    Not yet reported Elixir Medical Corporation 2400 participants Est. completion 2028-07-31 19 sites Stand-alone
    Cardiovascular disease Other conditions: Ischemic Heart Disease
    View official trial listing →
  • Status unknown NCT NCT04570345

    3 Months Versus 12 Months Dual Antiplatelet Therapy After Drug-eluting Stent Implantation in STEMI

    Not yet reported Dong-A University 1002 participants Est. completion 2022-08 1 site
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT04571697

    A Study of Comparing Rates of Dementia and Alzheimer's Disease in Participants Initiating Methotrexate Versus Those Initiating Anti-tumor Necrosis Factor (TNF)-Alpha Therapy

    Janssen Research & Development, LLC 34647 participants Est. completion 2020-10-27 1 site
    Other conditions: Dementia, Alzheimer Disease
    View official trial listing →
  • Completed NCT NCT04582084

    Assessment of Treatment Safety and Quality of Life in Patients Receiving Etanercept Biosimilar for Autoimmune Arthritis

    AryoGen Pharmed Co. 583 participants Est. completion 2018-03-19 10 sites
    Other conditions: Rheumatoid Arthritis, Ankylosing Spondylitis, Psoriatic Arthritis
    View official trial listing →
  • Active, not recruiting NCT NCT04582136

    Efficacy and Safety of Sirolimus in Active Systemic Lupus Erythematosus

    Not yet reported Chinese SLE Treatment And Research Group 146 participants Est. completion 2026-01 6 sites Stand-alone
    Other conditions: Systemic Lupus Erythematosus
    View official trial listing →
  • Active, not recruiting NCT NCT04584710

    A Phase 2 Study of RTB101 as COVID-19 Post-Exposure Prophylaxis in Older Adults

    Not yet reported Restorbio Inc. 60 participants Est. completion 2021-02 2 sites
    Other conditions: Covid19
    View official trial listing →
  • Withdrawn NCT NCT04585711

    Pharmacokinetics and Pharmacodynamics of Biologic Drugs in Obese Patients With Arthritis

    Not yet reported Duke University Est. completion 2027-02-28 1 site
    Other conditions: Juvenile Idiopathic Arthritis, Rheumatoid Arthritis, Obesity
    View official trial listing →
  • Status unknown NCT NCT04590183

    The Effectiveness and Safety of FK-506 for the Treatment of Posner-Schlossman Syndrome

    Not yet reported Peking University 30 participants Est. completion 2021-09 1 site
    Other conditions: Posner Schlossman Syndrome
    View official trial listing →
  • Status unknown NCT NCT04591938

    FANTOM ENCORE Sirolimus-eluting Bioresorbable Scaffold for Treatment of De-novo CAD: the ENCORE-I Study

    Not yet reported Joost Daemen 50 participants Est. completion 2025-12-31 3 sites
    Other conditions: Percutaneous Coronary Intervention, Myocardial Revascularization, Tomography, Optical Coherence
    View official trial listing →
  • Status unknown NCT NCT04594889

    Comparison of Sirolimus vs Paclitaxel Drug Eluting Balloon for Below-the-knee Angioplasty in Critical Limb Ischemia

    Not yet reported Ospedale San Donato 170 participants Est. completion 2022-12-31 1 site Stand-alone
    Other conditions: Critical Limb Ischemia, Drug Effect
    View official trial listing →
  • Completed NCT NCT04595513

    Stopping TSC Onset and Progression 2: Epilepsy Prevention in TSC Infants

    Not yet reported, Not yet reported Children's Hospital Medical Center, Cincinnati 5 participants Est. completion 2022-12-15 1 site Stand-alone
    Other conditions: Tuberous Sclerosis Complex, Epilepsy
    View official trial listing →
  • Status unknown NCT NCT04615910

    A GLP-1 Receptor PET Imaging Substudy Within the VER-A-T1D Trial Investigating the Effects on Beta Cell Mass

    Not yet reported Radboud University Medical Center 30 participants Est. completion 2025-07-01 2 sites
    Other conditions: Diabetes Mellitus
    View official trial listing →
  • Status unknown NCT NCT04629118

    Intervention With Selution SLR™ Agent Balloon for Endovascular Latent Limus Therapy for Failing AV Fistulas (ISABELLA) Trial

    Singapore General Hospital 40 participants Est. completion 2023-10-30 1 site
    Other conditions: Arteriovenous Fistula, Dialysis Access Malfunction
    View official trial listing →
  • Active, not recruiting NCT NCT04629248

    A Study Evaluating the Efficacy and Safety of Obinutuzumab in Participants With Primary Membranous Nephropathy

    Not yet reported Hoffmann-La Roche 142 participants Est. completion 2027-12-21 50 sites
    Other conditions: Primary Membranous Nephropathy
    View official trial listing →
  • Active, not recruiting NCT NCT04629495

    Rapamycin - Effects on Alzheimer's and Cognitive Health

    Not yet reported The University of Texas Health Science Center at San Antonio 40 participants Est. completion 2027-03-05 1 site
    Other conditions: Mild Cognitive Impairment, Alzheimer Disease
    View official trial listing →
  • Status unknown NCT NCT04633733

    The Study of Pharmacokinetic Interactions Between HL237 and Tacrolimus

    Not yet reported Hanlim Pharm. Co., Ltd. 24 participants Est. completion 2021-01 1 site Stand-alone
    Other conditions: Healthy Male Volunteers
    View official trial listing →
  • Completed NCT NCT04645667

    Tacrolimus in Allogeneic Hematopoietic Stem Cell Transplant (HCT)

    UNC Lineberger Comprehensive Cancer Center 38 participants Est. completion 2023-10-15 1 site
    Other conditions: Acute GVHD
    View official trial listing →
  • Completed NCT NCT04646356

    Tacrolimus Trial for Hereditary Hemorrhagic Telangiectasia (HHT)

    Not yet reported Unity Health Toronto 10 participants Est. completion 2024-10-21 1 site Stand-alone
    Other conditions: Hereditary Hemorrhagic Telangiectasia, Epistaxis Nosebleed
    View official trial listing →
  • Status unknown NCT NCT04657562

    The New LC-MS/MS Method for Determination of Unbound Tacrolimus in Plasma

    National Science Centre, Poland 380 participants Est. completion 2023-05 1 site
    Other conditions: Immunosuppression, Kidney Transplant Rejection, Kidney Transplant; Complications, Liver Transplant Rejection, Liver Transplant; Complications, Metabolism Medication Toxicity, Genetic Predisposition
    View official trial listing →
  • Active, not recruiting NCT NCT04665310

    Evaluation of Anti-rejection Drug, Tacrolimus, in African-Americans With Kidney Transplant

    Not yet reported The Methodist Hospital Research Institute 46 participants Est. completion 2025-10-31
    Other conditions: Kidney Disease, End-Stage, Donor Specific Antibodies, Acute Rejection of Renal Transplant
    View official trial listing →
  • Completed NCT NCT04669210

    PTCy and Ruxolitinib vs PTCy, Tacrolimus and MMF in MUD and Haploidentical HSCT

    Not yet reported St. Petersburg State Pavlov Medical University 128 participants Est. completion 2025-03-28 2 sites Stand-alone
    Other conditions: Graft-versus-host-disease, Stem Cell Transplant Complications, Acute Myeloid Leukemia, Acute Lymphoid Leukemia
    View official trial listing →
  • Status unknown NCT NCT04670926

    Immunosuppression Management in Renal Transplant Recipients With Transplant Excellence Based on TruGraf Test

    Not yet reported Transplant Genomics, Inc. 75 participants Est. completion 2023-09-30 1 site Stand-alone
    Other conditions: Kidney Transplant Rejection, Immunosuppression
    View official trial listing →
  • Completed NCT NCT04698512

    MAgicTouch™ Intervention Leap for Dialysis Access (MATILDA) Trial

    Singapore General Hospital 35 participants Est. completion 2021-01-30 1 site
    Other conditions: Dialysis Access Malfunction, End Stage Renal Failure on Dialysis, End Stage Renal Disease, Fistulas Arteriovenous, Stenosis
    View official trial listing →
  • Status unknown NCT NCT04700709

    Efficacy and Safety of Sirolimus Plus CNI Compared With MMF Plus CNI in ABO-i Kidney Transplant Recipients.

    Not yet reported Chong Kun Dang Pharmaceutical 158 participants Est. completion 2025-01 1 site Stand-alone
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT04701528

    Anti-Viral Effects of Voclosporin in COVID-19 Positive Kidney Transplant Recipients

    Not yet reported Leiden University Medical Center 20 participants Est. completion 2022-10-25 1 site Stand-alone
    Other conditions: Covid19, Kidney Transplant Infection
    View official trial listing →
  • Status unknown NCT NCT04705584

    Topical Immuonosuppressant Drugs in Spring Catarrh

    Not yet reported Assiut University 180 participants Est. completion 2022-02 1 site Stand-alone
    Other conditions: Vernal Keratoconjunctivitis
    View official trial listing →
  • Completed NCT NCT04706559

    Efficacy of Oral Supplementation of Probiotics in Children With Atopic Dermatitis

    Not yet reported B.P. Koirala Institute of Health Sciences 98 participants Est. completion 2021-12-15 1 site Stand-alone
    Other conditions: Atopic Dermatitis
    View official trial listing →
  • Completed NCT NCT04707209

    Sirolimus for Retinal Astrocytic Hamartoma

    Not yet reported The Hospital for Sick Children 1 participants Est. completion 2024-03-22 1 site Stand-alone
    Other conditions: Retinal Astrocytic Hamartoma
    View official trial listing →
  • Withdrawn NCT NCT04711291

    Efficacy of Envarsus XR and Digital Health Technology in Reducing Tacrolimus Fluctuation and Frequency of Dose Changes

    Not yet reported Beth Israel Deaconess Medical Center Est. completion 2023-07-01 Stand-alone
    Other conditions: Medication Adherence, Renal Transplant
    View official trial listing →
  • Completed NCT NCT04718311

    Study on Treatment for Patients With Symptomatic Oral Lichen Planus

    Not yet reported University of Catania 60 participants Est. completion 2020-03-20 1 site
    Other conditions: Lichen Planus, Oral
    View official trial listing →
  • Completed NCT NCT04720326

    Bioavailability and Practicability of Envarsus Versus Advagraf in Liver Transplant Recipients

    Not yet reported Edward Geissler 268 participants Est. completion 2026-10-29 15 sites Stand-alone
    Other conditions: Prophylaxis Against Liver Transplant Rejection
    View official trial listing →
  • Terminated NCT NCT04720664

    Oral SM-88 in Patients With Metastatic HR+/HER2- Breast Cancer

    Not yet reported Georgetown University 11 participants Est. completion 2023-02-10 5 sites Stand-alone
    Other conditions: Breast Cancer, Metastatic Breast Cancer, Hormone Receptor Positive Breast Carcinoma
    View official trial listing →
  • Completed NCT NCT04725682

    Bioequivalence Study of Tacrolimus in Healthy Volunteers

    Not yet reported Food and Drug Administration (FDA) 67 participants Est. completion 2021-06-17 1 site
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Status unknown NCT NCT04733508

    Glucagon Like Peptide 1 Receptor (GLP1R) Expression and Beta-cell Mass in Patients With Type 2 Diabetes

    Not yet reported Radboud University Medical Center 28 participants Est. completion 2022-12-01 1 site
    Type 2 diabetes Other conditions: Diabetes Mellitus
    View official trial listing →
  • Not yet recruiting NCT NCT04736589

    Inetetamab Plus Rapamycin and Chemotherapy for HER2+ Metastatic Breast Cancer With Abnormal Activation of PAM Pathway

    Not yet reported Peking Union Medical College 270 participants Est. completion 2027-02-02 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT04736953

    Sirolimus Treatment Of Patients With SLE

    Not yet reported State University of New York - Upstate Medical University 220 participants Est. completion 2029-01-01
    Other conditions: Lupus Erythematosus, Systemic
    View official trial listing →
  • Completed NCT NCT04738981

    Efficacy and Safety of UC-MSCs for the Treatment of Steroid-resistant aGVHD Following Allo-HSCT

    Not yet reported Peking University People's Hospital 130 participants Est. completion 2023-05-02 1 site
    Other conditions: Graft Vs Host Disease
    View official trial listing →
  • Status unknown NCT NCT04747080

    The Combination of Tacrolimus and High-dose Dexamethasone as First-line Treatment in Adult Immune Thrombocytopenia

    Not yet reported Peking University People's Hospital 120 participants Est. completion 2023-07-01 1 site Stand-alone
    Other conditions: ITP, Immune Thrombocytopenia
    View official trial listing →
  • Completed NCT NCT04761731

    To Evaluate the Efficacy and Safety of ADVAGRAF® After Treatment With a Tacrolimus in New Liver Transplant Recipients

    Not yet reported Linical Korea 31 participants Est. completion 2017-12-14 Stand-alone
    Other conditions: Liver Transplantation
    View official trial listing →
  • Completed NCT NCT04763096

    Evaluate the Efficacy and Safety of the ADVAGRAF®

    Not yet reported Linical Korea 101 participants Est. completion 2020-04 1 site Stand-alone
    Other conditions: Evidence of Liver Transplantation
    View official trial listing →
  • Status unknown NCT NCT04765826

    Comparison Between Systemic Steroids, Topical Steroids, or Calcineurin Inhibitors With Mini Punch Grafting in Treatment of Stable Non-segmental Vitiligo

    Not yet reported Alexandria University 60 participants Est. completion 2022-08 1 site Stand-alone
    Other conditions: Vitiligo
    View official trial listing →
  • Status unknown NCT NCT04768465

    Tacrolimus Combined With Low-dose Prednisone for Treatment of Myasthenia Gravis

    Da, Yuwei, M.D. 160 participants Est. completion 2024-10-31 1 site
    Other conditions: Myasthenia Gravis
    View official trial listing →
  • Terminated NCT NCT04773392

    Simplified IMmunosuppressive Protocol Utilizing Low Dose EnvarsusXR

    Not yet reported University of Southern California 20 participants Est. completion 2024-02-23 1 site
    Other conditions: Kidney Transplantation, Kidney Transplant Rejection
    View official trial listing →
  • Completed NCT NCT04775173

    Efficacy and Safety of Different Concentrations of Sirolimus in the Treatment of Kaposiform Hemangioendothelioma.

    Not yet reported West China Hospital 79 participants Est. completion 2023-08-10 1 site Stand-alone
    Other conditions: Kaposiform Hemangioendothelioma
    View official trial listing →
  • Active, not recruiting NCT NCT04776434

    SUCCESS (SelUtion, Safety, effiCaCy, hEalth economicS and promS) PTA Study

    Not yet reported M.A. Med Alliance S.A. 723 participants Est. completion 2028-12-31 27 sites Stand-alone
    Other conditions: Peripheral Artery Disease
    View official trial listing →
  • Withdrawn NCT NCT04776850

    Pre-transplant Immunosuppression and Donor Stem Cell Transplant for the Treatment of Severe Hemoglobinopathies

    Not yet reported M.D. Anderson Cancer Center Est. completion 2022-12-05 Stand-alone
    Other conditions: Beta Thalassemia Major, Sickle Beta 0 Thalassemia, Sickle Beta Plus Thalassemia, Sickle Beta Thalassemia, Sickle Cell Disease, Sickle Cell-SS Disease
    View official trial listing →
  • Completed NCT NCT04788641

    Study to Assess the Effect of Sodium Zirconium Cyclosilicate on the Pharmacokinetics of Tacrolimus and Cyclosporin in Healthy Subjects

    Not yet reported AstraZeneca 62 participants Est. completion 2021-09-16 1 site Stand-alone
    Other conditions: Hyperkalaemia
    View official trial listing →
  • Active, not recruiting NCT NCT04789070

    Phase III Trial of Sirolimus in IBM

    Not yet reported University of Kansas Medical Center 140 participants Est. completion 2027-12 10 sites
    Other conditions: Inclusion Body Myositis
    View official trial listing →
  • Completed NCT NCT04798287

    Safety of TofAcitinib in Routine Care Patients With Rheumatoid Arthritis (STAR-RA)-Cancer Endpoints

    Brigham and Women's Hospital 105711 participants Est. completion 2022-05-16 1 site
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Completed NCT NCT04805619

    Evaluation of the Neointimal Healing by OCT of the Tapered DES Biomime Morph (TAPER-I Study)

    Not yet reported University of Sao Paulo General Hospital 35 participants Est. completion 2021-12-08 1 site Stand-alone
    Other conditions: Atherosclerosis
    View official trial listing →
  • Completed NCT NCT04810143

    Tacrolimus Microsampling

    Not yet reported Children's Hospital Medical Center, Cincinnati 16 participants Est. completion 2022-07-28 1 site Stand-alone
    Obstructive sleep apnea
    View official trial listing →
  • Completed NCT NCT04818632

    AZD9833 China PK Study

    Not yet reported AstraZeneca 28 participants Est. completion 2023-09-07 4 sites
    Other conditions: ER+, HER2-, Metastatic Breast Cancer
    View official trial listing →
  • Completed NCT NCT04825262

    Efficacy of Achieving Early Target Trough Levels of Tacrolimus Using CYP3A5 Guided Dosing Versus Weight-based Dosing in a Multi-ethnic Population of Kidney Transplant Recipients in Singapore

    Not yet reported Singapore General Hospital 74 participants Est. completion 2024-04-09 1 site Stand-alone
    Other conditions: Kidney Transplant Rejection, Kidney Transplant; Complications
    View official trial listing →
  • Completed NCT NCT04838288

    Cognitive Outcomes in Stable Renal Transplant Patients Switched fromTacrolimus to Envarsus XR™

    Not yet reported Vanderbilt University Medical Center 56 participants Est. completion 2025-10-22 1 site Stand-alone
    Other conditions: Renal Transplant
    View official trial listing →
  • Status unknown NCT NCT04849325

    IBS Titan vs. PTA in Patients With Infrapopliteal Arterial Stenosis or Occlusive Disease

    Not yet reported Biotyx Medical (Shenzhen) Co., Ltd. 120 participants Est. completion 2024-10 29 sites Stand-alone
    Other conditions: Critical Limb Ischemia (CLI)
    View official trial listing →
  • Completed NCT NCT04852523

    18F-Fluciclovine PET/CT in the Assessment of Pancreatic Transplants

    Not yet reported University of Utah 4 participants Est. completion 2022-10-06 1 site
    Other conditions: Pancreatitis, Graft, Pancreatic Transplant Post-Transplant Dysfunction Rejection
    View official trial listing →
  • Active, not recruiting NCT NCT04859946

    Itacitinib for the Prevention of Graft Versus Host Disease

    Not yet reported M.D. Anderson Cancer Center 31 participants Est. completion 2027-04-01 1 site Stand-alone
    Other conditions: Hematologic and Lymphocytic Disorder
    View official trial listing →
  • Completed NCT NCT04862052

    Optimal Treatment for Coronary Drug Eluting Stent In-stent Restenosis

    Not yet reported Semmelweis University Heart and Vascular Center 108 participants Est. completion 2025-01-30 2 sites Stand-alone
    Other conditions: Coronary Stent Restenosis
    View official trial listing →
  • Status unknown NCT NCT04867720

    Efficacy and Safety of CertiroBell® Tablet Plus Tacrolimus in Primary Living Donor Liver Transplant Recipients

    Not yet reported Chong Kun Dang Pharmaceutical 112 participants Est. completion 2023-02-22 1 site Stand-alone
    Other conditions: Liver Transplant
    View official trial listing →
  • Active, not recruiting NCT NCT04870203

    Combination of Baricitinib and Anti-TNF in Rheumatoid Arthritis

    Not yet reported University Hospital, Bordeaux 160 participants Est. completion 2027-03 36 sites Stand-alone
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Terminated NCT NCT04885816

    Drug-eluting Balloon Versus Drug-eluting Stent for High Bleeding Risk Angioplasty

    Not yet reported Instituto Nacional de Cardiologia Ignacio Chavez 5 participants Est. completion 2021-09-29 1 site
    Cardiovascular disease Other conditions: High Bleeding Risk, Percutaneous Coronary Intervention (PCI)
    View official trial listing →
  • Status unknown NCT NCT04892212

    Sirolimus in Treatment of Proteinuric Flares of Lupus Nephritis

    Not yet reported, Not yet reported Peking Union Medical College Hospital 20 participants Est. completion 2023-10-30 Stand-alone
    Other conditions: Lupus Nephritis, Immunosuppression, Effect of Drug
    View official trial listing →
  • Active, not recruiting NCT NCT04893291

    Sirolimus-coated Balloon Versus Drug-eluting Stent in Native Coronary Vessels - TRANSFORM II

    Not yet reported Fondazione Ricerca e Innovazione Cardiovascolare ETS 1820 participants Est. completion 2030-08-30 53 sites Stand-alone
    Cardiovascular disease Other conditions: Coronary Artery Stenosis
    View official trial listing →
  • Terminated NCT NCT04895748

    DFF332 as a Single Agent and in Combination With Everolimus & Immuno-Oncology Agents in Advanced/Relapsed Renal Cancer & Other Malignancies

    Not yet reported Novartis Pharmaceuticals 40 participants Est. completion 2026-02-13 11 sites
    Other conditions: Carcinoma, Renal Cell
    View official trial listing →
  • Completed NCT NCT04897802

    Identification and Clinical Relevance of an Oxytocin Deficient State (GLP1 Study)

    Not yet reported Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 42 participants Est. completion 2024-12-31 1 site Stand-alone
    Other conditions: Hypopituitarism, Central Diabetes Insipidus, Panhypopituitarism, Psychological Disorder, Social Isolation, Hypothalamic Diseases, Pituitary Diseases, Oxytocin Deficiency
    View official trial listing →
  • Active, not recruiting NCT NCT04899141

    Prospective Registry of ihtDEStiny® Coronary Stent in Regular PCI Practice

    Fundación EPIC 400 participants Est. completion 2028-05-01 20 sites
    Cardiovascular disease Other conditions: Ischemic Heart Disease
    View official trial listing →
  • Status unknown NCT NCT04899583

    ACOART SCB BIF: Treatment of Coronary Bifurcation Lesion by Sirolimus Coated Balloon vs Paclitaxel Coated Balloon

    Not yet reported Acotec Scientific Co., Ltd 230 participants Est. completion 2025-11-01 1 site Stand-alone
    Other conditions: Coronary Bifurcation Lesions
    View official trial listing →
  • Withdrawn NCT NCT04903054

    Selective CD28 Blockade in Renal Transplant Recipients

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) Est. completion 2022-09-22 1 site
    Other conditions: Kidney Transplantation, Renal Transplant Recipients
    View official trial listing →
  • Active, not recruiting NCT NCT04904588

    HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide

    Not yet reported Center for International Blood and Marrow Transplant Research 300 participants Est. completion 2026-12 39 sites Stand-alone
    Other conditions: Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Mixed Phenotype Acute Leukemia, Acute Leukemia, Myelodysplastic Syndromes, Chronic Myelogenous Leukemia, Chronic Lymphocytic Leukemia, Lymphoma
    View official trial listing →
  • Completed NCT NCT04906304

    Comparison of Safety and Efficacy of de Novo Everolimus

    Not yet reported Shahid Beheshti University of Medical Sciences 35 participants Est. completion 2020-08-01 1 site
    Other conditions: Cytomegalovirus Infections
    View official trial listing →
  • Completed NCT NCT04909333

    Exenatide-test for Diagnosing Endogenous Hyperinsulinemic Hypoglycemia

    Not yet reported University Hospital, Basel, Switzerland 29 participants Est. completion 2024-04-30 1 site Stand-alone
    Other conditions: Endogenous Hyperinsulinism
    View official trial listing →
  • Status unknown NCT NCT04912401

    the Efficacy and Safety of Etanercept (Yi Sai Pu) in Chinese Patients With Moderate-to-Severe Psoriasis

    Second Affiliated Hospital, Zhejiang University, School of Medicine 100 participants Est. completion 2025-12-04 40 sites
    Other conditions: Psoriasis, Etanercept
    View official trial listing →
  • Status unknown NCT NCT04917718

    Renal Tubular Injury and Transplant Outcomes in Cardiac Recipients Converting From IR Tacrolimus to XR Tacrolimus

    Not yet reported Loyola University 42 participants Est. completion 2024-12-31 1 site Stand-alone
    Chronic kidney disease Other conditions: Heart Transplant
    View official trial listing →
  • Status unknown NCT NCT04918615

    Compare Sirolimus Coated Balloon Catheter With Paclitaxel Coated Balloon Catheter in De Novo Coronary Bifurcated Lesions

    Not yet reported Shanghai MicroPort Medical (Group) Co., Ltd. 236 participants Est. completion 2024-12-31 1 site Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Active, not recruiting NCT NCT04936282

    Treatment of Early Borderline Lesions in Low Immunological Risk Kidney Transplant Patients (TRAINING)

    Not yet reported Fundación Canaria Instituto de Investigación Sanitaria de Canarias 80 participants Est. completion 2027-06-30 4 sites Stand-alone
    Other conditions: Kidney Transplant Failure and Rejection
    View official trial listing →
  • Withdrawn NCT NCT04936971

    Introduction of mTor Inhibitors and the Activation of the Cytomegalovirus (CMV) -Specific Cellular Immune Response

    Not yet reported Edoardo Melilli Est. completion 2021-09 1 site Stand-alone
    Other conditions: Kidney Transplantation, Cytomegalovirus Infections
    View official trial listing →
  • Completed NCT NCT04942730

    Benadamustine, Fludarabine and Busulfan Conditioning in Recipients of Haploidentical Stem Cell Transplantation (FluBuBe)

    Not yet reported St. Petersburg State Pavlov Medical University 50 participants Est. completion 2024-04-30 1 site Stand-alone
    Other conditions: Leukemia, Acute Lymphoblastic, Myeloid Leukemia, Acute, Biphenotypic Acute Leukemia, Lymphoblastic Lymphoma, Myelodysplastic Syndromes, Myeloproliferative Neoplasm
    View official trial listing →
  • Completed NCT NCT04943757

    Post-transplantation Benadamustine and Cyclophosphamide in Patients With Refractory Myeloid Malignancies

    Not yet reported St. Petersburg State Pavlov Medical University 50 participants Est. completion 2024-05-30 1 site Stand-alone
    Other conditions: Myeloid Leukemia, Acute, Chronic Myeloid Leukemia, Myelodysplastic Syndromes, Myeloproliferative Neoplasm
    View official trial listing →
  • Active, not recruiting NCT NCT04945785

    " SAVE Study (Switch AdVagraf® to Envarsus®) for Fast Metabolizers Kidney Transplant Recipients"

    Nantes University Hospital 226 participants Est. completion 2026-05-28 1 site
    Other conditions: Renal Transplant Failure
    View official trial listing →
  • Active, not recruiting NCT NCT04948203

    Assessing the Efficacy of Sirolimus in Patients With COVID-19 Pneumonia for Prevention of Post-COVID Fibrosis

    Not yet reported, Not yet reported University of Chicago 60 participants Est. completion 2026-12 1 site
    Other conditions: Pulmonary Fibrosis, COVID-19 Pneumonia, Long COVID
    View official trial listing →
  • Active, not recruiting NCT NCT04953715

    Microbiome and Immunosuppression: The Mission Study

    The University of Texas Medical Branch, Galveston 140 participants Est. completion 2033-01-01 2 sites
    Other conditions: Kidney Transplant Rejection, Kidney Transplant
    View official trial listing →
  • Completed NCT NCT04956484

    Belimumab In Early Systemic Lupus Erythematosus

    Not yet reported Peking Union Medical College Hospital 16 participants Est. completion 2022-04-08 1 site
    Other conditions: Lupus Erythematosus, Systemic
    View official trial listing →
  • Withdrawn NCT NCT04961801

    Acalabrutinib for GVHD Prophylaxis in Allogeneic Hematopoietic Stem Cell Transplantation in Lymphomas and Leukemia

    Not yet reported, Not yet reported Shin Mineishi Est. completion 2030-01 Stand-alone
    Other conditions: Lymphoma, Leukemia
    View official trial listing →
  • Completed NCT NCT04965597

    Treosulfan-Based Conditioning Regimen Before a Blood or Bone Marrow Transplant for the Treatment of Bone Marrow Failure Diseases (BMT CTN 1904)

    Not yet reported Fred Hutchinson Cancer Center 40 participants Est. completion 2026-02-18 24 sites Stand-alone
    Other conditions: Bone Marrow Failure Syndrome, Congenital Amegakaryocytic Thrombocytopenia, Diamond-Blackfan Anemia, Hereditary Sideroblastic Anemia, Paroxysmal Nocturnal Hemoglobinuria, Shwachman-Diamond Syndrome, Hematologic Neoplasm With Germline GATA2 Mutation, Hematologic Neoplasm With Germline SAMD9 Mutation, Hematologic Neoplasm With Germline SAMD9L Mutation
    View official trial listing →
  • Withdrawn NCT NCT04973982

    ENvarsus for Impaired Glucose Tolerance Post REnal transplAnT

    Not yet reported Barts & The London NHS Trust Est. completion 2022-10-01 1 site
    Other conditions: Renal Transplant Failure
    View official trial listing →
  • Completed NCT NCT04976933

    Post-HSCT Medication Adherence mHealth App

    Micah Skeens 15 participants Est. completion 2023-01-31 1 site
    Other conditions: Stem Cell Transplantation
    View official trial listing →
  • Status unknown NCT NCT04979611

    The Clinical Application of 68Ga-NOTA-exendin-4 PET/CT in Detecting Insulinoma

    Not yet reported First Affiliated Hospital of Fujian Medical University 60 participants Est. completion 2025-08-01 1 site
    Other conditions: Insulinoma
    View official trial listing →
  • Completed NCT NCT04989686

    Microsampling Assays for Immunosuppressive Drugs in Children

    Children's Hospital of Philadelphia 66 participants Est. completion 2025-05-01 1 site
    Other conditions: Immunosuppression
    View official trial listing →
  • Completed NCT NCT04990323

    US Study of ECT-001-CB in Pediatric and Young Adult Patients With High-Risk Myeloid Malignancies

    Not yet reported, Not yet reported ExCellThera inc. 13 participants Est. completion 2025-12-31 1 site Stand-alone
    Other conditions: High Risk Myeloid Malignancies, Cord Blood Transplant
    View official trial listing →
  • Withdrawn NCT NCT04994561

    VIAging Deceleration Trial Using Metformin, Dasatinib, Rapamycin and Nutritional Supplements

    Not yet reported Vitality in Aging Research Group, Inc. Est. completion 2023-12
    Other conditions: Aging
    View official trial listing →
  • Status unknown NCT NCT05001074

    Trial Comparing Immediate Versus Extended Release Tacrolimus; Reducing Calcineurin Inhibitor Related Toxicity in Lung Transplantation Patients

    Not yet reported Heleen Grootjans 145 participants Est. completion 2024-08-01 1 site Stand-alone
    Other conditions: Lung Transplant; Complications
    View official trial listing →
  • Completed NCT NCT05005221

    Home-based Therapeutic Drug Monitoring in Kidney Transplantation

    Not yet reported University of Michigan 41 participants Est. completion 2024-05-08 1 site Stand-alone
    Other conditions: Kidney Transplant
    View official trial listing →
  • Status unknown NCT NCT05011916

    The Safety and Efficacy of KDR2-2 Suspension Eye Drops in the Treatment of Corneal Neovascularization

    Not yet reported, Not yet reported Zhongshan Ophthalmic Center, Sun Yat-sen University 60 participants Est. completion 2022-08-09 2 sites
    Other conditions: Corneal Neovascularization
    View official trial listing →
  • Status unknown NCT NCT05013034

    Exploratory Regimen of Basiliximab for Treatment of Pulmonary Cytokine Storm in SARS-CoV-2 Hospitalized Adult Patients

    Not yet reported Fort Worth Clinical Sciences Working Group 300 participants Est. completion 2022-12-01 Stand-alone
    Other conditions: SARS-CoV-2 Acute Respiratory Disease, SARS-CoV2 Infection, Cytokine Storm
    View official trial listing →
  • Status unknown NCT NCT05021276

    Basiliximab Combined With Ruxolitinib as Second-line Treatment of Grade 3-4 Steroid-resistant aGVHD

    Not yet reported The First Affiliated Hospital of Soochow University 50 participants Est. completion 2022-12-15 1 site Stand-alone
    Other conditions: Safety and Efficacy
    View official trial listing →
  • Completed NCT NCT05029310

    Effects of Patiromer on Pharmacokinetics of Immunosuppresive Drugs in Renal Transplant Recipients

    Not yet reported Oslo University Hospital 13 participants Est. completion 2023-02-01 1 site Stand-alone
    Other conditions: Hyperkalemia, Kidney Transplant
    View official trial listing →
  • Completed NCT NCT05032248

    Uses of Tacrolimus in Behcet Disease

    Not yet reported Assiut University 40 participants Est. completion 2019-12-01 1 site Stand-alone
    Other conditions: Oral Ulcer, Behcet Syndrome
    View official trial listing →
  • Completed NCT NCT05051137

    Real-World Emulation of the SWEFOT Trial

    Karolinska Institutet 509 participants Est. completion 2020-11-16 1 site
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Status unknown NCT NCT05061303

    Omeprazole and Famotidine in Chronic Dysfunction of the Transplanted Kidney

    Poznan University of Medical Sciences 24 participants Est. completion 2024-06-30 1 site
    Other conditions: Kidney Rejection Transplant
    View official trial listing →
  • Terminated NCT NCT05065411

    Efficacy & Safety Evaluation of Enobosarm in Combo With Abemaciclib in Treatment of ER+HER2- Metastatic Breast Cancer

    Not yet reported Veru Inc. 5 participants Est. completion 2024-01-09 30 sites
    Other conditions: Metastatic Breast Cancer
    View official trial listing →
  • Terminated NCT NCT05066789

    CHoice of Optimal Anti-Thrombotic Strategy in Patients Undergoing Implantation of Coronary Drug-Eluting Stents 4

    Not yet reported Samsung Medical Center 100 participants Est. completion 2024-03-22 1 site
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT05073692

    Comparison of Type 2 Diabetes Pharmacotherapy Regimens

    Kaiser Permanente 241981 participants Est. completion 2025-03-12 6 sites
    Type 2 diabetesCardiovascular disease
    View official trial listing →
  • Withdrawn NCT NCT05073822

    NOMINATE/ Minimisation of Immunosuppression in Kidney Transplantation

    Not yet reported, Not yet reported University College, London Est. completion 2027-02-20
    Other conditions: Renal Transplant Rejection, Renal Transplant Infection
    View official trial listing →
  • Completed NCT NCT05076084

    Evaluation of the Efficacy and Safety of Tacrolimus Drops in Children With Vernal Keratoconjunctivitis

    Fondation Ophtalmologique Adolphe de Rothschild 15 participants Est. completion 2021-11-10 1 site
    Other conditions: Vernal Keratoconjunctivitis
    View official trial listing →
  • Completed NCT NCT05077254

    COVID Protection After Transplant-Immunosuppression Reduction

    Not yet reported National Institute of Allergy and Infectious Diseases (NIAID) 48 participants Est. completion 2025-02-21 15 sites
    Other conditions: Kidney Transplant Recipients, Liver Transplant Recipients
    View official trial listing →
  • Completed NCT NCT05080218

    COVID-19 VaccinE Response in Rheumatology Patients

    Not yet reported Jeffrey Curtis 841 participants Est. completion 2024-05-28 8 sites
    Other conditions: Rheumatoid Arthritis, Psoriatic Arthritis, Spondylarthritis
    View official trial listing →
  • Active, not recruiting NCT NCT05088356

    Reduced Intensity Allogeneic HCT in Advanced Hematologic Malignancies w/T-Cell Depleted Graft

    Not yet reported Stanford University 66 participants Est. completion 2028-05 1 site Stand-alone
    Other conditions: Allogeneic Hematopoietic Cell Transplantation (HCT), Advanced Hematologic Malignancies, Acute Leukemia, Chronic Myelogenous Leukemia, Myelodysplastic Syndromes, Myeloproliferative Disorders
    View official trial listing →
  • Completed NCT NCT05103358

    Phase 2 Basket Trial of Nab-sirolimus in Patients With Malignant Solid Tumors With Pathogenic Alterations in TSC1/TSC2 Genes (PRECISION 1)

    Not yet reported Aadi Bioscience, Inc. 128 participants Est. completion 2024-12-23 166 sites Stand-alone
    Other conditions: Tumor, Tumor, Solid, Metastasis, Metastatic Cancer, Cancer, Cancer Metastatic, Tumors, Neoplasms, Neoplasm Metastasis, Solid Tumor, Advanced Solid Tumor, Advanced Cancer, Malignant Solid Tumor, Malignant Solid Neoplasm, Malignant Neoplasm, Malignant Tumor, TSC, TSC1, TSC2, Metastatic Solid Tumor, Metastatic Neoplasm
    View official trial listing →
  • No Longer Available NCT NCT05108740

    MAP Treatment Plan With Afinitor for Postmenopausal Women With Advanced HR+ Breast Cancer

    Novartis Pharmaceuticals
    Other conditions: Advanced Hormone Receptor Positive (HR+) Breast Cancer
    View official trial listing →
  • Completed NCT NCT05109390

    A Study of the Drug Interactions Between Danicopan and Cyclosporine, Tacrolimus, Antacids, and Omeprazole in Healthy Adults

    Not yet reported Alexion Pharmaceuticals, Inc. 72 participants Est. completion 2018-10-17 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT05115630

    Off-the-shelf NK Cells + SCT for Myeloid Malignancies

    Not yet reported M.D. Anderson Cancer Center 24 participants Est. completion 2025-05-15 1 site Stand-alone
    Other conditions: Myeloid Malignancies, Acute Myeloid Leukemia, Myelodysplastic Syndrome, Chronic Myeloid Leukemia
    View official trial listing →
  • Status unknown NCT NCT05115903

    Biologic Tapering Study of TNF Inhibitors in Axial Spondyloarthritis

    Not yet reported University Health Network, Toronto 15 participants Est. completion 2024-08-01 1 site Stand-alone
    Other conditions: Axial Spondyloarthritis
    View official trial listing →
  • Status unknown NCT NCT05124431

    Anlotinib Plus Everolimus as First-line Treatment for Advanced Non Clear Cell Renal Cell Carcinoma

    Not yet reported Fudan University 30 participants Est. completion 2024-12 1 site
    Other conditions: Renal Cell Carcinoma
    View official trial listing →
  • Active, not recruiting NCT NCT05132361

    SELUTION4SFA Trial

    Not yet reported M.A. Med Alliance S.A. 300 participants Est. completion 2030-12-01 34 sites Stand-alone
    Other conditions: Peripheral Arterial Disease, Superficial Femoral Artery Stenosis
    View official trial listing →
  • Available NCT NCT05134922

    Expanded Access Protocol for Subjects Previously Treated With Gedatolisib in B2151009

    Celcuity Inc 5 sites
    Other conditions: Breast Neoplasm Malignant Female
    View official trial listing →
  • Status unknown NCT NCT05135312

    Etanercept Therapy for Nails Psoriasis Monitoring With Noninvasive Imaging

    Not yet reported OptiSkin Medical 10 participants Est. completion 2022-08-08 1 site
    Other conditions: Psoriasis, Psoriatic Arthritis, Psoriatic Nail
    View official trial listing →
  • Active, not recruiting NCT NCT05139004

    90Y-DOTA-anti-CD25 Basiliximab, Fludarabine, Melphalan, and Total Marrow and Lymphoid Irradiation for the Treatment of High-Risk Acute Leukemia or Myelodysplastic Syndrome

    Not yet reported City of Hope Medical Center 7 participants Est. completion 2027-06-13 1 site Stand-alone
    Other conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Myelodysplastic Syndrome, Secondary Acute Myeloid Leukemia
    View official trial listing →
  • Completed NCT NCT05139667

    Evaluation of Mucoadhesive Tacrolimus Patch on Caspase-3 Inducing Apoptosis in Oral Lichen Planus

    Not yet reported Ain Shams University 30 participants Est. completion 2021-10-20 1 site Stand-alone
    Other conditions: Oral Lichen Planus
    View official trial listing →
  • Active, not recruiting NCT NCT05148715

    Calcineurin Inhibitor in NEuRoloGically Deceased Donors to Decrease Kidney delaYed Graft Function (CINERGY)

    Not yet reported Université de Sherbrooke 414 participants Est. completion 2026-01 9 sites Stand-alone
    Other conditions: Organ Transplant Failure or Rejection, Brain Death, Ischemic Reperfusion Injury
    View official trial listing →
  • Completed NCT NCT05152628

    A Study of Modigraf® (Tacrolimus Granules) to Evaluate the Pharmacokinetics and Long-term Safety and Efficacy in De Novo Pediatric Allograft Liver and Kidney Transplantation Recipients

    Not yet reported Astellas Pharma China, Inc. 55 participants Est. completion 2024-03-06 4 sites Stand-alone
    Other conditions: Liver Transplantation, Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT05153668

    Everolimus Trial in Laryngotracheal Stenosis

    Not yet reported Johns Hopkins University 8 participants Est. completion 2025-10-23 1 site
    Other conditions: Idiopathic Subglottic Tracheal Stenosis
    View official trial listing →
  • Completed NCT NCT05153915

    A Study to Evaluate the Safety and Efficacy of a Modigraf® Based Immunosuppression Regimen in De Novo Pediatric Allograft Liver and Kidney Transplantation Recipients

    Not yet reported Astellas Pharma China, Inc. 56 participants Est. completion 2024-03-14 7 sites Stand-alone
    Other conditions: Liver Transplantation, Kidney Transplantation
    View official trial listing →
  • Active, not recruiting NCT NCT05156710

    BIVV020 (SAR445088) in Prevention and Treatment of Antibody-mediated Rejection (AMR)

    Not yet reported Sanofi 48 participants Est. completion 2026-10-20 27 sites Stand-alone
    Other conditions: Transplant Rejection
    View official trial listing →
  • Status unknown NCT NCT05161429

    BESTMED: Observational Evaluation of Second Line Therapy Medications in Diabetes

    Brigham and Women's Hospital 550000 participants Est. completion 2024-06-30 5 sites
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT05180708

    A Multicenter, Phase 3 Randomized, Double-Blind, Vehicle-Controlled Study Evaluating the Safety and Efficacy of QTORIN 3.9% Rapamycin Anhydrous Gel in the Treatment of Pachyonychia Congenita

    Not yet reported Palvella Therapeutics, Inc. 87 participants Est. completion 2023-06-30 8 sites
    Other conditions: Pachyonychia Congenita
    View official trial listing →
  • Status unknown NCT NCT05190627

    Effect of Loratadine in Lymphangioleiomyomatosis

    Not yet reported Institut d'Investigació Biomèdica de Bellvitge 62 participants Est. completion 2023-12-30 6 sites
    Other conditions: Lymphangioleiomyomatosis
    View official trial listing →
  • Active, not recruiting NCT NCT05193565

    Study to Compare the Efficacy and Safety After Conversion to RaparoBell® or My-Rept® in Kidney Transplant Patients

    Not yet reported Chong Kun Dang Pharmaceutical 206 participants Est. completion 2026-11 1 site Stand-alone
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT05202145

    Drug-Drug Interaction (DDI) Study of ALXN2050 in Healthy Adult Participants

    Not yet reported Alexion Pharmaceuticals, Inc. 61 participants Est. completion 2022-03-21 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Active, not recruiting NCT NCT05205499

    A Clinical Trial to Evaluate the Safety and Efficacy of IBS in Patients With Coronary Artery Disease

    Not yet reported Biotyx Medical (Shenzhen) Co., Ltd. 1059 participants Est. completion 2028-08 1 site Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Active, not recruiting NCT NCT05220917

    Comparative Effectiveness and Safety of Four Second Line Pharmacological Strategies in Type 2 Diabetes Study

    Brigham and Women's Hospital 781430 participants Est. completion 2027-09-30 1 site
    Type 2 diabetes Other conditions: Cardiovascular Events, Renal Disease
    View official trial listing →
  • Status unknown NCT NCT05221411

    Tacrolimus Versus Mycophenolate for Autoimmune Hepatitis Patients With Incomplete Response on First Line Therapy

    Not yet reported Leiden University Medical Center 86 participants Est. completion 2024-01 6 sites Stand-alone
    Other conditions: Autoimmune Hepatitis
    View official trial listing →
  • Completed NCT NCT05247203

    Telitacicept Study in Chinese Subjects With Systemic Lupus Erythematosus

    Not yet reported RemeGen Co., Ltd. 92 participants Est. completion 2023-11-13 19 sites Stand-alone
    Other conditions: Systemic Lupus Erythematosus
    View official trial listing →
  • Completed NCT NCT05252585

    A Phase IV Study of Safety and Efficacy of Everolimus in Taiwanese Patients With Tuberous Sclerosis Complex Who Have Renal Angiomyolipoma (TSC-AML)

    Not yet reported Novartis Pharmaceuticals 10 participants Est. completion 2026-10-13 4 sites
    Other conditions: Renal Angiomyolipoma
    View official trial listing →
  • Active, not recruiting NCT NCT05256537

    Fludarabine and Total Body Irradiation 800 Centigray (cGy) or 1125 cGy For Allogeneic Stem Cell Transplant Using Graft Versus Host Disease Prophylaxis With Post-Transplant Cyclophosphamide and Tacrolimus, Without Mycophenolate Mofetil

    Not yet reported Ronald Paquette 60 participants Est. completion 2027-01-07 1 site
    Other conditions: Hematologic Neoplasms
    View official trial listing →
  • Status unknown NCT NCT05267548

    Investigating the Safety and Clinical Performance of Seven iVascular Devices for Endovascular Intervention in the Popliteal and/or Infrapopliteal Arteries

    iVascular S.L.U. 143 participants Est. completion 2025-05 8 sites
    Other conditions: Peripheral Arterial Disease Below The Knee
    View official trial listing →
  • Completed NCT NCT05274308

    Stability of Tacrolimus, Cyclosporine A, Everolimus and Sirolimus in Whole Blood Patient Samples

    Thermo Fisher Scientific Oy 46 participants Est. completion 2022-07-26 1 site
    Other conditions: Transplantation Drugs Stability
    View official trial listing →
  • Status unknown NCT NCT05277792

    Dosage of Tacrolimus Metabolites in Blood and Bile for Prediction of Its Side Effects in Liver Transplant Recipients

    Rennes University Hospital 48 participants Est. completion 2024-06-08 1 site
    Other conditions: Blood Concentration of Tacrolimus Metabolites
    View official trial listing →
  • Completed NCT NCT05281614

    Immune Effects of Vedolizumab With or Without Anti-TNF Pre-treatment in T1D

    Not yet reported Benaroya Research Institute 20 participants Est. completion 2024-01-10 2 sites Stand-alone
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Withdrawn NCT NCT05293509

    Pharmacologic Pretransplant Immunosuppression (PTIS) + Reduced Toxicity Conditioning (RTC) Allogeneic Stem Cell Transplantation in Inherited Hematologic Disorders

    Not yet reported M.D. Anderson Cancer Center Est. completion 2023-09-18 1 site Stand-alone
    Other conditions: Stem Cell Transplantation
    View official trial listing →
  • Active, not recruiting NCT NCT05293964

    Phase I Study to Evaluate SIM0270 Alone or in Combination in ER+, HER2- Locally Advanced or Metastatic Breast Cancer

    Not yet reported Jiangsu Simcere Pharmaceutical Co., Ltd. 214 participants Est. completion 2025-09-08 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT05294666

    Evaluation of 0.05% CsA and 0.1% FK506 Eye Drops in Ocular GVHD Treatment

    Not yet reported Peking University Third Hospital 89 participants Est. completion 2021-07-01 1 site Stand-alone
    Other conditions: Graft Versus Host Disease in Eye
    View official trial listing →
  • Status unknown NCT NCT05294822

    Autologous Regenerative Islet Transplantation for Insulin-dependent Diabetes

    Not yet reported Shanghai Changzheng Hospital 20 participants Est. completion 2023-12 1 site Stand-alone
    Other conditions: Diabetes
    View official trial listing →
  • Terminated NCT NCT05298358

    RIC alloBMT With Post-transplant Cyclophosphamide for Refractory Systemic Sclerosis

    Not yet reported Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 1 participants Est. completion 2024-11-21 1 site Stand-alone
    Other conditions: Systemic Sclerosis
    View official trial listing →
  • Not yet recruiting NCT NCT05303727

    Allogeneic Hematopoietic Stem Cell Transplantation for 4/M Neuroblastoma

    Not yet reported Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 64 participants Est. completion 2027-08 1 site Stand-alone
    Other conditions: Neuroblastoma
    View official trial listing →
  • Status unknown NCT NCT05316038

    Metabolic and Infectious Complications Post Belatacept Conversion

    University Hospital, Grenoble 100 participants Est. completion 2024-06-01
    Cardiovascular disease Other conditions: Kidney Transplant Infection, Immunosuppression, Kidney Transplant; Complications
    View official trial listing →
  • Active, not recruiting NCT NCT05316701

    Precision-T: A Randomized Study of Orca-T in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies

    Not yet reported Orca Biosystems, Inc. 187 participants Est. completion 2026-07 19 sites Stand-alone
    Other conditions: Acute Myeloid Leukemia, Acute Lymphoid Leukemia, Mixed Phenotype Acute Leukemia, Undifferentiated Leukemia, Myelodysplastic Syndrome, Acute Leukemia, Therapy-Related Myelodysplastic Syndrome
    View official trial listing →
  • Completed NCT NCT05324618

    Tacrolimus Versus Hydrocortisone in Atopic Dermatitis

    Not yet reported Ain Shams University 200 participants Est. completion 2023-04-30 1 site
    Other conditions: Atopic, Dermatitis
    View official trial listing →
  • Completed NCT NCT05325073

    Erythropoietin Therapy to Induce Regulatory T Cells in Liver Transplant Recipients

    Not yet reported Northwestern University 9 participants Est. completion 2024-12-30 1 site
    Other conditions: Liver Transplant Rejection
    View official trial listing →
  • Status unknown NCT NCT05328843

    Study to Evaluate the Pharmacokinetic Characteristics of Pegylated Exenatide Injection (PB-119) in Subjects With Different Degrees of Renal Insufficiency and Matched Subjects With Normal Renal Function

    Not yet reported PegBio Co., Ltd. 24 participants Est. completion 2022-10-01 1 site
    Other conditions: Type2Diabetes
    View official trial listing →
  • Status unknown NCT NCT05333640

    A Real-world Registry Investigating Sirolimus-coated Balloon Versus Paclitaxel-coated Balloon Angioplasty for the Treatment of Dysfunctional Arteriovenous Fistula

    Singapore General Hospital 200 participants Est. completion 2024-04-30 1 site
    Other conditions: Dialysis Access Malfunction, Stenosis
    View official trial listing →
  • Completed NCT NCT05345119

    Sirolimus in Graves' Orbitopathy

    University of Pisa 30 participants Est. completion 2021-06-15 1 site
    Other conditions: Graves Ophthalmopathy
    View official trial listing →
  • Terminated NCT NCT05347147

    A Trial to Determine the Efficacy and Safety of Presendin in IIH

    Not yet reported Invex Therapeutics Ltd. 14 participants Est. completion 2023-10-20 24 sites
    Other conditions: Idiopathic Intracranial Hypertension
    View official trial listing →
  • Completed NCT NCT05352880

    Hypomagnesemia and Its Association With Calcineurin Inhibitors Use in Renal Transplant Recipients

    Not yet reported Alexandria University 80 participants Est. completion 2022-09-10 1 site Stand-alone
    Other conditions: Renal Transplantation; Complication
    View official trial listing →
  • Status unknown NCT NCT05353010

    A Study to Evaluate Effect of IN-A001 on Pharmacokinetics of Tacrolimus in Healthy Volunteers

    Not yet reported HK inno.N Corporation 12 participants Est. completion 2022-11-01 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Active, not recruiting NCT NCT05364762

    Adding Itacitinib to Cyclophosphamide and Tacrolimus for the Prevention of Graft Versus Host Disease in Patients Undergoing Hematopoietic Stem Cell Transplants

    Not yet reported City of Hope Medical Center 20 participants Est. completion 2027-03-25 1 site Stand-alone
    Other conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, Myelodysplastic Syndrome, Myeloproliferative Neoplasm, Primary Myelofibrosis, Secondary Myelofibrosis
    View official trial listing →
  • Status unknown NCT NCT05379049

    Therapeutic Response to Tumor Necrosis Factor-alpha (TNF-alpha) Antagonists in Rheumatoid Arthritis.

    University of Sulaimani 80 participants Est. completion 2022-10-01 1 site
    Other conditions: Rheumatoid Arthritis, Inflammatory Arthritis, Ankylosing Spondylitis
    View official trial listing →
  • Withdrawn NCT NCT05379322

    The Use of Synovial Biopsies in Predicting Response to Biologic Therapy in Rheumatoid Arthritis Patients

    Not yet reported Abu Dhabi Stem Cells Center Est. completion 2023-03-01 1 site
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Active, not recruiting NCT NCT05386914

    This Study Consists of Two Study Parts Conducted Under a Single IRB. Part I: Short Term ApoE-dependent Cerebral Blood Flow Response to Sirolimus in Cognitively Normal Adults Part II: Short Term ApoE-dependent Cerebral Blood Flow and Lung Perfusion Response to Sirolimus in Cognitively Normal Adults

    Not yet reported University of Missouri-Columbia 205 participants Est. completion 2027-12 1 site Stand-alone
    Other conditions: Genetic Predisposition to Disease, Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT05396898

    Tacrolimus Formulation and Glucose Metabolism After Kidney Transplantation (TAGLUMET Trial)

    Not yet reported University Hospital Tuebingen 44 participants Est. completion 2023-12-30 1 site Stand-alone
    Other conditions: Posttransplant Diabetes Mellitus
    View official trial listing →
  • Withdrawn NCT NCT05423496

    KidneyCare Immuno-optimization in Renal Allografts (KIRA)

    Not yet reported CareDx Est. completion 2023-02-23
    Other conditions: Kidney Transplant, Immunosuppression, Allograft
    View official trial listing →
  • Status unknown NCT NCT05424393

    Real-World Study on Long-term Treatment With YISAIPU for Fujian RA Patients

    The First Affiliated Hospital of Xiamen University 500 participants Est. completion 2025-12-31 1 site
    Other conditions: Rheumatoid Arthritis
    View official trial listing →
  • Status unknown NCT NCT05429684

    Precise Therapy for Refractory HER2 Positive Advanced Breast Cancer

    Not yet reported First Affiliated Hospital Xi'an Jiaotong University 120 participants Est. completion 2024-02-28 2 sites
    Other conditions: HER2+ Breast Cancer
    View official trial listing →
  • Enrolling by invitation NCT NCT05432518

    Pilot Trial for Treatment of Recurrent Glioblastoma

    Not yet reported AHS Cancer Control Alberta 10 participants Est. completion 2027-12-01 1 site
    Other conditions: Glioblastoma, Recurrent Disease, Recurrent Glioblastoma
    View official trial listing →
  • Not yet recruiting NCT NCT05432765

    AIIM Trial: Personalized Medicine Approach to Kidney Allograft Function

    Not yet reported University of Florida 34 participants Est. completion 2031-01-01 1 site Stand-alone
    Other conditions: Kidney Transplant Rejection
    View official trial listing →
  • Status unknown NCT NCT05450042

    Vascular Effects Through Sirolimus vs. Paclitaxel DCB Implantation

    Not yet reported University Hospital, Essen 70 participants Est. completion 2024-04-06 1 site Stand-alone
    Other conditions: Peripheral Arterial Disease, Flow-mediated Dilation, Drug Eluting Balloon, Infrainguinal Peripheral Arterial Disease
    View official trial listing →
  • Active, not recruiting NCT NCT05457556

    Mismatched Related Donor Versus Matched Unrelated Donor Stem Cell Transplantation for Children, Adolescents, and Young Adults With Acute Leukemia or Myelodysplastic Syndrome

    Not yet reported Children's Oncology Group 66 participants Est. completion 2027-07-07 63 sites Stand-alone
    Other conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Mixed Phenotype Acute Leukemia, Myelodysplastic Syndrome
    View official trial listing →
  • Active, not recruiting NCT NCT05467397

    Feasibility of [11C]Acetate-PET in LAM and TSC

    Not yet reported, Not yet reported Brigham and Women's Hospital 7 participants Est. completion 2026-06-30 1 site
    Other conditions: Lymphangioleiomyomatosis, Tuberous Sclerosis Complex
    View official trial listing →
  • Status unknown NCT NCT05471050

    The Combination of Tacrolimus and Danazol as the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia

    Not yet reported Peking University People's Hospital 120 participants Est. completion 2023-06-01 1 site Stand-alone
    Other conditions: Immune Thrombocytopenia
    View official trial listing →
  • Active, not recruiting NCT NCT05477576

    Study of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA Therapy

    Not yet reported RayzeBio, Inc. 343 participants Est. completion 2030-12 54 sites
    Other conditions: GEP-NET, Gastroenteropancreatic Neuroendocrine Tumor, Gastroenteropancreatic Neuroendocrine Tumor Disease, Neuroendocrine Tumors, Carcinoid, Carcinoid Tumor, Pancreatic NET
    View official trial listing →
  • Completed NCT NCT05490342

    Effect of SARS-CoV-2 Vaccination in Liver Transplant Recipients

    University of Rome Tor Vergata 61 participants Est. completion 2022-06-30 1 site
    Other conditions: SARS-CoV-2 Vaccination, Liver Transplantation
    View official trial listing →
  • Completed NCT NCT05490511

    Drug-gene-nutraceutical Interactions of Cannabidiol and Tacrolimus

    Not yet reported Indiana University 57 participants Est. completion 2025-08-31 1 site
    Other conditions: CBD, Transplant Complication, Kidney Disease, Chronic
    View official trial listing →
  • Completed NCT NCT05495425

    Clinical Study of NPC-12Y Gel in Patients With Skin Lesions Associated With TSC

    Not yet reported Nobelpharma 43 participants Est. completion 2024-10-30 5 sites Stand-alone
    Other conditions: Tuberous Sclerosis Complex
    View official trial listing →
  • Terminated NCT NCT05501574

    An Open Label Trial Evaluating the Safety, Tolerability, Efficacy and Pharmacokinetic Profile of Tacrolimus Inhalation Powder in Adult Lung Transplant Recipients

    Not yet reported TFF Pharmaceuticals, Inc. 14 participants Est. completion 2024-12-23 2 sites Stand-alone
    Other conditions: Lung Transplant Rejection
    View official trial listing →
  • Status unknown NCT NCT05508620

    A Study of Sirolimus for Injection (Albumin-bound) in Patients With Advanced Solid Tumors

    Not yet reported CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 270 participants Est. completion 2024-12 Stand-alone
    Other conditions: Malignant Solid Tumors
    View official trial listing →
  • Active, not recruiting NCT NCT05508906

    Phase 1b Study of OP-1250 (Palazestrant) in Combination With Ribociclib, Alpelisib, Everolimus, or Atirmociclib in ER+, HER2- Breast Cancer

    Not yet reported Olema Pharmaceuticals, Inc. 190 participants Est. completion 2028-01-31 16 sites
    Other conditions: Metastatic Breast Cancer, ER-positive Breast Cancer, HER2-negative Breast Cancer, Breast Cancer, Locally Advanced Breast Cancer
    View official trial listing →
  • Status unknown NCT NCT05532111

    Efficacy and Safety of the Treatment of Primary Membranous Nephropathy: A Randomized Clinical Trial

    Not yet reported RenJi Hospital 60 participants Est. completion 2024-09-30 Stand-alone
    Other conditions: Efficacy and Safety
    View official trial listing →
  • Status unknown NCT NCT05546047

    A Study of Acthar Gel Alone or With Tacrolimus to Reduce Proteinuria in Fibrillary Glomerulopathy Patients

    Not yet reported NephroNet, Inc. 34 participants Est. completion 2024-10-27 5 sites
    Other conditions: Fibrillary Glomerulonephritis
    View official trial listing →
  • Status unknown NCT NCT05548023

    Time-trend Analysis of Clinical Characteristic and Outcomes in Patients With Unprotected Left Main Coronary Artery Disease Treated With PCI Over a 10-year Period

    Not yet reported Chinese University of Hong Kong 500 participants Est. completion 2025-02-07 1 site
    Cardiovascular disease
    View official trial listing →
  • Status unknown NCT NCT05553496

    Assessment of Rituximab Therapeutic Response Versus Conventional Treatment

    Not yet reported, Not yet reported Ain Shams University 40 participants Est. completion 2023-10-01
    Other conditions: Pharmacological Action
    View official trial listing →
  • Completed NCT NCT05556681

    Study of BD Sirolimus Drug Coated Catheter for Treatment of Femoropopliteal Arteries

    Not yet reported C. R. Bard 34 participants Est. completion 2025-11-24 10 sites Stand-alone
    Other conditions: Peripheral Arterial Disease, Peripheral Artery Disease, Stenosis Artery
    View official trial listing →
  • Active, not recruiting NCT NCT05563220

    Open-Label Umbrella Study To Evaluate Safety And Efficacy Of Elacestrant In Various Combination In Participants With Metastatic Breast Cancer

    Not yet reported, Not yet reported Stemline Therapeutics, Inc. 435 participants Est. completion 2028-12-28 83 sites
    Other conditions: Breast Cancer, Metastatic Breast Cancer
    View official trial listing →
  • Terminated NCT NCT05571670

    Bile Acids in Acute Insulin Resistance

    Columbia University 3 participants Est. completion 2022-06-10 1 site
    Other conditions: PI3K Gene Mutation, AKT Gene Mutation, MTOR Gene Mutation, Cancer, Insulin Resistance
    View official trial listing →
  • Completed NCT NCT05577637

    Comparitive Study Between Uvb Alone and Uvb With Topical Tacrolimus 0.03% for the Treatment of Vitiligo

    Not yet reported Combined Military Hospital Abbottabad 60 participants Est. completion 2021-11-30 1 site
    Other conditions: Vitiligo
    View official trial listing →
  • Active, not recruiting NCT NCT05589896

    A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients With Hematologic Malignancies

    Not yet reported, Not yet reported Ossium Health, Inc. 12 participants Est. completion 2029-05-31 9 sites Stand-alone
    Other conditions: Acute Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Acute Biphenotypic Leukemia, Acute Undifferentiated Leukemia, CLL (Chronic Lymphocytic Leukemia), Chronic Myeloid Leukemia (CML), MDS (Myelodysplastic Syndrome), Non-Hodgkin Lymphomas, Hodgkins Lymphoma, Cutaneous T Cell Lymphomas (CTCL)
    View official trial listing →
  • Completed NCT NCT05607901

    A Comparative Clinical Trial Evaluating the Effect and Safety of Tacrolimus Versus Hydrocortisone

    Not yet reported Tanta University 100 participants Est. completion 2023-08-20 1 site
    Other conditions: Dermatologic Disease
    View official trial listing →
  • Active, not recruiting NCT NCT05613010

    Leveraging Technology to Improve Medication Adherence in Youth With Kidney or Liver Transplant

    Not yet reported Johns Hopkins University 65 participants Est. completion 2027-08-30 1 site Stand-alone
    Other conditions: Transplant;Failure,Kidney, Transplant; Failure, Liver, Adherence, Medication, Adherence, Patient, Adherence, Treatment
    View official trial listing →
  • Status unknown NCT NCT05613166

    Adjunctive Everolimus Treatment of Refractory Epilepsy

    Not yet reported National Institute on Drug Dependence, China 108 participants Est. completion 2023-03 1 site
    Other conditions: Epilepsy
    View official trial listing →
  • Status unknown NCT NCT05618730

    Safety, Tolerability, Plug Retention and Preliminary Efficacy of Tacrolimus-loaded Punctal Plug in Patients With Moderate to Severe Dry Eye Disease - Cohort B

    Not yet reported Eximore Ltd. 20 participants Est. completion 2023-12-30 1 site Stand-alone
    Other conditions: Dry Eye, Keratoconjunctivitis Sicca, Ocular Inflammation
    View official trial listing →
  • Active, not recruiting NCT NCT05621759

    Cyclophosphamide, Abatacept, and Tacrolimus for the Prevention of GvHD

    Not yet reported NYU Langone Health 27 participants Est. completion 2027-01-30 1 site Stand-alone
    Other conditions: Graft Vs Host Disease
    View official trial listing →
  • Status unknown NCT NCT05622123

    BetaFIT Study: Beta Cell Imaging After Faecal mIcrobiota Transplantation

    Not yet reported Radboud University Medical Center 20 participants Est. completion 2024-03-30 1 site
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Active, not recruiting NCT NCT05622318

    De-escalated Cyclophosphamide (PTCy) and Ruxolitinib for Graft-versus-Host Disease (GVHD) Prophylaxis

    Not yet reported Medical College of Wisconsin 56 participants Est. completion 2028-08-06 1 site Stand-alone
    Other conditions: Graft-versus-host Disease
    View official trial listing →
  • Status unknown NCT NCT05625919

    A Study of Safety and Efficacy of Sirolimus for Injection (Albumin-bound) in Patients With Advanced Malignant Perivascular Epithelioid Cell Tumor (PEComa)

    Not yet reported, Not yet reported CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 54 participants Est. completion 2024-11 1 site Stand-alone
    Other conditions: Advanced Malignant Perivascular Epithelioid Cell Tumor (PEComa)
    View official trial listing →
  • Enrolling by invitation NCT NCT05655273

    Conversion of Maintenance Prograf to Envarsus in Liver Transplant Recipients

    Not yet reported University Health Network, Toronto 40 participants Est. completion 2026-02-28 1 site
    Other conditions: Liver Transplant Rejection, Immune System Suppression
    View official trial listing →
  • Status unknown NCT NCT05662618

    To Verify the Efficacy and Safety of Rapamycin Coated Peripheral Balloon Catheter in the Treatment of Femoral Popliteal Artery Disease

    Not yet reported Shanghai Bomaian Medical Technology Co., Ltd 276 participants Est. completion 2025-06-30 1 site
    Other conditions: Peripheral Arterial Disease
    View official trial listing →
  • Status unknown NCT NCT05666336

    Multi-omics Studies on the Efficacy of Telitacicept in Chinese SLE Patients

    Not yet reported Fen Li 30 participants Est. completion 2024-06-30 1 site Stand-alone
    Other conditions: Systemic Lupus Erythematosus
    View official trial listing →
  • Status unknown NCT NCT05667896

    Prognostic Model of GC/TAC in the Treatment of MN

    Qianfoshan Hospital 50 participants Est. completion 2023-12
    Other conditions: Idiopathic Membranous Nephropathy
    View official trial listing →
  • Status unknown NCT NCT05667922

    Prognostic Model of TAC in the Treatment of MN

    Qianfoshan Hospital 50 participants Est. completion 2023-12
    Other conditions: Idiopathic Membranous Nephropathy
    View official trial listing →
  • Completed NCT NCT05669001

    A Study of TCD601 in de Novo Renal Transplant Recipients

    Not yet reported ITB-Med LLC 76 participants Est. completion 2026-04-10 18 sites
    Other conditions: Renal Transplantation
    View official trial listing →
  • Completed NCT NCT05677711

    Safety and Efficacy of the Ultimaster Stent

    Yonsei University 204 participants Est. completion 2025-01-03 1 site
    Cardiovascular disease Other conditions: Drug-eluting Stents
    View official trial listing →
  • Status unknown NCT NCT05678335

    Tacrolimus for Thrombocytopenia in SS

    Not yet reported, Not yet reported Peking Union Medical College Hospital 54 participants Est. completion 2024-03 Stand-alone
    Other conditions: Sjogren Syndrome With Other Organ Involvement
    View official trial listing →
  • Status unknown NCT NCT05694130

    Tacrolimus Plus Glucocorticoid for Severe Thrombocytopenia in SS

    Not yet reported, Not yet reported Peking Union Medical College Hospital 110 participants Est. completion 2024-12 Stand-alone
    Other conditions: Sjogren Syndrome With Other Organ Involvement
    View official trial listing →
  • Status unknown NCT NCT05696106

    Risk of Incident IMID in Patients Treated With Biologics and Immunosuppressive Drugs for a Single IMID

    Assistance Publique - Hôpitaux de Paris 750000 participants Est. completion 2024-01-15 1 site
    Other conditions: Inflammatory Disease
    View official trial listing →
  • Status unknown NCT NCT05703646

    Safety and Clinical Performance of the Yukon Choice PC, Yukon Chrome PC & Yukon Choice Flex Stents in Routine Practice

    Translumina GmbH 5000 participants Est. completion 2026-03-30 1 site
    Other conditions: Ischemic Heart Disease
    View official trial listing →
  • Active, not recruiting NCT NCT05705973

    Ultimaster Nagomi™ Sirolimus Eluting Coronary Stent System in Complex PCI Patients

    Terumo Europe N.V. 3000 participants Est. completion 2027-04-29 52 sites
    Cardiovascular disease Other conditions: Coronary Artery Occlusion, Ischemic Heart Disease
    View official trial listing →
  • Completed NCT NCT05706636

    T Central Memory Cells in Early Localized Non-Segmental Vitiligo

    Not yet reported Cairo University 22 participants Est. completion 2025-04-15 1 site
    Other conditions: Vitiligo
    View official trial listing →
  • Active, not recruiting NCT NCT05707377

    A Study to Examine the Efficacy and Safety of Zanubrutinib Given to Adults With Primary Membranous Nephropathy

    Not yet reported, Not yet reported BeOne Medicines 178 participants Est. completion 2027-10 45 sites
    Other conditions: Primary Membranous Nephropathy
    View official trial listing →
  • Status unknown NCT NCT05739630

    M-PTCy vs BuCy in Haploidentical HSCT for Acute Leukemia

    Not yet reported, Not yet reported The First Affiliated Hospital of Soochow University 60 participants Est. completion 2025-01-31 1 site
    Other conditions: Acute Leukemia
    View official trial listing →
  • Status unknown NCT NCT05744635

    Assessment of the Pharmacokinetic Profile of Tacrolimus Medications and Their Relation to Effectiveness and Safety in Liver Transplant Patients

    Chiesi Hungary Ltd. 110 participants Est. completion 2026-06-01 2 sites
    Other conditions: Liver Failure
    View official trial listing →
  • Not yet recruiting NCT NCT05746689

    Study of Sirolimus in IgG4-related Disease

    Not yet reported Peking University International Hospital 20 participants Est. completion 2028-12-31 Stand-alone
    Other conditions: IgG4-related Disease
    View official trial listing →
  • Terminated NCT NCT05762744

    Pharmacogenomics of GLP1 Receptor Agonists

    Not yet reported University of Maryland, Baltimore 63 participants Est. completion 2022-10-31 1 site
    Type 2 diabetes
    View official trial listing →
  • Terminated NCT NCT05773326

    Superselective Intra-arterial Cerebral Infusion of Temsirolimus in HGG

    Not yet reported Nader Sanai 5 participants Est. completion 2025-10-16 1 site
    Other conditions: High Grade Glioma, Glioma, Glioma, Malignant, Glioblastoma
    View official trial listing →
  • Status unknown NCT NCT05797038

    Study on the Application of Hyperspectral Imaging Technique in the Treatment of IMN by TAC

    Qianfoshan Hospital 40 participants Est. completion 2023-12-30
    Other conditions: Idiopathic Membranous Nephropathy, Tacrolimus, Hyperspectral Imaging
    View official trial listing →
  • Completed NCT NCT05799755

    Myositis Interstitial Lung Disease Nintedanib Trial

    Not yet reported Rohit Aggarwal, MD 62 participants Est. completion 2025-12-31 10 sites
    Other conditions: Myositis Associated Interstitial Lund Disease (MA-ILD)
    View official trial listing →
  • Active, not recruiting NCT NCT05806749

    Immunological Tolerance in Patients With Mismatched Kidney Transplants

    Not yet reported University of California, Los Angeles 16 participants Est. completion 2028-08 1 site Stand-alone
    Chronic kidney disease Other conditions: End Stage Kidney Disease, Immunological Tolerance, Kidney Transplant Failure and Rejection
    View official trial listing →
  • Status unknown NCT NCT05833815

    Addition of Everolimus to Standard of Care in Carcinoma Gallbladder

    Not yet reported, Not yet reported Banaras Hindu University 56 participants Est. completion 2024-12-30 1 site
    Other conditions: Gallbladder Cancer
    View official trial listing →
  • Completed NCT NCT05835999

    Everolimus Aging Study

    Not yet reported University of Wisconsin, Madison 106 participants Est. completion 2026-07-22 1 site
    Other conditions: Aging, Insulin Resistance
    View official trial listing →
  • Active, not recruiting NCT NCT05836025

    Effect of Rapamycin in Ovarian Aging

    Not yet reported Columbia University 50 participants Est. completion 2026-09 1 site
    Other conditions: Perimenopausal
    View official trial listing →
  • Status unknown NCT NCT05836441

    Improved Phototherapy in Patients With Vitiligo

    Not yet reported The First Affiliated Hospital with Nanjing Medical University 110 participants Est. completion 2023-12-30 1 site
    Other conditions: Vitiligo
    View official trial listing →
  • Terminated NCT NCT05840510

    Adagrasib in Combination With Nab-Sirolimus in Patients With Advanced Solid Tumors and Non-Small Cell Lung Cancer With a KRAS G12C Mutation (KRYSTAL -19)

    Not yet reported Mirati Therapeutics Inc. 6 participants Est. completion 2024-12-27 3 sites Stand-alone
    Other conditions: Solid Tumor, Adult, NSCLC, Advanced Cancer, Metastatic Cancer, Malignant Neoplastic Disease
    View official trial listing →
  • Terminated NCT NCT05856994

    Clinical Assessment of Protopic® Ointment in Deep Partial-Thickness Burns

    Not yet reported Vanderbilt University Medical Center 1 participants Est. completion 2026-04-20 1 site Stand-alone
    Other conditions: Burn Injury
    View official trial listing →
  • Active, not recruiting NCT NCT05860881

    Topical Sirolimus in Chemoprevention of Facial Squamous Cell Carcinomas in Solid Organ Transplant Recipients (SiroSkin)

    Not yet reported Melanoma and Skin Cancer Trials Limited 146 participants Est. completion 2027-09-30 6 sites Stand-alone
    Other conditions: Solid Organ Transplant Recipients, Skin Cancer
    View official trial listing →
  • Status unknown NCT NCT05863936

    Trial of Belimumab Combined With Multi-target Induction Therapy in Lupus Nephritis

    Not yet reported Nanjing University School of Medicine 15 participants Est. completion 2024-12-31 1 site
    Other conditions: Lupus Nephritis, Remission, Safety Issues
    View official trial listing →
  • Completed NCT NCT05885269

    Comparative Efficacy of Tacrolimus and Clobetasol Propionate in Alopecia Areata

    Not yet reported Combined Military Hospital Abbottabad 70 participants Est. completion 2023-04-30 1 site
    Other conditions: Alopecia Areata
    View official trial listing →
  • Status unknown NCT NCT05899907

    Efficacy and Safety of Telitacicept in Early SLE

    Not yet reported Peking Union Medical College Hospital 180 participants Est. completion 2025-09-01 20 sites
    Other conditions: Lupus Erythematosus, Systemic
    View official trial listing →
  • Active, not recruiting NCT NCT05907746

    Allogeneic Hematopoietic Stem Cell Transplantation With Briquilimab-Based Conditioning in Participants With GATA2 Deficiency

    Not yet reported National Cancer Institute (NCI) 13 participants Est. completion 2028-07-31 1 site Stand-alone
    Other conditions: GATA2, Immunodeficiency
    View official trial listing →
  • Status unknown NCT NCT05913596

    The Safety and Efficacy of CD38 Monoclonal Antibody Monotherapy for CaAMR in Renal Transplantation

    Not yet reported First Affiliated Hospital of Zhejiang University 15 participants Est. completion 2024-08-30 1 site Stand-alone
    Other conditions: Antibody-mediated Rejection, Kidney Tranplant
    View official trial listing →
  • Completed NCT NCT05915468

    Large De-NOVo Coronary artEry Disease Treated With Sirolimus Drug Eluting Balloon (LOVE DEB)

    Wrightington, Wigan and Leigh NHS Foundation Trust 306 participants Est. completion 2025-12-11 1 site
    Cardiovascular disease
    View official trial listing →
  • Status unknown NCT NCT05916781

    Effectiveness of Mycophenolate Mofetil Combined With Tacrolimus for Steroid Tapering in Systemic Lupus Erythematosus

    Not yet reported Chinese SLE Treatment And Research Group 220 participants Est. completion 2026-07-31 1 site Stand-alone
    Other conditions: Systemic Lupus Erythematosus, Lupus Nephritis
    View official trial listing →
  • Status unknown NCT NCT05920512

    Combination Regimen With Sodium Valproate for Severe Hemophilia: a Single-arm, Phase 1, Pilot Trial.

    Not yet reported, Not yet reported Xue-chun Lu 10 participants Est. completion 2025-04-01 1 site Stand-alone
    Other conditions: Hemophilia
    View official trial listing →
  • Status unknown NCT NCT05929248

    Exploring the Therapeutic Effect of Telitacicept on Lupus Erythematosus Complicated With Thrombocytopenia

    Not yet reported Guanmin Gao 64 participants Est. completion 2024-12-30
    Other conditions: Systemic Lupus Erythematosus
    View official trial listing →
  • Status unknown NCT NCT05938530

    Sirolimus Drug-coated Balloon Versus Stent Graft

    Not yet reported Singapore General Hospital 100 participants Est. completion 2026-08 1 site Stand-alone
    Other conditions: Arteriovenous Shunt Thrombosis, Blood Vessel Prosthesis
    View official trial listing →
  • Active, not recruiting NCT NCT05946629

    SELUTION 4 De Novo Small Vessel IDE Trial

    Not yet reported M.A. Med Alliance S.A. 960 participants Est. completion 2031-09 70 sites Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Enrolling by invitation NCT NCT05950724

    RENAL: TNF-alpha Inhibitor for Improving Renal Dysfunction and Primary Graft Dysfunction After Lung Transplant

    Not yet reported Northwestern University 20 participants Est. completion 2027-12 1 site Stand-alone
    Other conditions: Lung Transplant; Complications
    View official trial listing →
  • Active, not recruiting NCT NCT05952206

    Ischemic and Bleeding Outcomes After Angiolite Stent Implantation and an Abbreviated Dual Antiplatelet Therapy

    Not yet reported iVascular S.L.U. 2312 participants Est. completion 2030-01-13 38 sites Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Enrolling by invitation NCT NCT05973734

    Islet Transplantation With Recipient T-Reg Cells or Deceased Donor Vertebral Bone Marrow Therapy

    Not yet reported Stanford University 24 participants Est. completion 2030-12 1 site Stand-alone
    Other conditions: Islet Transplantation
    View official trial listing →
  • Completed NCT NCT05975450

    Subcutaneous Abatacept in Renal Transplant Recipients

    Not yet reported Idelberto Badell 16 participants Est. completion 2025-02-14 2 sites Stand-alone
    Other conditions: Kidney Transplant Recipient
    View official trial listing →
  • Completed NCT NCT05983770

    Safety and Efficacy of Tegoprubart in Patients Undergoing Kidney Transplantation

    Not yet reported Eledon Pharmaceuticals 127 participants Est. completion 2025-09-25 43 sites
    Other conditions: Kidney Transplant Rejection
    View official trial listing →
  • Completed NCT NCT05997056

    Trial of Nab-sirolimus in Patients With Well-differentiated Neuroendocrine Tumors (NETs) of the Gastrointestinal Tract, Lung, or Pancreas Who Have Not Received Prior Treatment With mTOR Inhibitors

    Not yet reported Aadi Bioscience, Inc. 12 participants Est. completion 2025-10-03 4 sites Stand-alone
    Other conditions: Neuroendocrine Tumors, NET, Pancreatic Neuroendocrine Tumor, Gastrointestinal Neuroendocrine Tumor, Pulmonary Neuroendocrine Tumor
    View official trial listing →
  • Status unknown NCT NCT06000982

    Comparison of Different Dose of Post-transplantation Cyclophosphamide as Graft Versus Host Disease Prophylaxis

    Not yet reported Shanghai Jiao Tong University School of Medicine 138 participants Est. completion 2026-04-01 2 sites Stand-alone
    Other conditions: GVHD
    View official trial listing →
  • Active, not recruiting NCT NCT06001385

    HLA-Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation With Reduced Dose Post Transplantation Cyclophosphamide GvHD Prophylaxis

    Not yet reported Center for International Blood and Marrow Transplant Research 313 participants Est. completion 2026-12-30 32 sites Stand-alone
    Other conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Acute Leukemia, Myelodysplastic Syndromes, Chronic Myeloid Leukemia, Chronic Lymphocytic Leukemia, Myeloproliferative Neoplasm, Lymphoma, Chronic Myelomonocytic Leukemia, Pro-Lymphocytic Leukemia, Myelofibrosis
    View official trial listing →
  • Active, not recruiting NCT NCT06019507

    A Study of TCD601 in the Induction of Tolerance in de Novo Liver Transplantation

    Not yet reported ITB-Med LLC 12 participants Est. completion 2029-06 1 site
    Other conditions: Liver Transplantation
    View official trial listing →
  • Completed NCT NCT06022068

    Evaluating Rapamycin Treatment in Alzheimer's Disease Using Positron Emission Tomography

    Not yet reported, Not yet reported Karolinska Institutet 14 participants Est. completion 2025-01-17 1 site Stand-alone
    Other conditions: Alzheimer Disease
    View official trial listing →
  • Status unknown NCT NCT06029569

    Rapamycin Coated Balloon Dilation Catheter for Arteriovenous Fistula

    Not yet reported Shanghai Bomaian Medical Technology Co., Ltd 256 participants Est. completion 2025-12-15
    Other conditions: Peripheral Arterial Disease
    View official trial listing →
  • Completed NCT NCT06035614

    Efficacy and Safety of 308-nm Excimer Lamp Combined With Tacrolimus vs Tacrolimus as Monotherapy in Treating Vitiligo on Children

    Not yet reported Clarteis 50 participants Est. completion 2023-07-01 1 site
    Other conditions: Vitiligo, Pediatric ALL, Dermatologic Disease, Autoimmune Diseases
    View official trial listing →
  • Completed NCT NCT06044558

    Effect of Azole/Echinocandin Use on Tacrolimus Pharmacokinetics

    LI YAN 507 participants Est. completion 2023-06-01 1 site
    Other conditions: Kidney Transplant Patients
    View official trial listing →
  • Status unknown NCT NCT06057545

    Pharmacokinetics, Effectiveness and Tolerability of Prolonged-release Tacrolimus After Paediatric Kidney Transplantation

    Not yet reported University Hospital, Essen 30 participants Est. completion 2025-03 4 sites Stand-alone
    Other conditions: Pediatric Kidney Disease
    View official trial listing →
  • Completed NCT NCT06066476

    Efficacy and Safety of GENOSS® DES in Patients with Coronary Artery Disease

    Genoss Co., Ltd. 1022 participants Est. completion 2024-10-31 1 site
    Cardiovascular disease
    View official trial listing →
  • Status unknown NCT NCT06066840

    Vedolizumab, Anti-CD25 Antibody, Rapid Reduction of Glucocorticoids for SR-aGVHD With Gastrointestinal Involvement

    Not yet reported The First Affiliated Hospital of Soochow University 45 participants Est. completion 2025-12-31 1 site Stand-alone
    Other conditions: Safety and Efficacy
    View official trial listing →
  • Active, not recruiting NCT NCT06075368

    Efficacy and Safety of GENOSS® SES in Patients With Acute Coronary Syndrome (GENOSS ACS)

    Genoss Co., Ltd. 757 participants Est. completion 2027-12-31 1 site
    Other conditions: Acute Coronary Syndrome, Percutaneous Coronary Intervention
    View official trial listing →
  • Completed NCT NCT06080490

    Tacrolimus Blood Concentration and Transplant-related Outcomes in Pediatric HSCT Recipients

    University of Pisa 125 participants Est. completion 2024-12-31 1 site
    Other conditions: Graft Vs Host Disease, Transplant Failure, Stem Cell Transplant Complications
    View official trial listing →
  • Not yet recruiting NCT NCT06084780

    Intestinal & Multivisceral Transplantation for Unresectable Mucinous Carcinoma Peritonei (TRANSCAPE)

    Not yet reported Case Comprehensive Cancer Center 20 participants Est. completion 2027-12-31 1 site Stand-alone
    Other conditions: Secondary Malignant Neoplasm of Retroperitoneum, Secondary Malignant Neoplasm of Peritoneum, Pseudomyxoma Peritonei
    View official trial listing →
  • Enrolling by invitation NCT NCT06086496

    Effectiveness and Safety of Abluminal Biodegradable Polymer Sirolimus-eluting Stent (GENOSS® DES)

    Genoss Co., Ltd. 1000 participants Est. completion 2027-12-31 1 site
    Cardiovascular disease Other conditions: Percutaneous Coronary Intervention
    View official trial listing →
  • Completed NCT NCT06091995

    Use of Belatacept to Delay Tacrolimus Initiation in Kidney Transplant Patients With Delayed Graft Function

    Methodist Health System 67 participants Est. completion 2025-07-07 1 site
    Other conditions: Use of Belatacept in Kidney Transplant Patients
    View official trial listing →
  • Completed NCT NCT06095895

    Model Informed preciSion doSIng tO iNdividualise and Optimize Pharmacotherapeutic Treatment

    Radboud University Medical Center 29 participants Est. completion 2025-11-20 1 site
    Other conditions: Pharmacokinetics, Area Under Curve, Tacrolimus, Immunosuppressive Agents, Mycophenolic Acid
    View official trial listing →
  • Status unknown NCT NCT06114953

    Comparative Efficacy of Mizoribine With Mycophenolate Mofetil for Living Related Kidney Transplantation Recipients

    Not yet reported Lee's Pharmaceutical Limited 152 participants Est. completion 2025-03-01 6 sites Stand-alone
    Other conditions: Kidney Transplant Immunosuppression
    View official trial listing →
  • Active, not recruiting NCT NCT06120140

    Enhanced Dermatological Care to Reduce Rash and Paronychia in Epidermal Growth Factor Receptor (EGRF)-Mutated Non-Small Cell Lung Cancer (NSCLC) Treated First-line With Amivantamab Plus Lazertinib

    Not yet reported Janssen Research & Development, LLC 305 participants Est. completion 2030-06-30 93 sites Stand-alone
    Other conditions: Carcinoma, Non-Small-Cell Lung
    View official trial listing →
  • Not yet recruiting NCT NCT06122974

    Drug Eluting Temporary Spur Stent System vs Percutaneous Balloon Angioplasty for the Treatment of Critical Limb Ischemia

    Not yet reported ReFlow Medical, Inc. 518 participants Est. completion 2037-12
    Other conditions: Critical Limb Ischemia
    View official trial listing →
  • Enrolling by invitation NCT NCT06126380

    Long-Term Safety and Efficacy of Tegoprubart in Kidney Transplant Recipients

    Not yet reported Eledon Pharmaceuticals 132 participants Est. completion 2029-12 43 sites
    Other conditions: Kidney Transplant Rejection
    View official trial listing →
  • Active, not recruiting NCT NCT06126835

    A Study to Evaluate the Safety of Ozanimod Exposure During Pregnancy in Women With Ulcerative Colitis and Their Infants

    Bristol-Myers Squibb 2828 participants Est. completion 2032-06-30 1 site
    Other conditions: Ulcerative Colitis
    View official trial listing →
  • Active, not recruiting NCT NCT06145282

    Non-myeloablative Haploidentical HCT Study for Patients With Sickle Cell Disease, Including Compromised Organ Function

    Not yet reported, Not yet reported National Heart, Lung, and Blood Institute (NHLBI) 6 participants Est. completion 2027-11-26 1 site Stand-alone
    Other conditions: Sickle Cell Disease
    View official trial listing →
  • Not yet recruiting NCT NCT06147375

    Efficacy and Safety of Immunosuppressive Withdrawal After Pediatric Liver Transplantation

    Not yet reported Wei Gao 47 participants Est. completion 2028-12 1 site Stand-alone
    Other conditions: Immune Tolerance, Immunosuppression, Liver Transplant; Complications
    View official trial listing →
  • Status unknown NCT NCT06147648

    Early Conversion of Prolonged-release Tacrolimus in Liver Transplantation.

    Not yet reported Beijing Tsinghua Chang Gung Hospital 352 participants Est. completion 2026-07-30 Stand-alone
    Other conditions: Liver Transplantation
    View official trial listing →
  • Status unknown NCT NCT06178146

    Thymosin Alpha-1 for irAE Secondary to ICIs

    Not yet reported Jun Wang 40 participants Est. completion 2025-04 1 site
    Other conditions: IrAE
    View official trial listing →
  • Suspended NCT NCT06195891

    Orca-T Following Chemotherapy and Total Marrow and Lymphoid Irradiation for the Treatment of Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia or Myelodysplastic Syndrome

    Not yet reported City of Hope Medical Center 33 participants Est. completion 2030-03-22 1 site Stand-alone
    Other conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Myelodysplastic Syndrome
    View official trial listing →
  • Status unknown NCT NCT06196996

    Allogeneic Regenerative Islet Transplantation for the Treatment of Brittle Type 1 Diabetes Mellitus

    Not yet reported Shanghai Changzheng Hospital 18 participants Est. completion 2026-09 1 site Stand-alone
    Other conditions: Brittle Type 1 Diabetes Mellitus
    View official trial listing →
  • Status unknown NCT NCT06197022

    Scoring-Balloon Angioplasty and Sirolimus-Eluting Balloon Angioplasty for the Treatment of Diffuse, Small Vessel Coronary Artery Disease (SCA-DEB Study)

    Not yet reported University National Heart Hospital 106 participants Est. completion 2024-12 1 site
    Cardiovascular disease
    View official trial listing →
  • Status unknown NCT NCT06203470

    Botox Versus Tacrolimus in Psoriasis Vulgaris

    Not yet reported Assiut University 60 participants Est. completion 2026-10 Stand-alone
    Other conditions: Psoriasis Vulgaris
    View official trial listing →
  • Completed NCT NCT06219616

    Prediction of BK Virus Reactivation in Kidney Transplant Recipient

    Not yet reported King Chulalongkorn Memorial Hospital 80 participants Est. completion 2025-05-31 1 site
    Other conditions: Kidney Transplant Infection, BK Virus Infection, BK Virus Nephropathy
    View official trial listing →
  • Status unknown NCT NCT06225206

    Analysis of Donor-derived Cell Free DNA in Liver Transplant Patients

    Methodist Health System 300 participants Est. completion 2024-12-31 1 site
    Other conditions: Liver Transplant Failure
    View official trial listing →
  • Status unknown NCT NCT06233591

    Evaluating LP-10 in Subjects With OLP

    Not yet reported Lipella Pharmaceuticals, Inc. 24 participants Est. completion 2025-06-01 7 sites Stand-alone
    Other conditions: Oral Lichen Planus
    View official trial listing →
  • Completed NCT NCT06235905

    Open-Label of SPN-820 in Adults With Major Depressive Disorder

    Not yet reported Navitor Pharmaceuticals, Inc. 40 participants Est. completion 2024-08-18 1 site
    Other conditions: Major Depressive Disorder
    View official trial listing →
  • Active, not recruiting NCT NCT06239480

    SELVA: A Phase 3 Study Evaluating QTORIN 3.9% Rapamycin Anhydrous Gel in the Treatment of Microcystic Lymphatic Malformations

    Not yet reported Palvella Therapeutics, Inc. 51 participants Est. completion 2026-07 15 sites
    Other conditions: Microcystic Lymphatic Malformation
    View official trial listing →
  • Active, not recruiting NCT NCT06241118

    A Study to Evaluate the Efficacy and Safety of Subcutaneous Amlitelimab on Background Topical Corticosteroids Therapy in Participants Aged 12 Years and Older With Moderate-to-severe AD Who Have Had an Inadequate Response to Prior Biologic Therapy or an Oral JAK Inhibitor

    Not yet reported Sanofi 464 participants Est. completion 2028-09-29 154 sites Stand-alone
    Other conditions: Dermatitis Atopic
    View official trial listing →
  • Enrolling by invitation NCT NCT06257420

    Low Dose Rapamycin in ME/CFS, Long-COVID, and Other Infection Associated Chronic Conditions

    Simmaron Research Inc. 150 participants Est. completion 2027-07-01 5 sites
    Other conditions: Myalgic Encephalomyelitis, Long-COVID
    View official trial listing →
  • Active, not recruiting NCT NCT06257966

    A Phase 3 Study to Evaluate the Efficacy of JY09 Compared With Dulaglutide in Combination Therapy Diabetes Mellitus Type 2 Patients With Metformin

    Not yet reported Beijing Dongfang Biotech Co., Ltd. 600 participants Est. completion 2026-11-30 1 site
    Type 2 diabetes
    View official trial listing →
  • Active, not recruiting NCT NCT06268769

    Tacrolimus C:D Ratio Measured in Renal Transplant Recipients Treated With Once-daily Prolonged-release Drugs

    Not yet reported Edward Geissler 322 participants Est. completion 2028-11 13 sites Stand-alone
    Other conditions: Immunosuppression
    View official trial listing →
  • Status unknown NCT NCT06279494

    Sirolimus+Abatacept+Mycophenolate Mofetil for Prophylaxis of aGVHD in Patients Receiving Haplo-HSCT Who Are Intolerant to Calcineurin Inhibitors

    Not yet reported, Not yet reported Peking University People's Hospital 6 participants Est. completion 2025-03 Stand-alone
    Other conditions: Acute Leukemia, Myelodysplastic Syndromes, Severe Aplastic Anemia
    View official trial listing →
  • Not yet recruiting NCT NCT06291103

    Screening for Subclinical Antibody Mediated Rejection and Efficacy of Belatacept in the Context of de Novo Donor Specific Antibody After Kidney Transplantation (BELA-M-R)

    Not yet reported, Not yet reported University Hospital, Rouen 290 participants Est. completion 2032-08-01 1 site
    Other conditions: Kidney Transplant Rejection
    View official trial listing →
  • Not yet recruiting NCT NCT06300268

    Advapro Coronary Stent System in Coronary Artery Diseased Patients.

    Not yet reported Advanced MedTech Solutions Pvt. Ltd. 120 participants Est. completion 2026-12
    Cardiovascular disease Other conditions: De Novo Stenosis Lesion, Coronary Stent Implantation
    View official trial listing →
  • Not yet recruiting NCT NCT06301386

    Everolimus Combined With PD-1 in Advanced Colorectal Cancer Patients

    Not yet reported Fudan University 25 participants Est. completion 2026-12-01 2 sites
    Other conditions: Colon Cancer
    View official trial listing →
  • Active, not recruiting NCT NCT06305286

    Safety, Tolerability, and Efficacy of Immunomodulation With A Monoclonal Antibody Against CD40L in Combination With Transplanted Islet Cells in Adults With Brittle Type 1 Diabetes Mellitus (T1D)

    Not yet reported, Not yet reported University of Chicago 70 participants Est. completion 2029-03 1 site
    Other conditions: Type 1 Diabetes Mellitus
    View official trial listing →
  • Enrolling by invitation NCT NCT06306274

    Topical Tacrolimus for Breast Cancer-related Lymphedema

    Not yet reported, Not yet reported Odense University Hospital 80 participants Est. completion 2026-03-31 3 sites Stand-alone
    Other conditions: Lymphedema
    View official trial listing →
  • Status unknown NCT NCT06306989

    Observational Clinical Study of Letermovir for Preventing CMV Infection After Allo-HSCT

    Cao Weijie 150 participants Est. completion 2025-12-01 1 site
    Other conditions: Letemovir for the Prevention of CMV Infection After Allo-HSCT
    View official trial listing →
  • Status unknown NCT NCT06307808

    Viral Immunity in Solid Organ Transplant Recipients: Monitoring Of The Response To Hepatitis B Booster Vaccination

    University Hospital, Grenoble 66 participants Est. completion 2025-10-01 1 site
    Other conditions: HBV, Kidney Transplantation, Liver Transplantation
    View official trial listing →
  • Status unknown NCT NCT06317298

    Fruquintinib Plus Everolimus as 2nd Line Therapy of ccRCC Patients Progressed Post IO and TKI Therapy

    Not yet reported Peking University First Hospital 36 participants Est. completion 2025-12-01 1 site
    Other conditions: Renal Cell Carcinoma, Clear Cell, Somatic
    View official trial listing →
  • Status unknown NCT NCT06319391

    Analysis of the Effect of Donor CYP3A5 Gene Polymorphism on Early Tacrolimus Concentration and Postoperative Acute Renal Injury After Liver Transplantation

    Ziqiang Li 60 participants Est. completion 2025-10-01 1 site
    Other conditions: Complete and Accurate Statistical Data of 60 Patients, CYP3A5*3 Genotypes of 60 Donors and Recipients Were Analyzed Accurately, Postoperative Tacrolimus Concentrations Were Accurately Recorded in 60 Patients, According to the Diagnosis and Grading Criteria of Acute Kidney Injury, the Cases and Grading of Postoperative Acute Kidney Injury in 60 Patients Were Counted, Scientific and Rigorous Statistical Analysis of Data
    View official trial listing →
  • Status unknown NCT NCT06338306

    Tacrolimus and Personalized Therapy to Prevent Acute Rejection Episodes

    Fondazione IRCCS Policlinico San Matteo di Pavia 25 participants Est. completion 2025-06-30 1 site
    Other conditions: Heart Transplant Failure
    View official trial listing →
  • Completed NCT NCT06342505

    Tacrolimus in CD3+ T Lymphocytes

    Erasmus Medical Center 28 participants Est. completion 2022-11-10 1 site
    Other conditions: Immunosuppression
    View official trial listing →
  • Status unknown NCT NCT06348446

    Tacrolimus Exposure in Kidney Transplantation

    Seoul National University Hospital 12000 participants Est. completion 2024-08-30 4 sites
    Other conditions: Kidney Transplant Rejection
    View official trial listing →
  • Status unknown NCT NCT06348602

    Evaluation of Safety & Efficacy for the Prevention of Ocular GVHD With Ophthalmic Tacrolimus vs Cyclosporine in Allo-HSCT

    Not yet reported, Not yet reported Hospital Universitario Dr. Jose E. Gonzalez 60 participants Est. completion 2025-12-31 1 site Stand-alone
    Other conditions: Ocular Graft-versus-host Disease
    View official trial listing →
  • Status unknown NCT NCT06361732

    Prevalence of CYP3A5 Polymorphisms in the Donors and ABCB1 Polymorphisms in the Recipients Undergoing Pediatric Liver Transplant and Their Influence on Tacrolimus Levels and Graft Function.

    Institute of Liver and Biliary Sciences, India 80 participants Est. completion 2024-10-30 1 site
    Other conditions: Pediatric Liver Transplant
    View official trial listing →
  • Completed NCT NCT06362005

    The Efficacy of Selenium as an Alternative or Complementary Topical Treatment of Oral Lichen Planus

    Not yet reported Al-Azhar University 50 participants Est. completion 2025-10-01 1 site Stand-alone
    Other conditions: Lichen Planus, Oral
    View official trial listing →
  • Terminated NCT NCT06365437

    A Dose Escalation Study of TCD601 Compared to ATG in de Novo Renal Transplantation

    Not yet reported ITB-Med LLC 33 participants Est. completion 2024-12-11 7 sites Stand-alone
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT06392074

    A Study Investigating the Safety, Absorption, and Elimination of MB04, a New Compound That May Potentially be Used in the Treatment of Autoimmune Disorders

    Not yet reported mAbxience Research S.L. 141 participants Est. completion 2025-05-12 1 site Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Not yet recruiting NCT NCT06405100

    Efficacy and Safety of Tacrolimus in Combination With Ripertamab in the Initial Treatment of Patients With MCD

    Not yet reported Air Force Military Medical University, China 81 participants Est. completion 2027-04
    Other conditions: Minimal Change Disease
    View official trial listing →
  • Enrolling by invitation NCT NCT06438679

    3T Therapy in the Treatment of MDA5-positive Dermatomyositis

    Not yet reported Second Affiliated Hospital, Zhejiang University, School of Medicine 133 participants Est. completion 2026-12 1 site Stand-alone
    Other conditions: Dermatomyositis
    View official trial listing →
  • Suspended NCT NCT06445205

    Utilising Volumetric Absorptive Microsampling (VAMS) Technology to Monitor Tacrolimus and Creatinine

    Lancashire Teaching Hospitals NHS Foundation Trust 50 participants Est. completion 2026-11-30 1 site
    Other conditions: Kidney Transplant Rejection, Kidney Replacement
    View official trial listing →
  • Status unknown NCT NCT06449235

    Real-World Evaluation of Omarigliptin for Type 2 Diabetes Meliitus in Bangladesh

    Not yet reported Bangladesh Institute of Research and Rehabilitation in Diabetes, Endocrine and Metabolic Disorders 938 participants Est. completion 2025-06 1 site
    Other conditions: Type2diabetes
    View official trial listing →
  • Completed NCT NCT06488651

    Trajectory of Immunosuppression-Caused Tremor In Kidney and Lung Transplant Recipients

    University Medical Center Groningen 72 participants Est. completion 2025-09-12 1 site
    Other conditions: Kidney Transplantation, Tremor
    View official trial listing →
  • Not yet recruiting NCT NCT06490562

    Low-dose Cyclophosphamide or CNI in the Prevention of Acute Graft-versus-host Disease After gDLI

    Not yet reported Institute of Hematology & Blood Diseases Hospital, China 66 participants Est. completion 2028-12
    Other conditions: Acute Graft-versus-host Disease
    View official trial listing →
  • Active, not recruiting NCT NCT06494150

    Nab-Sirolimus and Endocrine Therapy in Recurrent Low Grade Serous Ovarian Cancer (NARETO)

    Not yet reported University of Oklahoma 37 participants Est. completion 2029-09 1 site Stand-alone
    Other conditions: Low Grade Ovarian Serous Adenocarcinoma
    View official trial listing →
  • Active, not recruiting NCT NCT06503731

    A Study to Evaluate the Safety and Tolerability of Efgartigimod PH20 SC Given by Prefilled Syringe in Kidney Transplant Recipients With Antibody-Mediated Rejection (AMR)

    Not yet reported argenx 33 participants Est. completion 2027-11 23 sites Stand-alone
    Other conditions: Antibody-mediated Rejection
    View official trial listing →
  • Status unknown NCT NCT06504225

    EVEROLD LONG TERM FOLLOW-UP

    University Hospital, Brest 260 participants Est. completion 2025-08-01 14 sites
    Other conditions: Transplant; Complication, Failure
    View official trial listing →
  • Status unknown NCT NCT06561022

    Precision Treatment of HR+ HER2- Advanced Breast Cancer Based on SNF Molecular Subtyping

    Not yet reported Fudan University 260 participants Est. completion 2026-06-30 1 site
    Other conditions: Breast Cancer
    View official trial listing →
  • Completed NCT NCT06563635

    Frequency of Tuberculosis in Psoriasis Patients

    Bezmialem Vakif University 719 participants Est. completion 2023-07-31 1 site
    Other conditions: Psoriasis Vulgaris, Tuberculosis
    View official trial listing →
  • Status unknown NCT NCT06584773

    Efficacy of a Quadruple Immunosuppressor Regimen With mTOR Inhibitors in Sensitized Kidney Transplant Patients

    Not yet reported University of Sao Paulo General Hospital 80 participants Est. completion 2025-07 1 site Stand-alone
    Other conditions: Disorder Related to Renal Transplantation
    View official trial listing →
  • Completed NCT NCT06585293

    Comparability of Fingerprick vs Venous Blood for Tacrolimus Monitoring

    Nottingham University Hospitals NHS Trust 56 participants Est. completion 2025-03-14 1 site
    Other conditions: Immunosuppression
    View official trial listing →
  • Active, not recruiting NCT NCT06596798

    Deep Learning Model and Risk Factors for Tacrolimus-related Acute Kidney Injury

    Qianfoshan Hospital 1200 participants Est. completion 2026-12-30 1 site
    Other conditions: AKI
    View official trial listing →
  • Status unknown NCT NCT06607198

    Clinical-pathological Evaluation of Pit-NETs

    Fondazione Policlinico Universitario Agostino Gemelli IRCCS 940 participants Est. completion 2026-10-01 1 site
    Other conditions: Pituitary, Cancer, Neuroendocrine Tumors
    View official trial listing →
  • Active, not recruiting NCT NCT06621524

    EucaLimus Post-Market Registry

    OrbusNeich 251 participants Est. completion 2029-01 10 sites
    Other conditions: Coronary Arterioscleroses
    View official trial listing →
  • Completed NCT NCT06638879

    Tacrolimus Toothpaste for Management of Oral Chronic Graft vs. Host Disease (cGVHD)

    Not yet reported Children's Hospital Medical Center, Cincinnati 7 participants Est. completion 2026-02-18 1 site Stand-alone
    Other conditions: Chronic Graft Versus Host Disease Oral
    View official trial listing →
  • Active, not recruiting NCT NCT06653842

    A Phase 2, Baseline-Controlled Study Evaluating the Safety and Efficacy of PTX-022 (Sirolimus) Topical Gel 3.9% in the Treatment of Cutaneous Venous Malformations

    Not yet reported Palvella Therapeutics, Inc. 15 participants Est. completion 2026-03 10 sites
    Other conditions: Cutaneous Venous Malformations
    View official trial listing →
  • Active, not recruiting NCT NCT06665256

    Phase 2 Study of Rapcabtagene Autoleucel in Myositis

    Not yet reported Novartis Pharmaceuticals 21 participants Est. completion 2032-11-29 68 sites
    Other conditions: Idiopathic Inflammatory Myopathies
    View official trial listing →
  • Suspended NCT NCT06680661

    ABBA CORD: dCBT w/ Abatacept for aGVHD Prophylaxis

    Not yet reported Leland Metheny 20 participants Est. completion 2028-10-31 1 site Stand-alone
    Other conditions: Acute Myelogenous Leukemia, Acute Lymphatic Leukemia, Chronic Myelogenous Leukemia, Myelodysplastic Syndromes, Myelodysplastic Syndrome Other, Chronic Myelomonocytic Leukemia, Lymphoma, Hodgkin Lymphoma
    View official trial listing →
  • Active, not recruiting NCT NCT06680921

    A Study of SIM0270 Combined With Everolimus vs. Treatment of Physician's Choice in Patients With ER+/HER2- Advanced Breast Cancer (SIMRISE)

    Not yet reported Jiangsu Simcere Pharmaceutical Co., Ltd. 482 participants Est. completion 2028-08-31 57 sites
    Other conditions: Locally Advanced or Metastatic Breast Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT06682767

    A Nutritional and Pharmacological Intervention for Body, Brain, and Longevity Effects (NIBBLE)

    Not yet reported, Not yet reported Cedars-Sinai Medical Center 60 participants Est. completion 2028-06 1 site
    Other conditions: Cerebral Blood Flow, APOE 4
    View official trial listing →
  • Status unknown NCT NCT06683118

    Registration Trial of the Drug-coated Balloon for the Symptomatic Cerebral Atherosclerotic Stenosis

    Not yet reported MicroPort NeuroTech Co., Ltd. 212 participants Est. completion 2026-07-27 2 sites
    Other conditions: Cerebral Atherosclerotic Stenosis
    View official trial listing →
  • Not yet recruiting NCT NCT06708455

    Phase 2b of RAPA-201 Cell Therapy in Post-PD-(L)-1 Melanoma

    Not yet reported Rapa Therapeutics LLC 65 participants Est. completion 2029-09-30 1 site
    Other conditions: Malignant Melanoma With Metastasis, Malignant Melanoma, Malignant Melanoma Stage IIIc, Malignant Melanoma Stage IV
    View official trial listing →
  • Active, not recruiting NCT NCT06821542

    A Study to Evaluate Axatilimab Versus Best Available Therapy in Participants With Chronic Graft Versus Host Disease After at Least 2 Prior Lines of Systemic Therapy

    Not yet reported Incyte Corporation 9 participants Est. completion 2032-11-30 130 sites
    Other conditions: Chronic Graft-versus-host-disease
    View official trial listing →
  • Active, not recruiting NCT NCT06841510

    Efficacy and Safety of GENOSS SES in Patients With Coronary Artery Disease

    Genoss Co., Ltd. 1118 participants Est. completion 2025-11-30 1 site
    Other conditions: Coronary Arterial Disease (CAD)
    View official trial listing →
  • Enrolling by invitation NCT NCT06843811

    Sirolimus for Leigh Syndrome

    Not yet reported Matthew Demczko 15 participants Est. completion 2027-12 1 site Stand-alone
    Other conditions: Leigh Syndrome
    View official trial listing →
  • Not yet recruiting NCT NCT06867042

    Tacrolimus Lipid Suspension for Enema in Adult Subjects with Mild to Moderately Active Left-sided/Distal Ulcerative Colitis Who Had an Inadequate Response to the Treatment

    Not yet reported Jina Pharmaceuticals Inc. 150 participants Est. completion 2026-04 Stand-alone
    Other conditions: Ulcerative Colitis (UC), Ulcerative Colitis, Active Moderate
    View official trial listing →
  • Enrolling by invitation NCT NCT06880042

    COMPARISON OF EFFICACY AND SAFETY OF NARROWBAND UVB WITH 0.1% TACROLIMUS VS NARROWBAND UVB WITH 0.005% CALCIPOTRIOL IN TREATMENT OF VITILIGO

    Not yet reported Dr ayesha wahid 60 participants Est. completion 2025-08-30 1 site
    Other conditions: Vitiligo - Macular Depigmentation, Tacrolimus
    View official trial listing →
  • Not yet recruiting NCT NCT06928883

    Ticin Pilot Study: Sirolimus-Eluting Balloon for Stabilization and Regression of Non-Obstructive Coronary Plaques.

    Not yet reported Cardiocentro Ticino 24 participants Est. completion 2028-12-31 1 site Stand-alone
    Cardiovascular disease Other conditions: Coronary Arterial Disease (CAD), Vulnerable Coronary Plaques, Coronary Vessel, Acute Coronary Syndromes (ACS)
    View official trial listing →
  • Not yet recruiting NCT NCT06941142

    A Study of Sirolimus (Albumin-Bound) in Combination With Palbociclib and Fulvestrant for the Treatment of Advanced Breast Cancer

    Not yet reported CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 382 participants Est. completion 2028-06 Stand-alone
    Other conditions: Advanced Breast Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT06942156

    Optimize Immunosuppressive Therapy Using Everolimus and Low-dose Calcineurin Inhibitors in Heart Transplant Patients in Korea

    Not yet reported Chong Kun Dang Pharmaceutical 140 participants Est. completion 2030-12 1 site
    Other conditions: Heart Transplant
    View official trial listing →
  • Not yet recruiting NCT NCT06949267

    A Study of iMSC for the Prevention of Acute Graft-versus-host Disease After Allogeneic Hematopoietic Stem Cell Transplantation

    Not yet reported Ruijin Hospital 56 participants Est. completion 2028-03-31 Stand-alone
    Other conditions: Acute Graft-versus-Host Disease
    View official trial listing →
  • Not yet recruiting NCT NCT06960824

    Real-word Study of the de NOVO Extended-release tacrolimuS in Kidney Transplantation Using an ARTificial Intelligence

    Chiesi SAS 165 participants Est. completion 2027-12-31 1 site
    Other conditions: Chronic Renal Disease
    View official trial listing →
  • Active, not recruiting NCT NCT06991829

    Clinical Study on the Safety and Efficacy of Immunophenotyped Pancreatic Endocrine Organoid Bank in Treating Patients With T3c Diabetes

    Not yet reported Shanghai Zhongshan Hospital 29 participants Est. completion 2027-10-31 1 site
    Other conditions: Diabetes Mellitus
    View official trial listing →
  • Not yet recruiting NCT NCT07003438

    Study on the Efficacy and Safety of Fecal Microbiota Transplantation in the Treatment of Steroid - Dependent /Steroid-resistant Nephrotic Syndrome in Children

    Not yet reported Zhang Ting 120 participants Est. completion 2028-04-01
    Other conditions: Steroid-Resistant Nephrotic Syndrome, Steroid-Dependent Nephrotic Syndrome
    View official trial listing →
  • Completed NCT NCT07030660

    Model-based Medication Dosing Assist for Tacrolimus in Kidney Transplantation

    Not yet reported KU Leuven 357 participants Est. completion 2025-03-28 1 site
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Completed NCT NCT07041112

    Ten-Year Biologic Drug Survival in Psoriasis: Role of Genetic and Cardiometabolic Predictors

    Juan Ruano Ruiz 1000 participants Est. completion 2024-06-01 1 site
    Metabolic syndrome Other conditions: Psoriasis, Psoriatic Arthritis (PsA), Cardiovascular Risk Factors, Drug Survival, Pharmacogenetics
    View official trial listing →
  • Completed NCT NCT07049172

    Rituximab and Targeted Nursing for Pediatric Nephrotic Syndrome

    Not yet reported Wuhan Children's Hospital 91 participants Est. completion 2023-12-31 1 site
    Other conditions: Nephrotic Syndrome in Children
    View official trial listing →
  • Active, not recruiting NCT NCT07058974

    A Study of Exercise and Pharmacologic Intervention on Systemic Inflammation

    Not yet reported Icahn School of Medicine at Mount Sinai 20 participants Est. completion 2027-06-15 1 site Stand-alone
    Other conditions: Smokers, Former Smokers
    View official trial listing →
  • Not yet recruiting NCT NCT07083830

    ECP-DL Cell Infusion for Induction in Living Donor Kidney (LDK) Transplants

    Not yet reported Northwestern University 24 participants Est. completion 2029-08-25 Stand-alone
    Other conditions: Kidney Transplant Failure and Rejection, Kidney Transplant; Complications
    View official trial listing →
  • Enrolling by invitation NCT NCT07118475

    Autologous Islet Transplantation for Diabetes

    Not yet reported Shanghai Zhongshan Hospital 24 participants Est. completion 2027-05-30 1 site
    Type 2 diabetes
    View official trial listing →
  • Not yet recruiting NCT NCT07138742

    Tacrolimus Eye Drops in Treatment of Vernal Keratoconjunctivitis

    Not yet reported Sohag University 90 participants Est. completion 2027-09 Stand-alone
    Other conditions: Vernal Keratoconjunctivitis
    View official trial listing →
  • Not yet recruiting NCT NCT07157514

    Radioimmunotherapy Conditioning With 131I- Apamistamab for Allogeneic Transplant in Relapse/Refractory AML

    Not yet reported, Not yet reported Actinium Pharmaceuticals 306 participants Est. completion 2034-02 Stand-alone
    Other conditions: Acute Leukemia, Myeloid Leukemia, Acute Myelogenous Leukemia, Acute Myeloid Leukemia, Acute Myeloid Leukemia, in Relapse, Myelogenous Leukemia, Myelogenous Leukemia, Acute, Myelogenous Leukemia in Relapse, Transplant-Related Disorder, Allogeneic Disease, Refractory AML
    View official trial listing →
  • Enrolling by invitation NCT NCT07159087

    The Safety and Efficacy for In-segment Late Lumen Loss of the 'Genoss® SCB' Versus 'SeQuent® Please NEO' in Patients With Coronary ISR

    Not yet reported Genoss Co., Ltd. 94 participants Est. completion 2027-01-31 1 site Stand-alone
    Other conditions: Coronary Arterial Disease (CAD)
    View official trial listing →
  • Not yet recruiting NCT NCT07162896

    Crisaborole 2% Versus Tacrolimus 0.1% in Children With Mild to Moderate Atopic Dermatitis

    Not yet reported Shalamar Institute of Health Sciences 66 participants Est. completion 2027-06 1 site
    Other conditions: Atopic Dermatitis, Atopic Dermatitis (AD)
    View official trial listing →
  • Not yet recruiting NCT NCT07166354

    Clinical Study of mTOR Inhibitor as a Treatment for Grey Hair (Canities)

    Not yet reported, Not yet reported Applied Biology, Inc. 100 participants Est. completion 2027-12-15
    Other conditions: Canities, Grey Hair
    View official trial listing →
  • Not yet recruiting NCT NCT07173556

    A Phase Ib/II Study of QLC1401 Combined With CDK4/6 or mTOR Inhibitors in ER+/HER2- Advanced Breast Cancer

    Not yet reported, Not yet reported Qilu Pharmaceutical Co., Ltd. 96 participants Est. completion 2028-10
    Other conditions: Advanced Breast Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT07203664

    Use of Tacrolimus and MTOR Inhibitors With Anticipatory Therapy vs. Tacrolimus and Mycophenolic Acid With Universal Prophylaxis in Renal Recipients at High Risk of Posttransplant Cytomegalovirus.

    Not yet reported Hospital Universitario La Paz 30 participants Est. completion 2026-12-31 1 site Stand-alone
    Other conditions: Evaluate the Effectiveness of CMV Prevention Strategies in Kidney Transplant Recipients
    View official trial listing →
  • Completed NCT NCT07239128

    Photobiomodulation in Combination With Topical Cyclosporine A or Tacrolimus

    Not yet reported University of Seville 160 participants Est. completion 2025-06-01 2 sites Stand-alone
    Other conditions: Dry Eye Disease (DED)
    View official trial listing →
  • Completed NCT NCT07302932

    Metformin and Molecular Aging in Prediabetes

    Not yet reported Diabetes Foundation, India 112 participants Est. completion 2025-01-30 1 site
    Prediabetes
    View official trial listing →
  • Not yet recruiting NCT NCT07307534

    Nevus Removal vs. Conservative Treatment in Halo Nevus With Vitiligo: A Randomized Study

    Not yet reported Xijing Hospital 60 participants Est. completion 2027-10-01 1 site Stand-alone
    Other conditions: Vitiligo, Halo Nevus
    View official trial listing →
  • Withdrawn NCT NCT07349771

    Axatilimab Plus Standard of Care Therapy for the Prevention of Graft Versus Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Hematologic Cancer, ABRAXAS Trial

    Not yet reported Mayo Clinic Est. completion 2033-06-01 3 sites Stand-alone
    Other conditions: Hematopoietic and Lymphatic System Neoplasm
    View official trial listing →
  • Not yet recruiting NCT NCT07352566

    Utilization of a Microdevice for Psoriasis and Atopic Dermatitis

    Not yet reported University of California, San Francisco 10 participants Est. completion 2030-06-01 1 site Stand-alone
    Other conditions: Psoriasis, Atopic Dermatitis
    View official trial listing →
  • Active, not recruiting NCT NCT07354620

    A Pilot Study on Reverse Aging (The REVERSE Study)

    Not yet reported The Christ Hospital 52 participants Est. completion 2026-05 1 site
    Other conditions: Aging
    View official trial listing →
  • Not yet recruiting NCT NCT07364123

    Kidney Transplant Immunosuppressive Therapy Adherence Trial (KITE)

    Not yet reported University of Gaziantep 60 participants Est. completion 2026-08-15 1 site
    Other conditions: Kidney Transplantation, Medication Non-Adherence, Immunosuppressive Therapy, Renal Transplant Recipients
    View official trial listing →
  • Not yet recruiting NCT NCT07367932

    Comparative Study of Crisaborole vs. Tacrolimus in Atopic Dermatitis

    Not yet reported Cairo University 30 participants Est. completion 2026-07
    Other conditions: Dermatitis, Atopic, Eczema
    View official trial listing →
  • Completed NCT NCT07368673

    Comparative Effectiveness of Ruxolitinib Monotherapy Versus Its Combination With Tacrolimus and Corticosteroids in the Management of Vitiligo: A Randomized Controlled Trial

    Not yet reported Dow University of Health Sciences 120 participants Est. completion 2026-01-05 1 site
    Other conditions: Vitiligo
    View official trial listing →
  • Enrolling by invitation NCT NCT07386587

    Methotrexate Alone vs Methotrexate + Etanercept for Minimal/Low Disease Activity in Juvenile Idiopathic Arthritis

    Not yet reported University of Child Health Sciences and Children's Hospital, Lahore 60 participants Est. completion 2026-07-27 1 site Stand-alone
    Other conditions: Juvenile Idiopathic Arthritis
    View official trial listing →
  • Not yet recruiting NCT NCT07408674

    COMPETE-LM Trial: Drug-Coated Balloon-Enhanced Provisional Stenting in Complex Left Main Disease.

    Not yet reported Rede Optimus Hospitalar SA 186 participants Est. completion 2029-05
    Other conditions: Complex Left Main Bifurcation Stenosis, Left Main Coronary Artery Stenosis, Coronary Bifurcation Stenosis
    View official trial listing →
  • Not yet recruiting NCT NCT07422012

    Tacrolimus in Pregnancy

    Baylor Research Institute 55 participants Est. completion 2028-03 1 site
    Other conditions: Unbound Tacrolimus in Pregnant Uterus Transplant Recipients, Whole Blood Tacrolimus in Pregnant Uterus Transplant Recipients
    View official trial listing →
  • Active, not recruiting NCT NCT07430683

    Valganciclovir Prophylaxis Versus Preemptive Therapy for Cytomegalovirus in Living Donor Kidney Transplant Recipients

    Not yet reported University of Guadalajara 68 participants Est. completion 2026-07-31 1 site Stand-alone
    Other conditions: Cytomegalovirus Infections
    View official trial listing →
  • Not yet recruiting NCT NCT07435584

    Everolimus in CDK12-Deficient Metastatic Colorectal Cancer (EVER-RECODE)

    Not yet reported, Not yet reported Second Affiliated Hospital, Zhejiang University, School of Medicine 38 participants Est. completion 2028-12-31
    Other conditions: Colorectal Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT07436611

    Rapamycin Dose-Ranging Efficacy Study in Port Wine Stains

    Not yet reported AFT Pharmaceuticals, Ltd. 30 participants Est. completion 2027-10 2 sites
    Other conditions: Port Wine Stains
    View official trial listing →
  • Not yet recruiting NCT NCT07437534

    Comparative Evaluation of the Safety and Effectiveness of Crisaborole Ointment (2%) Versus Tacrolimus Ointment (0.1%) for the Topical Treatment of Atopic Dermatitis

    Not yet reported Hayat Abad Medical Complex, Peshawar 148 participants Est. completion 2026-08-30 1 site Stand-alone
    Other conditions: Atopic Dermatitis
    View official trial listing →
  • Completed NCT NCT07475546

    Combination Gerotherapeutic Interventions for Healthspan Improvement

    Not yet reported AgelessRx 26 participants Est. completion 2026-04-09 1 site
    Other conditions: Healthspan Improvement, Aging, Longevity
    View official trial listing →
  • Not yet recruiting NCT NCT07514988

    Sirolimus-Coated vs Paclitaxel-Coated DCBs in ACS Treatment

    Not yet reported China National Center for Cardiovascular Diseases 60 participants Est. completion 2028-07-01 1 site Stand-alone
    Other conditions: Acute Coronary Syndromes (ACS)
    View official trial listing →
  • Active, not recruiting NCT NCT07519005

    Ex Vivo Perfusion of Gene-Edited Porcine Livers in Patients With Severe Hepatic Failure

    Not yet reported Xijing Hospital 1 participants Est. completion 2026-12-31 1 site Stand-alone
    Other conditions: Hepatic Failure
    View official trial listing →
  • Not yet recruiting NCT NCT07519031

    Study of Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes in Vitiligo

    Not yet reported, Not yet reported Xijing Hospital 96 participants Est. completion 2028-03 1 site Stand-alone
    Other conditions: Vitiligo, Mesenchymal Stem Cells, Exosomes
    View official trial listing →
  • Not yet recruiting NCT NCT07519174

    A Randomized Controlled Trial Comparing the Effectiveness and Safety of Topical Tacrolimus 0.03% Versus Crisaborole 2% in Patients With Mild to Moderate Atopic Dermatitis Over 8 Weeks

    Not yet reported Foundation University Islamabad 72 participants Est. completion 2027-01-01 1 site Stand-alone
    Other conditions: Atopic Dermatitis
    View official trial listing →
  • Not yet recruiting NCT NCT07524530

    Stem Cell Transplantation for Participants With Germline RUNX1 Associated Blood Cancers

    Not yet reported National Cancer Institute (NCI) 102 participants Est. completion 2036-06-01 1 site Stand-alone
    Other conditions: Core Binding Factor Alpha Subunits, Hematologic Neoplasms, Leukemia, Lymphoma
    View official trial listing →
  • Completed NCT NCT07532330

    Tyrosine Vs Tacrolimus With NB-UVB in Vitiligo

    Not yet reported Minia University 67 participants Est. completion 2026-04-15 1 site Stand-alone
    Other conditions: Vitiligo
    View official trial listing →
  • Not yet recruiting NCT NCT07549230

    Model-Informed Precision Dosing of Tacrolimus in Pediatric Kidney Transplantation

    Helwan University 130 participants Est. completion 2027-06-01
    Other conditions: Pediatric Kidney Transplantation
    View official trial listing →
  • Not yet recruiting NCT NCT07570433

    HORUS-Cytomegalovirus Open Proof-of-concept Exploratory Trial

    Not yet reported Oriol Manuel 100 participants Est. completion 2028-03 4 sites Stand-alone
    Other conditions: CMV Infection
    View official trial listing →
  • Not yet recruiting NCT NCT07572695

    Salvage Haploidentical HSCT With DLI and Targeted Therapy for R/R AML

    Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 40 participants Est. completion 2028-12
    Other conditions: Acute Myeloid Leukemia, Relapsed/Refractory Acute Myeloid Leukemia, AML, Relapsed/Refractory
    View official trial listing →
  • Not yet recruiting NCT NCT07612657

    A Phase 3 Study of Extended-release Tacrolimus in Subjects With Pulmonary Arterial Hypertension and Functional Limitations

    Not yet reported VIVUS LLC 300 participants Est. completion 2029-11-30 Stand-alone
    Other conditions: Pulmonary Arterial Hypertension, Pulmonary Arterial Hypertension (PAH), Pulmonary Arterial Hypertension (PAH) (WHO Group 1 PH), Pulmonary Arterial Hypertension PAH, Pulmonary Arterial Hypertension WHO Group I
    View official trial listing →
  • Not yet recruiting NCT NCT07634536

    Automated Total Marrow and Lymphoid Irradiation for Allogeneic Hematopoietic Cell Transplant

    Not yet reported Stanford University 30 participants Est. completion 2028-08 1 site Stand-alone
    Other conditions: Acute Myeloid Leukemia, Myeloproliferative Neoplasm, Myelodysplastic Syndromes
    View official trial listing →
  • Not yet recruiting NCT NCT07634601

    Elacestrant With Everolimus for the Treatment of Recurrent Advanced or Metastatic ER-Positive Endometrial Cancer

    Not yet reported Jonsson Comprehensive Cancer Center 50 participants Est. completion 2029-12-18 1 site
    Other conditions: Advanced Endometrial Carcinoma, Metastatic Endometrial Carcinoma, Recurrent Endometrial Carcinoma, Stage III Endometrial Cancer, Stage IV Endometrial Cancer
    View official trial listing →
  • Not yet recruiting NCT NCT07656493

    Liposomal Amphotericin B for Invasive Fungal Disease in Solid Organ Transplant Recipients

    Sichuan Provincial People's Hospital 120 participants Est. completion 2028-06-30 1 site
    Other conditions: Invasive Fungal Infection, Solid Organ Transplantation, Opportunistic Infections
    View official trial listing →
  • Not yet recruiting NCT NCT07660783

    Naive T Cell Deplete Grafts for GVHD Prevention in Non-Malignant Diseases

    Not yet reported Fred Hutchinson Cancer Center 40 participants Est. completion 2035-09 2 sites
    Other conditions: Bone Marrow Failure, Hemoglobinopathies, Primary Immune Deficiency (PID), Autoimmune Cytopenia, Immune Dysregulation, Hemophagocytic Lymphohistiocytosis (HLH), Non Malignant Disorders
    View official trial listing →
  • Not yet recruiting NCT NCT07680673

    ENCRT-103-hPI: Evaluation of an Immune-protected ENCRT-103-hPI Containing Primary Human Islets in Adults With Type 1 Diabetes, With and Without Standard-of-care Portal Vein Islet Infusion.

    Not yet reported Encellin 10 participants Est. completion 2029-01 2 sites
    Other conditions: Type 1 Diabetes
    View official trial listing →
  • Not yet recruiting NCT NCT07684287

    A Phase 2 Study of Sirolimus for Injection (Albumin-bound) in Patients With Progressive or Symptomatic Epithelioid Hemangioendothelioma

    Not yet reported CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 40 participants Est. completion 2027-11-30 1 site Stand-alone
    Other conditions: Epithelioid Hemangioendothelioma
    View official trial listing →
  • Not yet recruiting NCT NCT07709845

    CC-101 (f/k/a NR1) Neural Stem Cell Transplantation for Adults With Chronic Ischemic Stroke

    Not yet reported Clarion Cells, Inc. 36 participants Est. completion 2029-01 Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Not yet recruiting NCT NCT07713186

    Azithromycin in Atopic Dermatitis

    Not yet reported Cairo University 40 participants Est. completion 2027-01 1 site Stand-alone
    Other conditions: Atopic Dermatitis
    View official trial listing →
  • Not yet recruiting NCT NCT07715734

    Cemiplimab for Kidney Transplant Recipients With Advanced Cutaneous Squamous Cell Carcinoma

    Not yet reported Washington University School of Medicine 22 participants Est. completion 2031-04-30 1 site Stand-alone
    Other conditions: Kidney Transplant Recipient, Cutaneous Squamous Cell Carcinoma (CSCC), Advanced Cutaneous Squamous Cell Carcinoma, Kidney Transplant
    View official trial listing →
  • Not yet recruiting NCT NCT07718308

    CD38 mAb Induction + Azathioprine Maintenance for Chronic Active AMR in Kidney Transplant Recipients

    Not yet reported wujianyong 20 participants Est. completion 2028-03-15 Stand-alone
    Other conditions: Kidney Transplantation, Antibody-mediated Rejection
    View official trial listing →
  • Not yet recruiting NCT NCT07725874

    Safety and Efficacy of Liposomal Amphotericin B for Patients With Invasive Mold Diseases in Liver Transplant Recipients

    Not yet reported Beijing Friendship Hospital 60 participants Est. completion 2028-08-15 Stand-alone
    Other conditions: Invasive Mold Diseases
    View official trial listing →
  • Not yet recruiting NCT NCT07737249

    Efficacy and Safety of Golidocitinib for Rapidly Progressive Interstitial Lung Disease

    Not yet reported Peking Union Medical College Hospital 60 participants Est. completion 2027-08-31 1 site
    Other conditions: Interstitial Lung Diseases
    View official trial listing →
  • Not yet recruiting NCT NCT07769567

    Optimization of Therapeutic Drug Monitoring in Pediatric Kidney Transplant

    Children's Hospital Medical Center, Cincinnati 25 participants Est. completion 2028-12-31
    Other conditions: Kidney Transplant
    View official trial listing →
  • Not yet recruiting NCT NCT07796620

    Sirolimus+Ruxolitinib+Mycophenolate Mofetil for Prophylaxis of aGVHD in Patients Receiving Haplo-HSCT Who Are Intolerant to CNI

    Not yet reported, Not yet reported Peking University People's Hospital 40 participants Est. completion 2028-09-30 Stand-alone
    Other conditions: Acute Leukemia, Myelodysplastic Syndromes, Severe Aplastic Anemia (SAA)
    View official trial listing →
  • Not yet recruiting NCT NCT07806136

    Biomarker-Guided Mycophenolate Mofetil Elimination in Low-Risk Older Adult Kidney Transplant Recipients

    Not yet reported Virginia Commonwealth University 20 participants Est. completion 2029-08-01 Stand-alone
    Other conditions: Kidney Transplant Recipient
    View official trial listing →
  • Completed NCT NCT07806240

    Safety and Efficacy Study of RTP-008 (an Absorbable Tacrolimus Lacrimal Canalicular Plug) for Dry Eye

    Not yet reported Zhejiang Raytone Bioscience Co.,Ltd 40 participants Est. completion 2026-02-28 1 site Stand-alone
    Other conditions: Dry Eye Disease (DED)
    View official trial listing →
  • Not yet recruiting NCT NCT07808112

    CSF-1R Inhibitor, Axatilimab, for Prevention of Acute and Chronic GVHD After HLA-Matched Related and Unrelated Donor Allogeneic Stem Cell Transplantation

    Not yet reported Medical College of Wisconsin 72 participants Est. completion 2031-11 1 site Stand-alone
    Other conditions: Graft -Versus-host-disease
    View official trial listing →
  • Not yet recruiting NCT NCT07812974

    Extracellular Vesicle-based Strategy to Stratify Islets and Improve Their FItness Before Transplantation

    University Hospital, Strasbourg, France 25 participants Est. completion 2032-01 1 site
    Other conditions: Type 1 Diabetes (T1D)
    View official trial listing →
  • Not yet recruiting NCT NCT07815938

    Immune Monitoring-Guided Individualized Tacrolimus Therapy in Renal Transplant Recipients: An Observational Study and PK/PD Modeling

    Zhongnan Hospital 50 participants Est. completion 2028-12-31
    Other conditions: Transplant Recipient (Kidney)
    View official trial listing →
  • Completed NCT NCT07819071

    EFFICACY AND TOLERANCE OF AN EYELID BALM IN COMBINATION WITH TACROLIMUS 0.1% IN PATIENTS WITH EYELID ATOPIC DERMATITIS

    Not yet reported Pierre Fabre Dermo Cosmetique 33 participants Est. completion 2026-01-10 1 site Stand-alone
    Other conditions: Atopic Dermatitis (AD)
    View official trial listing →
  • Not yet recruiting NCT NCT07828223

    Cardiac Improvement by Eplerenone Among Patients Under Cyclosporine or Tacrolimus for Kidney Transplantation.

    Not yet reported Central Hospital, Nancy, France 132 participants Est. completion 2030-12 3 sites
    Other conditions: Kidney Transplantation
    View official trial listing →
  • Not yet recruiting NCT NCT07835581

    Study of Tegoprubart Efficacy and Safety Compared With Tacrolimus in Kidney Transplantation

    Not yet reported Eledon Pharmaceuticals 620 participants Est. completion 2033-03
    Other conditions: Kidney Transplant Rejection
    View official trial listing →
  • Not yet recruiting NCT NCT07853105

    Phase I/II Trial of Dinutuximab Beta in Combination With Irinotecan and Rapamycin in Pediatric, Adolescents and Adult Patients With Relapsed/Refractory Bone Tumors.

    Not yet reported, Not yet reported University Hospital, Strasbourg, France 89 participants Est. completion 2033-02 12 sites Stand-alone
    Obstructive sleep apnea Other conditions: Bone Cancer, Ewing Sarcomas
    View official trial listing →
  • Not yet recruiting NCT NCT07865130

    Study of CDK8 Inhibitor RVU120 in Combination With Everolimus in Children With Recurrent or Progressive Group 3 or 4 Medulloblastoma

    Not yet reported Bożenna Dembowska Bagińska 48 participants Est. completion 2033-06 1 site
    Other conditions: Medulloblastoma Recurrent, Medulloblastoma
    View official trial listing →
  • Completed NCT NCT07869953

    Oftac Eye Drops (0.05% Tacrolimus Ophthalmic Emulsion) for the Treatment of Active Non-infectious Anterior Uveitis

    Not yet reported, Not yet reported BioNanoSim Ltd. 18 participants Est. completion 2025-03-25 7 sites Stand-alone
    Other conditions: Non-Infectious Anterior Uveitis
    View official trial listing →
  • Not yet recruiting NCT NCT07877103

    Study on the Safety and Efficacy of a Time-of-Day-Based Individualized Tacrolimus Dosing Regimen in Kidney Transplant Recipients

    Not yet reported The First Affiliated Hospital of Guangzhou Medical University 100 participants Est. completion 2028-12-30 1 site Stand-alone
    Other conditions: End-Stage Renal Disease
    View official trial listing →
  • Completed NCT NCT07884084

    Effect of Probiotics on Immunosuppressant Therapy in Kidney Transplant Recipients

    Not yet reported Federico II University 40 participants Est. completion 2025-10-03 1 site
    Other conditions: Kidney Transplantation, Kidney Transplantation Recipients
    View official trial listing →
  • Not yet recruiting NCT NCT07892339

    Efficacy of Crisaborole 2% Ointment Versus Tacrolimus 0.1% Ointment in the Treatment of Intertriginous and/or Anogenital Psoriasis.

    Not yet reported Cairo University 40 participants Est. completion 2027-01-10 1 site
    Other conditions: Psoriasis, Psoriasis Genital
    View official trial listing →
  • Not yet recruiting NCT NCT07893691

    Microbiota Changes Related to Outcomes in Kidney Transplantation

    Hospices Civils de Lyon 30 participants Est. completion 2029-01-15 1 site
    Other conditions: End-stage Renal Disease (ESRD), Kidney Transplantation
    View official trial listing →
  • Not yet recruiting NCT NCT07896928

    Study of Allogeneic Stem Cell Transplant in Myelodysplastic Syndrome Following Conditioning With Fludarabine and Total Body Irradiation 800 cGy

    Not yet reported Ronald Paquette 20 participants Est. completion 2030-12 1 site Stand-alone
    Other conditions: MDS, Myelodysplastic Syndrome MDS, Myelodysplastic Syndrome (MDS), Myelodysplastic Syndrome
    View official trial listing →
  • Not yet recruiting NCT NCT07904780

    Withdrawal Versus Continued TNF Inhibitor Monotherapy Treatment in Children With Inactive Juvenile Idiopathic Arthritis

    Not yet reported Oslo University Hospital 90 participants Est. completion 2030-11-11 3 sites Stand-alone
    Other conditions: Juvenile Idiopathic Arthritis (JIA)
    View official trial listing →
  • Not yet recruiting NCT NCT07919873

    Efficacy of Fractional Co2 Laser With Topical Tacrolimus 0.1 in the Treatment of Nail Psoriasis

    Not yet reported Cairo University 29 participants Est. completion 2027-02
    Other conditions: Nail Psoriasis
    View official trial listing →
  • Not yet recruiting NCT NCT07920055

    Sirolimus-Coated Versus Paclitaxel-Coated Balloon for Recurrent Coronary In-Stent Restenosis After Prior Paclitaxel-Coated Balloon Treatment (SPRIT)

    Not yet reported Sir Run Run Shaw Hospital 106 participants Est. completion 2028-11-30 1 site Stand-alone
    Cardiovascular disease Other conditions: Coronary In-stent Restenosis
    View official trial listing →
  • Completed NCT NCT07931352

    Evaluation of the Effects of Anti-TNF Therapy on the Retina in Patients With Rheumatoid Arthritis and Ankylosing Spondylitis

    Ankara City Hospital Bilkent 53 participants Est. completion 2026-06-23 1 site
    Other conditions: Rheumatoid Arthritis (RA), Ankylosing Spondylitis (AS)
    View official trial listing →
  • Completed NCT NCT07932119

    GLP-1 Receptor Agonists in the Surgical Patient: Prevalence, Epidemiology, and Pulmonary Complications

    University of Virginia 25505 participants Est. completion 2026-02-28 1 site
    Other conditions: GLP-1 Receptor Agonist Treatment
    View official trial listing →
Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources

Also known as: Tacrolimus, Prograf, Prograf (SOC), Islets of Langerhans transplantation, Islets of Langerhan, Basiliximab, Sirolimus, Etanercept, Exenatide

Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.